<<

advancing science, linking people

24th United European Week Vienna, Austria October 15-19, 2016 Venue: Austria Center Vienna

Final Programme Download the UEG Week App

• Create your personal programme itinerary • Watch live-streamed sessions, find floorplans, Industry Sponsored Symposia, Exhibitor profiles and more

Participate in audience voting and Q & A dedicated sessions via the app.

Q & A Tool

advancing science, linking people The Q & A tool is available in the following session rooms: Vienna, Austria October 15-19, 2016 Venue: Austria Center Vienna • Room A • Room E1 • Room B • Room E2 • Room C • Room F1 • Room D • Room F2

Audience Voting Tool

The Audience Voting tool is available in the following session rooms:

Room A, B, C Sat – Sun Room D, E2 Mon – Tue Room E2 Wed

Available at:

UEG Week App incl. Q&A Tool

16_08_Inserat_UEGWEEK_FP_App_160x220mm_RZ.indd 1 13.09.16 15:06 Table of Contents : UEG Week Final Programme

Table of Contents

5 Welcome Address 249 Ultrasound Learning Area

7 About UEG 253 Surgical Learning Area

8 Awards and Grants 257 UEG Evidence Based Medicine Course

13 Scientific Information 261 20th ESGENA Conference

23 Young GI Network 273 Common Interest Group Meetings

27 Scientific Programme Overview 277 Business Meetings

37 Postgraduate Teaching Programme 281 Industry Sponsored Symposia

Scientific Programme by Day 289 Congress Information 46 Monday October 17, 2016 68 Tuesday October 18, 2016 295 Metro Map of Vienna 95 Wednesday October 19, 2016 296 Acknowledgements

Poster Sessions by Day 299 List of Exhibitors and Exhibition Floor Plans 112 Monday October 17, 2016 156 Tuesday October 18, 2016 305 List of Reviewers 201 Wednesday October 19, 2016 311 Index of Authors and Co-Authors

245 ESGE Learning Area 355 Floor Plans Austria Center Vienna

3 Do you have any questions about UEG’s activities and how you can participate or simply want to meet the team?

Week

Education

Research

Journal

Clinical EU Affairs Affairs

Stop by the UEG Booth – your dedicated info hub in the Entrance Foyer or find out more at www.ueg.eu

16_08_Inserat_UEGWEEK_FP_Allg_160x220mm_RZ.indd 1 13.09.16 15:07 Welcome Address : UEG Week Final Programme

Welcome Address from the UEG President to UEG Week Vienna 2016

The United European Gastroenterology Week remains at the heart of UEG’s activities.

Vienna has been our home since 2007, which was firmly In our digital world, it is sometimes said that the need endorsed by the opening of the House of Gastroenter- for meetings like UEG Week will decline. ology in 2012. The development of the scientific pro- gramme for UEG Week 2016 is now complete, and will While there is no doubt that UEG will continue to engage contain some exciting new initiatives which will ensure with advanced digital technologies to enhance learning, that postgraduate education and training in gastroen- notably through the expansion of our activities through terology and remains at the ‘cutting edge’. online learning or the UEG Week Live concept, the need for clinicians and scientists to meet face to face to dis- The importance of high quality continuing profession- cuss clinical innovations and research challenges will, al development has never been more important as the in my opinion, not disappear. The opportunities offered move towards revalidation, or re-licensing, of medical by personal interaction that catalyse new thinking will practitioners becomes more widely adopted. never be replaced by the screen alone!

Although UEG Week is a medical congress firmly based I warmly welcome you in Vienna for UEG Week 2016 in Europe, we are delighted to welcome increasing which I am certain will be another resounding success. numbers of participants from 114 countries from Asia, North and South America, the Middle East, Africa and Australia. Presentation of new research from countries outside Europe enriches our programme and provides the opportunity for European investigators to develop new international research collaborations. Michael Manns UEG President

5 Engage and connect UEG Week Wifi with the community or network: UEG Week simply discover UEG Week at your fingertips wherever you are facebook.com/myueg

CME www.ueg.eu/week/24-7 Credits #uegweek #WeekChat

UEG Week App www.live.ueg.eu/week incl. Q&A Tool

Any open questions? We are happy to help, visit us at the UEG Booth in the Entrance Foyer or send an email to [email protected]

16_08_Inserat_UEGWEEK_FP_new_media_160x220mm_RZ.indd 1 13.09.16 15:03 About UEG and UEG Week : UEG Week Final Programme

About UEG and UEG Week

Mission & Goals Organiser The UEG’s mission is continually to improve standards United European Gastroenterology GmbH of care in gastroenterology, and promote ever greater House of European Gastroenterology understanding of digestive and – among Wickenburggasse 1 the public and medical experts alike. As part of that 1080 Vienna, Austria work, the UEG runs a number of education and train- T +43 1 997 16 39 ing courses facilitated by highly respected experts. They F +43 1 997 16 39 10 also organise UEG Week – the largest and most presti- [email protected] gious meeting of its kind in Europe. UEG Week has been www.ueg.eu running since 1992, in a variety of major cities, and now attracts more than 14,000 people from across the world. UEG Week Official Registration and Housing Agency Mondial Congress & Events UEG is committed to: Operngasse 20b • Raising awareness and expanding knowledge of GI 1040 Vienna and liver diseases among the public and medical pro- Austria fession, to deliver benefits for patients T +43 1 58804 0 • Coordinating the activities of clinical and scientific as- F +43 1 58804 185 sociations in our field [email protected] • Harmonising and improving clinical standards across [email protected] Europe • Fostering basic and clinical research in the field, and raising the profile of this work worldwide • Promoting and delivering excellence in clinical and scientific education.

UEG consisting of 16 Ordinary Member Societies and 46 National Societies is a vibrant organisation that con- stantly adapts to the changing requirements of scientific research and health care.

For detailed information please visit the websites www.ueg.eu/about-ueg/structure/boards-committees/ and www.ueg.eu/about-ueg/who-we-are/

Visit our social media profiles: Like us on Face- book at www.facebook.com/myUEG Tweet us on @my_ueg

7 UEG Week Final Programme : Awards and Grants

Awards and Grants UEG Research Prize

Ernst J. Kuipers UEG Research Prize Winner 2016 Rotterdam, The Netherlands

€ 100,000 Awarded for the most outstanding research programme

The UEG Research Prize is awarded every year for excel- The Prize money will support Ernst J. Kuipers and his lence in basic science, translational or clinical research. team in their continued research in the field of preven- The recipient must be able to demonstrate that the pre- tion and detection of early GI cancer. Professor Kuipers’ vious work has had an impact in its field and that its special interest for his future research consists in risk quality has been recognised internationally. The recip- factors and progression rates of premalignant gastric ient will have produced a substantial body of research lesions to invasive cancer, to identify subjects at highest in a focused area of gastroenterology, hepatology or risk and to learn more about the impact of surveillance related disciplines. and early endoscopic removal of early neoplastic lesions.

Ernst J. Kuipers is awarded the UEG Research Prize 2016 for his outstanding project on “Hidden in plain sight; Award Ceremony at the Opening Session the opportunities for targeted surveillance and inter- Monday, October 17, 2016 // 08:00 – 12:00 vention for early gastric neoplasia”. He is Professor of Room A Medicine and currently serving as CEO of the Erasmus 08:57 – 09:12 Project Presentation and Award Ceremony MC University Medical Center Rotterdam, The Nether- lands, with different ongoing research programmes un- Research Prize 2016: Hidden in plain sight; the oppor- der his direction. tunities for targeted surveillance and intervention for early gastric neoplasia.

8 9 Awards and Grants : UEG Week Final Programme

UEG Lifetime Achievement Award

Günter J. Krejs UEG Lifetime Achievement Award 2016 Graz, Austria

Recipients have proven lifelong excellence and leadership in the field

The UEG Lifetime Achievement Award recognizes out- In 1990, the first multi-society meeting termed European standing individuals whose pioneering and inventive- Digestive Disease Week – the forerunner of today’s UEG ness throughout their careers have improved the Feder- Week – took place in Vienna under his presidency. He ation and inspired others. was also instrumental when seven societies had joined for future cooperation and a new name was generated: Günter J. Krejs has worked in Gastroenterology for 44 UEGF & UEGW (today ‘UEG’ and ‘UEG Week’). Professor years in Switzerland, the United States and Austria Krejs was Chairman of the Coordinating Council of UEGF and has shown outstanding leadership as Department in 1991 when the first meeting under the new name was Chairman for 19 years and as Division Chief GI and prepared for 1992 in Athens. He served on the UEGF Hepatology for 27 years. His research activity is reflected Council to represent EAGE (today EAGEN), one of the by his election to membership in the prestigious Amer- seven founding sister societies, until 1999. ican Society for Clinical Investigation. He has published extensively, several papers appeared in the New En- gland Journal of Medicine, including the first descrip- Award Ceremony at the Opening Session tion of the somatostatinoma syndrome (G.J. Krejs et al., Monday, October 17, 2016 // 08:00 – 12:00 NEJM 1979, 301:285-292). Room A 09:24 – 09:34 Laudation and Presentation of the Award

9 UEG Week Final Programme : Awards and Grants

UEG Journal Best Paper Award

Tara Raftery UEG Journal Best Paper Award 2016 Dublin, Ireland

Recognition of the first-named author for the best original research, published in UEG Journal 2015

UEG Journal provides an international forum for re- Raftery is one of Ireland’s aspiring young researchers search in gastroenterology, publishing original articles with a special interest in IBD. She has published several which describe basic research, translational and clinical peer reviewed articles, book chapters and has presented studies of interest to gastroenterologists and research- work nationally and internationally. After completing her ers in related fields. In 2016, UEG Journal received its scholarship founded PhD at the Trinity College Dublin, first full Impact Factor of 2.93, placing it 32th out of 78 Dr. Raftery is now working as G.I. Research Coordinator titles in the Gastroenterology and Hepatology category in the National Centre for Paediatric Gastroenterology, of the Journal Citation Reports®. Dublin. Her responsibility includes the management of clinical research data for several international Paediatric With the Best Paper Award we recognize the first- IBD studies and the DOCHAS initiative (Determinants and named author of the best original scientific research, Outcomes in Children and Adolescents with IBD) – the published in UEG Journal in the past year. The best sub- first prospective study of paediatric IBD in Ireland. In ad- mitted article is selected by a panel of experts presided dition to IBD she is also co-researcher on studies relating over by Chief Editor Professor Jan Tack. to eosinophilic oesophagitis, long-term total parental nutrition and biliary atresia. The Journal Best Paper Award 2016 is awarded to Tara Raftery (National Centre for Paediatric Gastroenterolo- gy, Our Lady's Children's Hospital, Dublin, Ireland) as Award Ceremony at the Opening Session the first author of the winning article:Effects of vitamin Monday, October 17, 2016 // 08:00 – 12:00 D supplementation on intestinal permeability, cathelicidin Room A and disease markers in Crohn’s disease: Results from a 11:02 – 11:07 Presentation of the Award randomised double-blind placebo-controlled study. The article is available for download at ueg.sagepub.com UEG Journal Best Paper Award 2016: Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study.

10 11 Awards and Grants : UEG Week Final Programme

Travel Grants Rising Star Awards ª UEG offers Travel Grants of € 1,000 to the presenters of UEG National Societies Committee and UEG Scientific the best abstracts submitted to UEG Week. 200 Grants Committee jointly select 6-8 clinical scientists every year, are available to clinicians and scientists, 140 to basic who are awarded with the UEG Rising Stars Award. Se- scientists of 40 years of age or younger. Basic scien- lection is based on a track of international quality tists must be supported by a letter from the Head of research and developing scientific independence. This Department. initiative provides a durable platform for these young All travel grants are awarded based on scientific mer- researchers to further evolve their professional career. it, using the evaluation and review process of the UEG Scientific Committee. Winners are informed once the National Scholar Awards ª notifications of acceptance of abstracts have been an- The National Scholarship is designed to support promis- nounced. ing young investigators at a junior level and to encour- age them to work towards the more senior UEG Rising Poster Champ Award Stars Award. The award recognises the highest scoring Every day during lunch break, the highest scoring post- abstract from every UEG National Member country, ers are presented in the interactive Poster Champ Ses- which is presented by a colleague below the age of 35. sions at the E-poster Terminals of the Scientific Centre. The best presenter of each session receives the Poster Top Abstract Prizes ª Champ Award. Awardees receive a certificate and free The presenting first authors of the top 5 submitted registration to next year’s UEG Postgraduate Teaching abstracts to UEG Week are awarded the Top Abstract Programme. Prize every year. The prize money of € 10,000 is to be spent on future research. In case of industry sponsored International Scholarship Award multi-centre studies, the author is required to waive UEG awards 30 International Scholarships to young the monetary part of the prize. Awarded abstracts must gastroenterologists, aged 40 and below. Awardees neither been previously presented at an international receive € 1,000 to help cover travel expenses and free meeting nor been fully published. registration to UEG Week including the Postgraduate Training Programme. The scholarships are restricted to Oral Free Paper Prizes citizens of countries with a Human Development Index The best presenter of every Free Paper and Poster in (HDI) of less than 0.8 according to the latest Human De- the Spotlight session is awarded this prize. The winners velopment Report. are selected by the session chairs who take the quality of research and the originality of the presented work as well as the presentation itself into account. Prize win- ners receive a certificate of excellence.

International Scholars 2015

11 Wherever you are

We bring the scientific presentations from the lecture halls directly to your screen. Follow the livestream on the UEG website and get updated on the latest GI and liver topics! Visit www.live.ueg.eu/week

Dynamic programme Livestreams including overview on currently Q&A options streaming sessions

UEG Week 24/7 features all recorded

Daily updates sessions from the on our Social Wall previous days

Make ww.ueg.eu your mobile landing page for the complete congress experience

16_08_Inserat_UEGWEEK_FP_uegweeklive_160x220mm_RZ.indd 1 13.09.16 14:59 Scientific Information

UEG Week Final Programme : Scientific Information

Welcome by the Chair Scientific Committee

I would like to welcome all of you to UEG Week 2016 in Vienna – the place to be for clinicians as well as for researchers!

This year’s programme features the latest advances in clinical management, the best research in GI and liver disease and includes several different kinds of symposia and fora, where cutting edge gastroenterology and hepatology is being discussed.

I would like to draw your attention to some of the highlights in 2016:

• The UEG Week Scientific Centre – a place where all • The Translational/Basic Science pathway including possibilities to present an abstract are united, featur- topics that will affect clinical practice within the ing the UEG Week Hotspot, the E-Poster Lounges, the foreseeable future, thereby being attractive for both E-Poster Terminals as well as the poster exhibition. basic/translational scientists and clinicians.

• Again, “Clinical trials revisited” will be a part of UEG • The Young GI Track, where sessions of special inter- Week. These sessions feature a recently published est for young GI fellows will be highlighted in the clinical trial, followed by a critical review and a pan- programme. The mentoring programme will be ex- el discussion with experts in the field. panded additionally.

• Posters in the Spotlight sessions and Poster Champ • Our clinically oriented one-day symposium within Sessions will be completed by an exciting new for- the meeting, entitled “Advances in Clinical Gastro- mat of Clinical Case presentations – the “Exemplary enterology and Hepatology”, focusing on an area clinical cases”. where substantial progress has been made, will be repeated with the topic ‘IBD’. • The following symposia are running in their third year due to their great success: • We also continue our two day “Today’s Science; To- morrow’s Medicine” initiative in 2016 with the topic • Therapy updates, where the current state-of-the-art “Advanced diagnostics for individualised medicine”. treatment options in some of the major GI and liver diseases are presented. • For the prcatical minded, we will again offer the most popular live endoscopy sessions and we will • National Societies Symposia, where differences further extend our Hands-on Training areas: A sur- and similarities in clinical practice, epidemiology gical section will complete the well established en- and guidelines in different parts of Europe will be doscopy and ultrasound learning areas. presented.

14 15 Scientific Information : UEG Week Final Programme

• Wednesday afternoon features the“What’s new E-Posters, quick abstract presentations at the UEG in…?” session, which will again provide delegates Week Hotspot and an impressive poster exhibition – with a comprehensive summary in major areas in GI where researchers and clinicians can meet and discuss and liver disease of recent changes in management, science – will be provided. major research publications and important advances. As you can easily understand from this, UEG Week is the • With the Postgraduate Teaching Programme 2016, place to be for you! the rolling 3-year curriculum is going into its third year. It provides all major updates in GI & hepatolo- gy. A great mix of teaching methods with a focus on interactivity is employed.

• As science remains the most important feature of our meeting, we have again worked hard to offer a large Magnus Simrén number of sessions devoted to original research. Chair of the UEG Scientific Committee

UEG Scientific Committee Thank you!

15 Highlights recommended by the Scientific Chair

Visit the Scientific Centre in Halls X4 and X5 hosting all possibilities to present an abstract

Thrilling symposia and debates at the UEG Week Hotspot This extraordinary setting is home to Abstracts on Fire sessions revealing frontiers in research as well as Clinical trials revisited sessions and most controversial discussions.

Advances in Clinical Gastroenterology and Hepatology This clinically oriented one-day symposium focuses on IBD where substantial progress has been made and which has changed clinical practice. Page 34

Even more exciting poster formats Poster Champ Sessions Poster in the Spotlight Sessions Clinical Cases

Today’s Science; Tomorrow’s Medicine This two day symposium on Advanced diagnostics for individual medicine presents the best basic and translational scientists from around the world. Pages 31, 32

Translational / Basic Science Pathway Presents topics that potentially affect clinical practice within the foreseeable future. Pages 31, 32, 35

Download the app to create your personal programme itinerary

17

16_08_Inserat_UEGWEEK_FP_highlights_160x220mm_RZ.indd 1 13.09.16 16:39 Scientific Information : UEG Week Final Programme

Overview Scientific Programme

Saturday Sunday Monday Tuesday Wednesday October 15, 2016 October 16, 2016 October 17, 2016 October 18, 2016 October 19, 2016

Opening Session

Postgraduate Teaching Programme Symposia

Translational/Basic Science Pathway

Today’s Science; Advances in Clinical Tomorrow’s Medicine (TSTM) GI and Hepatology

UEG Week Hotspot

Live Endoscopy Video Case Session

Free Paper Sessions

Scientific Centre: Poster Exhibition / Poster Champ Sessions / Posters in the Spotlight / Clincial Cases

Round Table Discussions

ESGE Learning Area

Ultrasound Learning Area

Surgical Learning Area

Business Meetings / Common Interest Groups

Industry Sponsored Symposia

Technical Exhibition

20th ESGENA Conference

17 UEG Week Final Programme : Scientific Information

Format Descriptions

Postgraduate Teaching Programme Symposia developed in close collaboration with our The UEG Week Postgraduate Teaching comprises two colleagues from the US, Latin America and will days of world-class continuing medical education for feature again best science from around the world and gastroenterologists in training and in practice. It also promise to be very interesting. To meet the needs of offers established GI physicians and general practi- our young colleagues, some symposia will be bundled tioners profound updates of latest developments in GI into a most attractive Young GI Track in the programme. and hepatology topics. Translational/Basic Science Pathway A great mix of teaching methods with a focus on in- These sessions include topics that will potentially affect teractivity is employed: Session recordings and syllabus clinical practice within the near future, thereby being contributions are available online in our UEG Education attractive for both basic/translational scientists and Library at www.ueg.eu/education/library. clinicians.

In 2016, the three-year rolling curriculum goes into its Interactive Formats 3rd year. The curriculum follows recommendations given The UEG Scientific Committee continuously works on in the EBGH Blue Book. It ensures that delegates who improving session formats used in the programme with attend each of the three years receive teaching and up- the purpose of making symposia modern interactive ex- dates on recent developments in all the main topics in periences. We have once again more Debates, where gastroenterology, hepatology, endoscopy, surgery, imag- two speakers argue opposing cases, and more Tandem ing and other diagnostic modalities. Delegates can start Talks, where experts present different aspects of the the curriculum at any year of the cycle and will receive a same problem. certificate once they have completed all three years. Symposia with a Panel Discussion at the end have also Please see further information on page 37 and following. increased. All speakers will be on stage, take up con- troversial comments and discuss burning questions. Opening Session Panel discussions are great for understanding what the The Opening Session is held on Monday morning and speakers REALLY think! These discussions are always includes official speeches and the opening of the core lively and informative – make sure you stay and see for scientific programme, with a mixture of invited speak- yourself! ers and presentations of the best submitted abstracts. UEG awards the UEG Research Prize, the UEG Lifetime Finally, we also continue to encourage wide use of cas- Achievement Award and the UEG Journal Best Paper es to illustrate talks and anchor them in medical expe- Award at the Opening Session. rience. For all these sessions we work hard to improve our faculty instructions to increase interactivity with the Symposia audience, by interactive chairing and encouraging au- Interdisciplinary symposia cover new approaches to di- dience voting. agnosis and treatment, and place major emphasis on innovative, technical advances in the non-invasive man- Today’s Science; Tomorrow’s Medicine agement of gastrointestinal and hepatic disorders and UEG Week Vienna hosts again the two-days “Today’s translational/basic science, including state-of-the-art Science; Tomorrow’s Medicine” initiative in the main lectures. Therapy updates on latest treatment options, programme. In 2016, the theme is “Advanced diagnos- guidelines in clinical practice, and the one-day sympo- tics for individualised medicine”. sium Advances in Clinical GI and Hepatology on ‘IBD’ on Wednesday present the hot topics in 2016. Top class scientists have been invited to discuss how the current stage of knowledge is ready to be used in clini- The National Societies Symposia on optimising clinical cal practice, and to establish strategies to foster further trials, oesophageal cancer and C therapy ad- progression of knowledge in this area. The Today’s Sci- dress the differences and similarities in clinical practice, ence; Tomorrow’s Medicine symposium is a combina- epidemiology, guidelines etc. in different parts of Eu- tion of both, invited sessions featuring the world’s top rope – controversial discussions can be expected! scientists and free paper sessions where work is pre- sented by young and established researchers.

18 19 Scientific Information : UEG Week Final Programme

This special initiative is open to all UEG Week delegates Free Paper Sessions at no extra cost and provides a unique platform for gas- The most important feature of UEG Week is science and troenterologists and hepatologists to learn how this im- we are constantly trying to attract the best science to portant field will impact their discipline. our meeting. This is recognised in the core programme with a large number of Free Paper Sessions devoted to UEG Week Hotspot original research, and an impressive number of mixed The UEG Week Hotspot is THE place to be at UEG Week sessions where invited talks and free paper presen- 2016, where the most controversial sessions, hottest tations alternate. Both of these session formats allow debates and interactive abstract discussions will take lively discussions about the best original research sub- place. These sessions promise to be most intense! mitted to UEG Week and this is your opportunity to hear about GI and liver research in Europe and worldwide Heated discussions of the UEG “Abstracts on Fire” (Fron- before it is published. tiers In REsearch) and breaking news will be launched and sessions such as “A survivors guide for a happy Posters in the Spotlight and successful career in Gastroenterology”, “Moving Posters in the Spotlight sessions boost science even GI education into the future: Current challenges, future further and have become a fixture at UEG Week. UEG needs” and “Drug development for digestive diseases: promotes hot topic research and gives poster present- From clinical needs to regulatory perspectives”, – a ers additional exposure on stage. Poster presenters are joint UEG-EMA symposium – take place at this center invited to present their work on an E-Poster Terminal in stage of UEG Week. Also featured at the Hotspot are the the E-Poster Lounges. The following intensive discus- Clinical trials revisited sessions, where the latest results sion is led by two moderators and experts in the field. from recent large clinical trials will be presented and The Posters in the Spotlight are an excellent platform discussed by experienced investigators. Do not miss to for in-depth scientific exchange with faculty and peers pass by this high-tech scientific environment and attend in a relaxed atmosphere and present an ideal oppor- these exciting sessions taking place from Monday until tunity to assist highly interactive and expert-led poster Wednesday! presentations. Access is open to all congress delegates. So do pass by the E-Poster Lounges, sit down on one of Live Endoscopy the cubes and question the researchers directly. Live endoscopy is included in the core programme on Tuesday. Top international experts demonstrate cutting- edge techniques alongside basic procedures trans- mitted directly from the Hôpital Erasme in Brussels to the auditorium. The use of multiple parallel cases and experienced chairs ensure interactive learning without unnecessary gaps.

Improve your practical skills on Level 1 Visit the ESGE (training in cooperation with ESGENA), the Ultrasound and the Surgical Learning Areas. Find more information on pages 245-256

16_08_Inserat_UEGWEEK_FP_handson_136x62mm_RZ.indd 1 16.09.16 12:3619 UEG Week Final Programme : Scientific Information

Poster Exhibition/E-Posters Round Table Discussions Poster Sessions feature a very spacious room layout Due to their great success in previous years, Round and poster format. Printed posters are displayed and Table Discussions will again take place during lunch changed daily from 10:30 – 17:00 (Mon), 09:00 – 17:00 break. For each of these sessions we have invited four (Tue) and 09:00 – 14:00 (Wed) in Hall X4 and X5. experts who will discuss a common clinical situation based on a case presentation. The discussion of clinical cases during daily poster ses- sions offer the presenters a relevant platform for de- The Round Table Discussions take place between 12:45 bating difficult clinical problems. These posters will be and 13:45 each day and no extra charge applies. There visited by a panel of multidisciplinary experts who will are four sessions each on Monday, Tuesday and Wednes- comment on the clinical presentation and management day in the Rooms G, K, L7 and L8. There is no pre-booking strategies each day in the poster exhibition from 12:30 – required but come early as there are limited seats which 14:00. Furthermore, we will launch the Exemplary clin- will be filled on a first-come, first-served basis. ical cases on Tuesday, where clinical cases get additonal exposure by presenting their intriguing case orally at ESGE Learning Area the E-Poster Terminals in the E-Poster Lounges I and II. The ESGE Learning Area incorporates different educa- tional formats in order to provide both beginner en- All accepted posters also have the opportunity to get doscopists as well as proven experts a platform for skill published electronically in addition to the printed post- enhancement and professional discourse. In coopera- er. All E-Posters which were uploaded prior to UEG tion with ESGENA, the Hands-on Training Centre gives Week can be searched for and viewed on the six E-Post- practical insight into basic and advanced endoscopic er Terminals in the poster exhibition, from Monday until techniques. Participants can test their skills under the Wednesday. E-Posters allow all poster presenters to in- guidance of expert doctor and nurse tutors. Lively talks clude interactive media files, such as radiology images, between young experts and established senior discus- endoscopy videos, etc. sants are held in the Lecture Theatre where debate on the how and why of current procedures prompts audi- Poster Champ Sessions ence involvement. Video teaching is an essential part The Poster Champ Sessions have proven to be a sur- of endoscopy training. The DVD Learning Centre shows rounding success. Consequently, we will run four Poster continuous films from the ESGE eLibrary and also in- Champ Sessions in parallel from Monday until Wednes- cludes videos contributed by the ASGE and JGES. The day from 12:30 – 13:30. 2-minutes presentations of the Learning Area is open to all delegates during the gen- highest scoring posters will be given at the E-Poster eral opening hours of the congress. Terminals in the poster exhibition, followed by 3-min- utes Q&As from the chairs. The Poster Champ of each Please see further information on page 245 and following. session will be awarded during the official award cer- emony at the E-Poster Lounge I at 13:45 each day. All The Ultrasound Learning Centre (ULC) Poster Champs get a certificate and free registration to Please see further information on page 249 and following. the Postgraduate Teaching Programme of next year’s UEG Week in Barcelona. Poster Champ Sessions are Surgical Learning Area open to all delegates. Please see further information on page 253 and following.

Please see further information on page 112 and following. Business Meetings > upon invitation only Video Case Session Association, board and committee meetings for The Video Case Session is an excellent platform for brief elected (UEG) leadership. information on recent issues of endoscopy. During this Please see further information on page 277. session short videos showing examples of new, unex- pected or exceptional endoscopic practice are present- Common Interest Group Meetings ed and briefly discussed. Thus, the Video Case Session > open to all delegates presents unusual cases or new technologies based on Activities taking place outside of the core scientific diagnostic and therapeutic endoscopy. programme and open to all UEG Week delegates. Please see further information on page 273.

20 21 Scientific Information : UEG Week Final Programme

ESGENA Conference Disclosure Policy The Conference of the European Society of Gastroenter- ology and Endoscopy Nurses and Associates (ESGENA) UEG is committed to ensuring scientific rigour and ob- is an associated meeting at the congress with separate jectivity in all of its educational activities. These include scientific programme and registration. all aspects of the educational programme at UEG Week including those that are directly and jointly sponsored Please see further information on page 261. activities.

All presenters, whether invited faculty or abstract pre- Other Scientific Information senters, are required to disclose to those organising and attending meetings any relevant financial or other EACCME – Continuing Medical Education relationship that may lead to a potential bias. UEG re- “UEG Week Vienna 2016” is accredited serves the right to review the information disclosed for by the European Accreditation Council potential conflicts of interest. Please note that the sole for Continuing Medical Education (EAC- responsibility for the content of each presentation lies CME) to provide the following CME activ- with the presenting author. ity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), The UEG Scientific Committee requires all presenters to www.uems.net. disclose any financial relationship with or any adviso- ry role in the Biomedical Industry and the Biomedical “UEG Week Vienna 2016” is designated for a max- Technology Industry during the past two years. These imum of 28 hours of European external CME credits. and any other potential conflicts of interest should be Each medical specialist should claim only those hours disclosed during introductory comments to the presen- of credit that he/she actually spent in the education- tation. al activity. Full congress days count for 6 credits, half congress days for 3 credits. A maximum of 28 European Invited speakers and oral abstract presenters are re- CME credits can be obtained. quested to disclose potential conflicts of interest on a PowerPoint slide to be shown immediately at the be- Through an agreement between the European Union ginning of the presentation. Poster presenters are re- of Medical Specialists and the American Medical Asso- quested to disclose potential conflicts of interest at the ciation, physicians may convert EACCME credits to an bottom of their poster. equivalent number of AMA PRA Category 1 Credit™. Information on the process to convert EACCME credit Conflicts of interest may exist through a financial rela- to AMA credit can be found at www.ama-assn.org/go/ tionship or when the individual has the opportunity to internationalcme. influence the content of a presentation, and can involve grants, honoraria, shares, paid positions on advisory Live educational activities, occurring outside of Cana- boards, etc. Conflicts of interest are frequent and ex- da, recognised by the UEMS-EACCME for ECMEC credits pected, and do not preclude an individual from giving a are deemed to be Accredited Group Learning Activities presentation providing the conflict is disclosed. If there (Section 1) as defined by the Maintenance of Certifica- is any doubt about the relevance of a potential conflict tion Programme of The Royal College of Physicians and of interest UEG requires all presenters to err on the safe Surgeons of Canada. side and to disclose it.

In order to obtain CME credits, UEG requires feedback on its educational activities. Therefore, we kindly ask all delegates to complete the online evaluation form, which can be found on the UEG Week website as of Wednesday, October 19, after conclusion of UEG Week 2016. The CME Certificate of EACCME will be available for download after completion of the online evaluation.

21 Participation Young GI Young Talent in other UEG Lounge at UEG Group Committees Week

Job Networking Corner Events

Online Postgraduate Standards Library Teaching & Guidelines at UEG Week

Classroom Online Courses Courses

Networking & Exchange Travel Grants for Education UEG Week

How can we support your Grants Research career? Prize

International Scholarship Award

Research & Science

Your work presented in the spotlight Mentoring Abstract based Awards

Journal Best Paper Award Visiting Mentoring Guided Rising Star Fellowship Programme Poster Tours Award Programme

Poster Recognition Prizes Find out more, visit www.ueg.eu

16_08_Inserat_UEGWEEK_FP_SupportYourCareer_160x220mm_RZ.indd 1 13.09.16 15:01 Young GI Network

This initiative provides young delegates with the oppor- tunity to network, exchange scientific ideas and discuss the congress programme with peers and senior experts. All delegates up to the age of 40 are invited to access the lounge and to participate in the activities.

Young GI Lounge This comfortable area on Level 0 is the place to meet for trainees and fellows at UEG Week. Form new collabora- tions over a cup of coffee, meet UEG Young Talent Group members, and senior experts in the field, and attend special sessions for young delegates.

Opening hours Saturday October 15 09:00 – 17:00 Sunday October 16 09:00 – 17:00 Monday October 17 09:00 – 18:00 Tuesday October 18 09:00 – 18:00 Wednesday October 19 09:00 – 14:00

Mix and mingle in the Young GI Lounge on Level 0! New friends, scientific exchange and coffee are waiting for you!

Access is granted to UEG Week delegates below the age of 40 and dedicated Young GI Network mentors.

Join the Young GI Network on facebook Find out more on www.ueg.eu/week

25

16_08_Inserat_UEGWEEK_FP_YoungGI_160x220mm_RZ.indd 1 13.09.16 14:58 Scientific Information : UEG Week Final Programme

Young GI Network

Young GI Mentoring Programme 15:45 – 17:15 E-Poster Lounge Young congress participants will have the possibility to Optimising the patient-provider relationship using network with senior experts and receive scientific guid- effective communication techniques ance by participating in a mentoring programme on Chair: Douglas Drossman Monday and Tuesday. Delegates who have registered for this programme pri- Young GI Network - Let's meet! or to the congress are asked to meet with their mentors Sunday, October 16 19:00 – 24:00 Wolke 19 in the Young GI Lounge: This special event for young congress delegates takes place Monday, October 17 > 10:00 – 10:30 // 12:00 – 13:00 in Wolke 19 and provides an informal atmosphere to net- Tuesday, October 18 > 08:00 – 08:30 // 12:00 – 13:00 work with colleagues and mentors and to exchange scien- tific ideas. Admission is restricted to ticket holders, please Remaining spots in this programme can be booked onsite present your ticket and congress badge at the entrance. at the Young GI Lounge on a first-come first-served basis. Young GI Network – Let’s tweet! Guided Poster Tours We invite all congress delegates and interested clini- Come to the Poster Service Desk (Hall X4) to join one of cians and researchers to follow and participate in our the groups and review posters in your field of interest to- moderated Twitter discussion at #UEGWeek. Join in the gether with a senior expert. No registration is required. discussion, ask the experts or express your point of view by using the hashtag #Weekchat in your tweets: Monday October 17 12:30 – 13:30 Sunday October 16 13:00 – 14:00 Tuesday October 18 12:30 – 13:30 Career Tips for Young Endoscopists Wednesday October 19 12:30 – 13:30 Expert: Peter Siersema Moderator: Mostafa Ibrahim Young GI Sessions Be part of an interactive session on communication Come to the Young GI Lounge and meet your fellow techniques, discuss the future of GI education, listen to tweeters personally: Rising Star’s presentations, learn from female experts Tuesday October 18 17:15 – 18:00 about their career paths in GI, and learn more about Tweet Up – Meet your peers, extend your the UEG Visiting Fellowship Programme and how you Network can participate! Moderator: Werner Dolak

Monday, October 17 Young GI Track 12:15 – 13:15 Hotspot This part of the UEG Week Pathways Tool will highlight Moving GI education into the future: Current challenges, recommended sessions for young gastroenterologists future needs and scientists from the huge choice that our scientific Chairs: Heinz F. Hammer, Isabelle Cremers programme at UEG Week Vienna offers. The UEG Week Pathways Tool is available as part of the UEG Week App 13:00 – 14:00 Young GI Lounge and as pdf on our website for download. Career Chat: Meet the women who broke the glass ceiling Moderators: Nurdan Tözün, Madaline Ilie Meet the Web Editors Take the opportunity to meet the UEG Education Web 15:45 – 17:15 E-Poster Lounge 2 Editors in the Young GI Lounge. Learn how to engage Rising Stars in IBS from Europe and the USA with UEG E-learning activities, share your ideas, and Chairs: Luigi Ricciardiello, Deborah Denise Proctor become part of the GI learning community.

Tuesday, October 18 Tuesday October 18 10:00 – 10:30 13:00 – 14:00 Young GI Lounge Wednesday October 19 12:30 – 13:00 Visiting Fellowship Programme Information Meeting

25 Larger funds than ever for researchers – How to get your share?

Join our HORIZON 2020 session!

Horizon 2020, the present EU Framework Programme for Research and Innovation, holds € 80bn support MONDAY for researchers. October 17, 2016 Co-chaired by UEG President Michael Manns, the 15:45 – 17:15 session will feature experts from European institutions, Location: E-Poster national contact points and successful grant holders Lounge 1 in to provide you with knowledge and tips how to get at the funds. Page 66 Hall X4

Find out more, visit www.ueg.eu/eu-affairs

16_08_Inserat_UEGWEEK_FP_Horizon_160x220mm_RZ.indd 1 13.09.16 16:52 Scientific Programme Overview

UEG Week Final Programme : Scientific Programme Overview

Postgraduate Teaching Programme Overview

Saturday, October 15, 2016 Room A Room B Room C Room E1 Level 1 Voting Room Voting Room Voting Room Plenary I : Still important for

09:00 – 10:30 gastroentero- logists in 2016? 10:30 – 11:00 Coffee Break Video Case Parallel Session Session

Video Case Update on Proctology for Alcohol- ESGE Surgical Ultrasound Session I: ERCP Barrett‘s the practical related liver Learning Learning Learning in normal and oesophagus gastroentero- disease: Area Area Area 11:00 – 13:00 post-surgical logist Treatment and anatomy prevention 09:00 – 18:00 09:00 – 18:00 09:00 – 18:00 13:00 – 14:00 Lunch Break Video Case Parallel Session Session Video Case Multidiscip- Primary Scleros- Chronic Session II: linary ing Cholangitis : ESGENA Diagnosis and management (PSC) and From bench management of colorectal Primary Biliary to bedside 14:00 – 17:30 14:00 – 16:30 of early neo- cancer (PBC): plasia in the Pearls for the upper GI tract clinician

Sunday, October 16, 2016 }} Room A Room B Room C Room E1 Room E2 Room M Room N1 Room N2 Room L8 Room 1.86 Level -2 Level 1 Voting Room Voting Room Voting Room Parallel Session Acute – How to improve Hot topics in chro- Therapy update: Optimal manage- medical and quality in endos- nic ment of swallow–

08:30 – 10:30 surgical therapy copy ing disorders in 2016

10:30 – 11:00 Coffee Break 10:30 – 11:00 Coffee Break Clinical Case Based Session Clinical Case Based Session ESGE Surgical Ultrasound IBD: Usefulness of Small bowel Gastric polyps: Diverticular Complications of Fulminant Autoimmune Obstruction Endocrine Management ESGENA Learning Learning Learning symptoms and ob– tumours – rare Diagnostic and disease: Medical liver cirrhosis hepatitis and liver liver disease: and tumours: What the of weight loss Area Area Area jective markers in entities and how therapeutic and surgical transplantation Diagnosis and gastroenterologists and loss of 09:00 – 18:30 11:00 – 13:00 disease monitoring to find them approach management treatment need to know appetite 09:00 – 18:00 09:00 – 18:00 09:00 – 18:00 13:00 – 14:00 Lunch Break 13:00 – 14:00 Lunch Break Plenary II Management of : Current and future 14:00 – 16:00 treatment 16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia 16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia

28 29 Scientific Programme Overview : UEG Week Final Programme

Missed a session? Watch it on www.ueg.eu/week/24-7

}} 16_08_Inserat_UEGWEEK_FP_24_7_136x96mm_RZ.indd 1 14.09.16 15:49 Room A Room B Room C Room E1 Room E2 Room M Room N1 Room N2 Room L8 Room 1.86 Level -2 Level 1 Voting Room Voting Room Voting Room Parallel Session Acute colitis – How to improve Hot topics in chro- Therapy update: Optimal manage- medical and quality in endos- nic pancreatitis Hepatitis C ment of swallow–

08:30 – 10:30 surgical therapy copy ing disorders in 2016

10:30 – 11:00 Coffee Break 10:30 – 11:00 Coffee Break Clinical Case Based Session Clinical Case Based Session ESGE Surgical Ultrasound IBD: Usefulness of Small bowel Gastric polyps: Diverticular Complications of Fulminant Autoimmune Obstruction Endocrine Management ESGENA Learning Learning Learning symptoms and ob– tumours – rare Diagnostic and disease: Medical liver cirrhosis hepatitis and liver liver disease: and ileus tumours: What the of weight loss Area Area Area jective markers in entities and how therapeutic and surgical transplantation Diagnosis and gastroenterologists and loss of 09:00 – 18:30 11:00 – 13:00 disease monitoring to find them approach management treatment need to know appetite 09:00 – 18:00 09:00 – 18:00 09:00 – 18:00 13:00 – 14:00 Lunch Break 13:00 – 14:00 Lunch Break Plenary II Management of ulcerative colitis: Current and future 14:00 – 16:00 treatment 16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia 16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia

29 UEG Week Final Programme : Scientific Programme Overview

Scientific Programme Overview Monday, October 17, 2016 }} Scientific Centre (Hall X4, X5)

Room A Room D Room B Room C Room E1 Room E2 Room F1 Room F2 Room G Room K Room M Room Room N1 Room N2 Room L7 Room L8 Room 1.86 E-Poster E-Poster Hotspot Level 1 Voting Room Voting Room 1.61/1.62 Lounge 1 Lounge 2

07:00 – 08:00 Industry Sponsored Symposia 07:00 – 08:00 Industry Sponsored Symposia

Opening Session: Part 1 08:00 – 10:00

Symposium Free Paper Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Symposium Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Posters in Posters in Free Paper Session Session Basic Science Session Session Session Session the Spotlight the Spotlight Session Post-operative Established Is mass Clinical ma- Update on Quality Food intake, An update on Improvements Hot topics Prevention of A new era of New Mechanisms Basic me- Gastroduo- Disease Gastroe- Abstracts on Opening management and new drugs eradication nagement of chronic indicators in metabolic the manage- of endoscopic from Latin GI cancers: imaging in GI perspectives of Primary chanisms of denal damage: mechanisms sophageal Fire: GORD Session: Part 2 of Crohn's in IBD of H. pylori extraintestinal pancreatitis upper GI disorders and ment of resection America Nutrition and diseases in diagnostic Sclerosing intestinal car- H. pylori, acid in inflamma– reflux dis– on Fire 10:30 – 12:00 10:30 10:30 – 12:00 10:30 disease rational? symptoms in GI endoscopy: endoscopy hepatocellular techniques in chemopreven- and thera- Cholangitis cinogenesis and bile tory bowel ease: From diseases Ready for carcinoma the colon tion peutic EUS disease mechanisms prime time? to treatment

RTD* RTD* RTD* RTD* Posters in Symposium 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 the Spotlight 12:15 – 13:15 How to use Colonoscopic Optimal Bacterial 13:45 Moving GI FODMAPs and surveillance management infections in Poster education other diets in strategies of gastric end stage Champ into the fu-

your clinical cardia cancers liver disease 12:00 – 14:00 Award ture: Current ESGE Surgical Ultrasound practice? Ceremony challenges, Learning Learning Learning future needs Area Area Area 12:00 – 14:00 Lunch Break 12:00 – 14:00 Lunch 09:00 – 18:00

Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Free Paper Free Paper Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Posters in Posters in Symposium Session Session Session Basic Science Session Session Session Session the Spotlight the Spotlight Best of DDW Management Therapy Endoscopy Improving Management Japanese Liver diseases Long-term Microbiota Late Breaking IBD: The Free Paper From What is new Gastric Basic Irritable Advances in Clinical Trials of bloating and update: performance the adenoma of oesophageal European beyond management and diet: Abstracts I role of Session: The symptoms in gastric function in mechanisms Bowel therapeutic Revisited: flatulence Therapeutic measures: detection rate motility perspectives: alcohol, fatty of IBD From bench to different cell future of to diagnosis Endoscopic health and in pancreatic Syndrome: upper GI Practice EUS – New What you disorders Endoscopic liver and viral bedside types in the diagnostics in IBS Submucosal disease cancer What can we endoscopy changing 14:00 – 15:30 14:00 – 15:30 indications should be classifications hepatitis inflammatory in hepatology Dissection learn from trials in doing update process and upper GI (ESD) epidemiolog- pancreato- diseases ical studies? logy Symposium Symposium Symposium Free Paper Symposium Symposium Symposium Symposium Symposium Free Paper Free Paper Translational/ Free Paper Free Paper Free Paper Free Paper Free Paper Symposium Symposium Symposium Session Session Session Basic Science Session Session Session Session Session Rome IV: New Update on viral Therapy Future drugs Non-bleeding Interventional Autoimmune Endoscopy Management Hot topics in Late Breaking Novel models Can we detect Upper GI Endoscopic Hepatic cysts Mechanisms Horizon 2020 Rising Stars Compli- diagnostic hepatitis 2016 update: in IBD emergencies ultrasound: pancreatobili- meets of early rectal ERCP Abstracts II for GI diseases inflammatory nerve-gut management and hepa- of liver cancer in IBS from cations of criteria for Transluminal of the oeso- See what you ary disease pathology: tumours GI diseases interactions of upper gast- to- and portal Europe and cirrhosis: functional GI endoscopy in phagus do! Polyps and early? rointestinal disorders hypertension the USA Which

15:45 – 17:15 15:45 disorders the upper GI polyposis cancer – 17:15 15:45 prophylaxis tract – From syndromes in should we bench to the upper GI use ? clinical practice tract 17:45 – 19:15 Industry Sponsored Symposia 17:45 – 19:15 Industry Sponsored Symposia

* RTD – Round Table Discussions / TSTM – Today’s Science; Tomorrow’s Medicine 30 31 Scientific Programme Overview : UEG Week Final Programme

}} Scientific Centre (Hall X4, X5)

Room A Room D Room B Room C Room E1 Room E2 Room F1 Room F2 Room G Room K Room M Room Room N1 Room N2 Room L7 Room L8 Room 1.86 E-Poster E-Poster Hotspot Level 1 Voting Room Voting Room 1.61/1.62 Lounge 1 Lounge 2

07:00 – 08:00 Industry Sponsored Symposia 07:00 – 08:00 Industry Sponsored Symposia

Opening Session: Part 1 08:00 – 10:00

Symposium Free Paper Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Symposium Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Posters in Posters in Free Paper Session Session Basic Science Session Session Session Session the Spotlight the Spotlight Session Post-operative Established Is mass Clinical ma- Update on Quality Food intake, An update on Improvements Hot topics Prevention of A new era of New Mechanisms Basic me- Gastroduo- Disease Gastroe- Abstracts on Opening management and new drugs eradication nagement of chronic indicators in metabolic the manage- of endoscopic from Latin GI cancers: imaging in GI perspectives of Primary chanisms of denal damage: mechanisms sophageal Fire: GORD Session: Part 2 of Crohn's in IBD of H. pylori extraintestinal pancreatitis upper GI disorders and ment of resection America Nutrition and diseases in diagnostic Sclerosing intestinal car- H. pylori, acid in inflamma– reflux dis– on Fire 10:30 – 12:00 10:30 10:30 – 12:00 10:30 disease rational? symptoms in GI endoscopy: endoscopy hepatocellular techniques in chemopreven- and thera- Cholangitis cinogenesis and bile tory bowel ease: From diseases Ready for carcinoma the colon tion peutic EUS disease mechanisms prime time? to treatment

RTD* RTD* RTD* RTD* Posters in Symposium 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 the Spotlight 12:15 – 13:15 How to use Colonoscopic Optimal Bacterial 13:45 12:00 – 14:00 Moving GI FODMAPs and surveillance management infections in Poster Poster education other diets in strategies of gastric end stage Champ Sessions into the fu-

your clinical cardia cancers liver disease 12:00 – 14:00 Award ture: Current ESGE Surgical Ultrasound practice? Ceremony challenges, Learning Learning Learning future needs Area Area Area 12:00 – 14:00 Lunch Break 12:00 – 14:00 Lunch 09:00 – 18:00

Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Free Paper Free Paper Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Posters in Posters in Symposium Session Session Session Basic Science Session Session Session Session the Spotlight the Spotlight Best of DDW Management Therapy Endoscopy Improving Management Japanese Liver diseases Long-term Microbiota Late Breaking IBD: The Free Paper From What is new Gastric Basic Irritable Advances in Clinical Trials of bloating and update: performance the adenoma of oesophageal European beyond management and diet: Abstracts I role of Session: The symptoms in gastric function in mechanisms Bowel therapeutic Revisited: flatulence Therapeutic measures: detection rate motility perspectives: alcohol, fatty of IBD From bench to different cell future of to diagnosis Endoscopic health and in pancreatic Syndrome: upper GI Practice EUS – New What you disorders Endoscopic liver and viral bedside types in the diagnostics in IBS Submucosal disease cancer What can we endoscopy changing 14:00 – 15:30 14:00 – 15:30 indications should be classifications hepatitis inflammatory in hepatology Dissection learn from trials in doing update process and upper GI (ESD) epidemiolog- pancreato- diseases ical studies? logy Symposium Symposium Symposium Free Paper Symposium Symposium Symposium Symposium Symposium Free Paper Free Paper Translational/ Free Paper Free Paper Free Paper Free Paper Free Paper Symposium Symposium Symposium Session Session Session Basic Science Session Session Session Session Session Rome IV: New Update on viral Therapy Future drugs Non-bleeding Interventional Autoimmune Endoscopy Management Hot topics in Late Breaking Novel models Can we detect Upper GI Endoscopic Hepatic cysts Mechanisms Horizon 2020 Rising Stars Compli- diagnostic hepatitis 2016 update: in IBD emergencies ultrasound: pancreatobili- meets of early rectal ERCP Abstracts II for GI diseases inflammatory nerve-gut management and hepa- of liver cancer in IBS from cations of criteria for Transluminal of the oeso- See what you ary disease pathology: tumours GI diseases interactions of upper gast- to-biliary tract and portal Europe and cirrhosis: functional GI endoscopy in phagus do! Polyps and early? rointestinal disorders hypertension the USA Which

15:45 – 17:15 15:45 disorders the upper GI polyposis cancer – 17:15 15:45 prophylaxis tract – From syndromes in should we bench to the upper GI use ? clinical practice tract 17:45 – 19:15 Industry Sponsored Symposia 17:45 – 19:15 Industry Sponsored Symposia

31 UEG Week Final Programme : Scientific Programme Overview

Scientific Programme Overview Tuesday, October 18, 2016 }} Scientific Centre (Hall X4, X5)

Room A Room D Room B Room C Room E1 Room E2 Room F1 Room F2 Room G Room K Room M Room 1.61/1.62 Room N1 Room N2 Room L7 Room L8 Room 1.86 E-Poster E-Poster Hotspot Level 1 Voting Room Voting Room Lounge 1 Lounge 2

07:00 – 08:00 Industry Sponsored Symposia 07:00 – 08:00 Industry Sponsored Symposia Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Free Paper Free Paper Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Symposium Session Session Session Basic Science Session Session Session Session

Intestinal and Therapy Challenging Management Management Quality in Advanced Optimising Drug-induced Outcomes Liver fibrosis: Free Paper Improving Surgery in IBD GI infections Colon Exemplary Exemplary Diagnosis of Live extra-intestinal update: situations in of GI and liver of Barrett's ERCP: It is how pancreato- anti-TNF upper GI in Peroral From Session: Novel detection of from cancer: From clinical clinical IBS: What is endoscopy cancers in IBD Functional diagnosis and diseases oesophagus: you do it that biliary imaging therapy bleeding Endoscopic mechanism diagnostic tools: polyps mechanisms screening to cases I cases II the prefered 09:00 – 10:00 08:30 – 10:00 upper GI treatment during The gold counts Myotomy to therapy Going deeper to treatment palliation strategy? syndromes of acute pregnancy standard (POEM) and deeper pancreatitis into the bowel Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Symposium Free Paper Free Paper Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Posters in the Posters in the Free Paper Session Session Session Basic Science Session Session Session Session Spotlight Spotlight Session Does my Therapy IBD in young Prevention and From Colon cancer: Complications Detection and Colorectal can- : Structural Bringing mole- Improving Barret‘s Accuracy Small bowel Imaging and Optimising Abstracts on Live patient really update: people early diagnosis guidelines More than one in IBD management cer screening: Natural history changes in cular tests to GI detection and associated in upper GI disease and interventional the use of Fire: GI: endoscopy have GORD? Constipation of pancreatic to clinical disease? of serrated State-of-the- and treatment functional cancer clinics treatment of neoplasia endoscopy nutritional radiology in colonoscopy All about cancer practice: Portal lesions of the art GI disorders: colonic polyps therapy liver diseases in clinical microbiota? 10:30 – 12:00 10:30 10:30 – 12:00 10:30 hypertensive colorectum Time to remo- settings bleeding the term „functional“?

RTD* RTD* RTD* RTD* Posters in the Symposium 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 Spotlight 12:15 – 13:15 Multidiscipli- Challenges in Peptic ulcer Cystic 13:45 Drug develop- Ul- nary treatment ERCP disease: pancreatic Poster ment for ESGE Surgical trasound of IBS patients Pharma- tumours: Champ Award digestive Learning Learning Learning with cological, Biopsy, Ceremony diseases: From Area Area 12:00 – 14:00 Area

comorbidities endoscopic follow-up or clinical needs 09:00 – 18:00 and surgical resect? to regulatory

12:00 – 14:00 Lunch Break 12:00 – 14:00 Lunch treatment perspectives

Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Free Paper Translational/ TSTM* Symposium Free Paper Free Paper Free Paper Posters in the Posters in the Symposium Session Session Basic Science Session Session Session Spotlight Spotlight From Therapy National Socie- Liver nodules Endoscopic What to do Functional Improving Biomarkers Clinical trials Intestinal New tests for Hot topics in Intestinal Prognostic General Clinical Colorectal Clinical Trials Live guidelines update: Colon ties Symposia: in different treatment of with small GI symptoms early diagnosis in IBD in functional microbiota treatment pancreatology failure: From factors in hepatology aspects on cancer: Dia- Revisited: endoscopy to clinical cancer Case finding clincial complications colorectal in organic of upper GI GI disorders in health and stratification in pathways to lower GI acute and gnostic and IBD – Can it practice: strategies and situations after upper GI polyps? diseases cancer disease GI cancer treatment cancer chronic therapeutic be cured with 14:00 – 15:30 14:00 – 15:30 Complex IBD access to hep C surgery pancreatitis. aspects transplanta- cases therapy across tion? Europe Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Symposium Free Paper Session Basic Science Session Session Session Session Session Management From Therapy Resection and Visualising National Socie- NAFLD-NASH: East meets Rectal cancer: Late Breaking Mitochondria New diagnostic Pathophysiology (Epi)Genetics Novel The intestinal Optimising Abstracts on of refractory guidelines Update: ablation of small bowel ties Symposia: for the Where are we West: Organ Abstracts III and the and therapeutic of IBS in IBD techniques epithelium the patient- Exemplary Fire: Acute Crohn's to clinical Challenges in early neoplastic diseases Optimising clinician going? Same disease, preserving digestive tools in GI in lower GI - Stem cells, provider clinical pancreatitis: disease practice: H. biliary stone Barrett's: What clinical trials different strategies system diseases: malignancies inflamation relationship cases III From 15:45 – 17:15 15:45 pylori management is the best by networking clinical pat- Gimmicks or and cancer – 17:15 15.45 using effective mechanisms approach? – LINKing up terns adding value communicati- to disease Europe on techniques 17:45 – 19:15 Industry Sponsored Symposia 17:45 – 19:15 Industry Sponsored Symposia * RTD – Round Table Discussions / TSTM – Today’s Science; Tomorrow’s Medicine 32 33 Scientific Programme Overview : UEG Week Final Programme

}} Scientific Centre (Hall X4, X5)

Room A Room D Room B Room C Room E1 Room E2 Room F1 Room F2 Room G Room K Room M Room 1.61/1.62 Room N1 Room N2 Room L7 Room L8 Room 1.86 E-Poster E-Poster Hotspot Level 1 Voting Room Voting Room Lounge 1 Lounge 2

07:00 – 08:00 Industry Sponsored Symposia 07:00 – 08:00 Industry Sponsored Symposia Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Free Paper Free Paper Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Symposium Session Session Session Basic Science Session Session Session Session

Intestinal and Therapy Challenging Management Management Quality in Advanced Optimising Drug-induced Outcomes Liver fibrosis: Free Paper Improving Surgery in IBD GI infections Colon Exemplary Exemplary Diagnosis of Live extra-intestinal update: situations in of GI and liver of Barrett's ERCP: It is how pancreato- anti-TNF upper GI in Peroral From Session: Novel detection of from cancer: From clinical clinical IBS: What is endoscopy cancers in IBD Functional diagnosis and diseases oesophagus: you do it that biliary imaging therapy bleeding Endoscopic mechanism diagnostic tools: polyps mechanisms screening to cases I cases II the prefered 09:00 – 10:00 08:30 – 10:00 upper GI treatment during The gold counts Myotomy to therapy Going deeper to treatment palliation strategy? syndromes of acute pregnancy standard (POEM) and deeper pancreatitis into the bowel Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Symposium Free Paper Free Paper Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Posters in the Posters in the Free Paper Session Session Session Basic Science Session Session Session Session Spotlight Spotlight Session Does my Therapy IBD in young Prevention and From Colon cancer: Complications Detection and Colorectal can- Viral hepatitis: Structural Bringing mole- Improving Barret‘s Accuracy Small bowel Imaging and Optimising Abstracts on Live patient really update: people early diagnosis guidelines More than one in IBD management cer screening: Natural history changes in cular tests to GI detection and associated in upper GI disease and interventional the use of Fire: GI: endoscopy have GORD? Constipation of pancreatic to clinical disease? of serrated State-of-the- and treatment functional cancer clinics treatment of neoplasia endoscopy nutritional radiology in colonoscopy All about cancer practice: Portal lesions of the art GI disorders: colonic polyps therapy liver diseases in clinical microbiota? 10:30 – 12:00 10:30 10:30 – 12:00 10:30 hypertensive colorectum Time to remo- settings bleeding ve the term „functional“?

RTD* RTD* RTD* RTD* Posters in the Symposium 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 Spotlight 12:15 – 13:15 12:00 – 14:00 Multidiscipli- Challenges in Peptic ulcer Cystic 13:45 Drug develop- Poster Ul- nary treatment ERCP disease: pancreatic Poster ment for ESGE Surgical Sessions trasound of IBS patients Pharma- tumours: Champ Award digestive Learning Learning Learning with cological, Biopsy, Ceremony diseases: From Area Area 12:00 – 14:00 Area

comorbidities endoscopic follow-up or clinical needs 09:00 – 18:00 and surgical resect? to regulatory

12:00 – 14:00 Lunch Break 12:00 – 14:00 Lunch treatment perspectives

Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Free Paper Translational/ TSTM* Symposium Free Paper Free Paper Free Paper Posters in the Posters in the Symposium Session Session Basic Science Session Session Session Spotlight Spotlight From Therapy National Socie- Liver nodules Endoscopic What to do Functional Improving Biomarkers Clinical trials Intestinal New tests for Hot topics in Intestinal Prognostic General Clinical Colorectal Clinical Trials Live guidelines update: Colon ties Symposia: in different treatment of with small GI symptoms early diagnosis in IBD in functional microbiota treatment pancreatology failure: From factors in hepatology aspects on cancer: Dia- Revisited: endoscopy to clinical cancer Case finding clincial complications colorectal in organic of upper GI GI disorders in health and stratification in pathways to lower GI acute and gnostic and IBD – Can it practice: strategies and situations after upper GI polyps? diseases cancer disease GI cancer treatment cancer chronic therapeutic be cured with 14:00 – 15:30 14:00 – 15:30 Complex IBD access to hep C surgery pancreatitis. aspects transplanta- cases therapy across tion? Europe Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Translational/ TSTM* Free Paper Free Paper Free Paper Free Paper Symposium Free Paper Session Basic Science Session Session Session Session Session Management From Therapy Resection and Visualising National Socie- Coeliac disease NAFLD-NASH: East meets Rectal cancer: Late Breaking Mitochondria New diagnostic Pathophysiology (Epi)Genetics Novel The intestinal Optimising Abstracts on of refractory guidelines Update: ablation of small bowel ties Symposia: for the Where are we West: Organ Abstracts III and the and therapeutic of IBS in IBD techniques epithelium the patient- Exemplary Fire: Acute Crohn's to clinical Challenges in early neoplastic diseases Optimising clinician going? Same disease, preserving digestive tools in GI in lower GI - Stem cells, provider clinical pancreatitis: disease practice: H. biliary stone Barrett's: What clinical trials different strategies system diseases: malignancies inflamation relationship cases III From 15:45 – 17:15 15:45 pylori management is the best by networking clinical pat- Gimmicks or and cancer – 17:15 15.45 using effective mechanisms approach? – LINKing up terns adding value communicati- to disease Europe on techniques 17:45 – 19:15 Industry Sponsored Symposia 17:45 – 19:15 Industry Sponsored Symposia

33 UEG Week Final Programme : Scientific Programme Overview

Scientific Programme Overview Wednesday, October 19, 2016 }} Scientific Centre (Hall X4, X5)

Room D Room E1 Room E2 Room F1 Room F2 Room G Room K M Room Room 1.61/1.62 Room N1 Room N2 Room L7 Room L8 Room 1.86 E-Poster E-Poster Hotspot Level 1 Voting Room Lounge 1 Lounge 2

07:00 – 08:00 Industry Sponsored Symposia 07:00 – 08:00 Industry Sponsored Symposia Advances in Clinical Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Translational/ Free Paper Free Paper Free Paper Free Paper Free Paper Posters in the Posters in the Symposium GI & Hepatology Session Basic Science Session Session Session Session Session Spotlight Spotlight New treatment Improving The role of food in Standards Percutaneous New trends in Drug induced Eosinohilic Injury and Diagnosis and Constipation New insights in Liver cell biology Murine models Risk factors for Enteral feeding: Eosinophilic targets in IBD outcomes of IBS and other and novel gastrostomy and gastric cancer liver injury: oesophagitis regeneration treatment of and fecal upper GI and fibrosis of intestinal non-alcoholic Pros and cons oesophagitis: non-variceal functional GI developments jejunostomy What is new? and GORD pancreatic incontinence: endoscopy inflammation fatty liver Overlooked upper GI disorders for pancreatic cancer and its From bench to techniques disease too often or 09:00 – 10:00 08:30 – 10:00 bleeding neuroendocrine precursors bedside searched for too tumours fanatically?

Advances in Clinical Symposium Symposium Symposium Symposium Symposium Free Paper Translational/ Symposium Free Paper Free Paper Free Paper Free Paper Posters in the Posters in the Free Paper GI & Hepatology Session Basic Science Session Session Session Session Spotlight Spotlight Session What is success in Current Surgery meets Non-coeliac National The patient Upper GI Immunotherapy Complications of Improving Burden of liver Translational Gastric and Management of Improving the Abstracts on treating IBD? Video Case management of endoscopy in the gluten sensitivity Societies with severely bleeding in cancer liver cirrhosis: quality of disease aspects of IBD junctional clostridium clinical outcome Fire: New Session tumours colon and wheat Symposia: disturbed GI Beyond bleeding screening cancers difficile infection in patients with Approaches allergy in the gut Oesophageal function: and ascites colonoscopy upper GI to colorectal 10:30 – 12:00 10:30 10:30 – 12:00 10:30 cancer across Optimal bleeding disease Europe management in 2016 ESGE Surgical Ultrasound Learning Learning Learning RTD* RTD* RTD* RTD* Posters in the Symposium Area Area Area 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 Spotlight 12:15 – 13:15 09:00 – 14:00 Multidisciplinary Management Dyspepsia: Steroids for 13:45 A survivors management of of obscure GI Differential acute alcoholic Poster guide for a perianal fistula bleeding diagnoses and hepatitis: Cure Champ Award happy and management or curse? Ceremony successful

strategies 12:00 – 14:00 career in Gastroenterology – Hosted by 12:00 – 14:00 Lunch Break 12:00 – 14:00 Lunch women in GI

Advances in Clinical Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium GI & Hepatology Optimal use of Hepatology: New technologies Pancreatology: Food-related Neurogastro- Gut microbiota: Oesophageal Benign colorectal Colorectal immunosu– What's new in endoscopy: What‘s new in disorders: What's enterology and What's new in diseases: What's diseases: What's cancer: What's pressants and in 2016 What's new in 2016? new in 2016? motility: What‘s 2016? new in 2016? new in 2016? new in 2016? anti-TNF in IBD 2016? new in 2016? 14:00 – 15:30

* RTD – Round Table Discussions / TSTM – Today’s Science; Tomorrow’s Medicine 34 35 Scientific Programme Overview : UEG Week Final Programme

}} Scientific Centre (Hall X4, X5)

Room D Room E1 Room E2 Room F1 Room F2 Room G Room K M Room Room 1.61/1.62 Room N1 Room N2 Room L7 Room L8 Room 1.86 E-Poster E-Poster Hotspot Level 1 Voting Room Lounge 1 Lounge 2

07:00 – 08:00 Industry Sponsored Symposia 07:00 – 08:00 Industry Sponsored Symposia Advances in Clinical Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Translational/ Free Paper Free Paper Free Paper Free Paper Free Paper Posters in the Posters in the Symposium GI & Hepatology Session Basic Science Session Session Session Session Session Spotlight Spotlight New treatment Improving The role of food in Standards Percutaneous New trends in Drug induced Eosinohilic Injury and Diagnosis and Constipation New insights in Liver cell biology Murine models Risk factors for Enteral feeding: Eosinophilic targets in IBD outcomes of IBS and other and novel gastrostomy and gastric cancer liver injury: oesophagitis regeneration treatment of and fecal upper GI and fibrosis of intestinal non-alcoholic Pros and cons oesophagitis: non-variceal functional GI developments jejunostomy What is new? and GORD pancreatic incontinence: endoscopy inflammation fatty liver Overlooked upper GI disorders for pancreatic cancer and its From bench to techniques disease too often or 09:00 – 10:00 08:30 – 10:00 bleeding neuroendocrine precursors bedside searched for too tumours fanatically?

Advances in Clinical Symposium Symposium Symposium Symposium Symposium Free Paper Translational/ Symposium Free Paper Free Paper Free Paper Free Paper Posters in the Posters in the Free Paper GI & Hepatology Session Basic Science Session Session Session Session Spotlight Spotlight Session What is success in Current Surgery meets Non-coeliac National The patient Upper GI Immunotherapy Complications of Improving Burden of liver Translational Gastric and Management of Improving the Abstracts on treating IBD? Video Case management of endoscopy in the gluten sensitivity Societies with severely bleeding in cancer liver cirrhosis: quality of disease aspects of IBD junctional clostridium clinical outcome Fire: New Session bile duct tumours colon and wheat Symposia: disturbed GI Beyond bleeding screening cancers difficile infection in patients with Approaches allergy in the gut Oesophageal function: and ascites colonoscopy upper GI to colorectal 10:30 – 12:00 10:30 10:30 – 12:00 10:30 cancer across Optimal bleeding disease Europe management in 2016 ESGE Surgical Ultrasound Learning Learning Learning RTD* RTD* RTD* RTD* Posters in the Symposium Area Area Area 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 12:45 – 13:45 Spotlight 12:15 – 13:15 12:00 – 14:00 09:00 – 14:00 Multidisciplinary Management Dyspepsia: Steroids for 13:45 Poster A survivors management of of obscure GI Differential acute alcoholic Poster Sessions guide for a perianal fistula bleeding diagnoses and hepatitis: Cure Champ Award happy and management or curse? Ceremony successful

strategies 12:00 – 14:00 career in Gastroenterology – Hosted by 12:00 – 14:00 Lunch Break 12:00 – 14:00 Lunch women in GI

Advances in Clinical Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium GI & Hepatology Optimal use of Hepatology: New technologies Pancreatology: Food-related Neurogastro- Gut microbiota: Oesophageal Benign colorectal Colorectal immunosu– What's new in endoscopy: What‘s new in disorders: What's enterology and What's new in diseases: What's diseases: What's cancer: What's pressants and in 2016 What's new in 2016? new in 2016? motility: What‘s 2016? new in 2016? new in 2016? new in 2016? anti-TNF in IBD 2016? new in 2016? 14:00 – 15:30

35 Choose among 194 sessions which run in parallel with up to 20 at the same time. The UEG Week Pathways Tool helps you navigate through this huge choice, UEG Week Pathways Tool searching the scienti c programme by topic. See at one glance which sessions are most relevant and interesting for your specialty

YOUNG GI SURGERY STOMACH & TRACK SMALL RADIOLOGY & H. PYLORI PRIMARY INTESTINE & PANCREAS IMAGING NUTRITION th PAEDIATRICS CARE 24 United European Gastroenterology Week OESO- NEURO- October 15-19, 2016 | Vienna, Austria IMMUNO- PHAGUS IBD GASTRO- HISTO- LOGY ENTEROLOGY HEPATO- GUT PATHOLOGY & MOTILITY ENDOSCOPY BILIARY DISEASE MICROBIOTA DIGESTIVE MECHANISMS WEDNESDAY CHAIRMANʼS ONCOLOGY CHOICE YOUNG GI TRACK TUESDAY

Scientific Centre (Hall X4) MONDAY Hotspot E-Poster E-Poster Room 1.86 Lounge 2 Room L8 Lounge 1 SATURDAY | SUNDAY Room L7 Room N2 Room N1 Room Room M Room K 1.61/1.62 Room G Room F2 Room F1 Room E2 Room E1 Monday, October 17, 2016 Room C Room B Room D Room A Free Paper Posters Posters Session: Opening Free Paper in the Available on the Free Paper in the Abstracts on Session: Free Paper Session: Spotlight Free Paper Session: Spotlight Fire: GORD Part 1 TSTM*: Session: Gastroduo- Preventi- Session: Basic on Fire Hot topics A new era of Mechanisms denal Free Paper on of GI New mechanisms UEG Week App or An update from Latin imaging in of Primary damage: Food intake, Session: cancers: perspectives of intestinal 08:00-10:00 Quality on the America GI diseases Sclerosing H. pylori, Update on metabolic Impro- Nutrition in diagnostic carcinoge- Clinical indicators management Cholangitis acid and Is mass chronic disorders vements of and chemo- and thera- nesis Free Paper management in upper GI of hepa- bile 12:15-13:15: visit www.ueg.eu/week Post- eradication pancreatitis and endoscopic prevention peutic EUS Opening Session: of extrain- endoscopy: tocullular Moving GI operative of H. pylori endoscopy resection Session: Established testinal Ready for carcinoma education management rational? techniques Part 2 and new symptoms in prime time? into the of Crohn's in the colon Bacterial drugs in IBD GI diseases Round Table Discussions Optimal future: disease infections in management Current

end stage challenges, 10:30-12:00 of gastric Colonoscopic liver disease future needs How to use cardia surveillance FODMAPs cancers Clinical strategies Posters and other Posters Trials Free Paper in the diets in Free Paper in the Revisited: 16_08_Inserat_UEGWEEK_FP_pathways_307x220mm_RZ.indd 1 Free Paper Session: Spotlight 05.09.16 13:06 your clinical Free Paper Session: Spotlight Practice TSTM*: Session: Basic practice? IBD: The role Session: Gastric changing Free Paper Free Paper What is new mechanisms Free Paper of different From function in trials in pan- Session: Session: The in gastric in pancreatic

Free Paper cell types symptoms health and creatology 12:45-13:45 Liver Session: Japanese Session: Late future of Endoscopic cancer Management diseases Microbiota in the to diagnosis disease Improving European Long-term Breaking diagnostic Submucosal Endoscopy of oesopha- beyond and diet: inflammatory in IBS Therapy the adenoma perspectives: management Abstracts I in HBP and Dissection Compli- Management performance geal motility alcohol, From bench process Rising Stars Best of DDW update: detection Endoscopic of IBD upper GI (ESD) Horizon cations of of bloating measures: disorders fatty liver to bedside Free Paper in IBS from Therapeutic rate classifica- Free Paper 2020 cirrhosis: and What you and viral Free Paper Session: Europe and EUS – New tions update Free Paper Session: Which flatulence should be hepatitis Free Paper Session: Mechanisms the USA indications Novel Session: Hepatic cysts prophylaxis doing Free Paper Session: Endoscopic of liver Free Paper models for Upper GI and hepato- should we Management Session: Can we management cancer and Endoscopy Session: GI diseases nerve-gut biliary tract use ? 14:00-15:30 Autoimmune of early rec- Late detect of upper portal Interven- meets Hot topics in interactions - disorders Non- pancreatobi- tal tumours Breaking inflammatory gastrointes hypertension Free Paper tional pathology: ERCP Therapy bleeding liary disease Abstracts II GI diseases tinal cancer Update Session: ultrasound: Polyps and Rome update: emergencies early? on viral Future drugs See what polyposis IV: New Transluminal of the hepatitis in IBD you do! syndromes diagnostic endoscopy in oesophagus 2016 in the upper criteria for the upper GI GI tract functional GI tract – From disorders bench to

15:45-17:15 clinical practice

* TSTM – Today’s Science; Tomorrow’s Medicine Postgraduate Teaching Programme

Overview Icons

Livestream

Q&A

Audience Voting

Recorded Session

The scientific programme is as September 12, 2016. Later changes are published in the online programme and in the UEG Week App.

Course Directors Marianna Arvanitakis, Belgium Mark Fox, Switzerland Roger Leicester, United Kingdom Dominique Thabut, France Herbert Tilg, Austria Gijs van den Brink, The Netherlands

The syllabus for the Postgraduate Teaching Programme will be available in the online programme as well as in the UEG Library at www.ueg.eu/education/library. UEG Week Final Programme : Postgraduate Teaching Programme Saturday, October 15, 2016

Postgraduate Teaching Programme Saturday, October 15, 2016

Plenary I 12:00 - 12:30 IP009 Saturday, October 15, 2016 09:00 - 10:30 Room A Biliary stones Peptic ulcer disease: Still important for gastroenterol- Marianna Arvanitakis, Belgium ogists in 2016? 12:30 - 13:00 IP010 Chairs: Christopher John Hawkey, United Kingdom ERCP in post-surgical anatomy Peter Malfertheiner, Germany Lars Aabakken, Norway

09:00 - 09:00 IP001 Parallel Sessions Welcome words by the UEG President 11:00 - 13:00 Room B Michael Manns, Germany Update on Barrett's oesophagus Chairs: Jacques J. Bergman, The Netherlands 09:00 - 09:30 IP002 Joachim Labenz, Germany Peptic ulcer and functional dyspepsia: Changing pat- tern with opposing trends? Alexander Charles Ford, United Kingdom 11:00 - 11:30 IP011 09:30 - 09:45 IP003 How does Barrett's oesophagus develop and progress, Management of non-complicated peptic ulcer: A case- and how can it be prevented? Massimiliano di Pietro, United Kingdom based presentation Tamara Matysiak Budnik, France 11:30 - 12:00 IP012 09:45 - 10:00 IP004 Barrett's oesophagus: Who to screen, and who and Management of bleeding peptic ulcer: A case-based how to survey? Bas L. A. M. Weusten, The Netherlands presentation Krish Ragunath, United Kingdom 12:00 - 12:30 IP013 Debate Treatment of Barrett's oesophagus: Who should be 10:00 - 10:15 IP005 treated and how? Alexander Meining, Germany Peptic ulcer is no longer an important clinical problem - Pro Debate Christopher John Hawkey, United Kingdom 12:30 - 12:45 IP014 10:15 - 10:30 IP006 Barrett's oesophagus with low grade dysplasia should Peptic ulcer is no longer an important clinical problem be treated with ablation therapy Stefan Seewald, Switzerland - Con Peter Malfertheiner, Germany 12:45 - 13:00 IP015 Barrett's oesophagus with low grade dysplasia: Prim- Parallel Sessions um non nocere 11:00 - 13:00 Room A Arjun D. Koch, The Netherlands Video Case Session I: ERCP in normal and post-surgi- cal anatomy Parallel Sessions Chairs: Thierry Ponchon, France 11:00 - 13:00 Room C Lars Aabakken, Norway Proctology for the practical gastroenterologist Chairs: Anton Emmanuel, United Kingdom Ian Jenkins, United Kingdom 11:00 - 11:30 IP007 Biliary cannulation Paul Fockens, The Netherlands 11:00 - 11:30 IP016 11:30 - 12:00 IP008 Common anorectal conditions: Recognition and man- Biliary sphincterotomy and precut agement Michael Häfner, Austria William Whitehead, USA

38 Livestream Q&A Audience Voting Recorded Session Saturday, October 15, 2016 Postgraduate Teaching Programme : UEG Week Final Programme

11:30 - 12:00 IP017 15:00 - 16:00 IP026 Clinical classification and assessment of defaecatory Diagnosis and management of early gastric lesions disorders Helmut Messmann, Germany Anton Emmanuel, United Kingdom 16:00 - 16:30 IP027 12:00 - 12:30 IP018 Approach to early duodenal neoplastic lesions Medical and surgical treatment of defecatory disorders Torsten Beyna, Germany Giuseppe Chiarioni, Italy Parallel Sessions 12:30 - 13:00 IP019 Assessment and management of 14:00 - 16:30 Room B Ian Jenkins, United Kingdom Multidisciplinary management of Chairs: Jeanin E. van Hooft, The Netherlands Parallel Sessions Bjorn Rembacken, United Kingdom Saturday, October 15, 2016 15, October Saturday, 11:00 - 13:00 Room E1 Alcohol-related liver disease: Treatment and prevention 14:00 - 14:30 IP028 Chairs: Philippe Mathurin, France Diagnosis and workup of colorectal cancer Mark Thursz, United Kingdom Monique van Leerdam, The Netherlands Tandem Talks 11:00 - 11:30 IP020 14:30 - 14:45 IP029 Epidemiology of alcohol-related liver disease and Endoscopic or surgical resection for T1 rectal cancer? public health interventions The surgeon's view Helena Cortez-Pinto, Portugal Mario Morino, Italy 11:30 - 12:00 IP021 14:45 - 15:00 IP030 Is liver biopsy necessary for the diagnosis of alcoholic Endoscopic or surgical resection for T1 rectal cancer? hepatitis? The gastroenterologist's view Robert Goldin, United Kingdom Yutaka Saito, Japan Debate 15:00 - 15:30 IP031 12:00 - 12:15 IP022 Strengths, weaknesses and threats of state of the art Transplantation for alcohol-related liver disease is a colonic surgery waste of scarce resources - Pro Pär Myrelid, Sweden James Neuberger, United Kingdom 15:30 - 16:00 IP032 12:15 - 12:30 IP023 Treatment for the elderly poor-risk patient with col- Transplantation for alcohol-related liver disease is a orectal cancer waste of scarce resources - Con Dieter Hahnloser, Switzerland Philippe Mathurin, France Tandem Talks 12:30 - 13:00 IP024 16:00 - 16:15 IP033 Psychosocial and pharmacological interventions for Stent or surgery for malignant colonic obstruction: The alcohol dependence gastroenterologist's view Antoni Gual, Spain Javier Jimenez, Spain 16:15 - 16:30 IP034 Parallel Sessions Stent or surgery for malignant colonic obstruction: The 14:00 - 16:30 Room A surgeon's view Video Case Session II: Diagnosis and management of Yves Panis, France early neoplasia in the upper GI tract Chairs: Mario Dinis-Ribeiro, Portugal Alexander Meining, Germany

14:00 - 15:00 IP025 Diagnosis and management of Barrett's oesophagus and associated neoplastic lesions Jacques J. Bergman, The Netherlands

38 Livestream Q&A Audience Voting Recorded Session 39 UEG Week Final Programme : Postgraduate Teaching Programme Saturday, October 15, 2016

Parallel Sessions Parallel Sessions 14:00 - 16:30 Room C 14:00 - 16:30 Room E1 Primary Sclerosing Cholangitis (PSC) and Primary Chronic constipation: From bench to bedside Biliary Cholangitis (PBC): Pearls for the clinician Chairs: Robin Spiller, United Kingdom

Saturday, October 15, 2016 Chairs: Ulrich H. W. Beuers, The Netherlands Jan Tack, Belgium Tom Hendrik Karlsen, Norway

14:00 - 14:30 IP040 14:00 - 14:30 IP035 Pathogenesis and pathophysiology of constipation Novel insights in the pathogenesis of PSC and PBC Maura Corsetti, United Kingdom Gideon Hirschfield, United Kingdom 14:30 - 15:00 IP041 14:30 - 15:00 IP036 Diagnostic approach for chronic constipation Diagnostic challenges in PSC and other benign and Anton Emmanuel, United Kingdom malignant cholangiopathies Michael Trauner, Austria 15:00 - 15:30 IP042 Behavioural treatment for chronic constipation 15:00 - 15:30 IP037 William Whitehead, USA The role of endoscopy in PSC Cyriel Y. Ponsioen, The Netherlands 15:30 - 16:00 IP043 Pharmacological treatment options for chronic consti- 15:30 - 16:00 IP038 pation Medical treatment in PBC and PSC: Where do we go Paul Moayyedi, Canada from UDCA? Olivier Chazouilleres, France 16:00 - 16:30 IP044 Surgical therapy for chronic constipation: When, why 16:00 - 16:30 IP039 and how? Unmet clinical needs in PBC: Management of choles- Carolynne Vaizey, United Kingdom tatic pruritus and fatigue David Jones, Ireland

40 Livestream Q&A Audience Voting Recorded Session Sunday, October 16, 2016 Postgraduate Teaching Programme : UEG Week Final Programme

Postgraduate Teaching Programme Sunday, October 16, 2016

Parallel Sessions 10:00 - 10:30 IP054 08:30 - 10:30 Room A Quality in teaching Acute colitis: Medical and surgical therapy Vivian Ekkelenkamp, The Netherlands Chairs: Iris Dotan, Israel Willem Bemelman, The Netherlands Parallel Sessions 08:30 - 10:30 Room C Hot topics in 08:30 - 09:00 IP045 Chairs: Julia Mayerle, Germany Efficacy of current medical treatment strategies: Are Myriam Delhaye, Belgium we getting better? Franck Carbonnel, France 09:00 - 09:30 IP046 08:30 - 09:00 IP055 What are the best new treatement options for acute Genetics and other infrequent etiological factors in colitis beyond anti-TNFs? chronic pancreatitis: What needs to be tested and why? Severine Vermeire, Belgium Markus M. Lerch, Germany 09:00 - 09:30 IP056 Debate 09:30 - 09:45 IP047 Autoimmune pancreatitis: An overlooked or overesti- Partial responders to rescue therapy require intensive mated disease? Vinciane Rebours, France outpatient medical therapy, not surgery Sandro Ardizzone, Italy Tandem Talks 09:45 - 10:00 IP048 09:30 - 09:45 IP057 Partial responders to rescue therapy should be re- How to treat pain in patients with chronic pancreatitis: ferred to early surgery The gastroenterologist's view Antonino Spinelli, Italy Asbjørn M. Drewes, Denmark 09:45 - 10:00 IP058 Tandem Talks 10:00 - 10:15 IP049 How to treat pain in patients with chronic pancreatitis: The dysfunctioning pouch: The surgeon's view The surgeon's view 2016 16, October Sunday, Willem A. Bemelman, The Netherlands Marja A. Boermeester, The Netherlands 10:15 - 10:30 IP050 10:00 - 10:30 IP059 The dysfunctioning pouch: The gastroenterologist's view Difficult clinical problems in treatment of chronic pan- Ailsa Hart, United Kingdom creatitis: A case-based presentation Andrea Tringali, Italy Parallel Sessions Parallel Sessions 08:30 - 10:30 Room B 08:30 - 10:30 Room E1 How to improve quality in endoscopy Chairs: Horst Neuhaus, Germany Therapy update: Hepatitis C Pierre Eisendrath, Belgium Chairs: Heiner Wedemeyer, Germany Marc Bourlière, France

08:30 - 09:00 IP051 08:30 - 09:00 IP060 Quality in endoscopy department design Roger Leicester, United Kingdom Update on available drugs against HCV Alessio Aghemo, Italy 09:00 - 09:30 IP052 09:00 - 09:30 IP061 Quality measurement in endoscopic practice Siwan Thomas-Gibson, United Kingdom Open issues in HCV therapy Mario Reis Alvares-da-Silva, Brazil 09:30 - 10:00 IP053 Quality in reporting Olivier Le Moine, Belgium

40 Livestream Q&A Audience Voting Recorded Session 41 UEG Week Final Programme : Postgraduate Teaching Programme Sunday, October 16, 2016

09:30 - 10:00 IP062 11:30 - 12:00 IP071 HCV: Treatment of decompensated cirrhosis and post Symptoms, objective markers of disease activity and liver transplantation the role of endoscopy and imaging Marina Berenguer, Spain Charlie Lees, United Kingdom Debate 12:00 - 12:30 IP072 10:00 - 10:15 IP063 Case Presentation Prioritisation or treating all HCV patients: Prioritisation Gareth Jones, United Kingdom is needed and reasonable Jerzy Jaroszewicz, Poland 12:30 - 13:00 IP073 Monitoring and optimizing treatment with biologics 10:15 - 10:30 IP064 utilizing biomarkers and therapeutic drug monitoring Prioritisation or treating all HCV patients: All patients Krisztina Barbara Gecse, Hungary should receive antiviral therapy Alessandra Mangia, Italy Clinical Case Based Session 11:00 - 13:00 Room B Parallel Sessions Small bowel tumours: Rare entities and how to find them 08:30 - 10:30 Room E2 Chairs: Peter Bauerfeind, Switzerland Optimal management of swallowing disorders in 2016 Thomas Rösch, Germany Chairs: Nathalie Rommel, Belgium Moderator: Joost P.H. Drenth, The Netherlands Shaheen Hamdy, United Kingdom

11:00 - 11:30 IP074 08:30 - 09:00 IP065 Case Presentation

Sunday, October 16, 2016 Epidemiology and psychosocial burden of dysphagia Stefan Groth, Germany Shaheen Hamdy, United Kingdom 11:30 - 12:00 IP075 Tandem Talks Evidence-based approach to capsule endoscopy 09:00 - 09:15 IP066 Peter Bauerfeind, Switzerland Assessment of swallowing function: Radiological view Olle Ekberg, Sweden 12:00 - 12:30 IP076 Case Presentation 09:15 - 09:30 IP067 Stefan Groth, Germany Assessment of swallowing function: Non-radiological view 12:30 - 13:00 IP077 Nathalie Rommel, Belgium Evidence-based approach to enteroscopy Thomas Rösch, Germany 09:30 - 10:00 IP068 Current and emerging treatments for oropharyngeal Clinical Case Based Session dysphagia 11:00 - 13:00 Room C Emilia Michou, United Kingdom Gastric polyps: Diagnostic and therapeutic approach 10:00 - 10:30 IP069 Chairs: Oliver Pech, Germany Optimal assessment and management of neurogenic Pradeep Bhandari, United Kingdom pharyngeal dysphagia Moderator: Raf Bisschops, Belgium Rainer Dziewas, Germany 11:00 - 11:30 IP078 Clinical Case Based Session Case Presentation 11:00 - 13:00 Room A Jürgen Pohl, Germany IBD: Usefulness of symptoms and objective markers in disease monitoring 11:30 - 12:00 IP079 Chairs: Krisztina Barbara Gecse, Hungary Pathological and endoscopic differentiation of gastric Charlie Lees, United Kingdom polyps Moderator: Gijs R. van den Brink Pradeep Bhandari, United Kingdom 12:00 - 12:30 IP080 11:00 - 11:30 IP070 Case Presentation Case Presentation Jürgen Pohl, Germany Gareth Jones, United Kingdom

42 Livestream Q&A Audience Voting Recorded Session Sunday, October 16, 2016 Postgraduate Teaching Programme : UEG Week Final Programme

12:30 - 13:00 IP081 Clinical Case Based Session Endoscopic management of gastric polyps and neoplasia 11:00 - 13:00 Room M Oliver Pech, Germany Fulminant hepatitis and liver transplantation Chairs: Julia Wendon, United Kingdom Clinical Case Based Session Claire Francoz, France 11:00 - 13:00 Room E1 Moderator: Bjorn Rembacken, The Netherlands Diverticular disease: Medical and surgical management Chairs: Desmond C. Winter, Ireland Wolfgang Kruis, Germany 11:00 - 11:30 IP090 Moderator: Robin Spiller, United Kingdom Case Presentation Mark McPhail, United Kingdom 11:30 - 12:00 IP091 11:00 - 11:30 IP082 Acute , organ failure support and prognos- Case Presentation tic models for decision making Gia P. Nguyen, Germany Claire Francoz, France 11:30 - 12:00 IP083 12:00 - 12:30 IP092 Pathogenesis, classification and conservative manage- Case Presentation ment of acute diverticular disease Mark McPhail, United Kingdom Wolfgang Kruis, Germany 12:30 - 13:00 IP093 12:00 - 12:30 IP084 Liver support systems and management of complica- Case Presentation tions in the post transplantation period Gia P. Nguyen, Germany Julia Wendon, United Kingdom 12:30 - 13:00 IP085 Clinical risk assessment and imaging guided surgical Clinical Case Based Session management of 11:00 - 13:00 Room N1 Desmond C. Winter, Ireland Autoimmune liver disease: Diagnosis and treatment Chairs: Gerd Bouma, The Netherlands Clinical Case Based Session Michael Manns, Germany 11:00 - 13:00 Room E2 Moderator: Herbert Tilg, Austria Complications of liver cirrhosis Chairs: Dominique Thabut, France 2016 16, October Sunday, Raj Mookerjee, United Kingdom Moderator: Heinz Florian Hammer, Austria 11:00 - 11:30 IP094 Case Presentation Ynto de Boer, The Netherlands 11:00 - 11:30 IP086 Case Presentation 11:30 - 12:00 IP095 Marika Rudler, France : Diagnostic approach Michael Manns, Germany 11:30 - 12:00 IP087 Screening and prevention of complications of portal 12:00 - 12:30 IP096 hypertension Case Presentation Dominique Thabut, France Ynto de Boer, The Netherlands 12:00 - 12:30 IP088 12:30 - 13:00 IP097 Case Presentation Autoimmune hepatitis: Treatment and follow-up Marika Rudler, France Gerd Bouma, The Netherlands 12:30 - 13:00 IP089 Diagnosis and treatment of Raj Mookerjee, United Kingdom

42 Livestream Q&A Audience Voting Recorded Session 43 UEG Week Final Programme : Postgraduate Teaching Programme Sunday, October 16, 2016

Clinical Case Based Session Clinical Case Based Session 11:00 - 13:00 Room N2 11:00 - 13:00 Room 1.86 Obstruction and ileus Management of weight loss and loss of appetite Chairs: Ian Jenkins, United Kingdom Chairs: André Van Gossum, Belgium Tom Moreels, Belgium Francisca Joly, France Moderator: Roger Leicester, United Kingdom Moderator: Jean-François Dufour, France

11:00 - 11:30 IP098 11:00 - 11:30 IP106 Case Presentation Case Presentation Alaa Taha, Belgium Anneline Cremer, Belgium 11:30 - 12:00 IP099 11:30 - 12:00 IP107 Causes and investigation of ileus, including differentia- Weight loss of undetermined etiology: Diagnostic tion between ileus, ischaemia and obstruction approach Tom Moreels, Belgium André Van Gossum, Belgium 12:00 - 12:30 IP100 12:00 - 12:30 IP108 Case Presentation Case Presentation Alaa Taha, Belgium Anneline Cremer, Belgium 12:30 - 13:00 IP101 12:30 - 13:00 IP109 Surgical and endoscopic management of acute intesti- From obesity to undernutrition: The paradox of bariat- nal obstruction ric surgery Ian Jenkins, United Kingdom Francisca Joly, France Sunday, October 16, 2016 Clinical Case Based Session Plenary II 11:00 - 13:00 Room L8 14:00 - 16:00 Room A Endocrine tumours: What the gastroenterologists Management of ulcerative colitis: Current and future need to know treatment Chairs: Jean-Luc Van Laethem, Belgium Chairs: Geert D'Haens, The Netherlands Philippe Ruszniewski, France Walter Reinisch, Austria Moderator: Mark Fox, Switzerland

14:00 - 14:30 IP110 11:00 - 11:30 IP102 Mesalazine: The art of optimal use Case Presentation Axel Dignass, Germany Louis de Mestier, France 14:30 - 15:00 IP111 11:30 - 12:00 IP103 Use of immunosuppressants in ulcerative colitis Diagnostic aspects Iris Dotan, Israel Jean-Luc Van Laethem, Belgium 15:00 - 15:30 IP112 12:00 - 12:30 IP104 Anti-TNF or anti-Integrins? A patient tailored approach Case Presentation Gert Van Assche, Belgium Louis de Mestier, France Debate 12:30 - 13:00 IP105 15:30 - 15:45 IP113 Treatment aspects When everything fails: Drugs of the future! Philippe Ruszniewski, France Gijs R. van den Brink, The Netherlands 15:45 - 16:00 IP114 When everything fails: Surgery! Willem A. Bemelman, The Netherlands

44 Livestream Q&A Audience Voting Recorded Session Scientific Programme by Day

Overview Icons

Livestream ª Rising Star Q&A ª Top Abstract Prize Audience Voting ª National Scholar Recorded Session

The scientific programme is as of September 12, 2016. Later changes are published in the online programme and in the UEG Week App.

44 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

Scientific Programme by Day Monday, October 17, 2016

Opening Session 09:44 - 09:54 IP122 Monday, October 17, 2016 08:00 - 10:00 Room A Advanced diagnostics for individualised medicine: It's Opening Session: Part 1 all in the blood! Chairs: Magnus Simrén, Sweden Alberto Bardelli, Italy Michael Manns, Germany 09:54 - 10:04 IP123 Presidential address Michael Manns, Germany 08:00 - 08:05 IP115 Words of welcome Magnus Simrén, Sweden Opening Session 10:30 - 12:00 Room A 08:05 - 08:25 IP116 Opening Session: Part 2 New treatment strategies for ulcerative colitis Chairs: Magnus Simrén, Sweden Julian Panés, Spain Paul Fockens, The Netherlands 08:25 - 08:37 OP001 LAPAROSCOPIC ILEOCECAL RESECTION VERSUS INFLIX- 10:30 - 10:50 IP124 IMAB TREATMENT OF TERMINAL IN CROHN'S DISEASE: THE LIR!C TRIAL ª What's new in Gastroenterology in 2016? Joline de Groof, The Netherlands; Willem A. Bemelman; Jan Tack, Belgium Emma Eshuis; Tjibbe Gardenbroek; Patrick M. Bossuyt; 10:50 - 11:02 OP003 Bart van Wagensveld; Menno A. Brink; Esther Consten; MULTIVARIATE MODELLING OF GUT MICROBIAL PROFILES Christianne J. Buskens; Geert R. A. M. D'Haens; Pieter PREDICTS RESPONSIVENESS TO A DIET LOW IN FODMAPS ª Stokkers; Cyriel Y. Ponsioen Sean M. P. Bennet, Sweden; Lena Böhn; Stine Störsrud; 08:37 - 08:57 IP117 Therese Liljebo; Lena Collin; Perjohan Lindfors; Hans Törnblom; Lena Öhman; Magnus Simrén New insights into gluten and wheat protein related disorders 11:02 - 11:07 IP125 Detlef Schuppan, Germany UEG Journal Best Paper Award 08:57 - 09:12 IP118 Tara Raftery, Ireland UEG Research Prize 11:07 - 11:27 IP126 Ernst J. Kuipers, The Netherlands What's new in Endoscopy in 2016? 09:12 - 09:24 OP002 Michael Bretthauer, Norway CELL AUTONOMOUS AND NON-CELL AUTONOMOUS 11:27 - 11:39 OP004 RESCUE OF NNOS DEFICIENT MOUSE COLON FOLLOW- ENDOSCOPIC OR SURGICAL STEP-UP APPROACH FOR ING IN VIVO ENTERIC NERVOUS SYSTEM STEM CELL NECROTIZING PANCREATITIS, A MULTI-CENTER RAN- TRANSPLANTATION ª DOMIZED CONTROLLED TRIAL ª Conor J. McCann, United Kingdom; Julie Cooper; Dipa Sandra van Brunschot, The Netherlands Natarajan; Benjamin S. Jevans; Alan J. Burns; Nikhil Thapar 11:39 - 11:59 IP127 What's new in Hepatology in 2016? 09:24 - 09:29 IP119 Rajiv Jalan, United Kingdom Laudation UEG Lifetime Achievment Awardee Michael Trauner, Austria Symposium 09:29 - 09:34 IP120 10:30 - 12:00 Room D UEG Lifetime Achievment Award Post-operative management of Crohn's disease Günter Krejs, Austria Chairs: Geert D'Haens, The Netherlands Martine De Vos, Belgium Tandem Talks 09:34 - 09:44 IP121 Advanced diagnostics for individualised medicine: 10:30 - 10:52 IP128 Seeing is believing Pathophysiology of post-operative recurrence Sarah Bohndiek, United Kingdom Matthieu Allez, France

46 ª Rising Star ª Top Abstract Prize ª National Scholar 47 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

10:52 - 11:14 IP129 11:18 - 11:30 OP008 Decision on post-operative treatment PREDICTORS OF NON-RESPONSE OR LOSS OF RE- Ailsa L. Hart, United Kingdom SPONSE TO TUMOUR NECROSIS FACTOR ANTAGONIST THERAPIES IN INFLAMMATORY BOWEL DISEASE Tandem Talks Laurent Peyrin-Biroulet, France; Alessandro Armuzzi; 11:14 - 11:24 IP130 Javier P. Gisbert; Geoffrey C. Nguyen; Bernd Bokemeyer; Assessing recurrence: Endoscopy James Lindsay; Michael Smyth; Melvin Munsaka; Gert Van Assche, Belgium Sreeram Ramagopalan; Javaria M. Khalid 11:24 - 11:34 IP131 11:30 - 11:42 OP009 Assessing recurrence: Imaging INFLAMMATORY BOWEL DISEASE COURSE AND THERA- Andrea Laghi, Italy PEUTIC MANAGEMENT IN REAL LIFE PRACTICE IN THE 11:34 - 11:56 IP132 CURRENT ERA OF ANTI-TNFS: ANALYSIS OF THE FRENCH Early surgical complications: Risk factors, multidisci- ADMINISTRATIVE HEALTH DATABASES 2009-2014 2016 17, October Monday, plinary management and long term sequelae Julien Kirchgesner, France; Magali Lemaitre; Antoine Dieter Hahnloser, Switzerland Racine; Mahmoud Zureik; Franck Carbonnel; Rosemary Dray-Spira Free Paper Session 11:42 - 11:54 OP010 10:30 - 12:00 Room B CHARACTERISTICS OF CHILDREN WITH CROHN'S Established and new drugs in IBD DISEASE FAILING SUSTAINED REMISSION DESPITE Chairs: Jean-Frederic Colombel, France ANTI-TNF EXPOSURE Erwin Dreesen, Belgium Lucas L. Wauters, Belgium; Françoise Smets; Ilse Hoffman; Elisabeth De Greef; Patrick Bontems; Philippe Alliet; Wim Arts; Bruno Hauser; Stephanie Van 10:30 - 10:42 IP133 Biervliet; Els Van de Vijver; Isabelle Paquot; Harald State-of-the-art introduction Peeters; Peter Bossuyt; Jean-François Rahier; Tom Jean-Frederic Colombel, France Moreels; Olivier Dewit; Denis Franchimont; Vinciane 10:42 - 10:54 OP005 Muls; Fernand Fontaine; Edouard J. Louis; Jean-Charles EFFICACY AND SAFETY OF DOSE ADJUSTMENT AND Coche; Martine De Vos; Filip Baert; Jerome Paul; DELAYED RESPONSE TO USTEKINUMAB IN MODERATE Severine Vermeire; Gigi Veereman ?SEVERE CROHN'S DISEASE PATIENTS: RESULTS FROM THE IM-UNITI MAINTENANCE STUDY Symposium Bruce E. Sands; Christopher Gasink; Douglas Jacobstein; 10:30 - 12:00 Room C Long L. Gao; Jewel Johanns; Philippe Szapary; Is mass eradication of H. pylori rational? Jean-Frederic Colombel, USA; Stephan Targan; Subrata Chairs: John Atherton, United Kingdom Ghosh; William Sandborn Marcis Leja, Latvia 10:54 - 11:06 OP006 VEDOLIZUMAB EXPOSURE CORRELATES WITH CLIN- 10:30 - 10:52 IP134 ICAL, BIOLOGICAL AND ENDOSCOPIC OUTCOME IN Is gastric cancer disappearing? PATIENTS WITH INFLAMMATORY BOWEL DISEASE David Forman, France Ann Gils; Erwin Dreesen; Griet Compernolle; Miet Peeters; Els Brouwers; Vera Ballet; Maja Noman; Marc 10:52 - 11:04 OP011 Ferrante; Gert Van Assche; Severine Vermeire, Belgium IS HELICOBACTER PYLORI ERADICATION ABLE TO IMPROVE THE SCORES OF ATROPHIC AND 11:06 - 11:18 OP007 INTESTINAL METAPLASIA?? LONG-TERM FOLLOW-UP EARLY VEDOLIZUMAB DRUG LEVELS AND INDUCTION STUDY IN HIGH RISK POPULATION OF GASTRIC CANCER. SUCCESS IN PATIENTS WITH INFLAMMATORY BOWEL Young J. Hwang, Republic of Korea; Nayoung Kim; DISEASE Yoon J. Choi; Hyuk Yoon; Cheol M. Shin; Young S. Park; Bella Ungar, Israel; Uri Kopylov; Matti Waterman; Ola Dong H. Lee Haj-Natour; Miri Yavzori; Orit Picard; Ella Fudim; Yehuda Chowers; Rami Eliakim; Shomron Ben-Horin 11:04 - 11:16 OP012 THE EFFECT OF CURRENT HELICOBACTER PYLORI INFECTION ON GASTRIC CANCER IN A LARGE POPULA- TION BASED STUDY Su Nam, Republic of Korea; Bum J. Park; Ji H. Nam

Livestream Q&A Audience Voting Recorded Session 47 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

11:16 - 11:38 IP135 11:12 - 11:34 IP144 Effects of mass eradication ofH. pylori on morbidity Pain management in chronic pancreatitis: Standards and mortality and new developments Alexander C. Ford, United Kingdom Asbjørn M. Drewes, Denmark

Monday, October 17, 2016 11:38 - 12:00 IP136 11:34 - 11:56 IP145 Potential negative health consequences of popula- Total pancreatectomy and islet transplantation: An tion-wide H. pylori eradication option for the treatment of chronic pancreatitis Franco Bazzoli, Italy Martin L. Freeman, USA

Symposium Symposium 10:30 - 12:00 Room E1 10:30 - 12:00 Room F1 Clinical management of extraintestinal symptoms in Quality indicators in upper GI endoscopy: Ready for GI diseases prime time? Chairs: Detlef Schuppan, Germany Chairs: Mario Dinis-Ribeiro, Portugal Kok-Ann Gwee, Singapore Raf Bisschops, Belgium

10:30 - 10:52 IP137 10:30 - 10:52 IP146 Psychological comorbidity in GI diseases: A primer for Detection of early neoplastic lesions the gastroenterologist Naohisa Yahagi, Japan Douglas Drossman, USA 10:52 - 11:14 IP147 10:52 - 11:14 IP138 Differentiation and delineation of early neoplastic lesions Extraintestinal symptoms in IBS Andrea May, Germany Lin Chang, USA Tandem Talks 11:14 - 11:36 IP139 11:14 - 11:24 IP148 Extraintestinal manifestations of coeliac disease Need for histopathology: The endoscopist's view David S. Sanders, United Kingdom Marcia L. Canto, USA 11:36 - 11:58 IP140 11:24 - 11:34 IP149 Extraintestinal symptoms of IBD Need for histopathology: The pathologist's view Cyriel Y. Ponsioen, The Netherlands Massimo Rugge, Italy 11:34 - 11:56 IP150 Symposium How to correctly report your procedure? 10:30 - 12:00 Room E2 Alexander Meining, Germany Update on chronic pancreatitis Chairs: Markus M. Lerch, Germany Symposium Martin L. Freeman, USA 10:30 - 12:00 Room F2 Food intake, metabolic disorders and endoscopy 10:30 - 10:52 IP141 Chairs: Giovanni Barbara, Italy Chronic pancreatitis: Disease presentation and com- Marc Barthet, France plications Julia Mayerle, Germany 10:30 - 10:52 IP151 Debate Rising Star: The gastric endocrine X/A-like cell as a 10:52 - 11:02 IP142 unique dual regulator of food intake ª Endoscopic therapy for chronic pancreatitis Andreas Stengel, Germany Matthias Löhr, Sweden 10:52 - 11:14 IP152 11:02 - 11:12 IP143 Endocrinological effects of bariatric procedures and Surgical therapy for chronic pancreatitis duodenal exclusion Christiane Bruns, Germany Neil G. Docherty, Ireland 11:14 - 11:36 IP153 Bariatric endoscopic procedures Christopher C. Thompson, USA

48 ª Rising Star ª Top Abstract Prize ª National Scholar 49 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

11:36 - 11:58 IP154 10:54 - 11:06 OP016 Endoscopic resurfacing of the duodenal mucosa for SCISSORS TYPE KNIFE SIGNIFICANTLY IMPROVED type 2 diabetes SELF-COMPLETION RATE OF COLORECTAL ENDOSCOPIC Jacques Deviere, Belgium SUBMUCOSAL DISSECTION PERFORMED BY SUPER- VISED RESIDENTS: A PROSPECTIVE RANDOMIZED TRIAL Symposium Takeshi Yamashina, Japan; Yoji Takeuchi; Noriya Uedo 10:30 - 12:00 Room G 11:06 - 11:18 OP017 An update on the management of hepatocellular FEASIBILITY, SAFETY AND EFFICACY OF KNIFE ASSIST- carcinoma ED RESECTION (KAR) OF RECTAL POLYPS EXTENDING Chairs: Tim Greten, USA TO THE DENTATE LINE: HOW LOW CAN YOU GO? Jean-François Dufour, Switzerland Kesavan Kandiah, United Kingdom; Fergus J. Q. J. 10:30 - 10:52 IP155 Chedgy; Sreedhari Thayalasekaran; Sharmila Combined locoregional therapy Subramaniam; Rupam Bhattacharyya; Fergus 2016 17, October Monday, Wolfgang Sieghart, Austria Thursby-Pelham; Pradeep Bhandari 10:52 - 11:14 IP156 11:18 - 11:30 OP018 New drugs THERMAL ABLATION OF THE MARGIN OF THE POST EN- Nisar P. Malek, Germany DOSCOPIC MUCOSAL RESECTION (EMR) MUCOSAL DEFECT IS HIGHLY EFFECTIVE IN THE PREVENTION OF ADENOMA 11:14 - 11:26 OP013 RECURRENCE FOLLOWING EMR. THE "SCAR" STUDY APLN PROMOTES TUMORIGENICITY IN HEPATOCEL- Amir Klein; Vanoo Jayasekeran; Luke Hourigan; David J. LULAR CARCINOMA THROUGH ACTIVATING PI3K-AKT Tate, Australia; Rajvinder Singh; Gregor Brown; Farzan PATHWAY AND ITS EXPRESSION IS ASSOCIATED WITH Bahin; Nicholas Burgess; Stephen J. Williams; Eric Lee; POOR SURVIVAL IN PATIENTS Michael J. Bourke Huarong Chen, Hong Kong Prc; Qiaoyi Liang; Jiayun Shen; Joseph J. Y. Sung; Jun Yu 11:30 - 11:30 OP019 EVALUATION OF THE LONG-TERM OUTCOMES OF 11:26 - 11:38 OP014 ENDOSCOPIC SUBMUCOSAL DISSECTION PERFORMED TUMORS SKEW THE CCR2-DEPENDENT ANTI-TUMOR WITH A SCISSORS-TYPE KNIFE FOR EARLY COLORECTAL IMMUNE RESPONSE INITIATED BY ONCOGENE-INDUCED NEOPLASMS SENESCENCE TOWARDS TUMOR GROWTH PROMOTION Toshio Kuwai, Japan; Toshiki Yamaguchi; Hiroki Imagawa; Tobias Eggert, USA; Mathias Heikenwälder; Xin W. Yuki Sumida; Takeshi Takasago; Yuki Miyasako; Wang; Lars Zender; Tim Greten Tomoyuki Nishimura; Sumio Iio; Atsushi Yamaguchi; Hirotaka Kouno; Hiroshi Kohno 11:38 - 12:00 IP157 Transplantation: Beyond the Milano criteria 11:30 - 11:30 OP020 Patrizia Burra, Italy THE EFFICACY OF THE NOVEL TISSUE GRASPER-CLIPS TECHNIQUE FOR LARGE SIGMOID COLON PERFORA- Free Paper Session TIONS IN EXPERIMENTAL SIMULATION MODEL 10:30 - 12:00 Room K SU J. HAN; Yonho Jung, Republic of Korea; Il-Kwun Improvements of endoscopic resection techniques in Chung; Young S. Cho; Tae H. Lee; Sang-Heum Park; the colon Sun-Joo Kim Chairs: Mostafa Ibrahim, Belgium Yutaka Saito, Japan Symposium 10:30 - 12:00 Room M 10:30 - 10:42 IP158 Hot topics from Latin America State-of-the-art introduction Chairs: Michael Manns, Germany Yutaka Saito, Japan Luis Carlos Sabbagh, Colombia 10:42 - 10:54 OP015 10:30 - 10:52 IP159 COLD FORCEPS AVULSION (CFA) WITH ADJUVANT Advances in endoscopic treatment of the upper GI tract SNARE TIP SOFT COAGULATION (STSC) IS AN EFFEC- Fabian Emura, Colombia TIVE AND SAFE STRATEGY FOR THE MANAGEMENT OF NON-LIFTING LARGE LATERALLY SPREADING 10:52 - 11:14 IP160 COLORECTAL LESIONS (NL-LSLS) ERCP – New frontiers David J. Tate, Australia; Farzan Bahin; Lobke Desomer; Guillermo de la Mora, Mexico Vikas Gupta; Mayenaaz Sidhu; Michael J. Bourke

Livestream Q&A Audience Voting Recorded Session 49 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

11:14 - 11:36 IP161 Today's Science, Tomorrow's Medicine Endoscopic necrosectomy: Indications and results 10:30 - 12:00 Room N1 José C. Ardengh, Brazil A new era of imaging in GI diseases 11:36 - 11:48 OP021 Chairs: Evelien Dekker, The Netherlands Monday, October 17, 2016 ENDOSCOPIC TREATMENT OF COMPLEX BILIARY STONES: Iris D. Nagtegaal, Netherlands SPYGLASS + ELECTROHYDRAULIC LITHOTRIPSY X BAL- LOON DILATION OF THE MAJOR PAPILLA - PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL 10:30 - 10:52 IP165 Tomazo Franzini, Brazil; Renata N. Moura; Gustavo O. Endoscopic molecular imaging Luz; Marcos E. L. dos Santos; Thiago F. de Souza; Massimiliano di Pietro, United Kingdom Gustavo L. R. Silva; Sergio E. Matuguma; Spencer 10:52 - 11:14 IP166 Cheng; Priscilla C. Bonifacio; Luiz A. C. D'Albuquerque; PET/SPECT Paulo Sakai; Eduardo G. H. de Moura Ambros Beer, Germany 11:48 - 12:00 OP022 11:14 - 11:36 IP167 SAFETY AND EFFICACY OF HYBRID-APC IN GASTRIC MRI ANTRAL VASCULAR ECTASIA (GAVE): A PILOT STUDY Simon Walker-Samuel, United Kingdom Oscar V. V. Hernandez Mondragon, Mexico; Gerardo Blanco Velasco; Juan M. Blancas Valencia 11:36 - 11:58 IP168 Imaging techniques for the future: What is on the horizon? Translational Basic Science Sarah Bohndiek, United Kingdom 10:30 - 12:00 Room 1.61/1.62 Free Paper Session Prevention of GI cancers: Nutrition and chemoprevention Chairs: Thomas Aparicio, France 10:30 - 12:00 Room N2 Roger Leicester, United Kingdom New perspectives in diagnostic and therapeutic EUS Chairs: Todd H. Baron, USA Peter Vilmann, Denmark 10:30 - 10:52 IP162 10:30 - 10:42 IP169 What is the evidence from epidemiological studies? State-of-the-art introduction Krasimira Aleksandrova, Germany Todd H. Baron, USA 10:52 - 11:14 IP163 10:42 - 10:54 OP025 What is the evidence from lab studies? LOW PROCUREMENT YIELD AND DIAGNOSTIC ACCURA- Luigi Ricciardiello, Italy CY OF EUS-GUIDED FINE NEEDLE BIOPSY OF TRANS- 11:14 - 11:36 IP164 DUODENAL LESIONS USING THE 19-GAUGE FLEXIBLE What is the evidence from clincal trials? NEEDLE: A LARGE MULTICENTER PROSPECTIVE STUDY Andrew T. Chan, USA Mihai Rimbas, Romania; Fabia Attili; Carlo Fabbri; Ichiro Yasuda; Lorenzo Fuccio; Laurent Palazzo; ilaria tarantino; 11:36 - 11:48 OP023 John DeWitt; Leonardo Frazzoni; Alberto Larghi CD24 INDUCES THE ACTIVATION OF B-CATENIN IN INTESTINAL TUMORIGENESIS 10:54 - 11:06 OP026 Ahmad Fokra, Israel; Shiran Shapira; Dina Kazanov; RANDOMIZED TRIAL COMPARING THE 22 AND 25 Faina Bedny; Eli Brazowski; Chen Varol; Sarah Kraus; GAUGE NEEDLES USING THE SUCTION-IN AND Nadir Arber NO-SUCTION (SINS) TECHNIQUES FOR EUS-GUIDED FNA OF PANCREATIC MASSES 11:48 - 12:00 OP024 Ji Y. Bang, USA; Shantel LOSS OF PTPN2 IN MACROPHAGES AGGRAVATES COLITIS Hebert-Magee; Muhammad Hasan; Udayakumar BUT PROTECTS FROM COLORECTAL TUMOUR FORMATION Navaneethan; Robert Hawes; Shyam Varadarajulu Marianne R. Spalinger, Switzerland; Stephanie H. Kasper; Susan Bengs; Claudia Gottier; Kirstin Atrott; 11:06 - 11:18 OP027 Tina Raselli; Gerhard Rogler; Michael Scharl EUS-GUIDED BILIARY DRAINAGE VERSUS PERCUTANE- OUS BILIARY DRAINAGE: RESULTS OF A MULTICENTER RANDOMIZED PHASE II STUDY Erwan Bories, France; Jean P. Ratone; Fabrice Caillol; Christian Pesenti; Christophe Zemmour; Jean-Marie Boher; Dominique Genre; Marc Barthet; Bertrand Napoléon; Marc Giovannini

50 ª Rising Star ª Top Abstract Prize ª National Scholar 51 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

11:18 - 11:30 OP028 10:54 - 11:06 OP032 EUS-GUIDED GASTROENTEROSTOMY IS COMPARABLE TARGET-SPECIFIC ANTI-PANCREATIC ANTIBODIES ARE TO ENTERAL STENTING IN TERMS OF TECHNICAL FREQUENT IN PATIENTS WITH PRIMARY SCLEROSING FEASIBILITY AND CLINICAL SUCCESS WITH LOWER CHOLANGITIS AND ASSOCIATED WITH POOR DISEASE RATES OF RE-INTERVENTION: AN INTERNATIONAL OUTCOME MULTICENTER COMPARATIVE STUDY Mária Papp, Hungary; Tamas Tornai; Nora Sipeki; Yen-I Chen, USA; Takao Itoi; Todd H. Baron; Jose Zsuzsanna Vitalis; Istvan Tornai; Kai Fechner; Dirk Nieto; Yamile Haito-Chavez; Ian S. Grimm; Saowanee Roggenbuck; David Tornai; Gary L. Norman; Zakera Ngamruengphong; Majidah Bukhari; Gulara Hajiyeva; Shums; Gabor Veres; Peter Orosz; Bela Lombay; Judit Amr Ismail; Awad Alawad; Vivek Kumbhari; Mouen Gervain; Gabriella Par; Alajos Par; Peter L. Lakatos; Khashab Ferenc Szalay; Peter Antal-Szalmas 11:30 - 11:42 OP029 11:06 - 11:18 OP033

DEDICATED BI-FLANGED METAL STENT WITH ENDO- GUT BARRIER FAILURE BIOMARKERS ARE ASSOCIATED 2016 17, October Monday, SCOPIC "STEP-UP APPROACH" REDUCES THE NEED FOR WITH POOR DISEASE OUTCOME IN PATIENTS WITH DIRECT NECROSECTOMY IN WON - LARGE EXPERIENCE PRIMARY SCLEROSING CHOLANGITIS FROM A SINGLE TERTIARY CARE CENTRE. Tamas Tornai; Gyorgy Kovacs; Zsuzsanna Vitalis; Sundeep Lakhtakia, India; Jahangeer Basha; Rupjyoti Istvan Tornai; Kai Fechner; Dirk Roggenbuck; David Talukdar; Rajesh Gupta; Mohan K. Ramchandani; BVN Tornai; Gary L. Norman; Gabor Veres; Zakera Shums; K. Sureddi; Partha Pal; Zaheer Nabi; Rakesh Kalpala; Peter Orosz; Bela Lombay; Judit Gervain; Gabriella Palle M. Reddy; Jagadeesh R. Singh; Rebala Pradeep; Par; Alajos Par; Peter L. Lakatos; Ferenc Szalay; Peter G. V. Rao; D. N. Reddy Antal-Szalmas; Mária Papp, Hungary 11:42 - 11:54 OP030 11:18 - 11:30 OP034 CLINICAL OUTCOME AFTER BILIARY DRAINAGE FOR COMPARISONS OF IMAGING AND BILIARY BIOPSY METASTATIC COLORECTAL CANCER: SURVIVAL ANALYSIS BETWEEN IGG4-RELATED SCLEROSING CHOLANGITIS AND PRONOSTIC FACTORS AND EXTRAHEPATIC CHOLANGIOCARCINOMA. Floriane Sellier, France; Erwan Bories; Camille Toru Matsui, Japan; Hiroyuki Matsubayashi; Hirotoshi Sibertin-Blanc; Karolina Griffiths; Laetitia Dahan; Ishiwatari; Sayo Ito; Noboru Kawata; Kenichiro Imai; Marc Giovannini; Jean Gaudart; Jean F. Seitz; Masaki Tanaka; Kohei Takizawa; Naomi Kakushima; René Laugier; Philippe Grandval Kinichi Hotta; Hiroyuki Ono 11:30 - 11:42 OP035 Free Paper Session SELECTIVE TARGETING OF FXR? ISOFORMS BY NOVEL 10:30 - 12:00 Room L7 BILE ACID DERIVATIVES IS ASSOCIATED WITH INHIBI- Mechanisms of Primary Sclerosing Cholangitis TION OF LIPOTOXICITY IN LIVER CELLS Chairs: Tim Lankisch, Germany Hugo M. D. S. Brito, Portugal; Salete Batista; Maria M. C. Erik Schrumpf, Norway Silva; Jorge Salvador; Rui E. Castro; Cecília M. P. Rodrigues 10:30 - 10:42 IP170 11:42 - 11:54 OP036 State-of-the-art introduction THE IMPACT OF PNPLA3 (RS738409 C>G P.I148M) Tim Lankisch, Germany ALLELE DOSE ON DISEASE COURSE IN PRIMARY SCLE- 10:42 - 10:54 OP031 ROSING CHOLANGITIS (PSC) BILE DUCT INFLAMMATION ASSESSED BY BILIARY CAL- Martti A. Färkkila, Finland; Hannu Kautiainen; Kalle PROTECTIN AND NEUTROPHILS CORRELATES WITH RISK Jokelainen; Johanna Arola; Kimmo Kontula OF BILIARY DYSPLASIA AND CHOLANGIOCARCINOMA Martti A. Färkkila, Finland; Harri Mustonen; Kalle Free Paper Session Jokelainen; Johanna Arola; Henrik Alfthan 10:30 - 12:00 Room L8 Basic mechanisms of intestinal carcinogenesis Chairs: C. Richard Boland, USA Trevor A. Graham, United Kingdom 10:30 - 10:42 IP171 State-of-the-art introduction C. Richard Boland, USA

Livestream Q&A Audience Voting Recorded Session 51 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

10:42 - 10:54 OP037 10:42 - 10:54 OP043 TRANSGENIC EXPRESSION OF HUMAN LYSOPHOS- PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT PHATIDIC ACID RECEPTOR (LPA2) IN MOUSE INTESTINAL (HP-EUREG): INTERIM ANALYSIS OF THE RESCUE TREAT- EPITHELIAL CELLS INDUCES INTESTINAL DYSPLASIA MENT WITH BISMUTH, LEVOFLOXACIN AND AMOXICILLIN

Monday, October 17, 2016 Michihiro Yoshida, Japan; Chris Yun; Kazuki Hayashi; Adrian G. McNicholl, Spain; Francis Megraud; Bojan Tesshin Ban; Itaru Naitoh; Hiromu Kondo; Yuji Nishi; Tepe; Marino Venerito; Antonio Gasbarrini; Dmitry Shuichiro Umemura; Yasuaki Fujita; Makoto Natsume; S. Bordin; Manuel Castro; Juan Ortuño; Javier Molina Akihisa Kato; Hirotaka Ohara; Takashi Joh Infante; Jesus Barrio; Jean-Charles Delchier; Maria G. Donday; Olga P. Nyssen; Colm O'Morain; Javier P. Gisbert 10:54 - 11:06 OP038 CELL-SPECIFIC ROLES OF CALCINEURIN IN INTESTINAL 10:54 - 11:06 OP044 TUMOR DEVELOPMENT ERADICATION RATES OF HELICOBACTER PYLORI USING Kenneth Peuker, Germany; Stefanie Muff; Jun Wang; A NEW GASTRIC ACID SUPPRESSANT, VONOPRAZAN, Marijana Basic; Anne Strigli; Arthur Kaser; Alexander COMPARED WITH AN ESOMEPRAZOLE REGIMEN Arlt; Gijs R. van den Brink; Clemens Schafmayer; Masahiro Tsujimae, Japan; Hiroshi Yamashita; Atsushi Jan-Hendrik Egberts; Thomas Becker; André Bleich; Kanamori; Kei Matsumoto; Akio Koizumi; Takaaki Christoph Röcken; Jochen Hampe; Stefan Schreiber; Eguchi; Akihiko Okada John Baines; Richard S. Blumberg; Sebastian Zeissig 11:06 - 11:18 OP045 11:06 - 11:18 OP039 STROMAL MYOFIBROBLASTS ORCHESTRATE GASTRIC ALIX POSITIVE EXOSOMES IN COLORECTAL ADENO- EPITHELIAL WNT-SIGNALING AND STEM CELL KINET- MA-CARCINOMA SEQUENCE ICS IN HEALTH AND DISAEASE Gabor Valcz; Orsolya Galamb; Tibor Krenacs; Arpad Michael Sigal, Germany; Manuel R. Amieva; Thomas V. Patai, Hungary; Sándor Spisák; Alexandra Kalmár; Meyer Barnabas Wichmann; Kristóf Dede; Zsolt Tulassay; Bela Molnar 11:18 - 11:30 OP046 THE ANTI-APOPTOTIC FACTOR CLUSTERIN IS INVOLVED 11:18 - 11:30 OP040 IN HYPERGASTRINEMIA-INDUCED REMODELING OF NHERF2 REGULATES COLON CANCER PROGRESS VIA THE GASTRIC OXYNTIC MUCOSA STAT3 Pål Vange, Norway; Torunn Bruland; Berit Doseth; Michihiro Yoshida, Japan; Chris Yun; Kazuki Hayashi; Mirta M. Sousa; Øystein Sørdal; Gunnar Qvigstad; Tesshin Ban; Itaru Naitoh; Hiromu Kondo; Yuji Nishi; Reidar Fossmark; Helge L. Waldum; Arne K. Sandvik; Shuichiro Umemura; Yasuaki Fujita; Makoto Natsume; Ingunn Bakke Akihisa Kato; Hirotaka Ohara; Takashi Joh 11:30 - 11:42 OP047 11:30 - 11:42 OP041 THE GREAT MAJORITY OF THE H. PYLORI INFECTED THE EXTRACELLULAR MATRIX PROTEIN EMILIN2 AS A POPULATION HAS REDUCED INTRAGASTRIC ACIDITY REGULATOR OF THE MYELOID RESPONSE IN A MODEL WHICH IS MOST MARKED CLOSE TO THE GASTRO- OF INFLAMMATION-INDUCED COLON CARCINOGENESIS. ESOPHAGEAL JUNCTION. Eva Andreuzzi, Italy; Alice Paulitti; Giulia Tarticchio; David Mitchell, United Kingdom; Mohammad Emma Di Carlo; Rosanna Pellicani; Alfonso Colombatti; Derakhshan; Angela Wirz; Clare Orange; David Hughes; Renato Cannizzaro; Maurizio Mongiat Stuart Ballantyne; James Going; Kenneth McColl 11:42 - 11:54 OP042 11:42 - 11:54 OP048 THE ROLE OF MIRNA-145 IN COLON CANCER STEM ASSOCIATION BETWEEN LUMINAL BILE SALT CONTENT CELL-LIKE CELLS AND DUODENAL MUCOSAL INTEGRITY IN HEALTHY Sofia E. Gomes, Portugal; Diane M. Pereira; André E. VOLUNTEERS S. Simões; Rui E. Castro; Pedro M. Borralho; Cecília M. Dorien Beeckmans, Belgium; Danny Riethorst; Ricard P. Rodrigues L. Farré Marti; Patrick Augustijns; Jan Tack; Hanne Vanheel Free Paper Session 10:30 - 12:00 Room 1.86 Gastroduodenal damage: H.pylori, acid and bile Chairs: Nikola Panic, Serbia Nicola Jones, Canada 10:30 - 10:42 IP172 State-of-the-art introduction Nicola Jones, Canada

52 ª Rising Star ª Top Abstract Prize ª National Scholar 53 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

Free Paper Session 11:40 - 11:50 OP056 10:30 - 12:00 Hotspot ENDOSTIM® LES STIMULATION THERAPY IMPROVES Abstracts on Fire: GORD on Fire GERD IN PATIENTS WITH LAPAROSCOPIC SLEEVE Chairs: Lesley Houghton, USA GASTRECTOMY (LSG) Martin Ďuriček, Slovak Republic Yves Borbély, Switzerland; Alejandro Nieponice; Leonardo Rodríguez; Henning Schulz; Camilo Ortiz; 10:30 - 10:40 OP049 Michael Talbot; David Martin; Nicole Bouvy MUCOSAL AFFERENT NERVES ARE MORE SUPERFICIAL IN THE DISTAL OESOPHAGUS OF PATIENTS WITH NERD 11:50 - 12:00 OP057 COMPARED TO CONTROLS ELECTRICAL STIMULATION OF THE LES - AN EMERGING Philip Woodland, United Kingdom; Federica Grassi; THERAPY FOR GERD PATIENTS WITH FAILED ESOPHA- Nikos Koukias; Chung Lee; Rubina Aktar; Madusha GEAL PERISTALSIS Peiris; Ashley Blackshaw; Daniel Sifrim Mauricio Ramirez; Cecilia Zubieta; Franco Ciotola; Claudio Bilder; Andres DiTaranto; Adolfo Badaloni; 2016 17, October Monday, 10:40 - 10:50 OP050 Alejandro Nieponice, Argentina MUCOSAL INTEGRITY AND SENSITIVITY TO ACID OF THE PROXIMAL IN PATIENTS WITH GAS- Symposium TROESOPHAGEAL REFLUX DISEASE 12:15 - 13:15 Hotspot Froukje B. van Hoeij, The Netherlands; Pim W. Moving GI education into the future: Current chal- Weijenborg; Marius A. van den Bergh Weerman; Rene lenges, future needs M. van den Wijngaard; Joanne Verheij; André Smout; Chairs: Heinz Florian Hammer, Austria Albert J. Bredenoord Isabelle Cremers, Portugal 10:50 - 11:00 OP051 LARYNGOPHARYNGEAL SYMPTOMS IN PRIMARY CARE: USEFULNESS OF SALIVARY PEPSIN MEASUREMENT IN 12:15 - 12:30 IP173 PREDICTING GERD The perspective of the European Board of Gastroenter- Alberto Bozzani; Rudi De Bastiani; Marco Della Coletta, ology and Hepatology: Curriculum and board exam Italy; Edoardo Savarino; Ignazio Grattagliano Ian Barrison, United Kingdom 11:00 - 11:10 OP052 12:30 - 12:45 IP174 INADEQUATE SYMPTOM CONTROL ON LONG-TERM PPI The perspective of UEG: Educational opportunities - THERAPY IN GERD? FACT OR FICTION? (LOPA II STUDY) Bench to bedside Joachim Labenz, Germany; Gisela Labenz; Dietmar Heinz F. Hammer, Austria Stephan; Frank Willeke 12:45 - 13:00 IP175 11:10 - 11:20 OP053 The perspective of the trainee EFFICACY OF ACOTIAMIDE IN PATIENTS WITH GAS- Valeria Castro, Sweden TROESOPHAGEAL REFLUX DISEASE UNRESPONSIVE TO 13:00 - 13:15 IP176 PROTON PUMP INHIBITOR THERAPY Hiroshi Yamashita, Japan; Atsushi Kanamori; Akihiko PANEL DISCUSSION Okada Round Table Discussion 11:20 - 11:30 OP054 12:45 - 13:45 Room G A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE How to use FODMAPs and other diets in your clinical CLINICAL EFFICACY OF ESOMEPRAZOLE VS. VONO- practice? PRAZAN FOR RESOLUTION OF GASTRO-ESOPHAGEAL Chair: Kevin Whelan, United Kingdom REFLUX DISEASE SYMPTOMS IN NEWLY DIAGNOSED Experts: Kevin Whelan, United Kingdom PATIENTS. Giovanni Barbara, Italy Shinichi Ishihara, Japan Jessica Biesiekierski, Belgium 11:30 - 11:40 OP055 Hungin, United Kingdom EFFICACY AND SAFETY OF THE ENDOLUMINAL MAN- AGEMENT OF REFRACTORY GASTROESOPHAGEAL REFLUX WITH BAND LIGATION Waseem M. Seleem, Egypt; Amr S. Hanafy

Livestream Q&A Audience Voting Recorded Session 53 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

Round Table Discussion Symposium 12:45 - 13:45 Room K 14:00 - 15:30 Room D Colonoscopic surveilllance strategies Management of bloating and flatulence Chair: Bjorn Rembacken, United Kingdom Chairs: Marc Benninga, The Netherlands

Monday, October 17, 2016 Experts: Bjorn Rembacken, United Kingdom Jutta Keller, Germany Evelien Dekker, The Netherlands Matthew Rutter, United Kingdom Michal Filip Kaminski, Poland 14:00 - 14:22 IP182 Which patients are we referring to? Round Table Discussion Vincenzo Stanghellini, Italy 12:45 - 13:45 Room L7 14:22 - 14:44 IP183 Optimal management of gastric cardia cancers Dietary treatment Chair: Paul Fockens, The Netherlands Jessica Biesiekierski, Belgium Experts: Paul Fockens, The Netherlands Giovanni de Manzoni, Italy 14:44 - 15:06 IP184 Fatima Carneiro, Portugal Drug treatment Anna Dorothea Wagner, Switzerland Carmelo Scarpignato, Italy 15:06 - 15:28 IP185 Round Table Discussion Behavioural therapy 12:45 - 13:45 Room L8 Fernando Azpiroz, Spain Bacterial infections in end stage liver disease Chair: Dominique Thabut, France Symposium Experts: Dominique Thabut, France 14:00 - 15:30 Room B Thomas Reiberger, Austria Therapy update: Therapeutic EUS - New indications Bogdan Dumitru Procopet, Romania Chairs: Alexander Meining, Germany Jonel Trebicka, Germany J. Enrique Dominguez-Munoz, Spain

Symposium 14:00 - 15:30 Room A 14:00 - 14:22 IP186 Best of DDW EUS-guided biliary duct drainage Chairs: Michael Manns, Germany Marc Giovannini, France Timothy C. Wang, USA 14:22 - 14:44 IP187 Pancreatic duct drainage: When the tranpapillary route is impossible 14:00 - 14:18 IP177 Jacques Deviere, Belgium GI oncology C. R. Boland, USA 14:44 - 15:06 IP188 EUS-guided hemostasis 14:18 - 14:36 IP178 Marc Barthet, France Liver Robert Fontana, USA 15:06 - 15:28 IP189 EUS-guided therapies for pancreatic cancer 14:36 - 14:54 IP179 Paul Fockens, The Netherlands IBD Deborah D. Proctor, USA Symposium 14:54 - 15:12 IP180 14:00 - 15:30 Room C Oesophagus and upper GI Endoscopy performance measures: What you should Stuart J. Spechler, USA be doing 15:12 - 15:30 IP181 Chairs: Ecaterina Daniela Dobru, Romania Pancreatic disorders Matthew Rutter, United Kingdom Santhi S. Vege, USA Tandem Talks 14:00 - 14:10 IP190 Upper GI performance measures Ecaterina D. Dobru, Romania 54 ª Rising Star ª Top Abstract Prize ª National Scholar 55 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

14:10 - 14:20 IP191 15:08 - 15:30 IP198 Lower GI performance measures Pros and cons of accessories for improving detection Michal F. Kaminski, Poland Ralf Kiesslich, Germany 14:20 - 14:30 IP192 Symposium Small bowel performance measures Cristiano Spada, Italy 14:00 - 15:30 Room E2 Management of oesophageal motility disorders 14:30 - 14:40 IP193 Chairs: Edoardo Savarino, Italy Pancreatobiliary performance measures Guy E. Boeckxstaens, Belgium Dirk Domagk, Germany 14:40 - 15:02 IP194 14:00 - 14:22 IP199 Endoscopy service performance measures

Diagnostic approach 2016 17, October Monday, Roland Valori, United Kingdom Sabine Roman, France 15:02 - 15:24 IP195 14:22 - 14:44 IP200 PANEL DISCUSSION and balloon dilatation Peter D. Siersema, The Netherlands Symposium 14:00 - 15:30 Room E1 14:44 - 15:06 IP201 Improving the adenoma detection rate Peroral Endoscopic Myotomy (POEM) Chairs: Jaroslaw Regula, Poland Guido Costamagna, Italy Marcia Irene Canto, USA 15:06 - 15:28 IP202 Laparoscopic myotomy Giovanni Zaninotto, Italy 14:00 - 14:22 IP196 Optimising colon preparation and performance of Symposium colonoscopy Cesare Hassan, Italy 14:00 - 15:30 Room F1 Japanese European perspectives: Endoscopic classifi- 14:22 - 14:34 OP058 cations update ENDOCUFF-ASSISTED COLONOSCOPY OUTPER- Chairs: Hisao Tajiri, Japan FORMS CONVENTIONAL COLONOSCOPY TO DETECT Lars Aabakken, Norway MISSED-ADENOMAS: EUROPEAN MULTICENTER, RANDOMIZED, BACK-TO-BACK STUDY. Konstantinos Triantafyllou, Greece; Dimitrios 14:00 - 14:15 IP203 Polymeros; Periklis Apostolopoulos; Catarina Brandão; Squamous cell carcinoma of the oesophagus Paraskevas Gkolfakis; Alessandro Repici; Ioannis S. Haruhiro Inoue, Japan Papanikolaou; Mario Dinis-Ribeiro; Georgios 14:15 - 14:30 IP204 Alexandrakis; Cesare Hassan Barrett's dysplasia 14:34 - 14:46 OP059 Oliver Pech, Germany THE DIAGNOSTIC ABILITY OF A COMPUTER-AIDED 14:30 - 14:45 IP205 DIAGNOSIS SYSTEM FOR NARROW-BAND IMAGING Early gastric cancer: Diagnostic algorithm ENDOCYTOSCOPY IS COMPARABLE TO THAT OF EX- Kenshi Yao, Japan PERT ENDOSCOPISTS Masashi Misawa, Japan; Shin-ei Kudo; Yuichi Mori; 14:45 - 15:00 IP206 Kenichi Takeda; Yasuharu Maeda; Shinichi Kataoka; Colorectal neoplasia: Narrow band imaging interna- Hiroki Nakamura; Toyoki Kudo; Kunihiko Wakamura; tional colorectal endoscopic classification Takemasa Hayashi; Hideyuki Miyachi; Atsushi Katagiri; Evelien Dekker, The Netherlands Toshiyuki Baba; Fumio Ishida; Haruhiro Inoue; Masahiro Oda; Kensaku Mori 15:00 - 15:15 IP207 Colorectal neoplasia: Japan narrow band imaging 14:46 - 15:08 IP197 expert team classification Impact of new generation of endoscopes Yutaka Saito, Japan Thierry Ponchon, France 15:15 - 15:30 IP208 IBD - Endoscopic classification James E. East, United Kingdom

Livestream Q&A Audience Voting Recorded Session 55 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

Symposium 14:24 - 14:36 OP061 14:00 - 15:30 Room F2 INCIDENT CANCER IN INFLAMMATORY BOWEL DISEASE: Liver diseases beyond alcohol, fatty liver and viral RISK FACTORS IN A LONG TERM MULTICENTER NESTED hepatitis CASE-CONTROL IG-IBD STUDY AT 4 YEARS

Monday, October 17, 2016 Chairs: Soo Aleman, Sweden Livia Biancone, Italy; Alessandro Armuzzi; Maria L. James Neuberger, United Kingdom Scribano; Renata D'Inca; Fabiana Castiglione; Erika Angelucci; Marco Daperno; Claudio Papi; Carmelina Petruzziello; Luisa Spina; Luisa Guidi; Anna Kohn; 14:00 - 14:22 IP209 Filippo Mocciaro; Patrizia Alvisi; Alessandra Ruffa; Vascular liver manifestations of systemic diseases Walter Fries; Gabriele Riegler; Emma Calabrese; Sara Isabelle Colle, Belgium Renna; Roberto Di MItri; Francesca Rogai; Gianmichele Meucci; Sandro Ardizzone; Maurizio Vecchi; Alessandra 14:22 - 14:44 IP210 Rossi; Ambrogio Orlando; Francesco Pallone Rising Star: The role of keratins and iron in the digestive system ª 14:36 - 14:48 OP062 Pavel Strnad, Germany USE OF IMMUNOSUPRESSANTS AND BIOLOGICAL AGENTS IN IBD PATIENTS WITH PAST HISTORY OF CANCER Tandem Talks Miriam Mañosa Ciria, Spain; Alba Juan Juan; Jordi 14:44 - 14:54 IP211 Guardiola; Ignacio Alfaro Perez; Miguel Minguez; Genetic liver disease in childhood Benito Velayos; Jose M. Benítez Cantero; Francisco Ulrich Baumann, Germany Mesonero; Maria Chaparro; Beatriz Sicília Aladrén; 14:54 - 15:04 IP212 Yamile Zabana; Albert Villoria; Rufo Lorente Poyatos; Genetic liver disease in adults Maria P. Martinez Montiel; Luis Bujanda Fernández Peter Ferenci, Austria de Piérola; Lucia Márquez Mosquera; Jesús Barrio Andrés; Marta Piqueras Cano; Nuria Jimenez; Cristina 15:04 - 15:26 IP213 Rodriguez Gutierrez; Pilar Nos Mateu; Miquel Montoro; Polycystic liver disease and Caroli disease MªC. Muñoz; Esther Rodriguez; Mariló Martin-Arranz; Joost P. H. Drenth, The Netherlands Antonio Rodriguez Perez; Manuel Van Domselaar; Montserrat Rivero; Jose L. Cabriada; María T. Free Paper Session Arroyo-Villarino; Patricia Romero; Santiago Garcia; 14:00 - 15:30 Room G Charro; Javier P. Gisbert; Eugeni Domènech Long-term management of IBD 14:48 - 15:00 OP063 Chairs: Gerassimos Mantzaris, Greece RISK OF SERIOUS AND OPPORTUNISTIC INFECTIONS IN Gareth Jones, United Kingdom PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A 14:00 - 14:12 IP214 NATIONWIDE FRENCH COHORT STUDY ª State-of-the-art introduction Julien Kirchgesner, France; Magali Lemaitre; Mahmoud Gerassimos Mantzaris, Greece Zureik; Franck Carbonnel; Rosemary Dray-Spira 14:12 - 14:24 OP060 15:00 - 15:12 OP064 LYMPHOMA IN PATIENTS WITH INFLAMMATORY BOWEL THE COURSE OF HEALTH-RELATED QUALITY OF LIFE IN IN- DISEASE: A FRENCH NATIONWIDE OBSERVATIONAL FLAMMATORY BOWEL DISEASE FIVE, TEN AND 20 YEARS COHORT STUDY AFTER DIAGNOSIS - DATA FROM THE IBSEN STUDY Magali Lemaitre, France; Julien Kirchgesner; Annie Gert Huppertz-Hauss, Norway; Bjørn Moum; Tomm Rudnichi; Fabrice Carrat; Antoine Racine; Mahmoud Bernklev Zureik; Rosemary Dray-Spira; Franck Carbonnel 15:12 - 15:24 OP065 PROGNOSTIC FACTORS FOR LONG-TERM INFLIXIMAB TREATMENT IN CROHN'S DISEASE PATIENTS: A 20- YEAR SINGLE CENTER EXPERIENCE Thomas Billiet, Belgium; Isabelle Cleynen; Vera Ballet; Marc Ferrante; Gert Van Assche; Ann Gils; Severine Vermeire

56 ª Rising Star ª Top Abstract Prize ª National Scholar 57 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

Free Paper Session 15:12 - 15:24 OP071 14:00 - 15:30 Room K FAECAL MICROBIOTA TRANSPLANTATION (FMT) IN UL- Microbiota and diet: From bench to bedside CERATIVE COLITIS (UC) IS ASSOCIATED WITH SPECIFIC Chairs: Paul Moayyedi, Canada BACTERIAL CHANGES: STOOL AND COLONIC MUCOSA Gianluca Ianiro, Italy 16S MICROBIOTA ANALYSIS FROM THE RANDOMISED CONTROLLED FOCUS STUDY ª 14:00 - 14:12 IP215 Sudarshan Paramsothy, Australia; Nadeem Kaakoush; State-of-the-art introduction Michael A. Kamm; Jeremiah Faith; Jose Clemente; Paul Moayyedi, Canada Alissa Walsh; Johan van den Bogaerde; Douglas 14:12 - 14:24 OP066 Samuel; Rupert W. Leong; Susan Connor; Watson CYCLIC ENTERAL NUTRITION FOR THE MAINTENANCE OF Ng; Ramesh Paramsothy; Enmoore Lin; Jean-Frederic REMISSION IN PEDIATRIC CROHN'S DISEASE PATIENTS. Colombel; Thomas J. Borody; Hazel Mitchell

Bénédicte PIGNEUR, France; Sara Nóbrega; Frank 2016 17, October Monday, Ruemmele Free Paper Session 14:00 - 15:30 Room M 14:24 - 14:36 OP067 Late breaking abstracts I CHANGES IN MUCOSAL-ASSOCIATED INTESTINAL Chairs: tbc MICROBIOTA AND FECAL BACTERIA IN INFLAMMATORY BOWEL DISEASE PATIENTS AND HEALTHY SUBJECTS: A Translational Basic Science PILOT STUDY Michele P. L. Guarino; Lorenza Putignani; Annamaria 14:00 - 15:30 Room 1.61/1.62 Altomare, Italy; Federica Del Chierico; Silvia Cocca; IBD: The role of different cell types in the inflamma- Sara Emerenziani; Bruno Dalla Piccola; Michele Cicala tory process Chairs: Silvio Danese, Italy 14:36 - 14:48 OP068 Britta Siegmund, Germany BACTERIOPHAGE THERAPY: A NEW STRATEGY TO TAR- GET ADHERENT-INVASIVE ESCHERICHIA COLI BACTERIA IN THE GI TRACT OF CROHN'S DISEASE PATIENTS 14:00 - 14:22 IP216 Matthieu Galtier; Luisa De Sordi; Adeline Sivignon, Myeloid cells France; Amélie de Vallée; Damien Maura; C Neut; Gijs R. van den Brink, The Netherlands Oumaira Rahmouni; Kristin Wannerberger; Pierre Desreumaux; Nicolas Barnich; Laurent Debarbieux 14:22 - 14:44 IP217 Innate lymphoid cells 14:48 - 15:00 OP069 Britta Siegmund, Germany CIPROFLOXACIN RESISTANCE IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH ESBL PRODUCING 14:44 - 15:06 IP218 ENTEROBACTERIACEAE COLONIZATION ª Epithelial cells Vita Skuja, Latvia; Katrina Pekarska; Zane Straume; Timon E. Adolph, Austria Elina Goida; Helena Dauvarte; Dace Rudzite; Elvira 15:06 - 15:28 IP219 Lavrinovica; Linda Piekuse; Aleksejs Derovs; Aivars Rising Star: Role of prenylated Rho proteins in IBD and Lejnieks; Angelika Krumina colitis-associated colon cancer ª 15:00 - 15:12 OP070 Imke Atreya, Germany CARD9 IMPACTS COLITIS BY ALTERING GUT MICROBIO- TA METABOLISM OF TRYPTOPHAN INTO ARYL HYDRO- Today's Science, Tomorrow's Medicine CARBON RECEPTOR LIGANDS 14:00 - 15:30 Room N1 Bruno , France; Mathias Lavie-Richard; Marie-Laure Free Paper Session: The future of diagnostics in Michel; Valentin Leducq; Chantal Bridonneau; Gregory Da hepatology and upper GI diseases Costa; Laurent Beaugerie; Philippe Langella; Harry Sokol Chairs: Tamara Matysiak Budnik, France Tomislav Bokun, Croatia 14:00 - 14:12 OP072 RELAXIN-COATED IRON-OXIDE MAGNETIC NANOPAR- TICLES AS A NOVEL THERANOSTIC APPROACH FOR DIAGNOSIS AND TREATMENT OF LIVER FIBROSIS Ruchi Bansal, The Netherlands; Beata Nagórniewicz1; Jai Prakash; Gert Storm

Livestream Q&A Audience Voting Recorded Session 57 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

14:12 - 14:24 OP073 14:12 - 14:24 OP079 A QUANTITATIVE IMAGING PLATFORM TO REAL-TIME POPULATION PREVALENCE OF ROME III AND ROME IV MEASURE SPECIFIC ROS LEVELS IN LIVER DISEASES (IBS) IN THE UNITED Haolu Wang, Australia; Xiaowen Liang; Xin Liu; Run STATES (US), CANADA AND THE UNITED KINGDOM (UK).

Monday, October 17, 2016 Zhang; Michael Roberts Olafur S. S. Palsson, USA; Miranda van Tilburg; Magnus Simrén; Ami D. Sperber; William E. Whitehead 14:24 - 14:36 OP074 RANDOMIZED CONTROLLED TRIAL (RCT) OF DOPPLER 14:24 - 14:36 OP080 ENDOSCOPIC PROBE (DEP) FOR BLOOD FLOW DETECTION FUNCTIONAL HEARTBURN OVERLAPS WITH IRRITABLE IN SEVERE NON-VARICEAL UGI HEMORRHAGE (NVUGIH) BOWEL SYNDROME MORE OFTEN THAN GERD - DE- Dennis M. Jensen, USA; Thomas O. Kovacs; Gordon V. VELOPMENT OF A PREDICTIVE MODEL FOR CLINICAL Ohning; Kevin Ghassemi; Gustavo Machicado; Gareth PRACTICE Dulai; Alireza Sedarat; Rome Jutabha; Jeffrey Gornbein Salvatore Tolone, Italy; Nicola De Bortoli; Leonardo Frazzoni; Edoardo Savarino; Marzio Frazzoni; Irene 14:36 - 14:48 OP075 Martinucci; Elisa Marabotto; Manuele Furnari; Giorgia ESOPHAGEAL HIGH RESOLUTION MANOMETRY WITH A Bodini; Lorenzo Fuccio; Vincenzo Savarino; Santino Marchi SOLID TEST MEAL IMPROVES THE DETECTION OF CLIN- ICALLY RELEVANT ESOPHAGEAL DYSFUNCTION AND 14:36 - 14:48 OP081 SYMPTOM REPRODUCIBILITY: A VALIDATION STUDY IN IRRITABLE BOWEL SYNDROME: WHICH SYMPTOMS A MULTIRACIAL ASIAN COHORT. ARE PERSISTENT AND WHICH ARE NOT? Daphne Ang, Singapore; My Lee; Terence Tan; Meng Egbert Clevers, Belgium; Jan Tack; Hans Törnblom; Zhang; Mark Fox Magnus Simrén; Lukas Van Oudenhove 14:48 - 15:00 OP076 14:48 - 15:00 OP082 THE NEW IMAGE ENHANCEMENT TECHNOLOGY SYMPTOMS COMPATIBLE WITH FUNCTIONAL BOWEL USING LINKED COLOR IMAGING WITH ACETIC ACID DISORDERS IN PATIENTS WITH ULCERATIVE COLITIS IN INDIGOCARMINE MIXTURE FOR DIAGNOSIS OF EARLY DEEP REMISSION. GASTRIC NEOPLASM Magnus Simrén, Sweden; Börje Jonefjäll; Olafur Yoshiro Kawahara, Japan; Hiromitsu Kanzaki; Hiroyuki Palsson; William E. Whitehead; Hans Törnblom; Lena Sakae; Kou Miura; Yoshiyasu Kono; Masaya Iwamuro; Öhman; Hans Strid Seiji Kawano; Hiroyuki Okada 15:00 - 15:12 OP083 15:00 - 15:12 OP077 ENHANCED DIAGNOSTIC PERFORMANCE OF SYMP- EXOSOMES DERIVED FROM GASTRIC CANCER PA- TOM-BASED CRITERIA FOR IRRITABLE BOWEL SYN- TIENTS AND CELLS COULD DELIVER MIR-21 TO ELICIT DROME BY HISTORY AND DIAGNOSTIC EVALUATION. TUMOR PROGRESSION AND METASTASIS AND COULD Ruchit Sood, United Kingdom; Michael Camilleri; David BE USED AS A POTENTIAL DIAGNOSTIC BIOMARKER J. Gracie; Matthew J. Gold; Natalie To; Graham R. Law; Xiaoying Zhou, China; Guoixn Zhang Alexander C. Ford 15:12 - 15:24 OP078 15:12 - 15:24 OP084 URINARY KALLIKREIN-10 PREDICTS INCURABILITY FOR HEALTHCARE RESOURCE UTILISATION AMONG PA- GASTRIC CANCER TIENTS WITH IRRITABLE BOWEL SYNDROME WITH Takaya Shimura, Japan; Masahide Ebi; Tomonori Yamada; DIARRHOEA IN THE EU5 Tamaki Yamada; Takahito Katano; Satoshi Nomura; Catherine Tucker, United Kingdom; Jessica L. Abel; Yoshinori Mori; Hiromi Kataoka; Takashi Joh Robyn T. Carson; Natalia M. Flores; Ryan Liebert

Free Paper Session Free Paper Session 14:00 - 15:30 Room N2 14:00 - 15:30 Room L7 From symptoms to diagnosis in IBS What is new in gastric Endoscopic Submucosal Chairs: Knut-Arne Wensaas, Norway Dissection (ESD) Kok-Ann Gwee, Singapore Chairs: Werner Dolak, Austria Pierre Henri Deprez, Belgium 14:00 - 14:12 IP220 State-of-the-art introduction 14:00 - 14:12 IP221 Kok-Ann Gwee, Singapore State-of-the-art introduction Pierre H. Deprez, Belgium

58 ª Rising Star ª Top Abstract Prize ª National Scholar 59 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

14:12 - 14:24 OP085 Free Paper Session LONG TERM OUTCOMES OF ENDOSCOPIC SUBMUCO- 14:00 - 15:30 Room L8 SAL DISSECTION (ESD) AND GASTRECTOMY BASED ON Gastric function in health and disease INDICATIONS FOR ESD Chairs: Odd Helge Gilja, Norway Wonjae Choi, Republic of Korea; Jong-Jae Park; Ji A. Ernst J. Kuipers, The Netherlands Lee; Yu R. Sim; Taehyun Kim; Moon K. Joo; Beom J. Lee; Hoon J. Chun; Sang W. Lee; Young-Tae Bak 14:00 - 14:12 IP222 State-of-the-art introduction 14:24 - 14:36 OP086 Odd H. Gilja, Norway PREDICTING CLINICAL OUTCOMES OF GASTRIC ENDO- SCOPIC SUBMUCOSAL DISSECTION USING A BAYESIAN 14:12 - 14:24 OP091 APPROACH ª CALORIC AND NON-CALORIC ARTIFICIAL SWEETENERS Diogo Libânio, Portugal; Mario Dinis-Ribeiro; Pedro HAVE DISSOCIABLE EFFECTS ON ANTRAL MOTILITY AND

Pimentel-Nunes; Cláudia C. Dias; Pedro P. Rodrigues PLASMA MOTILIN LEVELS IN HEALTHY VOLUNTEERS. 2016 17, October Monday, Anne C. Meyer-Gerspach, Belgium; Eveline Deloose; 14:36 - 14:48 OP087 Jessica Biesiekierski; Inge Depoortere; Lukas Van LONG-TERM OUTCOMES OF GASTRIC ENDOSCOPIC Oudenhove; Jan Tack SUBMUCOSAL DISSECTION: FOCUS ON METACHRONOUS AND NON-CURATIVE RESECTION MANAGEMENT 14:24 - 14:36 OP092 Diogo Libânio, Portugal; Pedro Pimentel-Nunes; Luís XYLITOL AND ERYTHRITOL INDUCE SATIATION PEPTIDE Afonso; Rui Henrique; Mario Dinis-Ribeiro RELEASE AND RETARDATION IN GASTRIC EMPTYING IN HEALTHY HUMANS ª 14:48 - 15:00 OP088 Anne C. Meyer-Gerspach, Switzerland; Ralph Peterli; EVALUATION OF METASTATIC POTENTIAL CAUSED BY Alison Doody; Jens F. Rehfeld; Juergen Drewe; SUBMUCOSAL OPERATION DURING ENDOSCOPIC SUB- Christoph Beglinger; Bettina Wölnerhanssen MUCOSAL DISSECTION FOR EARLY GASTRIC CANCER IN PATIENTS WHO UNDERWENT ADDITIONAL RADICAL 14:36 - 14:48 OP093 SURGERY : A MULTICENTER RETROSPECTIVE STUDY INFLUENCE OF LIRAGLUTIDE, A GLUCAGON-LIKE Hirotaka Ito, Japan; Takuji Gotoda; Tsuneo Oyama; PEPTIDE-1 ANALOG, ON HUNGER AND SATIETY, INTER- Noboru Kawata; Akiko Takahashi; Yoshikazu Yoshifuku; DIGESTIVE MOTILITY, GASTRIC ACCOMMODATION AND Shu Hoteya; Masahiro Nakagawa; Waku Hatta; Masaaki GASTRIC EMPTYING IN HEALTHY VOLUNTEERS Hirano; Mitsuru Esaki; Mitsuru Matsuda; Ken Ohnita; Alessandra Rotondo, Belgium; Catherine Morlion; Ryo Shimoda; Motoyuki Yoshida; Osamu Dohi; Jun Anne C. Meyer-Gerspach; Anja Luypaerts; Eveline Takada; Keiko Tanaka; Shinya Yamada; Tsuyotoshi Deloose; Kristin Verbeke; Jan Tack Tsuji; Yoshiaki Hayashi; Naoki Nakaya; Tomohiro 14:48 - 15:00 OP094 Nakamura; Tooru Shimosegawa INFLAMMATORY AND ANTIOXIDANT RESPONSE 15:00 - 15:12 OP089 FOLLOWING STANDARD MEAL CONSUMP- ENDOSCOPIC FULL-THICKNESS RESECTION WITH DEFECT TION IN PATIENTS WITH FUNCTIONAL DYSPEP- CLOSURE IN THE STOMACH BY USING A NOVEL GRASP- SIA AND HEALTHY VOLUNTEERS AND-LOOP (GAL) CLOSURE METHOD (WITH VIDEOS) Michele Di Stefano; Beatrice Valvo, Italy; Manuela Jian-Wei Hu, China; Ping-Hong Zhou; Mei-dong Xu; Bergonzi; Irene Benedetti; Mara De Amici; Cristina Quan-Lin Li; Tao Chen Torre; G Testa; Elisabetta Pagani; Gianluigi Marseglia; Gino R. Corazza 15:12 - 15:24 OP090 A CLINICAL STUDY OF ENDOSCOPIC FULL-THICK- 15:00 - 15:12 OP095 NESS RESECTION BY SEROSA SEALING METHOD FOR A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS- SUBMUCOSAL INVASIVE GASTRIC CANCER WITHOUT OVER STUDY USING BACLOFEN IN THE TREATMENT OF SENTINEL NODE METASTASIS. RUMINATION SYNDROME Hidekazu Kitakata, Japan; Tohru Itoh; Shinichi Kinami; Ans Pauwels, Belgium; Charlotte Broers; Brecht Van Sadafumi Azukisawa; Rika Kobayashi; Kazu Hamada; Houtte; Nathalie Rommel; Tim Vanuytsel; Jan Tack Ken Kawaura; Takeo Kosaka

Livestream Q&A Audience Voting Recorded Session 59 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

15:12 - 15:24 OP096 15:12 - 15:24 OP102 GASTRIC ELECTRICAL STIMULATION (GES) FOR REFRAC- MODELLING TUMOR CELL NERVE INTERACTIONS IN TORY VOMITING: RESULTS OF A PROSPECTIVE MULTI- PANCREATIC CANCER CENTER DOUBLE-BLINDED RANDOMIZED CONTROLLED Andreas Göhrig, Germany; Katharina M. Detjen; Andrea

Monday, October 17, 2016 CROSS-OVER TRIAL Behm; Alexandre Dumoulin; Hannes Schmidt; Fritz Philippe Ducrotté, France; Benoit Coffin; Nicolas G. Rathjen; Martina Welzel; Bertram Wiedenmann; Mathieu; Sebastien Fontaine; Stanislas Bruley des Christian Fischer Varannes; Frank Zerbib; Caiazzo; Jean C. Grimaud; Francois Mion; Samy Hadjadj; Lucine Vuitton; Symposium Alain Ropert; Philippe Pouderoux; Michel Dapoigny; 14:00 - 15:30 Hotspot Jean-Marc Sabate; Bruno Bonaz; Guillaume Gourcerol; Clinical Trials Revisited: Practice changing trials in Bruno Guerci pancreatology Chair: Thomas M. Gress, Germany Free Paper Session 14:00 - 15:30 Room 1.86 Basic mechanisms in pancreatic cancer 14:00 - 14:15 IP224 Chairs: Alexander Kleger, Germany Trial presentation - ESPAC4-trial: Adjuvant chemother- Rolf Graf, Switzerland apy pancreatic ductal adenocarcinoma with gemcit- abine and capecitabine versus gemcitabine 14:00 - 14:12 IP223 tba State-of-the-art introduction Alexander Kleger, Germany 14:15 - 14:30 IP225 Critical review 14:12 - 14:24 OP097 Jean-Luc Van Laethem, Belgium BCL-3 ACTS AS A PROTO-ONCOGENE IN PANCREATIC CANCER IN HUMANS AND MICE 14:30 - 14:45 IP226 Jiaoyu Ai, Germany; Sonja M. Wörmann; Kalliope N. PANEL DISCUSSION Diakopoulos; Dietrich Ruess; Marina Lesina; Hana Algül John Neoptolemos, United Kingdom 14:24 - 14:36 OP098 Julia Mayerle, Germany INTEGRIN ALPHA5 AS A NOVEL PROGNOSTIC AND Jean-Luc Van Laethem, Belgium THERAPEUTIC TARGET IN PANCREATIC TUMOR STROMA Thomas Seufferlein, Germany Praneeth Kuninty; Sanne W. L. De Geus; Ruchi Bansal; 14:45 - 15:00 IP227 Peter J. K. Kuppen; Alexander Vahrmeijer; Arne Trial presentation - Poncho trial: Same-admission versus Ostman; Cornelis F. Sier; Jai Prakash, Sweden interval cholecystectomy for mild pancreatitis 14:36 - 14:48 OP099 Hjalmar C. van Santvoort, The Netherlands MICRORNA-622 INHIBITS EPITHELIAL-MESENCHYMAL 15:00 - 15:15 IP228 TRANSITION BY TARGETING LONG NON-CODING RNA Critical review HULC IN HUMAN PANCREATIC CANCER Jean-Marc Dumonceau, Argentina Kenji Takahashi, Japan; Yu Ota; Yuko Suzuki; Hidetaka Iwamoto; Keisuke Yamakita; Yohei Kitano; Yuichi Makino 15:15 - 15:30 IP229 PANEL DISCUSSION 14:48 - 15:00 OP100 ESSENTIAL ROLE OF THE NON-RECEPTOR TYROSINE- Jean-Marc Dumonceau, Argentina PHOSPHATASE PTPN11/SHP-2 IN ORGAN DEVELOPMENT Todd H. Baron, USA AND HOMEOSTASIS OF THE MURINE EXOCRINE PANCREAS Jakob R. Izbicki, Germany Dietrich Ruess, Germany; Hana Algül Hjalmar C. van Santvoort, The Netherlands

15:00 - 15:12 OP101 Symposium RELA CONTROLS KRAS-DRIVEN PANCREATIC CAR- 15:45 - 17:15 Room A CINOGENESIS BY MEDIATING ONCOGENE-INDUCED Rome IV: New diagnostic criteria for functional GI disorders SENESCENCE VIA THE CXCL1/KC/CXCR2 AXIS Chairs: Douglas Drossman, USA Derya Kabacaoglu, Germany; Sonja M. Wörmann; Lin Chang, USA Jennifer Morton; Kalliope N. Diakopoulos; Henrik Einwächter; Mathias Heikenwälder; Hana Algül; Marina Lesina 15:45 - 15:45 IP230 Introduction Douglas Drossman, USA 60 ª Rising Star ª Top Abstract Prize ª National Scholar 61 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

15:45 - 16:07 IP231 16:51 - 17:13 IP242 Functional oesophageal disorders Creation of gastrojejunal anastomoses Frank Zerbib, France Marc Barthet, France 16:07 - 16:29 IP232 Free Paper Session Functional gastroduodenal disorders Vincenzo Stanghellini, Italy 15:45 - 17:15 Room C Future drugs in IBD 16:29 - 16:51 IP233 Chairs: Silvio Danese, Italy Functional bowel disorders Stefan Schreiber, Germany Fermin Mearín Manrique, Spain 16:51 - 17:13 IP234 15:45 - 15:57 IP243 Paediatric functional GI disorders

State-of-the-art introduction 2016 17, October Monday, Marc A. Benninga, The Netherlands Silvio Danese, Italy Symposium 15:57 - 16:09 OP103 15:45 - 17:15 Room D SELECTIVE IL-23 INHIBITION BY RISANKIZUMAB MOD- Update on viral hepatitis 2016 ULATES THE MOLECULAR PROFILE IN THE COLON OF Chairs: Mark Thursz, United Kingdom ACTIVE CROHN'S DISEASE PATIENTS Laurent Castera, France Princeton Lancaster, USA; Patrick Baum; Richard Vinisko; Ramona Schmid; Wulf Boecher; Steven Padula; Azucena Salas; Jay S. Fine; Julian Panés 15:45 - 16:07 IP235 16:09 - 16:21 OP104 Currative options for hepatitis B and D EFFICACY OF USTEKINUMAB FOR INDUCTION AND Frank Tacke, Germany MAINTENANCE OF ENDOSCOPIC HEALING IN PATIENTS 16:07 - 16:29 IP236 WITH CROHN'S DISEASE Hepatitis E: The new threat? Paul Rutgeerts, Belgium; Christopher Gasink; Daphne Marc Bourlière, France Chan; Yinghua Lang; Paul Pollack; Stephen Hanauer; Douglas Wolf; Douglas Jacobstein; Jewel Johanns; 16:29 - 16:51 IP237 Philippe Szapary; Brian G. Feagan; William Sandborn Hepatitis C treatment in 2016 Alessio Aghemo, Italy 16:21 - 16:33 OP105 FILGOTINIB, A SELECTIVE JAK1 INHIBITOR, INDUCES 16:51 - 17:13 IP238 CLINICAL REMISSION IN PATIENTS WITH MODER- Long-term follow up of patients after HCV cure ATE-TO-SEVERE CROHN'S DISEASE: FINAL ANALYSIS Katja Deterding, Germany OF THE PHASE 2 FITZROY STUDY Severine Vermeire, Belgium; Stefan Schreiber; Symposium R. Petryka; Tanja Kuehbacher; Xavier Hebuterne; 15:45 - 17:15 Room B Xavier Roblin; Maria Klopocka; Adrian Goldis; Maria Therapy update: Transluminal endoscopy in the upper Wisniewska Jarosinska; Andrey Baranovsky; Robert GI tract - From bench to clinical practice Sike; Kremana Stoyanova; Chantal Tasset; Annegret Chairs: Jacques Deviere, Belgium Van der Aa; Pille Harrison Horst Neuhaus, Germany 16:33 - 16:45 OP106 TOFACITINIB HAS INDUCTION EFFICACY IN MODERATE- 15:45 - 16:07 IP239 LY TO SEVERELY ACTIVE ULCERATIVE COLITIS, REGARD- Submucosal tunnelling for endoscopic resection LESS OF PRIOR TNF INHIBITOR THERAPY Ping-Hong Zhou, China Geert R. D'Haens; Bruce E. Sands; William J. Sandborn; Toshifumi Hibi; Chinyu Su; Wojciech Niezychowski; 16:07 - 16:29 IP240 Subrata Ghosh; Haiying Zhang; Dahong Yu; Deborah Endoscopic suturing: Techniques, indications and results Woodworth; Paul Healey; Amy Marren; Christopher C. Thompson, USA Julian Panés, Spain 16:29 - 16:51 IP241 Full thickness resection methods Karel Caca, Germany

Livestream Q&A Audience Voting Recorded Session 61 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

16:45 - 16:57 OP107 Symposium CLINICAL DISEASE ACTIVITY INFLUENCES THE THER- 15:45 - 17:15 Room E2 APEUTIC EFFICACY OF THE TOLL LIKE RECEPTOR-9 Interventional ultrasound: See what you do! AGONIST COBITOLIMOD IN PATIENTS WITH MODERATE Chairs: Dieter Nürnberg, Germany

Monday, October 17, 2016 TO SEVERE ACTIVE ULCERATIVE COLITIS Odd Helge Gilja, Norway Raja Atreya, Germany; Laurent Peyrin-Biroulet; Walter Reinisch; Franco Scaldaferri; Charlotte Admyre; Thomas Knittel; Jan Kowalski; Markus F. Neurath; 15:45 - 16:07 IP247 Christopher J. Hawkey New European guidelines 16:57 - 17:09 OP108 Christoph Dietrich, Germany SAFETY AND EFFICACY OF LONG-TERM TREATMENT 16:07 - 16:29 IP248 WITH OZANIMOD, AND ORAL S1P RECEPTOR MODULA- Ultrasound-guided ablation of liver metastases TOR, IN MODERATE TO SEVERE ULCERATIVE COLITIS: Luigi Solbiati, Italy TOUCHSTONE EXTENSION William J. Sandborn; Brian G. Feagan, Canada; 16:29 - 16:51 IP249 Geert R. A. M. D'Haens; Stephen Hanauer; Douglas Pancreatic biopsy: When and how? Wolf; Severine Vermeire; Subrata Ghosh; Allan Olson; Christian Jenssen, Germany Heather Smith; Matt Cravets; Paul A. Frohna; 16:51 - 17:13 IP250 Richard Aranda Endoscopic ultrasound: How to be a smooth operator Peter Vilmann, Denmark Symposium 15:45 - 17:15 Room E1 Symposium Non-bleeding emergencies of the oesophagus 15:45 - 17:15 Room F1 Chairs: Marcia Irene Canto, USA Autoimmune pancreatobiliary disease Frederic Gottrand, France Chairs: Vincent Huberty, Belgium David Jones, Ireland 15:45 - 16:07 IP244 Caustic lesions 15:45 - 16:07 IP251 Luigi Dall'Oglio, Italy The IgG4 syndrome 16:07 - 16:29 IP245 Ulrich H. W. Beuers, The Netherlands Food impaction and foreign bodies 16:07 - 16:29 IP252 D. Nageshwar Reddy, India Differential diagnosis of choliangopathies 16:29 - 16:51 IP246 Tim Lankisch, Germany Perforation 16:29 - 16:51 IP253 Pierre H. Deprez, Belgium Autoimmune pancreatitis: Role in the differential diag- 16:51 - 17:03 OP109 nosis of a pancreatic mass SELF ASSEMBLING PEPTIDE MATRIX FOR THE Vinciane Rebours, France PREVENTION OF AFTER EN- 16:51 - 17:13 IP254 DOSCOPIC RESECTION: A RANDOMIZED CONTROLLED Therapeutic management of autoimmune pancreatico- TRIAL IN A PORCINE MODEL. biliary disease Maximilien Barret, France; Benoit Bordaçahar; Frédéric Tom H. Karlsen, Norway Beuvon; Benoit Terris; Marine Camus; Romain Coriat; Stanislas Chaussade; Frédéric Batteux; Frederic Prat 17:03 - 17:15 OP110 INTRALESIONAL STEROID INJECTION COMBINED WITH ORAL STEROID ADMINISTRATION TO PREVENT ESOPH- AGEAL STRICTURE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION OF LESION NO LESS THAN A HALF OF CIRCUMFERENCE Mei-dong Xu, China; Yuan Chu; Chen Zhang

62 ª Rising Star ª Top Abstract Prize ª National Scholar 63 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

Symposium Free Paper Session 15:45 - 17:15 Room F2 15:45 - 17:15 Room K Endoscopy meets pathology: Polyps and polyposis Hot topics in ERCP syndromes in the upper GI tract Chairs: Jean-Marc Dumonceau, Argentina Chairs: Desmond C. Winter, Ireland Alexandre Oliveira Ferreira, Portugal Arzu Ensari, Turkey 15:45 - 15:57 IP264 State-of-the-art introduction 15:45 - 16:07 IP255 Jean-Marc Dumonceau, Switzerland characterisation and handling: The endoscopist's 15:57 - 16:09 OP111 view CLINICAL UTILITY OF SINGLE OPERATOR CHOLAN- Massimiliano di Pietro, United Kingdom GIOSCOPY USING SPYGLASS? DS COMPARED WITH

16:07 - 16:29 IP256 SPYGLASS? LEGACY? RESULTS FROM A LARGE 2016 17, October Monday, Polyps in hereditary syndroms MULTI-NATIONAL REGISTRY Fatima Carneiro, Portugal Jong H. Moon, Republic of Korea; Mohan K. Ramchandani; Amit Maydeo; Takao Itoi; Rungsun 16:29 - 16:51 IP257 Rerknimitr; Dong-Wan Seo; James Y. W. Lau; MaheshK. Sporadic polyps Goenka; Abdulrahman Aljebreen; Saad Niaz; Jong Lee; Cord Langner, Austria Tiing-Leong Ang; Nam Q. Nguyen; Jorg Reichenberger; Randhir Sud; Rakesh Kochhar; Benedict Devereaux; 16:51 - 17:13 IP258 Ichiro Yasuda; Arthur J. Kaffes; Masayuki Kitano Upper GI polyps: Surgical aspects Mario Morino, Italy 16:09 - 16:21 OP113 PROPOSAL OF A MACROSCOPIC CLASSIFICATION FOR Symposium TISSULAR LESIONS OF THE BILE DUCT DETECTED 15:45 - 17:15 Room G DURING PER ORAL CHOLANGIOSCOPY (POCS) Management of early rectal tumours Carlos Robles-Medranda, Ecuador; Miguel Soria; Chairs: Michael Bourke, Australia Manuel Valero; Miguel Puga; Haydee Alvarado; Jesenia Antonino Spinelli, Italy Ospina; Hannah Pitanga Lukashok Debate 16:21 - 16:33 OP114 15:45 - 15:55 IP259 RECTAL INDOMETHACIN MAY NOT DECREASE THE Staging of early rectal tumours is best done with radiology INCIDENCE OF POST-ERCP PANCREATITIS IN CONSECU- Doenja M. Lambregts, The Netherlands TIVE PATIENTS: A META-ANALYSIS OF RANDOMIZED AND CONTROLLED TRIALS 15:55 - 16:05 IP260 Yunlu Feng; Udayakumar Navaneethan; Shyam Staging of early rectal tumours is best done with Varadarajulu; Robert Hawes; Muhammad Hasan; endoscopy Aiming Yang, China Gregory G. Ginsberg, USA 16:33 - 16:45 OP115 16:05 - 16:27 IP261 PREVENTION OF POST-SPHINCTEROTOMY BLEEDING BY Histological assessment of T1 lesions in the PROTON PUMP INHIBITOR: A PROSPECTIVE RANDOM- Iris D. Nagtegaal, The Netherlands IZED TRIAL 16:27 - 16:49 IP262 Wai K. Leung, Hong Kong Prc; David Y. But; Siu Y. Endoscopic resection techniques for rectal tumours Wong; Kevin Liu; Ivan Hung Alexander Meining, Germany 16:45 - 16:57 OP116 16:49 - 17:11 IP263 IMPACT OF INTENSIVE HYDRATION ON THE INCIDENCE Surgical transanal resection of rectal tumours OF POST-ERCP PANCREATITIS: DOUBLE-BLINDED Roel Hompes, United Kingdom RANDOMIZED CONTROLLED TRIAL Pedro Boal Carvalho, Portugal; Francisca Dias de Castro; Mara Barbosa; Joana Magalhães; Bruno Rosa; José Cotter

Free Paper Session 15:45 - 17:15 Room M Late breaking abstracts II Chairs: tbc

Livestream Q&A Audience Voting Recorded Session 63 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

Translational Basic Science 15:57 - 16:09 OP117 15:45 - 17:15 Room 1.61/1.62 INTRAGASTRIC BITTER TASTANT ALTERS BRAIN Novel models for GI diseases ACTIVITY IN HOMEOSTATIC AND HEDONIC REGIONS Chairs: Dirk Haller, Germany AND DECREASES OCTANOYLATED GHRELIN LEVELS AND

Monday, October 17, 2016 Hayley Francies, United Kingdom HEDONIC FOOD INTAKE Julie Iven, Belgium; Jessica Biesiekierski; Dongxing Zhao; Inge Depoortere; Lukas Van Oudenhove; Jan Tack 15:45 - 16:07 IP265 16:09 - 16:21 OP118 3D models and organoids TRANSDIAGNOSTIC COGNITIVE BEHAVIOUR THERAPY Hayley Francies, United Kingdom SHOW PROMISE FOR BOTH MOOD AND GASTROIN- 16:07 - 16:29 IP266 TESTINAL SYMPTOMS IN PATIENTS WITH FUNCTIONAL Easy manipulation of the genome: CRISPR technology GASTROINTESTINAL DISORDERS Toshiro Sato, Japan Michael P. Jones, Australia; Blake Dear; Nickolai Titov; Vincent J. Fogliati; Nicholas J. Talley 16:29 - 16:51 IP267 What can we learn from animal models of inflammatory 16:21 - 16:33 OP119 bowel disease? DYSBIOSIS INDUCES GUT INFLAMMATION AND DE- Dirk Haller, Germany PRESSIVE-LIKE BEHAVIOR ASSOCIATED WITH BRAIN BIOCHEMICAL AND FUNCTIONAL ALTERATIONS WHICH 16:51 - 17:13 IP268 ARE RESTORED BY PROBIOTIC TREATMENT. Zebrafish Fabio Turco, Italy; Francesca Guida; Ilaria Palumbo; Giuseppe Spano, Italy Monica Iannotta; Anna Furiano; Livio Luongo; Rosario Cuomo; Sabatino Maione; Vito De Novellis Today's Science, Tomorrow's Medicine 16:33 - 16:45 OP120 15:45 - 17:15 Room N1 QUORUM SENSING MOLECULES OF GUT MICROBIOTA Can we detect inflammatory GI diseases early? Chairs: Herbert Tilg, Austria AFFECT INTESTINAL TASTE RECEPTORS AND ANOREXI- Giovanni Cammarota, Italy GENIC PEPTIDES TO CONTROL SATIETY IN THE HOST. Paola Brun, Italy; Anna Pellizzaro; Matteo Fassan; Andrea Porzionato; Carla Mucignat-Caretta; Ignazio 15:45 - 16:07 IP269 Castagliuolo Serum and faecal tests 16:45 - 16:57 OP121 Pia Munkholm, Denmark OXIDATIVE STRESS ACTIVATES NLRP3 INFLAMMASOME 16:07 - 16:29 IP270 AND IMPAIRS GASTRIC ANTRUM SMOOTH MUSCLE Biomarkers in celiac disease ACTIVITY IN OBESE PATIENTS Detlef Schuppan, Germany Annunziata Scirocco; Lucia Pallotta, Italy; Marilia Carabotti; Gianfranco Silecchia; Antonia Ignazzi; 16:29 - 16:51 IP271 Guglielmo Tellan; Francesca Abbatini; Maria A. Detecting food allergies Maselli; Marco Rengo; Alessia Cicenia; Enrico S. Alexander R. Moschen, Austria Corazziari; Carola Severi 16:51 - 17:13 IP272 16:57 - 17:09 OP122 NAFLD: Genetic testing and biomarkers ACOTIAMIDE-SENSITIVE IMPAIRED RECEPTIVE RE- Jean-François Dufour, Switzerland LAXATION OF LOWER ESOPHAGEAL SPHINCTER IN PA- TIENTS WITH ESOPHAGOGASTRIC JUNCTION OUTFLOW Free Paper Session OBSTRUCTION 15:45 - 17:15 Room N2 Kazumasa Muta, Japan; Eikichi Ihara; Bai Xiaopeng; Upper GI nerve-gut interactions Osamu Tsuchida; Toshiaki Toshiaki Ochiai; Tsutomu Chairs: Andreas Stengel, Germany Iwasa; Akira Aso; Kazuhiko Nakamura Shaheen Hamdy, United Kingdom 15:45 - 15:57 IP273 State-of-the-art introduction Andreas Stengel, Germany

64 ª Rising Star ª Top Abstract Prize ª National Scholar 65 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

Free Paper Session Free Paper Session 15:45 - 17:15 Room L7 15:45 - 17:15 Room L8 Endoscopic management of upper gastrointestinal cancer Hepatic cysts and hepato-biliary tract disorders Chairs: Hisao Tajiri, Japan Chairs: Tomislav Bokun, Croatia Torsten Beyna, Germany 15:45 - 15:57 IP275 15:45 - 15:57 IP274 State-of-the-art introduction State-of-the-art introduction tba Hisao Tajiri, Japan 15:57 - 16:09 OP129 15:57 - 16:09 OP123 THE EFFECT OF PASIREOTIDE IN CYST REDUCTION EFFICACY AND SAFETY OF ESD FOR SUPERFICIAL OF ASPIRATION SCLEROTHERAPY IN PATIENTS WITH CANCER OF THE CERVICAL ESOPHAGUS LARGE SYMPTOMATIC HEPATIC CYSTS, A RANDOMIZED

Toshiro Iizuka, Japan; Daisuke Kikuchi; Shu Hoteya; CONTROLLED TRIAL 2016 17, October Monday, Mitsuru Kaise Titus F. M. Wijnands, The Netherlands; Tom J. G. Gevers; Marten A. Lantinga; Leo J. Schultze Kool; Joost 16:09 - 16:21 OP124 P. H. Drenth SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION VS. THORACOSCOPIC SURGERY FOR LARGE SYMPTOMAT- 16:09 - 16:21 OP130 IC SUBMUCOSAL TUMORS IN THE ESOPHAGUS AND A STUDY TO INVESTIGATE RISK FACTOR FOR ENTERO- ESOPHAGOGASTRIC JUNCTION COCCUS SPECIES ISOLATION FROM BILE AND /OR BLOOD Tao Chen; Mei-dong Xu, China CULTURE OBTAINED FROM PATIENTS WITH CHOLANGITIS Yuki Karasawa, Japan; Nobuo Toda; Ken Kurokawa; 16:21 - 16:33 OP125 Jyunya Arai; Chikako Shibata; Kazuyoshi Hunato; Shig- CHARACTERISTICS OF METACHRONOUS GASTRIC NEO- eyuki Kurosaki; Satoshi Kawamura; Shuya Maeshima; PLASMS OCCURRING AFTER ENDOSCOPIC SUBMUCOSAL Mayuko Kondo; Kentaro Kojima; Takamasa Oki; Michi- DISSECTION FOR GASTRIC ADENOMAS AND CANCERS haru Seki; Kazumi Tagawa Shinya Kondo, Japan; Takayoshi Fujita; Yoshie Tsuzuki; Yu Sobajima; Hidemi Goto; Masatoshi Sakakibara 16:21 - 16:33 OP131 MENOPAUSAL HORMONE THERAPY AND RISK OF 16:33 - 16:45 OP126 BILIARY TRACT CANCER ª A SIMPLE SCORING SYSTEM TO STRATIFY CURABILITY Carl Kilander, Sweden; Jesper Lagergren; AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR Omid Sadr-Azodi; Nele Brusselaers EARLY GASTRIC CANCER WHICH HAS PATHOLOGICAL FACTORS HIGHLY RELATED WITH LYMPH NODE METAS- 16:33 - 16:45 OP132 TASIS: DEVELOPMENT AND VALIDATION OF "ECURA MUCIN3A, A PROMISING TUMOR MARKER FOR DIAG- SYSTEM" NOSIS OF EXTRAHEPATIC CHOLANGIOCARCINOMA Waku Hatta, Japan; Takuji Gotoda; Tsuneo Oyama; Jianfeng Yang, China; Xiaofeng Zhang; Hangbin jin; Noboru Kawata; Akiko Takahashi; Yoshikazu Yoshifuku; Hongzhang Shen Shu Hoteya; Masahiro Nakagawa; Masaaki Hirano; Mitsuru Esaki; Mitsuru Matsuda; Ken Ohnita; Kohei 16:45 - 16:57 OP133 Yamanouchi; Motoyuki Yoshida; Osamu Dohi; Jun KINETICS OF PULMONARY ANGIOGENESIS IN MOUSE Takada; Keiko Tanaka; Shinya Yamada; Tsuyotoshi LIGATION-INDUCED LIVER FIBROSIS Tsuji; Hirotaka Ito; Yoshiaki Hayashi; Naoki Nakaya; Sarah Raevens, Belgium; Lindsey Devisscher; Annelies Tomohiro Nakamura; Tooru Shimosegawa Paridaens; Sander Lefere; C. Casteleyn; Ken R. Bracke; Tania Maes; Xavier Verhelst; Hans Van Vlierberghe; 16:45 - 16:57 OP127 Christophe Van Steenkiste; Anja Geerts; Isabelle Colle COMPARISON OF EMR AND ENDOSCOPIC SUBMUCO- 16:57 - 17:09 OP134 SAL DISSECTION FOR RESECTION OF EARLY STAGE GASTROINTESTINAL CANCER EPIDEMIOLOGY OF GALLBLADDER POLYPS ON HISTO- Pietro Gambitta, Italy; Francesca Iannuzzi; Alessandro LOGICAL ASSESSMENT AFTER CHOLECYSTECTOMY Ballerini; Emilia Bareggi; Stefano Pallotta; Paola Sarah Z. Wennmacker, The Netherlands; Aafke H. van Fontana; Maurizio Vertemati Dijk; Joris Raessens; Philip R. de Reuver; Joost P. H. Drenth; Cees J. H. M. van Laarhoven; Iris D. Nagtegaal 16:57 - 17:09 OP128 LONG-TERM OUTCOME OF THE INCIDENCE RATE OF METACHRONOUS GASTRIC CANCERS AFTER HELICO- BACTER PYLORI ERADICATION? A FOLLOW-UP AND ANAL- YSES OF JAPAN GAST STUDY GROUP ENROLLED PATIENTS? Kazutoshi Fukase, Japan

Livestream Q&A Audience Voting Recorded Session 65 UEG Week Final Programme : Scientific Programme by Day Monday, October 17, 2016

Free Paper Session Symposium 15:45 - 17:15 Room 1.86 15:45 - 17:15 E-Poster Lounge 1 Mechanisms of liver cancer and Horizon 2020 Chairs: Nisar Peter Malek, Germany Chairs: Michael Manns, Germany

Monday, October 17, 2016 Marika Rudler, France Helena Cortez-Pinto, Portugal 15:45 - 15:57 IP276 15:45 - 15:50 IP277 State-of-the-art introduction Welcome and introducation - The importance of research Nisar P. Malek, Germany Michael Manns, Germany 15:57 - 16:09 OP135 15:50 - 16:05 IP278 CHANGES IN CIRCULATING MICRORNA AFTER TREAT- Horizon 2020 - Health research funding opportunities MENT: MICRORNA SIGNATURES TO PREDICT THERAPY Representative from the European Commission tba RESPONSE AND DISEASE FREE SURVIVAL IN HEPATO- CELLULAR CARCINOMA 16:05 - 16:15 IP279 Devis Pascut, Italy; Helena Krmac; Riccardo Patti; Questions and answers Danilo Licastro; Simeone Dal Monego; Nicolò Mezzina; 16:15 - 16:25 IP280 Cristiana Abazia; Flora Masutti; Lory S. Crocè; Raffaella How to write an outstanding grant proposal Calligaris; Claudio Tiribelli Astrid Hoebertz, Austria 16:09 - 16:21 OP136 16:25 - 16:35 IP281 HEPATITIS B VIRUS GENOTYPE, ZINC RIBBON DOMAIN- Where do I get help? The national contact points CONTAINING 1 ANTISENSE RNA 1 POLYMORPHISMS AND Astrid Hoebertz, Austria THEIR INTERACTIONS IN : A MULTI-CENTER CASE-CONTROL STUDY 16:35 - 16:50 IP282 Zhenzhen Liu; Li Liu, China; Zhining Fan Questions and answers 16:21 - 16:33 OP137 16:50 - 17:00 IP283 HMGB1-DEPENDENT AUTOPHAGY: A NEW PATHWAY Best practice: Managing a successful Horizon 2020 project TO MAINTAIN REGULATORY T CELL FUNCTION IN Arthur Kaser, United Kingdom PATIENTS WITH CHRONIC HEPATITIS B 17:00 - 17:05 IP284 Jing Li, China; Wei Jiang Questions and answers 16:33 - 16:45 OP138 17:05 - 17:05 IP285 RIOCIGUAT, A STIMULATOR OF THE GUANYLYL Closing remarks CYCLASE, REDUCES LIVER FIBROSIS AND PORTAL Michael Manns, Germany PRESSURE IN CIRRHOTIC RATS. Philipp Schwabl, Austria; Ksenia Brusilovskaya; Florian Riedl; David Bauer; Bastian Strobel; Paul Supper; Nataliya Rohr-Udilova; Hubert Hayden; Bruno Podesser; Thomas Reiberger; Michael Trauner; Markus Peck-Radosavljevic 16:45 - 16:57 OP139 MECHANISM OF LIVER ATROPHY DUE TO PORTAL VEIN EMBOLIZATION - ASSOCIATION WITH AUTOPHAGY AND APOPTOSIS - Yasuhito Iwao, Japan; Hidenori Ojima; Minoru Tanabe 16:57 - 17:09 OP140 EFFECT OF CHRONIC THIOACETAMIDE TREATMENT ON HEPATIC HEMODYNAMIC PARAMETERS IN RATS: EVAL- UATION BY MAGNETIC RESONANCE IMAGING Denise Schaffner, Germany; Dominik Elverfeldt; Peter Deibert; Adhara Lazaro; Irmgard Merfort; Lisa Lutz; Manfred W. Baumstark; Wolfgang Kreisel; Wilfried Reichardt

66 ª Rising Star ª Top Abstract Prize ª National Scholar 67 Monday, October 17, 2016 Scientific Programme by Day : UEG Week Final Programme

Symposium Symposium 15:45 - 17:15 E-Poster Lounge 2 15:45 - 17:15 Hotspot Rising Stars in irritable bowel syndrom (IBS) from Complications of cirrhosis: Which prophylaxis should Europe and the USA we use? Chairs: Luigi Ricciardiello, Italy Chair: Patrizia Burra, Italy Deborah D. Proctor, USA

15:45 - 15:50 IP286 15:45 - 15:48 IP297 Words of welcome Introduction Luigi Ricciardiello, Italy Patrizia Burra, Italy 15:50 - 15:53 IP287 15:48 - 16:10 IP298 Introduction of Kyle Staller, AGA Research Scholar Beta blockers for bleeding prophylaxis Deborah D. Proctor, USA Claire Francoz, France 2016 17, October Monday, 15:53 - 16:08 IP288 16:10 - 16:32 IP299 A prospective study of diet and lifestyle and risk of IBS Long-term antibiotic prophylaxis for spontaneous Kyle Staller, USA bacterial 16:08 - 16:16 IP289 Javier Fernandez, Spain Questions and answers 16:32 - 16:54 IP300 16:16 - 16:19 IP290 Early TIPS after portal hypertensive bleeding episode Introduction of Mira Wouters, UEG Rising Star 2016 in patients with severe liver disease Joost P.H. Drenth, The Netherlands Bogdan D. Procopet, Romania 16:19 - 16:34 IP291 TRP channel sensitisation in IBS Mira M. Wouters, Belgium 16:34 - 16:42 IP292 Questions and answers 16:42 - 16:45 IP293 Introduction of Lukas Van Oudenhove, UEG Rising Star 2012 Luigi Ricciardiello, Italy 16:45 - 17:00 IP294 The brain-gut axis in IBS: Bottom-up and top-down interplay between GI sensory signals and psychologi- cal processes Lukas Van Oudenhove, Belgium 17:00 - 17:08 IP295 Questions and answers 17:08 - 17:15 IP296 Closing remarks Deborah D. Proctor, USA

Livestream Q&A Audience Voting Recorded Session 67 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

Scientific Programme by Day Tuesday, October 18, 2016

Live Endoscopy Symposium 08:30 - 10:00 Room A 08:30 - 10:00 Room B Live endoscopy Therapy update: Functional upper GI syndromes Chairs: Lars Aabakken, Norway Chairs: Guy E. Boeckxstaens, Belgium Mario Dinis-Ribeiro, Portugal Carmelo Scarpignato, Italy Marianna Arvanitakis, Belgium Experts: Raf Bisschops, Belgium Daniel Bléro, Belgium 08:30 - 08:52 IP306 Jacques Deviere, Belgium Functional dyspepsia Pierre Eisendrath, Belgium Jan Tack, Belgium Marc Giovannini, France Mostafa Ibrahim, Belgium 08:52 - 09:14 IP307 Arnaud Lemmers, Belgium Olivier Le Moine, Belgium Vincenzo Stanghellini, Italy Stefan Seewald, Switzerland 09:14 - 09:36 IP308 Functional chest pain and functional heartburn Albert J. Bredenoord, The Netherlands Symposium 09:36 - 09:58 IP309 08:30 - 10:00 Room D Rumination, belching and aerophagia

Tuesday, October 18, 2016 Intestinal and extra-intestinal cancers in IBD Jutta Keller, Germany Chairs: Charlie Lees, United Kingdom Krisztina Barbara Gecse, Hungary Symposium 08:30 - 10:00 Room C Challenging situations in diagnosis and treatment of 08:30 - 08:52 IP301 Colorectal cancer in IBD: Epidemiology and risk profile Chairs: Matthias Löhr, Sweden Laurence Egan, Ireland Andrea Phillips, United Kingdom 08:52 - 09:14 IP302 Small bowel and ano-rectal cancer in IBD Franck Carbonnel, France 08:30 - 08:52 IP310 Classifying the severity of acute pancreatitis in clinical 09:14 - 09:36 IP303 practice: Revision of the atlanta classification (RAC) Treatment related haematologic malignant disorders and determinant based classification (DBC)? in IBD Hjalmar C. van Santvoort, The Netherlands Laurent Beaugerie, France 08:52 - 09:14 IP311 Debate Conservative treatment for acute pancreatitis: 09:36 - 09:46 IP304 Fluid-management, nutrition and pain management Use of biologics in an IBD patient with a recent cancer Enrique de-Madaria, Spain diagnosis: Pro Jean-Frederic Colombel, France 09:14 - 09:36 IP312 Emergency ERCP for biliary pancreatitis 09:46 - 09:56 IP305 Markus M. Lerch, Germany Use of biologics in an IBD patient with a recent cancer diagnosis: Con Debate Arthur Kaser, United Kingdom 09:36 - 09:46 IP313 Walled-off pancreatic necrosis: Minimally invasive interventions Marc G. H. Besselink, The Netherlands 09:46 - 09:56 IP314 Walled-off pancreatic necrosis: Endoscopic approaches Myriam Delhaye, Belgium

68 ª Rising Star ª Top Abstract Prize ª National Scholar 69 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

Symposium Symposium 08:30 - 10:00 Room E1 08:30 - 10:00 Room F1 Management of GI and liver diseases during pregnancy Quality in ERCP: It is how you do it that counts Chairs: John Atherton, United Kingdom Chairs: Todd H. Baron, USA Janneke van der Woude, The Netherlands Thomas Rösch, Germany

08:30 - 08:52 IP315 08:30 - 08:52 IP324 IBD Indications and preparation before the procedure Janneke van der Woude, The Netherlands Vincent Huberty, Belgium 08:52 - 09:14 IP316 08:52 - 09:14 IP325 Liver How to measure perprocedural success rates? Christian Strassburg, Germany Jeanin E. van Hooft, The Netherlands 09:14 - 09:36 IP317 09:14 - 09:36 IP326 Functional GI disorders Fluoroscopy and radiation: What the endoscopist Qasim Aziz, United Kingdom should know Jean-Marc Dumonceau, Switzerland 09:36 - 09:58 IP318 09:36 - 09:58 IP327 Marja A. Boermeester, The Netherlands Post-procedure complications and reporting Oliver Pech, Germany Symposium 08:30 - 10:00 Room E2 Symposium Management of Barrett's oesophagus: The gold standard 08:30 - 10:00 Room F2 Chairs: Peter D. Siersema, The Netherlands Advanced pancreato-biliary imaging Pierre Henri Deprez, Belgium Chairs: Tibor Gyökeres, Hungary Stuart Taylor, United Kingdom

Tandem Talks 08:30 - 08:40 IP319 08:30 - 08:52 IP328 Who is at risk? Adults MRI and CT: What's new? Bas L. A. M. Weusten, The Netherlands Maria A. Bali, Belgium 2016 18, October Tuesday, 08:40 - 08:50 IP320 08:52 - 09:14 IP329 Who is at risk? Children Advances in diagnostic pancreatobilary EUS Frederic Gottrand, France J. E. Dominguez-Munoz, Spain 08:50 - 09:12 IP321 09:14 - 09:36 IP330 How should patients with Barrett's oesophagus be Cholangioscopy: Are we getting any better? diagnosed? Torsten Beyna, Germany Marcia I. Canto, USA 09:36 - 09:58 IP331 09:12 - 09:34 IP322 Indeterminate biliary strictures: What else can we do? How should patients with Barrett's oesophagus be Marco J. Bruno, The Netherlands followed-up? Stuart J. Spechler, USA Free Paper Session 09:34 - 09:56 IP323 08:30 - 10:00 Room G When and how should treatment be initiated in Bar- Optimising anti-TNF therapy rett's oesophagus? Chairs: Pierre Michetti, Switzerland Giovanni Zaninotto, Italy David Drobne, Slovenia 08:30 - 08:42 IP332 State-of-the-art introduction Pierre Michetti, Switzerland

Livestream Q&A Audience Voting Recorded Session 69 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

08:42 - 08:54 OP141 09:42 - 09:54 OP146 CORRELATION OF ENDOSCOPIC FINDINGS WITH SERUM COST-UTILITY OF BIOSIMILAR INFLIXIMAB (INFLEC- DRUG CONCENTRATIONS AND NEED FOR RESCUE THER- TRA©) FOR THE TREATMENT OF LUMINAL CROHN'S APY: SUBANALYSIS OF THE TROUGH CONCENTRATION DISEASE IN NINE EUROPEAN COUNTRIES ADAPTED INFLIXIMAB TREATMENT (TAXIT) TRIAL ª Fanni Rencz, Hungary; Valentin Brodszky; Petra Baji; Lieven Pouillon, Belgium; Marc Ferrante; Gert Van Marta Pentek; Laszlo Gulacsi; Petra A. Golovics; Zsu- Assche; Maja Noman; Ann Gils; Severine Vermeire zsanna Vegh; Krisztina B. Gecse; Silvio Danese; Peter Irving; Peter L. Lakatos 08:54 - 09:06 OP142 FREQUENCY AND CHARACTERISTICS OF INFUSION Free Paper Session REACTIONS DURING BIOSIMILAR INFLIXIMAB TREAT- MENT IN INFLAMMATORY BOWEL DISEASES: RESULTS 08:30 - 10:00 Room K FROM CENTRAL EUROPEAN NATIONWIDE COHORT Drug-induced upper GI bleeding Anita Balint, Hungary; Mariann Rutka; Zsuzsanna Chairs: Krish Ragunath, United Kingdom Vegh; Zsuzsanna Kurti; Krisztina B. Gecse; Janos Banai; Madalina Ilie, Romania Laszlo Bene; Beata Gasztonyi; Tunde Kristof; Laszlo 08:30 - 08:42 IP333 Lakatos; Pal Miheller; Karoly Palatka; Arpad Patai; State-of-the-art introduction Agnes Salamon; Tamas Szamosi; Zoltan Szepes; Gabor Krish Ragunath, United Kingdom T. Toth; Aron Vincze; Renata Bor; Agnes Milassin; Ferenc Nagy; Martin Kolar; Martin Bortlik; Dana 08:42 - 08:54 OP147 Duricova; Veronica Hruba; Martin Lukas; Katarina IDARUCIZUMAB FOR EMERGENT REVERSAL OF DABIG- Mitrova; Karin Malickova; Milan Lukas; Peter L. Lakatos; ATRAN-RELATED ANTICOAGULATION DURING SEVERE Tamas Molnar; Klaudia Farkas GASTROINTESTINAL HEMORRHAGE: INTERIM RESULTS (N=123) FROM THE REVERSE-ADTM STUDY 09:06 - 09:18 OP143 Tuesday, October 18, 2016 James Aisenberg; Prapti Chatterjee; Paul Reilly; Fredrik AZATHIOPRINE DOSE REDUCTION INFLAMMATORY Gruenenfelder; Eva Kleine; Stephan Glund; Joanne van BOWEL DISEASE PATIENTS ON COMBINATION THERA- Ryn, Germany; Charles V. Pollack PY: A PROSPECTIVE STUDY Emilie Del Tedesco; Stéphane Paul; Hubert Marotte; 08:54 - 09:06 OP148 Nicolas Williet; Jean M. Phelip; Laurent Peyrin-Biroulet; ROLE OF MELATONIN RECEPTORS, SURVIVIN, INSULIN Jean-Frederic Colombel; Xavier Roblin, France GROWTH FACTOR-1 AND ITS RECEPTOR IN PROTECTIVE ACTION OF MELATONIN AGAINST INDOMETHACIN 09:18 - 09:30 OP144 DAMAGE OF GASTRIC EPITHELIAL CELLS DOSE DE-ESCALATION TO ADALIMUMAB 40 MG EVERY Iwona Brzozowska; Amrita Ahluwalia; Michael K. Jones; THREE WEEKS IN PATIENTS WITH INFLAMMATORY Andrzej S. Tarnawski; Tomasz Brzozowski, Poland BOWEL DISEASE: A RETROSPECTIVE COHORT ANALYSIS Sophie Van Steenbergen, Belgium; Sumin Bian; Vera 09:06 - 09:18 OP149 Ballet; Severine Vermeire; Gert Van Assche; Ann Gils; RISK OF REBLEEDING, VASCULAR EVENTS AND DEATH Marc Ferrante AFTER GASTROINTESTINAL BLEEDING IN ANTICOAGU- LANT AND/OR ANTIPLATELET USERS. 09:30 - 09:42 OP145 Beatriz Marcén, Spain; Carlos Sostres; Viviana Laredo; EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB Lara Ruiz; Enrique Alfaro; Patricia Camo; Patricia AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE Carrera; Angel Lanas NATIONWIDE COHORT Krisztina B. Gecse, Hungary; Zsuzsanna Vegh; 09:18 - 09:30 OP150 Zsuzsanna Kurti; Mariann Rutka; Klaudia Farkas; Janos NOVEL 4-THIAZOLIDINONE DERIVATIVES AS CYTOPRO- Banai; Laszlo Bene; Beata Gasztonyi; Petra A. Golovics; TECTIVE AGENTS AGAINST NSAID-INDUCED INJURY Barbara D. Lovasz; Tunde Kristof; Laszlo Lakatos; Pal Iryna Ilkiv, Ukraine; Roman Lesyk; O. Sklyarov Miheller; Ferenc Nagy; Karoly Palatka; Mária Papp; 09:30 - 09:42 OP151 Lilla Lakner; Arpad Patai; Agnes Salamon; Tamas BACTERICIDAL / PERMEABILITY INCREASING Szamosi; Zoltan Szepes; Balazs Szalay; Gabor T. Toth; FOLD-CONTAINING FAMILY B MEMBER 4 (BPIFB4) Aron Vincze; Tamas Molnar; Peter L. Lakatos ASSOCIATED WITH NSAID-INDUCED SMALL INTESTINAL MUCOSAL INJURY Shunji Fujimori, Japan; Koya Fukunaga; Mushiroda Taisei; Michiaki Kubo; Ryuzo Hanada; Mari Hayashida; Toshiyuki Sakurai; Keigo Mitsui; Katsuhiko Iwakiri; Choitsu Sakamoto

70 ª Rising Star ª Top Abstract Prize ª National Scholar 71 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

09:42 - 09:54 OP152 09:18 - 09:30 OP156 RISK OF GASTROINTESTINAL BLEEDING AND BENEFIT MAJOR PERI-OPERATIVE ADVERSE EVENTS OF FROM COLORECTAL CANCER REDUCTION. A 10-YEAR PERORAL ENDOSCOPIC MYOTOMY (POEM): 5 YEARS' POPULATION-BASED STUDY FOR LONG-TERM USE OF EXPERIENCE, 1680 PATIENTS LOW DOSE ACETYLSALICYLIC ACID. Quan-Lin Li, China; Xiao-Cen Zhang; Ping-Hong Zhou Joseph J. Y. Sung, China; Kelvin K. Tsoi 09:30 - 09:42 OP157 COMPARATIVE EVALUATION OF PERORAL ENDOSCOPIC Free Paper Session MYOTOMY (POEM) FOR THE TREATMENT OF ACHALA- 08:30 - 10:00 Room M SIA IN PATIENTS WITH FAILED HELLER MYOTOMY VS Outcomes in Peroral Endoscopic Myotomy (POEM) PATIENTS WITHOUT A HISTORY OF SURGICAL MYOTO- Chairs: Haruhiro Inoue, Japan MY: A MULTICENTER RETROSPECTIVE COHORT STUDY Hubert Louis, Belgium Saowanee Ngamruengphong, USA; Haruhiro Inoue; 08:30 - 08:42 IP334 Michael Ujiki; Amol Bapaye; Pankaj Desai; Thierry State-of-the-art introduction Ponchon; Shivangi Dorwat; Peter V. Draganov; Yaseen Haruhiro Inoue, Japan Perbtani; Ali Abbas; Davinderbir Pannu; Dennis Yang; Silvana Perretta; John Romanelli; David Desilets; Bu 08:42 - 08:54 OP153 Hayee; Lava Patel; Mathieu Pioche; Sabine Roman; COMPREHENSIVE ANALYSIS OF ADVERSE EVENTS Jérôme Rivory; Francois Mion; Aurélien Garros; Jun ASSOCIATED WITH PER ORAL ENDOSCOPIC MYOTOMY Nakamura; Yoshitaka Hata; Valerio (POEM) IN 1826 PATIENTS: AN INTERNATIONAL MULTI- Balassone; Manabu Onimaru; Gulara Hajiyeva; Amr CENTER STUDY Ismail; Yen-I Chen; Majidah Bukhari; Yamile H. Chavez; Yamile Haito Chavez, USA; Haruhiro Inoue; Kristin W. Vivek Kumbhari; Roberta Maselli; Alessandro Repici; Beard; Peter V. Draganov; Michael Ujiki; Burkhard H. Mouen Khashab A. Rahden; Pankaj Desai; Alessandro Repici; Mathieu Pioche; Bu Hayee; Payal Saxena; Kevin Reavis; Manabu 09:42 - 09:54 OP158 Onimaru; Valerio Balassone; Jun Nakamura; Yoshitaka GASTRIC PERORAL ENDOSCOPIC ANTRO-PY- Hata; Dennis Yang; Davinderbir Pannu; Ali Abbas; Ya- LORO-MYOTOMY (G-POEM) FOR THE TREATMENT OF seen Perbtani; Lava Patel; Jorg Filser; Roberta Maselli; REFRACTORY GASTROPARESIS: LARGEST SERIES WITH Sabine Roman; Jérôme Rivory; Francois Mion; Thierry CLINICAL AND SCINTIGRAPHHIC FOLLOW-UP Ponchon; Silvana Perretta; Saowanee Ngamrueng- Jean-Michel Gonzalez, France; Valentin Lestelle; Alban phong; Yen-I Chen; Majidah Bukhari; Gulara Hajiyeva; Benezech; Veronique Vitton; Marc Barthet Amr Ismail; Vivek Kumbhari; Mouen Khashab Translational Basic Science 2016 18, October Tuesday, 08:54 - 09:06 OP154 08:30 - 10:00 Room 1.61/1.62 LONG TERM OUTCOMES OF PERORAL ENDOSCOPIC Liver fibrosis: From mechanism to therapy MYOTOMY (POEM) IN ACHALASIA PATIENTS WITH A Chairs: Michael Trauner, Austria MINIMUM FOLLOW-UP OF 2 YEARS: AN INTERNATION- Antonio Moschetta, Italy AL MULTICENTER STUDY Saowanee Ngamruengphong, USA; Haruhiro Inoue; Amol Bapaye; Michael Ujiki; Lava Patel; Pankaj Desai; 08:30 - 08:52 IP335 Bu Hayee; Amyn Haji; Vivien Wong; Silvana Perretta; Nuclear receptors in liver fibrosis Shivangi Dorwat; Mathieu Pioche; Sabine Roman; Antonio Moschetta, Italy Jérôme Rivory; Francois Mion; Thierry Ponchon; Aurélien Garros; Jun Nakamura; Yoshitaka Hata; Vale- 08:52 - 09:14 IP336 rio Balassone; Manabu Onimaru; Gulara Hajiyeva; Amr Role of fatty acid synthesis inhibition Ismail; Yen-I Chen; Majidah Bukhari; Yamile H. Chavez; Antonio Vidal-Puig, United Kingdom Vivek Kumbhari; Roberta Maselli; Alessandro Repici; 09:14 - 09:36 IP337 Mouen Khashab Reconnect with the microbiota: Probiotics and faecal 09:06 - 09:18 OP155 transplantation A 5-YEAR LONG POEM EXPERIENCE. IS IT TIME TO Herbert Tilg, Austria DRAW CONCLUSIONS? Pietro Familiari, Italy; Anna Calì; Rosario Landi; Giovanni Gigante; Andrea Tringali; Ivo Boskoski; Vincenzo Bove; Vincenzo Perri; Federica Borrelli de Andreis; Guido Costamagna

Livestream Q&A Audience Voting Recorded Session 71 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

09:36 - 09:48 OP159 09:18 - 09:30 OP165 EXPRESSION OF CONSTITUTIVELY ACTIVE IKK2 LEADS TO TARGETED CHEMICAL ANALYSIS OF THE COLON CANCER LIVER FIBROSIS AND INCREASED CARCINOGENESIS IN MICROBIOME USING DESORPTION ELECTROSPRAY ION- THE BACKGROUND OF LIVER SPECIFIC TRP53 DELETION ISATION MASS SPECTROMETRY IMAGING (DESI-MSI) Michael Svinarenko, Germany; Sarah F. Katz; Sarah James Alexander, United Kingdom; Anna Mroz; Alvaro Fischer; Harald Maier; Andrea Tannapfel; Thomas Perdones-Monteiro; Alasdair Scott; Louise Gildea; Seufferlein; André Lechel Simon Cameron; Frankie Bolt; Francesca Rosini; Robert Goldin; James Mckenzie; Adam Burke; Nicole 09:48 - 10:00 OP160 Strittmatter; Nikolaos Koundouros; Kirill Veselkov; Ara EXPRESSION OF CD161 ON CD4+ T CELLS PROMOTES Darzi; George Poulogiannis; David Cunningham; HEPATITIS B VIRUS RELATED LIVER FIBROSIS THROUGH Jeremy Nicholson; Julian Marchesi; Zoltan Takats; ACID SPHINGOMYELINASE AND CD161-LECTIN-LIKE James Kinross; Julian Teare TRANSCRIPT-1 INTERACTION Li-sha Cheng, China; Si-Qi Wang; Wei Jiang 09:30 - 09:42 OP166 UNSUPERVISED, TRANSCRIPTOMICS-BASED CLUS- Today's Science, Tomorrow's Medicine TERING OF ULCERATIVE COLITIS PATIENTS REVEALS 08:30 - 10:00 Room N1 MARKED HETEROGENEITY THAT RELATES TO ANTI-TNF Free Paper Session: Novel diagnostic tools – Going TREATMENT RESPONSE deeper and deeper into the bowel Calixte Monast; Aleksandar Stojmirovic; Radu Dobrin; Chairs: Roland Valori, United Kingdom Carrie Brodmerkel; Frédéric Baribaud, USA Imke Atreya, Germany 09:42 - 09:54 OP167 08:30 - 08:42 OP161 COMPREHENSIVE CIRCULATORY TRANSCRIPTOME FULL SPECTRUM ENDOSCOPY (FUSE) IN THE DETEC- AND PROTEOMIC PROFILING IN NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES: A MULTI-CENTRE Tuesday, October 18, 2016 TION OF INFLAMMATORY BOWEL DISEASE NEOPLASIA (FUSION): A RANDOMIZED CROSSOVER TANDEM COHORT STUDY STUDY VERSUS CONVENTIONAL COLONOSCOPY Rahul Kalla, United Kingdom; Alex T. Adams; Jonas Rupert W. Leong, Australia; Marie Ooi; Crispin Corte; Lindstrom; IBD Character Consortium; Morten H. Vatn; Yunki Yau; Melissa Kermeen; Aladdin Alswaifi; Peter Jørgen Jahnsen; Petr Ricanek; Daniel Bergemalm; Johan Katelaris; Charles McDonald; Meng Ngu D. Söderholm; Marieke J. Pierik; Fernando Gomollon; Mauro D'Amato; Jonas Halfvarson; Jack Satsangi 08:42 - 08:54 OP162 THE ACCURACY OF WAVSTAT VERSION 4 OPTICAL BI- Free Paper Session OPSY FORCEPS IN CHARACTERIZING COLORECTAL POL- 08:30 - 10:00 Room N2 YPS LESS 10 MM : A PROSPECTIVE BLINDED STUDY Improving detection of polyps Noor Mohammed, United Kingdom; Ruchit Sood; Chairs: Luigi Ricciardiello, Italy Suresh V. Venkatachalapathy; Faisal Abid; Nick Burr; Yasmijn van Herwaarden, The Netherlands pavit luthra; James Meadows; Jenelyn Carboneli; Olorunda Rotimi; Venkataraman Subramanian 08:30 - 08:42 IP338 State-of-the-art introduction 08:54 - 09:06 OP163 Yasmijn van Herwaarden, The Netherlands DEEPER AND DEEPER INTO THE SMALL BOWEL IN PEDI- ATRIC CROHN'S DISEASE: PROSPECTIVE COMPARATIVE 08:42 - 08:54 OP168 STUDY BETWEEN CONTRAST ULTRA- A RANDOMIZED, CONTROLLED TRIAL COMPARING SONOGRAPHY (SICUS) AND MAGNETIC RESONANCE AIR INSUFFLATION, WATER IMMERSION AND WATER IMAGING EXCHANGE FOR ADENOMA DETECTION IN SCREENING Fortunata Civitelli, Italy; Francesca Maccioni; Salvatore COLONOSCOPY PATIENTS Oliva; Franca Viola; Anna Dilillo; Marina Aloi; Salvatore Sergio Cadoni, Italy; Premysl Falt; Emanuele Rondonotti; Cucchiara Franco Radaelli; Petr Fojtik; Paolo Gallittu; Mauro Liggi; Arnaldo Amato; Silvia Paggi; V. Smajstrla; Ondrej 09:06 - 09:18 OP164 Urban; Matteo Erriu; Felix W. Leung A ROLE FOR T CELL CLONAL EXPANSIONS IN THE POST-OPERATIVE RECURRENCE IN CROHN'S DISEASE: 08:54 - 09:06 OP169 A STUDY FROM THE REMIND GROUP EFFICACY OF ENDOCUFF-ASSISTED COLONOSCOPY IN Matthieu Allez, France; Marjolaine NGollo; Carmen THE DETECTION OF COLORECTAL POLYPS Stefanescu; Claire Auzolle; Stéphane Nancey; Faycal Yoshiki Wada, Japan; Yoko Wada; Masahiro Wada; Djenidi; Maria Nachury; Anthony Buisson; Harry Sokol; Yumiko Fukuma; Masayoshi Fukuda; Kazuo Ohtsuka Xavier Treton; Nicolas Barnich; Philippe Seksik; Lionel Le Bourhis 72 ª Rising Star ª Top Abstract Prize ª National Scholar 73 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

09:06 - 09:18 OP170 09:06 - 09:18 OP176 DEVELOPMENT AND VALIDATION OF A SIMPLE IMPACT OF MINIMALLY INVASIVE SURGERY ON QUAL- CLASSIFICATION SYSTEM FOR IN VIVO DIAGNOSIS OF ITY OF LIFE AFTER SURGERY FOR CROHN'S DISEASE COLORECTAL POLYPS USING THE NEWLY INTRODUCED TERMINAL ILEITIS OPTICAL ENHANCEMENT (OE) TECHNOLOGY Imerio Angriman, Italy; Oscar Zini; Renata D'Inca; Helmut Neumann, Germany; Michael Vieth; Lucia Fry; Giacomo C. Sturniolo; Romeo Bardini; Marco Scarpa Gian E. Tontini; Klaus Mönkemüller 09:18 - 09:30 OP177 09:18 - 09:30 OP171 CLOSE RECTAL DISSECTION VERSUS TOTAL MESOREC- FREQUENCY AND PREDICTORS OF ADVANCED HIS- TAL EXCISION IN PATIENTS WITH INFLAMMATORY TOLOGY IN LARGE NON-PEDUNCULATED COLORECTAL BOWEL DISEASE UNDERGOING PROCTECTOMY POLYPS: EXPERIENCE-BASED DATA AT A UNIVERSITY Joline de Groof, The Netherlands; Oddeke van Ruler; Manon HOSPITAL Wildenberg; Jessica de Bruyn; Pieter Tanis; Gijs R. van Hao R. Cheng, The Netherlands; Roel M. M. Bogie; den Brink; Willem A. Bemelman; Christianne J. Buskens Bjorn Winkens; Heike I. Grabsch; Rogier de Ridder; Jan W. A. Straathof; Ad A. Masclee; Silvia Sanduleanu 09:30 - 09:42 OP178 LONG-TERM FOLLOW-UP AFTER ILEORECTAL ANASTO- 09:30 - 09:42 OP172 MOSIS IN ULCERATIVE COLITIS (UC): A GETAID/GETAID HEALTH EFFECTS AND COSTS DUE TO POST-COLONOS- CHIRURGIE MULTICENTER RETROSPECTIVE COHORT OF COPY COLORECTAL CANCER 343 PATIENTS Mattias Aronsson, Sweden; Per Carlsson; Anders Mathieu Uzzan, France; Jacques Cosnes; Nathalie Ekbom; Rolf Hultcrantz; Anna Forsberg Gault; Aurelien Amiot; Jean-Marc Gornet; Philippe Seksik; Stéphane Nancey; David Laharie; Matthieu 09:42 - 09:54 OP173 Allez; Maria Nachury; Anne L. Pelletier; Vered Abitbol; COMPARISON OF COLONOSCOPY, SIGMOIDOSCOPY Mathurin Fumery; Anthony Buisson; Romain Altwegg; AND MULTIPLE ROUNDS OF FIT-BASED COLORECTAL Yves Panis; Xavier Treton CANCER SCREENING: LONG-TERM FOLLOW-UP Elisabeth J. Grobbee, The Netherlands; Manon van der 09:42 - 09:54 OP179 Vlugt; Anneke J. van Vuuren; An K. Stroobants; Rosalie C. THERAPY REFRACTORY UC PATIENTS MAY BENEFIT Mallant-Hent; Iris Lansdorp-Vogelaar; Patrick M. Bossuyt; FROM APPENDECTOMY; EARLY RESULT FROM THE Ernst J. Kuipers; Evelien Dekker; Manon C. W. Spaander PASSION STUDY Saloomeh Sahami, The Netherlands; Christianne J. Free Paper Session Buskens; Desmond C. Winter; Sean Martin; Geert R. A.

08:30 - 10:00 Room L7 M. D'Haens; Willem A. Bemelman 2016 18, October Tuesday, Surgery in IBD Chairs: Dieter Hahnloser, Switzerland Free Paper Session Gianluca Sampietro, Italy 08:30 - 10:00 Room L8 GI infections from mechanisms to treatment 08:30 - 08:42 IP339 Chairs: Antonio Gasbarrini, Italy State-of-the-art introduction Grainne Holleran, Ireland Gianluca Sampietro, Italy 08:30 - 08:42 IP340 08:42 - 08:54 OP174 State-of-the-art introduction OUTCOMES OF EMERGENCY ADMISSIONS WITH Antonio Gasbarrini, Italy CROHN'S DISEASE IN ADULTS IN ENGLAND BETWEEN 2004 AND 2014 08:42 - 08:54 OP180 James Rees, United Kingdom; Jemma Mytton; Felicity THE RISK OF CLOSTRIDIUM DIFFICILE INFECTION IN Evison; Prashant Patel; Rachel Cooney; Nigel Trudgill PATIENTS WITH PERNICIOUS ANAEMIA: A RETROSPEC- TIVE COHORT STUDY USING PRIMARY CARE DATABASE. 08:54 - 09:06 OP175 Fatmah Othman, United Kingdom; Colin J. Crooks; IS THE 'RESET' SURGERY EFFECTIVE FOR CROHN'S Timothy Card DISEASE PATIENTS REFRACTORY TO ANTI-TNF? THERAPY? 08:54 - 09:06 OP181 Shiho Takashima, Japan; Sakiko Hiraoka; Yoshitaka CONSISTENT AND REPRODUCIBLE PRODUCTION OF A Kondo; Toshihiro Inokuchi; Daisuke Takei; Asuka MICROBIOTA-BASED DRUG FOR RECURRENT C. DIFFI- Nakarai; Yuusaku Sugihara; Masahiro Takahara; Keita CILE INFECTION: APPLICATION OF A NOVEL DIAGNOSTIC Harada; Hiroyuki Okada FOR DYSBIOSIS Courtney Jones, USA

Livestream Q&A Audience Voting Recorded Session 73 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

09:06 - 09:18 OP182 08:54 - 09:06 OP187 A METHYL DONOR MOLECULES-SUPPLEMENTED DIET EVALUATION OF CLINICAL FACTORS ASSOCIATED WITH ERADICATES E. COLI POPULATION AND METHYLATES THE TECHNICAL DIFFICULTY OF SELF-EXPANDABLE CEACAM6 PROMOTER DECREASING ITS EXPRESSION IN METALLIC STENT PLACEMENT FOR MALIGNANT CO- COLONIC EPITHELIAL CELLS IN MICE LONIC OBSTRUCTION Elodie Gimier, France; Allison Agus; Nicolas Barnich; Mamoru Shimada, Japan; Toshio Kuwai; Akibumi Jérémy Denizot Kanazawa; Shuntaro Yoshida; Hiroyuki Isayama; Takeaki Matsuzawa; Tomonori Yamada; Shuji Saito; 09:18 - 09:30 OP183 Nobuto Hirata; Takashi Sasaki; Koichi Koizumi; Kenji COMPARATIVE GENOMICS AND SINGLE NUCLEOTIDE Tominaga; Iruru Maetani; Yoshihisa Saida POLYMORPHISM DISTRIBUTION BETWEEN ADHER- ENT-INVASIVE ESCHERICHIA COLI (AIEC) AND NON-AIEC 09:06 - 09:18 OP188 STRAINS FROM THE HUMAN INTESTINE 17 YEARS OF SINGLE CENTER EXPERIENCE WITH Carla Camprubí, Spain; Mireia Lopez-Siles; SELF-EXPANDABLE METAL STENTS IN COLONIC OB- Meritxell Ferrer-Guixeras; Laura Niubo-Carulla; STRUCTION Carles Abellà-Ametller; Jesús Garcia-Gil; Margarita Trine Bjerke, Denmark; Morten Rasmussen; Soren Meisner Martinez-Medina 09:18 - 09:30 OP189 09:30 - 09:42 OP184 LONG-TERM SURVIVAL AFTER ENDOSCOPIC STENTING ENTEROHEMORRHAGIC ESCHERICHIA COLI TROPISM AS A BRIDGE TO SURGERY IN OBSTRUCTIVE COLON TO PEYER'S PATCHES: ROLE OF LONG POLAR FIMBRIAE CANCER: A SINGLE CENTER STUDY AND INHIBITION BY A PROBIOTIC YEAST Bram Verstockt, Belgium; Annelien Van Driessche; Charlotte Cordonnier, France; Justine Ramboz; Marc De Man; Pieter van der Spek; Koen Hendrickx; Jonathan Thévenot; Lucie Etienne-Mesmin; Amandine Veerle Casneuf; Pieter Dobbels; Yves Van Molhem; Jo Rougeron; Sandra Renier; Nicolas Barnich; Stéphanie Vandervoort Tuesday, October 18, 2016 Blanquet-Diot; Valérie Livrelli 09:30 - 09:42 OP190 09:42 - 09:54 OP185 IMPACT OF MORTALITY FROM SURGICAL ADENOMA CURRENT OR PAST CLOSTRIDIUM DIFFICILE INFEC- REMOVAL ON THE EFFECTIVENESS OF COLORECTAL TION IS ASSOCIATED WITH INCREASED MORTALITY, CANCER SCREENING MORBIDITY AND RESOURCE UTILIZATION AMONG Maaike Buskermolen, The Netherlands; Miriam P. van PATIENTS HOSPITALIZED FOR CROHNS' DISEASE: der Meulen; Esther Toes-Zoutendijk; Monique van RESULTS OF A NATIONWIDE ANALYSIS Leerdam; Manon C. W. Spaander; Harry de Koning; Paul Kroner, USA; Marwan S. Abougergi Iris Lansdorp-Vogelaar 09:42 - 09:54 OP191 Free Paper Session SCREENING COLONOSCOPIES IN SENIORS OVER 70 08:30 - 10:00 Room 1.86 YEARS OF AGE Colon cancer: From screening to palliation Ivana Mikoviny Kajzrlikova, Czech Republic; Petr Vitek; Chairs: Dirk Domagk, Germany Josef Chalupa; Jan Kuchar; Jiri Platos; Pavel Reha Vivian Ekkelenkamp, The Netherlands 08:30 - 08:42 IP341 Symposium State-of-the-art introduction 09:00 - 10:00 Hotspot Dirk Domagk, Germany Diagnosis of IBS: What is the preferred strategy? Chair: Fermin Mearín Manrique, Spain 08:42 - 08:54 OP186 SELF-EXPANDABLE METALLIC STENT AS BRIDGE TO SURGERY IS MORE SUPERIOR THAN TRANSANAL DRAIN- 09:00 - 09:03 IP342 AGE TUBE AT QUALITY OF LIFE FOR THE PATIENTS WITH Introduction PRIMARY MALIGNANT COLORECTAL OBSTRUCTION. Fermin Mearín Manrique, Spain Kentaro Kojima, Japan; Nobuo Toda; Shigeyuki 09:03 - 09:08 IP343 Kurosaki; Kazuyoshi Funato; Satoshi Kawamura; A positive diagnostic strategy is preferred in IBS Yuki Karasawa; Shuya Maeshima; Takamasa Ohki; Lin Chang, USA Michiharu Seki; Kazumi Tagawa 09:08 - 09:16 IP344 PANEL DISCUSSION

74 ª Rising Star ª Top Abstract Prize ª National Scholar 75 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

09:16 - 09:21 IP345 11:34 - 11:56 IP353 IBS is a disorder of exclusion: An extensive diagnostic Can high-resolution manometry contribute to diagnose work-up is necessary GORD? David S. Sanders, United Kingdom Sabine Roman, France 09:21 - 09:29 IP346 Symposium PANEL DISCUSSION 10:30 - 12:00 Room B 09:29 - 09:34 IP347 Therapy update: Constipation IBS is an organic GI disease that should be defined by Chairs: Carolynne Vaizey, United Kingdom biomarkers Lesley Houghton, USA Giovanni Barbara, Italy

09:34 - 09:42 IP348 10:30 - 10:52 IP354 PANEL DISCUSSION Diet Robin Spiller, United Kingdom Live Endoscopy 10:52 - 11:14 IP355 10:30 - 12:00 Room A Medical treatment Live endoscopy Viola Andresen, Germany Chairs: Tomas Hucl, Czech Republic Guido Costamagna, Italy 11:14 - 11:36 IP356 Marianna Arvanitakis, Belgium Behavioural treatment Experts: Raf Bisschops, Belgium William E. Whitehead, USA Daniel Bléro, Belgium Jacques Deviere, Belgium 11:36 - 11:58 IP357 Pierre Eisendrath, Belgium Surgical treatment Marc Giovannini, France Charles H. Knowles, United Kingdom Mostafa Ibrahim, Belgium Arnaud Lemmers, Belgium Symposium Olivier Le Moine, Belgium 10:30 - 12:00 Room C Stefan Seewald, Switzerland IBD in young people Chairs: Franck Carbonnel, France Jan Taminiau, Belgium Symposium 2016 18, October Tuesday, 10:30 - 12:00 Room D Does my patient really have GORD? Debate Chairs: Frank Zerbib, France 10:30 - 10:40 IP358 Mark Fox, Switzerland Management of early Crohn's disease: Nutrional therapy! Sibylle Koletzko, Germany 10:30 - 10:52 IP349 10:40 - 10:50 IP359 Can we diagnose GORD on clinical history only? Management of early Crohn's disease: Immunosup- Pali Hungin, United Kingdom pression! Debate James Lindsay, United Kingdom 10:52 - 11:02 IP350 10:50 - 11:00 IP360 Upper GI endoscopy in patients with reflux: Biopsies Surgery in young female patients with ulcerative coli- should always be taken tis: Pro ileorectal anastomosis Cord Langner, Austria Pär Myrelid, Sweden 11:02 - 11:12 IP351 11:00 - 11:10 IP361 Upper GI endoscopy in patients with reflux: Biopsies Surgery in young female patients with ulcerative coli- are unnecessary tis: Pro ileal-pouch anastomosis Albert J. Bredenoord, The Netherlands Yves Panis, France 11:12 - 11:34 IP352 Rising Star: Clinical value of oesophageal imped- ance-pH monitoring in GORD management ª Edoardo Savarino, Italy

Livestream Q&A Audience Voting Recorded Session 75 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

Tandem Talks 11:14 - 11:36 IP371 11:10 - 11:20 IP362 What do you do when endoscopy does not help? Transition from the paediatrician to the adult gastroen- Bogdan D. Procopet, Romania terologist: What do we expect from each other? - The paediatrician's view 11:36 - 11:58 IP372 Gigi Veereman, Belgium Prophylaxis Thomas Reiberger, Austria 11:20 - 11:30 IP363 Transition from the paediatrician to the adult gastroen- Symposium terologist: What do we expect from each other? - The 10:30 - 12:00 Room F1 adult gastroenterologist's view Colon cancer: More than one disease? Britta Siegmund, Germany Chairs: Dirk Arnold, Germany 11:30 - 11:52 IP364 Nuno Figueiredo, Portugal PANEL DISCUSSION Debate: Symposium 10:30 - 10:52 IP373 10:30 - 12:00 Room E1 Left sided and right sided cancers: Consequences for Prevention and early diagnosis of pancreatic cancer treatment? – Pro Chairs: Thomas M. Gress, Germany Eric Van Cutsem, Belgium Marco J. Bruno, The Netherlands 10:52 - 11:14 IP374 Left sided and right sided cancers: Consequences for 10:30 - 10:52 IP365 treatment? – Con

Tuesday, October 18, 2016 Environmental risk factors for pancreatic cancer Dirk Arnold, Germany Nuria Malats, Spain 11:14 - 11:36 IP375 10:52 - 11:14 IP366 Predictive biomarkers in colorectal cancer: Ready for How should we screen for pancreatic cancer and what personalised treatment? should we be looking for? Thomas Aparicio, France Femme Harinck, The Netherlands 11:36 - 11:58 IP376 11:14 - 11:36 IP367 Stratification of tumour subtypes: Any progress for the How long does it take for pancreatic cancer to develop: adjuvant setting? Months or decades? Philippe Rougier, France Michael Goggins, USA Free Paper Session 11:36 - 11:58 IP368 Surgery for early pancreatic cancer 10:30 - 12:00 Room F2 John Neoptolemos, United Kingdom Complications in IBD Chairs: Laurent Beaugerie, France Simon Travis, United Kingdom Symposium 10:30 - 12:00 Room E2 From guidelines to clinical practice: Portal hyperten- 10:30 - 10:42 IP377 sive bleeding State-of-the-art Introduction Chairs: Dominique Thabut, France Laurent Beaugerie, France Rajiv Jalan, United Kingdom

10:30 - 10:52 IP369 Endoscopic treatment in active bleeding: Bands, glue, stents or powder? Todd H. Baron, USA 10:52 - 11:14 IP370 Medical treatment Jonel Trebicka, Germany

76 ª Rising Star ª Top Abstract Prize ª National Scholar 77 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

10:42 - 10:54 OP192 Symposium THE OCCURENCE OF ANAEMIA AND ANAEMIA 10:30 - 12:00 Room G SUBTYPES DURING THE FIRST YEAR OF DISEASE IN Detection and management of serrated lesions of the AN EAST-WEST EUROPEAN INCEPTION COHORT? AN colorectum ECCO-EPICOM COHORT STUDY Chairs: James Edward East, United Kingdom Johan Burisch, Denmark; Lars U. Gerdes; Sven Almer; Jaroslaw Regula, Poland S. Cukovic Cavka; Shaji Sebastian; Ioannis Kaimakliotis; Dana Duricova; Natalia Pedersen; Riina Salupere; Kari 10:30 - 10:52 IP378 R. Nielsen; Pia M. Oksanen; Konstantinos H. Katsanos; The pathologist's perspective Shmuel Odes; Vibeke Andersen; Daniela Valpiani; Limas Arzu Ensari, Turkey Kupcinskas; Svetlana Turcan; Fernando Magro; Adrian 10:52 - 11:14 IP379 Goldis; Kristofffer Kofod Vinding; Elena Belousova; Karin Endoscopic detection and characterisation Ladefoged; Yvonne Bailey; Vicent Hernandez; Jonas Evelien Dekker, The Netherlands Halfvarson; Olga Shonová; Naila Arebi; Marte L. Hoivik; Bjørn Moum; Ebbe Langholz; Peter L. Lakatos; Pia 11:14 - 11:36 IP380 Munkholm; Jens F. Dahlerup Endoscopic resection techniques Michael J. Bourke, Australia 10:54 - 11:06 OP193 INCIDENCE AND RISK FACTORS OF SERIOUS VIRAL 11:36 - 11:58 IP381 INFECTIONS IN INFLAMMATORY BOWEL DISEASE Surveillance strategies Andrew Wisniewski, France; Julien Kirchgesner; Cecilia Michal F. Kaminski, Poland Landman; Anne Bourrier; Isabelle Nion Larmurier; Harry Sokol; Philippe Seksik; Jacques Cosnes; Laurent Free Paper Session Beaugerie 10:30 - 12:00 Room K 11:06 - 11:18 OP194 Colorectal cancer screening: State-of-the-art COLORECTAL CANCER RISK IN A NATIONWIDE INFLAM- Chairs: Martina Mueller-Schilling, Germany MATORY BOWEL DISEASE COHORT WITH LOW GRADE Tomer Adar, Israel DYSPLASIA 10:30 - 10:42 IP382 Lauranne Derikx, The Netherlands; Sanne V. Tilburg; State-of-the-art introduction Iris D. Nagtegaal; Loes Nissen; Frank Hoentjen Martina Mueller-Schilling, Germany 11:18 - 11:30 OP195 10:42 - 10:54 OP198

ROLE OF DIFFUSION-WEIGHTED IMAGING (DWI) IN PREDICTORS AND TRENDS IN FECAL HEMOGLO- 2016 18, October Tuesday, MRI-ENTEROGRAPHY FOR THE EVALUATION OF SURGI- BIN CONCENTRATION: LONG-TERM FOLLOW-UP OF CAL RISK IN PATIENTS WITH CROHN'S DISEASE FIT-NEGATIVE SCREENEES IN POPULATION-BASED Anna Testa, Italy; Antonio Rispo; Pier P. Mainenti; COLORECTAL CANCER SCREENING Dario Musto; Nicola Imperatore; Matilde Rea; Olga M. Elisabeth J. Grobbee, The Netherlands; Eline H. Schreuders; Nardone; Nicola Caporaso; Fabiana Castiglione Bettina Hansen; Marco J. Bruno; Iris Lansdorp-Vogelaar; 11:30 - 11:42 OP196 Manon C. W. Spaander; Ernst J. Kuipers PREDICTORS OF FIRST COLONIC EPITHELIAL NEOPLASIA 10:54 - 11:06 OP199 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE MASS SCREENING FOR COLORECTAL CANCER BY USING UNDERGOING COLONOSCOPIC SURVEILLANCE A FECAL IMMUNOCHEMICAL TEST IN COMBINATION Julien Kirchgesner, France; Magali Svrcek; Cecilia WITH FEXIBLE SIMOIDOSCOPY Landman; Anne Bourrier; Isabelle Nion Larmurier; Ryoichi Nozaki, Japan; Kazutaka Yamada; Masahio Nadia Hoyeau; Harry Sokol; Philippe Seksik; Jacques Takano Cosnes; Jean-Francois Fléjou; Laurent Beaugerie 11:06 - 11:18 OP200 11:42 - 11:54 OP197 GASTROINTESTINAL EVENTS AFTER A NORMAL WITHDRAWN COLONOSCOPY IN FIT-POSITIVE PARTICIPANTS IN AN ORGANIZED, POPULATION-BASED COLORECTAL CAN- CER SCREENING PROGRAM Liseth Rivero Sánchez, Spain; Maria Pellise; Maria Lopez-Ceron; Jaume Grau; Angels Pozo; Anna Serradesanferm; Mireia Diaz; Cristina Rodriguez de Miguel; Josep M. Auge; Laura Llovet; Antoni Castells

Livestream Q&A Audience Voting Recorded Session 77 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

11:18 - 11:30 OP201 11:18 - 11:30 OP207 CHANGES IN HEALTH BEHAVIOUR ONE-YEAR AFTER COMBINATION THERAPY WITH DACLATASVIR AND TESTING NEGATIVE AT COLORECTAL CANCER SCREEN- ASUNAPREVIR IN CIRRHOTIC AND NON-CIRRHOTIC PA- ING? A RANDOMIZED CONTROLLED STUDY. TIENTS WITH HEPATITIS C VIRUS GENOTYPE 1B IN JAPAN Markus D. Knudsen, Norway; Anette Hjartåker; Geir Akihiro Tamori, Japan; Masaru Enomoto; Sawako Hoff; Thomas de Lange; Tomm Bernklev; Paula Berstad Kobayashi-Uchida; Hoang Hai; Yuga Teranishi; Hiroyuki Motoyama; Ritsuzo Kozuka; Etsushi Kawamura; Atsushi 11:30 - 11:42 OP202 Hagihara; Yoshiki Murakami; Norifumi Kawada SCREEN-DETECTED AND NON-SCREEN-DETECTED COLORECTAL CANCERS AFTER FOUR ROUNDS OF FECAL 11:30 - 11:42 OP208 IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER EXPERIENCE IN THE MANAGEMENT OF DECOMPENSAT- SCREENING ED HCV CIRRHOTIC PATIENTS WITH LOW DOSE SOFOS- Manon van der Vlugt, The Netherlands; Elisabeth J. BUVIR AND RIBAVIRIN COMBINED WITH DACLATASVIR. Grobbee; Patrick M. Bossuyt; Amanda Bos; Iris Lansdorp- Amr S. Hanafy, Egypt Vogelaar; Manon C. W. Spaander; Evelien Dekker 11:42 - 11:54 OP209 11:42 - 11:54 OP203 INTERFERON-FREE DAA TREATMENS DECREASE THE ADDED BENEFIT OF SURVEILLANCE IN COLORECTAL PORTAL PRESSURE AND HALT HISTOLOGICAL NECRO- CANCER SCREENING INFLAMMATION IN HIV/HCV - COINFECTED PATIENTS Marjolein J. E. Greuter, The Netherlands; Evelien WITH PORTAL HYPERTENSION ª Dekker; Gerrit A. Meijer; Veerle M. H. Coupé Philipp Schwabl, Austria; Mattias Mandorfer; Sebastian Steiner; Bernhard Scheiner; Theresa Bucsics; Katharina Free Paper Session Grabmeier-Pfistershammer; Maximilian Aichelburg; 10:30 - 12:00 Room M Wolfgang Sieghart; Arnulf Ferlitsch; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger Tuesday, October 18, 2016 Viral hepatitis: Natural history and treatment Chairs: Mario Reis Alvares-da-Silva, Brazil Alessandra Mangia, Italy Translational Basic Science 10:30 - 12:00 Room 1.61/1.62 10:30 - 10:42 IP383 Structural changes in functional GI disorders: Time to State-of-the-art introduction remove the term "functional"? Mario Reis Alvares-da-Silva, Brazil Chairs: Guy E. Boeckxstaens, Belgium 10:42 - 10:54 OP204 Roberto De Giorgio, Italy SUSTAINED VIROLOGIC RESPONSE TO INTERFER- ON-FREE THERAPIES AMELIORATES HCV-INDUCED PORTAL HYPERTENSION 10:30 - 10:52 IP384 Mattias Mandorfer, Austria; Karin Kozbial; Philipp Altered permeability Schwabl; Clarissa Freissmuth; Rémy Schwarzer; Rafael Daisy M. Jonkers, The Netherlands Stern; David Chromy; Albert F. Stättermayer; Thomas 10:52 - 11:14 IP385 Reiberger; Sandra Beinhardt; Wolfgang Sieghart; Intestinal microenvironment? food, bugs, bile and gas Michael Trauner; Harald Hofer; Arnulf Ferlitsch; Peter Fernando Azpiroz, Spain Ferenci; Markus Peck-Radosavljevic 11:14 - 11:36 IP386 10:54 - 11:06 OP205 Rising Star: Neuro-immune interactions in visceral WITHDRAWN hypersensitivity ª 11:06 - 11:18 OP206 Mira M. Wouters, Belgium RISK OF AND PREDICTORS FOR CLINICAL EVENTS 11:36 - 11:58 IP387 FOLLOWING VIROLOGICAL RELAPSE IN CHRONIC HEP- Structural and functional brain changes ATITIS B PATIENTS AFTER CESSATION OF NUCLEOS(T) Qasim Aziz, United Kingdom IDE ANALOGUE THERAPY Yao-Chun Hsu, ; Chun-Ying Wu; Chi-Yang Chang; Jaw-Town Lin

78 ª Rising Star ª Top Abstract Prize ª National Scholar 79 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

Today's Science, Tomorrow's Medicine 11:06 - 11:18 OP212 10:30 - 12:00 Room N1 ASSOCIATION OF CHROMOSOMAL INSTABILITY AND Bringing molecular tests to GI cancer clinics MICROSATELLITE INSTABILITY PATHWAYS WITH POST- Chairs: Fatima Carneiro, Portugal COLONOSCOPY COLORECTAL CANCER IN A RETROSPEC- Thomas Seufferlein, Germany TIVE COHORT STUDY Roel M. M. Bogie, The Netherlands; Chantal M. C. le Clercq; Quirinus J. M. Voorham; Martijn Cordes; Daoud 10:30 - 10:52 IP388 Sie; Evert van den Broek; Sara D. J. de Vries; Nicole C. Tumour sequencing: Hype or help for the clinician? T. van Grieken; Bauke Ylstra; Robert G. Riedl; Manon Jessica Zucman-Rossi, France van Engeland; Gerrit A. Meijer; Ad A. M. Masc Beatriz Carvalho; Silvia Sanduleanu 10:52 - 11:14 IP389 Colon cancer 11:18 - 11:30 OP213 Federica Di Nicolantonio, Italy MOTORIZED SPIRAL ENTEROSCOPY: A NEW TECHNIQUE FOR ONE-STAGE COMPLETE ENTEROSCOPY 11:14 - 11:36 IP390 Edward Belkin, USA; Kanishka Bhattacharya; E. Odstrcil; Barrett's and oesophageal cancer David Cave; Peter V. Draganov; D. Demarco Rebecca C. Fitzgerald, United Kingdom 11:30 - 11:42 OP214 11:36 - 11:58 IP391 THE AER-O-SCOPE COLONOSCOPE PROVIDES SUC- Pancreatic cancer CESSFUL ENDOSCOPIC THERAPY IN AN EX VIVO SWINE Dieter Saur, Germany COLON MODEL Stas Bezobchuk, Israel; Ian M. Gralnek Free Paper Session 11:42 - 11:54 OP215 10:30 - 12:00 Room N2 OUTCOME OF ENDOSCOPIC MUCOSAL RESECTION OF Improving detection and treatment of colonic polyps Chairs: Michael Häfner, Austria 424 LARGE SESSILE COLONIC POLYPS (?20MM) OVER A Monique van Leerdam, The Netherlands 9 YEAR PERIOD: A SINGLE CENTRE EXPERIENCE AND ANALYSIS OF CHANGE WITH TIME. 10:30 - 10:42 IP392 Dennis N. F. N. F. Lim, United Kingdom; Richard J. State-of-the-art introduction Robinson; Alison Moore; John De Caestecker; Peter Wurm Michael Häfner, Austria Free Paper Session 10:42 - 10:54 OP210 RANDOMIZED, BACK-TO-BACK TRIAL OF NEW GEN- 10:30 - 12:00 Room L7 2016 18, October Tuesday, ERATION OF NBI (HQ 290) FOR THE DETECTION OF Barret's associated neoplasia COLORECTAL POLYPS Chairs: Joachim Labenz, Germany Hyeon J. Goong, Republic of Korea; Bong M. Ko; Seong R. Pierre Henri Deprez, Belgium Jeon; HyunG. Kim; Su J. Hong; Jin-Oh Kim; Moon S. Lee 10:30 - 10:42 IP393 10:54 - 11:06 OP211 State-of-the-art introduction DIAGNOSTIC CHARACTERISTICS OF DEPRESSED TYPE Joachim Labenz, Germany COLORECTAL NEOPLASMS IN MAGNIFYING ENDOSCO- 10:42 - 10:54 OP216 PY AND ENDOCYTOSCOPY DEVELOPMENT AND VALIDATION OF A CLASSIFICATION Shinei Kudo, Japan; Kenta Igarashi; Shingo Matsudaira; SYSTEM TO IDENTIFY BARRETT'S NEOPLASIA USING Yuta Kouyama; Katsuro Ichimasa; Yuichi Mori; Masashi ACETIC ACID CHROMOENDOSCOPY: THE PREDICT Misawa; Toyoki Kudo; Tomokazu Hisayuki; Takemasa CLASSIFICATION Hayashi; Kunihiko Wakamura; Hideyuki Miyachi; Kesavan Kandiah, United Kingdom; Fergus J. Q. Atsushi Katagiri; Toshiyuki Baba; Fumio Ishida J. Chedgy; Gaius Longcroft-Wheaton; Oliver Pech; Pradeep Bhandari 10:54 - 11:06 OP217 STEPWISE DEVELOPMENT OF A VOLUMETRIC LASER ENDOMICROSCOPY PREDICTION SCORE FOR BAR- RETT'S NEOPLASIA USING MATCHED VLE-HISTOLOGY IMAGES OF ENDOSCOPIC RESECTION SPECIMENS AnneFré Swager, The Netherlands; Martijn G. H. van Oijen; Guillermo J. Tearney; Cadman L. Leggett; Sybren L. Meijer; Wouter L. Curvers; Jacques J. Bergman

Livestream Q&A Audience Voting Recorded Session 79 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

11:06 - 11:18 OP218 11:06 - 11:18 OP224 DETECTION OF DYSPLASIA IN BARRETT'S OESOPHAGUS FEASIBILITY OF A COMPUTER ALGORITHM FOR USING LECTIN-BASED NEAR INFRA-RED MOLECULAR DETECTION OF EARLY BARRETT'S NEOPLASIA USING IMAGING: AN EX-VIVO STUDY ON HUMAN TISSUE VOLUMETRIC LASER ENDOMICROSCOPY Massimiliano di Pietro, United Kingdom; André A. AnneFré Swager, The Netherlands; Fons van der Sommen; Neves; Maria O'Donovan; Dale J. Waterhouse; Sarah E. Svitlana Zinger; Sybren L. Meijer; Erik J. Schoon; Bohndiek; Kevin Brindle; Rebecca C. Fitzgerald Jacques J. Bergman; Peter de With; Wouter L. Curvers 11:18 - 11:30 OP219 11:18 - 11:30 OP225 RESULTS OF A PROSPECTIVE MULTICENTER BELGIAN OPTICAL ENHANCEMENT SYSTEM? PLUS OPTICAL REGISTRY OF RADIOFREQUENCY ABLATION FOR BAR- MAGNIFICATION UTILITY IN THE IDENTIFICATION OF RETT'S ESOPHAGUS. NORMAL GASTRIC MUCOSA, HELICOBACTER PYLORI Joke Vliebergh, Belgium; Pierre H. Deprez; Hilde Willekens; ASSOCIATED GASTRITIS, AND GASTRIC ATROPHY Danny De Looze; Hans Orlent; Elisabeth Macken; Paul Carlos Robles-Medranda, Ecuador; Manuel Valero; Christiaens; Fazia Mana; Gert De Hertogh; Raf Bisschops Miguel Puga; Miguel Soria; Jesenia Ospina; Haydee Alvarado; Hannah Pitanga Lukashok 11:30 - 11:42 OP220 LONG-TERM FOLLOW-UP RESULTS OF STEPWISE 11:30 - 11:42 OP226 RADICAL ENDOSCOPIC RESECTION FOR BARRETT'S FIRST-IN-MAN PILOT STUDY: FEASIBILITY OF LASER ESOPHAGUS WITH EARLY NEOPLASIA. MARKING IN BARRETT'S ESOPHAGUS WITH VOLUMET- Kamar Belghazi, The Netherlands; Frederike G. I. van RIC LASER ENDOMICROSCOPY Vilsteren; Bas L. A. M. Weusten; Sybren L. Meijer; AnneFré Swager, The Netherlands; A J. de Groof; Jacques J. Bergman; Roos E. Pouw Sybren L. Meijer; Bas L. A. M. Weusten; Wouter L. Curvers; Jacques J. Bergman 11:42 - 11:54 OP221

Tuesday, October 18, 2016 SPECIFIC BMP4 INHIBITION AS A POTENTIAL THERA- 11:42 - 11:54 OP227 PEUTIC STRATEGY FOR SMAD4 DEFECTIVE ESOPHA- ROAD MAP FLUOROSCOPY FOR SUCCESSFUL GUIDANCE GEAL ADENOCARCINOMAS OF ENDOSCOPIC INTERVENTIONS IN THE ESOPHAGUS Silvia Calpe; Matthew Read; Sanne Hoefnagel; Maria Jochen Weigt, Germany; Wilfried Obst; Arne Kandulski; D. C. Sancho Serra; Danielle Straub; Ana Correia; Nick Peter Malfertheiner Clemons; David Liu; Wayne Phillips; Kausilia K. Krishnadath, The Netherlands Free Paper Session 10:30 - 12:00 Room 1.86 Free Paper Session Small bowel disease and nutritional therapy 10:30 - 12:00 Room L8 Chairs: Katri Kaukinen, Finland Accuracy in upper GI endoscopy Imran Aziz, United Kingdom Chairs: Cesare Hassan, Italy Torsten Beyna, Germany 10:30 - 10:42 IP395 State-of-the-art introduction 10:30 - 10:42 IP394 Katri Kaukinen, Finland State-of-the-art introduction Cesare Hassan, Italy 10:42 - 10:54 OP228 GASTROINTESTINAL DISEASES IN COMMON VARIABLE 10:42 - 10:54 OP222 IMMUNODEFICIENCY PREMEDICATION WITH SIMETHICONE AND N-ACETYL- Sampsa Pikkarainen, Finland; Timi Martelius; Jannica CYSTEINE IN IMPROVING MUCOSAL VISIBILITY DURING Selenius; Mikko Seppänen; Martti A. Färkkila UPPER ENDOSCOPY? A PROSPECTIVE DOUBLE-BLIND- ED RANDOMIZED CONTROLLED TRIAL 10:54 - 11:06 OP229 Luís Elvas, Portugal; Miguel Areia; Susana Alves; BILE ACID DIARRHOEA: EVIDENCE FOR LOWER SEHCAT Daniel Brito; Sandra Saraiva; Ana T. Cadime RETENTION IN TYPE 3 PATIENTS FOLLOWING CHOLE- CYSTECTOMY 10:54 - 11:06 OP223 John McLaughlin, United Kingdom; Robert Logan; DIAGNOSIS OF TUMOR EXTENT OF EARLY GASTRIC Fiona Reid; Jennifer Summers CANCER BY MAGNIFYING NARROW BAND IMAGING VS. CHROMOENDOSCOPY: A MULTICENTER PROSPEC- TIVE RANDOMIZED CONTROLLED TRIAL Takashi Kanesaka, Japan; Takashi Nagahama; Noriya Uedo; Hisashi Doyama; Kunihisa Uchita; Tetsuya Ueo; Hideki Ishikawa; Kenshi Yao

80 ª Rising Star ª Top Abstract Prize ª National Scholar 81 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

11:06 - 11:18 OP230 11:00 - 11:10 OP237 EVALUATING THE UTILITY OF AMINO ACID CITRULLINE AS BILE MICROBIOTA IN PRIMARY SCLEROSING CHOL- A METABOLOMIC SIGNATURE IN PREDICTIVE AND FOL- ANGITIS: EFFECTS ON DISEASE STAGE AND RISK FOR LOW UP VALUE IN CELIAC DISEASE; SUGGESTING IT TO BILIARY DYSPLASIA BE A MARKER OF ENTEROCYTE VILLOUS DAMAGE ª Pedro Pereira, Finland; Velma Aho; Johanna Arola; Sonja Avinash Lomash, India; Somesh Kumar; Sunil K. Boyd; Kalle Jokelainen; Petri Auvinen; Martti A. Färkkila Polipalli; Seema Kapoor 11:10 - 11:20 OP238 11:18 - 11:30 OP231 INCREASED FAECAL LEVELS OF GRANINS IN IRRITABLE CELLULAR ZINC IS REQUIRED FOR INTESTINAL EPITHE- BOWEL SYNDROME ARE ASSOCIATED WITH LUMINAL LIAL BARRIER MAINTENANCE VIA THE REGULATION MICROBIOTA COMPOSITION AND SYMPTOM SEVERITY OF CLAUDIN-3 AND OCCLUDIN EXPRESSION. Johanna Sundin, Sweden; Sean M. P. Bennet; Julien Takuya Suzuki, Japan; Yuka Miyoshi Tap; Muriel Derrien; Boris Le Nevé; Mats Stridsberg; Hans Törnblom; Lena Öhman; Magnus Simrén 11:30 - 11:42 OP232 EVALUATING THE QUALITY OF LIFE OF ADULT PA- 11:20 - 11:30 OP239 TIENTS ON HOME PARENTERAL NUTRITION IN NORTH- MICROBIOTA ALTERATIONS IN TREATMENT NAÏVE IBD ERN AND NORTHEAST ENGLAND AND NON-IBD PATIENTS - THE EU IBD-CHARACTER Maxworth Hu, United Kingdom; Lisa Gemmell; Hannah PROJECT Cook; Hayley Leyland; John Leeds; Dina Mansour; Petr Ricanek, Norway; Simen Vatn; Rahul Kalla; Nicholas Thompson; Christopher Mountford Yolanda Ber; Ewa Ciemniejewska; Marieke J. Pierik; Jonas Halfvarson; Johan D. Söderholm; Jørgen Jahnsen; 11:42 - 11:54 OP233 Fernando Gomollon; Jack Satsangi; Morten H. Vatn; EARLY ENTERAL VERSUS TOTAL PARENTERAL NU- Monika Sekelja; Christina Casén TRITION IN PATIENTS UNDERGOING PANREATI- CODUODENECTOMY: A RANDOMIZED MULTICENTER 11:30 - 11:40 OP240 CONTROLLED TRIAL (NUTRI DPC) ª METABOLIC SYNDROME CORRELATES WITH MICROBIO- Julie Perinel, France; Christophe Mariette; Bertrand TA ENCROACHMENT IN HUMAN INTESTINE Dousset; I. Sielezneff; Alain Gainant; Jean-Yves Mabrut; Benoit Chassaing, USA; Shanthi Srinivasan; Andrew Sylvie Bin Dorel; Michel El Bechwaty; Marc Pocard; Gewirtz Emmanuel Buc; Alain Sauvanet; Mustapha Adham 11:40 - 11:50 OP241 CLINICAL FEATURES AND FECAL MICROBIOTA PROFILE Free Paper Session IN IRRITABLE BOWEL SYNDROME PATIENTS WITH 10:30 - 12:00 Hotspot SMALL INTESTINAL BACTERIAL OVERGROWTH 2016 18, October Tuesday, Abstracts on Fire: GI – All about microbiota? Zuojing Liu, China; Hui Wei; Shiwei Zhu; Yixuan Liu; Lu Chairs: Gianluca Ianiro, Italy Zhang; Kun Wang; John Y. Kao; Chung Owyang; Li-Ping Mirjana Rajilic-Stojanovic, Serbia Duan 10:30 - 10:40 OP234 11:50 - 12:00 OP242 DIETARY EMULSIFIERS DIRECTLY IMPACT THE HUMAN FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT GUT MICROBIOTA INCREASING ITS PRO-INFLAMMATO- C. DIFFICILE INFECTION: ANALYSIS OF FACTORS ASSOCI- RY POTENTIAL ATED WITH THE NEED FOR MULTIPLE FECAL INFUSIONS Benoit Chassaing, USA; Tom Van de Wiele; Andrew Gewirtz Gianluca Ianiro, Italy; Luca Masucci; Luca Valerio; 10:40 - 10:50 OP235 Domenico Nagel; Francesca D'Aversa; Remo Poto; THE CENTRAL ROLE OF THE GUT MICROBIOTA IN Francesco Dibitetto; Franco Scaldaferri; Marcantonio CHRONIC INTESTINAL PSEUDO-OBSTRUCTION. ª Gesualdo; Maurizio Sanguinetti; Antonio Gasbarrini; Sacha Sidani, Canada; Giada De Palma; Marc Pigrau; Giovanni Cammarota Jun Lu; Elena F. Verdu; Natalia Causada Calo; Christine H. Lee; Stephen M. Collins; Premysl Bercik 10:50 - 11:00 OP236 MICROBIOTA DIVERSITY AT TIME OF SURGERY PREDICTS ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE: A STUDY FROM THE REMIND GROUP Harry Sokol, France; Loic Brot; Carmen Stefanescu; Claire Auzolle; Nicolas Barnich; Anthony Buisson; Mathurin Fumery; Maria Nachury; Xavier Treton; Stéphane Nancey; Matthieu Allez; Philippe Seksik

Livestream Q&A Audience Voting Recorded Session 81 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

Symposium Round Table Discussion 12:15 - 13:15 Hotspot 12:45 - 13:45 Room K Drug development for digestive diseases: From clini- Challenges in ERCP cal needs to regulatory perspectives Chair: Horst Neuhaus, Germany Chair: Joachim Musaus, United Kingdom Experts: Horst Neuhaus, Germany Laurent Peyrin-Biroulet, France Marianna Arvanitakis, Belgium Tibor Gyökeres, Hungary Andrea Tringali, Italy Tandem Talks 12:15 - 12:23 IP396 Round Table Discussion The introduction of biosimilars: The Clinicians perp- 12:45 - 13:45 Room L7 sective in IBD Peptic ulcer disease: Pharmacological, endoscopic Silvio Danese, Italy and surgical treatment 12:23 - 12:31 IP397 Chair: Peter Malfertheiner, Germany The introduction of biosimilars: Regulatrory consider- Experts: Nicola Jones, Canada ations on interchangeability and extrapolation Ernst J. Kuipers, The Netherlands Andrea Laslop, Austria Karel Caca, Germany Peter Malfertheiner, Germany 12:31 - 12:39 IP398 Drug development in paediatric patients: IBD differen- Round Table Discussion tial drug effects in adults and children 12:45 - 13:45 Room L8 Gigi Veereman, Belgium Cystic pancreatic tumours: Biopsy, follow-up or resect? 12:39 - 12:47 IP399 Chair: Thomas M. Gress, Germany Tuesday, October 18, 2016 Drug development in paediatric patients: IBD clinical Experts: Thomas M. Gress, Germany outcomes of regulatory interest Philippe Lévy, France Jan Taminiau, Belgium Raneem Albazaz, United Kingdom John Neoptolemos, United Kingdom 12:47 - 12:55 IP400 Designing the framework for future developments: The Live Endoscopy expectations of learned societies and academics 14:00 - 15:30 Room A Colm O'Morain, Ireland Live endoscopy 12:55 - 13:03 IP401 Chairs: Horst Neuhaus, Germany Designing the framework for future developments: Cur- Thierry Ponchon, France rent situation of EMA interaction with learned societies Marianna Arvanitakis, Belgium Isabelle Moulon, United Kingdom Experts: Raf Bisschops, Belgium Daniel Bléro, Belgium 13:03 - 13:15 IP402 Jacques Deviere, Belgium PANEL DISCUSSION Pierre Eisendrath, Belgium Marc Giovannini, France Round Table Discussion Mostafa Ibrahim, Belgium 12:45 - 13:45 Room G Arnaud Lemmers, Belgium Multidisciplinary treatment of IBS patients with Olivier Le Moine, Belgium comorbidities Stefan Seewald, Switzerland Chair: Fermin Mearín Manrique, Spain Experts: Fermin Mearín Manrique, Spain Viola Andresen, Germany Symposium Maura Corsetti, United Kingdom 14:00 - 15:30 Room D Anton Emmanuel, United Kingdom From guidelines to clinical practice: Complex IBD cases Chair: Jean-Frederic Colombel, France Severine Vermeire, Belgium

Tandem Talks 14:00 - 14:10 IP403 Clinical case: An IBD patient with arthralgia Martine De Vos, Belgium 82 ª Rising Star ª Top Abstract Prize ª National Scholar 83 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

14:10 - 14:20 IP404 Symposium Arthralgia in IBD: How do guidelines help us? 14:00 - 15:30 Room C Axel Dignass, Germany National Societies Symposia: Case finding strategies 14:20 - 14:30 IP405 and access to hepatitis C therapy across Europe Chairs: Michael Manns, Germany PANEL DISCUSSION Nurdan Ayse Tözün, Turkey Tandem Talks 14:30 - 14:40 IP406 Clinical case: An IBD patient with fever 14:00 - 14:10 IP416 Rami Eliakim, Israel United Kingdom and Ireland Kosh Agarwal, United Kingdom 14:40 - 14:50 IP407 Fever in IBD patients: How do guidelines help us? 14:10 - 14:20 IP417 tba Scandinavia Soo Aleman, Sweden 14:50 - 15:00 IP408 PANEL DISCUSSION 14:20 - 14:30 IP418 Eastern Europe Tandem Talks Jerzy Jaroszewicz, Poland 15:00 - 15:10 IP409 Clinical case: An IBD patients with abnormal liver tests 14:30 - 14:40 IP419 Peter L. Lakatos, Hungary Southern Europe Marina Berenguer, Spain 15:10 - 15:20 IP410 IBD and abnormal liver tests: How do guidelines help us? 14:40 - 14:50 IP420 Herbert Tilg, Austria Central Europe Peter Ferenci, Austria 15:20 - 15:30 IP411 14:50 - 15:00 IP421 PANEL DISCUSSION South East Nurdan A. Tözün, Turkey Symposium 14:00 - 15:30 Room B 15:00 - 15:22 IP422 Therapy update: Colon cancer PANEL DISCUSSION

Chairs: Desmond C. Winter, Ireland 2016 18, October Tuesday, Thomas Aparicio, France Symposium 14:00 - 15:30 Room E1 Liver nodules in different clinical situations 4:00 - 14:22 IP412 Chairs: Dina Tiniakos, United Kingdom Surgery Joost P.H. Drenth, The Netherlands Christiane Bruns, Germany 14:22 - 14:44 IP413 Liver metastases: What is resectable? 14:00 - 14:22 IP423 Thomas Gruenberger, Austria Nodules and pregnancy Fabio Piscaglia, Italy 14:44 - 15:06 IP414 Novel systemic strategies 14:22 - 14:44 IP424 Philippe Rougier, France Nodules in children Ulrich Baumann, Germany 15:06 - 15:28 IP415 Novel therapeutics on the horizon 14:44 - 15:06 IP425 Thomas Seufferlein, Germany Nodules in the cirrhotic patient Jean-François Dufour, Switzerland 15:06 - 15:28 IP426 Nodules in the bright liver Elizabetta Bugianesi, Italy

Livestream Q&A Audience Voting Recorded Session 83 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

Symposium 14:34 - 14:46 OP246 14:00 - 15:30 Room E2 MANAGEMENT OF DIMINUTIVE, RECTOSIGMOID POL- Endoscopic treatment of complications after upper GI YPS BY USING COMPUTER-AIDED DIAGNOSTIC SYSTEM surgery Yuichi Mori, Japan; Shin-ei Kudo; Masashi Misawa; Chairs: Annette Fritscher-Ravens, Germany Kunihiko Wakamura; Toyoki Kudo; Kenichi Takeda; Ping-Hong Zhou, China Takemasa Hayashi; Atsushi Katagiri; Hideyuki Miyachi; Fumio Ishida; Haruhiro Inoue; Masahiro Oda; Kensaku Mori 14:00 - 14:22 IP427 14:46 - 15:08 IP431 Anastomotic leakage after oesophageal resection Leaving the lesion or optimising the technique of removal Helmut Messmann, Germany Michael Bretthauer, Norway 14:22 - 14:44 IP428 15:08 - 15:30 IP432 Fistulae after bariatric surgery Discarding the specimen or sending to the pathologist? Vincent Huberty, Belgium Jaroslaw Regula, Poland 14:44 - 15:06 IP429 Anastomotic strictures Symposium Krish Ragunath, United Kingdom 14:00 - 15:30 Room F2 15:06 - 15:18 OP243 Functional GI symptoms in organic diseases ENDOSCOPIC BALLOON DILATION FOLLOWED BY STE- Chairs: Giovanni Barbara, Italy ROID INJECTION IN ANASTOMOTIC STRICTURES AFTER Sandro Ardizzone, Italy ESOPHAGECTOMY: A MULTICENTER RANDOMIZED, DOUBLE-BLIND CONTROLLED TRIAL

Tuesday, October 18, 2016 14:00 - 14:22 IP433 Noboru Hanaoka, Japan; Ryu Ishihara; Noriya Uedo; Chronic GI symptoms after surgery Koji Higashino; Yoji Takeuchi; Tomofumi Akasaka; Marja A. Boermeester, The Netherlands Masahiko Yano; Yoshito Hayashi; Tetsuo Takehara; Hiroyasu Iishi 14:22 - 14:44 IP434 The functional dyspepsia - gastroparesis dilema: One 15:18 - 15:30 OP244 disease or different diseases? THE "TUNNEL + CLIP" METHOD FACILITATES OESOPH- Hans Törnblom, Sweden AGEAL ESD PROCEDURES: A PROSPECTIVE, CONSECU- TIVE BI-CENTRIC STUDY 14:44 - 15:06 IP435 Jérémie Jacques, France; Romain Legros; Jérôme Rivory; Functional GI symptoms in patients with coeliac disease Denis Sautereau; Thierry Ponchon; Mathieu Pioche David S. Sanders, United Kingdom

Symposium 15:06 - 15:28 IP436 The IBD-IBS overlap: Distinct disorders or part of the 14:00 - 15:30 Room F1 same spectrum? What to do with small colorectal polyps? Alexander C. Ford, United Kingdom Chairs: Ralf Kiesslich, Germany Evelien Dekker, The Netherlands Symposium 14:00 - 15:30 Room G 14:00 - 14:22 IP430 Improving early diagnosis of upper GI cancer How accurate is endoscopic characterisation? Chairs: Jacques J. Bergman, The Netherlands Ian M. Gralnek, Israel Kenshi Yao, Japan 14:22 - 14:34 OP245 14:00 - 14:22 IP437 DEVELOPMENT AND VALIDATION OF A SIMPLE Early recognition in primary care CLASSIFICATION SYSTEM FOR IN VIVO DIAGNOSIS OF Fiona M. Walter, United Kingdom COLORECTAL POLYPS USING THE NEWLY INTRODUCED 14:22 - 14:44 IP438 BLUE LIGHT IMAGING (BLI) Inherited predisposition and biomarkers: Are the tests Helmut Neumann, Germany; Michael Vieth; Lucia Fry; coming? Gian E. Tontini; Klaus Mönkemüller David Whiteman, Australia 14:44 - 15:06 IP439 Endoscopists should look more closely Thomas Rösch, Germany 84 ª Rising Star ª Top Abstract Prize ª National Scholar 85 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

Tandem Talks 14:12 - 14:12 OP251 15:06 - 15:16 IP440 INTRA- AND INTER-VARIABILITY OF FECAL CALPRO- When is endoscopic surveillance indicated? The pa- TECTIN IN INFLAMMATORY BOWEL DISEASE PATIENTS: thologist's view A PROSPECTIVE OBSERVATIONAL CASE-CONTROL Massimo Rugge, Italy ST UDY. Jade Ku, Belgium; Anneline Cremer; Leila Amininejad; 15:16 - 15:26 IP441 Claire Liefferinckx; Eric Quertinmont; Jacques Deviere; When is endoscopic surveillance indicated? The clini- André Van Gossum; Patrick Stordeur; Denis Franchimont cian's view Mario Dinis-Ribeiro, Portugal 14:12 - 14:12 OP252 ANALYTICAL PERFORMANCE OF A NEW IPHONE-BASED Free Paper Session PATIENT MONITORING SYSTEM COMPARABLE TO ELISA 14:00 - 15:30 Room K FOR MEASURING FECAL CALPROTECTIN IN IBD PATIENTS Biomarkers in IBD Karl F. Wintgens; Andina A. Wulandari; Axel Dignass; Chairs: Colm O'Morain, Ireland Franz Hartmann; Jürgen Stein, Germany Johan Burisch, USA Free Paper Session 14:00 - 14:12 IP442 14:00 - 15:30 Room M State-of-the-art introduction Clinical trials in functional GI disorders Colm O'Morain, Ireland Chairs: Gregory Rubin, United Kingdom 14:12 - 14:12 OP247 Niek J. De Wit, The Netherlands IBDOC – FIRST SMARTPHONE BASED CALPROTECTIN 14:00 - 14:12 IP443 HOME TEST? 18 MONTHS EXPERIENCE State-of-the-art introduction Christian Reinhard, Switzerland; Alicja Ritz; Marie-Eve Niek J. De Wit, The Netherlands Überschlag; Anita Beyer; Harald Vogelsang; Jakob Weber 14:12 - 14:24 OP253 14:12 - 14:12 OP248 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF A COMBINATION OF THE MONITOR IBD AT HOME BIOFEEDBACK FOR THE TREATMENT OF ABDOMINAL QUESTIONNAIRE AND A CALPROTECTIN HOME TEST AS DISTENSION. EXCELLENT SCREENING TOOL FOR MUCOSAL INFLAM- Elizabeth Barba, Spain; Anna Accarino; Juan R. MATION IN IBD PATIENTS Malagelada; Fernando Azpiroz Marin J. de Jong; Daisy M. Jonkers, The Netherlands; Marielle Romberg Camps; Alexander G. L. Bodelier; A. 14:24 - 14:36 OP254 Tuesday, October 18, 2016 18, October Tuesday, J. P. van de Wetering; T. van Etten; S. H. P. Conjaerts; T. LOW FODMAP DIET ALTERS SYMPTOMS, MICROBIOTA, Markus; Ad A. Masclee; Marieke J. Pierik SHORT-CHAIN FATTY ACIDS AND CYTOKINE PROFILES IN PATIENTS WITH IBS: A RANDOMIZED CONTROLLED 14:12 - 14:12 OP249 TRIAL ª ACCURACY OF NON-INVASIVE TESTS IN THE INITIAL Tonje N. Hustoft, Norway; Trygve Hausken; Synne O. DIAGNOSTIC WORK-UP OF PEDIATRIC INFLAMMATORY Ystad; Jørgen Valeur; Karl A. Brokstad; Jan G. BOWEL DISEASES Hatlebakk; Gulen A. Lied Fortunata Civitelli, Italy; Anna Dilillo; Marina Aloi; Salvatore Oliva; Franca Viola; Laura Stronati; Salvatore 14:36 - 14:48 OP255 Cucchiara PREDICTORS FOR THE OUTCOME OF THE FODMAP DIET IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL 14:12 - 14:12 OP250 DISORDERS THE SEROLOGIC MARKERS ASCA AND PANCA SHOW Clive H. Wilder-Smith, Switzerland; Søren S. Olesen; BETTER PREDICTABILITY THAN CRP, ESR AND Andrea Materna; Asbjørn M. Drewes CALPROTECTIN FOR ANTI- TNF TREATMENT AMONG PEDIATRIC IBD PATIENTS. 14:48 - 15:00 OP256 Christine Olbjørn, Norway; Milada S. Cvancarova; A RANDOMIZED TRIPLE BLIND CONTROLLED TRIAL Espen Thiis-Evensen; Britt Nakstad; Morten H. Vatn; ASSESSING THE EFFECTS OF DOXEPIN AND NORTRIPTY- Gøri Perminow LINE ON -PREDOMINANT IRRITABLE BOWEL SYNDROME Hosseinali Habibinejad, Iran; Mohammadreza Ghadir; Akram Heidari

Livestream Q&A Audience Voting Recorded Session 85 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

15:00 - 15:12 OP257 14:44 - 15:06 IP450 TREATMENT OF IRRITABLE BOWEL SYNDROME WITH Metabolomics and proteomics FECAL MICROBIOTA TRANSPLANTATION: A CASE Julia Mayerle, Germany SERIES OF 10 PATIENTS Jitaek Hong, Republic of Korea; Byoungwook Bang; 15:06 - 15:28 IP451 Yongwoon Shin; Hyung-Kil Kim; Kyesook Kwon What is the stratified trial design of the future? Dirk Arnold, Germany 15:12 - 15:24 OP258 1-MONTH TREATMENT WITH ELUXADOLINE FOR IBS-D Symposium PREDICTS SUSTAINED RESPONSE: CONTINUATION 14:00 - 15:30 Room N2 ANALYSES OF RESPONSE IN TWO PHASE 3 STUDIES Hot topics in pancreatology William D. Chey; David A. Andrae; Leonard S. Dove; Chairs: Rolf Graf, Switzerland Catherine R. Gutman; Paul S. Covington, USA Vinciane Rebours, France

Translational Basic Science 14:00 - 15:30 Room 1.61/1.62 14:00 - 14:22 IP452 Intestinal microbiota in health and disease Rising Star: Diagnosis and management of acute pan- Chairs: Mirjana Rajilic-Stojanovic, Serbia creatitis - Developments in the past 10 years ª Daisy Mae Jonkers, The Netherlands Hjalmar C. van Santvoort, The Netherlands 14:22 - 14:34 OP259 14:00 - 14:22 IP444 HUMAN PLURIPOTENT STEM CELL-DERIVED EXOCRINE/ Altered intestinal microbiota in GI diseases, cause or DUCTAL ORGANOIDS GENERATE HUMAN PANCREAS consequence? UPON ORTHOTOPIC TRANSPLANTATION AND ALLOW Tuesday, October 18, 2016 Stephan Bischoff, Germany DISEASE MODELLING Meike Hohwieler; Anett Illing; Martin Müller; 14:22 - 14:44 IP445 Qiong Lin; André Lechel; Patrick C. Hermann; Jonas The role of interactions between diet and GI microbio- Rosendahl; Thomas Seufferlein; Martin Wagner; ta in obesity and metabolic diseases Alexander Kleger, Germany Alexander R. Moschen, Austria 14:34 - 14:46 OP260 14:44 - 15:06 IP446 CANCER ASSOCIATED FIBROBLASTS (CAFS) SEQUES- Host factors of importance for shaping the gut microbiota TER GEMCITABINE TO INCREASE INTRATUMORAL Patrizia Brigidi, Italy DRUG DELIVERY IN MURINE PANCREAS CANCER Albrecht Neesse, Germany; Elisabeth Hessmann; 15:06 - 15:28 IP447 Melanie Patzak; T. E. Bapiro; D. I. Jodrell; Johannes M. Manipulating gut microbiota as a treatment strategy in Löhr; Thomas M. Gress; Volker Ellenrieder GI and metabolic diseases Josbert Keller, The Netherlands 14:46 - 15:08 IP453 Rising Star: Acute pancreatitis? the role of modifiable Today's Science, Tomorrow's Medicine factors ª 14:00 - 15:30 Room N1 Omid Sadr-Azodi, Sweden New tests for treatment stratification in GI cancer 15:08 - 15:20 OP261 Chairs: Jessica Zucman-Rossi, France CIRCULATING CELL-FREE DNA IS A RELIABLE TOOL Thomas M. Gress, Germany TO DETECT HOT SPOT MUTATIONS IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS ª Andreas Berger; Daniel Schwerdel, Germany; Ivan Costa; 14:00 - 14:22 IP448 Oliver Strobel; Thilo Hackert; Thomas Barth; Alexander Which genomic test for which purpose: Whole genome, Meining; Markus Büchler; Martin Zenke; Patrick C. exome, or targeted? Hermann; Thomas Seufferlein; Alexander Kleger Rebecca C. Fitzgerald, United Kingdom 14:22 - 14:44 IP449 Circulating free tumour DNA (cftDNA) and circulating tumour cells Federica Di Nicolantonio, Italy

86 ª Rising Star ª Top Abstract Prize ª National Scholar 87 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

Free Paper Session Free Paper Session 14:00 - 15:30 Room L7 14:00 - 15:30 Room L8 Intestinal failure: From pathways to treatment Prognostic factors in lower GI cancer Chairs: Jakub Fichna, Poland Chairs: Iris D. Nagtegaal, The Netherlands Charles H. Knowles, United Kingdom Eric Van Cutsem, Belgium Stefan Kubicka, Germany 14:00 - 14:12 IP454 State-of-the-art introduction 14:00 - 14:12 IP455 Jakub Fichna, Poland State-of-the-art introduction Iris D. Nagtegaal, The Netherlands 14:12 - 14:24 OP262 NOVEL GENE MUTATIONS IN NEUROGENIC CHRONIC 14:12 - 14:24 OP268 INTESTINAL PSEUDO-OBSTRUCTION EXPRESSION OF DDR2 CORRELATES WITH HIGH FRE- Elena Bonora, Italy; Claudio Graziano; Francesca Bianco; QUENCY OF PERITONEAL DISSEMINATION AND POOR Agnese Stanzani; Rita Rinaldi; Roberto D'Angelo; PROGNOSIS IN COLORECTAL CANCER Elisa Boschetti; Joshua D. Smith; Ghazaleh Assadi; Shin Sasaki, Japan; Masami Ueda; Tomohiro Iguchi; Mike Bamshad; Debora Nickerson; Greger Lindberg; Manabu Kaneko; Hiroshi Nakayama; Toshiyuki Mauro D'Amato; Vincenzo Stanghellini; Marco SERI; Watanabe; Atsuhiko Sakamoto; Koshi Mimori Roberto De Giorgio 14:24 - 14:36 OP269 14:24 - 14:36 OP263 GENETIC SUSCEPTIBILITY AND FAMILY HISTORY OF PROTEASE SIGNALING IN HUMAN SENSORY NEURONS COLORECTAL CANCER. RELEVANCE OF SINGLE NUCLE- Cleo Desormeaux, France; Tereza Bautzova; Corinne OTIDE POLYMORPHISMS IN THE DEVELOPMENT OF Rolland; Nathalie Vergnolle; Nicolas Cenac COLORECTAL PRENEOPLASTIC LESIONS. Carla J. Gargallo Puyuelo, Spain; Angel Lanas; Patricia 14:36 - 14:48 OP264 Carrera; Angel Ferrandez; Enrique Quintero Carrion; DIFFERENTIAL BASELINE CHARACTERISTICS IN SHORT Marta Carrillo Palau; Inmaculada Alonso Abreu; Pilar BOWEL SYNDROME DUE TO VASCULAR CATASTROPHES Roncales; Elena Piazuelo; Maria A. Garcia Gonzalez ARE ASSOCIATED WITH VARYING RESPONSE TO TEDU- GLUTIDE TREATMENT: POST HOC ANALYSIS 14:36 - 14:48 OP270 Palle B. Jeppesen, Denmark; Ulrich-Frank Pape; A NOVEL AMPLIFICATION GENE PCID2 PROMOTES Kishore Iyer; Hak-Myung Lee; Clement Olivier TUMORIGENICITY OF COLORECTAL CANCER THROUGH DIRECTLY DEGRADING A TUMOR SUPPRESSOR PML 14:48 - 15:00 OP265 AND IS ASSOCIATED WITH DISEASE RECURRENCE NUTRITIONAL OUTCOME IN SMALL BOWEL AND MULTI- Jingwan Zhang, Hong Kong Prc; Yanquan Zhang; 2016 18, October Tuesday, VISCERAL TRANSPLANT PATIENTS ª Ho Tsoi; Hua Wang; Jing Gao; Yin Y. GO; Siew C. Ng; Sze P. Yeap, United Kingdom; Rebecca Maddison; Stephen Joseph J. Y. Sung; Jun Yu J. Middleton; Andrew J. Butler; Jeremy M. Woodward; Neil K. Russell; Charlotte S. Rutter; Lisa M. Sharkey 14:48 - 15:00 OP271 PREDICTION OF COMPLETE RESECTIONS AFTER 15:00 - 15:12 OP266 CYTOREDUCTIVE SURGERY BASED ON THE EXTENT OF SUBANALYSIS OF TEDUGLUTIDE EFFICACY AND SAFETY COLORECTAL PERITONITEAL CARCINOMATOSIS DATA FROM PATIENTS WITH CROHN'S DISEASE AND W. H. van Eden; Max Lahaye, The Netherlands; Andrea ULCERATIVE COLITIS IN THE STEPS STUDY Delli pizzi; Doenja M. Lambregts; Niels Kok; Geerard L. Ulrich-Frank Pape, Germany; Palle B. Jeppesen; Beets; Regina G. H. Beets-Tan; Arend Aalbers Hak-Myung Lee; Andrew A. Grimm; Stephen J. O'Keefe 15:00 - 15:12 OP272 15:12 - 15:24 OP267 PREVALENCE OF LYMPH NODE METASTASIS AND LONG INDICATIONS AND OUTCOMES OF INTESTINAL AND TERM SURVIVAL OF T1 RECTAL CARCINOID TUMORS: MULTIVISCERAL TRANSPLANT AN ANALYSIS OF SURVEILLANCE, EPIDEMIOLOGY, AND Lisa M. Sharkey; Sze P. Yeap, United Kingdom; END RESULTS (SEER) DATABASE Charlotte S. Rutter; Dunecan C. O. Massey; Jeremy M. Saowanee Ngamruengphong, USA; Ayesha Kamal; Woodward; Andrew J. Butler; Neil K. Russell; Stephen Gulara Hajiyeva; Yen-I Chen; majidah Bukhari; Amr Is- J. Middleton mail; Daniela Fluxa; Yamile H. Chavez; Vivek Kumbhari; Vikesh Singh; MarciaI. Canto; Mouen Khashab

Livestream Q&A Audience Voting Recorded Session 87 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

15:12 - 15:24 OP273 15:00 - 15:12 OP278 LONG-TERM FOLLOW-UP FEATURES ON RECTAL MRI USEFULNESS OF MULTIPOLAR BIPOLAR RADIOFRE- DURING ?WATCH-AND-WAIT' IN CLINICAL COMPLETE QUENCY SYSTEM AND VALUE OF 3D SIM-NAVIGATOR RESPONDERS AFTER CHEMORADIOTHERAPY: AN Azusa Sakamoto, Japan; Toru Kimura; Gensyo Tanke; UPDATE OF 68 PATIENTS. Mio Taki; Manabu Fukuhara; Yoshiaki Ohara; Shinichiro Doenja M. Lambregts, The Netherlands; Miriam van Henmi; Takeshi Yamashina; Yugo Sawai; Sumio Saito; Heeswijk; Britt Hupkens; Rianne Beckers; Monique Norihiro Nishijima; Akihiro Nasu; Hideyuki Komekado; Maas; Marit van der Sande; Geerard L. Beets; Regina Akira Sekikawa; Masanori Asada; Takehiko Tsumura; G. H. Beets-Tan Ryuichi Kita; Takanori Maruo; Yukio Osaki 15:12 - 15:24 OP279 Free Paper Session ASSOCIATION BETWEEN ADIPOQ GENE POLYMOR- 14:00 - 15:30 Room 1.86 PHISMS AND THE RISK OF NEW-ONSET DIABETES General hepatology MELLITUS AFTER LIVER TRANSPLANTATION Chairs: Antonio Facciorusso, Italy Chao Cen, China; Songfeng Yu; Jun Yu; Qi Ling; Lin Marc Bourlière, France Zhou; Shusen Zheng 14:00 - 14:12 IP456 State-of-the-art introduction Symposium Marc Bourlière, France 14:00 - 15:30 Hotspot Clinical Trials Revisited: IBD – Can it be cured with 14:12 - 14:24 OP274 transplantation? ACCURACY OF A POINT SHEAR WAVE ELASTOGRA- Chair: Matthieu Allez, France PHY TECHNIQUE (ELASTPQ) IN THE NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IN A LARGE COHORT

Tuesday, October 18, 2016 OF LIVER PATIENTS 14:00 - 14:15 IP457 Matteo Garcovich, Italy; Mauruzio Pompili; Enrico Di Trial presentation - Fecal microbial transplantation in Stasio; Laura Riccardi; Maria E. Ainora; Antonio Grieco; IBD: Results from two clinical trials Gian L. Rapaccini; Massimo Siciliano; Antonio Geert D'Haens, The Netherlands; Paul Moayyedi, Canada Gasbarrini; Maria A. Zocco 14:15 - 14:30 IP458 14:24 - 14:36 OP275 Critical review COMPARATIVE STUDY BETWEEN TWO 2D-SHEAR Giovanni Cammarota Italy WAVES ELASTOGRAPHY TECHNIQUES FOR THE ASSESS- MENT OF LIVER STIFFNESS: 2D-SWE.SSI VS. 2D-SWE.GE 14:30 - 14:45 IP459 Felix Bende, Romania; Ioan Sporea; Roxana L. D. Sirli; PANEL DISCUSSION Alina Popescu; Mirela Danila; Ruxandra G. Mare; Geert D'Haens, The Netherlands Raluca Lupusoru Paul Moayyedi, Canada 14:36 - 14:48 OP276 Giovanni Cammarota Italy UTILITY OF REAL-TIME SHEAR WAVE ELASTOGRAPHY Gerassimos Mantzaris, Greece FOR ASSESSING LIVER FIBROSIS IN PATIENTS WITH 14:45 - 15:00 IP460 CHRONIC HEPATITIS C Trial presentation - Autologous stem cell transplantation Hiroshi Numao, Japan; Kohji Shimaya; Akihisa Kakuta; in IBD Kohichi Shibutani; Hidekachi Kurotaki; Shohei Igarashi; Christopher J. Hawkey, United Kingdom Keisuke Hasui; Norihiro Hanabata; Kohsuke Kanazawa; Masaki Munakata 15:00 - 15:15 IP461 Critical review 14:48 - 15:00 OP277 Arthur Kaser, United Kingdom ASSOCIATIONS OF TOLL LIKE RECEPTORS (TLR-2) & (TLR-4) ALLELES WITH THE HEPATITIS C VIRUS INFEC- 15:15 - 15:30 IP462 TION OUTCOME IN EGYPTIAN POPULATION :A MULTI- PANEL DISCUSSION CENTRE FAMILY BASED STUDY Christopher J. Hawkey, United Kingdom Mahmoud El-Bendary, Egypt; Mustafa Neamatallah; Arthur Kaser, United Kingdom Gamal Esmat; Emily Kamel; Hatem Elalfy; Tarek Iris Dotan, Israel Besheer; Lamiaa Kandeel; Asmaa Gomaa; Nasser Laurence Egan, Ireland Mousa; Mohamed Abd El-Maksoud; Roba Talaat; Wael Abdel-Mageed; Abdel-Hamid Aladl; Eman Medhat

88 ª Rising Star ª Top Abstract Prize ª National Scholar 89 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

Symposium 16:07 - 16:29 IP469 15:45 - 17:15 Room A What does the Kyoto consensus bring us? Management of refractory Crohn's disease Ernst J. Kuipers, The Netherlands Chairs: Krisztina Barbara Gecse, Hungary 16:29 - 16:51 IP470 Matthieu Allez, France What's new for clinical practice in paediatric guidelines? Nicola Jones, Canada 15:45 - 16:07 IP463 16:51 - 17:03 OP282 What to do when all biologics fail? PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT Jean-Frederic Colombel, France (HP-EUREG): INTERIM ANALYSIS OF THE SINGLE-CAP- SULE BISMUTH QUADRUPLE TREATMENT (PYLERA®) Tandem Talks Adrian G. McNicholl, Spain; Francis Megraud; Bojan 16:07 - 16:17 IP464 Tepe; Marino Venerito; Krzysztof Przytulski; Management of extensive small bowel Crohn's dis- Jean-Charles Delchier; Anne Courillon-Mallet; Bruno ease: The gastroenterologist's view Richard-Molard; Dino Vaira; Angeles Perez Aisa; Luis Severine Vermeire, Belgium Fernández Salazar; Luis Bujanda Fernández de Piérola; 16:17 - 16:27 IP465 Juan Ortuño; Maria G. Donday; Olga P. Nyssen; Colm Management of extensive small bowel Crohn's dis- O'Morain; Javier P. Gisbert ease: The surgeon's view 17:03 - 17:15 OP283 Gianluca Sampietro, Italy PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGE- 16:27 - 16:37 IP466 MENT (HP-EUREG): INTERIM ANALYSIS OF FIRST-LINE Refractory perianal fistulising disease: The gastroen- TREATMENT WITH BISMUTH, AMOXICILLIN AND CLAR- terologist's view ITHROMYCIN James Lindsay, United Kingdom Adrian G. McNicholl, Spain; Dmitry S. Bordin; Oleg Shvets; Yaron Niv; Galina Fadeenko; Liudmila 16:37 - 16:47 IP467 Vologzhanina; Luis Bujanda Fernández de Piérola; Refractory perianal fistulising disease: The surgeon's view Ines Modolell; Angeles Perez Aisa; Cristobal de la Carolynne Vaizey, United Kingdom Coba; Sergei Burkov; Oleg Zaytsev; Maria G. Donday; 16:47 - 16:59 OP280 Olga P. Nyssen; Colm O'Morain; Javier P. Gisbert DISAPPEARANCE OF ANTI-DRUG ANTIBODIES TO IN- FLIXIMAB AND ADALIMUMAB AFTER ADDITION OF AN Symposium

IMMUNOMODULATOR IN PATIENTS WITH INFLAMMA- 15:45 - 17:15 Room B 2016 18, October Tuesday, TORY BOWEL DISEASE Therapy Update: Challenges in biliary stone management Anne S. Strik, The Netherlands; Gijs R. van den Brink; Cyriel Chairs: Jeanin E. van Hooft, The Netherlands Y. Ponsioen; Ron Mathot; Mark Lowenberg; Geert D'Haens Guido Costamagna, Italy 16:59 - 17:11 OP281 POST-OPERATIVE COMPLICATIONS IN ELDERLY-ON- 15:45 - 16:07 IP471 SET INFLAMMATORY BOWEL DISEASE: A POPULA- Biliary stones: Pitfalls in diagnosis TION-BASED STUDY Lars Aabakken, Norway Sophie-Caroline Sacleux, France; Helene Sarter; Cloé Charpentier; Mathurin Fumery; Nathalie Guillon-Dellac; 16:07 - 16:29 IP472 Jean-Eric Laberenne; Benjamin Pariente; Laurent How to deal with large common bile duct (CBD) stones? Peyrin-Biroulet; Corinne Gower Rousseau; Horst Neuhaus, Germany Guillaume Savoye 16:29 - 16:51 IP473 Intrahepatic stone disease Symposium D. Nageshwar Reddy, India 15:45 - 17:15 Room D From guidelines to clinical practice: H. pylori Debate Chairs: Colm O'Morain, Ireland 16:51 - 17:01 IP474 Franco Bazzoli, Italy Acute : Percutaneous drainage first Raneem Albazaz, United Kingdom 17:01 - 17:11 IP475 15:45 - 16:07 IP468 Acute cholecystitis: Surgery first What's new for clinical practice in Maastricht V? Thomas van Gulik, The Netherlands Peter Malfertheiner, Germany

Livestream Q&A Audience Voting Recorded Session 89 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

Symposium Symposium 15:45 - 17:15 Room C 15:45 - 17:15 Room E2 Resection and ablation of early neoplastic Barrett's: National Societies Symposia: Optimising clinical trials What is the best approach? by networking - LINKing up Europe Chairs: Andrea May, Germany Chairs: Joost P. H. Drenth, The Netherlands Pradeep Bhandari, United Kingdom Peter L. Lakatos, Hungary

15:45 - 16:07 IP476 15:45 - 16:07 IP483 Pathologist's perspective Development of a new digestive diseases network Cord Langner, Austria Nicholas M. Croft, United Kingdom 16:07 - 16:29 IP477 16:07 - 16:29 IP484 Endoscopic mucosal resection (EMR) and endoscopic Dutch pancreatitis study group submucosal dissection (ESD): When and how? Marc G. H. Besselink, The Netherlands Michael J. Bourke, Australia 16:29 - 16:51 IP485 16:29 - 16:51 IP478 IBD networking for clinical trials and research Radiofrequency ablation, argon plasma coagulation Peter L. Lakatos, Hungary and cryoablation: When and how? Jacques J. Bergman, The Netherlands 16:51 - 17:13 IP486 Sharing data from clinical trials for secondary use: 16:51 - 17:15 IP479 Why and how? PANEL DISCUSSION Berthold Koletzko, Germany Tuesday, October 18, 2016 Symposium Symposium 15:45 - 17:15 Room E1 15:45 - 17:15 Room F1 Visualising small bowel diseases Coeliac disease for the clinician Chairs: Peter Bauerfeind, Switzerland Chairs: Kalle Kurppa, Finland Rami Eliakim, Israel Jessica Biesiekierski, Belgium

15:45 - 16:07 IP480 Tandem Talks Radiology of the small bowel 15:45 - 15:55 IP487 Andrea Phillips, United Kingdom Coeliac disease: Case finding by screening Kalle Kurppa, Finland 16:07 - 16:19 OP284 NOVEL MOTORIZED SPIRAL ENDOSCOPY: FIRST RE- 15:55 - 16:05 IP488 SULTS OF A EUROPEAN PROSPECTIVE TRIAL Coeliac disease: Case finding by clinical symptoms Torsten Beyna, Germany; Marianna Arvanitakis; Katri Kaukinen, Finland Markus Schneider; André Van Gossum; Jacques 16:05 - 16:15 IP489 Deviere; Horst Neuhaus Pitfalls in coeliac disease pathology 16:19 - 16:31 OP285 Alina Popp, Romania CROSS-SECTIONAL EVALUATION OF TRANSMURAL 16:15 - 16:25 IP490 HEALING IN PATIENTS WITH CROHN'S DISEASE ON Pitfalls in coeliac disease serology MAINTENANCE TREATMENT WITH BIOLOGICS Ilma R. Korponay-Szabo, Hungary Anna Testa, Italy; Antonio Rispo; Pier P. Mainenti; Nicola Imperatore; Giovanni D. De Palma; Matilde Rea; 16:25 - 16:35 IP491 Gaetano Luglio; Francesco Maione; Olga M. Nardone; Transition of patients with coeliac disease to adult care Nicola Caporaso; Fabiana Castiglione Jonas Ludvigsson, Sweden 16:31 - 16:53 IP481 16:35 - 16:45 IP492 The role of capsule endoscopy Monitoring of patients with coeliac disease after trans- Cristiano Spada, Italy fer to adult care Carolina Ciacci, Italy 16:53 - 17:15 IP482 Progress in enteroscopy Torsten Beyna, Germany

90 ª Rising Star ª Top Abstract Prize ª National Scholar 91 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

16:45 - 16:57 OP286 16:37 - 16:47 IP501 THE ENZYME ACTIVITY OF SMALL INTESTINAL MUCO- Management of gastric cancer in the West SA IN ADULT PATIENTS WITH CELIAC DISEASE. Alessandro Repici, Italy Elena Sabelnikova; Olga Ahmadullina, Russian Federa- tion; Nikolay Belostotsky; Asfold Parfenov 16:47 - 16:57 IP502 Functional GI disorders in the East 16:57 - 17:09 OP287 Kok-Ann Gwee, Singapore FODMAP RESTRICTION OF A GLUTEN FREE DIET IN PATIENTS WITH COELIAC DISEASE: A RANDOMIZED, 16:57 - 17:07 IP503 CONTROLLED CLINICAL STUDY Functional GI disorders in the West Kamilla Nuland, Norway; Ida Strindmo; Gudrun Kahrs; Bohumil Seifert, Czech Republic Jan G. Hatlebakk Symposium Symposium 15:45 - 17:15 Room K 15:45 - 17:15 Room F2 Rectal cancer: Organ preserving strategies NAFLD-NASH: Where are we going? Chairs: Dieter Hahnloser, Switzerland Chairs: Elizabetta Bugianesi, Italy Eric Van Cutsem, Belgium Alexander R. Moschen, Austria 15:45 - 16:07 IP504 Staging and restaging by magnetic resonance imaging Doenja M. Lambregts, The Netherlands 15:45 - 16:07 IP493 Diagnostic criteria 16:07 - 16:29 IP505 Claudia Oliveira, Brazil Systemic treatment: What does it take? Dirk Arnold, Germany 16:07 - 16:29 IP494 Microbiota: From mechanism to cure 16:29 - 16:51 IP506 Antonio Gasbarrini, Italy What is the best radiotherapy in rectal cancer? Karin Haustermans, Belgium 16:29 - 16:51 IP495 New drugs 16:51 - 17:13 IP507 Frank Tacke, Germany Is surgery always necessary? Nuno Figueiredo, Portugal 16:51 - 17:13 IP496 The role of bariatric surgery Free Paper Session 2016 18, October Tuesday, Helena Cortez-Pinto, Portugal 15:45 - 17:15 Room M Late breaking abstracts III Symposium Chairs: tbc 15:45 - 17:15 Room G East meets West: Same disease, different clinical Translational Basic Science patterns 15:45 - 17:15 Room 1.61/1.62 Chairs: Joseph Jao Yiu Sung, China Mitochondria and the digestive system John Atherton, United Kingdom Chairs: Stefan Schreiber, Germany 15:45 - 16:07 IP497 Antonio Moschetta, Italy Epidemiology of East-West differences in GI disease Sanjiv Mahadeva, Malaysia 15:45 - 16:07 IP508 Tandem Talks Mitochondria dysfunction in GI diseases 16:07 - 16:17 IP498 Roberto De Giorgio, Italy Autoimmune pancreatitis in the East Tooru Shimosegawa, Japan 16:07 - 16:29 IP509 Mitochondrial metabolism and 16:17 - 16:27 IP499 Autoimmune pancreatitis in the West 16:29 - 16:51 IP510 Paul Fockens, The Netherlands Mitochondrial targeting in IBD Dirk Haller, Germany 16:27 - 16:37 IP500 Management of gastric cancer in the East 16:51 - 17:13 IP511 Kenshi Yao, Japan Mitochondrial targeting in colon cancer Antonio Moschetta, Italy

Livestream Q&A Audience Voting Recorded Session 91 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

Today's Science, Tomorrow's Medicine 16:33 - 16:45 OP291 15:45 - 17:15 Room N1 LUBIPROSTONE IMPROVES THE INTESTINAL PER- New diagnostic and therapeutic tools in GI diseases: MEABILITY, A NEW APPROACH FOR "LEAKY GUT"; A Gimmicks or adding value PROSPECTIVE RANDOMIZED PILOT CLINICAL STUDY IN Chairs: Tom Moreels, Belgium HEALTHY VOLUNTEERS Simon Walker-Samuel, United Kingdom Takayuki Kato, Japan; Izumi Tsuchiya; Atsushi Nakajima 16:45 - 16:57 OP292 VISCERAL HYPERSENSITIVITY IS ASSOCIATED WITH GI 15:45 - 16:07 IP512 SYMPTOM SEVERITY IN FUNCTIONAL GI DISORDERS: Motility and GI function CONSISTENT FINDINGS FROM FIVE DIFFERENT PATIENT Mark Fox, Switzerland COHORTS. 16:07 - 16:29 IP513 Magnus Simrén, Sweden; Hans Törnblom; Olafur Palsson; Breath volatile markers for gastrointestinal cancer Miranda van Tilburg; Lukas Van Oudenhove; Jan Tack; detection William E. Whitehead Marcis Leja, Latvia 16:57 - 17:09 OP293 16:29 - 16:51 IP514 CHRONIC ORAL ADMINISTRATION OF THE GUANYLATE Surgery CYCLASE-C AGONIST LINACLOTIDE ATTENUATES COLITIS Roel Hompes, United Kingdom INDUCED LONG-TERM BLADDER AFFERENT HYPERAC- TIVITY 16:51 - 17:13 IP515 Luke Grundy, Australia; Sonia Garcia-Caraballo; Jessica Endoscopy Maddern; Grigori Rychkov; Gerhard Hannig; Caroline Thierry Ponchon, France B. Kurtz; Ada Silos-Santiago; Stuart M. Brierley Tuesday, October 18, 2016 Free Paper Session Free Paper Session 15:45 - 17:15 Room N2 15:45 - 17:15 Room L7 Pathophysiology of IBS (Epi)Genetics in IBD Chairs: Qasim Aziz, United Kingdom Chairs: Jakub Fichna, Poland Lesley Houghton, USA Gijs R. van den Brink, The Netherlands 15:45 - 15:57 IP516 15:45 - 15:57 IP517 State-of-the-art introduction State-of-the-art introduction Qasim Aziz, United Kingdom Jakub Fichna, Poland 15:57 - 16:09 OP288 15:57 - 16:09 OP294 ADDITIVE EFFECT OF PATHOPHYSIOLOGICAL FACTORS DIAGNOSING RARE INHERITED DISORDERS USING ON PATIENT REPORTED OUTCOMES IN IBS. TARGETED NEXT GENERATION SEQUENCING IN PA- Magnus Simrén, Sweden; Hans Törnblom; Olafur TIENTS WITH EARLY-ONSET INFLAMMATORY BOWEL Palsson; Miranda van Tilburg; Lukas Van Oudenhove; DISEASE: A POPULATION BASED STUDY William E. Whitehead; Jan Tack Franck Broly, France; Mathurin Fumery; Francis Vasseur; 16:09 - 16:21 OP289 Guillaume Savoye; Delphine Ley; Helene Sarter; INCREASED INHIBITORY NEUROTRANSMISSION WITHIN Jean-Louis Dupas; Dominique Turck; Corinne Gower ANTERIOR CINGULATE CORTEX IS RELATED TO COMOR- Rousseau BID ANXIETY IN IRRITABLE BOWEL SYNDROME 16:09 - 16:21 OP295 Adriane Icenhour, Sweden; Olga Bednarska; Sofie HYPOXIA INHIBITS INTESTINAL INFLAMMATION Tapper; Anders Tisell; Peter Lundberg; Suzanne T. Witt; THROUGH THE INHIBITION OF NLRP3 INFLAMMASOME Sigrid Elsenbruch; Susanna Walter AND THE ACTIVATION OF AUTOPHAGY 16:21 - 16:33 OP290 Pedro A. Ruiz-Castro, Switzerland; Jesus Cosin-Rog- BACTERIAL PASSAGE IS INCREASED IN THE COLON OF er; Simona Simmen; Kirstin Atrott; Hassan Melhem; WOMEN WITH IRRITABLE BOWEL SYNDROME INDE- Isabelle Frey-Wagner; Cheryl de Vallière; Patrick PENDENTLY OF STOOL CONSISTENCY SUBGROUP Spielmann; Roland H. Wenger; Jonas Zeitz; Stephan R. Olga Bednarska, Sweden; Susanna Walter; Magnus Vavricka; Gerhard Rogler Ström; Åsa Keita

92 ª Rising Star ª Top Abstract Prize ª National Scholar 93 Tuesday, October 18, 2016 Scientific Programme by Day : UEG Week Final Programme

16:21 - 16:33 OP296 16:21 - 16:33 OP302 EPIGENETIC ALTERATIONS IN INFLAMMATORY BOWEL EVALUATION OF RECTAL CANCER ANGIOGENESIS DISEASE - THE INFLUENCE OF GERMLINE VARIATION USING IMMUNOHISTOCHEMICAL AND COMPUTER-AS- (MEQTLS) ON GENOME-WIDE METHYLATION ALTER- SISTED ENDOSONOGRAPHIC METHODS ª ATIONS. Ludmila Tankova; Radislav Nakov, Bulgaria; Georgi Alex T. Adams, United Kingdom; Rahul Kalla; Elaine Stoilov; Antonina Gegova; Ventsislav Nakov; Vanya R. Nimmo; IBD Character Consortium; Morten H. Vatn; Gerova; Daniel Kovatchki Jørgen Jahnsen; Petr Ricanek; Jonas Halfvarson; Johan D. Söderholm; MariekeJ. Pierik; Fernando Gomollon; 16:33 - 16:45 OP303 IvoG. Gut; Mauro D'Amato; Jack Satsangi COMPARISON OF CLINICAL OUTCOMES AMONG DIFFER- ENT ENDOSCOPIC MODALITIES FOR RECTAL NEUROEN- 16:33 - 16:45 OP297 DOCRINE TUMOR AN AUTOPHAGY-RELATED PERIPHERAL BLOOD Se H. Park, Republic of Korea; Young-Seok Cho; Hyun MICRORNA SIGNATURE DIFFERENTIATES COLONIC H. Choi; Dae Y. Cheung; Jin S. Kim; Bo-In Lee; Myung- CROHN'S DISEASE FROM ULCERATIVE COLITIS Gyu Choi Aylia Mohammadi, Canada; Orlaith Kelly; Boyko Kabakchiev; Krzysztof Borowski; Michelle I. Smith; 16:45 - 16:57 OP304 David Kevans; Mark S. Silverberg ANAL CYTOLOGY, HISTOPATHOLOGY, AND ANOSCOPIC VISUAL IMPRESSION IN AN ANAL DYSPLASIA SCREEN- 16:45 - 16:57 OP298 ING PROGRAM: IS ANAL CYTOLOGY ENOUGH? ASSESSMENT OF INFLAMMATORY BURDEN IDENTIFIES Marco Silva, Portugal; Armando Peixoto; José A. Sarmento; CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENT Andreia Albuquerque; Rosa Coelho; Rosário Serrão; GROUPS WITH DIFFERENT DISEASE-DRIVING PATHWAYS Carmela Pinero; Helena Barroca; Guilherme Macedo AND THERAPEUTIC RESPONSE TO ANTI-TNF TREATMENT Stelios Pavlidis; Matthew J. Loza; Patrick Branigan; 16:57 - 17:09 OP305 Calixte Monast; Anthony Rowe; Frédéric Baribaud, USA NEW PLATFORM FOR TRANS-ANAL SUBMUCOSAL ENDOSCOPIC RESECTION- (TASER): UPDATED CLINICAL 16:57 - 17:09 OP299 RESULTS FROM TERTIARY CENTRE CROHN'S DISEASE-ASSOCIATED CIRCULATING MICROR- Zacharias P. Tsiamoulos, United Kingdom; Rajaratnam NAS ARE SECRETED IN EXOSOMES FROM AIEC-IN- Rameshshanker; Janindra Warusavitarne; Brian P. FECTED HUMAN MACROPHAGES AND INVOLVED IN Saunders REGULATION OF HOST INNATE IMMUNE RESPONSES IN RECIPIENT CELLS. Free Paper Session

Jessica Carrière; Anaïs Larabi, France; Cécily Lucas; 15:45 - 17:15 Room 1.86 2016 18, October Tuesday, Nicolas Barnich; Hang T. T. Nguyen The intestinal epithelium - Stem cells, inflamation and cancer Free Paper Session Chairs: Arthur Kaser, United Kingdom 15:45 - 17:15 Room L8 Imke Atreya, Germany Novel techniques in lower GI malignancies Chairs: Daniel Hartmann, Germany 15:45 - 15:57 IP519 Madalina Ilie, Romania State-of-the-art introduction Arthur Kaser, United Kingdom 15:45 - 15:57 IP518 State-of-the-art introduction 15:57 - 16:09 OP306 Daniel Hartmann, Germany THE PROREGENERATIVE ROLE OF INTERLEUKIN-22 SIGNALS IN THE INTESTINAL EPITHELIUM DEPENDS 15:57 - 16:09 OP300 ON AUTOPHAGY AND ER STRESS THE IMPLANTABLE MEDICATED MICRORESERVOIRS IN Florian Tran, Germany; Konrad Aden; Markus THE TREATMENT OF COLORECTAL CANCER. THE GOOD Tschurtschenthaler; Raheleh Sheibani-Tezerji; EFFECTS OF A SIMPLE PROCEDURE. EARLY RESULTS. Johannes Kuiper; Anne Luzius; Marlene Jentzsch; Yacob S. Bereznitsky; Volodymyr P. Sulyma; Oksana N. Stefan Schreiber; Richard S. Blumberg; Arthur Kaser; Popova, Ukraine Philip Rosenstiel 16:09 - 16:21 OP301 16:09 - 16:21 OP307 ENDOSCOPIC SUBMUCOSAL DISSECTION IN LATERALLY HOXA9 IS OVEREXPRESSED IN COLONIC ADENOMAS SPREADING TUMORS: EXPERIENCE OF 282 CASES AND CAUSES AN INCREASE IN CELL GROWTH FROM A TERTIARY REFERENCE CENTER IN TURKEY Pieter H. A. Wisse, The Netherlands; Vincent T. Fatih Aslan, Turkey; Melek Kucuk; Zehra Akpinar; Nese Janmaat; Auke P. Verhaar; Marco J. Bruno; Manon C. Ekinci; Derya A. Yurtlu; Emrah Alper; Belkis Unsal W. Spaander; Maikel Peppelenbosch

Livestream Q&A Audience Voting Recorded Session 93 UEG Week Final Programme : Scientific Programme by Day Tuesday, October 18, 2016

16:21 - 16:33 OP308 16:05 - 16:15 OP314 TOLL-INTERACTING PROTEIN DEFICIENCY PROTECTS GHRELIN INHIBITS TNF-ALPHA PRODUCTION IN ACUTE MICE FROM COLITIS-ASSOCIATED CANCER BY MODU- PANCREATITIS LATING ANTI-TUMORAL IMMUNITY Joanna Bonior; Piotr Ceranowicz; Michalina Kot; Artur Christina Begka, Switzerland; Simone Ragusa; Tatiana Dembi?ski; Zygmunt Warzecha, Poland; Piotr Pierzchalski; Petrova; Dominique Velin; Michel H. Maillard Jolanta Jaworek 16:33 - 16:45 OP309 16:15 - 16:25 OP315 CONSTRUCTION OF IN VITRO MODEL OF ULCERATIVE IDENTIFICATION AND CHARACTERISATION OF A NOVEL COLITIS USING MOUSE PRIMARY COLONIC ORGANOID EARLY ONSET DIABETES GENE USING HUMAN PLURIP- Shuji Hibiya, Japan; Kiichiro Tsuchiya; Sho Watanabe; OTENT STEM CELLS Tomoaki Shirasaki; Ryu Nishimura; Shigeru Oshima; Anett Illing; Ivan Costa; André Lechel; Qiong Lin; Thom- Ryuichi Okamoto; Tetsuya Nakamura; Mamoru Watanabe as Seufferlein; Alexander Kleger, Germany 16:45 - 16:57 OP310 16:25 - 16:35 OP316 THE RIBONUCLEASE RNASEH2B CONTROLS INTESTI- LACK OF CFTR RESULTS IN THE IMPAIRED FUNCTION NAL STEM CELL INTEGRITY OF THE PLASMA MEMBRANE CA2+ PUMP THAT Konrad Aden, Germany; Kareen Bartsch; Florian Tran; CAUSES INTRACELLULAR CA2+ OVERLOAD AND MI- Stefan Rose John; Stefan Schreiber; Philip Rosenstiel; TOCHONDRIAL DAMAGE IN THE PANCREATIC DUCTAL Björn Rabe EPITHELIAL CELLS OF CFTR KNOCK OUT MICE. Tamara Madacsy, Hungary; Júlia Fanczal; Petra Pallagi; 16:57 - 17:09 OP311 Viktoria Venglovecz; Zoltan Rakonczay; Péter Hegyi; COMMENSAL FUNGI AND THEIR CELL-WALL GLYCANS József Maléth INDUCE AUTOPHAGY IN INTESTINAL EPITHELIAL CELLS Sarit Cohen-Kedar, Israel; Hofit Elad; Yulia Ron; Iris 16:35 - 16:45 OP317

Tuesday, October 18, 2016 Dotan ENDOSCOPIC DILATION OF PANCREATIC DUCT STRIC- TURES IN CHRONIC PANCREATITIS WITH MULTIPLE Symposium PLASTIC STENTS: RESULTS IN 48 PATIENTS. 15:45 - 17:15 E-Poster Lounge 1 Andrea Tringali; Vincenzo Bove, Italy; Giorgio Valerii; Optimising the patient-provider relationship using Rosario Landi; Pietro Familiari; Ivo Boskoski; Vincenzo effective communication techniques Perri; Guido Costamagna Chair: Douglas Drossman, USA 16:45 - 16:55 OP318 Experts: Douglas Drossman, USA CARDIOVASCULAR RISK IN PATIENTS WITH CHRONIC Lin Chang, USA PANCREATITIS AND PANCREATIC EXOCRINE INSUFFI- CIENCY Free Paper Session Nicolau Vallejo-Senra, Spain; Daniel De la Iglesia-García; 15:45 - 17:15 Hotspot Andrea López-López; Julio Iglesias-García; Laura Nieto; Abstracts on Fire: Acute pancreatitis – From mecha- Juan E. Domínguez-Muñoz nisms to disease 16:55 - 17:05 OP319 Chairs: Alexander Kleger, Germany J. Enrique Dominguez-Munoz, Spain USE OF THE URINARY TRYPSINOGEN -2- DIPSTICK TEST IN EARLY DIAGNOSIS OF PANCREATITIS AFTER 15:45 - 15:55 OP312 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOG- HEPARANASE IN ACUTE PANCREATITIS: NEW IN- RAPHY ª SIGHTS INTO PATHOGENESIS AND THERAPY Azmi Alhakam, Yemen Iyad Khamaysi, Israel; Preeti Singh; Neta Ilan; Israel 17:05 - 17:15 OP320 Vlodavsky; Alessandro Noseda; Hoda Awad; Yehuda WHAT KIND OF INTRAVENOUS HYDRATION SHOULD BE Chowers; Zaid Abassi USED FOR THE PREVENTION OF POST-ERCP PANCRE- 15:55 - 16:05 OP313 ATITIS: A PROSPECTIVE RANDOMIZED MULTICENTER CIGARETTE SMOKE EXTRACT INHIBITS FLUID AND CLINICAL TRIAL HCO3- SECRETION AND CFTR ACTIVITY IN GUINEA PIG Chang-Hwan Park, Republic of Korea; Woo H. Paik; PANCREATIC DUCTAL CELLS Eun T. Park; Chan S. Shim; Tae Y. Lee; Changdon Kang; Petra Pallagi; Viktoria Venglovecz; Krisztina Tóth; Myung H. Noh; Sun Y. Yi; Jong K. Lee; Jong J. Hyun; Jun Andrea Schnúr; Emese Tóth; József Maléth; Dezso K. Lee CSupor; Zoltan Rakonczay; Kata Cseko; Zsuzsanna Helyes; Péter Hegyi, Hungary

94 ª Rising Star ª Top Abstract Prize ª National Scholar 95 Wednesday, October 19, 2016 Scientific Programme by Day : UEG Week Final Programme

Scientific Programme by Day Wednesday, October 19, 2016

Advances in Clinical GI & Hepatology Symposium 08:30 - 10:00 Room D 08:30 - 10:00 Room E2 New treatment targets in IBD The role of food in IBS and other functional GI disorders Chairs: Matthieu Allez, France Chairs: David Surendran Sanders, United Kingdom Arthur Kaser, United Kingdom Maura Corsetti, United Kingdom

08:30 - 08:52 IP520 08:30 - 08:52 IP528 Targeting cytokines beyond TNF Effects of food on GI function Walter Reinisch, Austria Fernando Azpiroz, Spain 08:52 - 09:14 IP521 08:52 - 09:14 IP529 Targeting cell and migration How important is food in the pathophysiology of IBS Arthur Kaser, United Kingdom and other functional GI disorders? Lesley Houghton, USA 09:14 - 09:36 IP522 Cell therapy 09:14 - 09:36 IP530 Julian Panés, Spain Rising Star: What is the future of functional foods? ª Jakub Fichna, Poland 09:36 - 09:58 IP523 Should we only target the immune system? 09:36 - 09:58 IP531 Stefan Schreiber, Germany Low FODMAP diet and gluten elimination in IBS: When, why and how? Symposium Kevin Whelan, United Kingdom 08:30 - 10:00 Room E1 Improving outcomes of non-variceal upper GI bleeding Symposium Chairs: Alessandro Repici, Italy 08:30 - 10:00 Room F1 Tomas Hucl, Czech Republic Standards and novel developments for pancreatic neuroendocrine tumours Chairs: Thomas M. Gress, Germany 08:30 - 08:52 IP524 Andrea Frilling, United Kingdom Rational diagnostic approach Ian M. Gralnek, Israel 08:30 - 08:52 IP532 08:52 - 09:14 IP525 Epidemiology, genetics and classification Management of patients with impaired coagulation Gabriele Capurso, Italy Joseph J. Y. Sung, China 08:52 - 09:14 IP533 09:14 - 09:36 IP526 Nuclear medicine in diagnosis and therapy Modern endoscopic treatment Vikas Prasad, Germany Pierre H. Deprez, Belgium 09:14 - 09:36 IP534 09:36 - 09:58 IP527 Surgical therapies Interventional radiology Andrea Frilling, United Kingdom Simon Jackson, United Kingdom 09:36 - 09:58 IP535 Medical therapies Jean-Luc Van Laethem, Belgium Wednesday, October 19, 2016 19, October Wednesday,

Livestream Q&A Audience Voting Recorded Session 95 UEG Week Final Programme : Scientific Programme by Day Wednesday, October 19, 2016

Symposium Tandem Talks 08:30 - 10:00 Room F2 09:36 - 09:46 IP543 Percutaneous gastrostomy and jejunostomy Personalising oncological treatment: The pathologist's Chairs: Karel Caca, Germany view Annette Fritscher-Ravens, Germany Cord Langner, Austria 09:46 - 09:56 IP544 Personalising oncological treatment: The gastro-oncol- Tandem Talks ogist's view 08:30 - 08:40 IP536 Anna D. Wagner, Switzerland Which device for which patient? Adults Maria E. Riccioni, Italy Symposium 08:40 - 08:50 IP537 08:30 - 10:00 Room K Which device for which patient? Children Drug induced liver injury (DILI): What is new? Frederic Gottrand, France Chairs: Erik Schrumpf, Norway 08:50 - 09:12 IP538 Claudia Oliveira, Brazil How to deal with a non-closing track? Michael Häfner, Austria 08:30 - 08:52 IP545 09:12 - 09:34 IP539 Epidemiology of DILI: How frequent is the problem? How to avoid and combat complications? Raul Andrade, Spain André Van Gossum, Belgium 08:52 - 09:14 IP546 09:34 - 09:46 OP321 Mechanisms of DILI GASTROINTESTINAL SAFETY OF LEVODOPA-CARBIDOPA Peter L. M. Jansen, The Netherlands INTESTINAL GEL IN ADVANCED PARKINSON'S DISEASE Debate PATIENTS: FINAL RESULTS FROM THE GLORIA LONG- 09:14 - 09:24 IP547 TERM REGISTRY Diagnosis of DILI: Is the pathologist helpful? YES Dirk Domagk, Germany; Sanne Dam-Larsen; Angelo Dina Tiniakos, United Kingdom Antonini; Lars Bergmann; Ashley Yegin; Werner Poewe 09:24 - 09:34 IP548 09:46 - 09:58 OP322 Diagnosis of DILI: Is the pathologist helpful? NO ENDOSCOPICALLY ASSISTED PERCUTANEOUS TRANSE- Christian Strassburg, Germany SOPHAGEAL GASTROTUBING (PTEG) AND THE PROGRESS Masato Murakami, Japan; Keiitio Nishino; Shigeto 09:34 - 09:56 IP549 Murakami; Kousuke Mori; Bonpei Murakami; Management of DILI Mizutomo Azuma; Satoshi Tanabe; Mitsuhiro Kida; Robert Fontana, USA Wasaburo Koizumi Free Paper Session Symposium 08:30 - 10:00 Room M 08:30 - 10:00 Room G Eosinohilic oesophagitis and GORD New trends in gastric cancer Chairs: André Smout, The Netherlands Chairs: Dirk Arnold, Germany Sabine Roman, France

Wednesday, October 19, 2016 David Whiteman, Australia 08:30 - 08:42 IP550 State-of-the-art introduction 08:30 - 08:52 IP540 Sabine Roman, France Early detection and endoscopic treatment Mario Dinis-Ribeiro, Portugal 08:52 - 09:14 IP541 Surgery: Is minimally invasive the standard? Mario Morino, Italy 09:14 - 09:36 IP542 Perioperative treatment: What is new? Philippe Rougier, France

96 ª Rising Star ª Top Abstract Prize ª National Scholar 97 Wednesday, October 19, 2016 Scientific Programme by Day : UEG Week Final Programme

08:42 - 08:54 OP323 Translational Basic Science STEP-UP EMPIRIC ELIMINATION DIET FOR PEDIATRIC AND 08:30 - 10:00 Room 1.61/1.62 ADULT EOSINOPHILIC : THE 2-4-6 STUDY. Injury and regeneration Javier Molina Infante, Spain; Ines Modolell; Javier Chairs: Christopher John Hawkey, United Kingdom Alcedo; Ruth Garcia-Romero; Ángel Arias Arias; Alicia Julia Mayerle, Germany Prieto-Garcia; Pedro L. Gonzalez-Cordero; Victor Vila-Miravet; Cecilio Santander; Edoardo Savarino; Carlos Guarner-Argente; Jose L. Martin-Lorente; Maria Tandem Talks L. Masiques-Mas; Roger Garcia-Puig; Marianette C. 08:30 - 08:40 IP551 Murzi Pulgar; Oscar Nogales Rincon; Alfredo J. Lucendo NSAIDs and ASA in injury and thrombosis 08:54 - 09:06 OP324 Christopher J. Hawkey, United Kingdom INCREASED MUCOSAL EXPRESSION OF TOLL-LIKE 08:40 - 08:50 IP552 RECEPTORS IN ADULT PATIENTS WITH EOSINOPHILIC NSAIDs and ASA in cancer prevention ESOPHAGITIS Andrew T. Chan, USA Ángel Arias Arias, Spain; Maria Vicario; Pilar Martínez Fernández; Ana M. González-Castro; Marina Fortea; 08:50 - 09:12 IP553 Jesús González-Cervera; José L. Yagüe-Compadre; Pancreatitis: Evidence for regneration Teresa Mota-Huertas; Alfredo J. Lucendo Julia Mayerle, Germany 09:06 - 09:18 OP325 09:12 - 09:34 IP554 A RANDOMISED, DOUBLE-BLIND, PLACEBO-CON- Injury and hepatocyte regeneration TROLLED TRIAL OF A NOVEL RECOMBINANT, HUMAN- Fotis Sampziotis, United Kingdom ISED, ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY 09:34 - 09:56 IP555 (RPC4046) IN PATIENTS WITH ACTIVE EOSINOPHILIC Stem cells at the crossroads of regeneration versus OESOPHAGITIS: RESULTS OF THE HEROES STUDY carcinogenesis Ikuo Hirano, USA; Margaret Collins; Yudith Assou- Simon Leedham, United Kingdom line-Dayan; Larry Evans; Sandeep Gupta; Alain Scho- epfer; Alex Straumann; Michael Grimm; Heather Smith; Free Paper Session Cindy-Ann Tompkins; Amy Woo; Robert Peach; Paul Frohna; Sheila Gujrathi; Richard Aranda; Evan Dellon 08:30 - 10:00 Room N1 Diagnosis and treatment of pancreatic cancer and its 09:18 - 09:30 OP326 precursors IMPAIRMENT OF CHEMICAL CLEARANCE AND - Chairs: Alexander Kleger, Germany COSAL INTEGRITY DISTINGUISH HYPERSENSITIVE Michael Goggins, USA ESOPHAGUS FROM FUNCTIONAL HEARTBURN Marzio Frazzoni; Nicola De Bortoli; Leonardo Marzio; 08:30 - 08:42 IP556 Manuele Furnari; Irene Martinucci; Salvatore Tolone; State-of-the-art introduction Andrea Farioli; Santino Marchi; Lorenzo Fuccio; Alexander Kleger, Germany Vincenzo Savarino; Edoardo Savarino, Italy 08:42 - 08:54 OP329 09:30 - 09:42 OP327 SURVEILLANCE OF HIGH RISK INDIVIDUALS DETECTS THE ADDED VALUE OF POST-REFLUX SWALLOW-IN- RESECTABLE PANCREATIC MALIGNANCIES AND HIGH- DUCED PERISTALTIC WAVE INDEX AND NOCTURNAL GRADE PRECURSORS: RESULTS OF A 16-YEAR EARLY BASELINE IMPEDANCE IN REFRACTORY GERD STUDIED DETECTION PROGRAM FOR FAMILIAL PANCREATIC WITH ON-THERAPY IMPEDANCE-PH MONITORING NEOPLASIA Marzio Frazzoni; Nicola De Bortoli; Leonardo Frazzoni; Jose A. Almario, USA; Marcia I. Canto; Ralph H. Manuele Furnari; Irene Martinucci; Salvatore Tolone; Hruban; Anne M. Lennon; Christopher Wolfgang; Santino Marchi; Vincenzo Savarino; Edoardo Savarino, Matthew Weiss; Kenzo Hirose; Eun J. Shin; Elliot K. Italy Fishman; Ihab R. Kamel; Charles Yeo; Richard Schulick; Michael Goggins 09:42 - 09:54 OP328 PRELIMINARY RESULTS OF A PROSPECTIVE MULTI-CEN- TER REGISTRY OF LOWER ESOPHAGEAL SPHINCTER

STIMULATION FOR GERD: THE LESS-GERD REGISTRY 2016 19, October Wednesday, Joachim Labenz, Germany; Henning Schulz; Andreas Leodolter; Jan Pedersen; Alejandro Nieponice; Ralf Weise; Nicole Bouvy

Livestream Q&A Audience Voting Recorded Session 97 UEG Week Final Programme : Scientific Programme by Day Wednesday, October 19, 2016

08:54 - 09:06 OP330 Free Paper Session CLINICAL IMPACT OF ENDOSCOPIC ULTRASONOG- 08:30 - 10:00 Room N2 RAPHY IMAGING OF CHRONIC PANCREATITIS IN THE Constipation and fecal incontinence: From bench to PANCREATIC PARENCHYMA IN PATIENTS WITH INTRA- bedside DUCTAL PAPILLARY MUCINOUS NEOPLASMS Chairs: Viola Andresen, Germany Mamoru Takenaka, Japan; Atsuhiro Masuda; Masayuki Giuseppe Chiarioni, Italy Kitano; Hideyuki Shiomi; Shunsuke Oomoto; Kosuke Minaga; Takeshi Miyata; Ken Kamata; Kentaro Yamao; 08:30 - 08:42 IP557 Hajime Imai; Yoshifumi Arisaka; Yoshihiro Okabe; State-of-the-art introduction Masatoshi Kudo Giuseppe Chiarioni, Italy 09:06 - 09:18 OP331 08:42 - 08:54 OP335 NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY ORAL ADMINISTRATION OF THE GUT-RESTRICTED GUA- (NCLE) FOR THE DIAGNOSIS OF SOLITARY PANCREATIC NYLATE CYCLASE-C AGONIST, LINACLOTIDE, REDUCES CYSTS: A PROSPECTIVE MULTICENTER STUDY ENDOMETRIOSIS-INDUCED VAGINAL HYPERALGESIA Bertrand Napoléon, France; Laurent Palazzo; Bertrand Pei Ge, USA; Jingmei Ren; Natalia Dmitrieva; Ada Pujol; Fabrice Caillol; Maxime Palazzo; Alain Aubert; Silos-Santiago; Caroline B. Kurtz; Gerhard Hannig Frédérique Maire; L. Buscail; Anne I. Lemaistre; Marc 08:54 - 09:06 OP336 Giovannini GUANYLATE CYCLASE-C EXPRESSION IS DOWN-REGU- 09:18 - 09:30 OP332 LATED IN COLONIC BIOPSIES FROM FEMALE IRRITABLE RISK OF PROGRESSION AMONG LOW RISK IPMNS IN A BOWEL SYNDROME PATIENTS WITH CONSTIPATION LARGE MULTICENTER SURVEILLANCE COHORT STUDY Sonia Garcia-Caraballo; Andrea M. Harrington; Joel Valerie Gausman, USA; Maria Moris; Maia Kayal; John Castro; Gerhard Hannig, USA; M. Poneros; Amrita Sethi; Francis G. Gress; Beth A. Caroline B. Kurtz; Ada Silos-Santiago; Lin Chang; Schrope; Lyndon Luk; Elizabeth Hecht; Michael B. Stuart M. Brierley Wallace; Tamas A. Gonda 09:06 - 09:18 OP337 09:30 - 09:42 OP333 PATIENTS' PERCEPTIONS OF CONSTIPATION DIFFER MULTIMODALITY TREATMENT OF LOCALLY ADVANCED STRIKINGLY FROM THOSE OF GASTROENTEROLOGY PANCREATIC CANCER, INCLUDING FOLFIRINOX SPECIALISTS AND GENERAL PRACTITIONERS, AND CHEMOTHERAPY, SURGICAL EXPLORATION AND IRRE- THERE IS NO CONSISTENT AGREEMENT WITH THE VERSIBLE ELECTROPORATION: PROSPECTIVE SERIES ROME III CRITERIA OF 132 CONSECUTIVE PATIENTS Eirini Dimidi, United Kingdom; Duolao Wang; Camilla Jantien A. Anne Vogel, The Netherlands; Steffi J. Cox; Susan Neville; S. M. Scott; Kevin Whelan Rombouts; Thijs de Rooij; Olivier R. C. Busch; Otto M. 09:18 - 09:30 OP338 van Delden; Marcel G. Dijkgraaf; Jeanin E. van Hooft; EFFICACY AND SAFETY OF NALDEMEDINE FOR THE Hanneke W. van Laarhoven; Robert C. Martin; Annuska TREATMENT OF OPIOID-INDUCED CONSTIPATION IN Schoorlemmer; Johanna W. Wilmink; Krijn P. van SUBJECTS WITH CHRONIC NON-CANCER PAIN RECEIV- Lienden; Marc G. H. Besselink ING OPIOID THERAPY: RESULTS FROM TWO PHASE 3 09:42 - 09:54 OP334 CLINICAL TRIALS. NATIONWIDE MULTIDISCIPLINARY ONLINE EXPERT- Martin E. Hale, USA; James Wild; Jyotsuna Reddy; PANEL FOR PANCREATIC CANCER: INITIAL RESULTS Tadaaki Yamada; Juan C. Arjona Ferreira

Wednesday, October 19, 2016 Jony van Hilst, The Netherlands; Marieke S. Walma; 09:30 - 09:42 OP339 Jantien A. Vogel; Steffi J. Rombouts; Bert A. Bonsing; PILOT STUDY COMPARING THREE METHODS OF Thomas Bollen; R. Bruijnen; R. V. Dam; R. S. Dwarkasing; SCREENING FOR FECAL INCONTINENCE Michael F. Gerhards; Bas Groot Koerkamp; Ignace D. Jan Busby-Whitehead; William E. Whitehead, USA; Hingh; Koert de Jong; Geert Kazemier; N. C. Krak; Steve Heymen; John S. Kizer; Olafur Palsson; Magnus Hanneke W. van Laarhoven; Cornelis J. van Laarhoven; Simrén Krijn P. van Lienden; Izaak Q. Molenaar; C. Y. Nio; S. S. Phoa; Hjalmar C. van Santvoort; J. J. J. de Vries; 09:42 - 09:54 OP340 Johanna W. Wilmink; Olivier R. C. Busch; Casper H. J. COPING WITH FAECAL INCONTINENCE: A POPULATION van Eijck; Marc G. H. Besselink STUDY Emma V. Carrington, USA; Olafur Palsson; Steve Heymen; Stuart Gould; Magnus Simrén; William E. Whitehead

98 ª Rising Star ª Top Abstract Prize ª National Scholar 99 Wednesday, October 19, 2016 Scientific Programme by Day : UEG Week Final Programme

Free Paper Session Free Paper Session 08:30 - 10:00 Room L7 08:30 - 10:00 Room L8 New insights in upper GI endoscopy techniques Liver cell biology and fibrosis Chairs: Helmut Messmann, Germany Chairs: Martina Mueller-Schilling, Germany Ecaterina Daniela Dobru, Romania Jessica Zucman-Rossi, France 08:30 - 08:42 IP558 08:30 - 08:42 IP559 State-of-the-art introduction State-of-the-art introduction Helmut Messmann, Germany Martina Mueller-Schilling, Germany 08:42 - 08:54 OP341 08:42 - 08:54 OP347 NOVEL ENDOLOOP VS. OVER-THE-SCOPE-CLIP (OTSC) CHARACTERISATION OF DIFFERENTLY ISOLATED IN ENDOSCOPIC CLOSURE OF GASTRIC FULL-THICK- HEPATIC PROGENITOR CELL POPULATIONS IN HUMAN NESS DEFECT: A MULTI-CENTER STUDY ALCOHOLIC LIVER Nan Gao; Rui Li, China; Dongtao Shi; Deqing Zhang; An Ceulemans, Belgium; Stefaan Verhulst; Leo A. Van Weichang Chen Grunsven; Tania Roskams 08:54 - 09:06 OP342 08:54 - 09:06 OP348 ENDOSCOPIC SUBMUCOSAL DISSECTION FOR DUODE- SORTILIN DEFICIENCY REDUCES DUCTULAR REACTION, NAL ADENOMA: COMPLICATION RATE AND FOLLOW UP HEPATOCYTE APOPTOSIS AND LIVER FIBROSIS IN OF 38 CASES. CHOLESTATIC-INDUCED LIVER INJURY Walter Margos, Belgium; Hrvoje Ivekovic; Ralph C. P. Isabel Zvibel, Israel; Einav Hubel; Sigal Fishman; Oren Yeung; Leila Shaza; Hubert Piessevaux; Pierre H. Deprez Shibolet 09:06 - 09:18 OP343 09:06 - 09:18 OP349 ENDOSCOPIC TREATMENT OF GASTRIC ANTRAL ACTIVATION OF NECROPTOSIS IN HUMAN AND EXPER- VASCULAR ECTASIA: A RETROSPECTIVE MULTICENTRE IMENTAL CLINICAL STUDY ª Marta B. Afonso, Portugal; Pedro M. Rodrigues; André Anna Fabian, Hungary; Renata Bor; Ella Szabo; Anita Simão; Helena Cortez-Pinto; Dimitry Ofengeim; Joana Balint; Klaudia Farkas; Agnes Milassin; Mariann Rutka; D. Amaral; Rui E. Castro; Junying Yuan; Cecília M. P. Tamas Molnar; Ferenc Nagy; Mónika Szücs; Katalin Rodrigues Lorinczy; Tibor Gyökeres; Janos Banai; György Gyimesi; Attila Z. Szepes; Valeria Kovacs; Istvan Racz; Zoltan G. 09:18 - 09:30 OP350 Szepes HEPATOMA-INTRINSIC CCRK SIGNALING PROMOTES IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT 09:18 - 09:30 OP344 BY REGULATING MYELOID-DERIVED SUPPRESSOR CELL WATERJET SUBMUCOSAL DISSECTION OF PORCINE ACCUMULATION ª ESOPHAGUS WITH THE HYBRIDKNIFE® AND ERBE- Alfred S. L. Cheng; Jingying Zhou, Hong Kong PRC; JET® 2 SYSTEM Man Liu; Hanyong Sun; Zhiwei Chen Daisuke Akutsu, Japan; Hideo Suzuki; Toshiaki Narasaka; Masahiko Terasaki; Tsuyoshi Kaneko; 09:30 - 09:42 OP351 Hirofumi Matsui; Yuji Mizokami; Ichinosuke Hyodo PROTECTIVE ROLE OF SPECIFIC PATHOGEN FREE MI- CROBIOTA IN BILE DUCT LIGATED AND CCL4 MICE 09:30 - 09:42 OP345 Sheida Moghadamrad, Switzerland; Kathleen McCoy; ORAL ADMINISTRATION OF CONDITIONED MEDIUM OB- Philipp Kellmann; Andrea De Gottardi TAINED FROM AMNION-DERIVED MESENCHYMAL STEM CELL CULTURE PREVENTS ESOPHAGEAL STRICTURE 09:42 - 09:54 OP352 AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION IN PIGS IMPROVING METABOLIC PARAMETERS IN NAFLD BY Takeshi Mizushima, Japan; Shunsuke Ohnishi; Hidetaka TARGETING NUCLEAR RECEPTORS Hosono; Momoko Tsuda; Naoya Sakamoto Pedro M. Rodrigues, Portugal; Marta B. Afonso; André Simão; Marta Caridade; Catarina C. Carvalho; 09:42 - 09:54 OP346 Alexandre Trindade; António Duarte; Pedro M. Borralho; ENDOSCOPIC ULTRASOUND VS PET-CT IN GASTRIC Mariana V. Machado; Helena Cortez-Pinto; Cecília M. P. CANCER STAGING BEFORE AND AFTER NEOADJUVANT Rodrigues; Rui E. Castro CHEMOTHERAPY Eduardo Redondo Cerezo, Spain; Juan G. Martinez-Cara; 2016 19, October Wednesday, Rita Jimenez-Rosales; Francisco Valverde-Lopez; Antonio Caballero-Mateos; Pablo Jervez-Puente; Jose L. Ariza-Fernandez; Margarita Ubeda-Muñoz; Mercedes Lopez de Hierro; Javier de Teresa

Livestream Q&A Audience Voting Recorded Session 99 UEG Week Final Programme : Scientific Programme by Day Wednesday, October 19, 2016

Free Paper Session Symposium 08:30 - 10:00 Room 1.86 09:00 - 10:00 Hotspot Murine models of intestinal inflammation Eosinophilic oesophagitis: Overlooked too often or Chairs: Dirk Haller, Germany searched for too fanatically? Timon Erik Adolph, Austria Chair: Stephen Attwood, United Kingdom 08:30 - 08:42 IP560 State-of-the-art introduction 09:00 - 09:03 IP561 Timon E. Adolph, Austria Introduction 08:42 - 08:54 OP353 Stephen Attwood, United Kingdom AN AUTOIMMUNITY-ASSOCIATED VARIANT IN PTPN22 09:03 - 09:08 IP562 PROTECTS FROM DISEASE ONSET IN MOUSE MODELS All patients with reflux symptoms should be biopsied OF COLITIS to rule out Eosinophilic oesophagitis Marianne R. Spalinger, Switzerland; Stephanie H. Alex Straumann, Switzerland Kasper; Claudia Gottier; Kirstin Atrott; Silvia Lang; Gerhard Rogler; Michael Scharl 09:08 - 09:16 IP563 08:54 - 09:06 OP354 PANEL DISCUSSION TOLL LIKE RECEPTOR 2 MODULATES THE INHIBITORY 09:16 - 09:21 IP564 MOTOR RESPONSE INDUCED BY HYDROGEN SULPHIDE In the absence of dysphagia and endoscopic abnormal- IN MOUSE COLON. ª ities, biopsies should not be taken Raquel Forcén García, Spain; Elena Layunta; Julián Albert J. Bredenoord, The Netherlands Pardo; José E. Mesonero; Laura Grasa 09:21 - 09:29 IP565 09:06 - 09:18 OP355 PANEL DISCUSSION DIRECT INHIBITION OF HMGB1 BY NEUTRALIZING ANTIBODY AMELIORATES EXPERIMENTAL COLITIS IN 09:29 - 09:34 IP566 MICE VIA TLR4-MYD88 PATHWAY PPI-refractory mucosal eosinophilia should be treated Fang Xiao, China; Binghua Sun; Junhua Li; Hanlin Mu; as Eosinophilic oesophagitis , regardless of symptoms Man Zhang; Demin Li; Huanjun Huang; Mei Liu; Ursula Ulrike von Arnim, Germany Seidler; Dean Tian 09:34 - 09:42 IP567 09:18 - 09:30 OP356 PANEL DISCUSSION NEW, PEPTIDE INHIBITOR OF DIPEPTIDYL PEPTIDASE IV, EMDB-1 ATTENUATES COLITIS IN MICE AFTER TOPI- Advances in Clinical GI & Hepatology CAL ADMINISTRATION 10:30 - 12:00 Room D Maciej Salaga, Poland; Paula Mosinska; Hubert What is success in treating IBD? Zatorski; Marta Zielinska; Jakub Fichna Chairs: Johan Burisch, USA 09:30 - 09:42 OP357 Sandro Ardizzone, Italy CHROMOFUNGIN (CHR) AMELIORATES EXPERIMENTAL COLITIS IN MICE VIA MODULATION OF MACROPHAGES' PLASTICITY 10:30 - 10:52 IP568 Nour Eissa, Canada; Fazle Rabbi; Marie-Hélène Defining the targets Wednesday, October 19, 2016 Metz-Boutigue; C. Bernstein; Jean-Eric Ghia Gert Van Assche, Belgium 09:42 - 09:54 OP358 10:52 - 11:14 IP569 DEFICIENCY OF PH-SENSING RECEPTOR TDAG8 AME- Empowering the patient LIORATES T-CELL TRANSFER COLITIS Pierre Michetti, Switzerland Irina Tcymbarevich, Switzerland; Cheryl de Vallière; 11:14 - 11:36 IP570 Jesus Cosin-Roger; Marianne R. Spalinger; Carsten A. Surgery in IBD: Always a failure or an option? Wagner; Klaus Seuwen; Isabelle Frey-Wagner; Gerhard Willem A. Bemelman, The Netherlands Rogler 11:36 - 11:58 IP571 Disability Laurent Peyrin-Biroulet, France

100 ª Rising Star ª Top Abstract Prize ª National Scholar 101 Wednesday, October 19, 2016 Scientific Programme by Day : UEG Week Final Programme

Video Case Session 11:18 - 11:28 VC07 10:30 - 12:00 Room E1 PROXIMALLY MIGRATED PANCREATIC STENT RETRIEVAL Video Case Session USING THE NEW SPYGLASS? DS VISUALIZATION SYSTEM Chairs: Lars Aabakken, Norway Dimitrios Kypraios; Stavros Stavrinidis, Greece; Horst Neuhaus, Germany Loukas Theodoropoulos; Nikolaos Sarimpegioglou; Apostolos Malachias; Stefanos Bassioukas; Dimitrios Dimitroulopoulos; Dimitrios Xinopoulos 10:30 - 10:35 VC01 11:28 - 11:36 VC08 A CASE OF ESOPHAGEAL CANCER DERIVED FROM ENDOSCOPIC MUCOSAL RESECTION OF GIANT FLAT GIANT DIVERTICULUM?TREATED BY ESD AND THORA- POLYP EXCLUSIVELY CLOSED WITH A SURGICAL HAE- COSCOPIC COLLABORATION SURGERY MOSTATIC AGENT Tsuneo Oyama, Japan; Akiko Takahashi; Nobukazu Alvaro Martinez Alcala, Spain; Felipe Martinez-Alcala Yorimitsu García; Klaus Mönkemüller; Jose M. P. Perez; Jose A. 10:35 - 10:43 VC02 Ciria Avila; Felipe A. Martinez NOVEL TECHNIQUE TO RELAX THE LOWER ESOPHA- 11:36 - 11:47 VC09 GEAL SPHINCTER (LES) DURING CHALLENGING PER THE INSERTION OF A PERCUATENOUS ENDOSCOPIC ORAL ENDOSCOPIC MYOTOMY (POEM) SIGMOIDOSTOMY TUBE Majidah Bukhari, USA; Vanessa Cubas, United Kingdom; Olufunso Adedeji Vivek Kumbhari; Yamile H. Chavez; Saowanee Ngamruengphong; Amr Ismail; Payal Saxena; 11:47 - 11:56 VC10 Mohamad ElZein; Mouen Khashab HIGH MAGNIFICATION DIAGNOSIS AND TREATMENT OF ESOPHAGEAL INTRAEPITHELIAL SQUAMOUS CELL 10:43 - 10:52 VC03 CARCINOMA NOVEL METHOD TO AVOID THE MIGRATION OF THE Valerio Balassone, Italy; Haruo Ikeda; Haruhiro Inoue METALLIC STENT INTO THE OMENTAL BURSA DURING EUS-GUIDED HEPATOGASTROSTOMY Symposium Hirofumi Kawamoto, Japan; Tomohiro Tanigawa; Noriyo Urata; Takahito Oka; Jun Nakamura; Mitsuhiko 10:30 - 12:00 Room E2 Suehiro; Ken Nishino; Miwa Kawanaka; Daisuke Goto; Current management of bile duct tumours Ken Haruma Chairs: Tim Lankisch, Germany Jeanin E. van Hooft, The Netherlands 10:52 - 11:00 VC04 GASTRIC PERFORATION DUE TO DUODENAL-JEJUNAL BYPASS SLEEVE: NON-SURGICAL, ENDOSCOPIC RE- Tandem Talks MOVAL PROCEDURE 10:30 - 10:40 IP572 Eduardo G. H. de Moura, Brazil; Christiano M. Sakai; Diagnosis and classification: Pathology Gustavo L. R. Silva; Diogo T. H. de Moura; Eduardo T. Dina Tiniakos, United Kingdom H. de Moura; Ana C. S. Borges; M. Passos Galvão Neto; Paulo Sakai 10:40 - 10:50 IP573 Diagnosis and classification: Radiology 11:00 - 11:09 VC05 Marco Rengo, Italy TUNNEL AND BRIDGE TECHNIQUE: A NOVEL AP- PROACH TO ENDOSCOPIC SUBMUCOSAL DISSECTION 10:50 - 11:12 IP574 OF GIANT RECTAL POLYPS Pre-operative endoscopy: When, why and how it Kesavan Kandiah; Sharmila Subramaniam, United should be performed Kingdom; Fergus J. Q. Chedgy; Sreedhari Thayalasekaran; Guido Costamagna, Italy Pradeep Bhandari 11:12 - 11:34 IP575 11:09 - 11:18 VC06 Surgical treatment ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) OF A Thomas van Gulik, The Netherlands 25MM NEUROENDOCRINE TUMOUR OF THE GASTRIC 11:34 - 11:56 IP576 BODY Chemotherapy Mayenaaz Sidhu, Australia; David J. Tate; Michael J. Thomas Seufferlein, Germany Bourke 2016 19, October Wednesday,

Livestream Q&A Audience Voting Recorded Session 101 UEG Week Final Programme : Scientific Programme by Day Wednesday, October 19, 2016

Symposium 10:52 - 11:14 IP582 10:30 - 12:00 Room F1 Can NCGS be diagnosed by biomarkers? Surgery meets endoscopy in the colon Detlef Schuppan, Germany Chairs: Roger Leicester, United Kingdom 11:14 - 11:36 IP583 Ian Jenkins, United Kingdom Can GI wheat allergy be differentiated from NCGS by endoscopic provocation ? Annette Fritscher-Ravens, Germany 10:30 - 10:52 IP577 Endoscopic full thickness resection of early colon cancer 11:36 - 11:58 IP584 Tomohiko Ohya, Japan Can the diagnosis of NCGS be made by double-blind food challenge? 10:52 - 11:14 IP578 Jessica Biesiekierski, Belgium Combined endoscopic-laparoscopic resection of colon polyps Symposium James E. East, United Kingdom 10:30 - 12:00 Room G Debate National Societies Symposia: Oesophageal cancer 11:14 - 11:24 IP579 across Europe Colonic perforation during endoscopy: Endoscopic Chairs: Andrea May, Germany management Rebecca Clare Fitzgerald, United Kingdom Marianna Arvanitakis, Belgium 11:24 - 11:34 IP580 10:30 - 10:52 IP585 Colonic perforation during endoscopy: Surgical man- Unifying European standards for diagnosis agement Rebecca Clare Fitzgerald, United Kingdom Desmond C. Winter, Ireland 10:52 - 11:14 IP586 11:34 - 11:46 OP359 Diagnostic tools across Europe TRANSANAL ENDOSCOPIC MICROSURGERY VERSUS Massimo Rugge, Italy ENDOSCOPIC MUCOSAL RESECTION FOR LARGE RECTAL ADENOMAS (TREND-STUDY). 11:14 - 11:36 IP587 Renée M. Barendse, The Netherlands; Gijsbert D. Musters; Endoscopic and surgical treatment: Are we following Eelco J. R. de Graaf; Frank J. C. van den Broek; Esther the same standard? C. J. Consten; Pascal G. Doornebosch; James C. H. Giovanni Zaninotto, Italy Hardwick; Ignace C. de Hingh; Christiaan Hoff; Jeroen M. Jansen; A. W. M. van Milligen de Wit; George van 11:36 - 11:58 IP588 der Schelling; Erik J. Schoon; Matthijs P. Schwartz; Bas Radiotherapy and chemotherapy: Differences in Europe? L. A. M. Weusten; Marcel G. Dijkgraaf; Paul Fockens; Karin Haustermans, Belgium Willem A. Bemelman; Evelien Dekker Symposium 11:46 - 11:58 OP360 10:30 - 12:00 Room K EFFICACY OF NON-EXPOSED ENDOSCOPIC WALL-IN- The patient with severely disturbed GI function: Opti- VERSION SURGERY (NEWS) AS AN ADVANCED METHOD mal management in 2016 OF FULL-THICKNESS RESECTION FOR GASTRIC TUMOR Chairs: Jutta Keller, Germany Keiko Niimi, Japan; Takashi Mitsui; Susumu Aikou; Shinya Wednesday, October 19, 2016 Paul Moayyedi, Canada Kodashima; Nobutake Yamamichi; Hiroharu Yamashita; Mitsuhiro Fujishiro; Yasuyuki Seto; Kazuhiko Koike 10:30 - 10:52 IP589 Symposium Nutrition in the patient with severely disturbed GI 10:30 - 12:00 Room F2 function Non-coeliac gluten sensitivity (NCGS) and wheat André Van Gossum, Belgium allergy in the gut Chairs: Jonas Ludvigsson, Sweden 10:52 - 11:14 IP590 Carolina Ciacci, Italy Achalasia Guy E. Boeckxstaens, Belgium 11:14 - 11:36 IP591 10:30 - 10:52 IP581 Chronic intestinal pseudoobstruction Pathogenesis of NCGS Hans Törnblom, Sweden Roberto De Giorgio, Italy 102 ª Rising Star ª Top Abstract Prize ª National Scholar 103 Wednesday, October 19, 2016 Scientific Programme by Day : UEG Week Final Programme

11:36 - 11:58 IP592 11:42 - 11:54 OP366 Faecal incontinence A HISTORY OF ISCHEMIC HEART DISEASE, HIGH BLOOD William E. Whitehead, USA UREA NITROGEN AND C-REACTIVE PROTEIN LEVELS, AND LOW HEMOGLOBIN LEVELS: AS PREDICTIVE CLIN- Free Paper Session ICAL FACTORS FOR EARLY DEATH AFTER PERCUTANE- 10:30 - 12:00 Room M OUS ENDOSCOPIC GASTROSTOMY Upper GI bleeding Tomoyuki Nishimura, Japan; Toshio Kuwai; Takeshi Chairs: Ian Mark Gralnek, Israel Takasago; Yuki Miyasako; Yuki Sumida; Sumio Iio; Wladyslaw Januszewicz, Poland Hiroki Imagawa; Toshiki Yamaguchi; Atsushi Yamaguchi; Hirotaka Kouno; Hiroshi Kohno 10:30 - 10:42 IP593 State-of-the-art introduction Translational Basic Science Ian M. Gralnek, Israel 10:30 - 12:00 Room 1.61/1.62 10:42 - 10:54 OP361 Immunotherapy in cancer MEDIUM- AND LONG-TERM RESULTS OF TREATMENT Chairs: Federica Di Nicolantonio, Italy WITH LANREOTIDE IN CASES OF CHRONIC OR RECUR- Dieter Saur, Germany RENT OBSCURE GASTROINTESTINAL BLEEDING OR DUE TO GASTROINTESTINAL Santiago Frago, Spain; Leticia Ollero; Maria Lazaro; 10:30 - 10:52 IP594 Edgar Peña-Galo; Natalia De la Llama; Javier Alcedo What is immunotherapy and what is the mechanism of action? 10:54 - 11:06 OP362 Stefan Kubicka, Germany SOMATOSTATIN ANALOGUES ARE LESS EFFECTIVE IN PATIENTS WITH ANGIODYSPLASIAS AT MULTIPLE SITES 10:52 - 11:14 IP595 OR LOCATED IN THE COLON: A POOLED ANALYSIS OF Evidence in colon and pancreatic cancer INDIVIDUAL PATIENT DATA Giovanni Germano, Italy Karina Grooteman, The Netherlands; Wietske Kievit; 11:14 - 11:36 IP596 Alba Rocco; Grainne Holleran; Paulo S. Salgueiro; Immunotherapy for gastric cancer Thomas Aparicio; Giuseppe Scaglione; Raúl Manzano; Timothy C. Wang, USA Denis Sautereau; Spyridon Michopoulos; Joost P. H. Drenth; Erwin J. M. Van Geenen 11:36 - 11:48 OP367 GLUTAMINOLYSIS INHIBITION AS A THERAPEUTIC 11:06 - 11:18 OP363 STRATEGY IN GLUTAMINE-ADDICTED KRAS MUTANT POST BANDING ULCER BLEED- COLORECTAL CANCER ING - DETERMINANTS AND IMPACT IN MORTALITY Chi C. Wong, Hong Kong PRC; Jiaying Xu; Qian Yun; Pedro Marques Da Costa, Portugal; Sofia Carvalhana; Xiaona Li; Wei Kang; Joseph J. Y. Sung; Zongwei Cai; João Lopes; Ana Valente; Mariana V. Machado; Rui Jun Yu Palma; Helena Cortez-Pinto; José Velosa 11:48 - 12:00 OP368 11:18 - 11:30 OP364 MOLECULAR DISSECTION OF TUMOR ANGIOGENESIS INTERNATIONAL PROSPECTIVE STUDY OF UPPER GI IN COLORECTAL CANCER HAEMORRHAGE: DOES WEEKEND ADMISSION AFFECT Eiichiro Yamamoto, Japan; Akira Yorozu; Hironori Aoki; OUTCOME? Toshihiko Nishidate; Hiroo Yamano; Tamotsu Sugai; Iain A. Murray; Adrian Stanley, United Kingdom; Harry Hiromu Suzuki; Hiroshi Nakase R. Dalton; Jing H. J. Ngu; Stig B. Laursen 11:30 - 11:42 OP365 Symposium PROGNOSTIC FACTORS FOR SECOND ENDOSCOPIC 10:30 - 12:00 Room N1 THERAPY FAILURE IN PEPTIC ULCER BLEEDING Complications of liver cirrhosis: Beyond bleeding and Artur G. G. Antunes, Portugal; Ana Vaz; Patrícia ascites Queirós; Tânia Gago; Joana Roseira; Bruno M. Santos Chairs: Dominique Thabut, France Peixe; Horácio Guerreiro Thomas Reiberger, Austria Wednesday, October 19, 2016 19, October Wednesday, 10:30 - 10:52 IP597 What is minimal encephalopathy? Peter Ferenci, Austria

Livestream Q&A Audience Voting Recorded Session 103 UEG Week Final Programme : Scientific Programme by Day Wednesday, October 19, 2016

10:52 - 11:14 IP598 11:18 - 11:30 OP374 Hyponatraemia in cirrhosis: Causes and consequences INCREASED ADENOMA DETECTION RATE BY G-EYE Andres Cardenas, Spain HIGH DEFINITION COLONOSCOPY IN COMPARISON TO STANDARD HIGH DEFINITION COLONOSCOPY- A PRO- 11:14 - 11:26 OP369 SPECTIVE RANDOMIZED MULTICENTRE STUDY RANDOMIZED CONTROLLED TRIAL OF BACLOFEN IN Haim Shirin; Beni Shpak; Julia Epshtein; Peter TREATMENT OF MUSCLE CRAMPS IN PATIENTS WITH Vilmann; Arthur Hoffman; Silvia Sanduleanu; Sauid LIVER CIRRHOSIS Ishaq; Pier A. Testoni; Seth A. Gross; Helmut Neumann; Sherief Abd-Elsalam, Egypt; Lobna Abo Ali; Samah Martin Goetz; Peter D. Siersema; Dov Abramowich; Soliman; Sheren Zakaria; Ibrahim Shehab El-Din; Mati Shnell; Meir Mizrahi; Jakob Hendel; Johannes W. Asem Elfert Rey; Rogier de Ridder; Edi Viale; Mark Pochapin; 11:26 - 11:38 OP370 Michael Yair; Nathan Gluck; Shaul Yaari; Trine Stigaard; SPONTANEOUS BACTERIAL PERITONITIS ? DOES THE Roman Simantov; Menachem Moshkowitz; Eran Israeli; INFECTION ACQUISITION SITE MATTERS? Stine Sloth; Shay Matalon; Alexander Vilkin; Ariel Benson; Artur G. G. Antunes, Portugal; Cristina Teixeira; Pedro Amit Maliar; Amir Waizbard; Tiberiu Hershcovici; Eyal Costa; Bruno M. Santos Peixe; Ana Alves; Sofia Santos; Shachar; Shmuel Rochberger; Eduard Tsvang; Michal Cristina Chagas; Ana P. Oliveira; Horácio Guerreiro Braverman; Harold Jacob; Yuri Brachman; John G. Karstensen; Daniel Teubner; Roel M. M. Bogie; Ralf 11:38 - 12:00 IP599 Kiesslich, Germany How to improve malnutrition in the cirrhotic patient Claire Francoz, France 11:30 - 11:42 OP375 EFFICACY AND SAFETY OF THE NOVEL 1L PEG AND Free Paper Session ASCORBATE BOWEL PREPARATION NER1006 VERSUS TRISULFATE SOLUTION IN OVERNIGHT SPLIT-DOSING 10:30 - 12:00 Room N2 ADMINISTRATION: RESULTS FROM THE PHASE 3 STUDY Improving quality of screening colonoscopy NOCT Chairs: Roland Valori, United Kingdom Michael DeMicco; Lucy B. Clayton, United Kingdom; Anneline Cremer, Belgium Richard Ng Kwet Shing; Michael S. Epstein 10:30 - 10:42 IP600 11:42 - 11:54 OP376 State-of-the-art introduction THE USE OF A SELF-EXPLANATORY BOOKLET FOR Roland Valori, United Kingdom BOWEL PREPARATION WITHOUT ORAL INSTRUC- 10:42 - 10:54 OP371 TIONS OVERCOMES BARRIERS AGAINST SPLIT-DOSE SEVEN YEARS OF QUALITY ASSURANCE IN SCREENING ADOPTION FOR EARLY MORNING COLONOSCOPY: A COLONOSCOPY IN AUSTRIA RANDOMIZED CONTROLLED TRIAL. Elisabeth Waldmann, Austria; Irina Gessl; Daniela Alida Andrealli, Italy; Silvia Paggi; Arnaldo Amato; Sallinger; Philip Jeschek; Martha Britto-Arias; Elisabeth Emanuele Rondonotti; Gianni Imperiali; Nicoletta Fasching; Werner Weiss; Michael Gschwantler; Michael Lenoci; Giovanna Mandelli; Natalia M. L. Terreni; Trauner; Monika Ferlitsch Giancarlo Spinzi; Franco Radaelli 10:54 - 11:06 OP372 Free Paper Session ENDORINGS? INCREASES ADR EVEN IN HIGH-RISK SCREENING COLONOSCOPY: RESULTS OF A SINGLE 10:30 - 12:00 Room L7 CENTRE PILOT STUDY Burden of liver disease Wednesday, October 19, 2016 Bu Hayee, United Kingdom; Guy Chung-Faye Chairs: Irina Girleanu, Romania Robert Fontana, USA 11:06 - 11:18 OP373 THE FIRST RANDOMISED CONTROLLED TRIAL OF 10:30 - 10:42 IP601 ENDOCUFF VISION® ASSISTED COLONOSCOPY VERSUS State-of-the-art introduction STANDARD COLONOSCOPY FOR POLYP DETECTION IN Robert Fontana, USA BOWEL CANCER SCREENING PATIENTS (E-CAP STUDY) 10:42 - 10:54 OP377 Rupam Bhattacharyya, United Kingdom; Fergus J. THE BURDEN OF OVERT AND OCCULT LIVER CIRRHOSIS IN Q. Chedgy; Kesavan Kandiah; Carole Fogg; Bernard PATIENTS WITH METABOLIC SYNDROME: ANALYSIS FROM Higgins; Ben Haysom-Newport; Lisa Gadeke; Fergus A LARGE GENERAL PRACTITIONERS DATABASE ª Thursby-Pelham; Richard Ellis; Patrick Goggin; Gaius Andrea Martini, Italy; Elena Ceranto; Angelo Gatta; Longcroft-Wheaton; Pradeep Bhandari Patrizia Pontisso

104 ª Rising Star ª Top Abstract Prize ª National Scholar 105 Wednesday, October 19, 2016 Scientific Programme by Day : UEG Week Final Programme

10:54 - 11:06 OP378 11:06 - 11:18 OP385 THE NATIONAL BURDEN IN FRANCE OF HOSPITAL CARE VITAMIN D REGULATES DENDRITIC CELL ACTIVITY AND FOR PATIENTS WITH HEPATIC ENCEPHALOPATHY: DATA TRAFFICKING IN CROHN'S DISEASE FROM THE FRENCH NATIONAL HOSPITAL DATABASE Philip Hendy, United Kingdom; Durga Reddi; David (PMSI) Bernardo; Lydia Durant; Alistair Noble; Nicholas English; Armand Abergel, France; Herve Hagege; Robert Stella C. Knight; Ailsa L. Hart Benamouzig; Cristophe Bureau; Cécile Blein; Camille Amaz; Emmanuelle Ribot-Mariotte; Irina Leurs 11:18 - 11:30 OP386 CIRCULATING DENDRITIC CELL SUBSETS IN CROHN'S 11:06 - 11:18 OP379 DISEASE SHOW ALTERATIONS IN TISSUE HOMING AND THE IMPACT OF RIFAXIMIN-ALPHA ON NHS HOSPITAL CYTOKINE PRODUCTION RESOURCE USE IN UK PATIENTS WITH HEPATIC EN- Philip Hendy, United Kingdom; Durga Reddi; David CEPHALOPATHY: A RETROSPECTIVE OBSERVATIONAL Bernardo; Lydia Durant; Alistair Noble; Nicholas English; STUDY (IMPRESS) Stella C. Knight; Ailsa L. Hart Richard Aspinall; Amr Radwan; Gabriel Shaya; Hanna Sodatonou, United Kingdom; Riccardo Cipelli; Mark 11:30 - 11:42 OP387 Hudson A PROTEOMIC APPROACH TO EXPLORE THE PROTEC- TIVE ROLE OF INULIN IN PREVENTING LPS-INDUCED 11:18 - 11:30 OP380 HUMAN COLONIC SMOOTH MUSCLE IMPAIRMENT WITHDRAWN Annamaria Altomare, Italy; Candida Vannini; Michele P. L. Guarino; Simone Barera; Vittoria Locato; Silvia 11:30 - 11:42 OP381 Cocca; Giorgio Arrigoni; Rossana Alloni; Laura De Gara; WITHDRAWN Michele Cicala 11:42 - 11:54 OP382 11:42 - 11:54 OP388 PREGNANCY OUTCOME IN MORE THAN 5000 BIRTHS TLR4 IS STILL ACTIVE IN GP96-DEFICIENT MACROPHAGES TO WOMEN WITH VIRAL HEPATITIS IN A POPULA- Jesus Cosin Roger, Switzerland; Claudia Stanzel; TION-BASED COHORT STUDY IN SWEDEN Anne Terhalle; Silvia Lang; Lutz Wolfram; Isabelle Knut Stokkeland, Sweden; Jonas F. Ludvigsson; Rolf Frey-Wagner; Martin Hausmann; Michael Fried; Hultcrantz; Anders Ekbom; Jonas Höijer; Matteo Bottai; Michael Scharl; Gerhard Rogler Olof Stephansson Free Paper Session Free Paper Session 10:30 - 12:00 Room 1.86 10:30 - 12:00 Room L8 Gastric and junctional cancers Translational aspects of IBD Chairs: Alexander Link, Germany Chairs: Timon Erik Adolph, Austria tba Catherine Reenaers, Belgium 10:30 - 10:42 IP603 10:30 - 10:42 IP602 State-of-the-art introduction State-of-the-art introduction Alexander Link, Germany Timon E. Adolph, Austria 10:42 - 10:54 OP389 10:42 - 10:54 OP383 A NEW, BIOLOGICALLY RELEVANT CLASSIFICATION ALTERATION OF THE RENIN-ANGIOTENSIN SYSTEM IN FOR ADENOCARCINOMA AT THE GASTRO-OESOPHA- THE CIRCULATION, TERMINAL AND COLON IN GEAL JUNCTION. PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A Jan Bornschein, United Kingdom; Juliane Perner; POTENTIAL NOVEL THERAPEUTIC TARGET Lorenz Wernisch; Maria Secrier; Shona MacRae; Mayur Garg, Australia; Simon Royce; Chris Tikellis; Ahmad Miremadi; Maria O'Donovan; Michael Selgrad; Claire Shallue; Pavel Sluka; Hady Wardan; Duygu Batu; Marino Venerito; Lawrence Bower; Matthew Eldridge; Elena Velkoska; Louise M. Burrell; Merlin Thomas; Peter Malfertheiner; Rebecca C. Fitzgerald Anne McFarlane; Peter R. Gibson; John Lubel 10:54 - 11:06 OP390 10:54 - 11:06 OP384 WITHDRAWN BLOCKADE OF αEβ7 INTEGRIN CONTROLS TRAF- FICKING OF CD8+ AND TH9 LYMPHOCYTES FROM IBD PATIENTS TO THE INFLAMED GUT IN VIVO 2016 19, October Wednesday, Sebastian Zundler, Germany; Anika Fischer; Raja Atreya; Rocío Lopez-Posadas; Alastair Watson; Clemens Neufert; Imke Atreya; Markus F. Neurath

Livestream Q&A Audience Voting Recorded Session 105 UEG Week Final Programme : Scientific Programme by Day Wednesday, October 19, 2016

11:06 - 11:18 OP391 10:50 - 11:00 OP397 SRGAP1, A CO-TARGET OF MIR-340 AND MIR-124, PREVALENCE OF SESSILE SERRATED ADENOMAS/POL- FUNCTIONS AS A POTENTIAL ONCOGENE WITH AM- YPS IN DISTAL COLON DURING SCREENING COLONOS- PLIFICATION AND RECURRENT MUTATION IN GASTRIC COPY/FLEXIBLE SIGMOIDOSCOPY: A SINGLE BOWEL TUMORIGENESIS CANCER SCREENING CENTRE EXPERIENCE FROM UK. Wei Kang, Hong Kong PRC; Tingting Huang; Yuhang Rajaratnam Rameshshanker, United Kingdom; Flaminia Zhou; Yujuan Dong; Joanna H. M. Tong; Ka F. To Purchiaroni; Ana Wilson; Zacharias P. Tsiamoulos; Arun Rajendran; Paris Tekkis; Brian P. Saunders 11:18 - 11:30 OP392 HOXB7 PROMOTES EPITHELIAL-MESENCHYMAL TRAN- 11:00 - 11:10 OP398 SITION AND METASTASIS IN GASTRIC CANCER SERRATED POLYPOSIS SYNDROME: A SURGICAL PER- Yu R. Sim, Republic of Korea; Jong-Jae Park; Taehyun SPECTIVE Kim; Wonjae Choi; Ji A. Lee; Moon K. Joo; Beom J. Lee; Salman A. Q. Rana, United Kingdom; Joep IJspeert; Hoon J. Chun; Sang W. Lee; Young T. Bak Nathan Atkinson; Yasmijn van Herwaarden; Iris D. Nagtegaal; Susan K. Clark; James E. East; Evelien 11:30 - 11:42 OP393 Dekker; Andrew Latchford SIGNIFICANCE OF COLONOSCOPY IN PATIENTS WITH GASTRIC HIGH GRADE DYSPLAIS OR EARLY GASTRIC 11:10 - 11:20 OP399 CANCER IMPROVED RISK CLASSIFICATION FOLLOWING COL- Ryu Daegon; Daehwan Kang; Hyungwook Kim; ORECTAL ADENOMA REMOVAL Cheolwoong Choi; Subum Park; Sujin Kim; Hyeongseok Paulina Wieszczy, Poland; Michal F. Kaminski; Robert Nam; Joonho Jeon; Jinhyuck Cho, Republic of Korea; Franczyk; Magnus Loberg; Jarek Kobiela; Maria Rupinska; Jungmin Park; Seunghwan Lee Bartlomiej Kocot; Maciej Rupinski; Øyvind Holme; Urszula Wojciechowska; Joanna Didkowska; Michael Bretthauer; 11:42 - 11:42 OP394 D Ransohoff; Mette Kalager; Jaroslaw Regula PALLIATIVE CHEMOTHERAPY AND TARGETED THER- APIES FOR ESOPHAGEAL AND GASTRO-ESOPHAGEAL 11:20 - 11:30 OP400 JUNCTION CANCER COST-EFFECTIVENESS ANALYSIS OF POST-POLYPEC- Vincent T. Janmaat, The Netherlands; Marco J. Bruno; TOMY COLONOSCOPY SURVEILLANCE USING JAPANESE Maikel Peppelenbosch; Ron H. J. Mathijssen; Ate van DATA: RISK-STRATIFIED SURVEILLANCE BASED ON der Gaast; Ewout W. Steyerberg; Ernst J. Kuipers; POLYP RESULTS IS MORE COST-EFFECTIVE Manon C. W. Spaander Masau Sekiguchi, Japan; Takahisa Matsuda; Ataru Igarashi; Hiroyuki Takamaru; Masayoshi Yamada; Taku Sakamoto; Free Paper Session Takeshi Nakajima; Yasuo Kakugawa; Yutaka Saito 10:30 - 12:00 Hotspot 11:30 - 11:40 OP401 Abstracts on Fire: New approaches to colorectal disease NEW NBI MAGNIFYING ENDOSCOPIC CLASSIFICATION Chairs: Yasmijn van Herwaarden, The Netherlands FOR COLORECTAL TUMORS PROPOSED BY THE JAPAN Michael Häfner, Austria NBI EXPERT TEAM (JNET) 10:30 - 10:40 OP395 Kyoku Sumimoto, Japan; Shinji Tanaka; Yasushi Sano; ECONOMIC EVALUATION OF ANTIBIOTIC THERAPY VS Shin-ei Kudo; Nana Hayashi; Shiro Oka; Mineo Iwatate; APPENDECTOMY FOR TREATMENT OF UNCOMPLICAT- Shoichi Saito; Takahisa Matsuda; Yoshiki Wada; Takahiro ED ACUTE APPENDICITIS: RESULTS OF THE APPAC Fujii; Hiroaki Ikematsu; Toshio Uraoka; Nozomui RANDOMIZED CLINICAL TRIAL Kobayashi; Hisashi Nakamura; Kinichi Hotta; Takahiro Wednesday, October 19, 2016 Paulina Salminen, Finland; Suvi Sippola; Risto Horimatsu; Naoto Sakamoto; Osamu Tsuruta; Hiroshi Tuominen; Hannu Paajanen; Tero Rautio; Pia Kawano; Hiroshi Kashida; Yoji Takeuchi; Hirohisa Nordström; Markku Aarnio; Tuomo Rantanen; Saija Machida; Toshihiro Kusaka; Naohisa Yoshida; Ichiro Hurme; Johanna Virtanen; Jukka-Pekka Mecklin; Hirata; Takeshi Terai; Hiro-o Yamano; Kazuhiro Kaneko; Juhani Sand; Airi Jartti; Juha Grönroos Takeshi Nakajima; Taku Sakamoto; Yuichiro Yamaguchi; Naoto Tamai; Naoko Maruyama; Hideki Ishikawa; 10:40 - 10:50 OP396 Yoshitaka Murakami; Shigeaki Yoshida; Yutaka Saito SURGERY VERSUS CONSERVATIVE TREATMENT FOR RECURRENT AND ONGOING DIVERTICULITIS; RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIAL (DIRECT-TRIAL). ª Marguerite Stam, The Netherlands; Bryan Wall vd; Werner A. Draaisma; Willem A. Bemelman; Marja A. Boermeester; Ivo A. M. J. Broeders; Eric Belgers; Boudewijn Toorenvliet; Hubert A. Prins; Esther C. J. Consten 106 ª Rising Star ª Top Abstract Prize ª National Scholar 107 Wednesday, October 19, 2016 Scientific Programme by Day : UEG Week Final Programme

11:40 - 11:50 OP402 Round Table Discussion SUBCLASSES OF TYPE-II PIT PATTERN REVEAL ALTER- 12:45 - 13:45 Room L7 NATIVE TUMORIGENIC PATHWAYS OF COLORECTAL Dyspepsia: Differential diagnoses and management SERRATED LESIONS strategies Hironori Aoki, Japan; Eiichiro Yamamoto; Hiro-o Chair: Pali Hungin, United Kingdom Yamano; Kenjiro Yoshikawa; Hiro-o Matsushita; Ryo Experts: Pali Hungin, United Kingdom Takagi; Eiji Harada; Yoshihito Tanaka; Tamotsu Sugai; Gregory Rubin, United Kingdom Hiromu Suzuki Jutta Keller, Germany 11:50 - 12:00 OP403 André Smout, The Netherlands ARTIFICIAL INTELLIGENCE (AI) IN ENDOSCOPY – DEEP LEARNING FOR OPTICAL BIOPSY OF COLORECTAL Round Table Discussion POLYPS IN REAL-TIME ON UNALTERED ENDOSCOPIC 12:45 - 13:45 Room L8 VIDEOS Steroids for acute : Cure or curse? Michael F. Byrne, Canada; Douglas K. Rex; Nicolas Chair: Mark Thursz, United Kingdom Chapados; Florian Soudan; Clemens Oertel; Milagros Experts: Mark Thursz, United Kingdom Linares Perez; Raymond Kelly; Nadeem Iqbal; Florent Andres Cardenas, Spain Chandelier Helena Cortez-Pinto, Portugal Gabriella Pár, Hungary Symposium 12:15 - 13:15 Hotspot Advances in Clinical GI & Hepatology A survivors guide for a happy and successful career in 14:00 - 15:30 Room D gastroenterology - Hosted by women in GI Optimal use of immunosuprressants and anti-TNF in IBD Expert: Rebecca Clare Fitzgerald, United Kingdom Chair: Iris Dotan, Israel Alexander R. Moschen, Austria

12:15 - 12:30 IP604 How to be a successful leader Tandem Talks Nurdan A. Tözün, Turkey 14:00 - 14:10 IP607 Impact of drug levels on management of anti-TNF failures 12:30 - 12:45 IP605 David Drobne, Slovenia Time management tips for success at work and a home-life 14:10 - 14:20 IP608 Marianna Arvanitakis, Belgium Impact of drug levels in patients doing well under anti-TNF 12:45 - 13:00 IP606 Yehuda Chowers, Israel Combining clinical work with research Gijs R. van den Brink, The Netherlands 14:20 - 14:42 IP609 Optimising use of thiopurines Round Table Discussion Peter Irving, United Kingdom 12:45 - 13:45 Room G Debate Multidisciplinary management of perianal fistula 14:42 - 14:52 IP610 Chair: Willem Bemelman, The Netherlands Combination therapy: Pro Experts: Willem Bemelman, The Netherlands Catherine Reenaers, Belgium Stuart Taylor, United Kingdom Yehuda Chowers, Israel 14:52 - 15:02 IP611 Pia Munkholm, Denmark Combination therapy: Con Peter László Lakatos, Hungary Round Table Discussion 15:02 - 15:24 IP612 12:45 - 13:45 Room K Predictors of response or non-response to biologics? Management of obscure GI bleeding Geert D'Haens, Belgium Chair: Cesare Hassan, Italy

Experts: Cesare Hassan, Italy 2016 19, October Wednesday, Andrea May, Germany Tomas Hucl, Czech Republic Joseph Jao Yiu Sung, China

Livestream Q&A Audience Voting Recorded Session 107 UEG Week Final Programme : Scientific Programme by Day Wednesday, October 19, 2016

Symposium 14:22 - 14:44 IP622 14:00 - 15:30 Room E1 Chronic pancreatitis Hepatology: What's new in 2016 J. E. Dominguez-Munoz, Spain Chairs: Erik Schrumpf, Norway 14:44 - 15:06 IP623 Christian Strassburg, Germany Cystic lesions Vinciane Rebours, France 14:00 - 14:22 IP613 15:06 - 15:28 IP624 Non-invasive diagnosis of fibrosis and cirrhosis Pancreatic cancer Laurent Castera, France Thomas Seufferlein, Germany 14:22 - 14:44 IP614 Symposium Autoimmune liver diseases Michael Trauner, Austria 14:00 - 15:30 Room F2 Food-related disorders: What's new in 2016? 14:44 - 15:06 IP615 Chairs: Kevin Whelan, United Kingdom Nonalcoholic fatty liver diseases Sibylle Koletzko, Germany Elizabetta Bugianesi, Italy 15:06 - 15:28 IP616 14:00 - 14:22 IP625 Viral hepatitis Coeliac disease Kosh Agarwal, United Kingdom Katri Kaukinen, Finland Symposium 14:22 - 14:44 IP626 14:00 - 15:30 Room E2 Food and functional GI disorders New technologies in endoscopy: What's new in 2016? Robin Spiller, United Kingdom Chairs: D. Nageshwar Reddy, India 14:44 - 15:06 IP627 Paul Fockens, The Netherlands Food allergy Stephan Bischoff, Germany 14:00 - 14:22 IP617 15:06 - 15:28 IP628 Novel imaging technologies Food and carcinogenesis Jacques J. Bergman, The Netherlands Elio Riboli, United Kingdom 14:22 - 14:44 IP618 Symposium New endoscopic submucosal dissection (ESD) techniques Naohisa Yahagi, Japan 14:00 - 15:30 Room G Neurogastroenterology and motility: What's new in 14:44 - 15:06 IP619 2016? Motorised spiral enteroscopy Chairs: Mira M. Wouters, Belgium Horst Neuhaus, Germany Mark Fox, Switzerland 15:06 - 15:28 IP620 Progress in EUS-guided interventions 14:00 - 14:22 IP629 Peter Vilmann, Denmark Wednesday, October 19, 2016 The Rome IV criteria for functional GI disorders: What's new for the clinican? Symposium Douglas Drossman, USA 14:00 - 15:30 Room F1 Pancreatology: What's new in 2016? 14:22 - 14:44 IP630 Chairs: Marco J. Bruno, The Netherlands New treatment options for patients with disturbed GI Julia Mayerle, Germany function Jan Tack, Belgium 14:44 - 15:06 IP631 14:00 - 14:22 IP621 Hot topics in basic/translational neurogastroenterology Acute pancreatitis and motility Omid Sadr-Azodi, Sweden Andreas Stengel, Germany

108 ª Rising Star ª Top Abstract Prize ª National Scholar 109 Wednesday, October 19, 2016 Scientific Programme by Day : UEG Week Final Programme

15:06 - 15:28 IP632 Symposium Diet, gut microbiota and GI function 14:00 - 15:30 Room N1 Daisy M. Jonkers, The Netherlands Benign colorectal diseases: What's new in 2016? Chairs: Wolfgang Kruis, Germany Symposium Pia Munkholm, Denmark 14:00 - 15:30 Room K Gut microbiota: What's new in 2016? Chairs: Patrizia Brigidi, Italy 14:00 - 14:22 IP642 Antonio Gasbarrini, Italy Andreas Münch, Sweden 14:22 - 14:44 IP643 14:00 - 14:22 IP633 Diverticulitis Gut microbiota in GI diseases Marja A. Boermeester, The Netherlands Mirjana Rajilic-Stojanovic, Serbia 14:44 - 15:06 IP644 Tandem Talks Clostridium difficile 14:22 - 14:32 IP634 Herbert Tilg, Austria Faecal microbial transplantation for IBD and other GI diseases 15:06 - 15:28 IP645 Paul Moayyedi, Canada Faecal incontinence Klaus Matzel, Germany 14:32 - 14:42 IP635 Faecal microbial transplantation for clostridium difficile Giovanni Cammarota, Italy Symposium 14:00 - 15:30 Room N2 14:42 - 15:04 IP636 Colorectal cancer: What's new in 2016? Gut microbiota and metabolic diseases Chairs: Thomas Gruenberger, Austria Josbert Keller, The Netherlands Wolff Schmiegel, Germany 15:04 - 15:30 IP637 PANEL DISCUSSION 14:00 - 14:22 IP646 Update on colorectal cancer screening in Europe Symposium Monique van Leerdam, The Netherlands 14:00 - 15:30 Room 1.61/1.62 Oesophageal diseases: What's new in 2016? 14:22 - 14:44 IP647 Chairs: Alex Straumann, Switzerland Innovations in chemoradiation of rectal cancer Thierry Ponchon, France Thomas Brunner, Germany 14:44 - 15:06 IP648 Tailored systemic treatment for colorectal cancer 14:00 - 14:22 IP638 Wolff Schmiegel, Germany GORD André Smout, The Netherlands 15:06 - 15:28 IP649 Minimal invasive surgery for colorectal cancer 14:22 - 14:44 IP639 Yves Panis, France Oesophageal motility disorders Sabine Roman, France 14:44 - 15:06 IP640 Eosinophilic oesophagitis Stephen Attwood, United Kingdom 15:06 - 15:28 IP641 Neoplastic Barrett's Gregory G. Ginsberg, USA Wednesday, October 19, 2016 19, October Wednesday,

Livestream Q&A Audience Voting Recorded Session 109 Keep on track with your training

Postgraduate Teaching Programme October 28-29, 2017 Barcelona, Spain

Major updates Enter the PGT 3-year curriculum!

Experience two days of world-class continuing medical education for medical and surgical gastroenterologists in training and in practice. Increased Join the 3-year cycle to get all major updates interactivity in GI & hepatology and you will be perfectly prepared for your professional career!

Full registration for UEG Week is not required.

Clinical cases Find out more, visit www.ueg.eu/week

16_08_Inserat_UEGWEEK_FP_PGT_160x220mm_RZ.indd 1 13.09.16 15:03 Poster Sessions by Day

Overview Icons

Poster in the Spotlight

Poster of Excellence

Clinical Case Session

Posters are displayed from Monday, October 17 until Poster Champs are awarded in the following categories: Wednesday, October 19 in the poster exhibition on Level 0 in halls X4 and X5. The posters are changed daily and 1. Upper gastrointestinal diseases are at display during the following times: 2. Lower gastrointestinal diseases 3. Liver, biliary and pancreatic diseases Monday October 17 10:30 – 17:00 4. Surgery, endoscopy and imaging Tuesday October 18 09:00 – 17:00 Wednesday October 19 09:00 – 14:00 Poster Champ Sessions are open to all delegates. All UEG Week 2016 attendees are kindly invited to join the Poster Champ Sessions and Poster Champ Award Cere- Four Poster Champ Sessions run in parallel from Mon- mony held in E-Poster Lounge I at 13:45 every day. day until Wednesday from 12:30 – 13:30. 2 minutes pre- sentations of the highest scoring posters will be given at Posters in the Spotlight will be presented additionally the E-Poster terminals in the poster exhibition, followed in dedicated sessions held daily in the E-Poster Lounge by 3 minutes Q&As from the chairs. I and II.

The scientific programme is as of September 16, 2016. Later changes are published in the online programme and in the UEG Week App. Poster Sessions Monday, October 17, 2016

Poster Sessions by Day Monday, October 17, 2016

Posters in the Spotlight 10:30 – 12:00 E-Poster Lounge 1 Disease mechanisms in inflammatory bowel disease Chairs: Johan Burisch, Denmark

P0239 EICOSAPENTAENOIC ACID-FREE FATTY ACID SUPPLE- MENTATION FOR THE PREVENTION OF COLITIS-ASSOCI- ATED COLORECTAL CANCER: A PHASE-I CLINICAL TRIAL Anna Prossomariti, Italy; E. Scaioli; C. Fazio; G. Piazzi; M. Bellanova; E. Biagi; M. Candela; P. Brigidi; T. Balbi; P. Chieco; A. Munarini; M. Minguzzi; F. Bazzoli; A. Belluzzi; L. Ricciardiello P0241 ALTERATION IN MICROBIOTA COMPOSITION CON- TRIBUTES TO CHRONIC INFLAMMATORY RESPONSE Visit the E-Poster TRIGGERED BY CROHN'S DISEASE-ASSOCIATED AIEC INFECTION IN GCN2 DEFICIENT MICE Alexis Bretin, France; G. Dalmasso; N. Barnich; R. Terminals & Poster Bonnet; H. T. T. Nguyen Champ Sessions P0242 ANTI-INFLAMMATORY AND ANTIBACTERIAL EFFECTS OF HUMAN CATHELICIDIN ACTIVE FRAGMENT KR-12 – A NOVEL POTENTIAL THERAPY OF INFLAMMATORY Find posters also electronically on BOWEL DISEASE Adam Fabisiak, Poland; N. Murawska; E. Kamysz; A. the E-Poster terminals in the Chmielowiec-Korzeniowska; W. Kamysz; J. Fichna Poster Exhibition (Hall X4 and X5). P0243 ANTI-TNFA ALTERS MOTIVATIONAL PROCESSING IN Additionally 4 Poster Champ CROHN'S DISEASE PATIENTS Sessions run in parallel each day M. Gray; C.-Y. Chao; D. Reutens; N. J. Talley; N. A. A. from 12:30 – 13:30 in the Poster Koloski; Gerald Holtmann, Australia Exhibition and a Poster Champ will P0244 CO-ABUNDANCE OF AKKERMANSIA MUCINIPHILA AND be selected out of the Posters of FAECALIBACTERIUM PRAUSNITZII IN THE MUCOSA OF Excellence in each category. HEALTHY AND DISEASED GUT Mireia Lopez-Siles, Spain; N. Enrich-Capó; M. Sabat-Mir; X. Aldeguer; S. H. Duncan; J. Garcia-Gil; M. Martinez-Medina

E-Posters will be published on www.ueg.eu/week/24-7 113 Poster Sessions Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

Posters in the Spotlight P0382 10:30 – 12:00 E-Poster Lounge 2 IMPACT OF IRRITABLE BOWEL SYNDROME WITH DIAR- Gastroesophageal reflux disease: From mechanisms RHOEA ON WORK PRODUCTIVITY AND DAILY ACTIVITY to treatment AMONG PATIENTS IN THE EU5 Chairs: Hubert Louis, Belgium Catherine Tucker, United Kingdom; J. L. Abel; R. T. Carson; N. M. Flores; R. Liebert P0383 P0446 HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS IMPAIRED MUCOSAL INTEGRITY IS PRESENT IN SOME WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA REFRACTORY GORD PATIENTS: THE RELEVANCE OF THE Catherine Tucker, United Kingdom; J. L. Abel; R. T. REFLUXATE Carson; N. M. Flores; R. Liebert Charlotte Broers, Belgium; N. Pardon; B. Van Houtte; H. Vanheel; T. Vanuytsel; J. Tack; A. Pauwels; R. L. P0384 Monday, October 17, 2016 17, October Monday, Farré Marti IS THERE AN ASSOCIATION BETWEEN SELF-REPORTED ALLERGIC CONDITIONS AND FUNCTIONAL GASTROIN- P0457 TESTINAL DISORDERS? A POPULATION BASED STUDY THE EXCRETION OF PANTOPRAZOL IN HUMAN BREAST N. A. A. Koloski; A. V. Zala; M. P. Jones; MILK Marjorie Walker, Australia; G. J. Holtmann; M. Veysey; Serhat Bor, Turkey; G. Yildiz Turkyilmaz; S. Karacaoglu; L. Bunby; L. Lambeth; L. Hayden; N. J. Talley S. Kipcak; P. Ergun; E. Karasulu P0385 P0458 ARE CONDITIONS OF IMMUNE DYSREGULATION RISK THE USE OF NON-ABLATIVE RF ENERGY (STRETTA) FACTORS FOR FUNCTIONAL GASTROINTESTINAL FOR THE TREATMENT OF GERD. TEN YEARS FOLLOW DISORDERS? FINDINGS FROM A RANDOM POPULATION UP RESULTS BASED STUDY L. Dughera; Giacomo Lo Secco, Italy; G. Catalano; F. N. A. A. Koloski; A. V. Zala; Marjorie Walker, Australia; Cisarò; M. Morino; M. Salizzoni; G. Montrucchio M. P. Jones; L. Bunby; M. Veysey; L. Lambeth; L. P0459 Hayden; G. J. Holtmann; N. J. Talley RESPONSE TO TREATMENT WITH PROTON PUMP IN- P0387 HIBITORS (PPI) OF ATYPICAL SYMPTOMS DEPENDING PERCEPTIONS OF PATIENTS WITH IRRITABLE BOWEL ON THEIR COEXISTENCE WITH TYPICAL SYMPTOMS Alba Zúñiga Ripa, Spain; F. Estremera Arévalo; I. Aresté SYNDROME IN RELATION TO THE CARE RECEIVED IN Anduaga; R. Iglesias Picazo; M. Oreja Arrayago THE PUBLIC HEALTH SYSTEM IN SPAIN José Mira, Spain; G. Lacima; X. Cortés Gil P0460 A NEW GASTRIC ACID SUPPRESSOR, "VONOPRAZAN" Posters in the Spotlight IS EFFECTIVE IN PROTON PUMP INHIBITOR-REFRAC- 14:00 – 15:30 E-Poster Lounge 2 TORY REFLUX ESOPHAGITIS Advances in therapeutic upper GI endoscopy H. Yamashita; Atsushi Kanamori, Japan Chair: Andrea May, Germany Mark Gralnek, Israel Posters in the Spotlight 14:00 – 15:30 E-Poster Lounge 1 Irritable Bowel Syndrome: What can we learn from P0119 epidemiological studies? MODIFIED PERORAL ENDOSCOPIC SHORTER MYOTOMY Chairs: Hans Törnblom, Sweden FOR THE TREATMENT OF SIGMOID-TYPE ACHALASIA: Niek de Wit, The Netherlands A PILOT STUDY X. Tang; Y. Ren; S. Huang; Q. Gao; Wei Gong, China

P0381 P0120 DEFECATORY SYMPTOMS IN PATIENTS WITH IRRITA- EFFICACY, RECURRENCE AND COMPLICATION RATES BLE BOWEL SYNDROME IN A PRIMARY HEALTH CARE OF ENDOSCOPIC MUCOSAL RESECTION VERSUS POPULATION IN SWEDEN ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY Jenny Sjödahl, Sweden; M. P. Jones; A.-K. Norlin; Å. BARRETT´S NEOPLASIA: A RETROSPECTIVE GERMAN Faresjö; S. Walter SINGLE CENTER ANALYSIS Christian Meinhardt, Germany; P. Troschel; A. Schütte; R. P. Henke; H. Seifert

Poster in the Spotlight Poster of Excellence Clinical Case Session 113

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0121 P0048 ENDOSCOPIC HAND SUTURING FOR MUCOSAL DEFECT PERFORMANCE OF CONTRAST ENHANCED ULTRA- CLOSURE AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL SOUND (CEUS) IN THE DIAGNOSTIC OF FOCAL LIVER DISSECTION IN IN VIVO ANIMAL MODELS AND CLINICAL LESIONS –MONOCENTRIC EXPERIENCE

Monday, October 17, 2016 CASES R. L. D. Sirli; C. Ivascu-Siegfried; T. Voicu Moga; Alina Osamu Goto, Japan; M. Sasaki; Y. Mitsunaga; T. Akimoto; Popescu, Romania; M. Danila; I. Sporea A. Fujimoto; Y. Ochiai; T. Maehata; T. Nishizawa; H. Takeuchi; Y. Kitagawa; N. Yahagi P0072 INTRADUCTAL PLASTIC STENT PLACEMENT IS AN EFFEC- P0125 TIVE THERAPY FOR MALIGNANT BILIARY STRICTURES OVER-THE-SCOPE CLIP SYSTEM VERSUS ENDOLOOP A. Yamaguchi; Y. Miyasako; Takeshi Takasago, Japan; COMBINED WITH METAL CLIPS APPLIED TO CLOSURE OF Y. Sumida; T. Nishimura; S. Iio; H. Imagawa; PERFORATION IN GASTRIC ENDOSCOPIC FULL-THICK- T. Yamaguchi; T. Kuwai; H. Kouno; H. Kouno NESS RESECTION: A SINGLE-CENTER PROSPECTIVE COMPARISON STUDY P0082 C. Zhang; J. Hu; Q. Li; Mei-Dong Xu, China THE POSSIBLE GENETIC BACKGROUND OF ALCO- HOL-INDUCED PANCREATIC STEATOSIS P0144 J. Li; Y. Xie; F. Yuan; B. Song; W. Yang; C. Tang; Huan TREATMENT OUTCOMES OF ESOPHAGEAL SCC WITH MM Tong, China INVASION COMPARING ENDSCOPIC RESECTION AND OPERATION P0088 Toshiyuki Yoshio, Japan; S. Yoshimizu; T. Tomohiro; A. MINIMALLY INVASIVE VERSUS OPEN NECROSECTOMY Ishiyama; H. Osumi; T. Shimizu; J. Fujisaki FOR NECROTIZING PANCREATITIS Robbert Hollemans, The Netherlands; S. van Brunschot; P0129 O. Bakker; M. G. H. Besselink; T. H. Baron; H. Beger; ENDOSCOPIC FULL-THICKNESS RESECTION OF UPPER M. A. Boermeester; T. Bollen; M. J. Bruno; R. Carter; R. AND LOWER GASTRO-INTESTINAL LESIONS USING A Charnley; D. Coelho; B. Dahl; M. G. Dijkgraaf; N. Doctor; NEW, FLAT BASED OVER-THE-SCOPE-CLIP; A FEASI- G. Farkas; P. Fagenholz; C. Fernandez-Del Castillo; P. BILITY STUDY Fockens; M. L. Freeman; T. Gardner; H. van Goor; H. Wouter Kappelle, The Netherlands; Y. Backes; L. M. G. Gooszen; G. Hannink; C. J. McKay; M. Peev; J. Neoptolemos; Moons; F. P. Vleggaar A. Oláh; R. Parks; M. Raraty; B. Rau; T. Rösch; M. Rovers; H. Seifert; A.K. Siriwardena; K. Horvath; H. van Santvoort Poster Champ Session P0096 12:30 – 13:30 Hall X5: Terminal 1 MIR 210-3P AND MIR 10B-5P AS A POTENTIAL BIO- Liver, biliary and pancreatic diseases MARKERS FOR DIFFERENTIATION BETWEEN CHRONIC Chairs: Matthias Löhr, Sweden PANCREATITIS AND PANCREATIC CANCER Tim Greten, USA Agnieszka Madro, Poland; M. Guz; W. Jeleniewicz; M. Cybulski; J. Kozicka; J. Kurzepa; A. Stepulak P0012 P0097 BACTERIAL ENDOTOXIN SIGNIFICANTLY DETERIORATE PANCREATIC ENDOCRINE FUNCTION IN PATIENTS CONSEQUENCES OF EXPERIMENTAL LIVER INJURY WITH CHRONIC PANCREATITIS: EVALUATION AND THROUGH "EXPLOSION" OF CYTOKINES RELATION TO MALNUTRITION Andriy Sydorchuk, Ukraine; R. Sydorchuk; P. Fomin; L. Sylvie Siminkovitch, Bulgaria; M. Kovacheva-Slavova; Sydorchuk; I. Sydorchuk B. Vladimirov; J. Genov; R. Mitova; P. Gecov; B. Golemanov P0026 P0103 ASSESSMENT OF THE CLINICAL IMPACT OF MULTI- COMPARISON OF REMNANT-INVAGINATION AND DRUG RESISTANT BACTERIA IN CIRRHOTIC PATIENTS DUCT-TO-MUCOSA PANCREATICOJEJUNOSTOMY Artur Gião Antunes, Portugal; C. Teixeira; A. Vaz; C. FOLLOWING WHIPPLE'S RESECTION: PROSPECTIVE Martins; P. Queirós; A. Alves; B. M. Santos Peixe; A. P. RANDOMIZED TRIAL IN PATIENTS AT HIGH RISK OF Oliveira; H. Guerreiro POSTOPERATIVE M. Del Chiaro; S. Sanjeevi; B. Björnsson; J. Sand; T. P0041 Gasslander; R. Segersvärd; Christoph Ansorge, Sweden REAL LIFE PRACTICE OF CHRONIC HEPATITIS C PA- TIENTS TREATED WITH DIRECT ACTING ANTIVIRALS (DAAS) IN A TERTIARY CENTER OF PORTUGAL Sofia Vitor, Portugal; S. R. R. Fernandes; P. Alexandrino; R. T. Marinho; J. Velosa

114 Poster in the Spotlight Poster of Excellence Clinical Case Session 115 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0104 P0149 THE EFFICACY AND SAFETY OF ENDOSCOPIC ULTRA- INDIVIDUAL SKILLS PARAMETERS ASSOCIATED WITH SOUND-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA) COMPETENCY AT COLONOSCOPIC POLYPECTOMY: A FOR PANCREATIC SOLID MASS LESIONS: A PROSPEC- RETROSPECTIVE ANALYSIS OF DIRECTLY OBSERVED TIVE MULTICENTER COHORT STUDY IN JAPAN POLYPECTOMY SKILLS (DOPYS) Shigetaka Yoshinaga, Japan; T. Itoi; K. Yamao; I. Arun Rajendran, United Kingdom; S. Thomas-Gibson; P. Yasuda; A. Irisawa; H. Imaoka; T. Tsuchiya; S. Doi; A. Dunckley; N. Sevdalis; A. Haycock Yamabe; Y. Murakami; H. Ishikawa; Y. Saito P0150 ACCURACY OF MODERN ENDOSCOPIC IMAGING TO Poster Champ Session DETERMINE THE KUDO NEOPLASTIC PIT PATTERN OF 12:30 – 13:30 Hall X5: Terminal 2 LARGE LATERALLY SPREADING COLONIC LESIONS (LSL) Surgery, endsocopy and imaging David Tate, Australia; L. Desomer; H. Awadie; M. J.

Chairs: Gregory G. Ginsberg, USA Bourke 2016 17, October Monday, Michael Bourke, Australia P0151 THE CLINICAL SIGNIFICANCE OF SOLITARY LARGE P0113 SESSILE SERRATED ADENOMAS USEFULNESS OF AN E-LEARNING SYSTEM FOR THE EN- Lobke Desomer, Australia; D. J. Tate; M. Jayanna; N. DOSCOPIC DIAGNOSIS OF EARLY GASTRIC CANCER USING Burgess; M. Pellise; H. Awadie; D. McLeod; M. J. Bourke MAGNIFYING ENDOSCOPY WITH NARROW-BAND IMAG- P0185 ING: A RANDOMIZED CONTROLLED MULTICENTER STUDY METAL OR PLASTIC STENTS TO RELIEVE OBSTRUCTIVE Koji Kojima, Japan; H. Doyama; H. Nakanishi; K. Yao; H. JAUNDICE PRIOR TO RESECTION OF PERIAMPULLARY Ishikawa; H. Araki; H. Kashida; A. Hosokawa; H. Mori; H. TUMORS RESULTS OF A PROSPECTIVE RANDOMIZED, Yamasita; O. Motohashi; K. Kobayashi; M. Hirayama; H. DOUBLE BLIND CLINICAL STUDY Kobayashi; M. Endo; H. Yamano; K. Murakami; T. Koike; Greger Olsson, Sweden; F. Frozanpor; L. Lundell; L. K. Hirasawa; Y. Miyaoka; H. Hamamoto; T. Hikichi; N. Enochsson; J. Blomberg; C. Ansorge; M. Reuter- Hanabata; R. Shimoda; S. Hori; T. Sato; S. Kodashima; H. wall-Hansson; U. Arnelo Okada; T. Mannami; S. Yamamoto; Y. Niwa; K. Yashima; S. Tanabe; H. Satoh; M. Numata; T. Yamazato; Y. Ikeda; P0198 H. Nishisaki; M. Nakagawa; A. Matsuda; F. Tamura; H. COST-EFFECTIVENESS OF CYANOACRYLATE GLUE Nishiyama; K. Arita; K. Kawasaki; K. Hoppo; M. Oka; S. INJECTIONS VERSUS ENDOSCOPIC ULTRASOUND GUID- Ishihara; M. Mukasa; H. Minamino; K. Uchita ED TREATMENT IN THE MANAGEMENT OF P0114 Carlos Robles-Medranda, Ecuador; M. Valero; M. Puga; RANDOMIZED CONTROLLED TRIAL (RCT) OF DOPPLER J. Ospina; M. Soria; H. Alvarado; H. Pitanga Lukashok ENDOSCOPIC PROBE (DEP) ASSISTED TREATMENT COM- PARED TO STANDARD HEMOSTASIS OF SEVERE VARICE- P0208 AL OR PORTAL HYPERTENSIVE LESION UGI BLEEDING PREP-LESS COLON CANCER SCREENING USING A NOV- Dennis M. Jensen, USA; T. O. Kovacs; G. V. Ohning; EL X-RAY IMAGING CAPSULE K. Ghassemi; G. Machicado; G. Dulai; A. Sedarat; R. M. Moshkowitz; M. Jean; N. Gluck; D. Schwartz; J. Jutabha; J. Gornbein; Los Angeles, CA/US Lechter; A. Milchem; Y. Ron; B. Shpak; R. Brun; T. Rösch; Nadir Arber, Israel P0115 RESULTS OF ENDOSCOPIC EN-BLOC RESECTION OF SUB P0225 EPITHELIAL TUMORS: A SINGLE CENTRE STUDY IMPROVEMENT IN GLUCOSE METABOLISM AFTER Amol Bapaye, India; M. R. Mahadik; N. A. Dubale; V. BARIATRIC SURGERY: COMPARISON OF LAPAROSCOPIC Vyas; R. Gaadhe; J. A. Bapaye ROUX-EN-Y GASTRIC BYPASS AND DUODENOJEJUNAL P0116 BYPASS LINER ASSESSMENT OF THE SAFETY OF ENDOSCOPIC SUB- Sarah Guenthert, Germany; C. Stier; R. Weiner; J. Stein MUCOSAL DISSECTION IN VERY ELDERLY PATIENTS P0226 Makoto Nishimura, Japan; J. Woo; Y. Fujii; Y. Kowazaki; THE EFFECT OF SLEEVE GASTRECTOMY ON ESOPHAGEAL M. Matsukawa; J. Matsuoka CHEMICAL CLEARANCE AND BASAL IMPEDANCE VALUES Salvatore Tolone, Italy; E. Savarino; N. De Bortoli; M. Frazzoni; M. Furnari; G. Bodini; I. Martinucci; S. Russo; G. del Genio; V. Savarino; L. Docimo

Poster in the Spotlight Poster of Excellence Clinical Case Session 115

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

Poster Champ Session P0298 12:30 – 13:30 Hall X5: Terminal 3 SAFETY, AND PHARMACODY- Lower gastrointestinal diseases NAMICS OF THE NOVEL ORAL PEPTIDE THERAPEUTIC Chairs: Charlie Lees, United Kingdom PTG-100 (ALPHA4-BETA7 INTEGRIN ANTAGONIST) IN

Monday, October 17, 2016 Ailsa Hart, United Kingdom NORMAL HEALTHY VOLUNTEERS Richard Shames, USA; L. Tozzi; L. Mattheakis; T. Annamalai; A. Bhandari; D. Liu P0238 P0299 VOLUNTARY EXERCISE IMPROVES THE HEALING OF EX- IMPACT OF NON-MEDICAL SWITCHING OF ANTI-TUMOR PERIMENTAL COLITIS IN MICE FED DIET-INDUCED OBESI- NECROSIS FACTOR AGENTS ON HEALTHCARE COSTS IN TY. ESSENTIAL ROLE OF ENDOCRINE FACTORS RELEASED EUROPE FROM SKELETAL MUSCLES AND ADIPOSE TISSUE Timothy Juday, USA; M. Skup; C. Streuper; U. Moerch; J. Bilski; A. Mazur-Bialy; M. Magierowski; D. Wojcik; G. S. Kopperud; O. Henriksen; S. Johnson; T. O'Connell B. Brzozowski; Z. Sliwowski; K. Magierowska; Tomasz Brzozowski, Poland P0360 HIGH RATES OF DISCORDANCE BETWEEN BRAF AND P0258 MLH1 METHYLATION TESTS IN CRC PATIENTS OVER 70 FAMILIAL AGGREGATION OF INFLAMMATORY BOWEL YEARS OLD IN A LYNCH SYNDROME UNIVERSAL SCREEN- DISEASE ON THE FAROE ISLANDS - A FAROESE IBD ING PROGRAM COHORT STUDY Tomer Adar, USA; L. H. Rodgers; K. M. Shannon; A. Kari Rubek Nielsen, Faroe Islands; J. Olsen; G. Mattia; G. Y. Lauwers; A. J. Iafrate; D. C. Chung Andorsdóttir; E. Gislason; J. Burisch P0371 P0268 POSITIVE LYMPH NODE RATIO IS A PROGNOSTIC FACTOR MRI REMISSION AFTER THERAPEUTIC INTERVENTION FOR STAGE III COLORECTAL CANCER PATIENTS WITH IS ASSOCIATED WITH MORE TIME SPENT IN CLINICAL MUCINOUS ADENOCARCINOMA AND SIGNET RING CELL CORTICOSTEROIDS-FREE REMISSION AND DECREASED CARCINOMA RISK OF SURGERY IN CROHN'S DISEASE Junichi Shibata, Japan; S. Ishihara; K. Kawai; K. Murono; Anthony Buisson, France; C. Hordonneau; F. Goutorbe; K. Sasaki; K. Yasuda; K. Otani; T. Nishikawa; T. Tanaka; K. C. Allimant; M. Goutte; V. Petitcolin; G. Bommelaer Hata; T. Kiyomatsu; H. Nozawa; K. Sugihara; T. Watanabe P0270 METABOLIC PROFILING OF URINE AND FAECES DIFFER- Poster Champ Session ENTIATES INFLAMMATORY BOWEL DISEASE PHENOTYPE 12:30 – 13:30 Hall X5: Terminal 4 AND HAS IMPLICATIONS ON THERAPEUTIC RESPONSE Upper gastrointestinal diseases Nik Sheng Ding, United Kingdom; M. Sarafian; Chairs: Marc Benninga,The Netherlands P. Hendy; R. Misra; L. Penez; E. Holmes; A. L. Hart Gregory Rubin, United Kingdom P0271 FINGER CLUBBING: HIGH PREVALENCE IN SEVERE P0417 SMALL BOWEL CROHN'S DISEASE IN A PROSPECTIVE HIGH DIAGNOSTIC PERFORMANCE OF A NOVEL ASSAY SINGLE-CENTER STUDY FOR AUTOANTIBODIES AGAINST ATP4A AND ATP4B M. Cossignani; B. Neri; S. Romeo; A. Ruffa; E. Lolli; SUBUNITS OF GASTRIC PROTON PUMP H+,K+-ATPASE E. Calabrese; Livia Biancone, Italy IN ATROPHIC BODY GASTRITIS PATIENTS P0296 Edith Lahner, Italy; V. Lampasona; C. Brigatti; L. MUCOSAL HEALING: MAYO 0 VS 1 AFTER 3 YEARS Piemonti; M. Carabotti; G. Scalese; H. W. Davidson; J. Giuseppe Frieri, Italy; M. Di Ruscio; A. Capannolo; G. M. Wenzlau; B. Annibale Latella; A. Pasetti; R. Tittoni; A. Viscido P0418 P0297 FROM THYROID AUTOIMMUNITY DISEASE TO AUTOIM- A POOLED SAFETY ANALYSIS FROM THE USTEKINUMAB MUNE CHRONIC ATROPHIC BODY GASTRITIS: POSSIBLE CROHN'S DISEASE AND PSORIATIC DISEASES PHASE 2 PREDICTOR MARKERS AND 3 CLINICAL TRIAL PROGRAMS Maria Piera Panozzo, Italy; M. Franceschi; Subrata Ghosh, Canada; B. E. Sands; W. de Villiers; E. G. Baldassarre; A. Antico Ott; C. Gasink; Y. Lang; P. Szapary; D. Jacobstein; B. G. Feagan

116 Poster in the Spotlight Poster of Excellence Clinical Case Session 117 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0426 P0526 PROGNOSIS OF ENDOSCOPIC HEMOSTASIS FOR THE GAS- CIRCULATING MICRORNA ASSOCIATED WITH VISCERAL TROINTESTINAL BLEEDING ULCER WAS DEPENDENT ON OBESITY: A POSSIBLE BIOMARKER OF DIGESTIVE THE CHARACTERISTICS OF THE PATIENTS, BUT NOT ON CANCERS CORRESPONDENCE OF THE MEDICAL STAFFS IN JAPAN Juntaro Matsuzaki, Japan; R. Shimizu-Hirota; Okamoto Norihiro, Japan; Y. Sakata; K. Miyahara; H. Tadokoro; Y. Iwao; T. Ochiya S. Matsuura; N. Turuoka; T. Noda; K. Yamamoto; H. Kawakubo; K. Yamanouchi; R. Iwakiri; K. Fujimoto P0531 IMPACT OF BODY MASS INDEX AND BODY COMPOSI- P0427 TION ON LUNG FUNCTION IN ADULT PATIENTS WITH INFORMATICS ASSESSMENT OF BURDEN OF ANAEMIA CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION POST UPPER GI BLEEDING IN AN UNIVERSITY HOSPITAL Katharina Staufer, Austria; S. Harm; E. Halilbasic; POPULATION P. Hillebrand; P. Jaksch; W. Klepetko; M. Trauner; L.

Neeraj Bhala, United Kingdom; D. Mcnulty; F. Evison; T. Kazemi-Shirazi 2016 17, October Monday, Read; N. Sharma; T. Iqbal Molecular biology, inflammation and fibrosis P0436 AMBULATORY HIGH RESOLUTION OESOPHAGEAL MANOMETRY: A NOVEL TOOL TO INVESTIGATE NON- Poster Session CARDIAC CHEST PAIN 10:30 - 17:00 Hall X4 E. Yazaki; P. Woodland; Joanne Ooi, United Kingdom; F. Liver and Biliary I Hughes; S. L. Preston; D. Sifrim P0001 P0445 THE PROTECTIVE EFFECT OF BERAPROST SODIUM IN MACROPHAGE FUNCTIONAL ACTIVITY DEPENDING ON MONOCROTALINE-INDUCED SINUSOIDAL OBSTRUCTION THE REFLUXATE TYPE IN GASTROESOPHAGEAL REFLUX SYNDROME IN MICE DISEASE Makoto Nakura, Japan; T. Miyashita; S. Kanou; Svetlana Lyamina, Russia; S. Kalish; A. Paraskevova; S. Takada; Y. Yamamoto; T. Ohta O. Storonova; I. Maev; A. Trukhmanov; V. Ivashkin; I. P0002 Malyshev HEPATOCYTE-SPECIFIC DELETION OF HYPOXIA P0455 INDUCIBLE FACTOR-2α ATTENUATES FIBROGENIC PRO- TJ-14 (HANGESHASHINTO) IMPEDES THE DEVELOPMENT GRESSION IN MICE WITH NON-ALCOHOLIC FATTY LIVER OF REFLUX-INDUCED ESOPHAGEAL CANCER IN A SUR- DISEASE GICAL RAT MODEL Elisabetta Morello, Italy; S. Sutti; S. Cannito; B. Foglia; Tomoharu Miyashita, Japan; D. Matsui; I. Makino; H. S. Bruzzì; E. Novo; C. Bocca; G. Villano; P. Pontisso; E. Tajima; A. K. Ahmed; J. W. Harmon; T. Ohta Bugianesi; E. Albano; M. Parola P0467 P0003 ENDOSCOPIC TREATMENT VS. SURGERY FOR HIGH-RISK WITHDRAWN EARLY ESOPHAGEAL CANCER P0004 Marek Kollar, Czech Republic; J. Krajciova; J. Maluskova; PROSPECTIVE COMPARISON OF NONINVASIVE TECH- E. Honsova; A. Pazdro; T. Harustiak; D. Kodetova; Z. NIQUES FOR THE ASSESSMENT OF LIVER STIFFNESS IN Vackova; J. Spicak; J. Martinek A COHORT OF COMPENSATED HCV LIVER CIRRHOSIS P0474 Raluca Lupusoru, Romania; I. Sporea; A. Popescu; R. L. CHARACTERISTICS AND RISK FACTORS FOR SOLITARY D. Sirli; M. Danila; A.-M. Stepan; R. G. Mare; F. Bende NON-AMPULLARY DUODENAL CARCINOMA. P0005 Naomi Kakushima, Japan; H. Ono; H. Matsubayashi; LIVER-SPECIFIC SIRT1 DELETION AGGRAVATES HEPAT- K. Takizawa; M. Tanaka; N. Kawata; S. Ito; K. Imai; K. IC FIBROSIS BY REGULATING BAS METABOLISM AND Hotta; H. Ishiwatari SUPPRESSES THE EXPRESSION OF IQGAP1 P0491 ª Xiaowei Liu, China; H. He; Y. Nie CHANGES OF INTESTINAL MICROBIOTA AFTER HELICO- BACTER PYLORI ERADICATION THERAPY Dilyara Safina, Russia; S. R. Abdulkhakov; T. Grigoryeva; B. Kovarsky; D. Khusnutdinova; M. Markelova; R. A. Abdulkhakov; V. Chernov

Poster in the Spotlight Poster of Excellence Clinical Case Session 117

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0006 P0014 CONTRIBUTION OF THE TH17 IMMUNE RESPONSE TO GUT MICROBIOTA SIGNATURES IN TURKISH NAFLD THE PROGRESSION OF NON ALCOHOLIC FATTY LIVER PATIENTS. DISEASE TO NON ALCOHOLIC Tarkan Karakan, Turkey; C. Erdogdu; M. Yalinay

Monday, October 17, 2016 Carla Chackelevicius, Italy; P. J. Giraudi; S. E. Gambaro; S. Palmisano; M. Giuricin; N. Demanzini; D. Bonazza; F. P0015 Zanconati; C. Tiribelli; N. Rosso RETROSPECTIVE ANALYSIS OF THE MICROBIAL EPIDEMI- OLOGY OF SPONTANEOUS BACTERIAL PERITONITIS AND P0007 BACTERIASCITES IN PATIENTS WITH LIVER CIRRHOSIS LIVER AND SKELETAL MUSCLE MIR-34A CONTRIBUTES Eva-Maria Fuchs, Austria; N. Pfisterer; F. Pleininger; C. TO MITOCHONDRIAL DYSFUNCTION AND INSULIN Illiasch; J. Feichtinger; T. Reiberger; C. Madl RESISTANCE IN EXPERIMENTAL NAFLD André Lopes Simão, Portugal; M. B. Afonso; P. M. Regeneration, stem cells and nutrition Rodrigues; C. M. P. Rodrigues; R. E. Castro P0016 P0008 THE ADAPTOR PROTEINS CARDIF/STING NEGATIVELY INHIBITION OF CANONICAL WNT SIGNALING PATHWAY REGULATE THE PROLIFERATION OF LIVER REGENERA- BY β-CATENIN/CBP INHIBITOR ICG001 AMELIORATES TION AFTER PARTIAL HEPATECTOMY IN MICE LIVER FIBROSIS IN VIVO THROUGH SUPPRESSION OF Sarah Schulze, Germany; M. Lu; B. Holzmann; H. STROMAL CXCL12 Friess; N. Hüser; D. Hartmann Ruchi Bansal, The Netherlands; B. Öztürk; G. Storm; J. Prakash P0017 THE ROLE OF GENETICALLY MODIFIED HSCS IN LIVER P0009 REGENERATION AFTER ACUTE LIVER DAMAGE HEPATITIS C CORE REGION MUTATIONS ARE COR- Elvira Ildarovna Sharipova, Russia; A. Titova; RELATED WITH LIVER DISEASE PROGRESSION A. Shafigullina; E. Garanina; M. O. Mavlikeev; G. Pevnev; B. Mohar Vitezic; Sandra Milic, Croatia; M. Carapina; D. G. R. Burganova; A. A. Gumerova; M. A. Titova; Kovac; D. Stimac; B. Grahovac A. Rizvanov; A. P. Kiyasov P0010 HIGH LEVELS OF SERUM AUGMENTER OF LIVER REGEN- Metabolic/genetic disorders ERATION (ALR) PREDICT BETTER PROGNOSIS OF ACUTE- P0018 ON-CHRONIC LIVER FAILURE (ACLF) AND ALR PROMOTER ANGIOTENSIN II TYPE 1 RECEPTOR GENE A1166C REGION GENETIC VARIANTS ASSOCIATE WITH ACLF RISK POLYMORPHISM IS ASSOCIATED WIT NON ALCOHOLIC Y. Bi; Min Min, China; Y. Liu FATTY LIVER DISEASE AND PREDICTS ITS SEVERITY P0011 Ahad Eshraghian, Iran; S. Iravani; P. Azimzadeh THE ROLE OF SARTANS (TELMISARTAN OR OLME- P0019 SARTAN) IN DECREASE OF INTERLEUKIN-6 LEVEL IN PATIENTS WITH POLYCYSTIC LIVERS MORE THAN TWO PATIENTS WITH STEATOHEPATITIS COMBINED WITH TIMES THE NORMAL SIZE ARE LIKELY TO DEVELOP ARTERIAL HYPERTENSION AND OBESITY SYMPTOMS E. Sklyarov; Olesya Bochar, Ukraine; V. Bochar Myrte K. Neijenhuis, The Netherlands; S. M. H. Verheesen; M. C. Hogan; J. A. Sloan; W. Kievit; Microbiology T. J. G. Gevers; J. P. H. Drenth P0012 P0020 BACTERIAL ENDOTOXIN SIGNIFICANTLY DETERIORATE LNCRNA PROFILE IN NAFLD AND IDENTIFICATION OF A CONSEQUENCES OF EXPERIMENTAL LIVER INJURY PROTECTIVE NOVAL LNCRNA FLRL2 IN NAFLD THROUGH "EXPLOSION" OF CYTOKINES Yi Chen, China; C. Xu; C. Yu; Y. Li Andriy Sydorchuk, Ukraine; R. Sydorchuk; P. Fomin; L. Sydorchuk; I. Sydorchuk P0021 NON-ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED P0013 WITH METABOLIC SYNDROME: MAJOR RISK FOR FUNGAL INFECTIONS IN CIRRHOTIC PATIENTS - MARK- ATHEROSCLEROSIS ER FOR AN ADVERSE OUTCOME? Mihai Alexandru Munteanu, Romania; G. A. Nagy; M. Diogo Branquinho, Portugal; A. Oliveira; C. Gregório; Gordan; S. D. Valean; M. Iancu; P. A. Mircea C. Sofia

118 Poster in the Spotlight Poster of Excellence Clinical Case Session 119 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0022 P0031 CAUSES OF DEATH IN PATIENTS WITH NON-ALCOHOLIC NEW TREATMENT WITH SULODEXIDUM FOR PORTAL FATTY LIVER DISEASE? RESULTS FROM A TERTIARY VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS HOSPITAL IN SOUTH CHINA Ionel Copaci, Romania; L. Micu; S. Ioanitescu; G. Junzhao Ye, China; M. Li; W. Yanqin; B. Zhong Chiriac; I. Lupescu P0023 P0032 THE EFFICACY AND SAFETY OF VILDAGLIPTIN TREAT- IS IT TIME TO CONSIDER ANTITHROMBOTIC PROPHY- MENT FOR NONALCOHOLIC FATTY LIVER DISEASE IN LAXIS IN CHRONIC LIVER DISEASE?: USEFULNESS OF TYPE 2 DIABETES MELLITUS CHA2DS2-VASC SCORE, HAS-BLED SCORE AND PLATE- Mehmet Celikbilek, Turkey; Z. T. Ozdemir; A. Aktas; T. LET COUNT Yildirim; H. I. Serin Elisa Soares, Portugal; M. Gravito-Soares; C. Lérias; S. Lopes; D. Gomes; P. Figueiredo; C. Agostinho; L. Tomé; P0024 C. Sofia 2016 17, October Monday, DIAGNOSTIC ALGORITHM FOR HIGH LIVER IRON OVER- LOAD: RESULTS FROM A PROSPECTIVE STUDY OF 312 P0033 PATIENTS WITH HYPERFERRITINEMIA CONTINUOUS PROTON PUMP INHIBITOR THERAPY Agustin Castiella Eguzkiza, Spain; E. Zapata; I. Urreta; INCREASES THE RISK OF BACTERIAL INFECTION IN J. M. Alustiza; E. Salvador; P. Otazua; M. D. De Juan; G. CIRRHOTIC PATIENTS Letamendi; B. Arrizabalaga; L. Zubiaurre; U. Mendarte; Artur Gião Antunes, Portugal; A. Vaz; P. Queirós; T. M. L. Rincon; J. I. Emparanza Gago; J. Roseira; B. M. Santos Peixe; H. Guerreiro P0025 P0034 INCREASED FREQUENCY OF KERATIN 8/18 VARIANTS IMPACT OF THE USE OF BETA-BLOCKERS IN DECOM- IN CHINESE NON-ALCOHOLIC FATTY LIVER DISEASE PA- PENSATED CIRRHOSIS TIENTS: AN ASSOCIATION WITH METABOLIC DISORDERS Paula Sousa, Portugal; D. Martins; J. Pinho; J. Fernandes; Rui Li, China; J. Ye; W. Yanqin; M. Li; B. Zhong R. Araújo; E. Cancela; A. Castanheira; P. Ministro; A. Silva P0035 Cirrhosis and complications: Clinical aspects EFFICACY OF TOLVAPTAN WITH CELL-FREE AND CON- P0026 CENRATED REINFUSION THERAPY FOR REFRACORY ASSESSMENT OF THE CLINICAL IMPACT OF MULTI- ASCITES IN PATIENTS WITH ADVANCED LIVER DISEASE DRUG RESISTANT BACTERIA IN CIRRHOTIC PATIENTS Takeshi Ichikawa, Japan; N. Machida; H. Sasaki; I. Aoki Artur Gião Antunes, Portugal; C. Teixeira; A. Vaz; C. P0036 Martins; P. Queirós; A. Alves; B. M. Santos Peixe; A. P. MEAN PLATELET VOLUME IS A PROMSIDING DIAG- Oliveira; H. Guerreiro NOSTIC MARKER FOR SYSTEMIC INFLAMMATION IN P0027 CIRRHOTIC PATIENTS WITH ASCITIC FLUID INFECTION EFFECTIVENESS OF TRANSJUGULAR INTRAHEPATIC Mahmoud Attalla, Egypt; E. Adel; A. T. Abdelmoez; Z. PORTOSYSTEMIC SHUNTS (TIPS) USING BARE METAL M. Hefny; M. A. El Zahry AND COVERED STENTS FOR THE TREATMENT OF VARI- P0037 CEAL BLEEDING IN CIRRHOSIS EVALUATION OF AN ALTERNATIVE MODEL TO MELD Theresa Bucsics, Austria; M. Schoder; M. Diermayr; M. FOR ANTICOAGULATED PATIENTS WITH CIRRHOSIS: Feldner-Busztin; N. Göschl; P. Schwabl; M. Mandorfer; MELD-XI (EXCLUDING INR) B. Angermayr; M. Cejna; A. Ferlitsch; W. Sieghart; M. Paula Sousa, Portugal; D. Martins; J. Pinho; J. Fernandes; Trauner; M. Peck-Radosavljevic; J. Karner; F. Karnel; T. R. Araújo; E. Cancela; A. Castanheira; P. Ministro; A. Silva Reiberger P0038 P0028 INCIDENCE AND PREDICTORS OF REBLEEDING AFTER WITHDRAWN BAND LIGATION IN PATIENTS WITH ACUTE ESOPHA- P0029 GEAL VARICEAL BLEEDING CYSTATIN C A REAL-TIME BIOMARKER FOR GLOMER- Vera Anapaz, Portugal; J. Carvalho E. Branco; M. ULARFILTRATION RATE IN CRITICALLY-ILL PATIENTS Cardoso; R. Carvalho; L. Santos; A. Martins; J. Reis WITH END STAGE LIVER DISEASE P0039 Elsayed Abdelaal, Egypt; E. S. Tharwa; S. Abbas; M. A. MORTALITY AFTER THE FIRST ADMISSION FOR HEPATIC Eljaky ENCEPHALOPATHY P0030 Marco Silva, Portugal; A. Albuquerque; H. Cardoso; A. WITHDRAWN Peixoto; R. Gaspar; G. Macedo

Poster in the Spotlight Poster of Excellence Clinical Case Session 119

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0040 Imaging, radiology (incl. interventional radiology) SEXUAL DYSFUNCTION IN CHRONIC LIVER DISEASE: IS IT A HOT TOPIC FOR CIRRHOTIC PATIENTS? P0048 Rosa Coelho, Portugal; M. Silva; A. Peixoto; H. Ribeiro; R. PERFORMANCE OF CONTRAST ENHANCED ULTRA- SOUND (CEUS) IN THE DIAGNOSTIC OF FOCAL LIVER

Monday, October 17, 2016 Gaspar; R. Gonçalves; P. Pereira; H. Cardoso; G. Macedo LESIONS –MONOCENTRIC EXPERIENCE R. L. D. Sirli; C. Ivascu-Siegfried; T. Voicu Moga; Alina Viral hepatitis C: Clinical aspects Popescu, Romania; M. Danila; I. Sporea P0041 P0049 REAL LIFE PRACTICE OF CHRONIC HEPATITIS C PATIENTS TRANSIENT ELASTOGRAPHY FOR DIAGNOSIS OF TREATED WITH DIRECT ACTING ANTIVIRALS (DAAS) IN A CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN TERTIARY CENTER OF PORTUGAL PATIENTS WITH ALCOHOL-RELATED LIVER CIRRHOSIS Sofia Vitor, Portugal; S. R. R. Fernandes; P. Alexandrino; Ekaterina Liusina, Russia; C. Pavlov; V. Ivashkin R. T. Marinho; J. Velosa P0050 P0042 A NEW ULTRASOUND-BASED METHOD TO DETECT GENDER-DEPENDENT DRUG-DRUG INTERACTIONS LIVER STEATOSIS USING CT AS REFERENCE STANDARD (DDIS) WITH NOVEL ALL ORAL HCV THERAPIES IN L. Carlo Pescatori; Gian Eugenio Tontini, Italy; R. Casale; GERMAN REAL-WORLD: LOW FREQUENCY OF DDIS C. Messina; D. Orlandi; G. Di Leo; F. Sardanelli; L. M. WITH ELBASVIR (EBV) AND GRAZOPREVIR (GRZ) Sconfienza Peter Buggisch, Germany; H. Löhr; G. Teuber; H. Steffens; M. Kraus; P. Geyer; B. Weber; T. Witthöft; U. Naumann; P0051 E. Zehnter; D. Hartmann; B. Dreher; M. Bilzer NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS BY MEANS OF TRANSIENT ELASTOGRAPHY AND FIBROTEST P0043 IN PATIENTS WITH HCV COMPENSATED LIVER CIRRHOSIS HIGH POTENTIAL FOR DRUG-DRUG INTERACTIONS Ioan Sporea, Romania; R. G. Mare; L. Sandulescu; (DDIS) DURING CHRONIC HEPATITIS C (CHC) THERAPY A. Popescu; R. L. D. Sirli; M. Danila WITH DIRECT ACTING ANTIVIRALS (DDAS) IN ROUTINE CLINICAL PRACTICE P0052 George Papatheodoridis, Greece; J. Goulis; THE VALUE OF ELASTPQ FOR THE EVALUATION OF S. Manolakopoulos; C. Triantos; K. Zachou; LIVER STIFFNESS IN PATIENTS WITH B AND C CHRONIC M. Papatheodoridi; A. Koukofiki; A. Kourikou; HEPATOPATHIES C. Tsoulas; K. Zisimopoulos; G. Dalekos Ruxandra Mare, Romania; I. Sporea; R. Lupusoru; R. L. D. Sirli; A. Popescu; M. Danila; F. Bende P0044 SOFOSBUVIR PLUS RIBAVIRIN FOR TREATMENT OF CIRRHOTIC HCV PATIENTS GENOTYPE-4 Liver neoplasia: Clinical Sherief Abd-Elsalam, Egypt; M. Sharaf-Eldin; P0053 Y. Ahmad; S. Tawefeek WITHDRAWN P0045 P0054 TREATMENT OF HEPATITIS C INFECTION IN RENAL ROLE OF LOW MOLECULAR WEIGHT HEPARINS (LMWH) TRANSPLANT RECIPIENTS: A GOLDEN AGE IN PREVENTION OF THROMBOEMBOLIC COMPLICATION Marta Lemos Rocha, Portugal; J. C. Sousa; T. Moreira; AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) J. M. Ferreira; I. Pedroto IN HEPATOCELLULAR CARCINOMA P0046 Sherief Abd-Elsalam, Egypt; O. Negm; S. Abou Saif; WITHDRAWN M. El Gharib; M. Yousef P0047 P0055 ROLE OF DIFFERENT CYTOKINE POLYMORPHISMS IN DRUG-ELUTING BEADS VERSUS CONVENTIONAL CHEMO– EMBOLIZATION FOR THE TREATMENT OF UNRESECTABLE PREDICTING THE RESPONSE TO PEGYLATED INTERFER- ON ALFA-2A PLUS RIBAVIRIN IN EGYPTIAN CHILDREN HEPATOCELLULAR CARCINOMA: A META-ANALYSIS WITH CHRONIC HEPATITIS C GENOTYPE 4 Antonio Facciorusso, Italy; M. Di Maso; N. Muscatiello Sana Barakat, Egypt; W. El-Gendy; S. Hefny; E. Shehata; M. Abd El-Kader; A. Mansour

120 Poster in the Spotlight Poster of Excellence Clinical Case Session 121 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0056 Cholestasis and : Clinical EFFICACY OF LOW DOSE CAPECITABINE AND SORAFENIB IN PATIENTS WITH ADVANCED ALFA-FETOPROTEIN P0063 SECRETING HEPATOCELLULAR CARCINOMA: A ONE YEAR GENETIC POLYMORPHISMS OF IL-4 (C-590T), TNF-A EXPERIENCE (G-308A), PRSS1 (R122H) AND CFTR (DELF508C) GENES Amr Hanafy, Egypt IN PATIENTS WITH ACUTE PANCREATITIS AND CHOLES- TATIC SYNDROME P0057 Andriy Sydorchuk, Ukraine; L. Sydorchuk; S. Ivashuk; O. CHANGING PATTERN IN ETIOLOGIC FACTORS OF HEPA- Plehutsa; I. Sydorchuk; R. Sydorchuk TOCELLULAR CARCINOMA IN LEBANON Cesar Yaghi, Lebanon; J. Hajal; R. Sayegh; R. Slim P0064 Karam; A. Abou Rached; J. Bou Jaoude; K. Honein DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 18 MONTHS OF OPEN-LABEL LONG-TERM P0058 SAFETY EXTENSION STUDY OF OBETICHOLIC ACID IN Monday, October 17, 2016 17, October Monday, HEPATIC RESECTION IS SUPERIOR TO TACE AND PRIMARY BILIARY CIRRHOSIS PERCUTANEOUS ABLATION IN B1-B2 SUBGROUPS OF Michael Trauner, Austria; F. Nevens; P. Andreone; PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLU- G. Mazzella; S. Strasser; C. Bowlus; P. Invernizzi; LAR CARCINOMA J.P.H. Drenth; P. Pockros; J. Regula; A. Floreani; S. Zeno Adrian Sparchez, Romania; P. Radu; I. Groza; C. Hohenester; V. Luketic; M. Shiffman; K. van Erpecum; Iancu; N. Al Hajjar V. Vargas; C. Vincent; B. Hansen; L. MacConell; T. Marmon; D. Shapiro P0059 PROGNOSIS OF EARLY STAGE HEPATOCELLULAR CAR- P0065 CINOMA SHOWING COMPLETE RESPONSE AFTER FIRST EUS FOR SUSPECTED CHOLEDOCHOLITHIASIS. FIRST TRANSARTERIAL CHEMOEMBOLIZATION:A ROLE OF RESULTS OF A CHANGE IN STRATEGY REGARDING INDI- SCHEDULED SECOND TACE CATION AND TIMING OF ERCP Sehee Jo, South Korea; D. H. Sinn; S. W. Shin; S. K. Rutger Quispel, The Netherlands; M. van der Voort; L. Cho; W. Kang; G.-Y. Gwak; J. H. Lee; K. C. Koh; S. W. M. van Driel; B. Veldt; M.J. Bruno Paik; M. S. Choi P0066 NEW METHOD TO INSERT LARGE CALIBER PLASTIC AND Vascular diseases of the liver, bile duct or pancreas SELF-EXPANDING METAL STENTS DURING BALLOON P0060 OVERTUBE ENTEROSCOPY (BAE) ASSISTED ERCP HEPATIC VENO-OCCLUSIVE DISEASE (VOD) AFTER HE- Paul Kroener, USA; Á. Martínez-Alcalá; I. Jovanovic; M. MATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) A. D'Assuncao; H. Neumann; K. Mönkemüller IN PEDIATRIC PATIENTS: ROLE OF LIVER STIFFNESS P0067 Federico Ravaioli, Italy; A. Colecchia; G. Marasco; R. TEMPORARY PLACEMENT OF BILIAY PIGTAIL STENTS Masetti; K. Kleinschmidt; A. Prete; A. Pession; D. Festi AFTER UNCERTAIN COMMON BILE DUCT STONES CLEARANCE IN ERCP Bile acids, transport, cholestasis, gallstones: Basic Jesus Garcia Cano, Spain; L. Taberna-Arana P0061 P0068 DIFFERENT METHODS HANDLING COMMON BILE DUCT ASSESSMENT OF SHORT SINGLE-BALLOON ENTERO- STONES WITH PERIAMPULLARY DIVERTICULA: THE SCOPE (SHORT-SBE) FOR THERAPEUTIC ERCP IN PA- EXPERIENCE COMPARISON BETWEEN TWO CENTERS TIENTS WITH ALTERED GASTROINTESTINAL ANATOMY FROM CHINA AND JAPAN Yuki Tanisaka, Japan; S. Ryozawa; H. Iwano; Kexiang Zhu, China; W. Zhou; L. Miao; J. Yan; W. Meng; M. Harada; T. Kobatake; S. Arai; Y. Mashimo L. Zhang; X. Zhu; X. Wang; H. Wang; N. Sakiyama; A. Suzuki; K. Tanaka; X. Li P0069 ROLE OF SPYGLASSTM-CHOLANGIOSCOPY: FIRST CLINI- P0062 CAL EXPERIENCES IN SWITZERLAND URSODEOXYCHOLIC ACID REDUCE THE WEIGHT GAIN VIA G.-M. Semadeni; Remus Frei, Switzerland; MODULATING THE COMPOSITION OF GUT MICROBIOTA C. Meyenberger; M. C. Sulz; J. Borovicka S. Jang; Y. Choi; Kihyun Ryu, South Korea; S. Han; K. Yu; Y. Kang; K. Huh; T. Lee; K. Song; H. Koo; M. Kang;

Poster in the Spotlight Poster of Excellence Clinical Case Session 121

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0070 P0077 BALLOON-OVERTUBE ENTEROSCOPY ASSISTED (BAE) A PROSPECTIVE STUDY TO ASSESS THE SAFETY AND VERSUS LAPAROSCOPY-ASSISTED ERCP IN BARIATRIC EFFICACY OF USING AIR FOR CHOLANGIOGRAPHY IN POST- ROUX-EN-Y GASTRIC BYPASS PATIENTS: A COM- PATIENTS WITH HILAR STRICTURES, HIGH CHOLANGIO

Monday, October 17, 2016 PARATIVE STUDY CARCINOMA IN CHD AND CHD STRICTURES SECONDARY Ujjwal Kumar, USA; P. T. Kroener; I. Jovanovic; J. P. TO CARCINOMA GALL BLADDER Gutierrez; H. Neumann; K. Mönkemüller Pankaj N. Desai, India; M. V. Kabrawala P0071 P0078 IS THE PERIAMPULLARY DIVERTICULUM A RISK FACTOR USEFULNESS OF SHORT-TYPE BALLOON-ASSISTED EN- FOR POST ERCP PANCREATITIS ACCORDING TO TYPE DOSCOPES AND METALLIC STENTS WITH A SMALL-DI- AND SIZE? AMETER DELIVERY SYSTEM FOR MALIGNANT BILIARY Jai Hoon Yoon, South Korea; D. H. Koh; Y. J. Kim OBSTRUCTION WITH SURGICALLY ALTERED ANATOMY Kazunaga Ishigaki, Japan; H. Kogure; A. Yamada; Biliary neoplasia: Basic H. Isayama; G. Umefune; D. Akiyama; K. Takagi; T. Watanabe; R. Uchino; N. Takahara; S. Mizuno; P0072 S. Matsubara; N. Yamamoto; Y. Nakai; T. Sasaki; M. INTRADUCTAL PLASTIC STENT PLACEMENT IS AN EFFEC- Matsuyama; N. Sasahira; M. Tada; K. Koike TIVE THERAPY FOR MALIGNANT BILIARY STRICTURES A. Yamaguchi; Y. Miyasako; Takeshi Takasago, Japan; Y. P0079 Sumida; T. Nishimura; S. Iio; H. Imagawa; THE SEQUENCE OF BRUSH CYTOLOGY AND INTRADUCT- T. Yamaguchi; T. Kuwai; H. Kouno; H. Kouno AL BIOPSY DO NOT AFFECT THE DIAGNOSTIC YIELD IN PATIENT WITH BILIARY STRICTURE P0073 Seung Young Seo, South Korea; I. S. Min; D. Kim; S. B. HUMAN EQUILIBRATIVE TRANSPORTER 1 (HENT1) Kim; S. H. Kim; I. H. Kim; S. W. Kim; S. T. Lee; D. G. Kim; EXPRESSION IS NOT PREDICTIVE FOR GEMCITABINE S. O. Lee OUTCOME IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER P0080 Jun Kyu Lee, South Korea; D. K. Jang; J. H. Son; J. W. COMPARING LIQUID BASED CYTOLOGY(CELLPREP®) Lee; S. H. Lee; J. K. Ryu; Y.-T. Kim; K.-B. Lee METHODS WITH CONVENTIONAL SMEAR METHODS FOR ERCP GUIDED BRUSHING CYTOLOGY OF BILE DUCT Biliary neoplasia: Clinical Yonghyeok Choi, South Korea; J. H. Han; H. B. Chae; S. M. Park P0074 ROLE OF THE NEW GENERATION SINGLE-OPERATOR Cell biology/secretion/enzymology/physiology CHOLANGIOSCOPY IN THE DIAGNOSIS OF INDETEREM- INATE BILIARY LESIONS: A SINGLE TERTIARY CENTRE P0081 PROSPECTIVE STUDY PERCUTANEOUS CHOLECYSTOSTOMY AS DEFINITE Noor Bekkali, United Kingsdom; A. Winstanley; G. J. M. TREATMENT FOR ACUTE CHOLECYSTITIS WITH UNRE- Webster SECTABLE KLASTKIN TUMOR R. Daegon; D. Kang; H. Kim; C. Choi; S. Park; S. Kim; H. P0075 Nam; H. Jang; Jinhyuck Cho, South Korea; J. Park; Y. Choi DEVELOPMENT OF AN EXTERNAL-TO-INTERNAL CON- VERTIBLE ENDOSCOPIC BILIARY DRAINAGE DEVICE Poster Session Akihiro Mori, Japan; S. Ito; M. Sawada; T. Yumura; H. Hachiya; S. Hayashi; N. Ohashi 10:30 - 17:00 Hall X4 Pancreas I P0076 A PROGNOSTIC MODEL ADOPTING NEW CRITERIA OF IN- P0082 VASION DEPTH IN DISTAL BILE DUCT CANCER: A BETTER THE POSSIBLE GENETIC BACKGROUND OF ALCOHOL- PREDICTOR OF SURVIVAL THAN PREVIOUS METHODS INDUCED PANCREATIC STEATOSIS Byoung-Kwan Son, South Korea; K.-W. Min; D.-H. Kim; J. Li; Y. Xie; F. Yuan; B. Song; W. Yang; C. Tang; Huan E.-K. Kim Tong, China P0083 BETAINE ATTENUATES ALCOHOLIC FATTY PANCREAS THROUGH DOWN-REGULATION OF DGAT2 W. Yang; J. Li; L. Huang; Huan Tong, China; Z. Huang; C. Tang

122 Poster in the Spotlight Poster of Excellence Clinical Case Session 123 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0084 P0091 EXPRESSION OF INSULIN AND GLUCAGON IN LIVER AND PREVALENCE OF POST-ERCP COMPLICATIONS AC- PANCREAS IN RAT COPPER-DEFICIENT MODEL OF INJURY CORDING TO HOSPITAL VOLUMES AND EXPERIENCE OF Kadriya Nailevna Saifullina, Russia; A. Abdulkhakova; OPERATORS: A PROSPECTIVE MULTICENTER STUDY A. Galyavieva; G. Pevnev; S. R. Abdulkhakov; A. A. Ki Ju Kim, South Korea; J. W. Choi; B. S. Lee; C.-M. Cho; Gumerova; A. Kiassov M. K. Jung; J. Heo; K. B. Cho; Y. S. Lee; H. G. Kim; J. Han; D. W. Lee; T. N. Kim; K.-H. Kim; H.-S. Kim P0085 A NEW ANIMAL MODEL IN PANCREATOLOGY- PANCRE- P0092 ATIC DUCTAL FLUID AND BICARBONATE SECRETION IN EUS-GUIDED INTERVENTIONS FOR WALLED-OFF WILD TYPE FERRETS PANCREATIC NECROSIS: CLINICAL OUTCOMES OF A Emese Tóth, Hungary; P. Pallagi; J. Maléth; STEP-UP APPROACH AND RISK FACTORS FOR FAILED V. Venglovecz; Z. Rakonczay; P. Hegyi ENDOSCOPIC TREATMENT

Mamoru Takenaka, Japan; K. Minaga; M. Kitano; S. 2016 17, October Monday, P0086 Oomoto; K. Kamata; T. Miyata; K. Yamao; H. Imai; M. CYCLIC ADENOSINE MONOPHOSPHATE PRODUCTION Kudo STIMULATED BY ORAI1 AND EXTENDED SYNAPTOTAG- MIN 1 P0093 Júlia Fanczal, Hungary; T. Madacsy; P. Hegyi; A. Malini; EVALUATION OF THE BISAP SCORE IN PREDICTING S. Muellem; J. Maléth SEVERITY AND PROGNOSIS IF ACUTE PANCREATITIS Patrícia Santos, Portugal; S. R. R. Fernandes; M. P0087 Moura; J. R. Carvalho; T. Antunes; J. Velosa VX-809 RESTORES THE EXPRESSION DEFECT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULA- P0094 TOR CAUSED BY ALCOHOL IN CAPAN-1 CELLS DIAGNOSIS, MANAGEMENT AND CLINICAL OUTCOME OF József Maléth, Hungary; T. Madacsy; P. Pallagi; P. Hegyi ACUTE BILIARY PANCREATITIS IN HUNGARY – NATION- WIDE, MULTICENTER, RETROSPECTIVE ANALYSIS Pancreatitis, acute Dr. Adrienn Halász, Hungary; F. Izbéki; J. Gervain; J. Hamvas; R. Takács; T. Takács; Z. Szepes; M. Varga; K. P0088 Csefko; L. Czakó; J. Novák; A. Z. Szepes; J. Czimmer; J. MINIMALLY INVASIVE VERSUS OPEN NECROSECTOMY Sümegi; A. Vincze; P. Sarlós; I. Szabó; A. Illés; J. Bajor; S. FOR NECROTIZING PANCREATITIS Gódi; A. Szentesi; B. Kui; A. Parniczky; P. Hegyi; I. Hritz Robbert Hollemans, The Netherlands; S. van Brunschot; O. Bakker; M. G. H. Besselink; T. H. Baron; H. Beger; M. A. P0095 Boermeester; T. Bollen; M. J. Bruno; R. Carter; R. Charnley; IMPACT OF FATTY LIVER ON SEVERITY OF ACUTE D. Coelho; B. Dahl; M. G. Dijkgraaf; N. Doctor; G. Farkas; PANCREATITIS P. Fagenholz; C. Fernandez-Del Castillo; P. Fockens; M. L. In-Seok Lee, South Korea; S. B. Yoon; M. H. Choi; K. J. Freeman; T. Gardner; H. van Goor; H. Gooszen; G. Hannink; Lee; H. K. Kim; M.-G. Choi C. J. McKay; M. Peev; J. Neoptolemos; A. Oláh; R. Parks; M. Raraty; B. Rau; T. Rösch; M. Rovers; H. Seifert; A. K. Pancreatitis, chronic (including hereditary disorders) Siriwardena; K. Horvath; H. van Santvoort; P0096 P0089 MIR 210-3P AND MIR 10B-5P AS A POTENTIAL BIO- THE FIRST MULTI-CENTRE EXPERIENCE FROM THE UK MARKERS FOR DIFFERENTIATION BETWEEN CHRONIC AND IRELAND OF THE USE OF THE HOT AXIOS SYSTEM PANCREATITIS AND PANCREATIC CANCER FOR TRANSLUMINAL DRAINAGE OF PANCREATIC FLUID Agnieszka Madro, Poland; M. Guz; W. Jeleniewicz; M. COLLECTIONS Cybulski; J. Kozicka; J. Kurzepa; A. Stepulak Suresh Vasan Venkatachalapathy, United Kingdom; A. Makin; S. P. Pereira; G. J. Johnson; N. Bekkali; I. P0097 Penman; K. Oppong; M. Nayar; N. R. Carroll; E. M. PANCREATIC ENDOCRINE FUNCTION IN PATIENTS WITH Godfrey; B. Ryan; V. parihar; C. J. McKay; M. Huggett CHRONIC PANCREATITIS: EVALUATION AND RELATION TO MALNUTRITION P0090 Sylvie Siminkovitch, Bulgaria; M. Kovacheva-Slavova; RED CELL DISTRIBUTION WIDTH AND RATIO RED CELL B. Vladimirov; J. Genov; R. Mitova; P. Gecov; B. Golemanov DISTRIBUTION WIDTH/TOTAL SERUM CALCIUM AS MAJOR PREDICTORS OF SEVERITY AND MORTALITY IN ACUTE PANCREATITIS Marta Gravito-Soares, Portugal; E. Gravito-Soares; D. Gomes; S. Lopes; C. Sofia

Poster in the Spotlight Poster of Excellence Clinical Case Session 123

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0098 P0104 RELATION BETWEEN VITAMIN D STATUS AND CARDIO- THE EFFICACY AND SAFETY OF ENDOSCOPIC ULTRA- VASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC SOUND-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA) AND RECURRENT PANCREATITIS - PRELIMINARY DATA FOR PANCREATIC SOLID MASS LESIONS: A PROSPEC-

Monday, October 17, 2016 Mila Kovacheva-Slavova, Bulgaria; S. Siminkovitch; B. TIVE MULTICENTER COHORT STUDY IN JAPAN Vladimirov; J. Genov; R. Mitova; P. Gecov; D. Svinarov; Shigetaka Yoshinaga, Japan; T. Itoi; K. Yamao; I. Yasuda; B. Golemanov A. Irisawa; H. Imaoka; T. Tsuchiya; S. Doi; A. Yamabe; P0099 Y. Murakami; H. Ishikawa; Y. Saito GENOME ANALYSIS WITH WHOLE EXOME SEQUENCING P0105 TO IDENTIFY GENETIC ALTERATIONS IN PATIENTS ECHOENDOSCOPIC ETHANOL ABLATION OF TUMOR WITH IDIOPATHIC PANCREATITIS COMBINED TO CELIAC PLEXUS NEUROLYSIS IN PATIENTS Jun Kyu Lee, South Korea; J. J. Hyun; J. H. Moon; T. J. WITH PANCREATIC ADENOCARCINOMA Jeon; B.-K. Son; S. H. Lee; K. H. Lee; D. K. Jang; W. H. Antonio Facciorusso, Italy; M. Di Maso; N. Muscatiello Paik; C. W. Park P0106 P0100 INTRAOPERATIVE US IS THE MAIN TOOL FOR MAKING PREVALENCE OF EXOCRINE PANCREATIC INSUFFICIENCY DECISION ON ARTERIAL RECONSTRUCTION DURING IN PATIENTS WITH CHRONIC PANCREATITIS WITHOUT DP-CAR. EXPERIENCE OF 20 MODIFIED APPLEBY PRO- FOLLOW-UP: NUTRITIONAL STATUS AND QUALITY OF CEDURES LIFE. PANCR-EVOL STUDY Viacheslav Ivanovich Egorov, Russia; R. Petrov; N. C. Marra-Lopez; E. Marín; F. Bolado; Spain; M. Francisco Starostina; T. Zhurenkova; M. Petukhova; J. Zhurina González; E. Martínez-Moneo; J. Millastre; A. Hernández Martín; A. Del Pozo-García; E. Pérez Rodríguez; E. P0107 Labrador; M. L. Orera Peña; E. de-Madaria PANCREATIC CANCER IN PATIENTS WITH AUTOIMMUNE PANCREATITIS: A SCOPING REVIEW P0101 Peter Macinga, Czech Republic; T. Hucl; M. Del Chiaro; CLINICAL FEATURES OF ACUTE OBSTRUCTIVE SUP- M. Löhr PURATIVE PANCREATIC DUCTITIS: A RETROSPECTIVE REVIEW OF 20 CASES P0108 Hiromu Kondo, Japan; I. Naitoh; K. Hayashi; T. Ban; K. KEY ENDOSCOPIC ULTRASOUND FINDINGS USEFUL FOR Miyabe; Y. Nishi; M. Yoshida; S. Umemura; Y. Hori; M. DIFFERENTIATING INVASIVE CARCINOMA FROM NON-IN- Natsume; A. Kato; H. Ohara; T. Joh VASIVE HIGH-GRADE DYSPLASIA IN PANCREATOBILIARY TYPE INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS P0102 OF THE PANCREAS THE INFLUENCE OF ERYTHROPOETIN ON APOPTOSIS AND Takashi Osoegawa, Japan; A. Aso; K. Nakamura; E. Ihara; FIBROSIS IN CHRONIC CERULEIN - INDUCED PANCREATI- H. Kubo; A. Goto; Y. Minoda; T. Ohtsuka; M. Nakamura; TIS IN RATS T. Ito Weronika Kazmierak, Poland; A. Korolczuk; G. Czechowska; J. Kurzepa; A. Boguszewska-Czubara; A. Madro P0109 ETHANOL VERSUS POVIDONE IODATE EUS-GUIDED FOR Pancreatic cancer: Clinical PANCREATIC CYSTIC LESIONS: A PROSPECTIVE AND COMPARATIVE STUDY P0103 Gabriela Paduani, Brazil; L. S. Hybner; J. G. G. G. D. A. L. COMPARISON OF REMNANT-INVAGINATION AND DUCT- Cabral; C. D. Nava; D. GARCIA; R. Kemp; J. S. dos Santos; TO-MUCOSA PANCREATICOJEJUNOSTOMY FOLLOWING J. C. Ardengh WHIPPLE'S RESECTION: PROSPECTIVE RANDOMIZED TRIAL IN PATIENTS AT HIGH RISK OF POSTOPERATIVE P0110 PANCREATIC FISTULA NONINVASIVE NOVEL THERAPY OF HIGH-INTENSITY M. Del Chiaro; S. Sanjeevi; B. Björnsson; J. Sand; T. FOCUSED ULTRASOUND (HIFU) FOR UNRESECTABLE Gasslander; R. Segersvärd; Christoph Ansorge, Sweden PANCREATIC CANCER Atsushi Sofuni, Japan; M. Fujita; T. Sano; S. Asai; T. Tsuchiya; S. Tsuji; R. Tanaka; K. Kamada; R. Tonozuka; M. Honjo; S. Mukai; K. Yamamoto; Y. Matsunami; T. Itoi

124 Poster in the Spotlight Poster of Excellence Clinical Case Session 125 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0111 P0117 SERIES OF 44 OPERATED PANCREATIC MUCINOUS CYS- DIAGNOSTIC YIELD OF ENDOSCOPIC ULTRASONOGRA- TIC LESIONS: CORRELATION BETWEEN MANAGEMENT PHY (EUS) FOR SUBMUCOSAL INVASION OF SUPER- RECOMENDATIONS (INTERNATIONAL, EUROPEAN AND FICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA AGA CONSENSUS) AND PATHOLOGICAL FINDINGS (ESCC), A POST HOC ANALYSIS OF MULTICENTER Judith Millastre Bocos, Spain; S. Espina; E. Martinez PROSPECTIVE CONFIRMATORY STUDY (JCOG0508) Moneo; G. Muñoz Gonzalez; E. Bajador Andreu Tomohiro Kadota, Japan; K. Minashi; J. Mizusawa; M. Wakabayashi; T. Yano; Y. Ezoe; T. Tsuchida; H. Ono; P0112 T. Iizuka; N. Hanaoka; I. Oda; Y. Morita; M. Tajika; J. PREDICTING FACTORS FOR UNRESECTABILITY IN Fujiwara; C. Katada; S. Hori; K. Takizawa; H. Katayama; PATIENTS WITH LOCALIZED PANCREATIC CANCER AND K. Nakamura; H. Fukuda; M. Muto SELECTIVE USE OF STAGING LAPAROSCOPY Hee Seung Lee, South Korea; S. Bang P0118

WITHDRAWN 2016 17, October Monday, Endoscopy, upper GI P0119 MODIFIED PERORAL ENDOSCOPIC SHORTER MYOTOMY Poster Session FOR THE TREATMENT OF SIGMOID-TYPE ACHALASIA: A 10:30 - 17:00 Hall X4 PILOT STUDY Endoscopy and Imaging I X. Tang; Y. Ren; S. Huang; Q. Gao; Wei Gong, China P0113 P0120 USEFULNESS OF AN E-LEARNING SYSTEM FOR THE EFFICACY, RECURRENCE AND COMPLICATION RATES OF ENDOSCOPIC DIAGNOSIS OF EARLY GASTRIC CANCER ENDOSCOPIC MUCOSAL RESECTION VERSUS ENDOSCOPIC USING MAGNIFYING ENDOSCOPY WITH NARROW-BAND SUBMUCOSAL DISSECTION FOR EARLY BARRETT´S IMAGING: A RANDOMIZED CONTROLLED MULTICENTER NEOPLASIA: A RETROSPECTIVE GERMAN SINGLE CENTER STUDY ANALYSIS Koji Kojima, Japan; H. Doyama; H. Nakanishi; K. Yao; H. Christian Meinhardt, Germany; P. Troschel; A. Schütte; Ishikawa; H. Araki; H. Kashida; A. Hosokawa; H. Mori; H. R. P. Henke; H. Seifert Yamasita; O. Motohashi; K. Kobayashi; M. Hirayama; H. Kobayashi; M. Endo; H. Yamano; K. Murakami; T. Koike; P0121 K. Hirasawa; Y. Miyaoka; H. Hamamoto; T. Hikichi; N. ENDOSCOPIC HAND SUTURING FOR MUCOSAL DEFECT Hanabata; R. Shimoda; S. Hori; T. Sato; S. Kodashima; H. CLOSURE AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL Okada; T. Mannami; S. Yamamoto; Y. Niwa; K. Yashima; DISSECTION IN IN VIVO ANIMAL MODELS AND CLINICAL S. Tanabe; H. Satoh; M. Numata; T. Yamazato; Y. Ikeda; CASES H. Nishisaki; M. Nakagawa; A. Matsuda; F. Tamura; H. Osamu Goto, Japan; M. Sasaki; Y. Mitsunaga; T. Akimoto; Nishiyama; K. Arita; K. Kawasaki; K. Hoppo; M. Oka; S. A. Fujimoto; Y. Ochiai; T. Maehata; T. Nishizawa; H. Ishihara; M. Mukasa; H. Minamino; K. Uchita Takeuchi; Y. Kitagawa; N. Yahagi P0114 P0122 RANDOMIZED CONTROLLED TRIAL (RCT) OF DOPPLER IMPROVED VISIBILITY OF EARLY GASTRIC CANCER ENDOSCOPIC PROBE (DEP) ASSISTED TREATMENT COM- USING IMAGE-ENHANCED LASER ENDOSCOPY PARED TO STANDARD HEMOSTASIS OF SEVERE VARICE- Osamu Dohi, Japan; K. Terasaki; T. Nakano; T. Ueda; AL OR PORTAL HYPERTENSIVE LESION UGI BLEEDING N. Iwai; A. Majima; Y. Gen; T. Okayama; N. Yoshida; Dennis M. Jensen, USA; T. O. Kovacs; G. V. Ohning; K. Kamada; K. Uchiyama; T. Ishikawa; O. Handa; H. K. Ghassemi; G. Machicado; G. Dulai; A. Sedarat; R. Konishi; Y. Naito; Y. Itoh Jutabha; J. Gornbein P0123 P0115 EFFECT OF ANTICOAGULANTS ON THE RISK OF DE- RESULTS OF ENDOSCOPIC EN-BLOC RESECTION OF SUB LAYED BLEEDING AFTER GASTRIC ESD EPITHELIAL TUMORS: A SINGLE CENTRE STUDY Ryuichiro Iwasaki, Japan; T. Yoshio; H. Tomida; T. Amol Bapaye, India; M. R. Mahadik; N. A. Dubale; V. Yamada; E. Mita; T. Ninomiya; K. Michitaka; J. Fujisaki Vyas; R. Gaadhe; J. A. Bapaye P0124 P0116 DETECTION OF UPPER GASTROINTESTINAL BLEEDING ASSESSMENT OF THE SAFETY OF ENDOSCOPIC SUB- WITH A NOVEL TELEMETRIC SENSOR CAPSULE ("HE- MUCOSAL DISSECTION IN VERY ELDERLY PATIENTS MOPILL ACUTE") - A PROSPECTIVE PILOT STUDY Makoto Nishimura, Japan; J. Woo; Y. Fujii; Y. Kowazaki; Arthur Schmidt, Germany; M. Bauder; C. Kama; A. M. Matsukawa; J. Matsuoka Küllmer; B. Meier; K. Caca

Poster in the Spotlight Poster of Excellence Clinical Case Session 125

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0125 P0134 OVER-THE-SCOPE CLIP SYSTEM VERSUS ENDOLOOP UPPER GASTROINTESTINAL ENDOSCOPY IN GRAFT- COMBINED WITH METAL CLIPS APPLIED TO CLOSURE OF VERSUS-HOST DISEASE PERFORATION IN GASTRIC ENDOSCOPIC FULL-THICK- J. Lage; Sara Pires, Portugal; L. Afonso; C. Brandao; M.

Monday, October 17, 2016 NESS RESECTION: A SINGLE-CENTER PROSPECTIVE Dinis-Ribeiro COMPARISON STUDY P0135 C. Zhang; J. Hu; Q. Li; Mei-Dong Xu, China DIAGNOSIS OF TUMORS IN THE CERVICAL AND UPPER P0126 THORACIC ESOPHAGUS: EFFICACY OF ENDOSCOPIC TWO DIFFERENT ENDOSCOPIC LONG INTESTINAL TUBE ULTRASONOGRAPHY USING A JELLY-FILLING METHOD PLACEMENTS FOR SMALL : WITH WATER-SOLUBLE LUBRICATING JELLY;A RETRO- TRANSNASAL ULTRATHIN ENDOSCOPY VERSUS CON- SPECTIVE SINGLE CENTER TRIAL VENTIONAL ENDOSCOPY Noriko Matsuura, Japan; N. Hanaoka; R. Ishihara; M. Y. Chu; C. Zhang; Mei-Dong Xu, China Kato; K. Hamada; Y. Tonai; Y. Yamasaki; T. Kanesaka; S. Yamamoto; T. Akasaka; Y. Takeuchi; K. Higashino; N. P0127 Uedo; H. Iishi RISK FACTORS FOR RECURRENCE OF UPPER GASTROIN- TESTINAL BLEEDING P0136 Juliana Pinho, Portugal; J. Fernandes; D. Martins; THE STUDY OF THE RESULTS OF DUODENOSCOPE P. Sousa; R. Cardoso; E. Cancela; R. Araújo; A. CHANNELS BY DIFFERENT DISINFECTION METHODS Castanheira; P. Ministro; A. Silva Su Ma, China; H. Xi P0128 P0137 INGESTED FOREIGN BODIES AND FOOD IMPACTIONS: ERGONOMICS OF ENDOSCOPY:PRE AND POST VIDEO RETROSPECTIVE ANALYSIS OF 383 CASES TRAINING EVALUATION OF GI FELLOWS' AWARENESS Rosa Coelho, Portugal; H. Ribeiro; A. Peixoto; M. Silva; OF OCCUPATIONAL INJURY DUE TO ENDOSCOPY AND J. Lage; R. Morais; A. Corte-Real Nunes; G. Macedo BEST PRACTICES FOR PREVENTION Ali Ahmed, USA; A. G. Martinez-Alcala; T. Abdi; K. P0129 Mönkemüller; H. Aslanian ENDOSCOPIC FULL-THICKNESS RESECTION OF UPPER AND LOWER GASTRO-INTESTINAL LESIONS USING A NEW, FLAT P0138 BASED OVER-THE-SCOPE-CLIP; A FEASIBILITY STUDY OBSERVER AGREEMENT AMONG NOVICES IN IMAGE Wouter Kappelle, The Netherlands; Y. Backes; L. M. G. ASSESSMENT OF BARRETT'S ESOPHAGUS USING A Moons; F. P. Vleggaar SIMPLIFIED NARROW-BAND IMAGING CLASSIFICA- TION: A RETROSPECTIVE MULTI-CENTER STUDY P0130 Yuichi Shimizu, Japan; K. Goda; M. Kato; A. Dobashi; ENDOSCOPISTS' BIOPSY RATE (EBR) AS A QUALITY IN- M. Takahashi; M. Kato DICATOR FOR DIAGNOSTIC OUTPATIENT GASTROSCOPY Wladyslaw Januszewicz, Poland; M. F. Kaminski; ; P. P0139 Wieszczy; J. Szlak; R. Serek; M. Rupinski; A. Mroz; L. ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPER- Wyrwicz; J. Regula FICIAL PROXIMAL ESOPHAGEAL NEOPLASIA IS HIGHLY SUCCESSFUL P0131 Zhang Yiqun, China; L. Yao; C. Zhang; Q. Li; W. Chen; ENDOSCOPIC ZENKER DIVERTICULOTOMY USING THE M. Cai; J. Hu; W. Qin; Y. Huang; T. Chen; P. Zhou; M. Xu WINDOW TECHNIQUE : A TECHNICAL TRICK TO IM- PROVE THE FIELD OF VIEW P0140 Laura Calavas, France; J. Rivory; S. Roman; J.C. Saurin; DETECTION OF NEOPLASIA IN BARRETT'S DISEASE WITH T. Ponchon; M. Pioche IMAGE ENHANCEMENT USING OE – AN EARLY EXPERIENCE Sneha John, Australia; D. Jones; H. Neumann P0132 ENDOSCOPIC DOUBLE-LAYER SUTURE FOR THE GASTRO– P0141 INTESTINAL WALL DEFECT AFTER FULL-THICKNESS DEVELOPMENT AND INITIAL VALIDATION OF A NEW RESECTION ENDOSCOPIC TRAINING MODEL FOR ADVANCED EN- Bingrong Liu, China; J.-T. Song; L.-Y. Tao DOSCOPIC PROCEDURES - THE HEAT INTERNATIONAL ENDOSCOPY STUDY P0133 Helmut Neumann, Germany; T. Buder; T. Rath; A. ENDOSCOPIC SEPTOTOMY IS A NOVEL TREATMENT FOR Nägel; W. Neuhuber CHRONIC LEAKS COMPLICATING LAPAROSCOPIC SLEEVE GASTRECTOMY Sigal Fishman, Israel; M. Shnell; N. Gluck; E. Santo

126 Poster in the Spotlight Poster of Excellence Clinical Case Session 127 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0142 P0150 A STUDY ON THE IMPACT FROM THE USE OF NAFAMO- ACCURACY OF MODERN ENDOSCOPIC IMAGING TO STAT MESILATE, A SYNTHETIC PROTEASE INHIBITOR, DETERMINE THE KUDO NEOPLASTIC PIT PATTERN OF AS AN ANTICOAGULANT FOR HEMODIALYSIS AFTER LARGE LATERALLY SPREADING COLONIC LESIONS (LSL) GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION ON David Tate, Australia; L. Desomer; H. Awadie; M. J. Bourke POST-ESD BLEEDING IN THE PATIENTS WITH END- STAGE RENAL DISEASE P0151 Kentaro Kojima, Japan; N. Toda; S. Kurosaki; K. Funato; THE CLINICAL SIGNIFICANCE OF SOLITARY LARGE S. Kawamura; Y. Karasawa; S. Maeshima; T. Ohki; M. SESSILE SERRATED ADENOMAS Seki; K. Tagawa Lobke Desomer, Australia; D. J. Tate; M. Jayanna; N. Burgess; M. Pellise; H. Awadie; D. McLeod; M. J. Bourke P0143 FEASIBILITY OF A STRUCTURED INTERNATIONAL ESD P0152 IMMEDIATE AND DELAYED BLEEDING AFTER COLD SNARE TRAINING PROGRAMME FOR INTERNATIONAL DOCTORS 2016 17, October Monday, IN JAPAN POLYPECTOMY: A PROSPECTIVE SINGLE-ARM TRIAL Jonas Woo, United Kingdom; Y. Kowazaki; J. Matsuoka; Noriko Matsuura, Japan; Y. Takeuchi; N. Uedo; M. Kato; M. Nishimura K. Hamada; Y. Tonai; Y. Yamasaki; T. Kanesaka; T. Akasaka; N. Hanaoka; K. Higashino; R. Ishihara; H. Iishi P0144 TREATMENT OUTCOMES OF ESOPHAGEAL SCC WITH MM P0153 INVASION COMPARING ENDSCOPIC RESECTION AND IMPACT OF LOW-VOLUME VERSUS STANDARD-VOLUME OPERATION BOWEL PREPARATION ON PARTICIPATION IN PRIMARY Toshiyuki Yoshio, Japan; S. Yoshimizu; T. Tomohiro; A. SCREENING COLONOSCOPY: A RANDOMIZED HEALTH Ishiyama; H. Osumi; T. Shimizu; J. Fujisaki SERVICES STUDY Malgorzata Pisera, Poland; R. Franczyk; P. Wieszczy; M. P0145 Polkowski; M. Rupinski; E. Kraszewska; J. Kobiela; A. DISCRIMINATING FACTORS FOR SIGNIFICANT BLEED- Chaber-Ciopinska; K. Janikowska; B. Krzeczewski; M. ING AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL Rupinska; M. Bretthauer; M. F. Kaminski; J. Regula DISSECTION NEEDING EMERGENT HEMOSTASIS Joo Hyun Lim, South Korea; S. G. Kim; J. P. Im; J. Choi; P0154 J. S. Kim; H. C. Jung NBI ENDOSCOPIC CRITERIA- A USEFULL TOOL TO CHAR- ACTERIZE COLONIC LESIONS IN CLINICAL PRACTICE P0146 Alina Boeriu, Romania; O. Pascarenco; D. Onisor; O. DIAGNOSTIC ACCURACY OF ENDOSCOPIC FORCEPS BI- Brusnic; E. D. Dobru OPSIES FOR SUPERFICIAL GASTROINTESTINAL LESIONS José Rodrigues, Portugal; L. Carvalho; M. Túlio; S. P0155 Marques; J. Carmo; P. Barreiro; C. Chagas KNIFE ASSISTED RESECTION OF RIGHT-SIDED COLONIC POLYPS: THE RIGHT WAY ROUND! P0147 Kesavan Kandiah, United Kingdom; S. Thayalasekaran; THE USE OF ENDOCLOT AS HEMOSTATIC POWDER F. J. Q. Chedgy; S. Subramaniam; R. Bhattacharyya; P. DURING GASTROINTESTINAL ENDOSCOPY Bhandari A. F. Hagel; M. Brix; P. Hempen; W. Dauth; M. F. Neur- ath; Martin Raithel, Germany P0156 EFFICACY OF SMALL AND LARGE VOLUME PREPARATIONS P0148 AS FREELY CHOSEN BY PATIENTS TO OBTAIN A CLEAN CLINICAL APPLICATION OF ENDOSCOPIC MINIMALLY COLON: ROLE OF VOLUMES, TIME DISTRIBUTION, DEMO- INVASIVE THERAPEUTIC TECHNIQUES FOR UPPER GRAPHIC AND CLINICAL PARAMETERS IN A PROSPEC- GASTROINTESTINAL SUBMUCOSAL TUMORS TIVE, OBSERVER-BLINDED OBSVERVATIONAL STUDY Xiaoteng Wang, China; S. Zhang; B. Lu Paola Soriani, Italy; S. Vavassori; M. Vecchi; F. Ambrogi; V. Milani; F. Bagolini; L. Pastorelli; L. Spina; G. E. Tontini Endoscopy, colon P0157 P0149 IMPACT OF FULL SPECTRUM ENDOSCOPY (FUSE® INDIVIDUAL SKILLS PARAMETERS ASSOCIATED WITH ENDOCHOICE®) IN ADENOMAS DETECTION: FIRST COMPETENCY AT COLONOSCOPIC POLYPECTOMY: A FRENCH PROSPECTIVE STUDY RETROSPECTIVE ANALYSIS OF DIRECTLY OBSERVED Jean Philippe Ratone, France; E. Bories; F. Caillol; C. POLYPECTOMY SKILLS (DOPYS) Pesenti; S. Godat; F. Sellier; S. Hoibian; M. Landon; C. Arun Rajendran, United Kingdom; S. Thomas-Gibson; Servajean; C. De Cassan; V. Lestelle; J.-P. Casanova; M. P. Dunckley; N. Sevdalis; A. Haycock Giovannini

Poster in the Spotlight Poster of Excellence Clinical Case Session 127

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0158 P0165 A PREDICTION SCORE TO IDENTIFY PATIENTS AT RISK PILOT RESULTS OF THE ECQI SELF-ASSESSMENT QUES- FOR INADEQUATE BOWEL PREPARATION EVALUATED TIONNAIRE TO EVALUATE QUALITY IN COLONOSCOPY IN BY A SELF-ADMINISTERED QUESTIONNAIRE EUROPE

Monday, October 17, 2016 Arthur Berger, France; E. Cesbron Metivier; S. Bertrais; Rodrigo Jover Martínez, Spain; A. Agrawal; P. Amaro; N. Dib; D. Luet; A. Olivier; A. Lannes; F. Foubert; F.-X. L. Brink; I. Demedts; P. Eisendrath; W. Fischbach; M. Caroli-Bosc Hünger; A. Ono; L. Petruzziello; E. Toth; A. Naidoo; C. Spada; J. F. Riemann P0159 EFFECTIVENESS OF ENDOSCOPIC SUBMUCOSAL DISSEC- P0166 TION USING THE "CLIP-FLAP METHOD" FOR SUPERFI- THERAPEUTIC STRATEGY OF ESD FOR COLORECTAL CIAL COLORECTAL TUMORS TUMORS ACCOMPANIED BY SEVERE DEGREE FIBROSIS Katsumi Yamamoto; Japan; S. Hayashi; H. Saiki; T. IN THE SUBMUCOSAL LAYER Nishida; N. Tatsumi; T. Michida; T. Ito Yoshiro Tamegai, Japan; H. Osumi; T. Kishihara; F. Tagao; A. Chino; S. Saito; M. Igarashi P0160 ENDOSCOPIC SUBMUCOSAL DISSECTION IN A WESTERN P0167 SETTING: RESULTS AND LEARNING CURVE PROGRESS "OVER-THE-SCOPE" CLIP (OTSC) DECREASES THE SUR- FROM A PROSPECTIVE SERIES OF 118 CASES IN TWO GERY RATE IN THE MANAGEMENT OF IATROGENIC PERFO- CENTERS RATIONS OCCURRING DURING ENDOSCOPIC PROCEDURES M. Lopez Gomez; M. Hernández Conde; J. Santiago; C. Sherine Khater, France; G. Rahmi; E. Samaha; L. González Lois; P. Matallanos; E. Blazquez; J. Fernández Abbes; H. Benosman; G. Malamut; C. Cellier Rial; J. Garcia; J. L. Calleja; L. Abreu; Alberto Herreros de Tejada, Spain P0168 CURRENT STATUS OF ERAT IN THE MANAGEMENT P0161 OFACUTE APPENDICITIS IN CHINA EXPECTED DIAGNOSTIC PERFORMANCE OF JOINT USE Bingrong Liu, China; X. Ma OF FECAL IMMUNOCHEMICAL TEST AND FLEXIBLE SIGMOIDOSCOPY IN COLORECTAL CANCER SCREENING P0169 Tobias Niedermaier, Germany; K. J. Weigl; M. Hoffmeister; SURVEILLANCE AFTER COLORECTAL CANCER RESEC- H. Brenner TION: THE ROLE OF COLONOSCOPY Rita Vale Rodrigues, Portugal; J. P. da Silva; I. Rosa; I. P0162 Santos; N. Pereira; C. Soares; A. Dias Pereira IS HYBRID ENDOSCOPIC SUBMUCOSAL DISSECTION EF- FECTIVE FOR TREATMENT OF LARGE NON-PEDUNCULAT- P0170 ED COLORECTAL POLYPS? A SINGLE CENTER EXPERIENCE BEYOND WHITE LIGHT: EMBARKING ON THE FIRST EX- Hao Ran Cheng, The Netherlands; R. M. M. Bogie; C. PERIENCE WITH THE NEW GREEN-RED-ORANGE LIGHT J. Huysentruyt; A. A. Masclee; S. Sanduleanu; J. W. A. OPTICAL ENHANCEMENT MAGNIFICATION COLONOS- Straathof COPY TO DEFINE SUBTLE INFLAMMATORY CHANGES IN ULCERATIVE COLITIS PATIENTS P0163 Marietta Iacucci, Canada; X. Gui; O. Akinola; R. APPROPRIATENESS AND YIELD OF SURVEILLANCE COLO- Panaccione; S. Ghosh NOSCOPY IN FIRST-DEGREE RELATIVES OF COLORECTAL CANCER PATIENTS: A 5-YEAR FOLLOW-UP STUDY IN A P0171 POPULATION-BASED SCREENING PROGRAM REMOVAL OF DIMINUTIVE COLORECTAL POLYPS: A PRO- Franco Armelao, Italy; R. Pertile; I. Avancini; R. Franch; SPECTIVE RANDOMIZED COMPARATIVE STUDY BETWEEN G. Miori; G. Franceschini; D. Giacomin; C. Pravadelli; COLD SNARE POLYPECTOMY AND HOT FORCEPS BIOPSY E. Tasini; A. Meggio; C. Tieppo; K. Faitini; P. Orlandi; R. Yoriaki Komeda, Japan; H. Kashida; T. Sakurai; K. Manfrini; F. Ridolfi; G. de Pretis Okamoto; M. Kono; R. Tanaka; M. Yamada; T. Adachi; H. Mine; T. Nagai; Y. Asakuma; S. Matsui; M. Kudo P0164 P0172 PREVALENCE AND SEX SPECIFIC DIFFERENCES IN LOCALIZATION OF SERRATED POLYPS WITHIN A LARGE A 5.9MM ENDOSCOPE CAN RELIEVE ABDOMINAL PAIN AUSTRIAN COLORECTAL CANCER SCREENING COHORT EFFECTIVELY IN UNSEDATED WATER-AIDED COLONOS- Daniela Sallinger, Austria; E. Waldmann; B. Majcher; COPY A. Dokladanska; M. Trauner; M. Ferlitsch S. Lee; Youlin Yang, China

128 Poster in the Spotlight Poster of Excellence Clinical Case Session 129 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0173 P0180 A COMPARATIVE STUDY OF PROPOFOL VERSUS PROPO- COMBINATION ENDOSCOPIC THERAPY USING ENDO- FOL-FENTANYL FOR SEDATED COLONOSCOPIES BY SPONGE AND OVER-THE-SCOPE-CLIP TO TREAT LARGE NON-ANESTHESIOLOGIST ENDOLUMINAL GI DEFECTS WITH INTRA-PERITONEAL Linette Achécar Justo, Spain; I. Blazquez Gomez; M. Del OR THORACIC ABSCESSES Río Izquierdo; X. Garcia Aguilera; A. González Pino; J. Juan Gutierrez, USA; Á. Martínez-Alcalá; P. T. Kroener; Pérez Lasala; M. Van Domselaar H. Neumann; K. Mönkemüller P0174 P0181 DIAGNOSTIC ABILITY OF AUTOMATED DIAGNOSIS HIGH COMPLETE RESECTION RATE FOR PRE LIFT AND SYSTEM USING ENDOCYTOSCOPY FOR INVASIVE COL- COLD BIOPSY OF DIMINUTIVE COLORECTAL POLYPS ORECTAL CANCER S. A. O'Connor; R. Valori; R. Carr; Trevor Brooklyn, Kenichi Takeda, Japan; S. Kudo; Y. Mori; S. Kataoka; United Kingdom; P. Dunckley; T. Somarathna; C. Foy; L.

Y. Maeda; H. Nakamura; M. Misawa; T. Kudo; K. Adamczyk; N. Shepherd; J. Anderson 2016 17, October Monday, Wakamura; H. Miyachi; A. Katagiri; T. Baba; E. Hidaka; F. Ishida; H. Inoue P0182 ASSESSMENT OF THE PATIENTS' PERCEPTIONS AFTER P0175 AN OUTPATIENT COLONOSCOPY AND THE QUALITY EXTRA WIDE ANGLE VIEW COLONOSCOPE (EWAVE) HAS PROCEDURE SUPERIOR POLYP DETECTION RATE WHEN COMPARED Maria Isabel Portillo Villares, Spain; I. Idigoras Rubio; TO A STANDARD COLONOSCOPE (SD): A RANDOMISED E. Arana-Arri; L. Bujanda Fernández de Piérola; I. TANDEM PRE-CLINICAL STUDY Bilbao; I. Indart; I. Ortega; L. Martínez-Indart Rajaratnam Rameshshanker, United Kingdom; A. Wilson; P. Tekkis; B. P. Saunders P0183 COLD SNARING POLYPECTOMY IS A BETTER PROCE- P0176 DURE FOR RESECTING THE DIMINUTIVE COLON POLYP THE FREQUENCY OF THE INAPPROPRIATE CONVERSION Hideyuki Chiba, Japan; M. Nishimura; J. Tachikawa; D. FROM COLONOSCOPY TO SIGMOIDOSCOPY AND ITS Kurihara; T. Suto; N. Kawano; K. Ashikari; M. Kaai; S. POTENTIAL EFFECT ON QUALITY INDICATORS Seki; T. Ida; T. Morohashi; T. Goto Sabina Beg, United Kingdom; S. Sansone; J. Schembri; J. Patel; M. H. Thoufeeq; G. Corbett; K. Ragunath P0184 THE ROLE OF ENDOSCOPIC SUBMUCOSAL DISSECTION P0177 IN EARLY-STAGE LOWER RECTAL TUMOUR TREATMENT CORRELATION BETWEEN ADENOMA DETECTION RATE Tadateru Maehata, Japan; T. Akimoto; A. Fujimoto; Y. AND SERRATED ADENOMA DETECTION RATE IN AN Ochiai; T. Nishizawa; O. Goto; T. Uraoka; N. Yahagi UNSELECTED POPULATION Sneha John, Australia; S. Stanley; D. Jones Endoscopy, ERCP P0178 P0185 RISK FACTORS FOR DELAYED BLEEDING AFTER METAL OR PLASTIC STENTS TO RELIEVE OBSTRUCTIVE ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR JAUNDICE PRIOR TO RESECTION OF PERIAMPULLARY COLORECTAL TUMORS IN JAPANESE PATIENTS RISK TUMORS RESULTS OF A PROSPECTIVE RANDOMIZED, FACTORS FOR DELAYED BLEEDING AFTER ENDOSCOPIC DOUBLE BLIND CLINICAL STUDY SUBMUCOSAL DISSECTION (ESD) FOR COLORECTAL Greger Olsson, Sweden; F. Frozanpor; L. Lundell; TUMORS IN JAPANESE PATIENTS L. Enochsson; J. Blomberg; C. Ansorge; Takashi Yoshimine, Japan; N. Ogasawara; T. Simmura; M. Reuterwall-Hansson; U. Arnelo H. Noda; Y. Kondou; S. Izawa; M. Ebi; Y. Funaki; M. Sasaki; K. Kasugai P0186 IMPACT OF DISCONNECTED PANCREATIC DUCT P0179 SYNDROME ON THE ENDOSCOPIC MANAGEMENT OF EFFICACY AND SAFETY OF THE NOVEL 1L PEG AND PANCREATIC FLUID COLLECTIONS ASCORBATE BOWEL PREPARATION NER1006 VERSUS Ji Young Bang, USA; M. Hasan; U. Navaneethan; P. STANDARD 2L PEG WITH ASCORBATE IN OVERNIGHT OR Arnoletti; R. Hawes; S. Peter; J. Christein; C. M. Wilcox; MORNING SPLIT-DOSING ADMINISTRATION: RESULTS S. Varadarajulu FROM THE PHASE 3 STUDY MORA Raf Bisschops, Belgium; J. Manning; L. B. Clayton; R. Ng Kwet Shing; M. A. Álvarez-González

Poster in the Spotlight Poster of Excellence Clinical Case Session 129

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0187 P0194 A NEW MODEL OF ACUTE OBSTRUCTIVE JAUNDICE COMPARISON OF ERCP SUCCESS RATE IN EST-NAÏVE MANAGEMENT IN THE EMERGENCY DEPARTMENT PATIENTS WITH ADVANCED AND NON-ADVANCED LIVER Veronica Ojetti, Italy; V. Perri; C. Petruzziello; A. Tringali; CIRRHOSIS

Monday, October 17, 2016 D. Sinatti; A. Gasbarrini; G. Costamagna; F. Franceschi Jongchan Lee, South Korea; J.-C. Lee; H. W. Kim; J.-H. Hwang; J. Kim P0188 SINGLE OPERATOR DIGITAL CHOLANGIOSCOPY (SODC): P0195 MULTICENTER EXPERIENCE IN 300 PATIENTS EFFICACY AND SAFETY OF LEFT LATERAL POSITION FOR Isaac Raijman, USA; P. Tarnasky; P. Kedia; R. Shah; D. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATO– Nguyen; D. Fishman; A. Desai; S. Patel; U. Mondal; I. GRAPHY Rosenkranz; R. Z. Sharaiha; A. Tyberg; M. Kahaleh Tae Young Park, South Korea; J. H. Yoon; Y. J. Yang; S. P. Shin; C. S. Bang; K. T. Suk; G. H. Baik; D. J. Kim P0189 EXTERNAL VALIDATION OF THE EGSE'S CRITERIA ON P0196 DIFFICULT ENDOSCOPIC BILIARY CANNULATION: IDEN- QUALITY OF ERCP IN A DISTRICT GENERAL HOSPITAL IN TIFYING OPTIMAL TIMING FOR A RESCUE TECHNIQUE UNITED KINGDOM Yoon Suk Lee, South Korea; K. B. Cho; C.-M. Cho; M. K. Mohamed Eisa, United Kingdom; K. Amin; T. Thomas; Jung; T. N. Kim; K.-H. Kim; H. G. Kim; J. Han; D. W. Lee; I. Khan H.-S. Kim; K. Daejin; K. S. Park; J. Y. Lee; Y. J. Lee P0197 P0190 ENDOSCOPIC PAPILLARY LARGE BALLOON DILATATION EVALUATION OF LEARNING CURVE FOR NEEDLE KNIFE (EPLBD) FOR EXTRACTION OF COMMON BILE DUCT PRECUT SPHINCTEROTOMY STONES James Li, Singapore; T.-L. Ang M. Alsenbesy; Mohamed Said, Egypt; M. A. Sobh; H. A. El-Amien P0191 EFFICACY AND SAFETY OF DILATION-ASSISTED STONE Endosonography EXTRACTION (DASE) PLUS SPHINCTEROTOMY (EST) IN PATIENTS WITH COMMON BILE DUCT LARGE STONES: A P0198 RETROSPECTIVE MULTICENTER STUDY COST-EFFECTIVENESS OF CYANOACRYLATE GLUE Roberto Di Mitri, Italy; G. M. Pecoraro; S. Pallio; A. INJECTIONS VERSUS ENDOSCOPIC ULTRASOUND GUIDED Anderloni; C. Luigiano; F. Mocciaro; A. Tortora; C. Zulli; TREATMENT IN THE MANAGEMENT OF GASTRIC VARICES S. Sferrazza; F. Tinè; A. Maurano Carlos Robles-Medranda, Ecuador; M. Valero; M. Puga; J. Ospina; M. Soria; H. Alvarado; H. Pitanga Lukashok P0192 CORRELATION OF MAGNETIC RESONANCE IMAGING P0199 WITH MARKERS OF DISEASE ACTIVITY AND PROGRES- FIDUCIAL MARKER PLACEMENT (FMP) FOR IMAGE- SION IN PRIMARY SCLEROSING CHOLANGITIS GUIDED RADIATION TREATMENT: EVALUATION OF THE Andrea Tenca, Finland; K. Lind; E. Lantto; H. Mustonen; IMPACT FOR RADIOTHERAPY IN OESOPHAGEAL AND S. Boyd; J. Arola; M. A. Färkkila RECTAL CANCER (FIDUCOR STUDY) Fabrice Caillol, France; M. Giovannini; A. Auttret; E. P0193 Bories; C. Pesenti; C. de Chaisemartin; J. P. Ratone; B. MANAGEMENT OF BILIARY ANASTOMOTIC STRICTURES Lelong; J. Guiramand; J. L. Raoul; A. Tallet; L. Moureau AFTER LIVER TRANSPLANTATION (BASALT STUDY): A NATIONWIDE ITALIAN SURVEY P0200 P. Cantù; Ilaria Parzanese; Italy; V. Balassone; A. Di HIGH YIELD OF CORE TISSUE FOR HISTOLOGICAL ANAL- Sario; F. Soggiu; G. Lombardi; F. Barbaro; A. Pisani; YSIS WITH HIGH DIAGNOSTIC ACCURACY OF EUS-FINE A. Baldan; G. Cariani; V. Boarino; A. Fasoli; H. Bertani; NEEDLE BIOPSY USING THE 22G AND 25G SHARKCORETM E. Forti; M. Bulajic; D. Ghinolfi; E. Nadal; A. Cerofolini; NEEDLES: A MULTICENTER RETROSPECTIVE STUDY L. Barresi; G. Catalano; I. Stroppa; S. Traini; V. Mazzaferro; Mihai Rimbas, Romania; F. Attili; A. Fantin; C. Fabbri; S. L. Cipolletta; A. Tringali; G. Costamagna; P. Ravelli; Carrara; G. Gibiino; L. Di Maurizio; A. Repici; A. Larghi F. Bazzoli; A. Merighi; M. C. Parodi; R. L. Conigliaro; M. Mutignani; M. Zilli; F. Filipponi; A. Fantin; L. Rodella; P0201 I. Tarantino; M. Traina; M. Salizzoni; R. Rosa; UTILITY OF CONTRAST-ENHANCED ULTRASONOGRAPHY F. Malinverno; F. Invernizzi; M. Manini; M. F. Donato; FOR DIFFERENTIAL DIAGNOSIS OF BILIARY TRUCT M. Colombo; D. Conte; G. Rossi; R. Penagini DISEASE Haruo Miwa, Japan; K. Sugimori; K. Sanga; Y. Goda; K. Irie; T. Ishii; T. Kaneko; K. Numata; K. Tanaka; S. Made

130 Poster in the Spotlight Poster of Excellence Clinical Case Session 131 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0202 P0209 ETOMIDATE VERSUS PROPOFOL ADMINISTRATION CAPSULE ENDOSCOPY SCORES FOR ASSESSMENT OF DURING ENDOSCOPIC ULTRASONOGRAPHIC PROCE- INFLAMATORY ACTIVITY OF SMALL-BOWEL IN CROHN'S DURES: A PROSPECTIVE DOUBLE-BLINDED RANDOM- DISEASE IZED CONTROLLED TRIAL Ana Ponte, Portugal; R. Pinho; A. Rodrigues; J. Silva; J. S. W. Park; Jae Hyun Kim, South Korea P. Rodrigues; M. Sousa; J. Carvalho P0203 P0210 ENDOSCOPIC ULTRASOUND-GUIDED INJECTION OF THE SENSITIVITY OF THE PILLCAM SB3 VIDEO CAP- GEMCITABINE LOADED IRON OXIDE NANOPARTICLES SULE IN COMPARISON TO THE PILLCAM SB2 REGARD- IN THE PORTAL VEIN AS A THERAPEUTIC OPTION FOR ING THE DETECTION OF THE PAPILLA VATERI PANCREATIC CANCER METASTASES Ingo Steinbrueck, Germany; C. Rüther; F. Hagenmüller; Bogdan Ungureanu, Romania; D. Pirici; A. Fifere; C. J. Pohl

Teodorescu; A. Saftoiu 2016 17, October Monday, P0211 P0204 CLINICAL USEFULNESS OF CLASSIFICATION BY CAPSULE THE HIGH DIAGNOSTIC PERFORMANCE OF EUS-ASSIST- ENDOSCOPY FOR DETECTION OF RADIATION ED SINGLE- INCISION NEEDLE-KNIFE (SINK) BIOPSY MAY Tamotsu Sagawa, Japan; H. Otha; Y. Sato; Y. Okagawa; AVOID FURTHER ENDOSCOPIC FOLLOW-UP OF SMALL A. Sakurada; K. Hamaguchi; F. Tamara; T. Hayashi; K. UPPER SUBEPITHELIAL TUMORS Fujikawa; Y. Takahashi Carlos De La Serna Higuera, Spain; I. Peñas-Herrero; B. Madrigal-Rubiales; A. Loza; R. Sanchez-Ocana; P. P0212 Gil-Simon; M. Pérez-Miranda SMALL INTESTINE CAPSULE ENDOSCOPY FOR THE EVALUATION OF OBSCURE GASTROINTESTINAL BLEED- P0205 ING IN THE ELDERLY CLINICAL IMPACT OF EUS TREATMENT OF WOPN WITH Maiko Ogawa, Japan; R. Sawada; T. Nishimura; K. Tsut- DEDICATED DEVICES: A RETROSPECTIVE ANALYSIS sui; S. Kanba; D. Ide; T. Iwasaki; Y. Arai; J. Mitobe; M. Ilaria Tarantino, Italy; D. Ligresti; L. Barresi; A. Granata; Mitsunaga; S. Arihiro; M. Matsuoka; T. Kato; M. Saruta G. Curcio; M. Traina P0213 P0206 VALIDATION OF THE COMPUTED ASSESSMENT OF CONCORDANCE BETWEEN MAGNETIC RESONANCE CHOL- CLEANSING SCORE IN MIROCAM® CAPSULE ENDOSCO- ANGIO-PANCREATOGRAPHY (MRCP) AND ENDOSCOPIC PY SYSTEM ULTRASOUND FOR THE EVALUATION OF MORPHOLOGI- Ana Ponte, Portugal; R. Pinho; A. Rodrigues; J. Silva; CAL FEATURES OF CYSTIC PANCREATIC TUMORS M. Sousa; J. Carvalho Laura Uribarri González, Spain; J. Lariño-Noia; J. Iglesias-García; Y. K. Chin; R. García-Figueiras; P0214 C. Villalba; J. E. Domínguez-Muñoz CAPSULE ENDOSCOPY WITH PILLCAM SB2 VERSUS PILLCAM SB3: DID TECHNOLOGICAL IMPROVEMENT P0207 GRANT A STEP FORWARD IN CLINICAL PRACTICE? FACTORS INFLUENCING THE ACCURACY OF EUS-GUIDED Sofia Xavier, Portugal; S. Monteiro; J. Magalhães; B. TISSUE ACQUISITION FOR THE EVALUATION OF EN- Rosa; M. J. Moreira; J. Cotter LARGED LYMPH NODES S. Rebolledo Olmedo; Daniel De la Iglesia-García, Spain; Cross sectional imaging J. Iglesias-García; L. Díaz-Hernández; J. Lariño-Noia; I. Abdulkader; H. Lazare Iglesias; J. E. Domínguez-Muñoz; P0215 WHOLE LIVER CT TEXTURE ANALYSIS TO PREDICT Capsule endoscopy THE DEVELOPMENT OF METACHRONOUS COLORECTAL LIVER METASTASES - A MULTICENTRE STUDY P0208 Doenja M. Lambregts, The Netherlands; R. Beckers; PREP-LESS COLON CANCER SCREENING USING A NOVEL R. Schnerr; S.-X. Rao; A. Kessels; M. Maas; C. H. C. X-RAY IMAGING CAPSULE Dejong; G. L. Beets; C. Verhoef; R. G. H. Beets-Tan M. Moshkowitz; M. Jean; N. Gluck; D. Schwartz; J. Lechter; A. Milchem; Y. Ron; B. Shpak; R. Brun; T. Rösch; Nadir Arber, Israel

Poster in the Spotlight Poster of Excellence Clinical Case Session 131

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0216 Interventional radiology DEFINITION OF AGE DEPENDENT REFERENCE VALUES FOR DIAMETER OF THE COMMON BILE DUCT AND P0223 PANCREATIC DUCT ON MRCP FROM A POPULATION THE EVOLUTION OF THE ENDOSCOPE ASSISTED PER- CUTANEOUS TRANS-ESOPHAGEAL GASTRO-TUBING AS

Monday, October 17, 2016 BASED COHORT STUDY Georg Beyer, Germany; F. Kasprowicz; A. Hannemann; A NEW ALTERNATIVE TO THE PERCUTANEOUS ENDO- A. A. Aghdassi; H. Völzke; T. Kohlmann; M. M. Lerch; J. SCOPIC GASTROSTOMY: 86 SUCCESSFUL CASES P. Kühn; J. Mayerle Hideto Oishi, Japan P0217 P0224 A PILOT STUDY OF PROBE-BASED CONFOCAL LASER TRANS-RADIAL ACCESS FOR ENDOVASCULAR AB- ENDOMICROSCOPY FOR GASTROINTESTINAL NEO- DOMINAL INTERVENTIONS: A SAFE AND FEASIBLE PLASMS: AN INITIAL EXPERIENCE IN JAPAN TECHNIQUE Yusaku Tanaka, Japan; S. Abe; Y. Ohno; I. Oda; T. Louisa van Dijk, The Netherlands; D. Leemreis; J. Florie; Matsuda; K. Kaneko; Y. Saito M. J. Bruno; A. Moelker P0218 Oesophagus / stomach / THE DIAGNOSTIC PERFORMANCE OF CT IN DETECTING COLORECTAL PERITONEAL METASTASES Poster Session W. H. van Eden; Max Lahaye, The Netherlands; A. Delli 10:30 - 17:00 Hall X4 Pizzi; D. M. Lambregts; N. Kok; G. L. Beets; R. G. H. Surgery I Beets-Tan; A. Aalbers P0225 P0219 IMPROVEMENT IN GLUCOSE METABOLISM AFTER DIAGNOSTIC VALUE OF IMAGING FOR THE DETECTION BARIATRIC SURGERY: COMPARISON OF LAPAROSCOPIC OF PERITONEAL METASTASES: A META-ANALYSIS ROUX-EN-Y GASTRIC BYPASS AND DUODENOJEJUNAL Max Lahaye, The Netherlands; D. M. Lambregts; W. H. BYPASS LINER van Eden; G. L. Beets; A. Aalbers; I. Bekkers; W. van Sarah Guenthert, Germany; C. Stier; R. Weiner; J. Stein Driel; R. G. H. Beets-Tan P0226 P0220 THE EFFECT OF SLEEVE GASTRECTOMY ON ESOPHAGEAL MR IMAGING FOR DEDICATED LOCAL STAGING OF CHEMICAL CLEARANCE AND BASAL IMPEDANCE VALUES COLON CANCER Salvatore Tolone, Italy; E. Savarino; N. De Bortoli; M. E. Nerad; D. M. Lambregts; E. Kersten; F. Bakers; H. Frazzoni; M. Furnari; G. Bodini; I. Martinucci; S. Russo; van den Bosch; H. Grabsch; R. G. H. Beets-Tan; Max G. del Genio; V. Savarino; L. Docimo Lahaye, The Netherlands P0227 P0221 LONG TERM QUALITY OF LIFE AFTER ESOPHAGECTOMY THE ROLE OF ENDOSCOPY IN PATIENTS WITH GASTRO- WITH GASTRIC PULL-UP INTESTINAL WALL THICKENING DETECTED DURING Silvia Mantoan, Italy; F. Cavallin; E. Pinto; L. M. Saadeh; ROUTINE IMAGING R. Alfieri; M. Cagol; M. C. Bellissimo; C. Castoro; M. Scarpa Samuel Raimundo Fernandes, Portugal; L. A. Correia; L. C. Ribeiro; J. Velosa P0228 PROSPECTIVE RANDOMISED STUDY COMPARING P0222 BILLROTH II WITH BRAUN ANASTOMOSIS VERSUS TRANSPARENTIZATION TECHNOLOGY ENABLES US TO ROUX-EN-Y RECONSTRUCTION AFTER RADICAL DISTAL RECONSTRUCT THREE-DIMENSIONAL HISTOPATHO- GASTRECTOMY LOGICAL STRUCTURE OF GASTROINTESTINAL MUCOSA Siva Gavini, India; V. Vutukuru; K. Radhakrishna; S. NON-DESTRUCTIVELY: A PORCINE MODEL STUDY Parthasarathy Hiroya Mizutani, Japan; S. Ono; T. Ushiku; H. Onodera; Y. Kudo; M. Ikemura; N. Yamamichi; M. Fujishiro; T. P0229 Someya; M. Fukayama; K. Koike COMPARISON OF SHORT TERM OUTCOMES FOLLOWING TOTALLY LAPAROSCOPIC AND LAPAROSCOPIC ASSIST- ED DISTAL GASTRECTOMY FOR GASTRIC CANCER Sung Don Oh, South Korea; S. J. Oh; B. J. Suh

132 Poster in the Spotlight Poster of Excellence Clinical Case Session 133 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0230 Basic/pathogenesis/pathology EFFICACY OF ORAL VITAMIN B12 SUPPLEMENTATION AFTER TOTAL GASTRECTOMY - RESULTS FROM A Poster Session PROSPECTIVE STUDY 10:30 - 17:00 Hall X5 Joana Moleiro, Portugal; S. Mão Ferro; S. Ferreira; M. IBD I Serrano; M. Silveira; A. Dias Pereira P0238 Postoperative complications VOLUNTARY EXERCISE IMPROVES THE HEALING OF EX- PERIMENTAL COLITIS IN MICE FED DIET-INDUCED OBESI- P0231 TY. ESSENTIAL ROLE OF ENDOCRINE FACTORS RELEASED SEXUAL DISORDERS AFTER LOW ANTERIOR RESEC- FROM SKELETAL MUSCLES AND ADIPOSE TISSUE TION OF THE RECTUM J. Bilski; A. Mazur-Bialy; M. Magierowski; D. Wojcik; Martyna Szewczyk, Poland; J. Sobolewska; A. Nowak; J. B. Brzozowski; Z. Sliwowski; K. Magierowska; Tomasz- Wlodarczyk; M. Wlodarczyk; A. Dziki; L. Dziki Brzozowski, Poland 2016 17, October Monday, P0232 P0239 OUTCOME PREDICTORS AND TREATMENT OF BILIARY EICOSAPENTAENOIC ACID-FREE FATTY ACID SUPPLE- COMPLICATIONS POST LIVER TRANSPLANTATION MENTATION FOR THE PREVENTION OF COLITIS-ASSOCI- Y. J. Wong; J. H. J. Ngu; C. K. Tan; W. C. Chow; H. K. ATED COLORECTAL CANCER: A PHASE-I CLINICAL TRIAL Tan; H. F. Lui; P. C. Cheow; R. Prema; Y. F. A. Chung; Anna Prossomariti, Italy; E. Scaioli; C. Fazio; G. Piazzi; K. P. Brian Goh; H. G. R. Lo; F. G. Irani; Steven Joseph M. Bellanova; E. Biagi; M. Candela; P. Brigidi; T. Balbi; Mesenas, Singapore P. Chieco; A. Munarini; M. Minguzzi; F. Bazzoli; A. P0233 Belluzzi; L. Ricciardiello EMERGENCY LAPAROTOMY: STRATEGIES TO ACHIEVE P0240 INTERNATIONAL BENCHMARKS IN LOW - MIDDLE WITHDRAWN INCOME COUNTRIES (LMIC) Nitin Vashistha, India; S. Budhiraja; B. Agarwal; R. P0241 Tobin; K. Fotedar; D. Singhal ALTERATION IN MICROBIOTA COMPOSITION CON- TRIBUTES TO CHRONIC INFLAMMATORY RESPONSE P0234 TRIGGERED BY CROHN'S DISEASE-ASSOCIATED AIEC OUTCOME, COMORBIDITY, HOSPITALIZATION AND 30- INFECTION IN GCN2 DEFICIENT MICE DAYS MORTALITY AFTER PERFORATION CLOSURE BY Alexis Bretin, France; G. Dalmasso; N. Barnich; R. THE OVER-THE-SCOPE-CLIP (OTSC) IN AN UNSELECTED Bonnet; H. T. T. Nguyen COHORT OF PATIENTS Martin Raithel, Germany; H. Albrecht; W. Scheppach; P0242 M. Farnbacher; W. Haupt; A. F. Hagel; V. Schellerer; F. ANTI-INFLAMMATORY AND ANTIBACTERIAL EFFECTS Vitali; M. F. Neurath; T. Schneider OF HUMAN CATHELICIDIN ACTIVE FRAGMENT KR-12 – A NOVEL POTENTIAL THERAPY OF INFLAMMATORY P0235 BOWEL DISEASE WITHDRAWN Adam Fabisiak, Poland; N. Murawska; E. Kamysz; A. P0236 Chmielowiec-Korzeniowska; W. Kamysz; J. Fichna LONG TERM QOL AFTER ESOPHAGECTOMY: DO P0243 POST-OPERATIVE COMPLICATIONS MATTER? ANTI-TNFA ALTERS MOTIVATIONAL PROCESSING IN A. E. Slaman; L. M. Saadeh; S. Mantoan; S. S. Gisbertz; CROHN'S DISEASE PATIENTS F. Cavallin; E. Jezerskyte; E. Pinto; C. Caberlotto; R. M. Gray; C.-Y. Chao; D. Reutens; N. J. Talley; N. A. A. Alfieri; M. Cagol; C. Castoro;Mark Ivo van Berge Koloski; Gerald Holtmann, Australia Henegouwen, The Netherlands; M. Scarpa P0244 Paediatric surgery CO-ABUNDANCE OF AKKERMANSIA MUCINIPHILA AND FAECALIBACTERIUM PRAUSNITZII IN THE MUCOSA OF P0237 HEALTHY AND DISEASED GUT ELECTRICAL STIMULATION THERAPY OF THE LOWER Mireia Lopez-Siles, Spain; N. Enrich-Capó; M. ESOGHAGEAL SPHINCTER IN TREATING GASTRO- Sabat-Mir; X. Aldeguer; S. H. Duncan; J. Garcia-Gil; M. ESOPHAGEAL REFLUX DISEASE IN CHILDREN, OPEN Martinez-Medina LABEL PROSPECTIVE TRIAL Rodrigo Hipolito, Mexico; R. Carmona; A. Vega; P. Espinosa

Poster in the Spotlight Poster of Excellence Clinical Case Session 133

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0245 P0253 FLAGELLA EXPRESSION OF ADHERENT-INVASIVE ESCH- IONIZING DIAGNOSTIC RADIATION EXPOSURE IN ERICHIA COLI AND BACTERIA PERSISTENCE IN THE GUT PATIENTS WITH CROHN´S DISEASE: A RETROSPECTIVE Gwladys Sevrin, France; S. Massier; A. Agus; N. Barnich STUDY IN A MEDIUM HOSPITAL AND ITS PREDICTIVE

Monday, October 17, 2016 FACTORS P0246 Esther Merino Rodríguez, Spain; E. Carrera Alonso; M. PROTEOMIC MARKERS OF EARLY RELAPSE IN PA- Torralba González de Suso; S. Rebolledo Olmedo; M. TIENTS WITH ULCERATIVE COLITIS IN REMISSION Sánchez da Silva; M. Martínez López; M. D. Arash Assadsangabi, United Kingdom; C. Evans; D. Sánchez-Tembleque Zarandona Majumdar; B. M. Corfe; A. J. Lobo P0254 P0247 CLAUSII IN COLITIS: ROLE AND MECHANISMS OF AC- ANTIBIOTIC RESISTANCE PROFILES OF ADHERENT INVA- TION OF BACILLUS CLAUSII IN EXPERIMENTAL COLITIS SIVE E. COLI AND NON- PATHOGENIC E. COLI ISOLATED Franco Scaldaferri, Italy; C. Graziani; V. Petito; L. R. FROM CROHN'S DISEASE PATIENTS AND CONTROLS Lopetuso; G. Quaranta; M. Sanguinetti; L. Masucci; F. Margarita Martinez Medina, Spain; B. Ruiz del Castillo; Franceschi; A. Poscia; V. Arena; D. Scannone; G. Ianiro; N. Serrano-Morillas; J. Garcia-Gil; L. Martínez-Martínez G. Cammarota; A. Sgambato; A. Gasbarrini P0248 P0255 HYPOXIA POSITIVELY REGULATES EXPRESSION OF THE IBD PHENOTYPES DIFFER IN GUT MYCOBIOTA COMPO- PH-SENSING G-PROTEIN COUPLED RECEPTOR OGR1 SITION (GPR68) P. Drastich; Lukas Bajer, Czech Republic; K. Klimesova; C. de Valliere; Jesus Cosin-Roger, Switzerland; S. M. Kostovcik; M. Kverka; J. Brezina; J. Spicak Simmen; H. Melhem; J. Zeitz; M. Madanchi; I. Tcymbarevich; M. Fried; G. A. Kullak-Ublick; S. R. P0256 Vavricka; B. Misselwitz; K. Seuwen; C. A. Wagner; HIGHER DISEASE ACTIVITY IN ULCERATIVE COLITIS PA- J. J. Eloranta; G. Rogler; P. A. Ruiz-Castro TIENTS WITH ESBL PRODUCING ENTEROBACTERIACE- AE GUT COLONIZATION: PRELIMINARY STUDY RESULTS P0249 Vita Skuja, Latvia; K. Pekarska; Z. Straume; E. Goida; CORRELATION BETWEEN THE PRESENCE OF BAC- H. Dauvarte; D. Rudzite; E. Lavrinovica; A. Derovs; A. TEROIDETES AND FAECAL CALPROTECTIN FOR THE Lejnieks; A. Krumina DETECTION OF ENDOSCOPIC ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE P0257 I. Baston-Rey; R. A. Sueiro; Manuel Barreiro-de Acosta, THE PROTECTIVE EFFECT OF METFORMIN ON MATAIN- Spain; L. Uribarri González; R. Ferreiro Iglesias; J. M. ING INTESTINAL BARRIER FUNCTION IN COLITIS Leiro; J. E. Domínguez-Muñoz Y. Chen; Jun Deng, China P0250 Aetiology/epidemiology 15-D-PGJ2 AS A NEW REGULATOR OF HEPCIDIN EXPRES- SION AND ITS INVOLVEMENT IN IRON METABOLISM P0258 Julia Martin, Germany; S. Ulrich-Rueckert; J. Stein FAMILIAL AGGREGATION OF INFLAMMATORY BOWEL DISEASE ON THE FAROE ISLANDS - A FAROESE IBD P0251 COHORT STUDY EFFECT OF CIRCADIAN DISRUPTION ON INFLAMMA- Kari Rubek Nielsen, Faroe Islands; J. Olsen; G. TORY BOWEL DISEASE ACTIVITY: AN EXPERIMENTAL Andorsdóttir; E. Gislason; J. Burisch STUDY ON A DSS-INDUCED MICE COLITIS MODEL Joseph Amara, Lebanon; V. Smayra; Y. Saliba; J. Hajale; P0259 C. Beaini; J.-J. Bakhos; R. Sayegh; N. Farès MEDICAL THERAPY, SURGERY AND HOSPITALIZATION RATES DURING THE 2-AND 3-YEAR FOLLOW-UP OF P0252 THE 2011 ECCO-EPICOM COHORT THERAPEUTIC EFFECT OF GHRELIN IN ACETIC AC- Zsuzsanna Vegh, Hungary; J. Burisch; I. Kaimakliotis; D. ID-INDUCED COLITIS DEPENDS ON THE RELEASE OF Duricova; K. Carlsen; K. R. Nielsen; D. K. Christodoulou; ENDOGENOUS GROWTH HORMONE AND IGF-1 L. Lakatos; D. Schwartz; A. De Padova; G. Kiudelis; S. Zygmunt Warzecha, Poland; D. Ceranowicz; J. Turcan; F. Magro; A. Goldis; V. Hernandez; S. Bell; E. Cieszkowski; P. Ceranowicz; B. Kusnierz-Cabala; J. Langholz; P. Munkholm; P. L. Lakatos Bonior; J. Jaworek; K. Galazka; A. Dembinski

134 Poster in the Spotlight Poster of Excellence Clinical Case Session 135 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0260 Diagnosis and monitoring REAL-WORLD EPIDEMIOLOGY AND INITIAL TREAT- MENT PATTERNS OF PATIENTS NEWLY DIAGNOSED P0268 WITH INFLAMMATORY BOWEL DISEASE IN ISRAEL MRI REMISSION AFTER THERAPEUTIC INTERVENTION C. Weil; G. Chodick; A. Yarden; Javaria Mona Khalid, IS ASSOCIATED WITH MORE TIME SPENT IN CLINICAL United Kingdom; V. Shalev CORTICOSTEROIDS-FREE REMISSION AND DECREASED RISK OF SURGERY IN CROHN'S DISEASE P0261 Anthony Buisson, France; C. Hordonneau; F. Goutorbe; LONG TERM OUTCOMES AND PREDICTORS OF DIS- C. Allimant; M. Goutte; V. Petitcolin; G. Bommelaer ABLING DISEASE AND BOWEL DAMAGE OF A POPULA- TION-BASED COHORT OF INCIDENT CROHN'S DISEASE P0269 DIAGNOSED BETWEEN 1995 AND 1997 WITHDRAWN M.-L. Rabilloud; J.-F. Bretagne; E. Bajeux; M. P0270 Pagenault; A. Gerfaud; L. Siproudhis; J.-F. Viel; I. Tron; METABOLIC PROFILING OF URINE AND FAECES DIFFER- 2016 17, October Monday, M. Robaszkiewicz; Guillaume Bouguen, France ENTIATES INFLAMMATORY BOWEL DISEASE PHENOTYPE P0262 AND HAS IMPLICATIONS ON THERAPEUTIC RESPONSE IS CELIAC DISEASE AN UNRECOGNIZED RISK FACTOR Nik Sheng Ding, United Kingdom; M. Sarafian; P. FOR INFLAMMATORY BOWEL DISEASE? Hendy; R. Misra; L. Penez; E. Holmes; A. L. Hart Ayesha Shah, Australia; N. J. Talley; N. Koloski; D. P0271 Burger; N. Martin; M. M. Walker; G. J. Holtmann FINGER CLUBBING: HIGH PREVALENCE IN SEVERE P0263 SMALL BOWEL CROHN'S DISEASE IN A PROSPECTIVE OBJECTIVE ASSESSMENT OF PHYSICIAN TO PATIENT SINGLE-CENTER STUDY M. Cossignani; B. Neri; S. Romeo; A. Ruffa; E. Lolli; E. CONCORDANCE AND BIOPSYCHOSOCIAL IMPACT ON Calabrese; Livia Biancone, Italy PERTINENT PATIENT REPORTED OUTCOMES AND MED- ICATION COMPLIANCE IN PATIENTS WITH INFLAMMA- P0272 TORY BOWEL DISEASE PREVALENCE OF ULTRASONOGRAPHIC LOWER AND Che-Yung Chao, Canada; W. Afif; A. Bitton; G. Wild; C. UPPER ENTHESITIS IN PATIENTS WITH INFLAMMATO- Lemieux; T. Bessissow RY BOWEL DISEASE P0264 Dolores Sgambato, Italy; M. Verde; A. Miranda; V. D'Abrosca; E. Ferrante; A. Federico; M. Romano; G. THE ONLINE HEALTH CARE REVOLUTION AND THE Cuomo ASSOCIATION BETWEEN UNCERTAINTY AND QUALITY OF LIFE IN CROHN'S DISEASE P0273 Galia Niv, Israel; S. Bar; O. Ben-Bassat; I. Avni; L. COMBINED PET/MR ENTEROGRAPHY FOR THE Lictenstein; Y. Niv; S. Barnoy NON-INVASIVE ASSESSMENT OF INFLAMMATORY ACTIVITY IN CROHN'S DISEASE Genetics Jost Langhorst, Germany; K. Beiderwellen; Y. Li; B. Gomez; P. Heusch; L. Umutlu; T. Lauenstein P0265 ASSOCIATION BETWEEN AND MICRORNA P0274 EXPRESSION AFTER RESTORATIVE PROCTOCOLECTOMY PRO-MC COLLABORATION: ESTABLISHMENT OF A IN PATIENTS WITH ULCERATIVE COLITIS PROSPECTIVE REGISTRY FOR MICROSCOPIC COLITIS IN Emi Inoue, Japan; K. Hata; H. KImura; M. Masaru Shinozaki EUROPE - A UEG LINK AWARD PROJECT B. P. M. Verhaegh; L. K. Munck; P. J. Engel; H. Hjortswang; P0266 ª S. Miehlke; M. J. Pierik; Andreas Münch, Sweden VARIANTS OF IL23R GENE AND CROHN'S DISEASE. N. Ben Mustapha; Maroua Hafi, Tunisia; M. Serghini; P0275 A. Laabidi; M. Fekih; J. Boubaker; A. Filali A HISTOLOGICAL APPRAISAL OF HEPATOBILIARY DIS- ORDERS IN INFLAMMATORY BOWEL DISEASE P0267 Patrícia Andrade, Portugal; S. Lopes; J. Lopes; G. Macedo ASSOCIATION STUDY BETWEEN OCTN1 FUNCTIONAL HAPLOTYPES AND A PENETRATING BEHAVIOUR OF P0276 CROHN'S DISEASE IN A KOREAN POPULATION EVALUATION OF QUALITY OF LIFE AND PAIN IN PATIENTS Eun Suk Jung, South Korea; H. J. Park; J. H. Choi; J. H. WITH ULCERATIVE COLITIS USING IBDQ, SF-36 AND EQ- Cheon 5D - FIRST STEP OF PERSONALIZATION OF TREATMENT Antonia Atanassova, Bulgaria; V. Velikova

Poster in the Spotlight Poster of Excellence Clinical Case Session 135

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0277 P0285 CROSS-SECTIONAL STUDY OF THE LOW SERUM CON- HOME-TESTING OF FAECAL CALPROTECTIN USING THE CENTRATIONS OF TESTOSTERONE IN IBD AND THE IBDOCTM SYSTEM: A COMPARATIVE PILOT STUDY INFLUENCE ON DISEASE ACTIVITY I. Y. Liew; P. Pavlidis; L. Medcalf; L. M. Choong; G.

Monday, October 17, 2016 Tibor Hlavaty, Slovakia; A. Krajcovicova; J. Kollerova; T. Chung-Faye; P. Dubois; R. Sherwood; Bu Hayee, United Koller; Z. Leskova; I. Sturdik; J. Payer Kingdom P0278 P0286 TOWARDS A PROACTIVE THERAPEUTIC DRUG MONITOR- WITHDRAWN ING OF INFLIXIMAB - ASSESSMENT AND VALIDATION OF A NEW POINT-OF-CARE QUANTIFICATION DEVICE P0287 Joana Afonso, Portugal; S. Lopes; R. Gonçalves; P. Caldeira; TRABECULAR BONE SCORE IN PATIENTS WITH IN- P. Lago; H. Tavares de Sousa; J. Ramos; A. R. Gonçalves; FLAMMATORY BOWEL DISEASES P. Ministro; I. Rosa; A. Vieira; F. Ferreira; F. Magro Anna Krajcovicova, Slovakia; T. Hlavaty; Z. Killinger; M. Kuzma; I. Sturdik; Z. Leskova; J. Payer P0279 ADHERENCE TO RECOMMENDATIONS AND QUALITY OF P0288 ENDOSCOPIC COLORECTAL CANCER SURVEILLANCE IN AN AUDIT OF ENDOSCOPY IN ULCERATIVE COLITIS; LONG-STANDING ULCERATIVE COLITIS SHOULD ENDOSCOPY FOR INFLAMMATORY BOWEL Giulia Santi, Switzerland; P. Michetti; F. Froehlich; V. DISEASE (IBD) BE PERFORMED BY AN IBD SPECIALIST? Pittet; M. H. Maillard Alice Moore, United Kingdom; M. Lythgoe; F. Kallon; J. Mawdsley P0280 WITHDRAWN P0289 THE USE OF THE WHO FACTURE RISK ASSESSMENT P0281 TOOL (FRAX) IN PREDICTING RISK OF FRACTURES IN FECAL CALPROTECTIN LEVEL LOOKS PROMISING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A IDENTIFYING ACTIVE DISEASE IN BEHÇET'S SYNDROME SYSTEMATIC REVIEW PATIENTS WITH GASTROINTESTINAL INVOLVEMENT: A Alfredo Lucendo Villarin, Spain; B. Serrano-Montalbán; CONTROLLED AND PILOT STUDY A. B. Friginal-Ruiz; Á. Arias Arias Ali Ibrahim Hatemi, Turkey; S. N. Esatoglu; Y. Ozguler; G. Hatemi; A. Ferhat Çelik; H. Yazici P0290 DEVELOPMENT OF A NOVEL ENDOSCOPIC SCORING P0282 ª SYSTEM PREDICTING THE RELAPSE AFTER SURGERY LIVER FIBROSIS EVALUATION BY TRANSIENT ELASTOG- IN INTESTINAL BEHCET'S DISEASE RAPHY (FIBROSCAN®) IN PATIENTS WITH INFLAMMA- Jung Won Park, South Korea; H. J. Lee; S. J. Park; S. P. TORY BOWEL DISEASE Hong; T. I. Kim; W. H. Kim; J. H. Cheon Sahare El Mahjoubi, Morocco; W. Khannoussi; A. El Mekkaoui; Z. Ismaili; G. Kharrasse P0291 SIGNIFICANCE OF SEROLOGICAL MARKERS IN THE P0283 DISEASE COURSE OF ULCERATIVE COLITIS CORRELATION OF FECAL CALPROTECTIN AND G. Kovacs; N. Sipeki; K. Palatka; I. Altorjay; K. Fechner; LACTOFERRIN LEVELS WITH ULCERATIVE COLITIS G. L. Norman; Z. Shums; G. Veres; P. L. Lakatos; Mária ENDOSCOPIC INDEX OF SEVERITY AND MAGNIFYING Papp, Hungary ENDOSCOPIC STRATIFICATION IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION P0292 Mine Shoichiro, Japan; F. Takeshima; K. Matsushima; INTER-OBSERVER AGREEMENT IN BOWEL ULTRA- H. Minami; Y. Akazawa; N. Yamaguchi; K. Ohnita; H. SONOGRAPHY FOR DIAGNOSTIC ASSESSMENT IN Isomoto; K. Nakao PATIENTS WITH CROHN'S DISEASE Emma Calabrese, Italy; T. Kucharzik; C. Maaser; G. P0284 Maconi; D. Strobel; S. R. Wilson; F. Zorzi; K. L. Novak; THERAPEUTIC DRUG MONITORING OF INFLIXIMAB D. H. Bruining; M. Iacucci; M. Watanabe; E. Lolli; C. AND ADALIMUMAB FOR DETECTION OF PATIENTS Chiaramonte; S. B. Hanauer; R. Panaccione; F. Pallone; AT RISK OF LOSS OF RESPONSE IN INFLAMMATORY G. Monteleone; S. Ghosh BOWEL DISEASE J. González-López; Manuel Barreiro-de Acosta, Spain; J. M. Giráldez-Montero; R. Ferreiro Iglesias; M. J. Lamas-Díaz; J. E. Domínguez-Muñoz

136 Poster in the Spotlight Poster of Excellence Clinical Case Session 137 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0293 P0301 THE BRISTOL STOOL FORM SCALE AND A VISUAL ANA- IMMUNOGENICITY PROFILE AND PREDICTORS OF TLS LOGUE SCORE FOR ABDOMINAL PAIN MAY BE USED AS AND ADA DEVELOPMENT OF BIOSIMILAR INFLIXIMAB PATIENT REPORTED OUTCOME MEASURES IN CROHN'S DURING THE FIRST 6 MONTHS OF THE THERAPY: RE- DISEASE SULTS FROM A PROSPECTIVE NATIONWIDE COHORT Daniël Robin Hoekman, The Netherlands; M. Löwenberg; Barbara Dorottya Lovasz, Hungary; Z. Kurti; M. Rutka; G. R. van den Brink; C. Y. Ponsioen; M. A. Benninga; G. Z. Vegh; K. B. Gecse; P. A. Golovics; K. Farkas; J. Banai; R. A. M. D'Haens L. Bene; B. Gasztonyi; T. Kristof; L. Lakatos; P. Miheller; K. Palatka; A. Patai; A. Salamon; T. Szamosi; Z. Szepes; P0294 E. Biro; G. T. Toth; A. Vincze; T. Molnar; P. L. Lakatos PRESARCOPENIA SCREENING OF CROHN'S PATIENTS - GEN- DER AND BMI SPECIFIC BODY COMPOSITION ASSESSMENT P0302 Agnes Anna Csontos, Hungary; A. Molnár; I. Kovács; Á. RATE AND PREDICTORS OF MUCOSAL HEALING IN

D. Anton; E. Pálfi; P. Miheller PATIENTS WITH ULCERATIVE COLITIS TREATED WITH 2016 17, October Monday, THIOPURINES: RESULTS OF A MULTICENTRIC COHORT P0295 STUDY CAPSULE ENDOSCOPY CROHN'S DISEASE ACTIVITY Caroline Prieux-Klotz, France; S. Nahon; A. Amiot; L. INDEX (CDEAIIC OR NIV SCORE) FOR THE SMALL BOWEL Sinayoko; C. Galeano; S. Chaussade; P. Lahmek; V. AND THE COLON Abitbol Yaron Niv, Israel; M. Hershkovitz; L. Lichtenstein; V. Gabovitz; E. Gal; I. Avni P0303 EFFICACY AND SAFETY OF TNF ANTAGONIST FOR THE Treatment-medical TREATMENT OF INTERNAL FISTULIZING CROHN'S DISEASE P0296 A. Huguet; L. Siproudhis; V. Desfourneaux; J.-F. Bretagne; MUCOSAL HEALING: MAYO 0 VS 1 AFTER 3 YEARS F. Cholet; A. Boureille; Guillaume Bouguen, France Giuseppe Frieri, Italy; M. Di Ruscio; A. Capannolo; G. Latella; A. Pasetti; R. Tittoni; A. Viscido P0304 DIFFERENT INDUCTION RESPONSE CRITERIA DO NOT P0297 INFLUENCE 1 YEAR RESPONSE AND REMISSION RATES A POOLED SAFETY ANALYSIS FROM THE USTEKI- OF USTEKINUMAB 90 MG Q8W IN PHASE III PROGRAM NUMAB CROHN'S DISEASE AND PSORIATIC DISEASES Dominik Naessens, Belgium; J. Johanns; C. Gasink PHASE 2 AND 3 CLINICAL TRIAL PROGRAMS Subrata Ghosh, Canada; B. E. Sands; W. de Villiers; E. P0305 Ott; C. Gasink; Y. Lang; P. Szapary; D. Jacobstein; B. G. PREDICTING OF SHORT AND MEDIUM-TERM EFFICACY Feagan OF BIOSIMILAR INFLIXIMAB THERAPY. DO TROUGH LEVELS/ADAS OR CLINICAL/BIOCHEMICAL MARKERS P0298 PLAY A MORE IMPORTANT ROLE? SAFETY, PHARMACOKINETICS AND PHARMACODY- Petra Anna Golovics, Hungary; Z. Vegh; M. Rutka; K. NAMICS OF THE NOVEL ORAL PEPTIDE THERAPEUTIC B. Gecse; A. Balint; K. Farkas; J. Banai; L. Bene; B. PTG-100 (ALPHA4-BETA7 INTEGRIN ANTAGONIST) IN Gasztonyi; T. Kristof; L. Lakatos; P. Miheller; K. Palatka; NORMAL HEALTHY VOLUNTEERS A. Patai; A. Salamon; T. Szamosi; Z. Szepes; G. T. Toth; Richard Shames, USA; L. Tozzi; L. Mattheakis; A. Vincze; E. Biro; B. D. Lovasz; Z. Kurti; F. Nagy; T. T. Annamalai; A. Bhandari; D. Liu Molnar; P. L. Lakatos P0299 P0306 IMPACT OF NON-MEDICAL SWITCHING OF ANTI-TUMOR TOFACITINIB FOR INDUCTION THERAPY IN PATIENTS NECROSIS FACTOR AGENTS ON HEALTHCARE COSTS IN WITH ACTIVE ULCERATIVE COLITIS IN TWO PHASE 3 EUROPE CLINICAL TRIALS: RESULTS BY LOCAL AND CENTRAL Timothy Juday, USA; M. Skup; C. Streuper; U. Moerch; ENDOSCOPIC ASSESSMENTS G. S. Kopperud; O. Henriksen; S. Johnson; T. O'Connell B. G. Feagan; S. Vermeire; Walter Reinisch, Canada; P0300 W. J. Sandborn; D. Tarabar; W. Niezychowski; C. Su; H. COMPARATIVE ANALYSIS OF PATIENTS WITH INFLAM- Zhang; D. Woodworth; D. Yu; B. E. Sands MATORY BOWEL DISEASE AND IRON DEFICIENCY/ANAE- MIA TREATED WITH ORAL VERSUS INTRAVENOUS IRON - A RETROSPECTIVE CLAIMS DATA ANALYSIS TO ASSESS THE IMPACT ON HOSPITTION IN GERMANY K. Borchert; T. Hardt; J. Haas; Siew Hwa Ong, Switzerland; E. Lechat; K. Nip; D. Foerster; S. Braun; J. Stein

Poster in the Spotlight Poster of Excellence Clinical Case Session 137

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0307 P0313 ESCHERICHIA COLI NISSLE 1917 MODULATE GUT MICRO- NONCLINICAL PHARMACOLOGICAL CHARACTERI- BIOTA COMPOSITION IN ULCERATIVE COLITIS PATIENTS ZATION AND IN VIVO EFFICACY OF THE PROPOSED Francesca Mangiola, Italy; F. Del Chierico; C. Graziani; ADALIMUMAB BIOSIMILAR GP2017 COMPARED TO THE

Monday, October 17, 2016 V. Petito; S. Pecere; E. Schiavoni; M. Pizzoferrato; L. ORIGINATOR ADALIMUMAB R. Lopetuso; A. Russo; L. Putignani; A. Gasbarrini; F. Antonio da Silva, Germany; C. Fritsch; H.-P. Hofmann; Scaldaferri O. Hainzl; A. Seidl P0308 P0314 THE INCIDENCE OF AND TIME TO SUBOPTIMAL THER- VEDOLIZUMAB: EARLY EXPERIENCE AND MEDI- APY AMONG PATIENTS WITH ULCERATIVE COLITIS AND UM-TERM FOLLOW UP DATA FROM TWO UK TERTIARY CROHN'S DISEASE INITIATING TUMOUR NECROSIS FAC- IBD CENTRES - A RETROSPECTIVE COHORT STUDY TOR ANTAGONISTS: A MULTI-COUNTRY CHART REVIEW Mark Samaan, United Kingom; P. Pavlidis; E. Johnston; Alessandro Armuzzi, Italy; J. Lindsay; H. Patel; B. B. Warner; J. Digby-Bell; I. Koumoutsos; S. Fong; R. Bokemeyer; J. P. Gisbert; G. C. Nguyen; L. Goldberg; S. Gulati; L. Medcalf; M. Sastrillo; C. Brown- Peyrin-Biroulet; M. Smyth; J. M. Khalid Clarke; J. Bidewell-Sullivan; K. Forsyth; E. Lee; A. Stanton; J. Duncan; G. Chung-Faye; P. Dubois; N. Powell; S. H. P0309 Anderson; J. Sanderson; B. Hayee; P. Irving TREATMENT WITH EUDRAGIT-COATED MESALAZINE TABLETS SIGNIFICANTLY IMPROVES THE WORK PRO- P0315 DUCTIVITY IN PATIENTS WITH MILDLY TO MODERATELY HIGHER EXPOSURE BUT LOWER RESPONSE RATE TO ACTIVE ULCERATIVE COLITIS INFLIXIMAB INDUCTION THERAPY IN ELDERLY PA- Axel Dignass, Germany; R. Schnabel; J. Romatowski; TIENTS WITH INFLAMMATORY BOWEL DISEASE V. Pavlenko; A. Dorofeyev; J. Derova; L. V. Jonaitis; T. Erwin Dreesen, Belgium; V. De Weerdt; T. Van Stappen; Nacak; R. Greinwald E. Peeters; T. Lobaton; G. Van Assche; S. Vermeire; A. Gils; M. Ferrante P0310 EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB FOR P0316 ª THE INDUCTION OF REMISSION IN INFLAMMATORY ANTI-TNF? ANTIBODY INDUCED PSORIASIS IN PA- BOWEL DISEASE PATIENTS TIENTS WITH INFLAMMATORY BOWEL DISEASE; A Maria Chaparro, Spain; M. Sierra-Ausin; F. Mesonero; A. PROSPECTIVE IRISH COHORT STUDY B. Beltran Niclos; N. Maroto Arce; R. De Francisco Garcia; Shivashini Kirthi, Ireland; A.-M. Tobin; D. McNamara M. Minguez; Y. González-; M. Barreiro-de Acosta; I. Marin; V. García; D. Busquets Casals; A. J. Lucendo; P0317 S. Garcia; F. Bermejo; R. Pajares Villarroya; B. Sicília A RANDOMIZED CONTROLLED TRIAL ON YOGA FOR Aladrén; D. Martín-Rodríguez; A. Gutiérrez; S. Rubio; ULCERATIVE COLITIS I. García Tercero; J. R. Pineda; M. Piqueras Cano; D. Jost Langhorst, Germany; M. Schaefer; M. Schoels; J. Ginard; C. Muñoz Villafranca; M. Martin-Arranz; A. Koecke; S. Elsenbruch; R. Lauche; H. Engler; G. Dobos; Echarri Piudo; L. Marti Romero; J. L. F. Forcelledo; H. Cramer E. M. Fernández Bonilla; B. Jucha; M. G. Donday; A. P0318 Garre; J. P. Gisbert A LOW FODMAPS DIET REDUCES FUNCTIONAL SYMP- P0311 TOMS IN PATIENTS WITH INFLAMMATORY BOWEL EFFICACY OF EXCLUSIVE ENTERAL NUTRITION IN DISEASE WITH NO SIGNS OF ACTIVE INFLAMMATION A. Testa; A. Rispo; M. Rea; N. Imperatore; Olga M. ADULT ACTIVE CROHN'S DISEASE WITH COMPLICA- Nardone, Italy; G. Accarino; L. Lucci; P. Gervetti; N. TIONS OR FAILURE OF MEDICAL TREATMENT Q. Yang; Xiang Gao, China; M. Zhi; H. Chen; P. Hu Caporaso; F. Castiglione P0312 P0319 THE EFFICACY OF DOSE SPLITTING THIOPURINES IN FAECAL MICROBIOTA TRANSPLANTATION (FMT) AS A HYPERMETHYLATORS RESCUE THERAPY FOR STEROID-DEPENDENT AND/OR Ben Warner, United Kingdom; S. Fong; E. Johnston; S. NON-RESPONSIVE PATIENTS WITH ULCERATIVE COLITIS Mashari; S. Patel; S. H. Anderson; P. Irving; A. Marinaki; (UC): A PILOT STUDY J. Sanderson Tarkan Karakan, Turkey; M. Ibis; Z. Gök Sargin

138 Poster in the Spotlight Poster of Excellence Clinical Case Session 139 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0320 P0328 INDIGO NATURALIS ALTERS THE GUT MICROBIAL COM- DOSE ESCALATION OF BIOLOGICS IN CROHN'S DIS- MUNITY AND MODIFIES COURSE OF INFLAMMATION IN EASE: CRITICAL REVIEW OF OBSERVATIONAL STUDIES THE MOUSE MODEL OF COLITIS Xin Lee, Denmark; F. Lelli; B. Bereza; T. Einarson Soichiro Adachi, Japan; N. Hoshi; J. Inoue; E. Yasutomi; D. Watanabe; K. Yuna; S. Nishiumi; H. Yamairi; M. Ooi; P0329 M. Yoshida; T. Azuma; Z. Wang; T. Otsuka; R. Dhakhwa SELECTIVE GRANULOCYTE AND MONOCYTE APHERE- SIS IS EFFECTIVE AND SAFE IN GERIATRIC PATIENTS P0321 WITH ULCERATIVE COLITIS TRENDS IN ENDOSCOPY MANAGEMENT AFTER SUR- Ayumi Ito, Japan; B. Iizuka; O. Teppei; H. Kashiwagi; K. GERY IN A NATIONAL COHORT OF SPANISH CROHN DIS- Tokushige; T. Hara EASE PATIENTS. RESULTS FROM PRACTICROHN STUDY Manuel Barreiro-de Acosta, Spain; M. Iborra; V. García; P0330 POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE A. Gutiérrez; S. Garcia; E. Domènech; M. D. Martín 2016 17, October Monday, Arranz; L. Cea-Calvo; C. Romero; B. Juliá De Páramo AND ITS ASSOCIATION WITH PLEXITIS Ágnes Milassin, Hungary; A. Sejben; L. Tiszlavicz; G. P0322 Lázár; R. Bor; A. Balint; M. Rutka; Z. G. Szepes; K. USE OF ANTI-TNF AGENTS IS ASSOCIATED WITH PARA- Farkas; T. Molnar DOXICAL PSORIASIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A KOREAN NATIONWIDE POPULA- P0331 TION-BASED STUDY RELATED RISK FACTORS ASSOCIATED WITH STEROID H.-H. Lee; Bo-In Lee, South Korea; J. S. Kim; J. M. Park; RESISTANCE IN AN IRISH IBD POPULATION Y.-S. Cho; I.-S. Lee; M.-G. Choi Mary Hussey, Ireland; G. Holleran; D. Keating; S. Whelan; P. Devitt; J. Healy; B. Ryan; D. McNamara P0323 COMBINATION THERAPY PREDICTS LONG-TERM P0332 MUCOSAL HEALING IN MODERATE-TO-SEVERE ULCER- THE INCIDENCE OF SUBOPTIMAL THERAPY AFTER ATIVE COLITIS TREATED WITH ANTI TNF-A INITIATING A SECOND TUMOUR NECROSIS FACTOR Daniela Pugliese, Italy; P. M. Ferraro; C. Felice; G. L. ANTAGONIST IN PATIENTS WITH CROHN'S DISEASE: A Rapaccini; A. Papa; L. Guidi; A. Armuzzi MULTI-COUNTRY CHART REVIEW Javier Gisbert, Spain; L. Peyrin-Biroulet; G. C. Nguyen; P0324 B. Bokemeyer; A. Armuzzi; J. Lindsay; I. Pree; H. Patel; ADSORPTIVE DEPLETION OF MYELOID LEUCO- J. M. Khalid CYTES IN PATIENTS WITH ULCERATIVE COLITIS: BASELINE DEMOGRAPHIC FEATURES OF NON-RESPONDERS AND P0333 RESPONDERS TO THIS APHERESIS TREATMENT OPTION REAL-WORLD CHARACTERISTICS OF THE FIRST USERS Tomotaka Tanaka, Japan; M. Akagi; H. Goishi; T. OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE Iiboshi; T. Kajihara; T. Miura PATIENTS IN ISRAEL C. Weil; G. Chodick; A. Yarden; K. Minda; Javaria Mona P0325 Khalid, United Kingdom; V. Shalev EFFICACY OF TUBERCULOSIS SCREENING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE P0334 Maroua Hafi, Tunisia; N. Ben Mustapha; M. Amri; A. POOR TOLERABILITY PROFILE OF THIOPURINES IN Laabidi; M. Serghini; M. Fekih; J. Boubaker; A. Filali INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE SINGLE-CENTRE EXPERIENCE P0326 Fabio Salvatore Macaluso, Italy; M. Maida; S. Renna; EXCLUSIVE ENTERAL NUTRITION IN ADULTS WITH AC- M. Dimarco; C. Sapienza; M. Affronti; E. Orlando; G. TIVE CROHN'S DISEASE IS ASSOCIATED WITH DECREASE Rizzuto; R. Orlando; M. Cottone; A. Orlando IN DISEASE ACTIVITY Tamar Pfeffer-Gik, Israel; H. Yanai; L. Godny; Y. Ron; N. P0335 Maharshak; I. Dotan PROGNOSTIC VALUE OF THE MAGNITUDE OF CYTOMEG- ALOVIRUS REACTIVATION EVALUATED BY IMMUNOHIS- P0327 TOCHEMICAL STAINING IN PATIENTS WITH ULCERATIVE COST PER CLINICAL OUTCOMES WITH VEDOLIZUMAB COLITIS FOR THE TREATMENT OF MODERATELY TO SEVERELY Ariadna Clos, Spain; P. Rodríguez-Martínez; M. ACTIVE ULCERATIVE COLITIS IN BRAZIL Manosa Ciria; A. Ruiz-Cerulla; M. J. Paúles; J. Llao; Tassia Decimoni, Brazil; G. Muricy; H. Patel; D. Demuth J. Gordillo; C. Fumagalli; T. Lobatón; I. Ojanguren; E. Cabré; J. Guardiola; E. Domenech

Poster in the Spotlight Poster of Excellence Clinical Case Session 139

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0336 P0344 FIVE YEAR BUDGET IMPACT ANALYSIS OF BIOSIMI- A RISK ANALYSIS OF POSTPOLYPECTOMY BLEEDING LAR INFLIXIMAB (CT-P13) FOR THE TREATMENT OF IN COLONOSCOPY DUE TO A COMBINATION OF ANTI- CROHN'S DISEASE AND ULCERATIVE COLITIS IN SPAIN THROMBOTIC AGENTS

Monday, October 17, 2016 Seong-Hee Han, South Korea; D.-H. Kwon; S.-W. Yoon Yoshihiro Kishida, Japan; K. Hotta; K. Imai; S. Ito; N. Kawata; M. Tanaka; N. Kakushima; K. Takizawa; H. Lower GI bleeding Ishiwatari; H. Matsubayashi; H. Ono P0345 Poster Session SENTIFIT 270 SYSTEM CLINICAL PERFORMANCE EVAL- 10:30 - 17:00 Hall X5 UATION COMPARED WITH OC SENSOR DIANA, FOR Other Lower GI Disorders I THE DETECTION OF HUMAN HAEMOGLOBIN AS FAECAL P0337 OCCULT BLOOD (FOB) OUTCOMES OF ACUTE LOWER GASTROINTESTINAL Roee Dvir, Italy; M. Clementi BLEEDING: DATA FROM A LARGE NATIONWIDE AUDIT P0346 Kathryn Oakland, United Kingdom; R. Guy; R. Uberoi; J. CORRELATION BETWEEN THE NATURE OF POSTPOLYP- Grant-Casey; M. Murphy; N. Mortensen; V. Jairath ECTOMY BLOODY STOOL AND THE RISK OF POSTPOL- P0338 YPECTOMY BLEEDING STIGMATA OF RECENT HEMORRHAGE AND NON-ASPIRIN Eun Mi Song, South Korea; D.-H. Yang; G. U. Kim; M. S. ANTIPLATELET DRUG ARE PREDICTIVE FACTORS FOR Seo; S. W. Hwang; S. H. Park; K.-J. Kim; B.D. Ye; J.-S. REFRACTORY COLONIC DIVERTICULAR HEMORRHAGE Byeon; S. J. Myung; S.-K. Yang Yuichi Shimodate, Japan; M. Mizuno; A. Doi; N. Nishimura; H. Mouri; K. Matsueda; H. Yamamoto Lower GI malignant disease-epidemiology P0339 P0347 COMPARISON OF CT, SIGMOIDOSCOPY AND COLONOS- ADENOMA RECURRENCE RATES AFTER CURATIVE RESEC- COPY AS INITIAL METHODS OF EXAMINATION FOR TION FOR RIGHT-SIDE OR LEFT-SIDE COLONIC CANCER PRESENCE OF F. Y. Lam; W. L. Law; I. Hung; Wai Keung Leung, Hong Jong Seok Joo, South Korea; K. D. Kim; S. H. Kang; H. Kong S. Moon; E. S. Lee; S. H. Kim; J. K. Sung; B. S. Lee; H. P0348 Y. Jeong HOW SIGNIFICANT IS THE ASSOCIATION BETWEEN P0340 METABOLIC SYNDROME AND PREVALENCE OF COL- ENDOCLOTTM PROPHYLAXIS FOLLOWING COMPLEX ORECTAL NEOPLASIA? ENDOSCOPIC RESECTION OF GASTROINTESTINAL NEO- Tomas Grega, Czech Republic; S. Suchanek; O. Majek; PLASIA: NO NEED TO BLEED! G. Vojtechova; O. Ngo; B. Seifert; M. Sachlova; E. Fergus J. Q. Chedgy, United Kingdom; K. Kandiah; S. Kundratova; F. Neumann; O. Shonova; K. Balihar; J. Subramaniam; S. Thayalasekaran; F. Thursby-Pelham; Cyrany; M. Benes; M. Zavoral G. Longcroft-Wheaton; P. Bhandari P0349 P0341 ADHERENCE TO COLORECTAL CANCER SCREENING: 4 RISK FACTORS FOR ACTIVE BLEEDING FROM COLONIC ROUNDS OF FECAL IMMUNOCHEMICAL TEST BASED CONFIRMED UNDER COLONOSOCPIC SCREENING OBSERVATION Manon van der Vlugt, The Netherlands; E. J. Grobbee; Naoyuki Nishimura, Japan; M. Mizuno; Y. Shimodate; P. M. Bossuyt; E. J. Kuipers; I. Lansdorp-Vogelaar; M.-L. A. Doi; H. Mouri; K. Matsueda; H. Yamamoto Essink-Bot; M. C. W. Spaander; E. Dekker P0342 P0350 PREVENTING DELAYED POST-POLYPECTOMY INDUCED AGING, CURRENT SMOKING AND METABOLIC FACTORS ULCER HEMORRHAGE BY USING DOPPLER ENDOSCOP- ARE INDEPENDENTLY ASSOCIATED WITH THE PREVA- IC PROBE AS A GUIDE TO RISK STRATIFICATION & LENCE OF COLORECTAL NEOPLASIA IN JAPAN: ANALY- PROPHYLACTIC HEMOSTASIS AFTER POLYPECTOMY SES OF COMPREHENSIVE HEALTH CHECKUP DATA Dennis M. Jensen, USA; G. V. Ohning Nagamu Inoue, Japan; M. Takayama; R. Bessho; T. Yoshida; K. Kashiwagi; K. Makino; R. Shimizu-Hirota; P0343 H. Hirose; H. Ogata; Y. Sugino; Y. Iwao WITHDRAWN

140 Poster in the Spotlight Poster of Excellence Clinical Case Session 141 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0351 P0359 SECOND REORGANISED CYCLE OF NATIONAL COLOREC- UNTANGLING MOLECULAR ORIGINS OF COLORECTAL TAL CANCER SCREENING PROGRAMME IN CROATIA CARCINOMAS AND ASSIGNMENT OF MAJOR PATH- Mirjana Kalauz, Croatia; N. Antoljak; M. Katicic; D. Skoko WAYS BASED ON CIMP/MSI/BRAF/KRAS/TP53/APC Poljak; V. Stamenic; D. Stimac; M. Kujundzic; M. Strnad PROFILES FROM ENDOSCOPIC TISSUE SAMPLING Pesikan; Z. Ebling; M. Samija; H. Ivekovic; M. Banic Petra Minarikova, Czech Republic; L. Benesova; T. Halkova; B. Belsanova; S. Suchanek; J. Cyrany; M. P0352 Zavoral; M. Minarik EARLY PERFORMANCE INDICATORS OF THE COLOREC- TAL CANCER SCREENING PROGRAMME IN NAVARRA Lower GI malignant disease, diagnosis/histopathology (SPAIN): HIGH PARTICIPATION AND ACCEPTANCE RATE Maria Rullan Iriarte, Spain; D. Oyon Lara; S. López P0360 López; A. Elosua; F. Estremera Arévalo; C. Saldaña HIGH RATES OF DISCORDANCE BETWEEN BRAF AND Dueñas; L. Casanova Ortiz; S. Oquiñena Legaz; A. MLH1 METHYLATION TESTS IN CRC PATIENTS OVER 2016 17, October Monday, Pueyo Royo; A. Guerra Lacunza 70 YEARS OLD IN A LYNCH SYNDROME UNIVERSAL SCREENING PROGRAM Lower GI malignant disease, pathogenesis Tomer Adar, USA; L. H. Rodgers; K. M. Shannon; A. Mattia; G. Y. Lauwers; A. J. Iafrate; D. C. Chung P0353 DEVELOPMENT OF COLITIS-ASSOCIATED COLORECTAL P0361 CANCER DEPENDS ON THE ACTIVITY OF THE ENDOGE- IMPLEMENTATION OF A STRUCTURED E-LEARNING IM- NOUS OPIOID SYSTEM PROVES THE INTER-LABORATORY CONSISTENCY IN THE Marta Zielinska, Poland; H. Zatorski; P. Poznanski; A. HISTOPATHOLOGICAL CLASSIFICATION OF SERRATED Nawrocka; M. Salaga; R. Kordek; M. Sacharczuk; J. Fichna POLYPS Joep IJspeert, The Netherlands; A. Madani; L. Overbeek; P0354 E. Dekker; I. D. Nagtegaal PROMOTER HYPOMETHYLATION AND OVEREXPRESSION OF LINC00152 LONG NON-CODING RNA DURING DEVEL- P0362 OPMENT AND PROGRESSION OF COLORECTAL CANCER THE GROWTH PATHWAY AND THE CLINICOPATHOLOGI- Orsolya Galamb, Hungary; A. Kalmár; B. Péterfia; P. CAL CHARACTERISTICS OF DEPRESSED-TYPE COLOREC- Hollosi; Z. B. Nagy; I. Csabai; B. Wichmann; A. Bodor; TAL CARCINOMAS D. Ribli; B. K. Bartak; Z. Tulassay; B. Molnar Shinei Kudo, Japan; S. Matsudaira; Y. Sato; Y. Kouyama; K. Ichimasa; Y. Mori; M. Misawa; T. Kudo; T. Hisayuki; T. P0355 Hayashi; K. Wakamura; H. Miyachi; A. Katagiri; T. Baba; CONTRIBUTION OF THE MEK5/ERK5 PATHWAY TO F. Ishida COLON CANCER STEM-LIKE CELL PROPERTIES Diane Pereira, Portugal; S. E. Gomes; A. E. S. Simões; P0363 R. E. Castro; P. M. Borralho; C. M. P. Rodrigues ELECTRONIC NOSE (AENOSETM) CAN DETECT COLOREC- TAL CARCINOMA IN EXHALED BREATH: A PILOT STUDY P0356 Maud Jansen, The Netherlands; B. Koekoek; M. J. A. SELECTIVE INHIBITION OF FATTY ACID AMIDE HY- Mulder; J. J. Kolkman DROLASE INHIBITOR PF-3845 DECREASES VIABILITY, MIGRATION AND INVASIVENESS OF HUMAN COLON P0364 ADENOCARCINOMA COLO-205 CELL LINE CLINICOPATHOLOGICAL STUDY OF LATERALLY SPREAD- Andrzej Wasilewski, Poland; U. Krajewska; K. Owczarek; ING TUMORS OF THE COLORECTUM U. Lewandowska; J. Fichna Masahiro Iwabuchi, Japan; M. Sugimura; K. Ukai; K. Tadokoro P0357 SECRETION PROTEIN VSTM2A IS A NOVEL TUMOR P0365 SUPPRESSOR AND ASSOCIATES WITH COLORECTAL MICROVESSEL DENSITY OF NEOVASCULAR VESSELS CANCER PATIENT SURVIVAL COULD BE A PREDICTOR OF DISTANT METASTASIS Yujuan Dong, Hong Kong; A. Higashimori; W. Kang; Y. OF COLORECTAL CANCER: IMMUNOHISTOCHEMICAL Zhang; S. S. Ng; J. Yu ASSESSMENT WITH CD105 ANTIBODY Tomonari Cho, Japan; E. Shiozawa; S.-E. Kudo; F. P0358 Urushibara; M. Misawa; H. Miyachi; T. Yamochi; M. MDM2 T309G POLYMORPHISM AND RISK OF COLOREC- Takimoto TAL CANCER Nikhil Aggarwal, United Kingdom, N. Donald; S. Malik; S. Selvendran; M. McPhail; K. Monahan

Poster in the Spotlight Poster of Excellence Clinical Case Session 141

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0366 P0373 CLINICOPATHOLOGICAL STUDY OF SERRATED LESIONS A COMPARATIVE STUDY FOR EFFECTIVENESS OF OF THE COLORECTUM IRREVERSIBLE ELECTROPORATION ABLATION ACCORD- Mikako Sugimura, Japan; M. Iwabuchi; K. Ukai; K. ING TO THERAPEUTIC METHOD AND PERIOD: COLON

Monday, October 17, 2016 Tadokoro CANCER ANIMAL MODEL J. M. Lee; H. S. Choi; H. J. Chun; S. H. Kim; I. K. Yoo; S. P0367 Y. Lee; B. K. Choi; J. M. Lee; E. S. Kim; B. Keum; Yoon COMPARISON OF A METHYLATED BCAT1/IKZF1 BLOOD Tae Jeen, South Korea; H. Lee; C. D. Kim; J. Y. Kim TEST WITH CEA FOR RECURRENT COLORECTAL CANCER Graeme Young, Australia; S. Mansfield; S. Pedersen; P0374 D. Murray; R. Baker; P. Hollington; P. Rabbitt; E. L. IDENTIFICATION OF PROTEOMIC PROFILES ASSOCIATED Symonds WITH TUMOR REGRESSION GRADING IN RECTAL CANCER Valli De Re, Italy; O. Repetto; M. Fornasarig; S. Maiero; P0368 A. De Paoli; A. Buonadonna; C. Belluco; R. Magris; V. CARBONIC ANHYDRASE IX AS THE MARKER OF THE HY- Canzonieri; R. Cannizzaro POXIA INDUCED EXTRACELLULAR VESICLE SECRETION A. Abols; Daiga Santare, Latvia; R. Toleikiene; E. P0375 Zandberga; Z. Kalnina; R. Vangravs; M. Takatalo-Laine; COLORECTAL CANCER IN THE ELDERLY - HOW MUCH M. Palviainen; P. Siljander; M. Leja; A. Line SHOULD WE INVEST? Filipa Ávila, Portugal; J. Castela; I. Rosa; I. Marques; J. P0369 P. da Silva; A. Dias Pereira OPTIMAL INTAKE OF CLEAR LIQUIDS DURING PREPA- RATION FOR COLONOSCOPY WITH LOW VOLUME POLY- P0376 ETHYLENE GLYCOL PLUS ASCORBIC ACID (PEG-ASC) COMPARISON OF ENDOSCOPIC SUBMUCOSAL DISSEC- Masahiro Tajika, Japan; T. Tanaka; M. Ishihara; Y. TION OUTCOME IN OUTPATIENTS VERSUS INPATIENTS Hirayama; S. Oonishi; N. Mizuno; K. Hara; S. Hujioka; Roberta Maselli, Italy; P. A. Galtieri; S. Sferrazza; E. C. H. Imaoka; T. Fujiyoshi; N. Okuno; N. Hieda; T. Yoshida; Ferrara; F. Mazza; L. Amato; A. Anderloni; S. Carrara; V. Bhatia; K. Yamao; M. Ando; Y. Niwa M. Di Leo; A. Repici P0370 P0377 DESIGN AND EVALUATION OF A GENES PANEL FOR DI- THE VALIDITY OF THREE STEPS LEARNING SYSTEM OF AGNOSING HEREDITARY GASTROINTESTINAL CANCER, COLORECTAL ESD ANALYZABLE BY NEXT-GENERATION SEQUENCING, NGS Keiichi Ashikari, Japan; H. Chiba; M. Nishimura; J. Maite Herraiz, Spain; C. Carretero; P. Perez; M. Betés Tachikawa; D. Kurihara; T. Suto; N. Kawano; M. Kaai; S. Ibáñez; A. Patiño Seki; T. Ida; T. Morohashi; T. Goto P0378 Lower GI malignant disease, management ANGIOGENESIS INHIBITOR-RELATED UL- P0371 CERS IN METASTATIC COLORECTAL CANCER PATIENTS POSITIVE LYMPH NODE RATIO IS A PROGNOSTIC F. Bergamo; S. Lonardi; C. Lacognata; B. Salmaso; F. FACTOR FOR STAGE III COLORECTAL CANCER PATIENTS Battaglin; L. M. Saadeh; A. Caruso; F. Cavallin; C. WITH MUCINOUS ADENOCARCINOMA AND SIGNET Aliberti; V. Zagonel; C. Castoro; Marco Scarpa, Italy RING CELL CARCINOMA P0379 Junichi Shibata, Japan; S. Ishihara; K. Kawai; K. Murono; PARTHENOLIDE ENHANCES ANTI-TUMOR EFFICACY OF K. Sasaki; K. Yasuda; K. Otani; T. Nishikawa; T. Tanaka; BALSALAZIDE IN HUMAN COLON CANCER CELLS AND K. Hata; T. Kiyomatsu; H. Nozawa; K. Sugihara; T. COLITIS-ASSOCIATED COLORECTAL CANCER BY BLOCK- Watanabe ADE OF NF-KB ACTIVATION P0372 Seung Young Seo, South Korea; I. S. Min; D. Kim; S. B. KNIFE - ASSISTED SNARE RESECTION (KAR) PROCE- Kim; S. H. Kim; I. H. Kim; S. O. Lee; S. T. Lee; D. G. Kim; DURE TIME FOR COLONIC DYSPLASTIC LESIONS AND S. W. Kim ASSOCIATED PROGNOSTIC FACTORS P0380 Sotiris Panagiotis Terzoudis, United Kingdom; S. EFFICACY OF PREOPERATIVE COLONOSCOPIC TATTOO- Subramaniam; S. Thayalasekaran; K. Kandiah; F. J. ING ON LYMPH NODE HARVEST Q. Chedgy; G. Longcroft-Wheaton; M. Abdulla; A. A. R. Daegon; D. Kang; H. Kim; C. Choi; S. Park; S. Kim; H. Alkandari; P. Bhandari Nam; W. Choi; J. Cho; Jungmin Park, South Korea; K. Oh

142 Poster in the Spotlight Poster of Excellence Clinical Case Session 143 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

Irritable bowel syndrome: Epidemiology Irritable bowel syndrome: Classification and diagnosis P0381 P0389 DEFECATORY SYMPTOMS IN PATIENTS WITH IRRITABLE ASSOCIATIONS BETWEEN HYDROGEN BREATH TEST AND BOWEL SYNDROME IN A PRIMARY HEALTH CARE POPU- SYMPTOM RESPONSES DURING A LACTULOSE NUTRIENT LATION IN SWEDEN CHALLENGE IN IBS PATIENTS AND HEALTHY CONTROLS Jenny Sjödahl, Sweden; M. P. Jones; A.-K. Norlin; Å. Lukas Van Oudenhove, Belgium; D. Pohl; H. Törnblom; Faresjö; S. Walter L. Oehmann; B. Le Nevé; J. Tack; M. Simrén P0382 P0390 IMPACT OF IRRITABLE BOWEL SYNDROME WITH DIAR- MIXTURE-MODEL BASED SUBGROUPING OF PATIENTS RHOEA ON WORK PRODUCTIVITY AND DAILY ACTIVITY WITH IBS AMONG PATIENTS IN THE EU5 Annikka Polster, Sweden; L. Van Oudenhove; M. P. Catherine Tucker, United Kingdom; J. L. Abel; R. T. Jones; L. Öhman; H. Törnblom; M. Simrén Monday, October 17, 2016 17, October Monday, Carson; N. M. Flores; R. Liebert P0391 P0383 LABORATORY INVESTIGATIONS FOR PATIENTS MEET- HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS ING DIAGNOSTIC CRITERIA FOR IRRITABLE BOWEL WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA SYNDROME: ARE WE MEETING THE STANDARDS? Catherine Tucker, United Kingdom; J. L. Abel; R. T. James Kennedy, United Kingdom; K. Wright; L. B. Carson; N. M. Flores; R. Liebert Materacki; S. Waterman; R. Makins; A. Di Mambro P0384 P0392 IS THERE AN ASSOCIATION BETWEEN SELF-REPORTED MANAGEMENT OF IRRITABLE BOWEL SYNDROME IN A ALLERGIC CONDITIONS AND FUNCTIONAL GASTROIN- DISTRICT HOSPITAL TESTINAL DISORDERS? A POPULATION BASED STUDY Shuann Shwana, United Kingdom; L. Alrubai N. A. A Koloski; A. V. Zala; M. P. Jones; Marjorie Walker, Australia; G. J. Holtmann; M. Veysey; L. Bunby; L. P0393 Lambeth; L. Hayden; N. J. Talley PERFORMANCE EVALUATION OF DYSBIOSIS STATUS AS A TOOL FOR CLINICAL INVESTIGATION IN PATIENTS P0385 WITH FUNCTIONAL GASTROINTESTINAL DISORDERS ARE CONDITIONS OF IMMUNE DYSREGULATION RISK Wolfgang Kruis, Germany; T. Lindahl; E. C. Bästlein; T. FACTORS FOR FUNCTIONAL GASTROINTESTINAL DISOR- Fiedler; S. Georgi; J. Ringel; L. Konopka; M. Mross; U. DERS? FINDINGS FROM A RANDOM POPULATION BASED Helwig; G. Terheggen; E. Ciemniejewska; C. Casén STUDY N. A. A Koloski; A.V. Zala; Marjorie Walker, Australia; P0394 M. P. Jones; L. Bunby; M. Veysey; L. Lambeth; L. NEGATIVE FAECAL CALPROTECTIN TESTING PROVIDES Hayden; G. J. Holtmann; N. J. Talley COST-EFFECTIVE DIAGNOSTIC REASSURANCE IN PA- TIENTS WITH IRRITABLE BOWEL SYNDROME P0386 Luke B. Materacki, United Kingdom; J. Kennedy; K. WITHDRAWN Wright; S. Waterman; R. Makins; A. Di Mambro P0387 Irritable bowel syndrome: Treatment PERCEPTIONS OF PATIENTS WITH IRRITABLE BOWEL SYNDROME IN RELATION TO THE CARE RECEIVED IN P0395 THE PUBLIC HEALTH SYSTEM IN SPAIN PERFORMANCE OF A NOVEL CARE PATHWAR FOR José Mira, Spain; G. Lacima; X. Cortés Gil FUNCTIONAL GASTROINTESTINAL DISORDERS: A PILOT P0388 STUDY-INTERIM RESULTS Ecushla C. Linedale, Australia; A. Mikocka-Walus; P. R. PROTON PUMP INHIBITORS INCREASE THE RISK FOR Gibson; J. M. Andrews IRRITABLE BOWEL SYNDROME - A POPULATION BASED STUDY P0396 A. V. Zala; M. P. Jones; N. A. A Koloski; Marjorie Walker, REDUCTION OF SYMPTOMS AND BREATH H2 PRODUC- Australia; G. J. Holtmann; M. Veysey; L. Bunby; L. TION IN A SUBGROUP OF PATIENTS WITH IRRITABLE Lambeth; L. Hayden; N. J. Talley BOWEL SYNDROME CHARACTERIZED BY DISTINCT GUT MICROBIOTA ACTIVITY: EFFECT OF A FERMENTED MILK PRODUCT CONTAINING BIFIDOBACTERIUM LACTIS CNCM I-2494 Boris Le Nevé, France; M. Derrien; J. Tap; R. Brazeilles; D. Guyonnet; L. Öhman; H. Törnblom; M. Simrén

Poster in the Spotlight Poster of Excellence Clinical Case Session 143

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0397 P0405 EFFICIENCY OF FMT IN CASES OF "TREATMENT-RESIS- COLON ISCHEMIA SEVERITY SCALE: EVALUATION AND TANT" IBS DETERMINATION OF ADDITIONAL SEVERITY MARKERS G. Syzenko; Liudmyla Budovska, Ukraine; K. Puchkov Jaime P. Rodrigues, Portugal; A. Coelho; C. Fernandes;

Monday, October 17, 2016 T. Freitas; J. Silva; A. Ponte; M. Sousa; J. Carvalho P0398 EFFICACY AND SAFETY OF LINACLOTIDE IN PATIENTS Diverticular disease WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPA- TION: RESULTS FROM A PHASE ; RANDOMIZED, DOU- P0406 BLE-BLIND, PLACEBO-CONTROLLED TRIAL IN CHINA BILATERAL IS AN INDIPENDENT RISK AND OTHER REGIONS FACTOR FOR DIVERTICULAR BLEEDING: AN INTERIM Yunsheng Yang, China; J. Fang; X. Guo; N. Dai; X. ANALYSIS OF ONGOING STUDY Shen; Y. Yang; J. Sun; D. S. Reasner; J. M. Johnston; P. Rosario Arena, Italy; A. Mussetto; B. Mario; A. Lisotti; Zeng; S. Lim O. Triossi P0399 P0407 UK CLINICAL EXPERIENCE AT 12 WEEKS WITH LIN- IMPARED HUMAN COLONIC CONTRACTILITY AND TOLL- ACLOTIDE FOR IRRITABLE BOWEL SYNDROME WITH LIKE RECEPTOR 4 EXPRESSION IN UNCOMPLICATED CONSTIPATION DIVERTICULAR DISEASE A. Emmanuel; J. McLaughlin; S. McLain-Smith; M. Rance; Michele P. L. Guarino, Italy; S. Carotti; S. Cocca; A. A. Agrawal; P.B. Allen; N. Arebi; S. Brown; M. Eugenicos; Altomare; S. Morini; M. Cicala Adam D. Farmer, United Kingdom; Y. Yiannakou P0408 P0400 ASSESSMENT OF FECAL MICROBIOTA AND FECAL POSITIVE EFFECTS FIVE YEARS AFTER A STRUCTURED METABOLOME IN SYMPTOMATIC UNCOMPLICATED PATIENT EDUCATION (IBS SCHOOL) FOR PATIENTS DIVERTICULAR DISEASE OF THE COLON WITH IRRITABLE BOWEL SYNDROME (IBS) Antonio Tursi, Italy; P. Mastromarino; D. Capobian- Gisela Ringström; Sweden; S. Storsrud; P. Jerlstad; H. co; W. Elisei; M. Picchio; G. Giorgetti; A. Miccheli; G. Törnblom; M. Simrén Capuani; G. Brandimarte P0401 CORRELATION BETWEEN FOOD INTAKE AND SYMPTOM Cell/molecular biology/pathology SEVERITY IN IBS Stine Störsrud, Sweden; B. Le Nevé; B. Holmes; H. Poster Session Törnblom; M. Simrén 10:30 - 17:00 Hall X5 Oesophageal, Gastric and Duodenal Disorders I P0402 USE OF LIFESTYLE INTERVENTIONS TO TREAT BOWEL P0409 AND/OR ABDOMINAL SYMPTOMS AMONG PATIENTS H19 NON CODING RNA-DERIVED MIR-6; ACTIVATED BY WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPA- HELICOBACTER PYLORI, PROMOTES GASTRIC CANCER TION (IBS-C) AND CHRONIC IDIOPATHIC CONSTIPATION FORMATION AND RESISTANCE TO CISPLATIN BY DOWN- (CIC): RESULTS FROM THE CONTOR STUDY REGULATING FADD Jessica L. Abel, USA; D. C. A. Taylor; J. A. Doshi; C. Jin Yan, China Martin; A. Goolsby Hunter; B. Essoi; P. Buzinec; R. T. P0410 Carson; W. D. Chey HYDROTALCITE PROTECTS GASTRIC EPITHELIUM FROM P0403 DICLOFENAC-INDUCED INJURY BY UPREGULATING EFFECTS OF FOOD ENRICHED WITH DIETARY FIBER IN EGF-R, IGF-1 AND SURVIVIN: NEW MECHANISMS OF WOMEN WITH CONSTIPATION-PREDOMINANT IRRITA- HYDROTALCITE'S PROTECTIVE ACTION AND THERAPEU- BLE BOWEL SYNDROME TIC IMPLICATIONS G. Sulaberidze; Maia Okujava, Georgia; K. Liluashvili Brigitte Havertz, Germany; A. Ahluwalia; M. K. Jones; A. S. Tarnawski Lower GI vascular disorders P0411 P0404 EXPRESSION OF ALPHA ACTININ-4 IN SPINDLE CELL SEVERE ACUTE : WHAT IS THE CARCINOMA OF THE ESOPHAGUS PLACE OF ENDOSCOPY IN THE MANAGEMENT STRATE- Takuro Nakazawa, Japan; S. Nobusawa; I. Hayato; H. GY? A LARGE RETROSPECTIVE FRENCH STUDY Yokoo; M. Yamada Diane Lorenzo, France; J.-M. Gonzalez; L. Beyer; S. Berdah; D. Birnbaum; A. Desjeux; J. C. GRIMAUD; M. Barthet

144 Poster in the Spotlight Poster of Excellence Clinical Case Session 145 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0412 P0420 THE ACTIVITY OF H+/ K+ -ATPASE IN BIOPSY MATERI- STUDY OF VARIATION BETWEEN THE ENDOSCOPIST, AL OF PATIENTS WITH GASTRIC ULCER PATHOLOGIST AND THE BIOCHEMIST IN THE DIAGNO- Olga Kharchenko, Ukraine; G. Shayakhmetova; O. SIS OF CHRONIC FUNDAL : THERE Kostuk; O. Savchuk IS NEED FOR DEFINITIVE GUIDELINES Tariq Mahmood, United Kingdom P0413 IMAGING THE GLYCOME IN RAT STOMACH MUCOSA P0421 UNDER CONDITIONS OF ULCERATION AND PRETREAT- THE USE OF CANCER-ASSOCIATED AUTOANTIBODIES MENT WITH TRIPEPTIDE T-34 AS BIOMARKERS IN GASTRIC MALIGNANCIES Christina Nasadyuk, Ukraine; E. Sogomonyan; A. Yash- Zane Kalnina, Lithuania; I. Meistere; J. Kupcinskas; P. chenko; O. Sklyarov Zayakin; A. Pismennaja; L. Kupcinskas; L. V. Jonaitis; M. Leja; C.-Y. Wu; A. Line P0414 Monday, October 17, 2016 17, October Monday, EFFECT OF TRIPEPTIDE T-34 ON SYALO- AND FUCOSE- P0422 SPECIFIC CARBOHYDRATE DETERMINANTS OF STOM- ORAL INTAKE OF PURIFIED AQUEOUS SOLUTION ACH MUCOSA IN INDOMETHACIN-INDUCED GASTRIC OF OAT B-GLUCANS HAS NO EFFECT ON GASTRIC LESIONS IN RATS MUCOSA HISTOLOGICAL CHANGES IN PATIENTS WITH Christina Nasadyuk, Ukraine; A. Yashchenko; E. Sogo- CHRONIC GASTRITIS: A PILOT PHASE II CLINICAL TRIAL monyan; O. Sklyarov Rafal Filip, Poland; S. Gudej; M. Juszczak; E. Lange; J. Harasym; D. Suchecka; K. Blaszczyk; J. Wilczak; J. P0415 Gromadzka-Ostrowska THE ROLE OF STOMACH DIFFUSE NEUROENDOCRINE SYSTEM AND PROLIFERATION IN REALIZATION OF P0423 CORREA CASCADE IN DISEASES ASSOCIATED WITH THE PREVALENCE OF ANTI-PARIETAL CELL AND ANTI-IN- HELICOBACTER PYLORI TRINSIC FACTOR ANTIBODIES, PEPSINOGENS AND GAS- M. A. Osadchuk; A. A. Svistunov; Nataliya V. Kireeva, TRIN-17 IN CORPUS-RESTRICTED GASTRITIS PATIENTS Russia; M. M. Osadchuk; K. S. Solodenkova Petra Krike, Latvia; Z. Shums; D. Rudzite; I. Polaka; S. Isajevs; G. L. Norman; M. Leja P0416 COLLAGEN PEPTIDES PREVENT THE STRESS-INDUCED P0424 ULCERATION BY REGULATING STRESS-ASSOCIATED ACTI- THE PREVALENCE OF AUTOIMMUNE GASTRITIS IN VATION OF NEUROENDOCRINE AND IMMUNE SYSTEMS CAUCASIANS WITH GASTRIC ADENOCARCINOMA Zanda V. Bakaeva, Russia; A. M. Surin; V. I. Torshin; Y. P. A. Urke; Petra Krike, Latvia; Z. Shums; D. Rudzite; I. Starshinov; I. G. Kozlov; L. A. Andreeva; N. F. Myasoedov Polaka; A. Sivins; I. Jelovskis; S. Isajevs; I. Bogdanova; V. Boka; U. Vikmanis; G.L. Norman; M. Leja Immunity and inflammation (not H. pylori) P0425 P0417 REDUCED 25-OH-VITAMIN D LEVELS IN PATIENTS HIGH DIAGNOSTIC PERFORMANCE OF A NOVEL ASSAY WITH CHRONIC AUTOIMMUNE ATROPHIC GASTRITIS FOR AUTOANTIBODIES AGAINST ATP4A AND ATP4B F. Cavalcoli; Alessandra Zilli, Italy; S. Bernasconi; D. SUBUNITS OF GASTRIC PROTON PUMP H+,K+-ATPASE Conte; C. Ciafardini; S. Massironi IN ATROPHIC BODY GASTRITIS PATIENTS Edith Lahner, Italy; V. Lampasona; C. Brigatti; L. Upper GI and small intestinal bleeding Piemonti; M. Carabotti; G. Scalese; H. W. Davidson; J. M. Wenzlau; B. Annibale P0426 PROGNOSIS OF ENDOSCOPIC HEMOSTASIS FOR THE GAS- P0418 TROINTESTINAL BLEEDING ULCER WAS DEPENDENT ON FROM THYROID AUTOIMMUNITY DISEASE TO AUTOIM- THE CHARACTERISTICS OF THE PATIENTS, BUT NOT ON MUNE CHRONIC ATROPHIC BODY GASTRITIS: POSSIBLE CORRESPONDENCE OF THE MEDICAL STAFFS IN JAPAN PREDICTOR MARKERS Okamoto Norihiro, Japan; Y. Sakata; K. Miyahara; Maria Piera Panozzo, Italy; M. Franceschi; G. S. Matsuura; N. Turuoka; T. Noda; K. Yamamoto; H. Baldassarre; A. Antico Kawakubo; K. Yamanouchi; R. Iwakiri; K. Fujimoto P0419 P0427 WITHDRAWN INFORMATICS ASSESSMENT OF BURDEN OF ANAEMIA POST UPPER GI BLEEDING IN AN UNIVERSITY HOSPITAL POPULATION Neeraj Bhala, United Kingdom; D. Mcnulty; F. Evison; T. Read; N. Sharma; T. Iqbal

Poster in the Spotlight Poster of Excellence Clinical Case Session 145

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0428 Upper GI motility disorders: Clinical INCIDENCE, CLINICAL CHARACTERISTICS AND RISK FACTORS OF UPPER GASTROINTESTINAL BLEEDING IN P0436 PATIENTS ON DUAL ANTI-PLATELET THERAPY AFTER AMBULATORY HIGH RESOLUTION OESOPHAGEAL MANOMETRY: A NOVEL TOOL TO INVESTIGATE NON-

Monday, October 17, 2016 PERCUTANEOUS CORONARY INTERVENTION IN SOUTH CHINA CARDIAC CHEST PAIN Zefeng Zhang, China; W. Sha; Q. Wang E. Yazaki; P. Woodland; Joanne Ooi, United Kingdom; F. Hughes; S. L. Preston; D. Sifrim P0429 SHORT-TERM USE OF GINKGO BILOBA INCREASE RISK P0437 OF UPPER GASTROINTESTINAL BLEEDING: A NATION- HETEROGENEITY IN HIGH RESOLUTION MANOMETRY WIDE POPULATION-BASED CASE-CROSSOVER STUDY (HRM) AND AMBULATORY PH TESTING AROUND THE Wen-Chieh Wu, Taiwan; B.-L. Yang; S.-K. Lin; H.-C. Lin; WORLD IN 2015 H.-Y. Hu; S.-Y. Lin; K. C. Fang; K. C. Fang; C.-H. Chang; R. Sweis; M. Fox; Henriette Heinrich, Switzerland Y.-H. Lai P0438 P0430 ENDOSCOPIC MYOTOMY FOR ACHALASIA USING THE CHADS2 SCORE IS A PREDICTOR OF DELAYED BLEED- HOOK KNIFE FOR A PRECISE CIRCULAR MUSCLE CUT: ING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION EVALUATION OF THE SAFETY AND THE EFFECTIVENESS FOR GASTRIC NEOPLASMS OF THE 132 FIRST CASES Takuya Inoue, Japan; S. Ito; T. Shimizu; Y. Yokoyama; S. Hélène Foisy, France; M. Pioche; S. Roman; A. Garro; J. Ishii; A. Inoue Rivory; F. Mion; T. Ponchon P0431 P0439 DIAGNOSTIC SCORES AS PREDICTORS OF OUTCOME IN ENDOSCOPIC PYLOROMYOTOMY VIA GASTRIC SUBMU- PATIENTS WITH BLEEDING PEPTIC ULCERS COSAL TUNNEL DISSECTION: A PROMISING TECHNIQUE Ivan Budimir, Croatia; D. Kralj; N. Ljubicic; M. Nikolic; FOR GASTROPARESIS N. Barsic; G. Mirosevic; I. Budimir yr K. He; L. Liu; M. Wang; X. Wang; Zhining Fan, China P0432 P0440 MANAGEMENT OF ACUTE UPPER GASTROINTESTINAL OPTIMAL NUMBER OF MULTIPLE RAPID SWALLOWING HAEMORRHAGE IN A DISTRICT HOSPITAL DURING HIGH RESOLUTION OESOPHAGEAL MANOMETRY Shuann Shwana, United Kingdom; L. Alrubaiy Aurelio Mauro, Italy; A. Elvevi; D. Consonni; M. Franchina; D. Pugliese; A. Tenca; D. Conte; R. Penagini P0433 MEDICAL VERSUS ENDOSCOPIC TREATMENT OF OE- P0441 SOPHAGEAL VARICES IN LIVER CIRRHOSIS MOTILITY AND OESOPHAGEAL CLEARANCE IN BAR- Abd El Fatah Hanno, Egypt; H. F. Abo el Kheir; D. A. El RETT'S OESOPHAGUS Wazza; M. I. Ibrahim R. Sweis; A. Raeburn; E. Athanasakos; N. Zarate-Lopez; L. B. Lovat; R. J. Haidry; M. Banks; Anton Emmanuel, P0434 United Kindom PERFORMANCE OF THE GLASGOW BLATCHFORD SCORE IN UPPER GASTROINTESTINAL BLEEDING: FOR WHICH P0442 PATIENTS, FOR WHAT OUTCOME AND WITH WHICH STUDIES OF THE CLINICAL DIAGNOSTIC VALUE OF THE THRESHOLD? ESOPHAGEAL HYPERTENSIVE PERISTALSIS BASED ON Nathalie Nayer, Belgium; V. Huberty; O. Le Moine; J. QUESTIONNAIRE, ESOPHAGEAL RADIOGRAPHY AND Deviere; A. Lemmers HIGH RESOLUTION MANOMETRY Kun Wang, China; L. Duan; Z. Xia; Z. Xu; Y. Ge P0435 APPROACH OF REBLEEDING IN UPPER GASTROINTES- P0443 TINAL NON-VARICEAL HAEMORRHAGE DOES BALLOON DILATATION AFFECT PER-ORAL ENDO- SCOPIC MYOTOMY PROCEDURE? M. Ilie; V. Sandru; Alina Constantin, Romania; D. Tabacelia; I. Moroi; G. Constantinescu Fatih Aslan, Turkey; Z. Akpinar; D.A. Yurtlu; M. Kucuk; I. Dogan; S. Bor; B. Unsal

146 Poster in the Spotlight Poster of Excellence Clinical Case Session 147 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0444 P0450 ESOPHAGEAL SHORTENING IN HIGH RESOLUTION PREVALENCE RATE OF TYPE OF GASTROESOPHAGEAL MANOMETRY: DOES IT MEAN ANYTHING? JUNCTION IN PATIENTS WITH GASTROESOPHAGEAL Fermin Estremera Arevalo, Spain; I. Aresté Anduaga; REFLUX DISEASE (GERD) AND PATIENTS WITHOUT GERD A. Zúñiga Ripa; V. Fernandez de Pinedo; M. Fraile Alba Zúñiga Ripa, Spain; F. Estremera Arévalo; M. González; H. Leon; R. Iglesias Picazo; E. Albéniz Arbizu; Fraile González; I. Aresté Anduaga; R. Iglesias Picazo S. Oquiñena Legaz P0451 RELATIONSHIP BETWEEN GASTRIC ACCOMMODATION Reflux disease, pathogenesis AND POSTPRANDIAL TRANSIENT LOWER OESOPHA- P0445 GEAL SPHINCTER RELAXATIONS AND REFLUX EVENTS MACROPHAGE FUNCTIONAL ACTIVITY DEPENDING IN HEALTH AND GASTRO-OESOPHAGEAL REFLUX ON THE REFLUXATE TYPE IN GASTROESOPHAGEAL DISEASE/FUNCTIONAL DYSPEPSIA OVERLAP REFLUX DISEASE Brecht Van Houtte, Belgium; C. Broers; T. Vanuytsel; N. 2016 17, October Monday, Svetlana Lyamina, Russia; S. Kalish; A. Paraskevova; Rommel; J. Tack; A. Pauwels O. Storonova; I. Maev; A. Trukhmanov; V. Ivashkin; I. P0452 Malyshev ACID SENSING ION CHANNELS AS TARGETS FOR THE P0446 MODULATION OF PAIN SENSATIONS IN GASTROESOPH- IMPAIRED MUCOSAL INTEGRITY IS PRESENT IN SOME AGEAL REFLUX DISEASE REFRACTORY GORD PATIENTS: THE RELEVANCE OF G. Ulrich-Merzenich; A. Shcherbakova; O. Kelber; Heba THE REFLUXATE Abdel-Aziz, Germany Charlotte Broers, Belgium; N. Pardon; B. Van Houtte; P0453 H. Vanheel; T. Vanuytsel; J. Tack; A. Pauwels; R. L. RELEVANCE OF SLEEP DISTURBANCE TO THE INTEGRI- Farré Marti TY AND CHARACTERISTICS OF SECONDARY PERISTAL- P0447 SIS IN PATIENTS WITH GERD DUODENAL EOSINOPHILIA AND POSTBRANDIAL Chien-Lin Chen, Taiwan; W.-Y. Lei; C.-H. Yi; T.-T. Liu; DISTRESS SYNDROME ARE ASSOCIATED WITH AN J.-S. Hung INCREASED RISK OF NEW ONSET GASTROESOPHAGEAL P0454 REFLUX IN FUNCTIONAL DYSPEPSIA: PROSPECTIVE INFLAMMATION MIGHT HAVE A ROLE IN EROSIVE TEN YEAR FOLLOW-UP OF THE KALIXANDA STUDY ESOPHAGITIS BUT NOT IN NON-EROSIVE REFLUX Jukka Ronkainen, Finland; P. Aro; L. Agréus; S.-E. DISEASE Johansson; M. M. Walker; N. J. Talley Pelin Ergun, Turkey; S. Kipcak; M. Dondurmaci; E. P0448 Yildirim Sozmen; S. Bor ESOPHAGO-GASTRIC JUNCTION MORPHOLOGY VARI- ABILITY DURING STANDARD MANOMETRIC PROTOCOL Reflux disease, treatment AND AFTER ESOPHAGEAL STIMULATION AND BODY CHANGE POSITION P0455 Marco Della Coletta, Italy; F. Galeazzi; A. Ioannou; F. TJ-14 (HANGESHASHINTO) IMPEDES THE DEVELOP- Torresan; E. Marabotto; P. Zentilin; N. De Bortoli; L. MENT OF REFLUX-INDUCED ESOPHAGEAL CANCER IN Surace; S. Marchi; C. Ogliari; M. Vecchi; A. Elvevi; A. A SURGICAL RAT MODEL Mauro; R. Penagini; S. Tolone; P. Iovino; V. Savarino; E. Tomoharu Miyashita, Japan; D. Matsui; I. Makino; H. Savarino Tajima; A. K. Ahmed; J. W. Harmon; T. Ohta P0449 P0456 INCREASED INTRA-BOLUS PRESSURE IS MORE COM- IN VITRO AND EX-VIVO QUANTITATIVE ASSESSMENT MON IN PATIENTS WITH NON-CARDIAC CHEST PAIN OF LOCAL INTERACTIONS OF ANTACIDS WITH OE- THAN IN THOSE WITH HEARTBURN - A STUDY USING SOPHAGEAL MUCOSA FOCUSED ON LAYER STABILITY HIGH-RESOLUTION MANOMETRY AND RESISTANCE TO HCL PENETRATION: SIGNIFICANT Marco Della Coletta, Italy; O. Bartolo; F. Galeazzi; E. THERAPEUTIC IMPLICATIONS Marabotto; G. Bodini; I. Martinucci; N. De Bortoli; S. Brigitte Havertz, Germany; R. Krastev Tolone; V. Savarino; E. Savarino P0457 THE EXCRETION OF PANTOPRAZOL IN HUMAN BREAST MILK Serhat Bor, Turkey; G. Yildiz Turkyilmaz; S. Karacaoglu; S. Kipcak; P. Ergun; E. Karasulu

Poster in the Spotlight Poster of Excellence Clinical Case Session 147

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0458 P0466 THE USE OF NON-ABLATIVE RF ENERGY (STRETTA) FOR ANTI-REFLUX ENDOSCOPIC SURGERY FOR REFRACTO- THE TREATMENT OF GERD. TEN YEARS FOLLOW UP RY GASTROESOPHAGEAL REFLUX DISEASE RESULTS Weon Jin Ko, South Korea; G. W. Song; J. Y. Cho

Monday, October 17, 2016 L. Dughera; Giacomo Lo Secco, Italy; G. Catalano; F. Cisarò; M. Morino; M. Salizzoni; G. Montrucchio Oesophageal neoplasia: Clinical P0459 P0467 RESPONSE TO TREATMENT WITH PROTON PUMP IN- ENDOSCOPIC TREATMENT VS. SURGERY FOR HIGH- HIBITORS (PPI) OF ATYPICAL SYMPTOMS DEPENDING RISK EARLY ESOPHAGEAL CANCER ON THEIR COEXISTENCE WITH TYPICAL SYMPTOMS Marek Kollar, Czech Republic; J. Krajciova; J. Maluskova; Alba Zúñiga Ripa, Spain; F. Estremera Arévalo; I. Aresté E. Honsova; A. Pazdro; T. Harustiak; D. Kodetova; Z. Anduaga; R. Iglesias Picazo; M. Oreja Arrayago Vackova; J. Spicak; J. Martinek P0460 P0468 A NEW GASTRIC ACID SUPPRESSOR, "VONOPRAZAN" IS DEVELOPMENT AND VALIDATION OF A TRAINING MOD- EFFECTIVE IN PROTON PUMP INHIBITOR-REFRACTORY ULE ON THE USE OF ACETIC ACID CHROMOENDOSCOPY REFLUX ESOPHAGITIS (AAC) TO DETECT BARRETT'S NEOPLASIA H. Yamashita; Atsushi Kanamori, Japan Fergus J. Q. Chedgy, United Kingdom; K. Kandiah; G. Longcroft-Wheaton; P. Bhandari P0461 ENDOSCOPIC NON-ABLATIVE RADIO FREQUENCY EN- P0469 ERGY TREATMENT (STRETTA®) FOR GASTROOESOPH- A RANDOMIZED CONTROLLED STUDY COMPARING AGEAL REFLUX DISEASE - THE FIRST U.K. SINGLE SEMI-COVERED STENTS VERSUS FULLY-COVERED CENTRE EXPERIENCE STENTS OF A NOVEL DESIGN WITH REGARD TO STENT Siby Punnoose, United Kingdom; R. Sathasivam; O. MIGRATION, IN PALLIATIVE TREATMENT OF OESOPHA- Reece-Bolton; A. Dhar; Y. Viswanath GUS AND CARDIA CANCER Jan Persson, Sweden; U. Smedh; Å. Johnsson; B. Ohlin; P0462 M. Sundbom; M. Nilsson; L. Lundell; E. Johnsson THE CONCEIVED LIMITATIONS OF COMMONLY PRE- SCRIBED PROTON PUMP INHIBITORS IN THE TREAT- P0470 MENT OF GASTROINTESTINAL REFLUX DISEASE LYMPHOVASCULAR INVASION MAY BE MORE RELEVANT Dan Carter, Israel; R. Dickman TO NODAL METASTASES THAN SUBMUCOSAL MASSIVE INVASION IN EARLY-STAGE ESOPHAGEAL SQUAMOUS P0463 CELL CANCERS: A RETROSPECTIVE ANALYSIS IN 29 CASES HOW TO REDUCE THE FAILURE RATE OF NISSEN FUN- Teppei Akimoto, Japan; O. Goto; Y. Kiguchi; Y. Mitsunaga; DOPLICATION? A PILOT STUDY ON A NOVEL SURGICAL A. Fujimoto; Y. Ochiai; T. Maehata; T. Nishizawa; T. APPROACH FOR GERD TREATMENT Uraoka; N. Yahagi Romeo Bardini, Italy; S. Rampado; A. Da Roit; S. De Gasperi; E. Savarino P0471 CLINICAL SIGNIFICANCE OF GLASGOW PROGNOSTIC P0464 SCORE FOR ESOPHAGEAL SQUAMOUS CELL CARCINO- CLINICAL YIELD OF USING COMMON REFLUX-SYMPTOM MA AFTER ESOPHAGECTOMY CORRELATION METHODS: A RETROSPECTIVE STUDY Toshiaki Tanaka, Japan; S. Matono; N. Mori; H. Hino; K. COMPARING THE DEMEESTER SCORE, SYMPTOM Kadoya; R. Nishida; K. Saisho; Y. Akagi INDEX, AND SYMPTOMS ASSOCIATION PROBABILITY IN PREDICTING RESPONSE TO ANTIREFLUX TREATMENT IN P0472 PATIENTS WITH GORD MISSED OESOPHAGOGASTRIC CANCERS AT ENDOSCOPY, M. Adesanya; Chirantha Premathilaka, United Kingdom; WHAT CAN WE LEARN FROM RETROSPECTIVE AUDIT? J. Jafari; I. Miah; T. Wong Anna Cavazza, United Kingdom; V. Karunanithi; A. Vaziri; J. Deacon; D. L. Morris P0465 A DOUBLE-BLIND, RANDOMIZED, MULTICENTER P0473 CLINICAL TRIAL INVESTIGATING THE EFFICACY AND THE OUTCOME OF ESOPHAGO-GASTRIC JUNCTIONAL SAFETY OF ESOMEPRAZOLE SINGLE THERAPY VERSUS ADENOCARCINOMA TREATED BY ESD AND ANALYSIS AND ESOMEPRAZOLE COMBINED THERAPY FOR THE RISK FACTOR OF LYMPH NODE METASTASIS IN PATIENTS WITH EROSIVE REFLUX DISEASE Akiko Takahashi, Japan; T. Oyama Ju Yup Lee, South Korea; S. K. Kim; K. B. Cho; J. G. Kwon; B. I. Jang

148 Poster in the Spotlight Poster of Excellence Clinical Case Session 149 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

Gastroduodenal neoplasia: Clinical P0482 THE INCIDENCE OF SYNCHRONOUS AND METACHRO- P0474 NOUS CANCERS AFTER ESD FOR UNDIFFERENTIAT- CHARACTERISTICS AND RISK FACTORS FOR SOLITARY ED-TYPE EARLY GASTRIC CANCER COMPARED TO NON-AMPULLARY DUODENAL CARCINOMA AFTER ESD FOR DIFFERENTIATED- TYPE Naomi Kakushima, Japan; H. Ono; H. Matsubayashi; Yuji Miyamoto, Japan; T. Yoshio; J. Fujisaki K. Takizawa; M. Tanaka; N. Kawata; S. Ito; K. Imai; K. Hotta; H. Ishiwatari P0483 EARLY GASTRIC CANCER WITH MIXED HISTOLOGICAL P0475 COMPONENTS IS HIGH-RISK FOR LYMPH NODE METAS- EFFECT OF VONOPRAZAN IN ARTIFICIAL ULCER HEALING TASIS AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION Akinori Shimayoshi, Japan; S. Yamamoto; K. Kozumi; Yohei Horikawa, Japan; H. Mizutamari; N. Mimori; Y. E. Kimura; E. Yoshida; F. Sano; C. Torizumi; T. Eri; Kato; S. Fushimi; S. Okubo M. Horie; K. Iwahashi; D. Nakamatsu; M. Murata; M. 2016 17, October Monday, P0476 Miyazaki; E. Satoshi; M. Oshita THE CORRELATION BETWEEN HISTOLOGICAL GASTRITIS P0484 STAGING – "OLGA/OLGIM" AND SEROLOGICAL PEPSINO- WITHDRAWN GEN TEST IN RISK ASSESSMENT OF GASTRIC CANCER IN CHINA P0485 Xiaoteng Wang, China; B. Lu; S. Zhang; C. Y. Chen; M. ANALYSIS OF PREDICTIVE FACTORS FOR VARIATION Zhang OF NEUTROPHIL COUNT DURING GASTROINTESTINAL CANCER CHEMOTHERAPY USING REAL WORLD DATA. P0477 Daisuke Yamaguchi, Japan; K. Taneishi; M. Hamanaka; UPCOMING PARADIGM SHIFT OF GASTRIC CANCER Y. Mori; M. Kanai; S. Matsumoto; M. Muto; Y. Okuno RISK: INCREASE OF H. PYLORI NEGATIVE GASTRIC CANCER AND THEIR RISK FACTORS P0486 Su Nam, South Korea; S. W. Jeon; H. Y. Park POTENTIAL ROLE OF MICRORNA-375 IN THE DIAGNO- SIS OF CANCERS: A META-ANALYSIS P0478 Jin Yan, China NEGATIVE PATHOLOGIC RESULTS AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION P0487 R. Daegon; D. Kang; H. Kim; C. Choi; S. Park; S. Kim; H. CLINICAL OUTCOMES OF ENDOSCOPIC SUBMUCOSAL Nam; S. Lee; J. Cho; Jungmin Park, South Korea; K. Oh DISSECTION IN PATIENTS WITH EARLY GASTRIC CANCER UNDER 40 YEARS OLD P0479 Kyu Yeon Hahn, South Korea; S. K. Lee; C. H. Park; H. EFFICACY AND SAFETY OF A PATIENT-POSITIONING Chung; J. C. Park; Y. H. Youn; S. K. Shin; Y. C. Lee DEVICE (EZ-FIX) FOR ENDOSCOPIC SUBMUCOSAL DIS- SECTION OF GASTRIC EPITHELIAL NEOPLASM P0488 Sungik Pyeon, South Korea; D. W. Ha; C. J. Park; C. H. FEASIBILITY OF COLD SNARE POLYPECTOMY FOR Park; B. E. Lee; G. H. Kim; G. A. Song MULTIPLE DUODENAL ADENOMAS IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS: A PILOT STUDY P0480 Kenta Hamada, Japan; Y. Takeuchi; H. Ishikawa; Y. Tonai; USEFULNESS OF A NOVEL MAGNIFYING LCI WITH IN- N. Matsuura; Y. Ezoe; R. Ishihara; Y. Tomita; H. Iishi DIGO CARMINE DYE IN THE DIFFERENTIAL DIAGNOSIS OF GASTRIC SMALL DEPRESSIVE LESIONS P0489 Yoshiyasu Kitagawa, Japan; T. Hara; T. Suzuki; T. ORAL HEALTH-RELATED BEHAVIOR AMONG CANCER Yamaguchi SURVIVORS IN KOREA USING POPULATION-BASED NATIONWIDE SURVEY P0481 Mi Ah Han, South Korea; M. G. Oh; J. Park; S. Y. Ryu; S. NEUTROPHIL LYMPHOCYTE RATIO VERSUS PLATELET W. Choi LYMPHOCYTE RATIO IN PREDICTION OF SURVIVAL IN PATIENTS WITH GASTRIC ADENOCARCINOMA P0490 Salih Gundogdu, Turkey; B. Yildiz; M. Tez GASTROINTESTINAL STROMAL TUMORS TREATED WITH CURATIVE INTENT Filipa Ávila, Portugal; R. Vale Rodrigues; J. P. da Silva; I. Francisco; C. Albuquerque; A. Dias Pereira

Poster in the Spotlight Poster of Excellence Clinical Case Session 149

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

Treatment H. pylori-associated malignancy P0498 Poster Session CLINICOPATHOLOGICAL FEATURES OF HELICOBACTER 10:30 - 17:00 Hall X5 PYLORI-NEGATIVE EARLY GASTRIC CANCER Monday, October 17, 2016 H. Pylori I Kohei Matsumoto, Japan; H. Ueyama; A. Nagahara; P0491 ª Y. Akazawa; H. Komori; T. Takeda; K. Matsumoto; D. CHANGES OF INTESTINAL MICROBIOTA AFTER HELICO- Asaoka; M. Hojo; T. Yao; S. Watanabe BACTER PYLORI ERADICATION THERAPY P0499 Dilyara Safina, Russia; S. R. Abdulkhakov; T. Grigoryeva; IMPLEMENTATION OF A CLINICAL-ENDOSCOPIC-PATHO- B. Kovarsky; D. Khusnutdinova; M. Markelova; R. A. LOGICAL -INDEX (CEPIX) FOR ESTIMATING THE RISK OF Abdulkhakov; V. Chernov SPORADIC NON-CARDIA GASTRIC CARCINOMA IN DYS- P0492 PECTIC PATIENTS AND GASTRITIS ASSOCIATED WITH HIGH DOSE CAM WITH VONOPRAZAN (P-CAB) PLUS INFECTION BY HELICOBACTER PYLORI IN A CLINICAL AMX REGIMEN IS THE STRONGEST H.PYLORI ERAD- SETTING. A PROPOSAL ICATION TRIPLE THERAPY REGIMENS TO IMPROVE Gabriel Arismendi-Morillo, Venezuela; I. Hernandez; SUCCESS RATE OF CAM BASED REGIMENS M. Lizarzabal; E. Mengual; G. Romero Takuji Yamasaki, Japan; M. Owari; Y. Tokai; Y. Amano; P0500 H. Nakashima; N. Sakaki; M. Yoshida USEFULNESS OF THE MAGNIFYING ENDOSCOPY WITH P0493 NARROW-BAND IMAGING FOR THE DETECTION OF EFFICACY OF VONOPRAZAN BASED NEW HELICO- TUMOR DEMARCATION IN EARLY GASTRIC CANCERS BACTER PYLORI ERADICATION THERAPY AFTER HELICOBACTER PYLORI ERADICATION Yu Sato, Japan; K. Yamamoto; M. Mori; A. Asakura; Yoichi Akazawa, Japan; H. Ueyama; A. Nagahara; H. Y. Kawasaki; T. Tokuda; M. Matsushita; H. Saiki; Y. Komori; T. Takeda; K. Matsumoto; K. Matsumoto; D. Tokuda; Y. Onishi; A. Ishimi; T. Kawai; M. Hamano; M. Asaoka; M. Hojo; T. Yao; S. Watanabe Chiba; K. Maeda; N. Tatsumi; T. Ito P0501 P0494 THE IMPACT OF HELICOBACTER PYLORI INFECTION ON HIGH DOSE ONE WEEK TRIPLE THERAPY FOR H.PYLORI THE RISK OF ADVANCED COLORECTAL NEOPLASM IS INFECTION DIFFERENT BY AGE GROUP Benedict Porter, United Kingdom; L. Lim; R. Logan Hyunsung Park, South Korea; J. J. Park; Y. M. Park; S. J. Baik; D. H. Jung; Y. H. Yoon; J. H. Kim; H. Park P0495 THE EFFECTIVENESS OF VONOPRAZAN-BASED H.PY- P0502 LORI ERADICATION THERAPY IN OUR HOSPITAL LONG-TERM FOLLOW UP OF PEPSINOGEN I/II RATIO Seita Kataoka, Japan; H. Osumi; J. Fujisaki; K. Miki AFTER HELICOBACTER PYLORI ERADICATION Su Nam, South Korea; S. W. Jeon; H. Y. Park; Y. H. Kwon P0496 EFFICACY OF RIFABUTIN-BASED TRIPLE THERAPY FOR P0503 HELICOBACTER PYLORI ERADICATION AS A RESCUE PERSISTENT HELICOBACTER PYLORI INFECTION AND THERAPY OLD AGE ARE RISK FACTORS FOR METACHRONOUS Cheng Yu Lin, Taiwan; C.-J. Kuo; C.-T. Chiu; M.-Y. Su RECURRENCE AFTER ENDOSCOPIC SUBMUCOSAL DIS- SECTION OF EARLY GASTRIC CANCER P0497 C. Chung; Jun-Won Chung, South Korea; D. K. Park; S. EFFICACY OF 7-DAY BISMUTH-BASED QUADRUPLE Y. Kim; K. A. Kwon; K. O. Kim; Y. J. Kim THERAPY VERSUS 14-DAY MOXIFLOXACIN-BASED TRIPLE THERAPY FOR SECOND-LINE TREATMENT OF P0504 HELICOBACTER PYLORI INFECTION CLINICOPATHOLOGICAL CHARACTERISTICS OF GASTRIC Sung Eun Kim, South Korea; J. H. Roh; M. I. Park; S. J. CANCER DETECTED AFTER SUCCESSFUL HELICO- Park; W. Moon; J. H. Kim; K. Jung; J. Lee; G. H. Jang BACTER PYLORI ERADICATION Naomi Kakushima, Japan; H. Ono; K. Takizawa; M. Tanaka; N. Kawata; S. Ito; K. Imai; K. Hotta; H. Ishiwatari; H. Matsubayashi

150 Poster in the Spotlight Poster of Excellence Clinical Case Session 151 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

P0505 P0513 DOWN-REGULATION OF LNCRNA NR_033122 REPRESSES PROTECTIVE EFFECT OF URSODEOXYCHOLIC ACID VPS11 EXPRESSION BY EPIGENETIC MODULATION IN H. AGAINST CHEMOTHERAPY-INDUCED MUCOSITIS PYLORI-RELATED GASTRIC CARCINOMA Seung Han Kim, South Korea; H. J. Chun; S. Y. Lee; B. Yini Dang, China; G. Zhang K. Choi; J. M. Lee; J. M. Lee; I. K. Yoo; H. S. Choi; E. S. Kim; B. Keum; Y. T. Jeen; H. S. Lee; C. D. Kim P0506 LINE-1 HYPOMETHYLATION IS A RARE EVENT IN PRE- P0514 NEOPLASTIC STAGES OF GASTRIC CARCINOGENESIS EXPERIENCE WITH NALOXONE HYDROCHLORIDE FOR THE Juozas Kupcinskas, Lithuania; R. Steponaitiene; C. TREATMENT OF ACUTE COLONIC PSEUDOOBSTRUCTION Langner; J. Skieceviciene; L. Kupcinskas; Vijay Sharma, India; R. Sharma; V. Vaishnav P. Malfertheiner; A. Link P0515 P0507 ARE NUTRITIONAL BEHAVIOR, LIFESTYLE-FACTORS Monday, October 17, 2016 17, October Monday, GISTAR PILOT STUDY: GROUP DESCRIPTION AND PRE- AND ANTIBIOTICS RISK FACTORS OF SMALL BOWEL LIMINARY RESULTS BACTERIAL OVERGROWTH (SIBO)? Marcis Leja, Latvia; A. Rudule; J. Y. Park; R. Murillo; I. K. Gewecke; C. von Castell; S. Nannen-Ottens; J. Keller; Liepniece-Karele; S. Isajevs; I. Kikuste; D. Rudzite; P. P. Layer; Viola Andresen, Germany Krike; S. Parshutin; I. Polaka; A. Kirsners; D. Santare; I. Daugule; R. Herrero P0516 A VALIDATION STUDY: INSERTION DEPTH MEASURE- P0508 MENT IN SINGLE BALLOON ENTEROSCOPY IN PORCINE INFECTIOUS AGENTS AND COLORECTAL CANCER: ANY MODEL. CORRELATION WITH CAPSULE ENDOSCOPY IMPLICATION OF HELICOBACTER PYLORI? Isis Araujo, Spain; G. Fernández-Esparrach; G. Gómez; Elisa Soares, Portugal; M. Gravito-Soares; C. Lérias; C. C. Rodriguez de Miguel; C. Romero; G. Martínez-Pallí; Sofia D. Capitán; O. Sendino; A. Gines; J. Llach; B. González- Suárez Small intestinal immunology, immunity and inflammation Coeliac disease (adult) Poster Session P0517 10:30 - 17:00 Hall X5 DIAGNOSIS OF CELIAC DISEASE WITHOUT DUODENAL Small Intestinal I BIOPSY IN ADULTS WITH POSITIVE SEROLOGY TESTING P0509 Gianluca Ianiro, Italy; L. Valerio; S. Pecere; G. L. DIFFUSION-WEIGHTED MAGNETIC RESONANCE FOR Scaglione; D. Arciuolo; S. Bibbò; R. Ricci; E. Capoluongo; ASSESSING ILEAL CROHN'S DISEASE FIBROTIC STE- A. Gasbarrini; G. Cammarota NOSIS: VALIDATION TROUGH COMPARISON WITH THE P0518 PATHOLOGIC SCORE OF SURGICAL SPECIMENS GENETIC VARIANTS ASSOCIATED WITH ANAEMIA IN I. Angriman; C. La Cognata; A. Caruso; R. D'Inca; C. ADULT COELIAC PATIENTS: THE ROLE OF TMPRSS6 AND Bortolato; Giovanni Tagliente, Italy; G. C. Sturniolo; R. HFE Bardini; M. Scarpa Nicola Imperatore, Italy; R. Tortora; L. De Falco; P. P0510 Capone; M. S. Bruno; N. Gerbino; N. Caporaso; A. WITHDRAWN Iolascon; A. Rispo P0511 P0519 THE ROLE OF ZONULIN AND HAPTOGLOBIN GENOTYPE FODMAPS FREE DIET: AN EFFECTIVE SOLUTION FOR IN TYPE 1 DIABETES SYMPTOMATIC COELIAC PATIENTS ON GLUTEN FREE DIET Hasan Ahmad Al-Saffar, Sweden; C. Sturgeon; R. Nicola Imperatore, Italy; A. Rispo; P. Capone; F. Freire; A. Fasano Castiglione; N. Gerbino; L. Lucci; G. Accarino; N. Caporaso; R. Tortora P0512 WNT SIGNALING ACTIVATION IN THE GUT ANTI-IN- P0520 FLAMMATORY PROCESS DRIVEN BY THE HERBAL VALUE OF FOLLOW-UP CONTROL BIOPSY AND SIGNIF- PREPARATION, STW5 ICANCE OF INCOMPLETE MUCOSAL RECOVERY CELIAC Thomas Bertalot, Italy; S. Schrenk; N. Facchinello; T. DISEASE Skobo; C. Cenzi; L. Dalla Valle; H. Abdel-Aziz; R. Di Henna Pekki, Finland; K. Kurppa, M. Maki, H. Huhtala, Liddo K. Laurila, P. Collin, K. Kaukinen

Poster in the Spotlight Poster of Excellence Clinical Case Session 151

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

P0521 P0528 MARKERS OF INNATE IMMUNITY AND GUT PERME- ENDOGASTRORIO CLINIC EXPERIENCE IN THE TREAT- ABILITY IN COELIAC DISEASE PATIENTS WITH PER- MENT OF EXCESS WEIGHT USING THE SPATZ3 BALLOON SISTENT SYMPTOMS ON A GLUTEN-FREE DIET Ricardo Jose Fittipaldi-Fernandez, Brazil; C. F. Diestel;

Monday, October 17, 2016 Pilvi Laurikka, Finland; K. Lindfors, M. Oittinen, H. M. Passos Galvão Neto Huhtala, K. Kurppa, K. Kaukinen P0529 P0522 ASPIREASSIST AS A TOOL TO TREAT OBESITY: 1, 2 AND THE LIVER IN CELIAC DISEASE: A MOROCCAN SINGLE 3 YEAR RESULTS TO DATE IN 100-SUBJECT ONGOING CENTER EXPERIENCE MULTI-CENTER POST-MARKET STUDY Hind Zejly, Morocco; I. Benelbarhdadi; F. Z. Ajana; R. Evzen Machytka, Czech Republic; H. Forssell; E. Noreen; Afifi; A. Essaid R. Turro; T. Bammer; P. A. Testoni; V. Fehlert P0523 P0530 SERUM 25-HYDROXYCHOLECALCIFEROL LEVELS AT CE- COMBINATION OF OMEGA-3 FATTY ACIDS WITH ALIVE LIAC DISEASE PRESENTATION PREDICT BONE MINERAL PROBIOTIC ARE SUPERIOR THAN PROBIOTIC ALONE DENSITY RECOVERY AFTER GLUTEN EXSCLUSION FOR NAFLD PREVENTION Konstantinos Efthymakis, Italy; M. Serio; R. Sanelli; A. Nazarii Kobyliak, Ukraine; T. M. Falalyeyeva; P. Bodnar; Milano; A. Bonitatibus; F. Laterza; M. Neri T. Beregova; L. I. Ostapchenko P0524 Nutrients and gut function CLINICAL OUTCOME OF PATIENTS WITH RAISED INTRAEPITHELIAL LYMPHOCYTES (IELS) WITH NORMAL P0531 VILLOUS ARCHITECTURE ON DUODENAL BIOPSY IMPACT OF BODY MASS INDEX AND BODY COMPOSI- Vikrant Parihar, Ireland; R. Stack; A. Alakkari; S. TION ON LUNG FUNCTION IN ADULT PATIENTS WITH Crowther; D. McNamara CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION Katharina Staufer, Austria; S. Harm; E. Halilbasic; P0525 P. Hillebrand; P. Jaksch; W. Klepetko; M. Trauner; L. COMPARING DIETITIAN-LED GROUP CLINICS TO Kazemi-Shirazi INDIVIDUAL APPOINTMENTS FOR NEWLY DIAGNOSED PATIENTS WITH COELIAC DISEASE (CD) P0532 Matthew Kurien, United Kingdom; N. Trott; F. Branchi; COMORBID FUNCTIONAL DYSPEPSIA AND PSYCHOLOGICAL D. S. Sanders SYMPTOM SEVERITY ARE INDEPENDENTLY ASSOCIATED WITH HIGHER GASTROINTESTINAL SYMPTOM SCORES Obesity AFTER A LACTULOSE NUTRIENT CHALLENGE TEST IN IBS Daniel Pohl, Switzerland; L. Van Oudenhove; H. Törnblom; Poster Session L. Oehmann; B. Le Nevé; J. Tack; M. Simrén 10:30 - 17:00 Hall X5 P0533 Nutrition I PROTON PUMP INHIBITORS - A RISK FOR MICRONUTRI- P0526 ENT DEFICIENCY. BUT ARE WE LOOKING OUT FOR THIS? CIRCULATING MICRORNA ASSOCIATED WITH VISCERAL Tareq El Menabawey, United Kingdom; S. Dluzewski; S. OBESITY: A POSSIBLE BIOMARKER OF DIGESTIVE Phillpotts; R. Preedy; K. Besherdas CANCERS P0534 Juntaro Matsuzaki, Japan; R. Shimizu-Hirota; H. Ta- A CROSS SECTIONAL STUDY ON THE MILK CONSUMP- dokoro; Y. Iwao; T. Ochiya TION IN SOUTHERN ITALY P0527 Fabiana Zingone, Italy; C. Bucci; P. Iovino; C. Ciacci INDIVIDUALIZED RESPONSES TO LIFESTYLE INTERVEN- P0535 TIONS CAN BE PREDICTED BY GUT MICROBIOTA NUTRITIONAL DEFICIENCIES IN PATIENTS WITH David Alejandro Muniz-Pedrogo, USA; B. A. Schmidt; CHRONIC ATROPHIC AUTOIMMUNE GASTRITIS M. D. Jensen; J. A. Murray; P. C. Kashyap; V. Nehra Alessandra Zilli, Italy; F. Cavalcoli; I. Fanetti; C. Ciafardini; D. Conte; S. Massironi

152 Poster in the Spotlight Poster of Excellence Clinical Case Session 153 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

Paediatric gastro-duodenal disorders (NOT H. pylori) P0542 HELICOBACTER PYLORI VIRULENCE GENES MAY DE- Poster Session TERMINE CLINICAL OUTCOME AND GASTRIC PATHOLGY 10:30 - 17:00 Hall X5 AMONG INFECTED EGYPTIAN CHILDREN Paediatric: Upper GI Sana Barakat, Egypt; N. Baddour; R. Harfoush; A. Hasab El-Naby P0536 CO-MORBIDITIES IN ADOLESCENTS WITH CELIAC DIS- P0543 EASE: FINDINGS FROM A POPULATION-BASED COHORT ROLE OF THE GLUTEN-FREE DIET ON NEUROLOGICAL- Amit Assa, Israel; Y. Frenkel-Nir; L. Katz; R. Shamir ELECTROENCEPHALOGRAPHY FINDINGS AND SLEEP DISORDERED BREATHING IN CHILDREN WITH CELIAC P0537 DISEASE ETHNIC DISPARITIES IN PHENOTYPE AND HISTOPA- Chiara Maria Trovato, Italy; P. Parisi; M. Montuori; C.

THOLOGY PROFILE IN CHILDREN WITH CELIAC DISEASE Anania; A. Ferretti; M. Arena; F. Valitutti; M. P. Villa; S. 2016 17, October Monday, Efrat Broide, Israel; B. Yerushalmi; S. Vosco; S. Cucchiara Matalon; H. Shirin P0544 P0538 SMALL INTESTINAL BACTERIAL OVERGROWTH IN ANTHROPOMETRIC MEASURES AND PREVALENCE CYSTIC FIBROSIS: EPIDEMIOLOGY, SYMPTOMS AND A TRENDS IN ADOLESCENTS WITH CELIAC DISEASE: A CLINICAL TRIAL WITH RIFAXIMIN POPULATION BASED CROSS SECTIONAL STUDY A. De Alessandri; Manuele Furnari, Italy; M. Bassi; M. Amit Assa, Israel; Y. Frenkel-Nir; Y. Leibovici-Weissman; Haupt; R. Haupt; P. Ganduglia; A. Calvi; F. Bagnasco; G. L. Katz; Z. Levi; R. Shamir Romanisio; V. Savarino; L. Minicucci

Paediatric H. pylori P0545 GASTRITIS AND HELICOBACTER PYLORI INFECTION IN P0539 CHILDREN WITH NEWLY DIAGNOSED CELIAC DISEASE CLINICAL PRESENTATION OF CELIAC DISEASE AND Marcin Banasiuk, Poland; A. Szaflarska-Poplawska; ESPGHAN CELIAC DISEASE GUIDELINES RETROSPECTIVE A. Mantei; A. Mazan; M. Mitrowski; A. Gawronska; P. REAL-TIME APPLICATION IN A SINGLE-CENTER EUROPE- Albrecht; A. Banaszkiewicz AN PEDIATRIC POPULATION: A 10 YEARS EXPERIENCE A. R. Di Biase; G. Marasco; A. Colecchia; M. G. Berardi; syndromes, food and F. Ravaioli; L. Iughetti; Davide Feste, Italy other small intestinal disorders (paediatric) P0540 P0546 SMALL INTESTINAL BACTERIAL OVERGROWTH AMONG ARE LYMPHOID FOLLICLES IN CHILDREN WITH ID- CHILDREN WITH GASTRO-ESOPHAGEAL REFLUX AND IOPATHIC GASTRITIS MUCH MORE COMMON THAN NONCELIAC GLUTEN SENSIVITY PREVIOUSLY THOUGHT? Oana Belei, Romania; L. Olariu; I. Simedrea; Efrat Broide, Israel; V. Richter; S. Mendlovic; H. Shirin T. Marcovici; O. Marginean P0547 Coeliac disease (paediatric) FRUCTOSE SENSITIVITY - AND NOT - CORRELATE WITH THE CLINICAL P0541 SYMPTOMS REPORTED BY CHILDREN WITH CHRONIC LINKED COLOR IMAGING COMBINE MAGNIFY ENDOS- ABDOMINAL PAIN? COPY FOR HELICOBACTER PYLORI INFECTION AND Veronika Hammer, Austria; K. Hammer; K. Hammer; J. INTESTINAL METAPLASIA: A PIONEER STUDY WITH Hammer PRELIMINARY RESULT IN TAIWAN Tsung-Hsing Chen, Taiwan; C.-T. Chiu P0548 HOW DO THE MATERNAL AND NEWBORNS PARAME- TERS INFLUENCE THE CHILDREN'S BIRTH WEIGHT? Cristina Oana Marginean, Romania; C. Marginean; L. Melit; M.O. Marginean

Poster in the Spotlight Poster of Excellence Clinical Case Session 153

UEG Week Final Programme : Poster Sessions Monday, October 17, 2016

Paediatric nutrition CC06 C.DIFFICILE-ASSOCIATED POUCHITIS AFTER TOTAL P0549 COLECTOMY TIMING OF SYMPTOMS DURING AND AFTER THE Anatoly Ulyanin, Russia; E. Poluektova; V. Ivashkin; O. FRUCTOSE HYDROGEN BREATH TEST IN CHILDREN

Monday, October 17, 2016 Shifrin; A. Tertychnyy; D. Fyodorov; A. Ivanova WITH CHRONIC ABDOMINAL PAIN Katharina Hammer, Austria; V. Hammer; K. Hammer; CC07 J. Hammer AN ADVERSE TATTOO REACTION Sam Smith, United Kingdom; A. Dhaliwal; S. Shah; N. Poster Session Hudson 10:30 - 17:00 Hall X5 CC08 Clinical Cases: IBD and Colon CLOSURE OF AN INTESTINAL PERFORATION WITH AN AUTOLOGOUS FAT PLUG IN A MAN WITH CROHN'S DISEASE CC01 Yuyong Tan, China; D. Ou; X. Wang; D. Liu HYPERHOMOCYSTEINEMIA, ISCHEMIC STROKE AND CROHN'S DISEASE: IS THERE A LINK? CC09 Farouk Benmediouni, Algeria; A. Tebaibia A THE CASE OF COLITIS WITH ULCERATIVE COLITIS-LIKE ENDOSCOPIC APPEARANCE ASSOCIATED WITH JUVE- CC02 NILE POLYPOSIS-HEREDITARY HEMORRHAGIC TELANGI- MILIARY TUBERCULOSIS IN CROHN´S DISEASE. A COM- ECTASIA SYNDROME AND SMAD4 MUTATIONS PLICATION OF THE IMMUNOSUPPRESSION Sakae Mikami, Japan; Y. Yamashita Carvalho Liliana, Portugal; M. A. Túlio; J. Rodrigues; S. Marques; S. Santos; T. Bana e Costa; C. Chagas CC10 RECTAL ISCHEMIA MIMICKING A TUMOR MASS CC03 Marco Silva, Portugal; A. Peixoto; J. A. Sarmento; G. LYMPHOMATOID GRANULOMATOSIS (LYG) ASSOCIATED Macedo WITH AZATHIOPRINE THERAPY IN CROHN'S DISEASE. A RARE SIDE-EFFECT CC11 G. Theocharis; Chrisostomos Tsolias, Greece; G. A CASE OF COLLISION TUMOR AT ASCENDING COLON Tsiaousis; V. Lazaris; E. Tzouvara; M. Kyriakopoulou; K. INVOLVEMENT IN 65-YEAR-OLD FEMALE Thomopoulos Hee Yun Ryu, South Korea; S. H. Kim; Y. S. Park CC04 CC12 ANTI-TUMOR NECROSIS FACTOR AND LATENT TUBER- A RARE CAUSE OF INTESTINAL OBSTRUCTION CULOSIS: A CASE OF PROPHYLAXIS AND EFFECTIVE Juliana Pinho, Portugal; P. Sousa; D. Martins; E. Cancela; THERAPY FAILURE R. Araújo; A. Castanheira; P. Ministro; A. Silva Diana Martins, Portugal; P. Sousa; J. Pinho; P. Crespo; CC13 R. Araújo; E. Cancela; A. Castanheira; A. Silva; C. SYNCHRONOUS PRIMARY ANORECTAL MELANOMA Casimiro; P. Ministro AND COLONIC ADENOCARCINOMA: A CASE REPORT CC05 Rafaela Vasconcelos Loureiro, Portugal; V. Borges; R. SNEDDON-WILKINSON'S DISEASE AND OTHER NEU- V. Rodrigues; T. Capela; C. Bernardes; M. J. Silva; P. TROPHILIC DERMATOSIS IN IBD Russo; M. Oliveira; M. Mendes; P. Duarte Aimen Belaïd, Belgium; M. M. Bruneau; M. Shapira; B. Devroey; J. M. Ghilain

154 Poster in the Spotlight Poster of Excellence Clinical Case Session 155 Monday, October 17, 2016 Poster Sessions : UEG Week Final Programme

CC14 5 YEARS AFTER CURATIVE TREATMENT FOR NEURO- BLASTOMA: ANTI-HU MEDIATED COLONIC DYSMOTILI- TY AND PSEUDOACHALASIA Radha Gadhok, United Kingdom; K. Frykos; N. Zarate-Lopez CC15 ISCHEMIC COLITIS ASSOCIATED WITH MESENTERIC PANNICULITIS João Pinto, Portugal; R. Azevedo; H. Ribeiro; C. Leitão; A. Caldeira; E. Pereira; A. Banhudo CC16 Monday, October 17, 2016 17, October Monday, PERIANAL PAGET'S DISEASE Marco Silva, Portugal; A. Albuquerque; M. Silva; C. Lisboa; G. Macedo CC17 GASTROINTESTINALLY MEDIATED FOOD ALLERGY (GMA) CAUSING SPONDYLARTHROPATHY-LIKE DIS- EASE Martin Raithel, Germany; R. Rieker; F. Vitali; J. Kressel; M. F. Neurath; H. Baenkler; S. Finzel CC18 POST-INFECTIOUS CHRONIC INTESTINAL PSEUDO-OB- STRUCTION DUE TO NEUROLYSIS OF MYOENTERIC PLEXUS Diana Martins, Portugal; P. Sousa; J. Fernandes; R. Araújo; E. Cancela; A. Castanheira; P. Ministro; A. Silva CC19 DIAGNOSTIC APPROACH OF INTESTINAL TUBERCULO- SIS:RISING INCIDENCE IN HIGH-RISK POPULATIONS Mitsuhiro Kaneto, Japan; M. Ito; S. Saito; M. Fujii; S. Ishiyama; A. Fujiwara; J. Nasu; M. Yoshioka; S. Junji CC20 SERONEGATIVE INTESTINAL VILLOUS ATROPHY: A DIAGNOSTIC CHALLENGE Claudio Martins, Portugal; C. Teixeira; É. Gamito; A. P. Oliveira

Poster in the Spotlight Poster of Excellence Clinical Case Session 155

Poster Sessions Tuesday, October 18, 2016

Poster Sessions by Day Tuesday, October 18, 2016

Posters in the Spotlight 10:30 – 12:00 E-Poster Lounge 1 Imaging and interventional radiology in liver diseases Focus on Chairs: Laurent Castera, France original research: Posters in the P0598 Spotlight THE ROLE OF TIPS IN THE MANAGEMENT OF LIVER TRANSPLANT CANDIDATES Lukas Unger, Austria; T. Stork; S. Maschke; M. Pawloff; T. Bucsics; S. Rasoul-Rockenschaub; M. Trauner; T. Reiberger; T. Soliman; G.A. Berlakovich P0600 OBLITERATION OF PORTOSYSTEMIC SHUNTS IMPROVES HEPATIC FUNCTIONAL RESERVE Nobuo Waguri, Japan; A. Osaki; M. Sato; M. Ogawa; A. Kimura; T. Aiba; O. Yoneyama; K. Furukawa; K. Igarashi P0601 CONTRAST ENHANCED ULTRASOUND AS A FIRST LINE IMAGING METHOD IN THE EVALUATION OF FLL IN DAI- LY PRACTICE. A LARGE MONOCENTRIC EXPERIENCE Tudor Moga, Romania; C. Ivascu-Siegfried; C. Pienar; A. Popescu; R. L. D. Sirli; M. Danila; I. Sporea P0602 EVALUATION OF LIVER FIBROSIS USING TRANSIENT Up to 6 posters featuring hot ELASTOGRAPHY IN NONALCOHOLIC STEATOHEPATITIS (NASH) PATIENTS topic research will be presented Ruxandra G. Mare, Romania; I. Sporea; A. Popescu; R. in the Posters in the Spotlight L. D. Sirli; A. Sima; R. Timar Sessions at the E-Poster P0603 Terminal in the E-Poster LIVER AND SPLEEN STIFFNESS ASSESSED BY TRANSIENT Lounges in Hall X4. ELASTOGRAPHY AND REAL-TIME 2D SHEAR WAVE A following discussion is led ELASTOGRAPHY AND ELFTM TEST HAVE VERY GOOD by two moderators and experts PERFORMANCE FOR NON-INVASIVE DETECTION AND in the field. At the end of each ESTIMATING SEVERITY OF PORTAL HYPERTENSION Ivica Grgurevic, Croatia; D. Cvetko; T. Bokun; S. Mustapic; session, the Oral Free Paper A. Lukic; M. Banic; B. Brkljacic; J. Curic; M. Kujundzic Prize will be awarded to the best presenter. P0604 OUTCOMES OF RADIOFREQUENCY ABLATION AND MICRO– WAVE ABLATION IN LIVER METASTASES: A SINGLE CENTER EXPERIENCE Z. A. Sparchez; Tudor Mocan, Romania; P. Radu; C. Cainap; G. Kacso; A. Seicean; N. Al Hajjar

E-Posters will be published on www.ueg.eu/week/24-7

157

16_08_Inserat_UEGWEEK_FP_posters_75_75x220mm_RZ.indd 1 14.09.16 16:02 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

Posters in the Spotlight P0703 10:30 – 12:00 E-Poster Lounge 2 VALIDATION OF ENDOSCOPIC CLASSIFICATION FOR Optimising the use of colonoscopy in clinical settings COLORECTAL LATERALLY SPREADING TUMORS USING Chairs: Bjorn Rembacken, United Kingdom AN EDUCATIONAL WEBSYSTEM Roel M. M. Bogie, The Netherlands; L.-C. Chang; B. Winkens; T. Matsuda; S. Tanaka; H. Yamano; M. Rutter; P0699 R. Kiesslich; A. Ono; A. Sanchez Yague; T. Kaltenbach; OPTIMIZING WITHDRAWAL TIME AND USE OF FUSE R. Soetikno; S.-E. Kudo; H. M. Chiu; S. Sanduleanu ENDOSCOPE ACHIEVE SIMILAR RESULTS IN TERM OF P0704 INCREASING ADENOMA DETECTION RATE. RESULTS OF COLORECTAL POLYPS DIAGNOSIS BY NARROW-BAND A PRELIMINARY OBSERVATIONAL STUDY IMAGING - DIFFERENCES BETWEEN THE CLINICAL Gianpiero Manes, Italy; M. Devani; S. Saibeni; I. Arena; TRIALS AND THE REAL WORLD G. De Nucci; P. Andreozzi; B. Omazzi Joana Castela, Portugal; J. Moleiro; R. Vale Rodrigues; P0700 C. Martins; F. Ávila; J. Cortez-Pinto; S. Mão de Ferro; PREDICTORS RELATED TO COLONOSCOPY COMPLICATIONS I. Rosa; M. Serrano; J. Pereira da Silva; S. Ferreira; I. IN AN ORGANISED COLORECTAL CANCER SCREENING Marques; I. Claro; P. Lage; A. Dias Pereira PROGRAMME WITH IMMUNOCHEMICAL FAECAL OCCULT BLOOD TEST Posters in the Spotlight I. Idigoras Rubio; Eunate Arana-Arri, Spain; I. Bilbao; 14:00 – 15:30 E-Poster Lounge 1 J. Fernandez; I. Fernandez; L. Martinez-Indart; Clinical aspects on acute and chronic pancreatitis I. Gutierrez-Ibarluzea; M. I. Portillo Villares Chairs: Marco J. Bruno, The Netherlands P0701 REAL TIME HISTOLOGY AT ENDOSCOPY - VIRTUAL P0634 ELECTRONIC CHROMOENDOSCOPY AND PROBE CON- ACUTE PANCREATITIS IN THE ELDERLY: A CAUSE FOR FOCAL LASER ENDOMICROSCOPY CAN ASSESS SUBTLE INCREASED CONCERN? RETROSPECTIVE EVALUATION MUCOSAL AND VASCULAR INFLAMMATORY CHANGES OF A TERTIARY REFERRAL CENTER IN ULCERATIVE COLITIS PATIENTS S. R. Fernandes; C. M. Moura; P. Santos; Joana Carvalho, Marietta Iacucci, Canada; X. Gui; O. Akinola; Portugal; T. Antunes; J. Velosa R. Panaccione; S. Ghosh P0635 P0702 ENDOSCOPIC AND PHARMACOLOGICAL PROPHYLAXIS DIAGNOSTIC ACCURACY OF THE NICE CLASSIFICATION 2016 18, October Tuesday, OF POST-ERCP PANCREATITIS: A META-ANALYSIS AND FOR PREDICTING DEEP SUBMUCOSAL INVASION IN CO- SYSTEMATIC REVIEW LON LESIONS ASSESSED IN VIVO. PRELIMINARY RESULT Salvatore Francesco Vadalà di Prampero, Italy; G. Ignasi Puig, Spain; M. Lopez-Ceron; M. Pellise; A. Herreros Faleschini; M. Bulajic; D. Berretti; M. Marino; N. Panic; de Tejada; A. Arnau; M. Fornells Sala; L. De Castro; A. M. Zilli Ferrandez; O. Nogales Rincon; J. López Vicente; A. Z. Gimeno Garcia; P. Vega; M. Hernández Conde; H. Nuñez; P0636 D. Rodriguez-Alcalde; A. Burgos; L. Rivero Sanchez; J. THE UTILITY OF SIRS AND BISAP SCORES FOR PRE- Garcia Alonso; E. Martinez-Bauer; P. Diez-Redondo; DICTING SEVERITY, MORBIDITY AND MORTALITY IN J. Mendoza; J. Ducons García; P. Estevez; J. Llao; V. PATIENTS WITH ACUTE PANCREATITIS Hernandez; S. Soto; D. Martinez-Ares; M. A. Álvarez- Pradeep Kakkadasam Ramaswamy, India; A. Yelsangikar; González; J. M. Pascual; F. Porta; F. Dominguez; J. A. Nagar Krishnamurthy; N. Bhat Cubiella; M. A. Simon; L. Cid; A. Isava; B. Peñas; A. Burgos; J. García Lledó; M. López Ibáñez; M. Bustamante; P0637 F. Gomollon; C. Sostres; F. Riu Pons; R. Macenlle; J. De A NEW SCORING SYSTEM TO PREDICT POST-ERCP la Revilla Negro; R. Campo Fernandez; G. de la Poza; PANCREATITIS A. Martínez Turnes; P. Quintas; N. Ascon; F. Vida Koichi Fujita, Japan; S. Yazumi; Y. Kodama; A. Sugahara; T. Kawamura P0644 MANAGEMENT OF PANCREATOLITHIASIS: A NATION- WIDE SURVEY IN JAPAN Kazuo Inui, Japan; A. Masamune; Y. Igarashi; H. Ohara; S. Tazuma; M. Sugiyama; Y. Suzuki; H. Miyoshi; S. Yamamoto; Y. Takeyama

Poster in the Spotlight Poster of Excellence Clinical Case Session 157

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0645 Poster Champ Session EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR 12:30 – 13:30 Hall X5: Terminal 1 PANCREATIC DUCT STONES IS EFFECTIVE IN TERMS OF Liver, biliary and pancreatic diseases PAIN RELIEF AND USE OF OPIOIDS Chairs: Gabriella Pár, Hungary Stefan Haraldsson, Denmark; S. Roug; C. Nøjgaard; S. Marc G. H. Besselink, The Netherlands Novovic; E. Feldager; P. N. Schmidt

Posters in the Spotlight P0550 ª 14:00 – 15:30 E-Poster Lounge 2 FACTORS ASSOCIATED WITH SIGNIFICANT LIVER Colorectal cancer: Diagnostic and therapeutic aspects STEATOSIS AND FIBROSIS AS ASSESSED BY TRANSIENT Chairs: Monique van Leerdam, The Netherlands ELASTOGRAPHY IN PATIENTS WITH ONE OR MORE Roger Leicester, United Kingdom COMPONENTS OF THE METABOLIC SYNDROME Ivana Mikolasevic, Croatia; L. Orlic; D. Stimac; S. Milic P0558 P0914 USING OPTICAL METABOLIC IMAGING TO INVESTIGATE PREVALENCE AND CHARACTERISTICS OF UNEXPECTED MECHANISMS OF PARACETAMOL INDUCED HEPATOXICITY RECTAL CANCER IN BENIGN APPEARING LARGE Xiaowen Liang, Australia; H. Wang; X. Liu; M. Roberts NON-PEDUNCULATED RECTAL POLYPS Maxime Bronzwaer, The Netherlands; G. D. Musters; P0559 R. M. Barendse; L. Koens; E. J. R. de Graaf; P. Tanis; E. A NOVEL IN VITRO TEST IMPROVES CAUSALITY ASSESS- Dekker; P. Fockens MENT OF DRUG INDUCED LIVER INJURY IN PATIENTS WITH POLYMEDICATION P0915 Andreas Benesic, Germany ; D. Dragoi; M.-L. Buchholtz; CLINICOPATHOLOGIC AND ENDOSCOPIC FEATURES OF

Tuesday, October 18, 2016 A. L. Gerbes EARLY STAGE COLORECTAL SERRATED ADENOCARCI- NOMA P0563 Daiki Hirano, Japan; S. Tanaka; S. Oka; B. Kazuki; Y. THE NON-STEROIDAL FXR AGONISTS PX20606 AND Ken; K. Sumimoto; N. Yuki; T. Yuzuru; A. Naoki; S. GS-9674 IMPROVE LIVER FIBROSIS AND PORTAL Kenjiro; N. Hayashi; S. Fumio; K. Chayama HYPERTENSION IN RODENT MODELS OF CHOLESTATIC, METABOLIC AND TOXIC LIVER CIRRHOSIS P0916 Philipp Schwabl, Austria; E. Hambruch; T. Reiberger; DIAGNOSTIC ACCURACY OF FECAL IMMUNOCHEMICAL P. Supper; D. Bauer; B.A. Payer; H. Hayden; TEST IN PATIENTS AT HIGH-RISK FOR COLORECTAL N. Rohr-Udilova; C. Kremoser; M. Trauner CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS Anastasia Katsoula, Greece; P. Paschos; A.-B. Haidich; P0564 A. Tsapas; O. Giouleme THE ROLE OF PNPLA3, RNF7, MERTK AND PCSK7 GENE POLYMORPHISMS IN THE DEVELOPMENT OF LIVER P0924 FIBROSIS AND CIRRHOSIS PRIMARY TUMOR RESECTION IN METASTASIZED COL- Irena Valantiene, Lithuania; G. Varkalaite; R. ORECTAL CANCER - A META-ANALYSIS Steponaitiene; J. Skieceviciene; J. Sumskiene; V. Christian Stöß, Germany; U. Nitsche; L. Stecher; D. Petrenkiene; J. Kondrackiene; L. Kupcinskas; Wilhelm; H. Friess; G. O. Ceyhan G. Kiudelis; J. Kupcinskas; F. Lammert P0925 P0572 ARE ENDOSCOPIC SUBMUCOSAL DISSECTIONS OF CECAL DOES NON-INVASIVE ASPARTATE AMINOTRANSFER- TUMOR INVOLVING THE ILEOCECAL VALVE AND APPEN- ASE/PLATELET RATIO INDEX (APRI) CORRELATES WITH DICEAL ORIFICE FEASIBLE? INVASIVE HEPATIC VENOUS PRESSURE GRADIENT Kinichi Hotta, Japan; K. Shinoki; K. Imai; S. Ito; Y. (HVPG) IN CIRRHOSIS? Yamaguchi; N. Kawata; M. Tanaka; N. Kakushima; K. Vijendra Kirnake, India; A. Arora; P. Sharma; A. Kumar Takizawa; H. Ishiwatari; H. Matsubayashi; H. Ono P0618 P0926 ENDOSCOPIC TREATMENT OF BILIARY STRICTURES THE PROGNOSTIC FACTORS AND THE IMPACT OF SUR- FOLLOWING LIVER TRANSPLANTATION – 15 YEARS' GERY ON REDUCING RECURRENCES IN T1 COLORECTAL EXPERIENCE IN A TERTIARY TRANSPLANT CENTER CANCERS BASED ON A LONG-TERM SURVEILLANCE A. Itzhak; L. Mlynarsky; M. Leshno; Erwin Santo, Israel; Yuta Kouyama, Japan; S.-E. Kudo; H. Miyachi; K. N. Gluck Ichimasa; S. Matsudaira; Y. Kimura; T. Hisayuki; K. Wakamura; T. Hayashi; T. Kudo; Y. Mori; M. Misawa; A. Katagiri; T. Baba; F. Ishida

158 Poster in the Spotlight Poster of Excellence Clinical Case Session 159 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0633 P0665 RISK STRATIFICATION DEPENDING ON THE TIMING ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC OF TRANSMURAL ENDOSCOPIC DEBRIDEMENT AFTER NEOPLASMS WITH THE CONTINUOUS USE OF LOW- SEVERE ACUTE PANCREATITIS: A RETROSPECTIVE DOSE ASPIRIN: ANALYSIS OF 101 PATIENTS GERMAN SINGLE CENTER ANALYSIS Hideaki Harada, Japan; S. Suehiro; D. Murakami; R. Christian Meinhardt, Germany; B. Dahl; P. Troschel; Nakahara; T. Shimizu; Y. Katsuyama; K. Hayasaka D. Scholz; M. Reuther; H. Seifert P0696 P0641 FULL THICKNESS RESECTION DEVICE (FTRD): A NOVEL INVOLVEMENT OF GENETIC FACTORS IN THE AETIOLO- TOOL FOR COLONOSCOPIC ADENOMA RESECTION. FIRST GY OF ALCOHOLIC CHRONIC PANCREATITIS CLINICAL EXPERIENCE FROM TWO TERTIARY REFERRAL Amandine Abrantes, France; E. Masson; CENTERS IN SWITZERLAND M. Robaszkiewicz; J.-M. Chen; C. Férec Patrick Roger Aepli, Switzerland; R. Frei; J. Borovicka; D. Criblez P0642 IS SURGERY USEFUL TO CURE CHRONIC PAIN IN ALCO- P0697 HOLIC CHRONIC PANCREATITIS? IMPLEMENTATION OF AN OPTICAL DIAGNOSIS STRATE- Benoit Bordacahar, France; A. Couvelard; M. Pierre GY SAVES COSTS AND DOES NOT IMPAIR CLINICAL OUT- Vullierme; P. Lévy; A. Sauvanet; P. Ruszniewski; V. COMES OF A FIT-BASED CRC SCREENING PROGRAMME Rebours Jasper Vleugels, The Netherlands; M. J. E. Greuter; Y. Hazewinkel; V. M. H. Coupé; E. Dekker P0643 BELGIAN NATIONWIDE REGISTRY ON CHRONIC PAN- P0698 CREATITIS: A PROSPECTIVE OBSERVATIONAL STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) OF MORE THAN 800 PATIENTS SUPERFICIAL COLORECTAL NEOPLASMS AT THE ANAL Michael Fernandez Y Viesca, Belgium; M. Arvanitakis; CANAL AND ILEOCECAL VALVE C. Musala; W. Van Steenbergen; V. Putzeys; F. Ausloos; Federico Iacopini, Italy; Y. Saito; T. Gotoda; W. Elisei; B. Bastens; P. Gast; G. Roeyen; E. Cesmeli; I. Scheers; C. Grossi; F. Montagnese; G. Costamagna M. Delhaye; P.H. Deprez P0731 DIRECT PERORAL CHOLANGIOSCOPY BY USING A NEWLY Poster Champ Session DEVELOPED MULTIBENDING ULTRASLIM ENDOSCOPE 12:30 – 13:30 Hall X5: Terminal 2 FOR THE TREATMENT OF DIFFICULT BILE DUCT STONES Surgery, endsocopy and imaging Jong Ho Moon, South Korea; Y. N. Lee; H. J. Choi; M. H. Chairs: Ian Jenkins, United Kingdom Choi; T. H. Lee; S.-W. Cha; Y. D. Cho; S.-H. Park 2016 18, October Tuesday, Mario Morino, Italy P0762 USEFULNESS OF THE NEWLY DESIGNED PLASTIC P0663 STENT FOR EUS-GUIDED HEPATICOGASTROSTOMY AND SIMPLE AND SAFE FORCEP STRIP TECHNIQUE FOR PANCREATIC DUCT DRAINAGE: LARGE CASE SERIES GASTRIC SUBMUCOSAL TUMORS ORIGINATING FROM EVALUATION MUSCULARIS PROPRIA LAYER Takayoshi Tsuchiya, Japan; A. Sofuni; S. Tsuji; K. Kamada; I. K. Yoo; H. J. Chun; J. M. Lee; J. M. Lee; S. H. Kim; H. R. Tanaka; R. Tonozuka; M. Honjo; S. Mukai; M. Fujita; S. Choi; Eun Sun Kim, South Korea; B. Keum; Y. T. Jeen; K. Yamamoto; Y. Matsunami; Y. Asai; T. Itoi H. S. Lee; C. D. Kim; S. Y. Lee; B. K. Choi P0772 P0664 DIGESTIVE ALTERATIONS AS EVALUATED BY THE 13C-MTG MINIMAL ESOPHAGEAL LESIONS DETECTED BY DIGITAL BREATH TEST IN PATIENTS AFTER BARIATRIC SURGERY CHROMOENDOSCOPY USING OPTICAL ENHANCEMENT Laura Uribarri González, Spain; L. Nieto; SYSTEMTM ASSOCIATED TO HIGH DEFINITION PLUS J. Lariño-Noia; J. Iglesias-García; A. Sueiro; J. Baltar; OPTICAL MAGNIFICATION IN NON EROSIVE REFLUX I. Baamonde; J. E. Domínguez-Muñoz DISEASE (NERD) P0773 Carlos Robles-Medranda, Ecuador; M. Valero; M. Soria; DIFFERENCES IN SURVIVAL AFTER CURATIVE R0-RE- M. Puga; J. Ospina; H. Alvarado; H. Pitanga Lukashok SECTION FOR KOREAN AND GERMAN GASTRIC CANCER PATIENTS: RESULTS FROM A PROPENSITY SCORE MATCHED ANALYSIS Daniel Reim, Germany; Y. W. Kim

Poster in the Spotlight Poster of Excellence Clinical Case Session 159

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0777 P0817 PREVENTION OF FISTULA AFTER DISTAL PANCREATIC THE ROLE OF FAECAL CALPROTECTIN IN A PRIMARY RESECTION CARE REFERRAL PATHWAY IN THE UK J. Wennerblom; C. Jönsson; B. Tingstedt; B. Björnsson; M. Tan; Y. Subramaniam; C. Cheong; F. Hasan; G. W. Christoph Ansorge, Sweden; J. Blomberg; M. Del Chiaro Moran; Waleed Fateen, United Kingdom; A. Jawhari P0778 P0841 RISK-BASED PATIENT SELECTION IN OPEN AND ETROLIZUMAB TREATMENT DOES NOT MODIFY LEVELS MINIMALLY-INVASIVE DISTAL PANCREATECTOMY: AN OF VCAM-1 IN ULCERATIVE COLITIS PATIENTS ACS-NSQIP STUDY F. Fuh; C. Looney; W. Tew; R. Erickson; R. Maciuca; M. Sjors Klompmaker, The Netherlands; D. van Zoggel; Tang; M. Keir; S. Vermeire; Teresa Ramirez Montagut, USA A. A. Watkins; M. F. Eskander; J. F. Tseng; M. G. H. Besselink; A. J. Moser; P0842 ONSET OF EFFICACY OF TOFACITINIB FOR INDUCTION THERAPY IN PATIENTS WITH ACTIVE ULCERATIVE COLI- Poster Champ Session TIS IN TWO MULTINATIONAL, PHASE 3 CLINICAL TRIALS 12:30 – 13:30 Hall X5: Terminal 3 W.J. Sandborn; Silvio Danese, Italy; J. Panés; H. Zhang; Lower gastrointestinal diseases D. Woodworth; A. Marren; C. Su Chairs: David Drobne, Slovenia Robin Spiller, United Kingdom P0843 ETROLIZUMAB TREATMENT MODULATES MADCAM-1 LEVELS IN SERUM IN ULCERATIVE COLITIS PATIENTS P0788 F. Fuh; R. Erickson; C. Schofield; M. Tang; R. Maciuca; SILVER NANOPARTICLES NANOAG1 AND NANOAG2 AT- M. Keir; S. Vermeire; Teresa Ramirez Montagut, USA TENUATE EXPERIMENTAL COLITIS IN MICE THROUGH

Tuesday, October 18, 2016 P0844 MODULATION OF COLONIC MICROBIOTA DEVELOPMENT AND ANALYTICAL CHARACTERIZATION Hubert Zatorski, Poland; K. Siczek; A. OF GP2017, A PROPOSED ADALIMUMAB BIOSIMILAR Chmielowiec-Korzeniowska; J. Pulit-Prociak; M. M. Schiestl; Christian Roesli, Germany Smiech; R. Kordek; L. Tymczyna; M. Banach; J. Fichna P0845 P0789 SUSTAINED RESOLUTION OF EXTRAINTESTINAL MAN- MACROPHAGES BEHAVIOUR AGAINST ADHERENT AND IFESTATIONS IN PATIENTS WITH CROHN'S DISEASE INVASIVE E. COLI (AIEC) ISOLATED FROM CROHN'S RECEIVING ADALIMUMAB DISEASE PATIENTS IN RELATION WITH HOST FACTORS Edouard J. Louis, Belgium; R. Löfberg; W. Reinisch; D. SUSCEPTIBILITY Schwartz; J.-F. Maa; S. Berg; B. Huang; A. W. Wang; A. Anthony Buisson, France; E. Vazeille; L. Ouchchane; M. Robinson; B. L. Pappalardo M. Goutte; J.-P. Hugot; A. Dubois; R. Minet-Quinard; D. Bouvier; G. Bommelaer; N. Barnich P0885 A STRUCTURED PAEDIATRIC TO ADULT TRANSITION SER- P0814 VICE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE DEVELOPMENT AND VALIDATION OF A TANDEM LIQUID REDUCES DISEASE FLARES, REQUIREMENT FOR STEROIDS CHROMATOGRAPHIC MASS SPECTROMETRIC (LC-MS/MS) AND EMERGENCY ADMISSIONS: THE TRANSIT STUDY ASSAY FOR THE MEASUREMENT OF VEDOLIZUMAB (VLZ) Sara McCartney, United Kingdom; J. O. Lindsay; R. K. LEVELS IN PATIENT SERUM Russell; D. R. Gaya; I. Shaw; T. Finney-Hayward; S. Christina Christ, Germany; A. Dignass; F. Hartmann; Sebastian J. Stein P0815 ª Poster Champ Session THE INFLUENCE OF VITAMIND ON EXPRESSION OF 12:30 – 13:30 Hall X5: Terminal 4 CYTOKINES MRNA IN IBD Upper gastrointestinal diseases Zuzana Leskova, Slovakia; A. Krajcovicova; K. Soltys; S. Chairs: Giovanni de Manzoni, Italy Stuchlik; I. Sturdik; T. Koller; M. Huorka; T. Hlavaty Bohumil Seifert, Czech Republic P0816 P0980 DEVELOPMENT OF A DIAGNOSTIC SCORING SYSTEM TO BRAIN MECHANISMS UNDERLYING THE EFFECT OF PREDICT MICROSCOPIC COLITIS MOTILIN RECEPTOR AGONIST ERYTHROMYCIN ON John S. Kane, United Kingdom; R. Sood; G. R. Law; D. J. HUNGER FEELINGS IN HEALTHY VOLUNTEERS Gracie; N. To; M. J. Gold; A. C. Ford Dongxing Zhao, Belgium; A. C. Meyer-Gerspach; E. Deloose; N. Weltens; J. Iven; I. Depoortere; J. Tack; L. Van Oudenhove

160 Poster in the Spotlight Poster of Excellence Clinical Case Session 161 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0986 P1090 DETAILED ANALYSIS OF A SINGLE U.S. CENTER EX- POSTPRANDIAL FLOW MEASUREMENTS OF THE PERIENCE WITH PERORAL ENDOSCOPIC MYOTOMY MESENTERIC ARTERIES AND PORTAL VEIN USING (POEM) SUGGESTS ITS EFFICACY AND SAFETY WITH MAGNETIC RESONANCE IMAGING: A PILOT STUDY SIGNIFICANT OCCURRENCE OF POST-PROCEDURAL Louisa J. D. van Dijk, The Netherlands; M. Ouhlous; GASTROESOPHAGEAL REFLUX D. Leemreis; A. C. De Vries; H. J. M. Verhagen; E. J. Yamile Haito Chavez, USA; S. Ngamruengphong; Y.-I. Kuipers; A. Moelker; M. J. Bruno Chen; M. Bukhari; G. Hajiyeva; A. Ismail; A. Kamal; G. Aguila; V. Kumbhari; V. Singh; M. Khashab P1091 A PROSPECTIVE, QUANTITATIVE ASSESSMENT OF PAIN P1010 AND QUALITY OF LIFE BEFORE AND 3 AND 12 MONTHS EFFECT OF NEOADJUVANT THERAPY ON DYSPHAGIA AFTER VASCULAR TREATMENT FOR CHRONIC MESEN- IN ESOPHAGEAL CANCER PATIENTS- DATA FROM A TERIC ISCHEMIA RANDOMIZED CONTROLLED TRIAL COMPARING CHEMO- Luuk Wymenga, The Netherlands; L. Everlo; P. B. Mensink; THERAPY TO CHEMORADIOTHERAPY M. Brusse-Keizer; E. J. Stassen; R. H. Geelkerken; J. J. Berit Sunde, Sweden; H. Song; M. Lindblad; I. Rouvelas; Kolkman L. Lundell; N. Wang; P. Lagergren; M. Nilsson P1096 P1018 A RANDOMIZED CROSS-OVER STUDY ON THE EFFECTS THE CLINICOPATHOLOGIC FEATURES AND PROGNOSIS OF FODMAPS ON GASTRIC ACCOMMODATION, SYMP- IN YOUNG GASTRIC CANCER PATIENTS ACCORDING TO TOM GENERATION AND EMOTION IN HEALTH AND HELICOBACTER PYLORI INFECTION IRRITABLE BOWEL SYNDROME Jae Jin Hwang, South Korea; D. H. Lee; H. Yoon; C. M. Imke Masuy, Belgium; L. Van Oudenhove; J. Tack; J. Shin; Y. S. Park; N. Kim Biesiekierski P1035 Metabolic/genetic disorders LONG NONCODING RNA MALAT1 PROMOTES AGGRES- SIVE GASTRIC CANCER THROUGH MMP1 OVER-EXPRES- SION AND TRANSCRIPTIONALLY ACTIVATED BY C-JUN Poster Session Xiaoying Zhou, China; G. Zhang 09:00 - 17:00 Hall X4 Liver & Biliary II P1036 ELEVATED PRC1 IN GASTRIC CARCINOMA EXERTS P0550 ª ONCOGENIC FUNCTION AND IS TARGETED BY PIPER- FACTORS ASSOCIATED WITH SIGNIFICANT LIVER LONGUMINE IN A P53-DEPENDENT MANNER STEATOSIS AND FIBROSIS AS ASSESSED BY TRANSIENT 2016 18, October Tuesday, B. Zhang; X. Shi; L. Wang; Xiaoping Zou, China ELASTOGRAPHY IN PATIENTS WITH ONE OR MORE COMPONENTS OF THE METABOLIC SYNDROME P1037 Ivana Mikolasevic, Croatia; L. Orlic; D. Stimac; S. Milic HOW DO INTRENATIONAL GASTRIC CANCER PREVENTION GUIDELINES REFLECT TO CLINICAL PRACTICE GLOBALLY? P0551 M. Leja; Evita Gasenko, Latvia; I. Polaka; R. Murillo; INVOLVEMENT OF AGE-RAGE SYSTEM FOR THE DEVEL- D. S. Bordin; A. Link; L. Garkalne; P. Malfertheiner; R. OPMENT OF HEPATIC FIBROSIS IN NASH Herrero; H. Haick Kensuke Munekage, Japan; M. Ono; T. Ochi; M. Ogasawara; A. Hirose; Y. Fujimura; S. Iwasaki; T. Saibara P1061 EFFICACY OF 7-DAY GENOTYPIC RESISTANCE-GUIDED P0552 TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADI- MATRIX METALLOPROTEINASES IN NAFLD: INTERPLAY CATION: PROSPECTIVE TRIAL IN A HIGH-RESISTANCE BETWEEN PLASMA, LIVER AND ADIPOSE TISSUE SETTING S. E. Gambaro; Pablo J. Giraudi, Italy; V. Marin; C. M. N. Mathou; S. Lycousi; Vasilios Papastergiou, Greece; Chackelevicius; M. Giuricin; D. Bonazza; F. Zanconati; K.D. Paraskeva; A. Giannakopoulos; E. Evgenidi; J. N. Demanzini; C. Tiribelli; S. Palmisano; N. Rosso Karagiannis P0553 P1077 EFFICACY OF LEPTIN PROFILE AND METABOLIC A RAPID POINT-OF-CARE TEST (POCT) IN ADULT SYNDROME ON OXIDATIVE STRESS AND DISEASE PRO- CASE-FINDING IN PRIMARY CARE FOR COELIAC DIS- GRESSION IN NON-ALCOHOLIC FATTY LIVER EASE: A COST-EFFECTIVENESS STUDY Billur Canbakan, Turkey; E. Koroglu; K. Atay; M. Tuncer; M. Rosinach; F. Fernández-Bañares; M. Llordés; J. Calpe; H. Senturk; A. Sonsuz; A. I. Hatemi; A. M. Dobrucali; G. Montserrat; M. Pujals; A. Cela; A. Carrasco; M. Ibarra; N. Kepil P. Ruiz; V. Gonzalo; C. Ferrer; Maria Esteve, Spain

Poster in the Spotlight Poster of Excellence Clinical Case Session 161

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0554 P0562 A CLINICOPATHOLOGICAL COMPARITIVE STUDY OF EVALUATION OF POTENTIAL FUTILITY IN ALCOHOLIC LEAN VERSUS OVERWEIGHT/OBESE PATIENTS OF HEPATITIS - MULTICENTRE STUDY. NONDIABETIC NONALCOHOLIC FATTY LIVER DISEASE Rita Barosa, Portugal; C. Teixeira; J. Branco; P. Marcos; Sanchit Budhiraja, India; A. K. Jain; V. K. Dixit; S. K. S. Marques; C. Fonseca Shukla; P. K. Asati; M. K. Tripathi Cirrhosis and complications: Basic aspects P0555 A COMPARISON OF DIAGNOSTIC PERFORMANCE OF P0563 NAFLD FIBROSIS SCORE, FIB-4 INDEX AND TRANSIENT THE NON-STEROIDAL FXR AGONISTS PX20606 AND ELASTOGRAPHY FOR THE DIAGNOSIS OF HEPATIC GS-9674 IMPROVE LIVER FIBROSIS AND PORTAL FIBROSIS IN PATIENTS WITH BIOPSY-PROVEN NON-AL- HYPERTENSION IN RODENT MODELS OF CHOLESTATIC, COHOLIC FATTY LIVER DISEASE METABOLIC AND TOXIC LIVER CIRRHOSIS Patrícia Andrade, Portugal; R. Gaspar; S. Rodrigues; S. Philipp Schwabl, Austria; E. Hambruch; T. Reiberger; Lopes; G. Macedo P. Supper; D. Bauer; B.A. Payer; H. Hayden; N. Rohr-Udilova; C. Kremoser; M. Trauner P0556 NON-INVASIVE ASSESSMENT OF HEPATIC FIBROSIS IN P0564 A SERIES OF PATIENTS WITH ALPHA-1-ANTITRYPSIN THE ROLE OF PNPLA3, RNF7, MERTK AND PCSK7 GENE DEFICIENCY POLYMORPHISMS IN THE DEVELOPMENT OF LIVER Agnieszka Bakula, Poland; M. Teisseyre; J. Kmiotek; W. FIBROSIS AND CIRRHOSIS Janczyk; P. Socha Irena Valantiene, Lithuania; G. Varkalaite; R. Steponaitiene; J. Skieceviciene; J. Sumskiene; P0557 V. Petrenkiene; J. Kondrackiene; L. Kupcinskas; G. ASSESSMENT OF CHANGE OF INTRAHEPATIC FAT

Tuesday, October 18, 2016 Kiudelis; J. Kupcinskas; F. Lammert AMOUNT USING CONTROLLED ATTENUATION PARAME- TER IN CLINICAL TRIAL P0565 Sang-Bong Ahn, South Korea; D. W. Jun; Y. S. Park; H. IS THERE THE CONNECTION BETWEEN THE SEROTONER- Y. Ryu; Y. K. Cho; S. H. Kim; B.-K. Son; Y. S. Park GIC SYSTEM AND ALFOSCERATE IN THE CONDI- TIONS OF EXPERIMENTAL HEPATIC ENCEPHALOPATHY? Hepatotoxicity/alcohol E. G. Manzhalii; Oleksandr V. Virchenko, Ukraine P0558 P0566 USING OPTICAL METABOLIC IMAGING TO INVESTIGATE REGULATION OF P53 - A POSSIBLE BACTERIAL DEFENSE MECHANISMS OF PARACETAMOL INDUCED HEPATOXICITY MECHANISM LEADING TO EPITHELIAL BARRIER DESTA- Xiaowen Liang, Australia; H. Wang; X. Liu; M. Roberts BILIZATION IN SPONTANEOUS BACTERIAL PERITONITIS? Marika Haderer, Germany; C. Kunst; E. Aschenbrenner; P0559 K. Pollinger; J. Middendorf; S. Schlosser; M. Müller-Schilling A NOVEL IN VITRO TEST IMPROVES CAUSALITY ASSESS- MENT OF DRUG INDUCED LIVER INJURY IN PATIENTS P0567 WITH POLYMEDICATION IGFBP2 - A NOVEL P53-FAMILY TARGET GENE IN HEPA- Andreas Benesic Germany; D. Dragoi; M.-L. Buchholtz; TOCELLULAR CARCINOMA A. L. Gerbes Dana Gschwind, Germany; M. Lohse; C. Kunst; T. Fuertjes; E. Aschenbrenner; K. Pollinger; S. Schlosser; P0560 M. Müller-Schilling THE RESPONSE OF HEPATOCYTE AND MACROPHAGE TO ETHANOL-INDUCED TOXICITY: AN IN VITRO CO-CULTURE P0568 MODEL QUINOLINIC ACID AS A PREDICTOR OF OUTCOME IN Veronica Marin, Italy; C. Tiribelli; N. Rosso CIRRHOTIC PATIENTS Reham Abdelaal El Aidy; Egypt; A. M. N. M. Nafee; H. I. P0561 Mohammed; H. F. Basha THE PROTECTIVE EFFECTS OF HELIX B SURFACE PEP- TIDE ON EXPERIMENTAL ACUTE LIVER INJURY P0569 Shengdi Wu, China; C. Yang; L. Wang; Y. Liu; J. Wang; VITAMIN D DEFICIENCY IN LIVER CIRRHOSIS X. Shen Otilia Gavrilescu, Romania; M. Dranga; M. A. Badea; C. Mihai; C. Cijevschi Prelipcean

162 Poster in the Spotlight Poster of Excellence Clinical Case Session 163 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0570 P0577 IMPROVEMENT OF THE MODELING AND DIAGNOSIS OF ACUTE-ON-CHRONIC LIVER FAILURE AN UNDENIABLE HEPATIC ENCEPHALOPATHY IN RATS ENTITY Elina Georgievna Manzhalii, Ukraine; O. V. Virchenko David Perdigoto, Portugal; P. Figueiredo; C. Sofia P0571 P0578 PROGNOSIS OF PATIENTS WITH ESOPHAGEAL VARICES ERECTIL (DYS)FUNCTION IN PATIENTS WITH LIVER POST BANDING ULCER BLEEDING CIRRHOSIS: A CROSS-SECTIONAL STUDY S. Carvalhana; Pedro Marques Da Costa, Portugal; Rosa Coelho, Portugal; A. Peixoto; M. Silva; H. Ribeiro; J. Lopes; A. Valente; M. V. Machado; R. Palma; R. Gaspar; R. Gonçalves; H. Cardoso; P. Pereira; G. Maced H. Cortez-Pinto; J. Velosa P0579 ª ELECTROCARDIOGRAPHIC CHANGES IN LIVER CIRRHOSIS Cirrhosis and complications: Clinical aspects Vera Matovic, Serbia; V. Nikolic; S. Zec; A. Veljkovic; M. P0572 Panic; T. Alempijevic DOES NON-INVASIVE ASPARTATE AMINOTRANSFER- P0580 ASE/PLATELET RATIO INDEX (APRI) CORRELATES WITH PROPRANOLOL AND LOSARTAN ADMINISTRATION IN INVASIVE HEPATIC VENOUS PRESSURE GRADIENT PATIENTS WITH DIFFERENT STAGES OF LIVER CIRRHOSIS (HVPG) IN CIRRHOSIS? Eugen Tcaciuc, Moldova; S. Matcovschi; D. Medvetchi- Vijendra Kirnake, India; A. Arora; P. Sharma; A. Kumar Munteanu; A. Tcaciuc; N. Nacu; L. Vlasov P0573 P0581 SERUM LEVELS OF LECTIN COMPLEMENT PATHWAY ULTRASOUND BASED ELASTOGRAPHIC METHODS FOR MOLECULES DO NOT PRIMARILY DETERMINE THE THE PREDICTION OF ESOPHAGEAL VARICES IN LIVER RISK OF BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS CIRRHOSIS Alina Popescu, Romania; I. Sporea; R. Lupusoru; A.-M. I. Foldi; D. Tornai; T. Tornai; Z. Vitalis; I. Tornai; T. Stepan; R. L. D. Sirli; M. Danila; T. Moga; C. Pienar; R. Dinya; P. Antal-Szalmas; Mária Papp, Hungary G. Mare; F. Bende; B. Miutescu P0574 P0582 SAFETY OF DAA THERAPY REGARDING RENAL FUNCTION PLATELET COUNT TO PORTAL VEIN DIAMETER RATIO IN POST-LIVER TRANSPLANT PATIENTS INFECTED WITH AS A NOVEL PREDICTOR OF ESOPHAGEAL VARICE IN HEPATITIS C INDEPENDENT OF PRE-EXISTING RENAL PATIENTS WITH LIVER CIRRHOSIS IMPAIRMENT, AND A 100% SVR12 RATE - A SINGLE Ahad Eshraghian, Iran; S. Nikeghbalian; S. A. R. 2016 18, October Tuesday, CENTRE STUDY Taghavi; M. R. Fattahi; S. A. Malek-Hosseini Georg Peschel, Germany; L. Baier; L. Moleda; M. Selgrad; M. Scherer; M. Müller; K. Weigand P0583 RECENT TREND OF VARICEAL BLEEDING IN PATIENTS P0575 WITH PORTAL HYPERTENSION AND ITS TREATMENTS CONCOMITANT NSBB TREATMENT DOES NOT INCREASE Takahiro Sato; Japan EFFICACY OF EBL IN PRIMARY PROPHYLAXIS BUT IMPROVES SURVIVAL IN SECONDARY PROPHYLAXIS OF P0584 VARICEAL BLEEDING REGENERATE: A PHASE 3, DOUBLE-BLIND, RANDOM- Nikolaus Pfisterer, Austria; C. Dexheimer; E.-M. Fuchs; IZED, PLACEBO-CONTROLLED MULTICENTER STUDY T. Bucsics; P. Schwabl; M. Mandorfer; T. Pachofszky; W. OF OBETICHOLIC ACID THERAPY FOR NONALCOHOLIC Dolak; M. Bischof; C. Schrutka-Kölbl; W. Sieghart; A. STEATOHEPATITIS Ferlitsch; M. Peck-Radosavljevic; M. Trauner; C. Madl; Vlad Ratziu, France; A. J. Sanyal; L. MacConell; R. T. Reiberger Shringarpure; T. Marmon; D. Shapiro; Z. Younossi P0576 P0585 RE-BLEEDING RATES AND SURVIVAL AFTER EARLY TIPS RISK FACTORS FOR OVERT HEPATIC ENCEPHALOPATHY IN CLINICAL PRACTICE AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC Theresa Bucsics, Austria; M. Schoder; N. Göschl; P. SHUNT IN PATIENTS WITH LIVER CIRRHOSIS Schwabl; M. Mandorfer; M. Diermayr; M. Feldner- Huan Tong, China; H. Wu; B. Wei; H. Huan; L. Zhang; Busztin; B. Angermayr; M. Cejna; A. Ferlitsch; W. C. Tang Sieghart; M. Trauner; M. Peck-Radosavljevic; J. Karner; F. Karnel; T. Reiberger

Poster in the Spotlight Poster of Excellence Clinical Case Session 163

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0586 P0593 ACUTE KIDNEY INJURY IN HOSPITALIZED PATIENTS WITH EMERGENCE OF MULTIDRUG-RESISTANT HEPATITIS CIRRHOSIS: ASSOCIATION WITH MORTALITY AT 30 DAYS C VIRUS DURING INTERFERON-FREE THERAPY WITH C. Teixeira; C. Martins; E. Dantas; Daniel Trabulo, ASUNAPREVIR AND DACLATASVIR AFTER SIMEPRE- Portugal; A. Alves; I. Cremers; A. P. Oliveira VIR-BASED TRIPLE THERAPY FOR RECURRENT HEPATI- TIS C AFTER LIVER TRANSPLANTATION Viral hepatitis C: Clinical aspects Yoshihide Ueda, Japan; H. Takeda; S. Ohtsuru; S. Uemoto; H. Marusawa P0587 HEPATITIS C VIRUS INFECTION TREATMENT WITH P0594 SOFOSBUVIR-LEDIPASVIR: SUSTAINED VIROLOGIC NON-INVASIVE HEPATIC FIBROSIS EVALUATION ON RESPONSE PREDICTING FACTORS HEPATITIS C - THE IMPACT OF NEW TREATMENTS Maria Ana Kopke Tulio, Portugal; L. Carvalho; S. Marques; Sofia Xavier, Portugal; J. Magalhães; C. Marinho; J. Cotter J. Rodrigues; J. Carmo; P. Costa; R. Herculano; F. Augusto; P. Barreiro; M. Bispo; T. Bana e Costa; L. Lebre; P. , transplantation/surgery Peixe; C. Chagas P0595 ª P0588 RISK FACTORS FOR PRIMARY SCLEROSING CHOLANGI- WITHDRAWN TIS RECURRENCE AFTER LIVER TRANSPLANTATION Lukas Bajer, Czech Republic; E. Sticova; P. Macinga; R. P0589 Janousek; P. Trunecka; J. Spicak; P. Drastich SOFOSBUVIR/SIMEPREVIR PLUS A FLAT DOSE OF RIBAVIRIN IS EFFICACY AND SAFETY IN ELDERLY GEN- P0596 OTYPE 1 CIRRHOTIC PATIENTS: A REAL WORLD STUDY HEPATIC COMPUTED TOMOGRAPHY VOLUMETRY FOR A. Pellicelli; Rodolfo Cosma Damiano Sacco, Italy; NON INVASIVE PREDICTION OF HEPATIC STEATOSIS AND Tuesday, October 18, 2016 V. Pace Palitti; P. Vignally; A. Moretti; P. Tarquini; G. STEATOHEPATITIS IN LIVING RELATED LIVER TRANS- Scifo; M. Siciliano; V. Messina; A. Izzi; M. Marignani; C. PLANTATION D'Ambrosio; L. Fondacaro; L. Alessio; L. Miglioresi; G. Ahad Eshraghian, Iran; A. Rasekhi; S. Nikeghbalian; S. Ettorre; P. Begini; A. Barlattani; B. Imperatore; A. Ascione; A. Malek-Hosseini O. Armignacco; R. Villani; P. Ialongo; F. Chiesara; G. Barbarini P0597 PARACETAMOL-INDUCED ACUTE LIVER FAILURE IN A P0590 PORCINE MODEL IS ASSOCIATED WITH SIGNIFICANT DIRECT OBSERVED THERAPY OF CHRONIC HEPATITIS GUT DYSBIOSIS C WITH INTERFERON-FREE ALL-ORAL REGIMENS AT Rohit Sinha, United Kingdom; M. H. Karavolos; P. A LOW-THRESHOLD DRUG TREATMENT FACILITY - A Treskes; P. C. Hayes; J. N. Plevris NEW CONCEPT FOR TREATMENT OF PATIENTS WITH BORDERLINE COMPLIANCE RECEIVING OPIOID SUBSTI- P0598 TUTION THERAPY THE ROLE OF TIPS IN THE MANAGEMENT OF LIVER Stephan Moser, Austria; A. Schütz; K. Marchart; TRANSPLANT CANDIDATES S. Ambrosch; J. Luhn; E. Gutic; H. Haltmayer; Lukas W. Unger, Austria; T. Stork; S. Maschke; M. Pawloff; M. Gschwantler T. Bucsics; S. Rasoul-Rockenschaub; M. Trauner; T. Reiberger; T. Soliman; G. A. Berlakovich P0591 P0599 PROMOTION OF INTRA-HOSPITAL REFERRAL OF HEPATI- TIS B AND C VIRUS CARRIERS TO HEPATOLOGY SPECIAL- POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER ISTS BY ELECTRONIC MEDICAL RECORD-BASED ALERT AFTER LIVER TRANSPLANTATION: LONG TERM SURVIV- SYSTEM: A CASE STUDY AT A UNIVERSITY HOSPITAL AL AND THE IMPACT OF SERUM TACROLIMUS LEVEL Masaru Enomoto, Japan; S. Uchida-Kobayashi; H. Fujii; Ahad Eshraghian, Iran; M. H. Imanieh; S. M. Dehghani; A. Iida-Ueno; H. Motoyama; R. Kozuka; A. Hagihara; E. S. Nikeghbalian; B. Geramizadeh; S. A. Malek-Hosseini Kawamura; H. Morikawa; Y. Murakami; A. Tamori; N. Kawada Imaging, radiology (incl. interventional radiology) P0592 P0600 CHANGES IN LIPID PROFILE WITH TREATMENT OF OBLITERATION OF PORTOSYSTEMIC SHUNTS IMPROVES HEPATITIS C WITH DIRECT-ACTING ANTIVIRALS HEPATIC FUNCTIONAL RESERVE Mário Jorge Silva, Portugal; T. Capela; R. Vasconcelos Nobuo Waguri, Japan; A. Osaki; M. Sato; M. Ogawa; A. Loureiro; V. Borges; C. Bernardes; P. Russo; F. Calinas Kimura; T. Aiba; O. Yoneyama; K. Furukawa; K. Igarashi

164 Poster in the Spotlight Poster of Excellence Clinical Case Session 165 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0601 P0610 CONTRAST ENHANCED ULTRASOUND AS A FIRST LINE EVALUATION OF SERUM NITRIC OXIDE LEVEL AND IMAGING METHOD IN THE EVALUATION OF FLL IN DAI- TUMOR EXPRESSION OF INDUCIBLE NITRIC OXIDE SYN- LY PRACTICE. A LARGE MONOCENTRIC EXPERIENCE THETASE ENZYME IN PATIENTS WITH HEPATOCELLULAR Tudor Moga, Romania; C. Ivascu-Siegfried; C. Pienar; CARCINOMA A. Popescu; R. L. D. Sirli; M. Danila; I. Sporea Nahed Baddour, Egypt; A. Zeid; A. A. Abd El Moety; A. M. Rady; D. Hashad P0602 EVALUATION OF LIVER FIBROSIS USING TRANSIENT Liver health services research ELASTOGRAPHY IN NONALCOHOLIC STEATOHEPATITIS (NASH) PATIENTS P0611 Ruxandra G. Mare, Romania; I. Sporea; A. Popescu; R. HBV-INFECTION IN GERMANY - COSTS IN A REAL-LIFE L. D. Sirli; A. Sima; R. Timar SETTING Hans Becker, Germany; J. T. Stahmeyer; A. L. Orlemann; P0603 C. Krauth; M. Manns; H. Wedemeyer LIVER AND SPLEEN STIFFNESS ASSESSED BY TRAN- SIENT ELASTOGRAPHY AND REAL-TIME 2D SHEAR P0612 WAVE ELASTOGRAPHY AND ELFTM TEST HAVE VERY KLEBSIELLA PNEUMONIAE INDUCED PYOGENIC LIVER GOOD PERFORMANCE FOR NON-INVASIVE DETECTION ABSCESS IN CRITICALLY ILL PATIENTS: A RETROSPECTIVE AND ESTIMATING SEVERITY OF PORTAL HYPERTENSION STUDY FROM A CHINESE MEDICAL CENTER, 1994-2015 Ivica Grgurevic, Croatia; D. Cvetko; T. Bokun; S. Mustapic; Yun Qian, China; C. C. Wong; H. Chen; W. Jiang; J. Si A. Lukic; M. Banic; B. Brkljacic; J. Curic; M. Kujundzic P0613 P0604 CHANGING HAV IMMUNITY IN ADULTS OF IRAN: NEW OUTCOMES OF RADIOFREQUENCY ABLATION AND MI- EVIDENCE FOR NEW POLICY CROWAVE ABLATION IN LIVER METASTASES: A SINGLE Kamran B. Lankarani, Iran; B. Honarvar CENTER EXPERIENCE P0614 Z. A. Sparchez; Tudor Mocan, Romania; P. Radu; C. ASYMPTOMATIC ELEVATION OF AMINOTRANSFERASES Cainap; G. Kacso; A. Seicean; N. Al Hajjar IN MILITARY VOLUNTEERS: THE SILENT ROLE OF NAFLD IN A "HEALTHY" POPULATION Liver neoplasia: Clinical Maria Ana Kopke Tulio, Portugal; T. Rodrigues; F. Serejo P0605 P0615

VALIDITY OF ALBI-T SCORING MODEL AS A PROGNOSTIC IDENTIFICATION OF PALLIATIVE CARE NEEDS IN HEPA- 2016 18, October Tuesday, INDICATOR IN EGYPTIAN PATIENTS WITH HEPATOCEL- TOLOGY - EXPERIENCE OF A MAJOR REFERRAL CENTRE LULAR CARCINOMA Joana Rita Carvalho, Portugal; M. Vascocelos; P. Omar A. Elshaarawy, Egypt; A. I. Gomaa; N. Allam; A. Marques da Costa; R. T. Marinho; N. Fatela; F. Ramalho Alsebaey; E. Ahmed Rewisha; I. A. Waked P0616 P0606 UNDER-REPORTING OF COMPLEMENTARY AND ALTER- WITHDRAWN NATIVE DRUG USE IN LIVER DISEASE PATIENTS P0607 Floor A. C. Berden, The Netherlands; G. P. C. A. Netten; ALBI SCORE: BEST PREDICTOR OF SHORT-TERM MOR- W. Kievit; J. P. H. Drenth TALITY IN HEPATOCELLULAR CARCINOMA P0617 Rosa Coelho, Portugal; H. Cardoso; M. Silva; A. Peixoto; INCIDENCE AND PREDICTORS OF HEPATITIS C TREAT- R. Gaspar; R. Morais; R. Gonçalves; S. Rodrigues; P. MENT INITIATION AMONG PEOPLE WHO INJECT DRUGS: Pereira; S. Lopes; A. M. Horta-Vale; G. Macedo LONGITUDINAL DATA FROM A GREEK TERTIARY CEN- P0608 TER, 2009-2015 MARITAL STATUS AND SURVIVAL IN PATIENTS WITH Vasilios Papastergiou, Greece; O. Anagnostou; PRIMARY LIVER CANCER: AN ANSWER FROM SEER M. Deutsch; A. Kourikou; D. Zampetas; E. Ionas; Xingkang He, China; Z. Lin; L. sun; Y. Qian H. Kranidioti; G. Kontos; S. Manolakopoulos P0609 NON-INVASIVE FIBROSIS SCORES AND LIVER IMAGING IN CHARACTERIZING INCIDENTALLY DETECTED SPACE OCCUPYING LIVER LESIONS IN CHRONIC HEPATITIS C Ragesh Babu Thandassery, Qatar; H. Wani; M. E. Soofi; M. Khanna; S. R. Al-Kaabi

Poster in the Spotlight Poster of Excellence Clinical Case Session 165

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

Cholestasis and gallstones: Clinical Paediatric liver disease P0618 Poster Session ENDOSCOPIC TREATMENT OF BILIARY STRICTURES FOLLOWING LIVER TRANSPLANTATION- 15 YEARS' 09:00 - 17:00 Hall X4 EXPERIENCE IN A TERTIARY TRANSPLANT CENTER Paediatric: Liver, Biliary and Pancreas A. Itzhak; L. Mlynarsky; M. Leshno; Erwin Santo, Israel; P0626 N. Gluck DIAGNOSTIC ACCURACY OF SHEAR WAVE ELASTOG- P0619 RAPHY FOR THE ASSESSMENT OF LIVER STIFFNESS IN EFFICACY AND SAFETY OF ENDOSCOPIC RETROGRADE CHILDREN WITH FATTY LIVER DISEASE CHOLANGIOPANCREATOGRAPHY IN ELDERLY PATIENTS Matteo Garcovich, Italy; S. Veraldi; E. Di Stasio; M. A. WITH CHOLEDOCHOLITHIASIS Zocco; L. Monti; P. Tomà; M. Pompili; A. Gasbarrini; V. Mara Barbosa, Portugal; P. Boal Carvalho; T. Cúrdia Nobili Gonçalves; B. Rosa; J. Cotter P0627 P0620 SILYMARIN FOR THE TREATMENT OF NAFLD/NASH: A COST IMPACT OF LONG TERM HEALTH CARE CONSUMP- MOLECULAR IN VIVO STUDY TION AND SICK LEAVE IN PATIENTS WITH PERSISTENT AB- Veronica Marin, Italy; S. E. Gambaro; M. Dal Ben; A. DOMINAL PAIN AFTER LAPAROSCOPIC CHOLECYSTECTOMY Raseni; S. Calligaris; M. Anese; C. Tiribelli; S. Gazzin; Sarah Z. Wennmacker, The Netherlands; M. Oostendorp; N. Rosso M. G. Dijkgraaf; G. P. Westert; J. P. H. Drenth; C. J. H. M. P0628 van Laarhoven; P. R. de Reuver DIFFICULTIES OF THE WILSON'S DISEASE DIAGNOSIS P0621 IN CHILDHOOD AND ADOLESCENCE Tudor Lucian Pop, Romania; A. Stefanescu; A. Grama; A.

Tuesday, October 18, 2016 A MEASURE OF QUALITY IN MANAGEMENT OF GALL BLADDER POLYPS IN A DISTRICT GENERAL HOSPITAL: Pirvan; S. Cainap; B. Simionescu; D. Serban; R. Cornean; THE UNITED KINGDOM EXPERIENCE O. Belei; M. Pop; P.-I. Velea; I. Simedrea; N. Miu Tariq Mahmood, United Kingdom P0629 P0622 NON-INVASIVE TOOLS FOR LIVER DISEASE ASSESSMENT THE DIAGNOSTIC PERFORMANCE OF NON-INVASIVE IN OBESE CHILDREN FIBROSIS MARKERS IN PATIENTS WITH PRIMARY BILI- Corina Pienar, Romania; P.-I. Velea; I. Ciuca; M. Tudor ARY CHOLANGITIS AND PRIMARY BILIARY CHOLANGITIS Voicu; A. Popescu; I. Sporea AND AUTOIMMUNE HEPATITIS VARIANT FORM: IS P0630 THERE ANY DIFFERENCE? STRUCTURAL CHANGES IN THE LIVER AND FEATURES Anna Sheptulina, Russia; E. Shirokova; V. Ivashkin OF METABOLIC CHANGES IN CHILDREN WITH NONALCO- P0623 HOLIC FATTY LIVER DISEASE COMBINED WITH BILIARY PRIMARY CLOSURE VERSUS T-TUBE AFTER LAPARO- DYSKINESIA SCOPIC COMMON BILE DUCT EXPLORATION FOR CHO- N. Zavgorodnya; Olga Lukyanenko, Ukraine LEDOCHOLITHIASIS? A SINGLE CENTER EXPERIENCE. Ehab El Hanafy, Egypt Paediatric P0624 P0631 IS LONG-TERM BILIARY STENTING FOR COMMON BILE A MULTICENTRE REGISTERED CLINICAL TRIAL ON DUCT STONES SAFER THAN STONE REMOVAL AFTER DIAGNOSTIC PRACTICE IN PEDIATRIC PANCREATITIS EST OR EPLBD IN THE ELDERLY? (PINEAPPLE - PAIN IN EARLY PHASE OF PEDIATRIC Hirofumi Tsugeno, Japan; J. Kataoka; D. Kawai; K. PANCREATITIS) Takemoto; R. Takenaka; S. Fujiki Dóra Mosztbacher, Hungary; A. Parniczky; A. Tóth; V. Ila; M. Abu El Haija; I. Tokodi; B. Fehér; T. Decsi; P. Hegyi P0625 EFFICACY OF OBETICHOLIC ACID IN THE TREATMENT OF P0632 PRIMARY BILIARY CIRRHOSIS BY CONTINENTAL REGIONS PRELIMINARY RESULTS FROM APPLE STUDY (ANALYSIS V. Luketic; P. Andreone; F. Nevens; Janet Owens-Grillo, OF PEDIATRIC PANCREATITIS). MULTICENTRIC, INTER- USA; R. Pencek; T. Marmon; L. MacConell NATONAL, PROSPECTIVE, CLINICAL TRIAL Andrea Parniczky, Hungary; B. Nemeth; D. Mosztbacher; A. Tóth; A. Demcsák; N. Lasztity; A. Szentesi; G. Tóth; V. Ila; J. Czelecz; C. Andorka; I. Guthy; I. Tokodi; L. Gárdos; I. Vass; A. Tarnok; G. Veres; P. Hegyi

166 Poster in the Spotlight Poster of Excellence Clinical Case Session 167 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

Pancreatitis, acute P0640 METABOLIC SYNDROME AND ACUTE PANCREATITIS Poster Session Ivana Mikolasevic, Croatia; S. Milic; L. Orlic; G. Poropat; 09:00 - 17:00 Hall X4 I. Jakopcic; A. Klanac; N. Kristo; D. Stimac Pancreas II Pancreatitis, chronic (including hereditary disorders) P0633 RISK STRATIFICATION DEPENDING ON THE TIMING P0641 OF TRANSMURAL ENDOSCOPIC DEBRIDEMENT AFTER INVOLVEMENT OF GENETIC FACTORS IN THE AETIOLO- SEVERE ACUTE PANCREATITIS: A RETROSPECTIVE GY OF ALCOHOLIC CHRONIC PANCREATITIS GERMAN SINGLE CENTER ANALYSIS Amandine Abrantes, France; E. Masson; Christian Meinhardt, Germany; B. Dahl; P. Troschel; D. M. Robaszkiewicz; J.-M. Chen; C. Férec Scholz; M. Reuther; H. Seifert P0642 P0634 IS SURGERY USEFUL TO CURE CHRONIC PAIN IN ALCO- ACUTE PANCREATITIS IN THE ELDERLY: A CAUSE FOR HOLIC CHRONIC PANCREATITIS? INCREASED CONCERN? RETROSPECTIVE EVALUATION Benoit Bordacahar, France; A. Couvelard; M. Pierre OF A TERTIARY REFERRAL CENTER Vullierme; P. Lévy; A. Sauvanet; P. Ruszniewski; V. S. R. Fernandes; C. M. Moura; P. Santos; Joana Carvalho, Rebours Portual; T. Antunes; J. Velosa P0643 P0635 BELGIAN NATIONWIDE REGISTRY ON CHRONIC PAN- ENDOSCOPIC AND PHARMACOLOGICAL PROPHYLAXIS CREATITIS: A PROSPECTIVE OBSERVATIONAL STUDY OF OF POST-ERCP PANCREATITIS: A META-ANALYSIS AND MORE THAN 800 PATIENTS. SYSTEMATIC REVIEW Michael Fernandez Y Viesca, Belgium; M. Arvanitakis; Salvatore Francesco Vadalà di Prampero, Italy; G. C. Musala; W. Van Steenbergen; V. Putzeys; F. Ausloos; Faleschini; M. Bulajic; D. Berretti; M. Marino; N. Panic; B. Bastens; P. Gast; G. Roeyen; E. Cesmeli; I. Scheers; M. Zilli M. Delhaye; P. H. Deprez P0636 P0644 THE UTILITY OF SIRS AND BISAP SCORES FOR PRE- MANAGEMENT OF PANCREATOLITHIASIS: A NATION- DICTING SEVERITY, MORBIDITY AND MORTALITY IN WIDE SURVEY IN JAPAN PATIENTS WITH ACUTE PANCREATITIS Kazuo Inui, Japan; A. Masamune; Y. Igarashi; H. Ohara; Pradeep Kakkadasam Ramaswamy, India; A. Yelsangikar; S. Tazuma; M. Sugiyama; Y. Suzuki; H. Miyoshi; S. Tuesday, October 18, 2016 18, October Tuesday, A. Nagar Krishnamurthy; N. Bhat Yamamoto; Y. Takeyama P0637 P0645 A NEW SCORING SYSTEM TO PREDICT POST-ERCP EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR PANCREATITIS PANCREATIC DUCT STONES IS EFFECTIVE IN TERMS OF Koichi Fujita, Japan; S. Yazumi; Y. Kodama; A. Sugahara; PAIN RELIEF AND USE OF OPIOIDS T. Kawamura Stefan Haraldsson, Denmark; S. Roug; C. Nøjgaard; S. Novovic; E. Feldager; P. N. Schmidt P0638 EFFICACY OF RECOMBINANT HUMAN SOLUBLE THROM- P0646 BOMODULIN FOR DISTURBANCES OF COAGULATION MALNUTRITION IS A COMMON COMPLICATION IN AND PANCREATIC ISCHEMIA/NECROSIS IN SEVERE CHRONIC PANCREATITIS OUTPATIENTS AND SIGNIFI- ACUTE PANCREATITIS CANTLY ASSOCIATED WITH IMPAIRED MUSCLE FUNCTION Takaaki Eguchi, Japan; M. Tsujimae; A. Kanamori; A. Jakob L. Poulsen, Denmark; S. S. S. Olesen; L. Koizumi; H. Yamashita; A. Okada Kuhlmann; H. H. Rasmussen; A. Madzak; A. M. Drewes P0639 P0647 NEW FULLY COVERED LARGE-BORE REMOVABLE METAL "DUODENAL DYSTROPHY", OR "GROOVE PANCREATITIS", STENT - WITH ANTI-MIGRATORY FLANGES FOR DRAIN- OR "PARADUODENAL PANCREATITIS." DOES IT MATTER AGE OF PANCREATIC FLUID COLLECTIONS: RESULTS OF WHICH NAME YOU CHOOSE? LESSONS OF 71 CASES. A SINGLE CENTER EXPERIENCE Viacheslav Ivanovich Egorov, Russia; R. Petrov; N. Amol Bapaye, India; V. Vyas; N. A. Dubale; H. Gadhikar; Starostina; A. Vankovich M. Mahadik; J. A. Bapaye; A. Kulkarni; R. Gaadhe

Poster in the Spotlight Poster of Excellence Clinical Case Session 167

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

Pancreatic cancer: Clinical P0656 A PROSPECTIVE COMPARATIVE STUDY OF THE 'SUCTION P0648 METHOD' VERSUS THE 'NO SUCTION PLUS SUCTION GLYPICAN-1 IDENTIFIES CANCER EXOSOMES AND DE- METHOD' IN ENDOSCOPIC ULTRASOUND-GUIDED FINE TECTS VARIOUS DIGESTIVE SYSTEM NEOPLASMS NEEDLE ASPIRATION OF MALIGNANT PANCREATIC Yan-Jie Chen, China; X. Shen SOLID MASSES P0649 Kei Kuraoka, Japan; Y. Okabe; Y. Naito; Y. Ishida; T. PANCREATIC CANCER DIAGNOSTIC BIOMARK- Ushijima; O. Fukahori; M. Yasumoto; O. Tsuruta; T. ERS-FROM LITERATURE TO CLINICAL TESTING Torimura Asif Ali, Pakistan; N. B. Jamieson; S. Bell; A. Bilsland; J. P0657 Morton; J. Slavin; V. Brown; V. Lynch; M. Elgoweini; D. ENDOSCOPIC ULTRASONOGRAPHY OF THE PANCREAS Chang; S. Denley; C. Orange; Z. Ul-Haq; D. Mackay; M. REFLECTS EXOCRINE AND ENDOCRINE FUNCTION Derakhshan; C. McKay; C. R. Carter; F. Duthie; K. A. Oien Yoshihiro Hamada, Japan; K. Maeshiro; Y. Nakayama P0650 REAL-LIFE USE OF INTENSIFIED CHEMOTHERAPY FOR Endocrine tumours of the pancreas METASTATIC PANCREATIC CANCER IN EUROPE P0658 Georg Beyer, Germany; M. A. Javed; N. Le; M. Schober; ENDOSCOPIC ULTRASOUND (EUS) HAS THE EDGE OVER A. Vinci; R. D. Morgan; R. Hubner; J. Valle; H. Wong; CT/MRI IN THE DETECTION OF PANCREATIC NEURO- S. Chowdhury; Y. T. Ma; D. Palmer; P. Maisonneuve; A. ENDOCRINE TUMOURS (PNETS) IN PATIENTS WITH Neesse; M. Sund; S. Krug MULTIPLE ENDOCRINE NEOPLASIA TYPE I (MEN1) P0651 Christopher T. W. Chia, Singapore; I. Koumoutsos; I. ENDOSCOPIC ULTRASOUND-GUIDED HYBRIDTHERM Nasr; S. DeMartino; J. Meenan

Tuesday, October 18, 2016 ABLATION IN PATIENTS WITH STAGE III PANCREATIC P0659 DUCTAL ADENOCARCINOMA: PROSPECTIVE SINGLE THE RELATIONSHIP BETWEEN GASTROENTEROPANCRE- CENTER COHORT STUDY ATIC NEUROENDOCRINE NEOPLASM (GEP-NEN) PROG- Maria Chiara Petrone, Italy; S. G. G. Testoni; M. Cava; NOSIS RE-STRATIFICATION AND KI-67 VARIABILITY: A E. Dabizzi; W. Linzenbold; M. Enderle; F. De Cobelli; S. SINGLE CENTER STUDY Gusmini; M. Reni; M. Falconi; P. G. Arcidiacono Rong Lin, China; Q. Zhang; Z. Ding P0652 P0660 WORLDWIDE SURVEY ON OPINIONS AND USE OF MINI- SLIT2-ROBO1 SIGNALLING ACTIVATES RAS TO SUPPRESS MALLY INVASIVE PANCREATIC RESECTION METASTASIS, AND IS ASSOCIATED WITH TIME-TO-PRO- Jony van Hilst, The Netherlands; T. de Rooij; M. Abu GRESSION IN PANCREATIC NEUROENDOCRINE TUMOURS Hilal; H. J. Asbun; J. Barkun; U. Boggi; O. R. C. Busch; Andreas Göhrig, Germany; K. M. Detjen; M. Welzel; A. K. Conlon; M. G. Dijkgraaf; H.-S. Han; P. D. Hansen; Behm; I. Eichhorn; A. Pascher; R. Arsenic; C. Grötzinger; M. L. Kendrick; A. L. Montagnini; C. Palanivelu; B. I. B. Wiedenmann; C. Fischer Rosok; S. V. Shrikhande; G. Wakabayashi; H. Zeh; C. M. Vollmer; D. A. Kooby; M. G. H. Besselink P0661 NATURAL HISTORY AFTER LONG-TERM FOLLOW UP P0653 OF PANCREATIC NEUROENDOCRINE TUMORS (PNET), WATCHFUL FOLLOW-UP IS ACCEPTABLE, BASED ON BASED ON THE DETECTION OF THE PROLIFERATION CLINICAL OUTCOMES OF MAIN DUCT INTRADUCTAL CELL INDEX (KI-67) OBTAINED BY EUS-GUIDED FINE PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS NEEDLE ASPIRATION (EUS-FNA) Atsushi Kubo; Japan; T. Noda; M. Izuta; C. Ogawa; T. M. F. Brasil; Carolin D. Nava, Brazil; J. G. G. G. D. A. L. Matsunaka; H. Tamaki; M. Shibatoge; Cabral; J. C. Ardengh; G. F. Paduani; L. S. Hybner P0654 P0662 WITHDRAWN THE ROLE OF EUS-FNA IN THE DIAGNOSIS AND GRAD- P0655 ING OF PANCREATIC NEUROENDOCRINE TUMORS CLINICAL EFFICACY OF PET/CT IN PATIENTS WITH Silvia Carrara, Italy; D. Rahal; M. Di Leo; A. Zerbi; A. INCREASED SERUM CA19-9 WITHOUT BILIARY TRACT Anderloni; L. Di Tommaso; D. Federico; A. Repici OR PANCREATIC MALIGNANCY Kyu Taek Lee, South Korea; J. H. Kim

168 Poster in the Spotlight Poster of Excellence Clinical Case Session 169 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

Endoscopy, upper GI P0670 PRAGUE CLASSIFICATION FOR BARRETTES OESOPHA- Poster Session GUS: A STUDY TO SEE THE DEGREE OF COMPLAINCE BY 09:00 - 17:00 Hall X4 THE ENDOSCOPISTS Endoscopy and Imaging II Tariq Mahmood, United Kingdom P0663 P0671 SIMPLE AND SAFE FORCEP STRIP TECHNIQUE FOR RISK FACTORS FOR METACHRONOUS GASTRIC CARCI- GASTRIC SUBMUCOSAL TUMORS ORIGINATING FROM NOMA DEVELOPMENT AFTER ENDOSCOPIC RESECTION MUSCULARIS PROPRIA LAYER OF GASTRIC DYSPLASIA; RETROSPECTIVE , SINGLE I. K. Yoo; H.J. Chun; J. M. Lee; J. M. Lee; S. H. Kim; H. S. CENTER STUDY Choi; Eun Sun Kim, South Korea; B. Keum; Y. T. Jeen; H. Hee Seok Moon, South Korea; J. S. Kim; S. H. Kang; J. S. Lee; C. D. Kim; S. Y. Lee; B. K. Choi K. Sung; H. Y. Jeong P0664 P0672 MINIMAL ESOPHAGEAL LESIONS DETECTED BY DIGITAL DOES SHOCK INDEX (SI) CONTRIBUTE IN THE RISK CHROMOENDOSCOPY USING OPTICAL ENHANCEMENT ASSESSMENT OF PATIENTS WITH ACUTE UPPER GAS- SYSTEMTM ASSOCIATED TO HIGH DEFINITION PLUS TROINTESTINAL BLEED (AUGIB)? OPTICAL MAGNIFICATION IN NON EROSIVE REFLUX Sonam Naik, United Kingdom; D. Forrest; S. I. Hus- DISEASE (NERD) saini; S. Gupta Carlos Robles-Medranda, Ecuador; M. Valero; M. Soria; P0673 M. Puga; J. Ospina; H. Alvarado; H. Pitanga Lukashok CREATING A VIRTUAL LESION WITH A POLYPECTOMY P0665 SNARE: A SIMPLE AND INEXPENSIVE METHOD TO ASSESS ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC THE "PIG R0 RESECTION RATE" DURING ENDOSCOPIC NEOPLASMS WITH THE CONTINUOUS USE OF LOW- SUBMUCOSAL DISSECTION TRAINING IN ANIMAL MODELS DOSE ASPIRIN: ANALYSIS OF 101 PATIENTS J. Jacques; R. Legros; Sophie Geyl, France; C.-Y. Couquet; Hideaki Harada, Japan; S. Suehiro; D. Murakami; R. P. Carrier; T. Tabouret; L. Bianchi; M. Debette-Gratien; Nakahara; T. Shimizu; Y. Katsuyama; K. Hayasaka A. Le-Sidaner; V. Loustaud-Ratti; D. Sautereau P0666 P0674 A NOVEL FULLY-SYNTHETIC AND SELF-ASSEMBLED WITHDRAWN PEPTIDE SOLUTION FOR ENDOSCOPIC SUBMUCOSAL P0675

DISSECTION INDUCED ULCER; A FEASIBILITY STUDY AUTOMATIC LABELING OF ABNORMAL MICROVESSELS ON 2016 18, October Tuesday, Toshio Uraoka, Japan; Y. Ochiai; A. Fujimoto; O. Goto; EARLY GASTRIC CANCER: MAGNIFYING NARROW-BAND K. Takabayashi; Y. Kawahara; K. Hori; T. Kanai; IMAGING USING GRAY-LEVEL CO-OCCURRENCE MATRIX S. Matsuda; Y. Kitagawa; N. Yahagi AND VECTOR QUANTIZATION TECHNIQUES P0667 Takashi Kanesaka, Japan; T.-C. Lee; N. Uedo; H.-Z. DETECTION OF EARLY NEOPLASIA AND PREDICTION OF Chen; J.-Y. Lee; H.-P. Wang; H.-T. Chang

TREATMENT EFFICACY FOR ADVANCED CANCERS USING P0676 HYPOXIA IMAGING ENDOSCOPY EQUIPPED WITH LASER NOVEL ENDOSCOPIC FINDINGS OF MULTIPLE WHITE SOURCE FLAT LESIONS: A NEW SUBTYPE OF HYPERPLASTIC Kazuhiro Kaneko, Japan; H. Yamaguchi; T. Saito; Y. POLYPS IN THE STOMACH Oono; H. Ikematsu; T. Yano; A. Sato; M. Kojima Rino Yamaoka, Japan; T. Kojima; K. Yao; K. Chuman; K. P0668 Imamura; H. Takahashi; S. Fujiwara; T. Nagahama; T. Ueki WITHDRAWN P0677 P0669 IMPACT OF TIME TO ENDOSCOPY ON MORTALITY IN HANDS-ON TRAINING ON PORCINE MODELS FOR ENDO- PATIENTS WITH NON VARICEAL UPPER GI BLEED SCOPIC SUBMUCOSAL DISSECTION (ESD) AND PER-ORAL Syed Anjum Ali Gardezi, United Kingdom; C. Tibbatts; ENDOSCOPICMYOTOMY (POEM) - DOES IT HELP TRAINING A. Foliaki OF PHYSICIANS FOR THESE ADVANCED PROCEDURES? P0678 Amol Bapaye, India; M. Mahadik; N. A. Dubale; V. APPLICATION OF A NOVEL ENDOSCOPIC SUTURING COIL Vyas; S. Dorwat; P. Desai IN ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) Y. Bi; Y. Liu; Min Min, China; L. Wang

Poster in the Spotlight Poster of Excellence Clinical Case Session 169

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0679 P0688 EFFICACY OF MAGNIFYING ENDOSCOPY WITH BLUE THE TUNNEL + CLIP STRATEGY INCREASES THE EASE LASER IMAGING FOR DIAGNOSIS OF RANGE OF EARLY AND SPEED OF OESOPHAGEAL ESD: A RANDOMIZED GASTRIC CANCER STUDY IN PIGS. Takahiro. Nakano, Japan; O. Dohi; K. Terasaki; N. Iwai; J. Jacques; Romain Legros, France; S. Geyl; C.-Y. Couquet; T. Ueda; A. Majima; Y. Gen; T. Okayama; N. Yoshida; K. P. Carrier; L. Bianchi; V. Loustaud-Ratti; D. Sautereau; Kamada; K. Uchiyama; T. Ishikawa; T. Takagi; O. Handa; H. Konishi; Y. Naito; Y. Itoh P0689 ENDOSCOPIC RESECTION FOR DUODENAL LESIONS: P0680 OUTCOMES OF THE 374 PATIENTS FROM A RETROSPEC- THE IMPACT OF THE UNITED KINGDOM NATIONAL OE- TIVE SINGLE-CENTER STUDY SOPHAGO-GASTRIC CANCER AWARENESS CAMPAIGN Quan-Lin Li, China; C. Lim; P.-H. Zhou Stavroula Pelitari, United Kingdom; N. Sharma; I. Rahman P0690 P0681 IMPROVING EFFICIENCY IN THE ENDOSCOPY UNIT: SAFETY AND USEFULNESS IN ELDERLY PATIENTS 80 WHAT CAN WE DO TO REDUCE ‘DID NOT ATTEND' (DNA) YEARS OR OLDER OF ENDOSCOPIC SUBMUCOSAL DISSEC- AND LATE CANCELLATION RATES? TION FOR EARLY GASTRIC AND ESOPHAGEAL CANCERS Yusuf Hussain, United Kingdom; S. Moreea Yasuo Miyamoto, Japan; S. Nonaka; I. Oda; S. Abe; H. Suzuki; S. Yoshinaga; Y. Kawaguchi; Y. Saito P0691 PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY AS THER- P0682 APEUTIC INDICATION IN PATIENTS WITH PARKINSON´S COMPARISON OF LANSOPRAZOLE WITH VONOPRAZAN DISEASE FOR TREATING POST-ENDOSCOPIC SUBMUCOSAL DIS- Zuzana Durkovicova, Slovakia; M. Szantova SECTION ULCERS

Tuesday, October 18, 2016 Akio Koizumi, Japan; H. Yamashita; A. Okada P0692 A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF P0683 VONOPRAZAN VS RABEPRAZOLE FOR GASTRIC ULCERS OVER-THE-SCOPE CLIP FOR THE MANAGEMENT OF AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION ENTEROCUTANEOUS FISTULA (ECF) AND PERISTOMAL Hiroyuki Komori, Japan; H. Ueyama; A. Nagahara; Y. LEAKAGE Akazawa; T. Takeda; K. Matsumoto; K. Matsumoto; D. Majidah Bukhari, USA; V. Kumbhari; M. ElZein; A. Asaoka; M. Hojo; S. Watanabe Ismail; Y.-I. Chen; Y. H. Chavez; S. Ngamruengphong; M. Khashab P0693 DIFFERENTIAL DIAGNOSIS OF DIFFERENTIATED P0684 GASTRIC CANCER BY USING RAPID FLOW CYTOMETRY EXPANDING RELATIVE INDICATION OF ESD FOR EARLY METHOD AS A CLINICAL APPLICATION. GASTRIC CANCER ACCORDING TO THE SURGICAL CASES Suzuki Akane, Japan; T. Yamada; T. Noguchi; A. Serizawa; OF POST NON-CURATIVE ESD S. Kotake; N. Ikari; N. Kanai; T. Shioyama; H. Kubo; S. Hideomi Tomida, Japan; T. Ninomiya; K. Michitaka Yamamori; N. Kobayashi; N. Hinata; Y. Nagashima; Y. Muragaki; K. Taniguchi; M. Yamamoto P0685 THE EFFECTIVENESS OF THE TRIAMCINOLONE-LOADED P0694 THERMOGEL SYSTEM TO PREVENT ESOPHAGEAL STRIC- OESOPHAGEAL ESD FOR BARRETT'S NEOPLASIA TAKES TURE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION IN 9.9MIM/CM2 & DEPENDS ON THE LESION SIZE & CIR- A PORCINE MODEL CUMFERRENTIAL EXTENSION OF THE NEOPLASIA C. Zhang; Q. Li; L. Yu; Mei-dong Xu, China M. Abdulla; A. A. Alkandari; F. J. Q. Chedgy; K. Kandiah; S. Subramaniam; G. Longcroft-Wheaton; Pradeep P0686 Bhandari, United Kingdom THE ROLE OF MINIPROBE ENDOSCOPIC ULTRASONOG- RAPHY IN THE DECISION OF EARLY GASTRIC CANCER P0695 TREATMENT NEW ENDOSCOPIC FINDING OF ESOPHAGEAL ACHALA- R. Daegon; D. Kang; H. Kim; C. Choi; S. Park; S. Kim; H. SIA WITH ST SHORT HOOD : "CORONA APPEARANCE" Nam; W. Choi; J. Cho; Jungmin Park, South Korea; S. Lee Hironari Shiwaku, Japan; K. Yamashita; T. Matsuoka; T. Ohmiya; H. Okada; Y. Shiwaku; S. Nimura; H. Inoue; S. P0687 Hasegawa USEFULNESS OF THE MARGIN AROUND LESION FINDINGS BY MAGNIFYING ENDOSCOPY WITH NAR- ROW-BAND IMAGING IN EARLY GASTRIC CARCINOMA. K. Hamada; Tohru Itoh, Japan

170 Poster in the Spotlight Poster of Excellence Clinical Case Session 171 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

Endoscopy, colon P0702 P0696 DIAGNOSTIC ACCURACY OF THE NICE CLASSIFICATION FULL THICKNESS RESECTION DEVICE (FTRD): A NOVEL FOR PREDICTING DEEP SUBMUCOSAL INVASION IN CO- TOOL FOR COLONOSCOPIC ADENOMA RESECTION. FIRST LON LESIONS ASSESSED IN VIVO. PRELIMINARY RESULT CLINICAL EXPERIENCE FROM TWO TERTIARY REFERRAL Ignasi Puig, Spain; M. Lopez-Ceron; M. Pellise; A. Herreros CENTERS IN SWITZERLAND. de Tejada; A. Arnau; M. Fornells Sala; L. De Castro; A. Patrick Roger Aepli, Switzerland; R. Frei; J. Borovicka; Ferrandez; O. Nogales Rincon; J. López Vicente; A. Z. D. Criblez Gimeno Garcia; P. Vega; M. Hernández Conde; H. Nuñez; D. Rodriguez-Alcalde; A. Burgos; L. Rivero Sanchez; J. P0697 Garcia Alonso; E. Martinez- Bauer; P. Diez-Redondo; IMPLEMENTATION OF AN OPTICAL DIAGNOSIS STRATE- J. Mendoza; J. Ducons García; P. Estevez; J. Llao; V. GY SAVES COSTS AND DOES NOT IMPAIR CLINICAL OUT- Hernandez; S. Soto; D. Martinez-Ares; M. A. Álvarez- COMES OF A FIT-BASED CRC SCREENING PROGRAMME González; J. M. Pascual; F. Porta; F. Dominguez; J. Jasper Vleugels, The Netherlands; M. J. E. Greuter; Y. Cubiella; M. A. Simon; L. Cid; A. Isava; B. Peñas; A. Hazewinkel; V. M. H. Coupé; E. Dekker Burgos; J. García Lledó; M. López Ibáñez; M. Bustamante; P0698 F. Gomollon; C. Sostres; F. Riu Pons; R. Macenlle; J. De ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) OF la Revilla Negro; R. Campo Fernandez; G. de la Poza; SUPERFICIAL COLORECTAL NEOPLASMS AT THE ANAL A. Martínez Turnes; P. Quintas; N. Ascon; F. Vida CANAL AND ILEOCECAL VALVE P0703 Federico Iacopini, Italy; Y. Saito; T. Gotoda; W. Elisei; C. VALIDATION OF ENDOSCOPIC CLASSIFICATION FOR Grossi; F. Montagnese; G. Costamagna COLORECTAL LATERALLY SPREADING TUMORS USING P0699 AN EDUCATIONAL WEBSYSTEM OPTIMIZING WITHDRAWAL TIME AND USE OF FUSE Roel M. M. Bogie, The Netherlands; L.-C. Chang; B. ENDOSCOPE ACHIEVE SIMILAR RESULTS IN TERM OF Winkens; T. Matsuda; S. Tanaka; H. Yamano; M. Rutter; INCREASING ADENOMA DETECTION RATE. RESULTS OF R. Kiesslich; A. Ono; A. Sanchez Yague; T. Kaltenbach; A PRELIMINARY OBSERVATIONAL STUDY R. Soetikno; S.-E. Kudo; H. M. Chiu; S. Sanduleanu Gianpiero Manes, Italy; M. Devani; S. Saibeni; I. Arena; P0704 G. De Nucci; P. Andreozzi; B. Omazzi COLORECTAL POLYPS DIAGNOSIS BY NARROW-BAND P0700 IMAGING - DIFFERENCES BETWEEN THE CLINICAL PREDICTORS RELATED TO COLONOSCOPY COMPLI- TRIALS AND THE REAL WORLD Joana Castela, Portugal; J. Moleiro; R. Vale Rodrigues; CATIONS IN AN ORGANISED COLORECTAL CANCER 2016 18, October Tuesday, SCREENING PROGRAMME WITH IMMUNOCHEMICAL C. Martins; F. Ávila; J. Cortez-Pinto; S. Mão de Ferro; FAECAL OCCULT BLOOD TEST I. Rosa; M. Serrano; J. Pereira da Silva; S. Ferreira; I. I. Idigoras Rubio; Eunate Arana-Arri, Spain; I. Bilbao; Marques; I. Claro; P. Lage; A. Dias Pereira J. Fernandez; I. Fernandez; L. Martinez-Indart; I. P0705 Gutierrez-Ibarluzea; M. I. Portillo Villares COLONOSCOPIC FINDINGS IN PATIENTS WITH INCIDEN-

P0701 TAL COLONIC FOCAL FDG UPTAKE REAL TIME HISTOLOGY AT ENDOSCOPY - VIRTUAL Eugénie Rigault, France; L. Lenoir; G. Bouguen; M. ELECTRONIC CHROMOENDOSCOPY AND PROBE CON- Pagenault; A. Lièvre; E. Garin; L. Siproudhis; J.-F. Bretagne FOCAL LASER ENDOMICROSCOPY CAN ASSESS SUBTLE P0706 MUCOSAL AND VASCULAR INFLAMMATORY CHANGES ENDOSCOPIC REMOVAL OF EARLY STAGE COLORECTAL IN ULCERATIVE COLITIS PATIENTS. CANCER IN A FIT-BASED SCREENING POPULATION: Marietta Iacucci, Canada; X. Gui; O. Akinola; PROGRESS STILL TO BE MADE R. Panaccione; S. Ghosh E. Wieten; Esmée Jacomina Grobbee, The Netherlands; E. J. Kuipers; P. Didden; M. J. Bruno; M. C. W. Spaander P0707 FULL SPECTRUM ENDOSCOPY (FUSE) VERSUS STAN- DARD FORWARD VIEWING ENDOSCOPE (SFVE) IN A HIGH RISK POPULATION Soeren Roepstorff, Denmark; S. Hadi; M. Rasmussen

Poster in the Spotlight Poster of Excellence Clinical Case Session 171

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0708 P0716 1L MORNING-ONLY POLYETHYLENE GLYCOL PLUS FACTORS AFFECTING THE IMPLEMENTATION OF NEW ASCORBIC ACID WITH PREPACKAGED LOW-RESIDUE DIET ACCEPTED PRACTICES (NAP) TO IMPROVE PATIENTS' VERSUS 2L POLYETHYLENE GLYCOL PLUS ASCORBIC ACID SAFETY IN GASTROINTESTINAL ENDOSCOPY UNITS FOR BOWEL PREPARATION: A RANDOMIZED TRIAL Yulia Shmunis, Isreal; E. Santo; S. Magzenik; Y. Cogan; Joon Young Choi, South Korea; H. Yoon; G. Na; C. M. S. Klenter; E. Abayev; R. Bruck Shin; Y. S. Park; N. Kim; D. H. Lee P0717 P0709 HIGHER NUMBER OF SMALL (<10MM) ADENOMAS DE- A NEW DEVICE FOR ACHIEVING ADEQUATE BOWEL TECTED WITH ENDOCUFF-ASSISTED COLONOSCOPY IN A PREP IN POORLY PREPPED PATIENTS RECEIVING A SCREENING POPULATION REDUCED PRE-PROCEDURAL PREPARATION Lucas G. Cavallaro, Italy; P. Lecis; E. Galliani; E. Dal J. Perez; L. Bermudez; M. Leopoldo; Ori Segol, Israel; Pont; A. Giacomin; P. Iuzzolino; E. Macrì; C. Roldo; F. M. Libes Soppelsa; S. Di Camillo; R. Mel; B. Germanà P0710 P0718 ACCURACY OF THE FULL SPECTRUM ENDOSCOPY PREVALENCE OF SERRATED ADENOMAS/POLYPS AT SYSTEM (FUSE) FOR PREDICTION OF COLORECTAL POLYP COLONOSCOPY IN A REGIONAL HOSPITAL IN HISTOLOGY ACCORDING TO THE REQUIREMENTS OF THE QUEENSLAND, AUSTRALIA PIVI STATEMENT Sneha John, Australia; A. Azzam; S. Stanley; D. Jones Helmut Neumann, Germany; G. E. Tontini; M. Vieth; K. Mönkemüller P0719 HISTOLOGY PREDICTION OF COLORECTAL POLYPS BY P0711 NARROW-BAND IMAGING - ACCURACY AND INTER-OB- EFFECT OF THE MAGNETIC ENDOSCOPE IMAGER ON CO- SERVER AGREEMENT IN STATIC IMAGES' EVALUATION Tuesday, October 18, 2016 LONOSCOPY PERFORMANCE BY A SINGLE ENDOSCOPIST Joana Castela, Portugal; J. Moleiro; R. Vale Rodrigues; F. Luke B. Materacki, United Kingdom; J. Kennedy; H. Ávila; C. Martins; S. Mão de Ferro; I. Rosa; M. Serrano; Kriel; T. Brooklyn J. Pereira da Silva; S. Ferreira; I. Marques; I. Claro; P. Lage; A. Dias Pereira P0712 ASSESSING PREDICTORS OF THE BOWEL PREPARATION P0720 QUALITY FOR COLONOSCOPY COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION Waleed Fateen, United Kingdom; V. nadesalingham; IN WESTERN WORLD: PROMISING LESSONS FROM A Y. Subramaniam; H. Thygesen; R. Rameshshanker; A. PROSPECTIVE SERIES OF 85 CASES Haycock; B. P. Saunders M. Lopez Gomez; M. Hernández Conde; J. Santiago; C. González-Lois; P. Matallanos; E. Blazquez; J. Fernández P0713 Rial; J. Garcia; J. L. Calleja; L. Abreu; A. Herreros de THE ADENOMA TO POLYP DETECTION RATE QUOTIENT Tejada, Spain VARIES AMONG DIFFERENT PATIENT POPULATIONS: IM- PLICATIONS FOR THE QUALITY METRICS OF COLONOSCOPY P0721 Andrea Buda, Italy; F. Vieceli; ; M. De Bona; A. ENDOSCOPIC SUBMUCOSAL DISSECTION FOR COLOREC- Bellumat; M. Tollardo; G. Terrosu; A. Anderloni; A. TAL NEOPLASMS MORE THAN 50MM IS A FEASIBLE Crudeli; C. Hassan; A. Repici; M. De Boni METHOD OF TREATMENT Yosuke Tsuji, Japan; M. Fujishiro; Y. Sakaguchi; C. P0714 Minatsuki; I. Asada-Hirayama; K. Niimi; S. Ono; S. CAN A SMALL POLYP SURPRISE A BIG ENDOSCOPIST? Kodashima; N. Yamamichi; K. Koike Szymon Pietruszka, Poland; P. Wyszynska; Z. Wojciechowska; A. Szczepanik P0722 IDENTIFICATION AND QUANTIFICATION OF THE CLINICAL P0715 FEATURES OF INFLAMMATORY BOWEL DISEASE AND NEWLY DESIGNED COLONIC EX-VIVO MODEL WITH REAL COLORECTAL CANCER IN PATIENTS AGED <50 YEARS: FLAT LESIONS FOR LEARNING ENDOSCOPIC SUBMU- WHO NEEDS URGENT COLONOSCOPY COSAL DISSECTION IN WESTERN COUNTRIES: DOUBLE S. Stapley; Gregory Rubin, United Kingdom; EVALUATION INCLUDING EXPERTS' ASSESSMENT AND E. Shephard; D. Alsina; W. Hamilton LEARNING CURVE STUDY ON FELLOWS Jean-Michel Gonzalez, France; G. Vanbiervliet; J. I. Tellechea; P. Miranda -Garcia; E. Coron; M. Barthet

172 Poster in the Spotlight Poster of Excellence Clinical Case Session 173 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0723 P0730 NARROW BAND IMAGING (NBI) VS. NBI WITH ACETIC PREDICT, RESECT AND DISCARD - A QUANTITATIVE ACID ENHANCEMENT FOR DIFFERENTIATION OF SMALL ASSESSMENT OF THE RISKS AND COST SAVINGS IN COLORECTAL POLYPS COLORECTAL CANCER SCREENING COMPARING TWO Dmitry Zavyalov, Russia; S. Kashin; R. Kuvaev; STRATEGIES FROM THE PORTUGUESE HEALTH SYSTEM E. Kraynova; T. Kryukova Joana Moleiro, Portugal; S. Ferreira; M. Serrano; A. Dias Pereira P0724 ENDOSCOPIC APPLICATION OF REGENERATED OXIDIZED Endoscopy, ERCP CELLULOSE AFTER RECTAL ENDOSCOPIC RESECTION Seiichiro Abe, Japan; Á. Martínez-Alcalá; P. T. Kroener; P0731 H. Neumann; Y. Saito; K. Mönkemüller DIRECT PERORAL CHOLANGIOSCOPY BY USING A NEWLY DEVELOPED MULTIBENDING ULTRASLIM ENDOSCOPE P0725 FOR THE TREATMENT OF DIFFICULT BILE DUCT STONES THE EFFICACY AND SAFETY OF ENDOSCOPIC MUCOSAL Jong Ho Moon, South Korea; Y. N. Lee; H. J. Choi; M. H. RESECTION USING BIPOLAR INSTRUMENT IN LARGE Choi; T. H. Lee; S.-W. Cha; Y. D. Cho; S.-H. Park PEDUNCULATED COLORECTAL POLYPS Hiroshi Nakamura, Japan; H. Ikematsu; S. Osera; N. P0732 Okamoto; Y. Yamamoto; T. Hombu; K. Takashima; M. RAPID CARBAPENEMASE RESISTANT ENTEROBACTE- Imajoh; T. Kadota; H. Morimoto; Y. Oono; T. Yano; K. RIACEAE (CRE) PCR TESTING OF DUODENOSCOPES: Kaneko FEASIBILITY AND ACCURACY Rahul Pannala, USA; D. O. Faigel; B. Baldwin; L. J. Miller; P0726 C. C. Nguyen; M. E. Harrison; F. Tenover; D. Persing; T. ENDOSCOPIC RESECTIONS BY EMR AND ESD IN CIR- E. Grys RHOTIC PATIENTS: A SAFE AND EFFICIENT PROCEDURE? Clothilde Miaglia, France; J. Dumortier; O. Guillaud; C. P0733 Chambon-Augoyard; J.C. Saurin; J. Rivory; T. Ponchon; SPYGLASS DIRECT VISUALIZATION SYSTEM VERSUS M. Pioche DIRECT PERORAL CHOLANGIOSCOPY USING BY A MU- LIBENDING ULTRASLIM ENDOSCOPE AS A SINGLE-OPER- P0727 ATOR PERORAL CHOLANGIOSCOPY FOR THE MANAGING RISK ASSESSMENT OF ANTICOAGULATION AND ANTI- BILIARY LESIONS: A PROSPECTIVE COMPARATIVE STUDY PLATELET THERAPY IN DELAYED POSTPOLYPECTOMY Jong Ho Moon, South Korea; Y. N. Lee; H. J. Choi; H. K. Kim; BLEEDING - A COHORT STUDY M. H. Choi; T. H. Lee; S.-W. Cha; Y. D. Cho; S.-H. Park Maria Pia Costa Santos, Portugal; C. Fidalgo; A. Ferreira; C. Palmela; C. Gouveia; R. Ferreira; J. Nunes; R. Loureiro; P0734 2016 18, October Tuesday, E. Barjas; L. Glória; A. A. Santos; M. Cravo A COMPARATIVE STUDY OF STRATEGIES FOR PREVEN- TION OF POST-ERCP PANCREATITIS AFTER EARLY PRE- P0728 CUT SPHINCTEROTOMY FOR BILIARY ACCESS PREDICTING ADENOMA DETECTION RATE BY POLYP T.-L. Ang; A. B. E. Kwek; Weiquan J. Li, Singapore; M. DETECTION RATE AND INDIVIDUAL ADENOMA-TO-POL- Song; P. H. Thurairajah YP-DETECTION-RATE-RATIO IN AVERAGE-RISK COLO- NOSCOPIES P0735 Christoph Schramm, Germany; I. Scheller; J. Franklin; ENDOSCOPIC MINOR PAPILLA SPHYNCTEROTOMY IS M. Demir; F. Kuetting; D. Nierhoff; T. Goeser; U. Toex; EFFECTIVE FOR THE TREATMENT OF SYMPTOMATIC SAN- H.-M. Prof. Dr. Steffen TORINICELE: LONG-TERM RESULTS IN A LARGE SERIES Stefano Francesco Crinó, Italy; M. C. Conti Bellocchi; P0729 L. Bernardoni; G. Malleo; R. Manfredi; A. Amodio; L. REAL-LIFE MANAGEMENT OF ANTIPLATELET THERAPY Frulloni; A. Gabbrielli (APT) PRIOR TO ENDOSCOPIC PROCEDURES: DOES DAILY PRACTICE FIT IN WITH GUIDELINES? P0736 Carla Satorres, Spain; M. Bustamante-Balén; G. Plumé; SPHINCTER OF ODDI DYSFUNCTION AFTER LIVER F. C. Díaz; D. Álvarez de Sotomayor; M. Ponce; TRANSPLANTATION: EXPERIENCE IN A HIGH VOLUME N. Alonso Lázaro; L. Argüello TRANSPLANT CENTER Alejandro Fernandez-Simon, Spain; D. Royg; O. Sendino; K. Chavez-Rivera; A. Mendez-Bocanegra; C. Rodriguez de Miguel; J. Llach; G. Crespo; J. Colmenero; M. Navasa; A. Cardenas

Poster in the Spotlight Poster of Excellence Clinical Case Session 173

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0737 P0744 A PROSPECTIVE COMPARISON OF DIRECT DIGITAL AND EUS-GUIDED HEPATICO-GASTROSTOMY VS PERCUTA- BALLOON-ASSISTED CHOLANGIOSCOPY IN COMPLEX NEOUS TRANSHEPATIC DRAINAGE FOR MALIGNANT BILIARY DISEASE BILIARY OBSTRUCTION AFTER FAILED ERCP Karl Herba, Australia; J. Behary; P. I. Craig Adrien Sportes, France; M. Camus; M. Greget; S. Leblanc; R. Coriat; J. Hochberger; S. Chaussade; F. Prat P0738 ERCP IN INFANTS, CHILDREN AND ADOLESCENTS IS P0745 FEASIBLE AND SAFE - RESULTS FROM A TERTIARY ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAIN- CARE CENTER AGE FOR MALIGNANT BILIARY OBSTRUCTION AFTER J. Felux; E. Sturm; A. Busch; E. Zerabruck; F. Graepler; FAILED ERCP: A SINGLE ITALIAN CENTER EXPERIENCE N.P. Malek; Martin Goetz, Germany Paolo Cecinato, Italy; F. Parmeggiani; F. Azzolini; F. Decembrino; G. Sereni; C. Tioli; V. iori; M. Cavina; R. P0739 Zecchini; R. Sassatelli COMPARISON OF MAGNETIC RESONANCE CHOLAN- GIOPANCREATOGRAPHY AND ENDOSCOPIC RETRO- P0746 GRADE CHOLANGIOGRAPHY IN DISEASE SEVERITY ACCURACY OF QUALITATIVE ENDOSCOPIC ULTRA- ASSESSMENT OF PRIMARY SCLEROSING CHOLANGITIS: SOUND-GUIDED ELASTOGRAPHY FOR THE DIAGNOSIS IMPACT ON PROGNOSIS OF MALIGNANCY OF LEFT ADRENAL GLAND MASSES Andrea Tenca, Finland; K. Lind; E. Lantto; H. Mustonen; Julio Iglesias-García, Spain; D. De la Iglesia-García; M. A. Färkkila J. Lariño-Noia; C. Calviño-Suárez; I. Abdulkader; J. E. Domínguez-Muñoz P0740 ENDOSCOPIC BILIARY STENT INSERTION THROUGH P0747 DUODENAL STENT IN PATIENTS WITH COMBINED COMPARISON OF SPECIMEN ADEQUACY AND DIAG- Tuesday, October 18, 2016 MALIGNANT BILIARY AND DUODENAL OBSTRUCTION NOSTIC PERFORMANCES ACCORDING TO EUS-FNA UNDER STENT OR PTBD GUIDANCE TECHNIQUES IN PANCREATIC LESIONS: NO SUCTION, Jong Jin Hyun, South Korea; J. W. Choe; D. W. Lee; S. Y. SUCTION AND CAPILLARY SUCTION Kim; S.-W. Jung; Y.-K. Jung; J.-S. Koo; H. J. Yim; S. W. Chang-Min Cho, South Korea; M. K. Jung; K. J. Kim; A. Lee; H. Lee; C. D. Kim N. Seo; H. I. Bae P0741 P0748 TRANSPANCREATIC SEPTOTOMY - AN ALTERNATIVE TO CONCORDANCE BETWEEN THE ROSEMONT AND THE PRECUT FOR DIFFICULT BILIARY ACCESS? STANDARD ENDOSCOPIC ULTRASOUND CLASSIFICA- Diogo Branquinho, Portugal; N. Almeida; D. Gomes; E. TION OF CHRONIC PANCREATITIS Camacho; S. Mendes; C. Sofia Cristina Calviño-Suárez, Spain; D. De la Iglesia-García; J. Iglesias-Garcia; J. López-Díaz; J. Lariño-Noia; J. E. Endosonography Domínguez-Muñoz P0742 P0749 INTERNATIONAL MULTICENTER COMPARATIVE TRIAL IMPACT OF VISUAL ON-SITE EVALUATION DURING EN- OF ENDOSCOPIC ULTRASONOGRAPHY GUIDED GAS- DOSCOPIC ULTRASOUND ON FINE NEEDLE ASPIRATION TROENTEROSTOMY VERSUS SURGICAL GASTROJE- CYTOLOGY JUNOSTOMY FOR THE TREATMENT OF MALIGNANT Anna Mariniello, Italy; M. Martino; M. Pandolfi; F. M. GASTRIC OUTLET OBSTRUCTION Di Matteo Majidah Bukhari, USA; T. Itoi; M. ElZein; T. H. Baron; J. Nieto; Y.-I. Chen; Y. H. Chavez; S. Ngamruengphong; V. Enteroscopy Kumbhari; A. Alawad; A. Ismail; M. Khashab P0750 P0743 IN VIVO CHARACTERIZATION OF ABNORMALITIES IN INTEROBSERVER AGREEMENT AMONGST EXPERT SMALL BOWEL DISEASES USING PROBE-BASED CON- ACADEMIC AND NON-ACADEMIC PATHOLOGISTS FOR FOCAL LASER ENDOMICROSCOPY THE NEW 20 GAUGE PROCORE BIOPSY NEEDLE; A Naoki Ohmiya, Japan; T. Tahara; M. Nagasaka; Y. PROSPECTIVE MULTICENTER STUDY OF 74 CASES Nakagawa; T. Shibata Priscilla Van Riet, The Nehterlands; D. L. Cahen; B. Hansen; A. Larghi; G. Rindi; G. Fellegara; P. Giorgio P0751 Arcidiacono; C. Doglioni; N. L. Decarli; J. Iglesias-García; DOUBLE-BALLOON COLONOSCOPY: A 7-YEAR EXPERI- I. Abdulkader; H. Lazare Iglesias; M. Kitano; T. Chikugo; ENCE FROM EDINBURGH S. Yasukawa; H. van der Valk; K. Biermann; M. J. Bruno Diana E. Yung, United Kingdom; A. Koulaouzidis; C. H. Fraser; K. C. Trimble; J. N. Plevris

174 Poster in the Spotlight Poster of Excellence Clinical Case Session 175 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0752 P0759 EFFICACY AND SAFETY OF URGENT DOUBLE BALLOON IS THERE ROLE OF PRE-READER FOR EXPERT, IN REAL ENTEROSCOPY-ASSISTED ENDOSCOPIC RETROGRADE? CLINICAL FIELD OF VIDEO CAPSULE ENDOSCOPY INTER- CHOLANGIOPANCREATOGRAPHY PRETATION Hiroyuki Hatamori, Japan; M. Fukushima; T. Inokuma S. Y. Lee; H. J. Chun; I. K. Yoo; J. M. Lee; S. H. Kim; H. S. Choi; Eun Sun Kim, South Korea; B. Keum; Y. T. Jeen; H. P0753 Lee; C. D. Kim; B. K. Choi; J. M. Lee UTILITY OF SINGLE-BALLOON ENTEROSCOPY FOR THE DIAGNOSIS AND MANAGEMENT OF SMALL BOWEL P0760 POLYPS/TUMORS DETECTED IN CAPSULE ENDOSCOPY IS FECAL CALPROTECTIN A SENSITIVE BIOMARKER Patrícia Andrade, Portugal; M. Marques; H. Cardoso; FOR SMALL BOWEL CROHN'S DISEASE AS DETECTED G. Macedo BY CAPSULE ENDOSCOPY? Hamid Yousuf, Ireland; R. Walsh; P. Maheshwari; U. P0754 Aleem; R. Egan; O. o Dwyer; C. Gallagher; S. Azhar; D. SMALL BOWEL REBLEEDING AFTER A SECOND ENDO- McNamara SCOPIC TREATMENT IS EVEN HIGHER THAN AFTER THE FIRST ENDOSCOPIC TREATMENT IN PATIENTS WITH P0761 OBSCURE GASTROINTESTINAL BLEEDING FECAL CALPROTECTIN AS A SELECTION TOOL FOR SMALL Ana Ponte, Portugal; R. Pinho; A. Rodrigues; J. Silva; J. BOWEL CAPSULE ENDOSCOPY IN SUSPECTED CROHN'S P. Rodrigues; M. Sousa; J. Carvalho DISEASE Sara Monteiro, Portugal; M. Barbosa; T. Cúrdia Gonçalves; P0755 P. Boal Carvalho; M. J. Moreira; B. Rosa; J. Cotter EFFECTS OF COMBINED CAPSULE AND BALLON-AS- SISTED ENTEROSCOPY ON SURGICAL ACTIVITY FOR Biliary and pancreatic stenting SMALL BOWEL DISEASES BASED ON 10-YEARS CLINICAL EXPERIENCE P0762 Ekaterina V. Ivanova, Russia; E. D. Fedorov; E. V. USEFULNESS OF THE NEWLY DESIGNED PLASTIC STENT Tikhomirova; D. E. Seleznev FOR EUS-GUIDED HEPATICOGASTROSTOMY AND PANCRE- ATIC DUCT DRAINAGE: LARGE CASE SERIES EVALUATION Capsule endoscopy Takayoshi Tsuchiya, Japan; A. Sofuni; S. Tsuji; K. Kamada; R. Tanaka; R. Tonozuka; M. Honjo; S. Mukai; M. Fujita; P0756 K. Yamamoto; Y. Matsunami; Y. Asai; T. Itoi A PROSPECTIVE 24-WEEK MUCOSAL HEALING AND DEEP REMISSION ASSESSMENT OF SMALL BOWEL AND P0763 COLONIC CROHN'S DISEASE AS DETECTED BY COLON A NOVEL LUMEN-APPOSING METAL STENT FOR ENDO- 2016 18, October Tuesday, CAPSULE ENDOSCOPY SCOPIC ULTRASOUND-GUIDED DRAINAGE: A SINGLE Salvatore Oliva, Italy; S. Cucchiara; M. Aloi; F. Civitelli; CENTER EXPERIENCE F. Viola; C. Hassan; F. Maccioni; E. Casciani; S. Cohen Andrea Anderloni, Italy; M. Di Leo; S. Carrara; R. Maselli; A. Buda; A. Amato; A. Repici P0757 WHICH FACTORS MAY PREDICT THE FAILURE OF A P0764 COMPLETE SMALL-BOWEL EXAMINATION IN CAPSULE LONG-TERM OUTCOMES OF A NEWLY DEVELOPED ENTEROSCOPY? HYBRID METAL STENT FOR ENDOSCOPIC ULTRA- Ana Ponte, Portugal; R. Pinho; A. Rodrigues; J. Silva; J. SOUND-GUIDED BILIARY DRAINAGE P. Rodrigues; M. Sousa; J. Carvalho Dong Hui Cho, South Korea; S. S. Lee; D. Oh; T. J. Song; D. H. Park; D.-W. Seo; S. K. Lee; M.-H. Kim P0758 IMMEDIATE DUODENAL DELEVERY, VS DELAYED ORAL P0765 INGESTION, OF CAPSULE ENDOSCOPY: IS THE SOONER THE ACTUAL IMPACT OF PREOPERATIVE BILIARY THE BETTER? A PROSPECTIVE COMPARISON OF SMALL DRAINAGE ON POSTOPERATIVE OUTCOME: ANALYSIS OF BOWEL VISUALIZATION QUALITY, ACCORDING TO A 1000 CONSECUTIVE PANCREATICODUODENECTOMIES. COMPUTED ASSESSMENT OF CLEANSING SCORE Matteo De Pastena, Italy; G. Marchegiani; S. Paiella; G. Rafaële Gerometta, France; G. Rahmi; S. Lecleire; A. Malleo; A. Gabbrielli; R. Salvia; C. Bassi Histace; E. Abou Ali; O. Romain; P. Marteau; C. Florent; X. Dray

Poster in the Spotlight Poster of Excellence Clinical Case Session 175

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0766 P0773 WIRELESS EUS-GUIDED CHOLEDOCHODUODENOSTOMY DIFFERENCES IN SURVIVAL AFTER CURATIVE R0-RE- BY A CAUTERY-TIPPED LUMEN APPOSING METAL STENT SECTION FOR KOREAN AND GERMAN GASTRIC CANCER FOLLOWED BY DUODENAL METAL STENT PLACEMENT: PATIENTS: RESULTS FROM A PROPENSITY SCORE A SINGLE SESSION SEQUENTIAL APPROACH FOR MATCHED ANALYSIS CONCOMITANT MALIGNANT BILIARY AND DUODENAL Daniel Reim, Germany; Y. W. Kim OBSTRUCTION Andrea Anderloni, Italy; S. Carrara; A. Buda; M. Di Leo; P0774 A. Repici PERIOPERATIVE TRANSFUSION OF BLOOD PRODUCTS IN GASTRIC CANCER PATIENTS NEGATIVELY INFLUENCES P0767 ONCOLOGIC OUTCOME - A RETROSPECTIVE PROPENSITY EUS-ASSISTED CHOLEDOCHODUODENOSTOMY WITH SCORE WEIGHTED ANALYSIS METAL STENTS FOR PATIENTS WITH MALIGNANT BILIARY Daniel Reim, Germany; A. Novotny OBSTRUCTION: A COMPARATIVE ANALYSIS OF OUTCOMES BETWEEN TUBULAR AND LUMEN-APPOSING STENTS P0775 Carlos De La Serna Higuera, Spain; R. Sanchez-Ocana; ESOPHAGECTOMY FOR ESOPHAGEAL CANCER WITH I. Peñas-Herrero; P. Gil-Simon; P. Diez-Redondo; V. SUPRACLAVICULAR LYMPH NODES METASTASIS Busto; R. Amo Alonso; M. Pérez-Miranda Satoru Matono, Japan; T. Tanaka; N. Mori; H. Hino; K. Kadoya; R. Nishida; K. Saisho; Y. Akagi; H. Fujita P0768 EFFICACY AND SAFETY OF ENDOSCOPIC-ULTRASOUND P0776 GUIDED BILIARY DRAINAGE; AN UPDATE META-ANALYSIS FEASIBILITY AND EFFICACY OF MODIFIED PERORAL Abdellah Hedjoudje, France; A. Sportes; S. Koch; L. ENDOSCOPIC MYOTOMY (LIU-POEM) IN PATIENTS WITH Vuitton; F. Prat ACHALASIA: A RETROSPECTIVE COMPARISON STUDY Bingrong Liu, China; Y. Guang; J.-T. Song Tuesday, October 18, 2016 P0769 NEWLY DEVELOPED FLOWER-TYPE COVERED SELF-EX- Hepatobiliary / pancreas / spleen PANDABLE METAL STENT FOR PREVENTING CHOLECYS- TITIS AND PANCREATITIS: PHYSICAL PROPERTIES P0777 Jong Kyun Lee, South Korea; J.-I. Yang; J. K. Park; K. H. PREVENTION OF FISTULA AFTER DISTAL PANCREATIC Lee; K. T. Lee; S.-G. Kang RESECTION J. Wennerblom; C. Jönsson; B. Tingstedt; B. Björnsson; P0770 Christoph Ansorge, Sweden; J. Blomberg; M. Del Chiaro RISK FACTORS FOR POSTPROCEDURAL PANCREATITIS AFTER ENDOSCOPIC PAPILLECTOMY P0778 Seong Jae Yeo, South Korea; C.-M. Cho; J. Heo; M. K. RISK-BASED PATIENT SELECTION IN OPEN AND Jung; K. J. Kim; M. H. Kim MINIMALLY-INVASIVE DISTAL PANCREATECTOMY: AN ACS-NSQIP STUDY P0771 Sjors Klompmaker, The Netherlands; D. van Zoggel; OUTCOMES AND TECHNICAL METHODS OF ENDOSCOPIC A. A. Watkins; M. F. Eskander; J. F. Tseng; M. G. H. THERAPY FOR ACUTE CHOLECYSTITIS IN OUR HOSPITAL Besselink; A. J. Moser Takayuki Fujimori, Japan; H. Kamada; T. Yamashita; K. Kobayashi; K. Kato; T. Masaki P0779 ROLE OF EXTERNAL JEJUNAL DRAINAGE AND PERIOP- Oesophagus / stomach / duodenum ERATIVE SERUM ALBUMIN EVALUATION IN PREDIC- TION AND MANAGEMENT OF PANCREATIC FISTULA Poster Session Mario Gruppo, Italy; A. Geron; F. Zingales; B. Martella; 09:00 - 17:00 Hall X4 V. Beltrame; I. Angriman; R. Bardini Surgery II P0780 P0772 TOTAL PANCREATECTOMY: SHORT-TERM AND LONG- DIGESTIVE ALTERATIONS AS EVALUATED BY THE 13C-MTG TERM OUTCOMES OF THE APANCREATIC STATE BREATH TEST IN PATIENTS AFTER BARIATRIC SURGERY Alessandra Pulvirenti, Italy; J. He; A. Pea; N. Reeze; Laura Uribarri González, Spain; L. Nieto; J. C. Gasparini; M. Weiss; J. L. Cameron; C. Bassi; C. Lariño-Noia; J. Iglesias-García; A. Sueiro; J. Baltar; I. Wolfgang; R. Salvia Baamonde; J. E. Domínguez-Muñoz

176 Poster in the Spotlight Poster of Excellence Clinical Case Session 177 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0781 Basic/pathogenesis/pathology SOLID PSEUDOPAPILLARY TUMOURS OF THE PANCRE- AS: SPECIFIC PATHOLOGICAL FEATURES PREDICT THE Poster Session LIKELIHOOD OF POSTOPERATIVE RECURRENCE 09:00 - 17:00 Hall X5 Giovanni Marchegiani, Italy; S. Andrianello; M. Massignani; IBD II G. Malleo; L. Maggino; S. Paiella; C. R. Ferrone; C. Luchini; A. Scarpa; P. Capelli; M. Mino-Kenudson; K. D. P0788 Lillemoe; C. Bassi; C. Fernandez-Del Castillo; R. Salvia SILVER NANOPARTICLES NANOAG1 AND NANOAG2 ATTENUATE EXPERIMENTAL COLITIS IN MICE THROUGH P0782 MODULATION OF COLONIC MICROBIOTA ACUTE CHOLECYSTITIS CLASSIFICATION. ANALYSIS Hubert Zatorski, Poland; K. Siczek; A. Chmielowiec- AND EVALUATION OF THE NEW DIAGNOSTIC CRITERIA Korzeniowska; J. Pulit-Prociak; M. Smiech; R. Kordek; AND SEVERITY OF ACUTE CHOLECYSTITIS REVISED BY L. Tymczyna; M. Banach; J. Fichna TOKYO GROUP 2013 S. L. Briones-Fraga; Norma Eleane Basurto-Acevedo, P0789 Mexico; A. Reding-Bernal; H. J. Rivera-Cadena; R. MACROPHAGES BEHAVIOUR AGAINST ADHERENT AND Gaxiola-Werge; J. L. De-Leon-Rendon INVASIVE E. COLI (AIEC) ISOLATED FROM CROHN'S DISEASE PATIENTS IN RELATION WITH HOST FACTORS P0783 SUSCEPTIBILITY MODIFIED FOLFOX6 AND BEVACIZUMAB AS NEOADJU- Anthony Buisson, France; E. Vazeille; L. Ouchchane; VANT CHEMOTHERAPY FOR PATIENTS WITH POTEN- M. Goutte; J.-P. Hugot; A. Dubois; R. Minet-Quinard; D. TIALLY CURABLE BILOBAR LIVER METASTASES FROM Bouvier; G. Bommelaer; N. Barnich COLORECTAL CANCER Atsuyuki Maeda, Japan; Y. Kaneoka; Y. Takayama; Y. P0790 Fukami; S. Onoe THE EFFECT OF ORAL S1P (FTY720) ON COMPLEMENT CASCADE AND NUMBER OF P0784 NORMAL STEM CELLS TRAFFICKING IN PERIPHERAL PERCUTANEOUS TRANSHEPATIC BILIARY DRAIN- BLOOD IN A MURINE MODEL OF ULCERATIVE COLITIS AGE - FIRST STEP IN THE PALLIATIVE TREATMENT OF Wojciech M. Marlicz, Poland; K. Serwin; E. Kubis; S. MALIGNANT BILIARY OBSTRUCTION? Rzeszotek; M. Lewandowska; E. Urasinska; M. Z. Ratajczak Povilas Ignatavicius, Lithuania; R. Riauka; G. Barauskas P0791 P0785 MICROBIAL COMPOSITION AND FUNCTION ARE RBC DISTRIBUTION WIDTH (RBC-DW) AND ACUTE

ASSOCIATED WITH ILEAL POUCH SYMPTOMS INDE- 2016 18, October Tuesday, CHOLECYSTITIS. CORRELATION BETWEEN THE RBC PENDENTLY OF INFLAMMATION DISTRIBUTION WIDTH (RBC-DW) AND THE DESCRIPTIVE Williams Turpin, Canada; K. Borowski; A. Tyler; K. TRANSOPERATIVE FEATURES TABLE (HGM), THE NEW Croitoru; O. Kelly; M. S. Silverberg DIAGNOSTIC CRITERIA AND SEVERITY ASSESSMENT IN TOKYO GUIDELINES P0792 Jorge Luis De-Leon-Rendon, Mexico; R. Gaxiola-Werge; PHARMACOKINETICS AND PHARMACODYNAMICS

N. E. Basurto-Acevedo; S. L. Briones-Fraga; H. J. FOLLOWING ORAL ADMINISTRATION OF PTG-100, A Rivera-Cadena; A. Reding-Bernal PEPTIDE ANTAGONIST OF INTEGRIN A4B7 Thamilarasi Annamalai, USA; L. Mattheakis; A. Bhandari; P0786 D. Liu; G. Zemede; S. Hadley; L. Zhao; N. Rao CONTEMPORARY APPROACHES TO CHOOSING SURGICAL TREATMENT FOR PATIENTS WITH COMPLICATED FORMS P0793 OF CHRONIC PANCREATITIS ENDOPLASMIC RETICULUM STRESS ENHANCES THE V. I. Pylypchuk; Volodymyr Galyuk, Ukraine RELEASE OF SERINE PROTEASES BY EPITHELIAL CELLS ALTERING THE INTESTINAL BARRIER FUNCTION P0787 Nuria Sola Tapias, France; C. Bonnart; A. Denadai-Souza; IMPACT OF PRE-TRANSPLANT SARCOPENIA AND C. Blanpied; A. Edir; C. Roland; G. Dietrich; C. Deraison; SEQUENTIAL CHANGES IN SARCOPENIC PARAMETERS N. Vergnolle; F. Barreau AFTER LIVING DONOR LIVER TRANSPLANTATION Toshimi Kaido, Japan; Y. Hamaguchi; S. Okumura; A. P0794 Kobayashi; H. Shirai; S. Yagi; Y. Tamai; N. Inagaki; S. EFFECTS OF HUMAN AMNION-DERIVED MESENCHYMAL Uemoto STEM CELL TRANSPLANTATION AND CONDITIONED MEDIUM ENEMA IN RATS WITH TRINITROBENZENE SULFONIC ACID-INDUCED COLITIS Shuichi Miyamoto, Japan; S. Ohnishi; I. Tsuchiya; R. Ohnishi; H. Hosono; H. Takeda; N. Sakamoto

Poster in the Spotlight Poster of Excellence Clinical Case Session 177

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0795 P0803 TERTIARY LYMPHOID ORGANS IN GUT MUCOSA OF THE ROLE OF PLATELETS IN INFLAMMATORY BOWEL NEWLY DIAGNOSED, UNTREATED INFLAMMATORY DISEASE BOWEL DISEASE PATIENTS Samuel Bourke, United Kingdom; A. Chauhan; T. Iqbal; Carolijn Smids, The Netherlands; C. S. Horjus Talabur P. F. Lalor Horje; J. W. R. Meijer; M. J. Groenen; M. K. Rijnders; E. G. van Lochem; P. J. Wahab P0804 LOSS OF PRDX6 AMELIORATES DSS-INDUCED ACUTE P0796 AND CHRONIC COLITIS TOLL-LIKE RECEPTOR 9 MODIFIES INTESTINAL SERO- Hassan Melhem, Switzerland; S. Lang; K. Atrott; G. TONERGIC SYSTEM Rogler; I. Frey-Wagner Elena Layunta, Spain; E. Latorre; R. Forcén; L. Grasa; J. Pardo; M. Castro; M. A. Plaza; M. P. Arruebo; J. E. Mesonero P0805 THE ROLE OF DIPEPTIDYL PEPTIDASES IN INFLAMMA- P0797 TORY BOWEL DISEASE ASSOCIATION OF BACTEROIDETES WITH ENDOSCOPIC Simone Jaenisch, Australia; A. Ferrante; C. Abbott; P. ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL Bampton; J. Fon; R. Yazbeck DISEASE (IBD) I. Baston-Rey; R. A. Sueiro; Manuel Barreiro-de Acosta, P0806 Spain; L. Uribarri González; R. Ferreiro Iglesias; J. M. ROLE OF EXTRINSIC PRIMARY AFFERENTS AND ASIC 3 Leiro; J. E. Domínguez-Muñoz IN PELVIC CROSS-ORGAN SENSITIZATION Karim Atmani, France; L. Langlois; G. Gourcerol; M. P0798 Meleine GENETIC DIFFERENCES IN THE OUTER MEMBRANE PROTEINS SEQUENCE AMONG COMMENSAL AND Aetiology/epidemiology Tuesday, October 18, 2016 ADHERENT-INVASIVE E. COLI STRAINS Carla Camprubí, Spain; B. Ruiz del Castillo; M. Fernandez- P0807 Diaz; L. Martínez-Martínez; M. Martinez-Medina INDIAN MIGRANTS HAVE A HIGHER INCIDENCE OF ULCERATIVE COLITIS, MORE SEVERE DISEASE PHE- P0799 NOTYPE AND YOUNGER AGE OF PRESENTATION IN ANTIBIOTICS-MEDIATED INCREASE IN LARGE IN- SECOND GENERATION MIGRANTS COMPARED WITH TESTINAL PROTEASE ACTIVITY IS ASSOCIATED WITH CAUCASIANS: RESULTS FROM A 1-YEAR PROSPECTIVE IMPAIRED INTESTINAL BARRIER FUNCTIONS AND POPULATION-BASED INCEPTION COHORT STUDY AGGRAVATION OF SPONTANEOUS COLITIS Ravi Misra, United Kingdom; O. Faiz; S. Sakuma; J. Hongsup Yoon, Germany; M. Schaubeck; D. Haller; G. Burisch; P. Munkholm; N. Arebi Hörmannsperger P0808 P0800 NATURAL HISTORY OF PERIANAL CROHN'S AND PRE- OXIDATIVE STRESS PARAMETERS FOR THE DISEASE AC- DICTORS: LONG-TERM FOLLOW-UP ON A POPULA- TIVITY EVALUATION IN ULCERATIVE COLITIS PATIENTS TION-BASED COHORT Kadri Atay, Turkey; B. Canbakan; E. Koroglu; I. Hatemi M.-L. Rabilloud; L. Siproudhis; J.-F. Bretagne; M. Pagenault; E. Bajeux; A. Gerfaud; J.-F. Viel; I. Tron; M. P0801 Robaszkiewicz; Guillaume Bouguen, France AQUAPORIN EXPRESSION AND LOCALIZATION IN COLON- IC BIOPSIES FROM PATIENTS P0809 A. Holm; A. Mancebo Gimenez; V. Loitto; E. Vikström; CLOSTRIDIUM DIFFICILE INFECTION WORSEN OUTCOME Andreas Münch, Sweden OF HOSPITALIZED PATIENTS WITH INFLAMMATORY BOWEL DISEASE P0802 Ye Chen, China; T. Zhang ALTERED HUMAN DENDRITIC CELL PHENOTYPE AND SUBSET COMPOSITION IN THE BLOOD AND GASTROIN- P0810 TESTINAL TRACT OF ULCERATIVE COLITIS PATIENTS INFLAMMATORY BOWEL DISEASE AND COLORECTAL David Bernardo, Spain; M. Chaparro; I. Mora-Gutierrez; CANCER: INTERIM ANALYSIS OF A SINGLE CENTER A. C. Marin; P. M. Linares; A. Diaz-Guerra; F. de la RETROSPECTIVE CHART REVIEW Morena; M. Jimenez; J. P. Gisbert Maria Fragkaki, Greece; M. Bachlitzanaki; K. Karmiris; A. Theodoropoulou; E. Vardas; G. Paspatis P0811 WITHDRAWN

178 Poster in the Spotlight Poster of Excellence Clinical Case Session 179 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0812 P0820 IMPACT OF BIOLOGICAL THERAPY ON IBD HOSPITAL- RISK OF COLORECTAL ADENOMAS IN PATIENTS WITH IZATIONS OUTCOMES: REPORT FROM AN ITALIAN MICROSCOPIC COLITIS: A CASE-CONTROL STUDY TERTIARY CENTRE BETWEEN 2000 AND 2013 Fernando Fernández-Bañares, Spain; A. Salas; Y. Franco Scaldaferri, Italy; M. T. Pistone; G. Rizzatti; V. Zabana; M. Aceituno; L. Ruiz; A. Castells; M. Esteve Ojetti; A. Poscia; L. R. Lopetuso; M. Volpe; E. Schiavoni; E. Gaetani; D. McNamara; A. Armuzzi; G. Cammarota; P0821 A. Gasbarrini POST-INDUCTION SERUM INFLIXIMAB TROUGH LEVEL WAS ASSOCIATED WITH MUCOSAL HEALING AFTER P0813 INITIATING THERAPY IN CROHN`S DISEASE PREVALENCE OF IRON DEFICIENCY WITHOUT ANAEMIA J. Tang; Gao Xiang, China; M. Zhi; P. Hu IN INFLAMMATORY BOWEL DISEASE AND ITS IMPACT ON THE QUALITY OF LIFE P0822 Carlos González Alayón, Spain; C. Pedrajas Crespo; PREDICTORS OF TISSUE HEALING IN ULCERATIVE COLI- S. Marín Pedrosa; J. M. Benítez Cantero; E. Iglesias TIS PATIENTS TREATED WITH ANTI-TNFA AGENTS Flores; V. García Sánchez N. Viazis; N. Viazis; G. Bamias; D. Goukos; T. Koukouratos; K. Katopodi; P. Karatzas; C. Triantos; C. Tsolias; G. Theocharis; S. D. Ladas; D. G. Karamanolis; Gerassimos Diagnosis and monitoring Mantzaris, Greece P0814 P0823 DEVELOPMENT AND VALIDATION OF A TANDEM LIQUID CLINICAL SIGNIFICANCE OF PERIPHERAL BLOOD TH17 CHROMATOGRAPHIC MASS SPECTROMETRIC (LC-MS/ CELLS IN EVALUATING DISEASE ACTIVITY OF INFLAM- MS) ASSAY FOR THE MEASUREMENT OF VEDOLIZUM- MATORY BOWEL DISEASE : A MULTI-CENTER CLINICAL AB (VLZ) LEVELS IN PATIENT SERUM STUDY Christina Christ, Germany; A. Dignass; F. Hartmann; J. Stein Nan Gao, China; R. LI; W. Chen P0815 ª P0824 THE INFLUENCE OF VITAMIND ON EXPRESSION OF A NOVEL FECAL CALPROTECTIN ASSAY USING THE CYTOKINES MRNA IN IBD LATEX AGGLUTINATION TURBIDIMETRIC IMMUNOAS- Zuzana Leskova, Slovakia; A. Krajcovicova; K. Soltys; S. SAY IS USEFUL FOR ULCERATIVE COLITIS PATIENTS IN Stuchlik; I. Sturdik; T. Koller; M. Huorka; T. Hlavaty EVALUATION OF MUCOSAL HEALING P0816 Sakiko Hiraoka, Japan; T. Inokuchi; S. Takashima; D. DEVELOPMENT OF A DIAGNOSTIC SCORING SYSTEM TO Takei; Y. Sugihara; M. Takahara; K. Harada; Y. Seki; K. PREDICT MICROSCOPIC COLITIS Watanabe; H. Okada 2016 18, October Tuesday, John S. Kane, United Kingdom; R. Sood; G. R. Law; D. J. P0825 Gracie; N. To; M. J. Gold; A. C. Ford MEASURING APPARENT DIFFUSION COEFFICIENT P0817 VALUES IN COLLAPSED AND DISTENDED SMALL BOWEL THE ROLE OF FAECAL CALPROTECTIN IN A PRIMARY LOOPS HAS A POTENTIAL IN EXCLUDING INFLAMMA- CARE REFERRAL PATHWAY IN THE UK TORY BOWEL DISEASE IN PATIENTS WITHOUT BOWEL M. Tan; Y. Subramaniam; C. Cheong; F. Hasan; G. W. PREPARATION: A STUDY IN HEALTHY SUBJECTS Moran; Waleed Fateen, United Kingdom; A. Jawhari I. Apine; J. Pokrotnieks; M. Leja; Santa Atteka, Latvia; I. Pukite; G. Krumina P0818 COLONOSCOPY SURVEILLANCE IN LONG STANDING P0826 INFLAMMATORY BOWEL DISEASE IN A GENERAL TERMINAL ILEAL MOTILITY AS A BIOMARKER FOR DISTRICT HOSPITAL AND COMPARISON BETWEEN CROHN'S DISEASE ACTIVITY DURING MR ENTEROGRA- WHITE LIGHT ENDOSCOPY AND CHROMOENDOSCOPY PHY: A PROSPECTIVE STUDY IN DETECTING DYSPLASIA DURING SURVEILLANCE Alex Menys, United Kingdom; C. Puylaert; C. E. Tutein Stavroula Pelitari, United Kingdom; G. Marinopoulos; Nolthenius; A. Plumb; J. Makanyanga; D. Pendsé; G. N. Sharma Bhatnagar; F. Vos; J. Stoker; S. Taylor P0819 P0827 ENDOSCOPY SIGNIFICANTLY IMPROVES OUTCOME EARLY CHANGE IN FECAL CALPROTECTIN PREDICTS PREDICTION IN ACUTE SEVERE COLITIS PRIMARY NON- RESPONSE TO ANTI-TNF? THERAPY IN Samuel Raimundo R. Fernandes, Portugal; P. Santos; INFLAMMATORY BOWEL DISEASE C. M. Moura; P. Marques da Costa; J. Carvalho; L. A. Polychronis Pavlidis, United Kingdom; S. Gulati; P. Correia; J. Velosa Dubois; G. Chung-Faye; J. Tumova; L. Medcalf; L. M. Choong; R. Sherwood; I. Bjarnason; B. Hayee

Poster in the Spotlight Poster of Excellence Clinical Case Session 179

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0828 P0836 CHARACTERISTICS OF ASYMPTOMATIC PERIANAL FIS- NO IRON AND NO ANEMIA: WHO ARE THESE CROHN'S TULA IN CROHN'S DISEASE DIAGNOSED BY MAGNETIC PATIENTS AND WHAT IS THEIR EVOLUTION? RESONANCE IMAGING Tiago Cúrdia Gonçalves, Portugal; S. Monteiro; M. Min Zhang, China; X. Jiang; J. Zhou; M. Su; M. Zhi; X. Barbosa; M. J. Moreira; J. Cotter Gao; P. Hu P0837 P0829 ANORECTAL FUNCTION AND QUALITY OF LIFE IN IBD DERMATOLOGICAL COMPLICATIONS OF ANTI-TNF PATIENTS WITH PERIANAL DISEASE: A PROSPECTIVE THERAPY IN INFLAMMATORY BOWEL DISEASE OBSERVATIONAL STUDY Patrícia Andrade, Portugal; S. Lopes; R. Gaspar; A. C. F. Litta; Franco Scaldaferri, Italy; A. Parello; T. Zinicola; Nunes; F. Magro; G. Macedo L. Donisi; M. Pizzoferrato; A. Gasbarrini; C. Ratto P0830 P0838 MR ENTEROCOLONOGRAPHY EVALUATION FOR SMALL PARALLEL TEMPORAL CHANGES IN HARVEY-BRAD- BOWEL STRICTURES IN PATIENT WITH CROHN'S DIS- SHAW INDEX, TNFA AND INTESTINAL FATTY ACID EASE: COMPARISON WITH BALLOON ENTEROSCOPY BINDING PROTEIN (I-FABP) IN RESPONSE TO INFLIX- Fujii Toshimitsu, Japan; K. Takenaka; M. Kimura; K. IMAB (REMICADE) IN CROHN'S DISEASE Matsuoka; M. Nagahori; K. Ohtsuka; M. Watanabe Anas Al-Saffar, Sweden; C. H. Meijer; V. R. Gannavarapu; G. Hall; H. Diaz; M. Lördal; T. Ljung; P. M. Hellström; P0831 D.-L. Webb CONVENTIONAL TREATMENT REGIMENS FOR ULCER- ATIVE COLITIS ALLEVIATE FATIGUE - AN OBSERVA- P0839 TIONAL COHORT STUDY MONITORING BONE MINERAL CONTENT WITH BY Tore Grimstad, Norway; K. B. Norheim; J. T. Kvaloy; K. BIOIMPEDANCE ANALYSES AMONG ANTI-TNF TREATED Tuesday, October 18, 2016 Isaksen; K. Leitao; A. Carlsen; L. Karlsen; L. Aabakken; INFLAMMATORY BOWEL DISEASE PATIENTS R. Omdal Agnes Anna Csontos, Hungary; A. Molnár; Z. M. Piri; S. Dakó; P. Miheller P0832 STRUCTURAL BOWEL DAMAGE REMAINS STABLE DURING P0840 FOLLOW UP OF QUIESCENT CROHN'S DISEASE PATIENTS ANTI-TNF INDUCED PSORIASIS IN INFLAMMATORY M. Zarchin; M. M. Amitai; A. Lahat; D. Yablecovitch; S. BOWEL DISEASE: A 10-YEAR EXPERIENCE Neuman; N. Levhar; E. Klang; B. Avidan; H. Yanai; I. Patrícia Andrade, Portugal; S. Lopes; R. Gaspar; A. C. Dotan; Y. Chowers; B. Weiss; S. Ben-Horin; R. Eliakim; Nunes; F. Magro; S. Magina; G. Macedo Uri Kopylov, Israel Treatment-medical P0833 RENAL INVOLVEMENT OF INFLAMMATORY BOWEL P0841 DISEASE: PROSPECTIVE STUDY ETROLIZUMAB TREATMENT DOES NOT MODIFY LEVELS Sahare El Mahjoubi, Morocco; I. Haddiya; W. Khannoussi; OF VCAM-1 IN ULCERATIVE COLITIS PATIENTS A. El Mekkaoui; Z. Ismaili; G. Kharrasse F. Fuh; C. Looney; W. Tew; R. Erickson; R. Maciuca; M. Tang; M. Keir; S. Vermeire; Teresa Ramirez Montagut, USA P0834 THE ECONOMIC BURDEN OF INFLAMMATORY BOWEL P0842 DISEASE ONSET OF EFFICACY OF TOFACITINIB FOR INDUCTION John Bonello, Malta; S. Chetcuti; M. Farrugia; J. Burisch; THERAPY IN PATIENTS WITH ACTIVE ULCERATIVE COLI- P. Ellul TIS IN TWO MULTINATIONAL, PHASE 3 CLINICAL TRIALS W. J. Sandborn; Silvio Danese, Italy; J. Panés; H. Zhang; P0835 D. Woodworth; A. Marren; C. Su RISK FACTORS OF CLINICAL RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC P0843 REMISSION ETROLIZUMAB TREATMENT MODULATES MADCAM-1 Margalida Calafat Sard, Spain; T. Lobatón; A. Hernán- LEVELS IN SERUM IN ULCERATIVE COLITIS PATIENTS dez-Gallego; M. Mañosa Ciria; P. Torres-Rodríguez; E. F. Fuh; R. Erickson; C. Schofield; M. Tang; R. Maciuca; Cabré; I. Ojanguren; E. Domènech M. Keir; S. Vermeire; Teresa Ramirez Montagut, USA P0844 DEVELOPMENT AND ANALYTICAL CHARACTERIZATION OF GP2017, A PROPOSED ADALIMUMAB BIOSIMILAR Martin Schiestl, Austria; C. Roesli

180 Poster in the Spotlight Poster of Excellence Clinical Case Session 181 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0845 P0853 SUSTAINED RESOLUTION OF EXTRAINTESTINAL MAN- GUT MICROBIOTA OFFERS UNIVERSAL BIOMARKERS IFESTATIONS IN PATIENTS WITH CROHN'S DISEASE FOR INFLAMMATORY BOWEL DISEASE ACTIVITY EVAL- RECEIVING ADALIMUMAB UATION AND TREATMENT OUTCOME PREDICTION Edouard J. Louis, Belgium; R. Löfberg; W. Reinisch; D. Youlian Zhou, China; Y. He; Z. Z. Xu; Y. Yang; Y. Nie; R. Schwartz; J.-F. Maa; S. Berg; B. Huang; A. W. Wang; A. Knight; H. Zhou; Y. Chen M. Robinson; B. L. Pappalardo P0854 P0846 EFFICACY AND SAFETY OF GRANULOCYTE, MONO- VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE CYTE/MACROPHAGE ADSORPTIVE APHERESIS IN ASSOCIATED WITH AUTOIMMUNE LIVER DISEASE PRE- STEROID-DEPENDENT ACTIVE UC WITH INSUFFICIENT AND POST-LIVER TRANSPLANTATION: A CASE SERIES RESPONSE OR INTOLERANCE TO IMMUNOSUPPRES- Tiong Yeng Lim, United Kingdom; P. Pavlidis; S. Gulati; SANTS AND/OR BIOLOGICAL THERAPIES (THE ART T. Pirani; M. Samaan; G. Chung-Faye; P. Dubois; P. TRIAL): CALPROTECTIN AND ENDOSCOPY RESULTS Irving; M. Heneghan; B. Hayee Axel Dignass, Germany; A. Akbar; B. Bonaz; P0847 P0855 PREGNANCY OUTCOMES IN WOMEN EXPOSED TO VEDOLIZUMAB PROVIDES CLINICAL BENEFIT OVER INFLIXIMAB (INNOVATOR) ONE YEAR IN PATIENTS WITH REFRACTORY INFLAM- J. Slater; J. Phillips; C.-Y. Guo; M. Clark; A. Geldhof; N. MATORY BOWEL DISEASE - RESULTS OF A PROSPEC- Gearhart; Riikka Nissinen, The Netherlands TIVE MULTICENTER OBSERVATIONAL STUDY Raja Atreya, Germany; D. C. Baumgart; T. Bruns; A. P0848 Dignass; K. Ende; J. Hampe; F. Hartmann; C. Langbein; CROHN'S DISEASE (CD) PATIENTS WITH HIGH BODY J. Maul; M. F. Neurath; J. C. Preiss; R. Schmelz; C. MASS INDEX PRESENT MORE FREQUENT AND RAPID Schmidt; H. Schulze; B. Siegmund; N. Teich; U. von LOSS OF RESPONSE TO INFLIXIMAB Arnim; A. Stallmach Loic Guerbau, France; R. Gerard; N. Duveau; P. Desreumaux; M. Boualit; J. Branche; V. Maunoury; L. P0856 Libier; S. Cattan; C. Gower Rousseau; A. Cotteau-leroy; PATTERNS OF DOSE ESCALATION AMONGST PATIENTS M. Nachury; B. Pariente WITH ULCERATIVE COLITIS AND CROHN'S DISEASE TREATED WITH VEDOLIZUMAB VS. INFLIXIMAB IN THE P0849 UNITED STATES (US) OUTCOMES OF EMERGENCY ADMISSIONS WITH ULCER- M. Raluy-Callado; Q. Li; M. Luo; K. Lasch; Javaria Mona

ATIVE COLITIS IN ADULTS IN ENGLAND BETWEEN 2004 Khalid, United Kingdom 2016 18, October Tuesday, AND 2014 James Rees, United Kingdom; J. Mytton; F. Evison; P. P0857 Patel; R. Cooney; N. Trudgill THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH LUMINAL FORM CROHN'S DISEASE MESENCHYMAL P0850 STROMAL CELLS OF THE BONE MARROW - 7 YEARS OF SYSTEMATIC REVIEW - MANAGEMENT OF CHRONIC OBSERVATION REFRACTORY POUCHITIS IN ADULTS UNDERGOING O. Knyazev; Nina Fadeeva, Russia; A. Kagramanova; I. RESTORATIVE PROCTOCOLECTOMY WITH ILEOANAL Ruchkina; A. Konoplyannikov; A. Parfenov; O. Boldyreva; POUCH ANASTOMOSIS FOR ULCERATIVE COLITIS A. Lishchinskaya; A. Babayan; N. Orlova Jonathan P. Segal, United Kingdom; N. S. Ding; S. K. Clark; A. L. Hart P0858 POSTOPERATIVE INFECTIOUS COMPLICATIONS IN P0851 CROHN'S DISEASE: RESULTS FROM PRACTICROHN STUDY INFLIXIMAB-TNF COMPLEXES DETERMINE THE AP- Ana Gutiérrez, Spain; M. Castro; C. Taxonera Samso; PEARANCE OF ANTI-DRUG ANTIBODIES V. García; M. Minguez; M. D. Martín Arranz; E. Haggai Bar-Yoseph, Israel; S. Pressman; A. Blatt; A. Domènech; L. Castro; M. Barreiro-de Acosta; L. Dahan; S. Ben-Horin; B. Ungar; U. Kopylov; Y. Chowers Cea-Calvo; C. Romero; B. Juliá De Páramo P0852 P0859 GO-COLITIS 6-WEEK INDUCTION PATIENT-REPORTED ABP 501, A PROPOSED BIOSIMILAR TO ADALIMUMAB: OUTCOMES OF PARTIAL MAYO SCORE RESULTS FUNCTIONAL SIMILARITY ADDS TO THE TOTALITY OF Shaji Sebastian, United Kingdom; C. Probert; D. R. Gaya; EVIDENCE IN SUPPORT FOR BIOSIMILARITY IN ALL P. J. Hamlin; P. Irving; G. Gillespie; H. Tate; C. Wheeler APPROVED INDICATIONS OF USE Helen McBride, USA; S. Kuhns; T. Born; P. Kaur

Poster in the Spotlight Poster of Excellence Clinical Case Session 181

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0860 P0868 PHARMACOECONOMIC ANALYSIS OF BIOSIMILAR INFLIX- OPEN LABEL OBSERVATIONAL STUDY EVALUATING THE IMAB (CT-P13) IN FIVE EUROPEAN COUNTRIES IN 2015 EFFECT OF INDUCTION THERAPY WITH VEDOLIZUMAB Seong-Hee Han, South Korea; S.-H. Yun; S.-W. Yoon IN PATIENTS WITH MODERATE TO SEVERE INFLAMMA- TORY BOWEL DISEASE INTOLERANT/RESISTANT TO AT P0861 LEAST TWO BIOLOGICALS PREDICTORS OF LOSS OF RESPONSE TO ADALIMUMAB Martine De Vos, Belgium; B. Dhooghe; S. Vermeire; E. THERAPY; THE IMPORTANCE OF THERAPEUTIC DRUG J. Louis; F. Mana; A. Elewaut; P. Bossuyt; F. Baert; C. MONITORING IN INFLAMMATORY BOWEL DISEASES Reenaers; M. Van Gossum; E. Macken; M. Ferrante; P. Zsuzsanna Kurti, Hungary; Z. Vegh; M. Rutka; L. Gonczi; Hindryckx; S. De Wit; T. Holvoet; D. Franchimont K. Farkas; B. D. Lovasz; K. B. Gecse; P. A. Golovics; B. Szalay; T. Molnar; P. L. Lakatos P0869 ULCERATIVE COLITIS: DISEASE COURSE AND PROGNO- P0862 SIS DURING THE FIRST YEAR OF DISEASE EFFICACY AND SAFETY OF VEDOLIZUMAB FOR IN- Samuel Raimundo Fernandes, Portugal; L. A. Correia; DUCTION OF REMISSION IN INFLAMMATORY BOWEL J. Velosa DISEASE- THE ISRAELI EXPERIENCE Uri Kopylov, Israel; Y. Ron; I. Avni-Biron; B. Koslovsky; M. P0870 Waterman; S. Daher; B. Ungar; H. Yanai; N. Maharshak; THE INCIDENCE OF SUBOPTIMAL THERAPY AFTER O. Ben-Bassat; L. Lichtenstein; A. Bar Gil Shitrit; E. INITIATING A SECOND TUMOUR NECROSIS FACTOR Israeli; R. Eliakim; Y. Chowers; S. Ben-Horin; I. Dotan ANTAGONIST IN PATIENTS WITH ULCERATIVE COLITIS: A MULTI-COUNTRY CHART REVIEW P0863 James Lindsay, United Kingdom; J. P. Gisbert; H. Patel; SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EF- L. Peyrin-Biroulet; A. Armuzzi; B. Bokemeyer; G. C. FECTIVENESS AND SAFETY OF VEDOLIZUMAB IN ADULT Nguyen; I. Pree; J. M. Khalid Tuesday, October 18, 2016 ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS S. M. Bovens; A. Solaman; R. Curtis; S. O'Byrne; J. M. P0871 Khalid; Dirk Demuth, United Kingdom PROBIOTICS ARE LESS EFFECTIVE THAN MESALAZINE IN MAINTAINING REMISSIONS IN IBD P0864 Andriy Sydorchuk, Ukraine; R. Sydorchuk; L. Sydorchuk; NO DIFFERENCE IN IMMUNOGENICITY OF THE ORIGI- I. Sydorchuk; O. Plehutsa NAL AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE P0872 K. Malickova; Dana Duricova, Czeck Republic; M. Kolar; BIOSIMILAR INFLIXIMAB IS EFFECTIVE AND SAFE IN M. Bortlik; V. Hruba; N. Machkova; K. Mitrova; M. INFLAMMATORY BOWEL DISEASE PATIENTS NAIVE TO Lukas; M. Lukas ANTI-TNF THERAPY: A TERTIARY CENTER EXPERIENCE Martin Bortlik, Czeck Republic; M. Kolar; D. Duricova; P0865 K. Malickova; V. Hruba; N. Machkova; K. Mitrova; M. RISK FACTORS ASSOCIATED WITH THE NEGATIVIZA- Lukas; M. Lukas TION OF ANTI-HBS ANTIBODIES IN INFLAMMATORY BOWEL DISEASE PATIENTS P0873 Alicia C. Marin, Spain; M. Chaparro; M. Ramas; A. Garre; CORRELATION BETWEEN ENDOSCOPIC AND HISTOLOG- P. M. Linares; J. Villagrasa; D. Bernardo; J. P. Gisbert ICAL HEALING IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE: DATA FROM EXTEND P0866 Walter Reinisch, Austria; J.-F. Colombel; P. Rutgeerts; AZATHIOPRINE IN THE MAINTAINANCE OF STE- K. Geboes; G. R. A. M. D'Haens; J. Petersson; S. Eichner; ROID-FREE REMISSION IN INFLAMMATORY BOWEL J.-F. Maa; A. M. Robinson DISEASE PATIENTS: EFFICACY AND SAFETY IN FIVE YEARS OF FOLLOW-UP P0874 Claudio Cassieri, Italy; R. Pica; E. V. Avallone; G. TUBERCULOSIS IN INFLAMMATORY BOWEL DISEASE Brandimarte; M. Zippi; P. Crispino; D. De Nitto; G. P. PATIENTS UNDER TREATMENT WITH ANTI TNF ALFA Lecca; P. Vernia; P. Paoluzi; E. S. Corazziari AGENTS: A FREQUENT COMPLICATION DESPITE RIG- OROUS SCREENING P0867 Roxana Vadan, Romania; M. L. Cojocaru; C. Gheorghe; IS FECAL CALPROTECTIN THE BETTER TOOL TO MONI- M. Diculescu; I. Stanel; N. Zamfirescu; L. S. Gheorghe TOR DISEASE ACTIVITY IN PREGNANT IBD PATIENTS? M. Julsgaard; Lisbet Ambrosius Christensen, Denmark; C. L. Hvas; J. Fallingborg; L. Svenningsen; J. Kjeldsen; M. P. Sparrow; S. Wildt; S. Bell

182 Poster in the Spotlight Poster of Excellence Clinical Case Session 183 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0875 P0884 ADHERENCE TO ULCERATIVE COLITIS MANAGEMENT COMPARISON OF THE EFFECTIVENESS AND COMPLICA- GUIDELINES BY ITALIAN GASTROENTEROLOGISTS: A MUL- TIONS OF INFLIXIMAB AND ADALIMUMAB IN COMBO TICENTRE PROSPECTIVE OBSERVATIONAL AIGO STUDY THERAPY WITH IMMUNOMODULATORS FOR CROHN'S Maria Lia Scribano, Italy; F. Costa; A. Bortoli; C. Papi; DISEASE M. Cappello; F. Bortoluzzi; L. Caserta; A. Ferronato; C. Agnieszka Budzynska, Poland; M. Gawron-Kiszka; E. Cortelezzi; F. Manguso; F. W. Guglielmi; A. Kohn Nowakowska-Dulawa; M. Hartleb P0876 Paediatric and adolescent IBD SKIN SIDE-EFFECTS OF BIOLOGIC THERAPY AND SYSTEMIC DRUGS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES Poster Session K. Juzlova; K. Koblova; J. Hercogova; Martin Bortlik, 09:00 - 17:00 Hall X5 Czeck Republic; D. Duricova; M. Kolar; M. Lukas Paediatric: Lower GI P0877 P0885 SYNERGY RESEARCH: INVESTIGATING THE COMBINED A STRUCTURED PAEDIATRIC TO ADULT TRANSITION ACTION OF CHAMOMILE, MYRRH AND COFFEE CHAR- SERVICE IN PATIENTS WITH INFLAMMATORY BOWEL COAL ON CHEMOKINE RELEASE OF ACTIVATED HUMAN DISEASE REDUCES DISEASE FLARES, REQUIREMENT MACROPHAGES FOR STEROIDS AND EMERGENCY ADMISSIONS: THE Cica Vissiennon, Germany; D. Hammoud; R. Jente; TRANSIT STUDY K.-H. Goos; J. Arnhold; K. Nieber Sara McCartney, United Kingdom; J. O. Lindsay; R. K. Russell; D. R. Gaya; I. Shaw; T. Finney-Hayward; S. P0878 Sebastian EFFECT OF ADALIMUMAB ON PATIENTS WITH MODER- ATE TO SEVERE ULCERATIVE COLITIS IN ITALIAN CLINI- P0886 CAL PRACTICE SETTING: RESULTS FROM INSPIRADA ACCELERATED STEP-UP APPROACH AND LONG-TERM Anna Kohn, Italy; L. Biancone; P. Gionchetti; S. Danese; DISEASE OUTCOMES IN PAEDIATRIC PATIENTS WITH A. Orlando; A. Lazar; A. M. Robinson; B. L. Pappalardo; CROHN'S DISEASE M. Bereswill; M. Skup; N. Chen; R. Merolla; S. Wang; Lucas I Wauters, Belgium; F. Smets; I. Hoffman; E. De R. B. Thakkar; S. Travis Greef; P. Bontems; P. Alliet; W. Arts; B. Hauser; S. Van Biervliet; E. Van de Vijver; I. Paquot; H. Peeters; P. P0879 Bossuyt; J.-F. Rahier; T. Moreels; O. Dewit; D. Franchimont; ULCERATIVE COLITIS: ARE WE DEVALUING ITS PRO- V. Muls; F. Fontaine; E.J. Louis; J.-C. Coche; M. De Vos; Tuesday, October 18, 2016 18, October Tuesday, GRESSIVE CHARACTER? F. Baert; J. Paul; S. Vermeire; G. Veereman Paulo Massinha, Portugal; F. Portela; S. Campos; M. Ferreira; S. Mendes; A. M. Ferreira; C. Sofia P0887 THE ASSOCIATION BETWEEN PEDIATRIC-ONSET P0880 INFLAMMATORY BOWEL DISEASE AND BONE MINERAL SAFETY PROFILE OF ANTI-TNF ALPHA THERAPY IN DENSITY IN ADULTHOOD THE ELDERLY - A COMPARATIVE STUDY Anat Guz Mark; F. Rinawi; R. Shamir; A. Assa, Israel Carlos Bernardes, Portugal; P. Russo; D. Carvalho; J. Saiote; J. Ramos P0888 REMISSION INDUCTION IN CORTICOSTEROID NAÏVE P0881 CHILDREN AND ADOLESCENTS WITH ACTIVE ULCERATIVE SAFETY AND EFFICACY OF FERINJECT® IN THE TREAT- COLITIS BY ADSORPTIVE LEUCOCYTAPHERESIS AS MONO- MENT OF IBD-RELATED IRON DEFICIENCY ANAEMIA THERAPY OR IN COMBINATION WITH LOW DOSE PRED- UNDER DAILY PRACTICE CONDITIONS - RESULTS FROM NISOLONE AFTER FAILURE OF FIRST-LINE A NON-INTERVENTIONAL POST-MARKETING SURVEIL- Tomotaka Tanaka, Japan; M. Akagi; H. Goishi; T. LANCE STUDY IN GERMANY Iiboshi; T. Kajihara; T. Miura Jürgen Stein, Germany; S. Vollmer; W. Klemm; S. Weber-Mangal; K. Nip; A. Dignass P0889 WITHDRAWN PREDICTING DISEASE COURSE OF PEDIATRIC CROHN'S DISEASE: ROLE OF CLINICAL, ENDOSCOPIC AND IMAG- P0883 ING FINDINGS AT THE DIAGNOSIS BIOLOGICAL THERAPY FOR IBD IN THE ELDERLY: Marina Aloi, Italy; F. Civitelli; S. Oliva; E. Casciani; G. SENSE, SCIENCE OR SENSIBILITY? D'Arcangelo; A. Spatoliatore; F. Viola; S. Cucchiara Bethany H. Miller, United Kingdom; B. Crooks; J. Scott; U. Nosegbe; J. K. Limdi

Poster in the Spotlight Poster of Excellence Clinical Case Session 183

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0890 P0897 THE CLINICAL BURDEN OF TRANSITION IN INFLAMMA- THE SUPPRESSIVE EFFECT OF REBAMIPIDE, SUCRALFATE TORY BOWEL DISEASE AND RIFAXIMIN ON INFLAMMATION AND APOPTOSIS IN K. Siau; Alexios Klonis, United Kingdom; H. Steed RADIATION INDUCED INTESTINAL INJURY OF MOUSE Won Moon, South Korea; S. J. Park; J. H. Kim; M. I. P0891 Park; S. E. Kim; K. Jung PEDIATRIC CROHN'S DISEASE AND ITS DISABILITY OVER TIME: A STUDY PERFORMED WITH A NEW PE- P0898 DIATRIC LÉMANN INDEX. PRELIMINARY DATA FROM A LOWER GASTROINTESTINAL ENDOSCOPY HAS IMPACT TERTIARY PEDIATRIC IBD CENTER IN THE CLINICAL OUTCOME OF GRAFT-VERSUS-HOST Giorgia Bodini, Italy; S. Arrigo; A. Bizzochi; E. Giannini; DISEASE V. Savarino; E. Savarino; A. Barabino; Sara Pires, Portugal; J. Lage; S. Carvalho; L. Afonso; C. Brandão; M. Dinis-Ribeiro P0892 OUTCOMES AND DETERMINING FACTORS OF A TRAN- P0899 SITION CLINIC PROGRAM FOR INFLAMMATORY BOWEL STROMAL DERIVED FACTOR-1 AS A SEROLOGIC BIO- DISEASES (IBD) BETWEEN 2 ITALIAN TERTIARY CARE MARKER FOR DIAGNOSIS OF COLON ISCHEMIA WITH CENTERS CARDIOVASCULAR DISEASE Franco Scaldaferri, Italy; O. A. Ricca; E. Romeo; V. Jihan Yu, South Korea; S. S. Kim; S. W. Kim; H. K. Kim; Giorgio; F. Torroni; S. Faraci; F. Rea; G. Angelino; L. H. H. choi; Y. W. Park; H.-S. Chae Dall'Oglio; P. De Angelis P0900 P0893 ACYL-HOMOSERINE LACTONE QUORUM SENSING FREQUENCY, CHRONOLOGICAL ORDER OF APPEAR- MOLECULE ACTIVATES THE BITTER TASTE RECEPTOR, ANCE AND ANTI-TNF TREATMENT OF EXTRAINTESTI- T2R138, IN ENTEROENDOCRINE CELLS Tuesday, October 18, 2016 NAL MANIFESTATIONS IN PEDIATRIC PATIENTS WITH J. Huyhn; J. Sinnett-Smith; S. Young; R. Latorre; G. INFLAMMATORY BOWEL DISEASE Vegezzi; R. De Giorgio; E. Rozengurt; Catia Sternini, USA Thomas Greuter, Switzerland; L. Biedermann; M. Scharl; G. Rogler; E. Safroneeva; C. Braegger; A. Nydegger; A. Lower GI malignant disease-epidemiology Schoepfer; S. R. Vavricka P0901 P0894 IMPLICATION OF STREPTOCOCCUS BOVIS IN COLOREC- ACCURACY OF IMAGING SCORING INDEXES IN PAEDI- TAL CARCINOGENESIS AND OTHER GASTROINTESTINAL ATRIC CROHN'S DISEASE PATIENTS PATHOLOGY Goran Hauser, Croatia; B. Candrlic; M. Radic; M. Perisc; Marta Gravito-Soares, Portugal; E. Gravito-Soares; S. G. Palcevski; D. Miletic; D. Stimac Lopes; N. Silva; G. Ribeiro; C. Sofia

Lower GI Immunology, immunity, inflammation (NOT IBD) P0902 THE ASSOCIATION BETWEEN SMOKING DURATION AND ABSTINENCE WITH ODDS OF COLORECTAL ADENOMAS Poster Session Naomi Fliss Isakov, Israel; S. Zelber-Sagi; R. Kariv 09:00 - 17:00 Hall X5 Other Lower GI Disorders II P0903 SECULAR TRENDS IN COLORECTAL CANCER IN THE P0895 UNITED KINGDOM IMPACT OF NF-?B SUBUNIT DELETION ON THE SMALL L. Cea Soriano; M. Soriano-Gabarró; Luis Alberto INTESTINAL EPITHELIAL TRANSCRIPTOME FOLLOWING García Rodríguez, Spain LIPOPOLYSACCHARIDE TREATMENT OF C57BL/6 MICE Michael D. Burkitt, United Kingdom; J. M. Williams; Y. P0904 Merga; N. Dyer; J. Caamano; P. Rosenstiel; B. Campbell; MUCINOUS AND SIGNET-RING CELL COLORECTAL CAN- D. M. Pritchard; C. Probert CER: RESULTS OF A POPULATION BASED COHORT Ulrich Nitsche, Germany; H. Friess; A. Agha; M. Angele; P0896 R. Eckel; W. Heitland; K.-W. Jauch; D. Krenz; N. FUNCTIONAL AND MOLECULAR ANALYSIS OF THE Nüssler; H.-G. Rau; R. Ruppert; G. Schubert-Fritschle; EFFECT OF OXIDATIVE STRESS AND AGEING ON SMALL C. Stöß; D. Wilhelm; J. Werner; J. Engel INTESTINE AND COLON Asma Almuhamamdi, United Kingdom; D. Grundy

184 Poster in the Spotlight Poster of Excellence Clinical Case Session 185 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0905 Lower GI malignant disease, diagnosis/histopathology INDICATION FOR COLONOSCOPY CORRELATES WITH STAGING AT TIME OF COLORECTAL CANCER DIAGNOSIS P0914 Gernot Leeb, Austria; A. Baierl; A. Püspök; A. Gsur; P. PREVALENCE AND CHARACTERISTICS OF UNEXPECT- Hofer; G. Böhm; K. Mach ED RECTAL CANCER IN BENIGN APPEARING LARGE NON-PEDUNCULATED RECTAL POLYPS P0906 Maxime E. S. Bronzwaer, The Netherlands; G. D. PATIENT SEX IS ASSOCIATED WITH LYMPH NODE ME- Musters; R. M. Barendse; L. Koens; E. J. R. de Graaf; P. TASTASIS IN T1 COLORECTAL CANCER: A SYSTEMATIC Tanis; E. Dekker; P. Fockens REVIEW AND META-ANALYSIS Katsuro Ichimasa, Japan; S.-E. Kudo; H. Miyachi; Y. P0915 Kouyama; F. Ishida; T. Baba; A. Katagiri; K. Wakamura; CLINICOPATHOLOGIC AND ENDOSCOPIC FEATURES OF T. Hayashi; T. Hisayuki; T. Kudo; M. Misawa; Y. Mori; S. EARLY STAGE COLORECTAL SERRATED ADENOCARCINOMA Matsudaira; Y. Kimura; Y. Kataoka Daiki Hirano, Japan; S. Tanaka; S. Oka; B. Kazuki; Y. Ken; K. Sumimoto; N. Yuki; T. Yuzuru; A. Naoki; S. P0907 Kenjiro; N. Hayashi; S. Fumio; K. Chayama CHARACTERIZATION OF PORTUGUESE FAMILIES WITH MUIR-TORRE SYNDROME P0916 C. Palmela; P. Lage; I. Claro; Joana Moleiro, Portugal; DIAGNOSTIC ACCURACY OF FECAL IMMUNOCHEMICAL I. Francisco; B. Filipe; C. Albuquerque; P. Rodrigues; P. TEST IN PATIENTS AT HIGH-RISK FOR COLORECTAL Chaves; A. Dias Pereira CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS Anastasia Katsoula, Greece; P. Paschos; A.-B. Haidich; A. Tsapas; O. Giouleme Lower GI malignant disease, pathogenesis P0917 P0908 DIMETHYLARGININE SERUM CONCENTRATIONS THE ASSOCIATION OF LOW PENETRANCE VARIANTS EFFECTIVELY IDENTIFY SUBJECTS WITH COLORECTAL IN DNA REPAIR GENES WITH COLORECTAL CANCER: A CARCINOMA SYSTEMATIC REVIEW AND META-ANALYSIS Sebastian Eder, Austria; T. Felder; A. Stadlmayr; U. Nikhil Aggarwal, United Kingdom; N. Donald; S. Malik; Huber-Schönauer; D. Niederseer; W. Patsch; E. Aigner; S. Selvendran; M. McPhail; K. Monahan C. Datz P0909 P0918 DIETARY EMULSIFIERS INDUCED LOW-GRADE INTESTI- GAS CHROMATOGRAPHY SENSOR PLATFORM FOR DIAG- NAL INFLAMMATION FAVORS COLONIC CARCINOGENESIS NOSING COLONIC NEOPLASIA USING FAECAL SAMPLES 2016 18, October Tuesday, Benoit Chassaing, USA; E. Viennois; D. Merlin; A. Ashley Bond, United Kingdom; R. Aggio; B. M. Corfe; Gewirtz S. Lewis; R. Hough; C. Probert; P0910 P0919 15-LIPOXYGENASE METABOLITES IN HUMAN COLON USE OF CT COLONOGRAPHY (CTC) IN SELECTED MUCOSA, ADENOMA AND CARCINOMA TISSUES PATIENTS REFERRED ON A SUSPECTED COLORECTAL H. Gottschall; Christoph Schmöcker, Germany; D. CANCER PATHWAY TO A UK UNIVERSITY TEACHING Hartmann; K. Rund; N. Rohwer; N. Schebb; K. Weylandt HOSPITAL - ASSESSING THE POTENTIAL FINANCIAL P0911 BENEFITS OF A STRAIGHT TO TEST MODEL BMI-1 PROMOTES INVASION AND MIGRATION OF COLON Thomas Garvey, United Kingdom; C. Kane; A. Plumb; R. CANCER STEM CELLS THROUGH DOWN-REGULATION OF Vega; E. Seward E-CADHERIN P0920 Zefeng Zhang, China; W. Sha; Q. Wang FIT IS A BETTER MARKER FOR COLONIC NEOPLASIA P0912 THAN LOWER GI BLEEDING WITHDRAWN Mercedes Navarro, Spain; A. Ferrandez; P. Carrera; G. Hijos; P. Roncales; F. Sopena; A. Lanas P0913 ASSOCIATION OF COLORECTAL ADENOMA WITH META- P0921 BOLIC SYNDROME ANALYSIS OF COLORECTAL CANCERS (CRCS) DEPEND- Zhong-Hui Liu, China; S.-J. Cui; X.-M. Hu; J. K. Fan; ING ON THE SCREENING HISTORY FOR CRC SCREENING J.-F. Gu; J.-S. Peng IN IBARAKI, JAPAN Yoko Saitoh, Japan; H. Suzuki; I. Hyodo; M. Kaneko

Poster in the Spotlight Poster of Excellence Clinical Case Session 185

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0922 P0930 USEFULNESS OF PET-CT FOR DETECTING THE PREMA- DOES STENTING AS A 'BRIDGE TO SURGERY' IN LIGNANT LESIONS IN COLON LEFT-SIDED COLORECTAL CANCER OBSTRUCTION Jae Gu Jung, South Korea; M.-O. Kwak; H. W. Kang REALLY WORSEN ONCOLOGICAL OUTCOMES? Min Seob Kwak, South Korea; D.-H. Yang; Y. S. Yoon; C. P0923 S. Yu; J. C. Kim; J.-S. Byeon A NEW BLOOD TEST FOR THE DETECTION OF COLORECTAL CANCER (CRC): MEASUREMENT OF NATURAL KILLER CELL P0931 ACTIVITY (NKA) IN PATIENTS UNDERGOING COLONOSCOPY EFFICACY AND SAFETY OF ENDOSCOPIC COLONIC Gilles Jobin, Canada; M. Provençal; G. Aumais; L.-C. STENTING: A RETROSPECTIVE COMPARISON OF WALL- Rioux; K. Herba; G. Durivage; J.-R. Lachance; K. Matouk FLEX AND NITI-S COLONIC STENTS S. Iio; T. Kuwai; Y. Miyasako; Y. Sumida; T. Takasago; T. Lower GI malignant disease, management Nishimura; Hiroki Imagawa, Japan; T. Yamaguchi; A. Yamaguchi; H. Kouno; H. Kohno P0924 COMPARISON OF CLINICAL OUTCOMES AMONG Lower GI motility disorders: Clinical DIFFERENT ENDOSCOPIC MODALITIES FOR RECTAL NEUROENDOCRINE TUMOR P0932 Se Hwan Park, South Korea; Y.-S. Cho; H. H. Choi; D. Y. TINED LEAD TEST STIMULATION TO PREDICT LONG- Cheung; J. S. Kim; B.-I. Lee; M.-G. Choi TERM BENEFIT FROM SACRAL NERVE STIMULATION IN PATIENTS WITH CHRONIC CONSTIPATION (TILTS-CC) P0925 Y. Yiannakou; Kevin J. Etherson, United Kingdom; H. ARE ENDOSCOPIC SUBMUCOSAL DISSECTIONS OF Close; A. Kasim; M. Mercer-Jones; S. Plusa; R. Maier; S. CECAL TUMOR INVOLVING THE ILEOCECAL VALVE AND Green; J. Cundall; C. H. Knowles; J. Mason APPENDICEAL ORIFICE FEASIBLE? Tuesday, October 18, 2016 Kinichi Hotta, Japan; K. Shinoki; K. Imai; S. Ito; Y. P0933 Yamaguchi; N. Kawata; M. Tanaka; N. Kakushima; K. SYN-010, A PROPRIETARY MODIFIED-RELEASE FORMU- Takizawa; H. Ishiwatari; H. Matsubayashi; H. Ono LATION OF LOVASTATIN LACTONE, LOWERED BREATH METHANE AND IMPROVED STOOL FREQUENCY IN P0926 PATIENTS WITH IBS-C: RESULTS OF A MULTI-CENTRE THE PROGNOSTIC FACTORS AND THE IMPACT OF SUR- RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED GERY ON REDUCING RECURRENCES IN T1 COLORECTAL PHASE 2A TRIAL CANCERS BASED ON A LONG-TERM SURVEILLANCE Klaus Gottlieb, USA; V. Wacher; J. Sliman; O. Coughlin; Yuta Kouyama, Japan; S.-E. Kudo; H. Miyachi; K. H. McFall; A. Rezaie; M. Pimentel Ichimasa; S. Matsudaira; Y. Kimura; T. Hisayuki; K. Wakamura; T. Hayashi; T. Kudo; Y. Mori; M. Misawa; A. P0934 Katagiri; T. Baba; F. Ishida A DIFFERENT MECHANISMS OF DISEASE IN SUBTYPES IR- RITABLE BOWEL SYNDROME AS DEMONSTRATED BY MRI P0927 Ching Lam, United Kingdom; G. Chaddock; L. Marciani; HEPATIC ARTERIAL INFUSION CHEMOTHERAPY FOR C. Costigan; E. Cox; C. L Hoad; S. Pritchard; P. Gowland; UNRESECTABLE LIVER METASTASES OF COLORECTAL R. Spiller CANCER: A MULTICENTER RETROSPECTIVE STUDY Annie Lim, France; S. Le Sourd; H. Senellart; D. Luet; F. P0935 Douane; C. Perret; A. Bouviet; S. Metairie; E. Cauchin; ABNORMAL BALLOON EVACUATION TEST DOES NOT P. Rougier; T. Matysiak Budnik; Y. Touchefeu IDENTIFY WHICH PATIENTS WILL RESPOND TO BIO- FEEDBACK; ANORECTAL MANOMETRY OR EMG, AND P0928 STRUCTURAL EVALUATION ARE NEEDED CHARACTERISTICS OF THE NON-RESPONDER GROUPS Giuseppe Chiarioni, Italy; O. Palsson; S. Heymen; M. OF THE COLORECTAL CANCER SCREENING PILOT STUDY Simrén; F. Cidoni; W. E. Whitehead IN LATVIA U. Kojalo; Daiga Santare, Latvia; I. Kojalo; M. Leja P0936 SIGNIFICANCE OF PUSH TEST AND BALLON EXPULSION P0929 TEST ESTABLISHED BY HIGH-RESOLUTION ANORECTAL IMPACT OF EVALUATION OF INDIVIDUALIZED CHEMO- MANOMETRY (HRAM) AND ITS SIGNIFICANCE FOR THERAPY FOR COLORECTAL CANCER (CRC) BASED ON DYSSYNERGIC DEFECATION DIAGNOSTICS COLLAGEN GEL DROPLET-EMBEDDED DRUG SENSITIV- Olga Storonova, Russia; A. Trukhmanov; V. Ivashkin ITY TEST (CD-DST). Takumi Ochiai, Japan; K. Nishimura; Y. Abe; I. Nagaoka

186 Poster in the Spotlight Poster of Excellence Clinical Case Session 187 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0937 P0945 IMPROVEMENT OF BOWEL HABITS AND PATIENT'S PHASIC AND CONTINUOUS PROTOCOLS IN ANORECTAL SATISFACTION - A POOLED ANALYSIS OF MOST RE- MANOMETRICAL ASSESSMENT OF RECTAL SENSITIV- CENT BISACODYL AND SODIUM PICOSULFATE TRIALS ITY: AGREEMENT AND CORRELATION WITH CLINICAL Sabine Niedermeier, Germany; H. Weigmann; E. PRESENTATION Richter; P. Kammann C. Peleman; K. Van Malderen; W. Verlinden; Heiko De Schepper, Belgium P0938 GOOD AGREEMENT BETWEEN ORO-ANAL TRANSIT P0946 TIME MEASURED BY WIRELESS MOTILITY CAPSULE THREE-DIMENSIONAL HIGH-RESOLUTION ANORECTAL AND RADIOPAQUE MARKERS IN PATIENTS WITH MANOMETRY AND RECTOANAL DELTA CONTRACTILE FUNCTIONAL BOWEL DISORDERS INTEGRAL FOR THE ASSESSMENT OF FUNCTIONAL Karin Engstrand, Sweden; P. Jerlstad; A. Lidén; G. DEFECATORY DISORDERS: TOY OR TOOL? Näslin; G. Ringström; M. Simrén; H. Törnblom Dario Gambaccini, Italy; M. Bellini; M. Zari; S. Russo; I. Martinucci; N. De Bortoli; A. Ricchiuti; F. Costa; M. G. P0939 Mumolo; S. Marchi WHAT IS MISSED AND WHAT IS STILL NEEDED FOR EFFICIENT TREATMENT OF CHRONIC CONSTIPATIONS? P0947 Dan Carter, Israel; R. Dickman PERCEPTIONS OF CURRENT TREATMENTS FOR FECAL INCONTINENCE P0940 Emma Carrington, United Kingdom; O. S. S. Palsson; EXTERNAL AND INTERNAL GUT IMAGING FOR MOR- M. Simrén; S. Heymen; A. Bharucha; S. S. C. Rao; A. PHO-FUNCTIONAL EVALUATION OF THE GUT Lowry; M. Gantz; S. Gould; W. E. Whitehead Carolina Malagelada, Spain; D. Sihuay; A. Bendezu; A. Montenegro; X. Molero; A. Nieto; A. Accarino; J. R. P0948 Malagelada; F. Azpiroz ANORECTAL COMPLICATIONS IN PATIENTS WITH HEMA- TOLOGIC DISEASES - A SINGLE CENTER EXPERIENCE P0941 Rafaela Vasconcelos Loureiro, Portugal; V. Borges; LEVATOR ANI TENDERNESS IN PATIENTS WITH DYS- C. Bernardes; T. Capela; P. Russo; M. J. Silva; M. J. SYNERGIC DEFECATION Bettencourt Giuseppe Chiarioni, Italy; O. Palsson; S. Heymen; C. Pedrazzani; W. E. Whitehead Lower GI health services research Ano-rectal disorders other than IBD or motility-related P0949 POTENTIATION OF LOPERAMIDE AND RACECADOTRIL 2016 18, October Tuesday, P0942 ANTI-DIARRHOEAL PROPERTIES BY SACCHAROMYCES POPULATION PREVALENCE OF ROME IV FECAL INCONTI- BOULARDII CNCM I-745 IN A MOUSE MODEL NENCE AND ASSOCIATED RISK FACTORS IN THE UNITED Philippe Girard, France; Y. Pansart; M. Verleye STATES (US), CANADA AND THE UNITED KINGDOM (UK). Olafur S. Palsson, USA; M. Simrén; M. van Tilburg; S. P0950 Heymen; A. D. Sperber; W. E. Whitehead COMBINATION FECAL IMMUNOCHEMICAL TEST AND CLINICAL RISK SCORES TO PRIORITIZE SCREENING P0943 COLONOSCOPY: A MULTICENTER STUDY IN THAILAND ANAL DYSPLASIA IN HIV INFECTED PATIENTS: LONG TERM S. Aniwan; R. Rerknimitr; Wiriyaporn Ridtitid, Thailand; RESULTS FROM A CYTOLOGICAL SCREENING PROGRAM T. Ratanachu-ek; S. Pongprasobchai; J. Limsrivilai; P. Marco Silva, Portugal; A. Peixoto; J.A. Sarmento; Pisespongsa; A. Sangchan; J. Sottisuporn; P. A. Albuquerque; R. Coelho; R. Serrão; C. Pinero; H. Angsuwatcharakon; V. Viriyautsahakul; P. Mairiang; Barroca; G. Macedo O.-A. Sottisuporn; P. Kullavanijaya P0944 P0951 ANAL CONDYLOMAS: PREDICTORS OF RECURRENCE DIFFERENCES AND SIMILARITIES OF GASTROENTER- AND PROGRESSION TO HIGH-GRADE DYSPLASIA / OLOGY TRAINING ACROSS EUROPE: A WEB-BASED, CARCINOMA IN SITU INTERNATIONAL SURVEY Armando Peixoto, Portugal; M. Silva; R. Castro; R. Gianluca Ianiro, Italy; M. Maida; L. Alrubaiy; T. Bokun; Coelho; A. Albuquerque; J. A. Sarmento; G. Macedo T. Bruns; V. Castro; L. China; G. Conroy; D. Trabulo; C. Van Steenkiste; R. Voermans; J. Burisch

Poster in the Spotlight Poster of Excellence Clinical Case Session 187

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0952 Upper GI and small intestinal bleeding RANDOMISED CLINICAL TRIAL: 1-DAY BOWEL PREPARA- TION VS 2-DAY BOWEL PREPARATION WITH POLYETH- Poster Session YLENE GLYCOL 3350 – A CONTROLLED STUDY OF EFFICACY 09:00 - 17:00 Hall X5 IN CHILDREN BOWEL PREPARATION FOR COLONOSCOPY Oesophageal, Gastric and Duodenal Disorders II Wallace Gois, Brazil; M. Averbach; F. H. Ejima; G. W. Ejima; W. A. Batista; W. C. Silva; M. Barcellos P0960 DELPHI STUDY ON THE MANAGEMENT OF IRON DEFI- P0953 CIENCY ANAEMIA IN PATIENTS WITH GASTROINTESTI- THE BURDEN OF GASTROINTESTINAL MORBIDITY AND NAL BLEEDING HEALTH RESOURCE UTILIZATION IN YOUNG ADULTS. Ingolf Schiefke, Germany; J. Stein; J. Wehkamp; C. Dan Carter, Israel; L. Katz Hankey; R. Wendt; P. Clarke; S. Keshav; D. Jayne; H. P0954 Boardman FIT SAMPLE STABILITY FOR HAEMOGLOBIN-POSITIVE P0961 FAECES USING THREE ANALYSIS SYSTEMS OVER SEVEN URGENT ENDOSCOPY FOR NONVARICEAL UPPER GAS- DAYS TROINTESTINAL HAEMORRHAGE: IMPACT OF OUT-OR- Carolyn Piggott, United Kingdom; C. John; H. Bruce HOURS PRESENTATION AND TIMING OF ENDOSCOPY P0955 Luís Maia, Portugal; E. Sampaio; P. S. Salgueiro; R. REFERRALS TO A TERTIARY HOSPITAL: A CLINICAL Küttner Magalhães; R. Marcos-Pinto; M. Dinis-Ribeiro SNAPSHOT OF PATIENTS WITH FUNCTIONAL GAS- P0962 TROINTESTINAL DISORDERS AND EFFECTIVENESS OF A COMPARATIVE STUDY OF RISK ASSESSMENT SCORES PRIMARY CARE MANAGEMENT FOR ACUTE UPPER GI BLEEDS, IN PREDICTING NEED & Ecushla Linedale, Australia; A. Mikocka-Walus; P. R. TIME FOR INTERVENTION Tuesday, October 18, 2016 Gibson; J. M. Andrews Syed Anjum Ali Gardezi, United Kingdom; C. Tibbatts; P0956 A. Foliaki GP PARTICIPATION IN INCREASING UPTAKE IN BOWEL P0963 CANCER SCREENING: THE PEARL PROJECT MALLORY-WEISS SYNDROME: NOT SO GOOD NEWS Piers Butler, United Kingdom; S. Duffy; K. Reed; M. Luís Maia, Portugal; E. Sampaio; P. S. Salgueiro; R. Chesters; S. Stanley; S. Rickard; R. Roope; S. Benton Marcos-Pinto; M. Dinis-Ribeiro; I. Pedroto P0957 P0964 POST-POLYPECTOMY BLEEDING AMONGST PARTICI- THE ROLE OF ENDOSCOPIC HEMOSTASIS FOR PERIAM- PANTS OF NEW ZEALAND BOWEL SCREENING PILOT PULLARY DIVERTICULAR BLEEDING PROGRAMME K. B. Kim; Yonghyeok Choi, South Korea; Y. Oh; E. B. Hui Syn Chan, New Zealand; P. Frankish Kim; K. Kim; J.-H. Han; S. M. Yoon; H. B. Chae; S. M. P0958 Park; S. J. Youn WITHDRAWN P0965 P0959 AIMS65 SCORE AND GLASGOW BLATCHFORD SCORE THE IDRI STUDY: EFFECT OF DYNAMIC, DIAGNOSE SHOW NO DIFFERENCE IN PREDICTING REBLEEDING SPECIFIC CHECKLISTS ON REFERRAL QUALITY IN GAS- RATE AND MORTALITY IN VARICEAL BLEEDING TROENTEROLOGY- A RANDOMIZED CROSS OVER STUDY. Ivan Budimir, Croatia; M. Gradiser; M. Nikolic; N. Sigrun Losada Eskeland, Norway; L. Aabakken; T. de Barsic; N. Ljubicic; D. Kralj; I. Budimir yr Lange P0966 A PHASE III CLINICAL TRIAL TO EVALUATE THE ENDO- SCOPIC EFFICACY AND SAFETY OF DA-5204, WITH NEW FORMULATION IN GASTRO-RETENTIVE SYSTEM, IN PATIENTS WITH ACUTE OR CHRONIC GASTRITIS Tae-Young Oh, South Korea; M.-G. Choi; S.-J. Lee; S. K. Kim; G. A. Song; P.-L. Rhee; H.-Y. Jung; D. Kang; Y. C. Lee; S.-H. Lee; S. C. Choi; K.-N. Shim; S.-Y. Seol; J. S. Moon; Y. Shin; H. S. Kim; S. T. Lee; J.-W. Cho; E. K. Choi; O.-Y. Lee; J. S. Chang; D. H. Lee

188 Poster in the Spotlight Poster of Excellence Clinical Case Session 189 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0967 P0974 IN-HOSPITAL AND DELAYED MORTALITY IN A SINGLE ACCELERATION OF EXPERIMENTAL GASTRIC ULCER CENTER SERIES OF UPPER GASTROINTESTINAL BLEED- HEALING BY MELATONIN. EVIDENCE FOR THE INTER- ING, A CRITICAL ANALYSIS. ACTION OF MELATONIN WITH MEL RECEPTORS AND Eduardo Redondo Cerezo, Spain; R. Jimenez-Rosales; J. MUCOSAL REGENERATING FACTORS EGF AND IGF-1 AND G. Martinez-Cara; F. Valverde-Lopez; M. Ubeda-Muñoz; THEIR RECEPTORS J. L. Ariza-Fernandez; A. Caballero-Mateos; P. Iwona Brzozowska, Poland; A. Ahluwalia; M. K. Jones; Jervez-Puente; M. Lopez de Hierro; J. de Teresa A. Chmura; A. S. Tarnawski; T. Brzozowski P0968 P0975 ACUTE NECROTIZING ESOPHAGITIS: A RETROSPECTIVE A NEW GASTRIC ACID SUPPRESSOR, "VONOPRAZAN", CASE SERIES IS EFFECTIVE IN PATIENTS WITH GASTROESOPHAGE- Claudio Martins, Portugal; C. Teixeira; É. Gamito; A. P. AL REFLUX DISEASE REFRACTORY TO PROTON PUMP Oliveira INHIBITORS Kei Matsumoto, Japan; H. Yamashita; A. Okada P0969 PREDICTION OUTCOME OF ACUTE NON-VARICEAL P0976 UPPER GASTROINTESTINAL BLEEDING: PROGNOSTIC THE OVERLAP BETWEEN IRRITABLE BOWEL SYN- VALUE OF NON-INVASIVE RISK ASSESSMENT SCORES DROME AND FUNCTIONAL DYSPEPSIA IN KOREA: AS- Elisa Soares, Portugal; M. Gravito-Soares; C. Lérias; C. SOCIATION OF SLC6A4 5-HTTLPR AND TRPV1 945G>C Sofia Yoon Jin Choi, South Korea; N. Kim; R. H. Nam; C. M. Shin; D. H. Lee; H. C. Jung Community dyspepsia Upper GI nerve-gut and motility: P0970 Transmitters/signals/receptors/enteric nervous system POPULATION PREVALENCE OF ROME IV AND ROME III FUNCTIONAL DYSPEPSIA IN THE UNITED STATES (US), P0977 CANADA AND THE UNITED KINGDOM (UK) THE PREDICTIVE VALUE OF A DISTINCT LABORATORY Olafur S. Palsson, USA; M. Simrén; M. van Tilburg; A. SCORE IN THE PREDICTION OF DELAYED GASTRIC D. Sperber; W. E. Whitehead EMPTYING AND AUTONOMIC NERVE DYSFUNCTION IN PATIENTS WITH AUTOIMMUNE GASTRITIS P0971 I. Soykan; Cagdas Kalkan, Turkey LOW YIELD REPEAT UPPER GI ENDOSCOPY FOR DYSPEPSIA PATIENTS: CONSECUTIVE SERIE FROM A P0978 TERTIARY REFERRAL CENTER EFFECTS OF PROTON PUMP INHIBITORS AND GENDER 2016 18, October Tuesday, S. Carvalhana; Sonia Bernardo, Portugal; L. Freitas; C. DIFFERENCE ON SERUM GASTRIN LEVELS Ferreira; L. C. Ribeiro; J. Velosa Ryo Katsumata, Japan; H. Matsumato; K. Gouda; T. Murao; M. Ishii; M. Fujita; A. Shiotani Functional upper GI disorders: Basic P0979 P0972 THE EFFECT OF K027, A NOVEL OXIME ACETYLCHOLIN- EVIDENCE FOR ANTIOXIDATIVE AND ANTIINFLAMMA- ESTERASE REACTIVATOR, ON OESOPHAGEAL MOTOR TORY PROPERTIES OF CARBON MONOXIDE AND HYDRO- FUNCTION IN EXPERIMENTAL PIGS GEN SULFIDE IN PATHOPHYSIOLOGY OF ASPIRIN-IN- Stanislav Rejchrt, Czech Republic; I. Tacheci; V. Radochova; DUCED GASTRIC DAMAGE J. Zdarova Karasova; J. Kvetina; K. Musilek; M. Kopacova; Marcin Magierowski, Poland; K. Magierowska; M. K. Kuca; T. Douda; J. Bures Hubalewska-Mazgaj; J. Adamski; Z. Sliwowski; D. Wojcik; S. Kwiecien; T. Brzozowski Upper GI nerve-gut and motility: Brain-gut and gut- brain axes, neuro-hormonal, neural-immune and P0973 visceral sensitivity USE OF DISTENSIBILITY TESTING TO DEMOSTRATE PYLORIC FUNCTION IN A PORCINE MODEL P0980 Jorge Arroyo, Sweden; P.-O. Park; M. Bergstrom; S. BRAIN MECHANISMS UNDERLYING THE EFFECT OF Bligh; B. P. McMahon MOTILIN RECEPTOR AGONIST ERYTHROMYCIN ON HUNGER FEELINGS IN HEALTHY VOLUNTEERS Dongxing Zhao, Belgium; A. C. Meyer-Gerspach; E. Deloose; N. Weltens; J. Iven; I. Depoortere; J. Tack; L. Van Oudenhove

Poster in the Spotlight Poster of Excellence Clinical Case Session 189

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P0981 P0989 SOMATIZATION IS THE KEY LINK IN THE OVERLAP BE- COMPARISON BETWEEN ANTERIOR AND POSTERIOR TWEEN FUNCTIONAL GASTROINTESTINAL DISORDERS MYOTOMY DURING PERORAL ENDOSCOPIC MYOTOMY AND OTHER FUNCTIONAL SOMATIC SYNDROMES FOR TREATING ACHALASIA: A RANDOMIZED, PRO- Michael P. Jones, Australia; D. McNaughton; A. Beath; SPECTIVE STUDY N. J. Talley Yuyong Tan, China; L. Lv; X. Wang; J. Huo; D. Liu P0982 P0990 AN INCREASED PREVALENCE OF NEURODEGENERA- ABNORMAL INTRA-BOLUS PRESSURE CORRELATES TIVE/DEMYELINATING PROCESSES IN PATIENTS WITH WITH ESOPHAGO-GASTRIC DYSFUNCTION AND WITH - A PROSPECTIVE STUDY INCREASING AGE - A STUDY USING HIGH-RESOLUTION Hana Svecová, Czech Republic; M. Jerie; E. Meluzinova; MANOMETRY D. Kautznerova; J. Spicak; J. Krajciova; Z. Vackova; J. Marco Della Coletta, Italy; O. Bartolo; F. Galeazzi; E. Peregrin; J. Martinek Marabotto; G. Bodini; N. De Bortoli; M. Furnari; S. Tolone; V. Savarino; E. Savarino P0983 CONCURRENT AUTOIMMUNE DISEASES AND ASSOCIATED P0991 FACTORS IN PATIENTS WITH AUTOIMMUNE GASTRITIS POSTPRANDIAL INTRAGASTRIC PH LEVELS ARE I. Soykan; Cagdas Kalkan, Turkey ELEVATED FOR SIGNIFICANTLY LONGER ON REFLUX MONITORING IN PATIENTS WITH CONFIRMED GAST- P0984 ROPARESIS. EFFECT OF INTRAGASTRIC FAT INFUSION ON THE Joanne Ooi, United Kingdom; E. Glasinovic; G. GENERALIZATION OF REWARD SENSITIVITY Amarasinghe; K. Nikaki; S. Gabieta-Sonmez; E. Yazaki; Dongxing Zhao, Belgium; M. van Gils; M. Moeni-Jazani; D. Sifrim; P. Woodland M. Tuk; J. Tack; L. Warlop; L. Van Oudenhove

Tuesday, October 18, 2016 P0992 P0985 MANAGEMENT OF RECURRENT SYMPTOMS AFTER RELATIONS AMONG AUTONOMIC NERVE FUNCTION AND PERORAL ENDOSCOPIC MYOTOMY IN ACHALASIA GASTRIC EMPTYING IN PATIENTS WITH AUTOIMMUNE Froukje van Hoeij, The Netherlands; F. A. Ponds; T. GASTRITIS Rösch; J. E. Pandolfino; P. Fockens; B. A. J. Bastiaansen; Ç. Kalkan; A. Maden; Irfans Soykan, Turkey J. M. Sternbach; Y. Werner; A. Smout; A. J. Bredenoord Upper GI motility disorders: Clinical P0993 WHICH IS THE BEST CUT-OFF TO DEFINE INEFFECTIVE P0986 ESOPHAGEAL MOTILITY? DETAILED ANALYSIS OF A SINGLE U.S. CENTER EX- Salvatore Russo, Italy; N. De Bortoli; S. Tolone; I. PERIENCE WITH PERORAL ENDOSCOPIC MYOTOMY Martinucci; M. Frazzoni; M. Furnari; L. Bertani; L. (POEM) SUGGESTS ITS EFFICACY AND SAFETY WITH Surace; S. Giannotti; M. Bellini; V. Savarino; S. Marchi; SIGNIFICANT OCCURRENCE OF POST-PROCEDURAL E. Savarino GASTROESOPHAGEAL REFLUX Yamile Haito Chavez, USA; S. Ngamruengphong; Y.-I. Eosinophilic oesophagitis Chen; M. Bukhari; G. Hajiyeva; A. Ismail; A. Kamal; G. Aguila; V. Kumbhari; V. Singh; M. Khashab P0994 DEVELOPMENT AND VALIDATION OF AN ENDOSCO- P0987 PY-BASED ACTIVITY INDEX FOR ADULTS WITH EOSINO– DOES ESOPHAGEAL ENDOSCOPIC RESECTION IMPAIR PHILIC ESOPHAGITIS ESOPHAGEAL MOTILITY? - A PROSPECTIVE STUDY A. Schoepfer; Ekaterina Safroneeva, Switzerland; I. USING HIGH RESOLUTION MANOMETRY Hirano; C. Kuehni; M. Coslovsky; M. Zwahlen; R. Panczak; Tsutomu Takeda, Japan; K. Matsumoto; A. Nagahara; E. Dellon; N. Gonsalves; J. Leung; C. Bussmann; Y. H. Komori; Y. Akazawa; Y. Yuta Nakagawa; K. Izumi; Romero; J. Alexander; G. Furuta; S. Gupta; S. Aceves; K. Matsumoto; H. Ueyama; Y. Shimada; D. Asaoka; M. M. Chehade; J. Spergel; A. Straumann Hojo; S. Watanabe P0995 P0988 LOW INCIDENCE OF EOSINOPHILIC OESOPHAGITIS. DO DELAYED GASTRIC EMPTYING IS ASSOCIATED WITH WE STILL LACK AWARENESS? INCREASED RISK OF CARDIOVASCULAR DISEASE INDE- Georgios Marinopoulos, United Kingdom; S. Pelitari; I. PENDENT OF THE AETIOLOGY OF GASTROPARESIS Rahman; N. Sharma Antonia Gaus, Germany; P. Layer; V. Andresen; J. J. Holst; J. Keller

190 Poster in the Spotlight Poster of Excellence Clinical Case Session 191 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P0996 P1004 INFLUENCE OF FOUR DIFFERENT BIOPSY FORCEPS STUDY OF THE PREVALENCE OF GERD SUBTYPES IN MODELS ON QUANTITY AND QUALITY OF EPITHELIAL THE NATURAL POPULATION WITH HIGH ESOPHAGEAL AND SUBEPITHELIAL TISSUE SAMPLING IN EOSINO– CANCER INCIDENCE OF CHINA PHILIC ESOPHAGITIS Kun Wang, China; L.-P. Duan; L. Zhang; L. Zhang; Z. Alain Schoepfer, Switzerland; C. Bussmann; E. Safroneeva; Liu; Z. He; Y. Ke C. Sempoux; S. Godat; H.-U. Simon; A. Straumann P1005 P0997 LIFESTYLE FACTORS AND GASTRO-ESOPHAGEAL REFLUX EFFICACY OF TOPICAL STEROIDS IN EOSINOPHILIC DISEASE: A CASE-CONTROL STUDY IN ALBANIAN ADULTS ESOPHAGITIS: A METAANALYSIS Indrit Kellici, Albania; A. Kocollari; S. Gjika; S. Prifti; L. Stephan Miehlke, Germany; P. Wohlmuth; A. Madisch; Cakerri; B. Kraja A. Morgner Reflux disease, complications P0998 WITHDRAWN P1006 PATHOLOGIC ACID REFLUX IS NOT A COMMON FINDING P0999 IN PATIENTS WITH SEVERE DENTAL EROSIONS SIX-FOOD ELIMINATION DIET EFFECTIVELY INDUCES Axel Josefsson, Sweden; A. L. Krarup; P. Jerlstad; K. AND MAINTAINS REMISSION IN ADULTS WITH EOSINO- Jonsson; H. Törnblom; M. Simrén PHILIC OESOPHAGITIS Susana Rodrigues, Portugal; R. Morais; R. Azevedo; G. Macedo Oesophageal neoplasia: Basic P1000 P1007 DIFFERENTIATION OF EOSINOPHILIC ESOPHAGEAL EXPRESSION OF LNCRNA CCAT2 IN PLASMA AS POTEN- MYOSITIS FROM TIAL BIOMARKER FOR DIAGNOSIS OF ESOPHAGEAL Hiroki Sato, Japan; N. Nakajima; G. Hasegawa; K. SQUAMOUS CELL CARCINOMA Takahashi; Y. Kawata; Y. Sato; T. Honma; S. Terai Xiaoying Zhou, China; G. Zhang P1008 Reflux disease, epidemiology INSULIN PROMOTES ESOPHAGEAL ADENOCARCINO- MA DEVELOPMENT IN A NON-OBESE MURINE MODEL P1001 AFTER SURGICALLY-INDUCED CHRONIC REFLUX THE PREVALENCE OF JOINT HYPERMOBILITY IN Diletta Arcidiacono, Italy; A. Dedja; C. Giacometti; L. DIFFERENT PHENOTYPES OF REFLUX DISEASE: IN- 2016 18, October Tuesday, Dall'Olmo; M. Fassan; K. Worms; M. Cassaro; M. Rugge; CREASED IN OESOPHAGEAL HYPERSENSITIVITY D. LeRoith; A. Alberti; S. Realdon A. Y. Nasr; A. Fikree; Q. Aziz; Daniel Sifrim, United Kingdom P1009 IMMUNONUTRION BEFORE ESOPHAGECTOMY: IMPACT P1002 ON IMMUNESURVEILLANCE MECHANISMS THE PREVALENCE OF GERD IN PRIMARY CARE M. Scarpa; Andromachi Kotsafti, Italy; M. Scarpa; M. PATIENTS IN RUSSIA: PRELIMINARY DATA OF THE Fassan; M. T. Nardi; E. Pinto; F. Cavallin; R. Alfieri; M. MULTICENTER STUDY Cagol; M. Rugge; I. Castagliuolo; C. Castoro Dmitry Bordin, Russia; R. A. Abdulkhakov; A. V. Solovyeva; M. A. Butov; S. R. Abdulkhakov; O. B. Yanova; N. P. Kirilenko Oesophageal neoplasia: Clinical P1003 P1010 QUALITATIVE EVALUATION OF THE COMPOSITION OF EFFECT OF NEOADJUVANT THERAPY ON DYSPHAGIA REFLUXATE BY 24-HOUR MULTICHANNEL ESOPHAGEAL IN ESOPHAGEAL CANCER PATIENTS- DATA FROM A INTRALUMINAL IMPEDANCE AND PH-MONITORING AND RANDOMIZED CONTROLLED TRIAL COMPARING CHE- ITS RELATIONSHIP WITH EXTRAESOPHAGEAL REFLUX MOTHERAPY TO CHEMORADIOTHERAPY DISEASE Berit Sunde, Sweden; H. Song; M. Lindblad; I. Rouvelas; Stefan Konecny, Czech Republic; R. Kroupa; T. Pavlik; L. Lundell; N. Wang; P. Lagergren; M. Nilsson J. Dolina P1011 THE CLINICAL AND SERVICE IMPACT OF THE NATIONAL OESOPHAGO-GASTRIC CANCER AWARENESS CAM- PAIGN: A LOCALITY ANALYSIS FROM COUNTY DURHAM Sara Koo, United Kingdom; B. Awadelkarim; S. Choudhary; A. Dhar

Poster in the Spotlight Poster of Excellence Clinical Case Session 191

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P1012 P1020 ESOPHAGEAL STRICTURES AFTER CHEMORADIOTHER- EPIDEMIOLOGY AND CLINICAL MANAGEMENT OF APY FOR ESOPHAGEAL CANCER; PREDICTORS AND PATIENTS WITH GASTRIC MALT LYMPHOMA:THE FIRST SURVIVAL RATE. POPULATION-BASED STUDY IN FRANCE Norifumi Nishide, Japan; T. Nishina; S. Hori; S. Nadano; Tamara Matysiak Budnik, France; A. Cowppli-Bony; H. Ishii L. Bouzid; S. Orazio; A. de Mascarel; A. Ruskoné- Fourmestraux; P. Jamet; A. Monnereau P1013 CLINICAL EFFICACY OF POLYGLYCOLIC ACID SHEET TO P1021 PREVENT ESOPHAGEAL STRICTURE AFTER ENDOSCOP- DELICATE FEATURES AND SUBTLE DETAILS FOR CHAR- IC SUBMUCOSAL DISSECTION ACTERIZATION OF GASTRIC EPITHELIAL NEOPLASIAS Keum Bit Hwang, South Korea; H. Lee; Y. W. Min; B.-H. BY HIGH DEFINITION AND MAGNIFIED NARROW-BAND Min; J. H. Lee; J. J. Kim ENDOSCOPY Olga Buntseva, Russia; E. D. Fedorov; K. Erendgenova; Z. P1014 Galkova; R. Plakhov; E. Mayat; S. Rauzina; L. Mikhaleva; CLINICAL OUTCOMES OF ENDOSCOPIC RESECTION FOR V. Mizgulin SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCI- NOMA IN CERVICAL ESOPHAGUS P1022 Yoichi Yamamoto, Japan; T. Yano; T. Kadota; K. Hori; Y. TREATMENT STRATEGY OF ENDOSCOPIC RESECTION Oono; H. Ikematsu; T. Maruo; T. Tomioka; T. Shinozaki; FOR SYNCHRONOUS DOUBLE EARLY GASTRIC CANCER: R. Hayashi; S. Fujii; K. Kaneko SIMULTANEOUS RESECTION VS. TWO-STAGE RESECTION Haruhisa Suzuki, Japan; I. Oda; M. Sekiguchi; Y. Tanaka; P1015 K. Inoki; S. Abe; S. Nonaka; S. Yoshinaga; Y. Saito ENDOSCOPIC ULTRASOUND (EUS) FOR PSEUDOACHA- LASIA, HISTORY REVISITED! P1023 Tuesday, October 18, 2016 Christopher Chia, Singapore; I. Koumoutsos; I. Nasr; S. ENDOSCOPIC SUBMUCOSAL DISSECTION FOR DeMartino; J. Meenan NON-AMPULLA DUODENAL NEOPLASIA Tsuneo Oyama, Japan; A. Takahashi; N. Yorimitsu P1016 EFFICACY OF MODIFIED ORAL STEROID ADMINIS- P1024 TRATION FOR PREVENTING ESOPHAGEAL STRICTURE DKK-2, A MODULATOR OF WNT-SIGNALING PATHWAY, AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION IS OVEREXPRESSED IN GASTRIC CANCER Toshiro Iizuka, Japan; D. Kikuchi; S. Hoteya; M. Kaise Michael Selgrad, Germany; J. Bornschein; M. Vieth; P. Malfertheiner P1017 TREATMENT STRATEGY FOR LATERAL SPREADING P1025 SUPERFICIAL ESOPHAGEAL CARCINOMA LOW-PASS FILTER VISUALIZES MARGINAL CRYPT EPI- Hirofumi Kawakubo, Japan; T. Omori; R. Nakamura; N. THELIUM OF GASTRIC MUCOSA WITH HIGH SENSITIVITY Wada; H. Takeuchi; N. Yahagi; Y. Kitagawa IN MAGNIFYING ENDOSCOPY WITH NARROW-BAND IMAGING Gastroduodenal neoplasia: Clinical K. Yoshida; Y. Sasaki; Norihiro Hanabata, Japan; T. Mikami; H. Kijima; S. Fukuda P1018 THE CLINICOPATHOLOGIC FEATURES AND PROGNOSIS P1026 IN YOUNG GASTRIC CANCER PATIENTS ACCORDING TO ENDOSCOPY GUIDED DA VINCI® ROBOTIC GASTRIC HELICOBACTER PYLORI INFECTION SURGERY FOR EARLY GASTRIC CANCER Jae Jin Hwang, South Korea; D. H. Lee; H. Yoon; C. M. Weon Jin Ko, South Korea; G. W. Song; J. Y. Cho; Shin; Y. S. Park; N. Kim P1027 P1019 PPI TEST FOR DIAGNOSIS OF BODY ATRHOPIC GASTRI- LYMPH NODE METASTASIS RISK FOR HISTOLOGIC TIS: A PROPECTIVE STUDY TYPE WITH POORLY COHESIVE COMPONENTS IN EGC Francesco Di Mario, Italy; S. Landi; S. Grillo; V. Corrente; CONFINED TO MUCOSA M. Franceschi; G. Grasso; R. Cannizzaro; F. Baldassarre; Jae Jin Hwang, South Korea; J. P. Han; S. J. Hong; B. M. M. Rugge Ko; H. K. Kim; G. S. Cho

192 Poster in the Spotlight Poster of Excellence Clinical Case Session 193 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P1028 P1036 PROGNOSTIC PREDICTORS IN PRIMARY GASTRIC DIF- ELEVATED PRC1 IN GASTRIC CARCINOMA EXERTS FUSE LARGE B-CELL LYMPHOMA ONCOGENIC FUNCTION AND IS TARGETED BY PIPER- Rafaela Vasconcelos Loureiro, Portugal; A. Tomé; M. J. LONGUMINE IN A P53-DEPENDENT MANNER Silva; T. Capela; V. Borges; C. Bernardes; P. Russo; L. B. Zhang; X. Shi; L. Wang; Xiaoping Zou, China Mascarenhas; J. Esteves P1037 P1029 HOW DO INTRENATIONAL GASTRIC CANCER PREVENTION GASTROINTESTINAL STROMAL TUMORS: NATURAL GUIDELINES REFLECT TO CLINICAL PRACTICE GLOBALLY? HISTORY AND OUTCOMES IN THE IMATINIB ERA M. Leja; Evita Gasenko, Latvia; I. Polaka; R. Murillo; Armando Peixoto, Portugal; M. Silva; A. L. Santos; P. C. D. S. Bordin; A. Link; L. Garkalne; P. Malfertheiner; R. Moreira; S. Lopes; G. Macedo Herrero; H. Haick P1030 P1038 FEASIBILITY OF PRECUT COAGULATION WITH AN POTENTIALLY FUNCTIONAL POLYMORPHISMS IN METHI- ENDO-KNIFE ALONE ON GASTRIC ENDOSCOPIC SUB- ONYL-TRNA SYNTHETASE RELATED GENE ARE ASSOCIAT- MUCOSAL DISSECTION: A CASE-CONTROL STUDY ED WITH GASTRIC CANCER IN A CHINESE POPULATION Yohei Horikawa, Japan; T. Toyonaga; H. Mizutamari; N. W. Liu; Li Liu, China; X. Wang; M. Wang; Z. Fan Mimori; Y. Kato; S. Fushimi; S. Okubo P1039 P1031 LNCRNA HOTAIR ACTS AS A COMPETING ENDOGENOUS SEROLOGIC SCREENING IN DIAGNOSTICS OF GASTRIC RNA TO PROMOTE CISPLATIN RESISTANCE IN GASTRIC PRECANCEROUS CONDITIONS AND EARLY GASTRIC CANCER VIA MIR-126/PI3K/ AKT/ MRP1 PATHWAY CANCER (EGC) Jin Yan, China Ekaterina Melnikova, Russia; I. Maev; S. Kashin; T. Kryukova P1040 NUCLEAR EXPRESSION OF MASPIN CORRELATES WITH P1032 POOR PROGNOSIS IN PATIENTS WITH GASTRIC CAN- ENDOSCOPIC RESECTION FOR DUODENAL SUBEPITHE- CER AND IS AS A POSSIBLE INDUCTOR OF EPITHELIAL LIAL TUMORS: A SINGLE-CENTER EXPERIENCE MESENCHYMAL TRANSITION Gwang Ha Kim, South Korea; T. W. Kim; C. H. Park; B. Simona Gurzu, Romania; J. Orlowska; Z. Szentirmay; H. E. Lee; D. H. Baek; G. A. Song Sugimura; I. Jung P1033 P1041 QUALITY OF LIFE OUTCOMES AFTER ENDOSCOPIC AND POPDC1/BVES AND POPDC3 ARE DOWNREGULATED IN 2016 18, October Tuesday, SURGICAL TREATMENT OF EARLY GASTRIC CANCER: A GASTRIC INTESTINAL METAPLASIA PROSPECTIVE COHORT STUDY. Rachel Gingold Belfer, Israel; M. Herman-Edelstein; H. K. Jeon; Geun Am Song, South Korea; G. H. Kim; B. S. Morgenstern; V. Kliminski; D. Boltin; Y. Niv; G. E. Lee; D. H. Kim; T. Y. Jeon; K. W. Ryu; Y. J. Lee; H. J. Kessler-Icekson Lee; H. Y. Jeong; Y. K. Park; J. H. Yook; W. S. Yu; I. H. Chung; S. H. Noh; H. Y. Yun; S. B. Park; D. H. Yang; T. P1042 S. Sohn TARGETING ALDEHYDE DEHYDROGENASE 2 FOR PREVEN- TION OF GASTRIC CANCER IN ESTABLISHED RISK GROUP P1034 Bossng Kang, South Korea; C.-Y. Bang; S.-Y. Choung CLINICAL USEFULNESS OF MAGNIFYING ENDOSCOPY FOR NON-AMPULLARY DUODENAL TUMORS P1043 Takeshi Mizumoto, Japan; Y. Sanomura; S. Oka; K. Kuroki; CORRELATIONS AMONG PH OF GASTRIC JUICE, ATRO- M. Kurihara; Y. Yoshihuku; S. Tanaka; K. Chayama PHIC GASTRITIS, INTESTINAL METAPLASIA AND H. PYLORI INFECTION Gastroduodenal neoplasia: Basic Jihee Sung, South Korea; N. Kim; Y. J. Choi; H. Yoon; C. M. Shin; Y. S. Park; D. H. Lee P1035 LONG NONCODING RNA MALAT1 PROMOTES AGGRES- P1044 SIVE GASTRIC CANCER THROUGH MMP1 OVER-EX- POTENTIAL ROLE OF MICRORNA-126 IN THE DIAGNOSIS OF PRESSION AND TRANSCRIPTIONALLY ACTIVATED BY CANCERS: A SYSTEMATIC REVIEW AND META-ANALYSIS C-JUN Jin Yan, China Xiaoying Zhou, China; G. Zhang

Poster in the Spotlight Poster of Excellence Clinical Case Session 193

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

Upper GI vascular disorders P1052 A DRAMATIC RISE IN CLARITHROMYCIN RESISTANCE OF P1045 HELICOBACTER PYLORI STRAINS AMONG CHILDREN IN POLYPOID LESIONS OF NON-TYPICAL VARICEAL MOR- LITHUANIA PHOLOGY SEEN IN UPPER GI ENDOSCOPY, IN PATIENTS Gintare Kevalaite, Lithuania; J. Kupcinskas; L. V. Jonaitis; WITH PORTAL HYPERTENSION. OUTCOMES OF INVES- V. Urbonas; R. Auzbikiene; T. Havnhoj Frandsen; R. TIGATION WITH ENDOSCOPIC ULTRASOUND Kucinskiene; E. Kadusevicius; L. Kupcinskas; L. Percival D. E. Sigounas; A. Shams; John Nicholas Plevris, United Andersen Kingdom; P. C. Hayes P1053 P1046 SCREENING OF PRECANCEROSIS AND EARLY GASTRIC HEREDITARY HEMORRAGIC TELANGIECTASIA: CHAR- CANCER IN NATURAL POPULATION OVER FORTY YEARS ACTERIZATION OF A LARGE COHORT OF PATIENTS OLD, SHENGZE, CHINA: ROLE OF SERUM GASTROPANEL WITH DIGESTIVE MANIFESTATIONS Yini Dang, China; G. Zhang Pedro Marques Da Costa, Portugal; L. C. Meireles; N. Fatela; C. Baldaia; R. Palma; L. A. Correia; P1054 H. Cortez-Pinto; J. Velosa RESIDE IN A RURAL AREA AND BEING WOMAN COULD INCREASE THE RISK OF HELICOBATER PYLORI ERADICA- P1047 TION FAILURE, USING THE CLASSIC TRIPLE THERAPY MECHANISM UNDERLYING STRESS-RELATED MUCOSAL E. Peña-Galo; J. Gotor; Y. Harb; M. Alonso; Javier DAMAGE: UPPER OPTICAL GASTROSCOPY Alcedo, Spain Oxana Semyachkina-Glushkovskaya; A. Abdurashitov; Ilana Agranovich, Russia Pathogenesis: Microbial factors P1048 P1055

Tuesday, October 18, 2016 SUPERIOR MESENTERIC ARTERY SYNDROME: A TRUE H.PYLORI VACA GENOTYPE IS A PREDOMINANT DETER- AND MISDIAGNOSED CLINICAL ENTITY MINANT OF IMMUNOLOGIC RESPONSE TO H. PYLORI R. Bardini; S. Rampado; S. Degasperi; I. Angriman; CAGA Angelica Ganss, Italy Alexander Link, Germany; C. Langner; W. Schirrmeister; P1049 W. Habendorf; J. Weigt; M. Venerito; I. Tammer; D. SUPERIOR MESENTERIC ARTERY SYNDROME AND Schlüter; A. Roessner; P. Schlaermann; T. Meyer; T. ACUTE PANCREATITIS Wex; P. Malfertheiner R. Bardini; S. Rampado; S. Degasperi; Angelica Ganss, P1056 Italy CAN BACTERIAL VIRULENCE FACTORS PREDICT ANTI- BIOTIC RESISTANT HELICOBACTER PYLORI INFECTION? Epidemiology/natural history Denise Brennan, Ireland; M. Feighery; C. Treacy; E. Fahy; J. Omorgbe; M. Hussey; D. Tighe; G. Holleran; C. Poster Session O'Morain; D. McNamara; S. Smith 09:00 - 17:00 Hall X5 H. Pylori II Diagnosis P1050 P1057 ASSOCIATION BETWEEN HELICOBACTER PYLORI LONG-TERM CHANGES OF EXTENT OF CHRONIC ATRO- INFECTION AND EOSINOPHILIC ESOPHAGITIS: RESULTS PHIC FUNDIC GASTRITIS AFTER H. PYLORI INFECTION OF A MULTICENTER PROSPECTIVE EUROPEAN STUDY OBSERVED IN AUTOFLUORESCENCE IMAGING VIDEOEN- Javier Molina Infante, Spain; E. Savarino; I. Modolell; DOSCOPY R. Penagini; A. Prieto-Garcia; O. Bartolo; A. Mauro; J. Noriya Uedo, Japan; K. Aoi; R. Ishihara; E. Toth Alcedo; J.A. Pajares Diaz; E. Marabotto; J. L. Dominguez-Jimenez; S. Tolone; C. Guarner-Argente; P1058 M. C. Murzi Pulgar; N. De Bortoli; A. M. Vegas; M. C. EFFECTS OF HELICOBACTER PYLORI STATUS ON Perona Vincenti; A. G. McNicholl; J. P. Gisbert DYSPEPSIA, PEPTIC ULCER, HEALTH CARE USE OR QUALITY OF LIFE - HEP-FYN 13-YEAR FOLLOW-UP P1051 Maria Bomme, Denmark; J. M. Hansen; M. Wildner- SURVEILLANCE OF HELICOBACTER PYLORI RESISTANCE Christensen; J. Hallas; O. B. Schaffalitzky de Muckadell TO ANTIBIOTICS IN FRANCE IN 2014 A. Ducournau; L. Bénéjat; E. Sifré; E. Bessède; P. Lehours; Francis Megraud, France

194 Poster in the Spotlight Poster of Excellence Clinical Case Session 195 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P1059 P1066 EFFICACY OF MULTIPLEX PCR-BASED DETECTION OF HELICOBACTER PYLORI SUSCEPTIBILITY TESTING IN HELICOBACTER PYLORI INFECTION IN PATIENTS WITH ALBERTA, CANADA PEPTIC ULCER BLEEDING Marthe Charles, Canada; R. Rennie; L. Turnbull; S. Su Jung Han, South Korea; Y. S. Cho; I.-K. Chung; Y. Veldhuyzen Van Zanten Jung; T. H. Lee; S.-H. Park; S.-J. Kim P1067 P1060 ADDITION OF CRANBERRY TOPROTON PUMP INHIB- CRYPT HYPERPLASTIC IN HELICO- ITOR BASED TRIPLE THERAPY FOR HELICOBACTER BACTER PYLORI INFECTED IBD PATIENTS PYLORI ERADICATION Daniel Vasile Balaban, Romania; A. Popp; J. Taavela; K. Jamshid Vafaeimanesh, Iran; M. Seyyedmajidi; M. Laurila; M. Maki; M. Jinga Bagherzadeh P1068 Treatment HELICOBACTER PYLORI ERADICATION EFFECT ON LIV- P1061 ER FAT CONTENT IN PATIENT WITH NON-ALCOHOLIC EFFICACY OF 7-DAY GENOTYPIC RESISTANCE-GUIDED FATTY LIVER DISEASE TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADI- Ahmed Arnaout, Egypt CATION: PROSPECTIVE TRIAL IN A HIGH-RESISTANCE SETTING Enterocyte biology/pathology and nutrient/water N. Mathou; S. Lycousi; Vasilios Papastergiou, Greece; transport/electrolyte transport K. D. Paraskeva; A. Giannakopoulos; E. Evgenidi; J. Karagiannis Poster Session P1062 09:00 - 17:00 Hall X5 THE INVESTIGATION OF OPTIMAL H.PYLORI ERADI- Small Intestinal II CATION TREATMENT USING VONOPRAZAN, A NOVEL P1069 POTASSIUM-COMPETITIVE ACID BLOCKER PLASMA LEVELS OF GUANYLINS ARE REDUCED IN Satoshi Egawa, Japan; K. Kozumi; E. Yoshida; E. Kimura; CROHN'S PATIENTS AND IN PATIENTS WITH FAMILIAL F. Sano; C. Torizumi; E. Tsumano; A. Shimayoshi; M. GUCY2C DIARRHEA SYNDROME Horie; K. Iwahashi; D. Nakamatsu; M. Murata; M. Hilde von Volkmann, Norway; T. Mazzawi; I. Brønstad; Miyazaki; M. Oshita K. Nylund; R. R. Tronstad; K. Hanevik; T. Hausken; O. H. P1063 Gilja; T. Fiskerstrand Tuesday, October 18, 2016 18, October Tuesday, UNSATISFACTORY EFFICACY OF LEVOFLOXACIN TRIPLE P1070 THERAPY IN THE FIRST AND SECOND LINE TREATMENT LOW DENSITY OF PYY IMMUNOREACTIVE CELLS IN OF HELICOBACTER PYLORI INFECTION- A SYSTEMIC TERMINAL ILEUM OF PATIENTS WITH FAMILIAL GU- REVIEW AND META-ANALYSIS CY2C DIARRHEA SYNDROME Jyh-Ming Liou, Taiwan; P.-Y. Chen; J.-T. Lin; M.-S. Wu Tarek Mazzawi, Norway; H. L. Von Volkmann; M. P1064 El-Salhy; ; R. R. Tronstad; K. Hanevik; T. Hausken; O. H. HELICOBACTER AND DUODENAL ULCERATION IN 2015: Gilja; T. Fiskerstrand HOW METICULOUS ARE WE AT ASSESSING, ERADICAT- P1071 ING AND RETESTING FOR HELICOBACTER? BORONIC ACID ARRAY FOR RAPID IDENTIFICATION OF Abigail Masding, United Kingdom; K. Besherdas INCREASED SMALL INTESTINAL PERMEABILITY P1065 A. Resendez; P. Panescu; R. Zuniga; I. Banda; B. Singaram; POTASSIUM-COMPETITIVE ACID BLOCKER-BASED Dominic-Luc Webb, Sweden THIRD-LINE TRIPLE THERAPY IN HELICOBACTER PY- LORI ERADICATION AND STUDY OF THE DIVERSITY OF Microbiology ANTIMICROBIAL SUSCEPTIBILITIES P1072 Yukari Yano, Japan; H. Mizuta; M. Kira; Y. Matsumura; INTESTINAL PERMEABILITY IN HEALTHY FIRST DEGREE T. Kitagawa; M. Hashiba; N. Okamoto; H. Takeuchi; M. RELATIVES OF CROHN'S DISEASE PATIENTS IS ASSOCI- Ono; T. Saibara ATED WITH FUNCTIONAL CAPACITY OF MICROBIOTA Williams Turpin, Canada; D. Kevans; K. Shestopaloff; M. I. Smith; D. Guttman; M. S. Silverberg; W. Xu; K. Madsen; A. Paterson; K. Croitoru

Poster in the Spotlight Poster of Excellence Clinical Case Session 195

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

P1073 P1081 DYSBIOSIS AND STABILITY OVER TWO YEARS IN PA- LONG-TERM RECOVERY OF HEALTH STATUS OF PA- TIENTS WITH IRRITABLE BOWEL SYNDROME TIENTS WITH CELIAC DISEASE Jostein Sauar, Norway; F.-A. Halvorsen; C. Corwin; S. Francisco Casellas Jorda, Spain; J. López Vivancos Olafsson P1082 P1074 DENTAL ENAMEL DEFECTS, DENTAL CARIES, ORAL THE INFLUENCE OF PROTON PUMP INHIBITER IN LICHEN PLANUS IN PATIENTS WITH CELIAC DISEASE - HUMAN MICROBIOTA AND METABOLIC PRODUCTION PROSPECTIVE COHORT STUDY INTRODUCTION: RELATED TO ADVERSE EVENTS Nitin Shanker Behl, India; A. B. Behl Takayuki Kato, Japan; I. Tsuchiya; A. Nakajima P1083 P1075 CELIAC DISEASE WITH NEGATIVE HLA-DQ2.5/8 IN PRESENCE OF SMALL INTESTINAL BACTERIAL OVER- SPAIN: SYSTEMATIC REVIEW AND META-ANALYSIS GROWTH IN PATIENTS WITH ACTIVE HELICOBACTER Fernando Fernández-Bañares, Spain; C. Nuñez; B. PYLORI INFECTION ASSESSED BY FUNCTIONAL BREATH Arau; R. Dieli-Crimi; M. Rosinach; M. Esteve TESTING Dietmar Enko, Austria; G. Kriegshäuser P1084 SERUM ANTI-GANGLIOSIDE M1 ANTIBODIES AND NEU- RON-SPECIFIC ENOLASE LEVELS IN NEUROLOGICAL AS- Small intestinal infections YMPTOMATIC CELIAC DISEASE PATIENTS - PILOT STUDY P1076 M. Przybylska-Felus; Malgorzata Zwolinska-Wcislo, A MULTI-CENTER, RANDOMIZED, CONTROLLED TRIAL Poland; A. Furgala; K. Salapa; T. Mach TO ASSESS THE EFFICACY, SAFETY AND TOLERABIL- P1085 ITY OF RACECADOTRIL VERSUS LOPERAMIDE IN THE

Tuesday, October 18, 2016 PREVALENCE OF CELIAC DISEASE IN PATIENTS WITH TREATMENT OF ACUTE DIARRHEA IN ADULTS AUTOIMMUNE THYROID DISEASE - A META-ANALYSIS Marion Eberlin, Germany; H. Weigmann; T. Mueck Monika Laszkowska, USA; A. Roy; J. Sundström; B. Lebwohl; P. H. Green; O. Kämpe; J. Ludvigsson Coeliac disease (adult) P1077 Small intestinal bleeding A RAPID POINT-OF-CARE TEST (POCT) IN ADULT P1086 CASE-FINDING IN PRIMARY CARE FOR COELIAC DIS- SERUM ANGIOPOIETIN-2 IS AN ACCURATE CAPSULE EASE: A COST-EFFECTIVENESS STUDY ENDOSCOPY SCREENING TOOL FOR THE DETECTION OF M. Rosinach; F. Fernández-Bañares; M. Llordés; J. Calpe; SMALL BOWEL ANGIODYSPLASIA G. Montserrat; M. Pujals; A. Cela; A. Carrasco; M. Ibarra; Grainne Holleran, Ireland; M. Hussey; O. O'Dwyer; S. P. Ruiz; V. Gonzalo; C. Ferrer; Maria Esteve, Spain Smith; D. McNamara P1078 P1087 POTENTIAL COELIAC DISEASE OF THE ADULTS: TO CROHN'S DISEASE DIAGNOSED BY CHANCE IN PATIENTS TREAT OR NOT TO TREAT, THAT IS THE QUESTION! SUBJECTED TO CAPSULE ENDOSCOPY FOR THE INVESTI- Nicola Imperatore, Italy; R. Tortora; P. Capone; N. GATION OF OBSCURE GASTROINTESTINAL BLEEDING Gerbino; N. Caporaso; A. Rispo N. Viazis; A. Tsigaridas; M. Galanopoulos; L. Varytimiadis; P1079 Emmanouela Tsoukali, Greece; C. Pontas; I. Tziortziotis; MAY MUCOSAL TRANSCRIPTOMIC ANALYSIS PREDICT C. Hatzievangelinou; F. Gkeros; G. Mantzaris THE DEVELOPMENT OF GLUTEN RELATED DISORDERS P1088 AMONG MICROSCOPIC ENTERITIS? REBLEEDING RATE AFTER ENDOSCOPIC TREATMENT OF Giuseppe Losurdo, Italy; D. Piscitelli; L. Montenegro; F. SMALL BOWEL ANGIODYSPLASIAS WITH SINGLE-BAL- Giorgio; A. Giangaspero; A. Iannone; A. Amoruso; M. LOON ENTEROSCOPY: PREVALENCE AND RISK FACTORS Barone; M. Principi; E. G. Ierardi; A. Di Leo Patrícia Andrade, Portugal; M. Marques; H. Cardoso; P1080 G. Macedo FLOW CYTOMETRIC ANALYSIS OF ABERRANT INTRA- EPITHELIAL LYMPHOCYTES IN REFRACTORY COELIAC DISEASE Annalisa Schiepatti, Italy; R. Ciccocioppo; E. Betti; F. Biagi; L. Vanelli; C. Picone; C. Alvisi; G.R. Corazza

196 Poster in the Spotlight Poster of Excellence Clinical Case Session 197 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

P1089 P1095 EXRESS VIEW READING EFFICIENTLY REDUCES READ- CD24 KO MALE MICE AS A MODEL SYSTEM OF EARLY ON- ING TIME FOR SMALL BOWEL CAPSULE ENDOSCOPY: A SET OBESITY IN MEN WITH INSULIN HYPER-SENSITIVITY PROSPECTIVE MULTICENTRIC STUDY S. Shapira; D. Kazanov; N. Maharshak; R. Dankner; I. Jean Christophe Saurin, France; S. Bramli; L. Heyries; F. Zvibel; F. Bedny; Nadir Arber, Israel Cholet; P. Jacob; I. Fassler; G. Rahmi; C. Pesanti; A. De Nutrients and gut function Leusse; J. Boulant P1096 A RANDOMIZED CROSS-OVER STUDY ON THE EFFECTS Vascular disorders OF FODMAPS ON GASTRIC ACCOMMODATION, SYMP- P1090 TOM GENERATION AND EMOTION IN HEALTH AND POSTPRANDIAL FLOW MEASUREMENTS OF THE MES- IRRITABLE BOWEL SYNDROME ENTERIC ARTERIES AND PORTAL VEIN USING MAGNET- Imke Masuy, Belgium; L. Van Oudenhove; J. Tack; J. IC RESONANCE IMAGING: A PILOT STUDY Biesiekierski Louisa van Dijk, The Netherlands; M. Ouhlous; D. P1097 Leemreis; A. C. De Vries; H. J. M. Verhagen; E. J. Kuipers; THE FEATURES OF POSTPRANDIAL ABDOMINAL HE- A. Moelker; M. J. Bruno MODYNAMICS IN PATIENTS WITH P1091 M. Rozhkova; Elena Ljaljukova, Russia; G. Nechaeva; A PROSPECTIVE, QUANTITATIVE ASSESSMENT OF PAIN M. Livzan AND QUALITY OF LIFE BEFORE AND 3 AND 12 MONTHS P1098 AFTER VASCULAR TREATMENT FOR CHRONIC MESEN- EFFECTIVENESS OF BETA-CRYPTOXANTHIN FOR NON- TERIC ISCHEMIA ALCOHOLIC STEATOHEPATITIS Luuk Wymenga, The Netherlands; L. Everlo; P. B. Bunzo Matsuura, Japan; S. Yamamoto; T. Miyake; S. Mensink; M. Brusse-Keizer; E. J. Stassen; R. H. Furukawa; Y. Hiasa Geelkerken; J. J. Kolkman P1099 Obesity A RANDOMIZED PATIENT -BLIND CONTROLLED PHASE III STUDY TO COMPARE THE EFFICACY AND SAFETY Poster Session OF INTRAVENOUS FERRIC CARBOXYMALTOSE (FER- 09:00 - 17:00 Hall X5 INJECT®) WITH PLACEBO IN PATIENTS WITH ACUTE Nutrition II ISOVOLEMIC ANEMIA AFTER GASTRECTOMY Young-Woo Kim, South Korea; J.-M. Bae; Y. K. Park; P1092 H.-K. Yang; W. S. Yu; J. H. Yook; S. H. Noh; K. W. Ryu; 2016 18, October Tuesday, LACTOBACILLUS AND BIFIDOBACTERIUM PROBIOTIC T. S. Sohn; H.-J. Lee; O. K. Kwon; S. Y. Ryu; J.-H. Lee; STRAINS REDUCE CHOLESTEROL LEVELS AND AFFECT S. Kim; H. M. Yoon; B. W. Eom; M.-G. Choi; B. S. Kim; THE GUT MICROBIOTA IN OBESE MICE B.-H. Nam L. P. Babenko; O. Y. Sokolviak; V. V. Mokrozub; O. O. Nechypurenko; O. M. Demchenko; Rostyslav Bubnov, P1100

Ukraine; L. M. Lazarenko; M. Y. Spivak CONVENTIONAL CONTINUOUS INSULIN INFUSION THERAPY OF PERIOPERATIVE MANAGEMENT AFTER P1093 ESOPHAGECTOMY INTRAGASTRIC BALLOON: A COMPARATIVE STUDY Kazuhiko Yamada, Japan; K. Nohara; S. Yamashita; D. ADJUSTABLE TWELVE MONTHS BALLOON VERSUS CON- Souma VENTIONAL SIX MONTHS BALLOON Bruno Sander, Brazil; M. Galvão Neto; J. C. D. Marchesini; Poster Session J. Schemberk Jr; E. Grecco; S. Barrichello; J. Scarparo 09:00 - 10:00 E-Poster Lounge 1 P1094 Exemplary clinical cases I EXERCISE DIFFERENTIALLY CHANGES METABOLIC DYS- Chairs: J. P. H. Drenth, The Netherlands REGULATION AND GUT MICROBIOTA IN DIFFERENT DIETS J.-L. Van Laethem, Belgium S.-R. Wu; C.-J. Wu; C.-Y. Cheng; T.-L. Lai; C.-Y. Wu; J.-J. CC61 Shieh; Jaw-Town Lin, Taiwan SARCOIDOSIS PRESENTING AS ACUTE PANCREATITIS Hyeon Jeong Yun, South Korea; W. S. Park; M. S. Chu; S.-H. Kim

Poster in the Spotlight Poster of Excellence Clinical Case Session 197

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

CC62 CC70 LIVER COMPLICATION AFTER BARIATRIC SURGERY - EOSINOPHILIC - A RARE CAUSE OF AN EMERGING PROBLEM ASCITES Irina Mocanu, Portugal; S. Carvalhana; P. Costa; A. R. Richard Azevedo, Portugal; C. Leitão; J. Pinto; H. Gonçalves; C. Baldaia; A. Valente; R. Palma Ribeiro; A. Caldeira; R. Sousa; E. Pereira; J. Tristan Barros; A. Banhudo CC63 "COLLISION TUMOURS"OF THE PANCREATIC BODY INCI- CC71 DENTALLY DIAGNOSED WITH ENDOSCOPIC ULTRASOUND ADULT INTUSSUSCEPTION CAUSED BY COLONIC MA- FINE NEEDLE ASPIRATION (EUS-FNA) - A CASE REPORT LIGNANT EXTRARENAL RHABDOID TUMOR: REPORT Giulia Gibiino, Italy; C. Fabbri; A. Fornelli; D. De Biase; OF A FIRST CASE S. Giovanelli; E. Jovine; A. Gasbarrini; V. Cennamo Su Jung Han, South Korea; Y. S. Cho; I.-K. Chung; Y. Jung; T. H. Lee; S.-H. Park; S.-J. Kim CC64 HEMOSUCCUS PANCREATICUS: RARE CAUSE OF GAS- CC72 TROINTESTINAL BLEEDING COLONIC NECROSIS INDUCED BY CALCIUM POLYSTY- Paula Sousa, Portugal; J. Rodrigues; J. Pinho; D. Martins; RENE SULFONATE R. Araújo; E. Cancela; A. Castanheira; P. Ministro; B. Helena Ribeiro, Portugal; C. Leitão; R. Azevedo; J. Pinto; Gonçalves; C. Daniel; J. Raposo; T. Carvalho; A. Silva A. Caldeira; J. Tristan Barros; E. Pereira; R. Sousa; A. Banhudo CC65 MALIGNANT HYPERCALCEMIA AS INITIAL MANIFESTA- Poster Session TION OF HEPATOCELLULAR CARCINOMA Marta Patita, Portugal; R. Barosa; G. Nunes; C. Fonseca 15:45 - 17:15 E-Poster Lounge 2 Exemplary clinical cases III

Tuesday, October 18, 2016 CC66 Chairs: D. Tiniakos, United Kingdom TUMOUR INDUCED HYPOGLYCAEMIA - BEYOND INSU- Y. van Herwaarden, The Netherlands LINOMA Pedro Marques Da Costa, Portugal; F. Tortosa; I. CC73 Fernandes; L. A. Correia; H. Cortez-Pinto; J. Velosa VON MEYENBURG COMPLEX ASSOCIATED WITH CIRRHOSIS IN A PATIENT WITH ASYMPTOMATIC ELE- Poster Session VATION OF CA 19-9 Rita Vale Rodrigues, Portugal; B. Pena; J. Pereira da 09:00 - 10:00 E-Poster Lounge 2 Silva; S. Ferreira; P. Lage; P. Chaves; A. Dias Pereira Exemplary clinical cases II Chair: M. Fox, Switzerland CC74 HEMOPHAGOCYTIC SYNDROME CAUSING ACUTE HEPA- CC67 TITIS - AN UNDERDIAGNOSED SEVERE DISEASE ASCENDING COLONIC VARICES - A RARE CAUSE OF Pedro Marques Da Costa, Portugal; M. V. Machado; C. MASSIVE GASTROINTESTINAL BLEEDING Baldaia; A. Valente; R. Palma; J. Velosa Mafalda Sousa, Portugal; I. Ribeiro; L. Proença; J. Silva; A. Ponte; J. P. Rodrigues; J. Carvalho CC75 A RARE CAUSE OF ACUTE LIVER FAILURE CC68 Sonia Bernardo, Portugal; S. Carvalhana; H. Cor- AN UNFORTUNATE COMBINATION OF A PRO-THROM- tez-Pinto; J. Velosa BOTIC AND OF A HEMORRHAGIC SYNDROME IN A YOUNG PATIENT: THERAPEUTIC DILEMMA CC76 Paula Sousa, Portugal; D. Martins; J. Pinho; C. Afonso; REMISSION OF MARGINAL ZONE LYMPHOMA AFTER HCV R. Araújo; E. Cancela; A. Castanheira; P. Ministro; ERADICATION WITH NEW DIRECT ANTIVIRAL AGENTS P. Amaral; A. Duran; J. Pereira; C. Constanço; B. P. Andrade; F. Principe; G. Macedo; Rui Gaspar, Portugal Gonçalves; P. Almeida; A. Silva CC77 CC69 FASCIOLA HEPATICA: A RARE CAUSE OF HODGKIN-LIKE PRIMARY RECTAL LYMPHOMA IN A Patrícia Santos, Portugal; P. Ferreira; T. Antunes; H. PATIETN WITH ULCERATIVE COLITIS ON 5-AMINO Cortez-Pinto; J. Velosa SALICYLIC ACID THERAPY Che-Yung Chao, Canada; A. Bitton

198 Poster in the Spotlight Poster of Excellence Clinical Case Session 199 Tuesday, October 18, 2016 Poster Sessions : UEG Week Final Programme

CC78 CC25 HEPATITIS B RE-ACTIVATION DURING HEPATITIS C WITHDRAWN TREATMENT WITH SOFSBUVIR Maria Pia Costa Santos, Portugal; R. Ferreira; J. Nunes; CC26 C. Palmela; M. Cravo ENDOSCOPIC PRESENTATION OF AMYLOIDOSIS Pedro Boal Carvalho, Portugal; S. Monteiro; J. CC79 Magalhães; M. J. Moreira; J. Cotter JAUNDICE IN A PREGNANT WOMAN: A CASE REPORT Sophiane Ibrahimi, Belgium; A. Mroue; E. Francois; R. CC27 Jagodzinski A SEVERE CASE OF MEDIAN ARCUATE LIGAMENT SYNDROME WITH SUBCLINICAL FORM AND SUCCESSFUL CC80 SURGICAL TREATMENT HEPATOCELLULAR CARCINOMA METASTASIS TO Gocha Barbakadze, Georgia; M. Kiladze; O. Kepuladze SPHENOID AND CAVERNOUS SINUS - AN UNEXPECTED CAUSE OF PTOSIS CC28 Rui Morais, Portugal; H. Cardoso; M. Silva; S. Rodrigues; SEVERE THROMBOCYTOPENIA IN A PATIENT WITH A. Albuquerque; R. Liberal; G. Macedo ISOLATED ESOPHAGEAL INVOLVEMENT OF CROHN'S DISEASE CC81 Yi Chu, China; H. Zhu; D. Liu SECONDARY BILIARY CIRRHOSIS CAUSED BY DIFFUSE BILIARY PAPILLOMATOSIS CC29 Inmaculada Ortiz, Spain; A. D. Polanco; P. Latorre; C. INTERSTICIAL PNEUMONIA DURING INFLIXIMAB Amurrio; A. Pascual; E. Moreno-Osset THERAPY FOR CROHN'S DISEASE: A CASE REPORT Diana Martins, Portugal; P. Sousa; J. Pinho; R. Araújo; E. Cancela; A. Castanheira; A. Silva; P. Ministro Poster Session 09:00 - 17:00 Hall X5 CC30 Clinical Cases: Upper and Lower GI A CASE OF SQUAMOUS CELL CARCINOMA AT THE ANAL CANAL RESECTED BY ENDOSCOPIC SUBMUCOSAL DISSECTION CC21 Mikako Sugimura, Japan; M. Iwabuchi; K. Ukai; K. EXTENSIVE ESOPHAGEAL HEMATOMA: A RARE COM- Tadokoro PLICATION OF SCLEROTHERAPY CC31 Marco Silva, Portugal; S. Lopes; A. Ribeiro; A. Peixoto; COMMON VARIABLE IMMUNODEFICIENCY DISORDER G. Macedo 2016 18, October Tuesday, DIAGNOSED TROUGH GASTROSCOPY REVEALING NOD- CC22 ULAR LYMPHOID HYPERPLASIA PRIMARY ASSESSED GASTRIC BLEEDING OF UNEXPECTED ORIGIN AS FAMILIAL ADENOMATOUS POLYPOSIS Angela Thiel, Germany; P. Fries; Y. J. Kim; S. Ezziddin; Anna Maria Pietrzak, Poland; A. Mroz; J. Pachlewski; B. Appenrodt; F. Lammert J. Regula CC23 CC32 AN EFFECTIVE APPLICATION OF THE MUCOSECTOMY WITHDRAWN USING ENDOSCOPIC SUBMUCOSAL DISSECTION FOR CC33 FOOD STAGNATION AFTER ESOPHAGECTOMY FOR RECURRENT GASTRIC ANISAKIASIS - ENDOSCOPIC ESOPHAGEAL CANCER AND ULTRASONOGRAPHIC FINDINGS Katsumi Yamamoto, Japan; H. Noro; Y. Sato; C. Son; A. Marta Patita, Portugal; L. Roque Ramos; R. Barosa; G. Kusakabe; H. Saiki; Y. Tokuda; N. Tatsumi; T. Michida; Nunes; P. Pinto-Marques T. Ito CC34 CC24 ESOPHAGEAL ULCER IN A YOUNG PATIENT - JUST THE ENDOSCOPIC REMOVAL OF AN ADJUSTABLE GASTRIC TIP OF THE ICEBERG? BAND COMPLETELY MIGRATED INTO THE GASTRIC Juliana Pinho, Portugal; J. Silva; D. Martins; P. Sousa; CAVITY E. Cancela; R. Araújo; R. Cardoso; A. Castanheira; A. Susana Chaves Marques, Portugal; J. Carmo; L. Carvalho; Silva; P. Ministro M. Bispo; C. Chagas

Poster in the Spotlight Poster of Excellence Clinical Case Session 199

UEG Week Final Programme : Poster Sessions Tuesday, October 18, 2016

CC35 CC39 A CASE OF A RARE INFECTIVE CAUSE OF OESOPHAGI- INDUCTION OF EOSINOPHILIC (EG) TIS COMPLICATING ACHALASIA IN AN IMMUNOCOM- WITH SEVERE EDEMA AND HYPOPROTEINEMIA AFTER PETENT PATIENT: ACTINOMYCOSIS. GASTROINTESTINAL ADENOVIRUS INFECTION Radha Gadhok, United Kingdom; R. Dor A. Nagel; A. F. Hagel; J. Bosch; C. Bechthold; R. Rieker; A. Missbichler; Martin Raithel, Germany CC36 A RARE CAUSE OF GASTROINTESTINAL HAEMOR- CC40 RHAGE IN A PATIENT WITH CREST SYNDROME AN UNUSUAL CAUSE OF AN OBSCURE GASTROINTES- Kanishka Bhattacharya, USA; J. Charpentier; N. Hosseini; TINAL BLEEDING IN THE SMALL BOWEL - SOMETIMES H. Malik; K. Bhattacharya CAPSULE ENDOSCOPY ONLY SHOWS "THE TIP OF THE ICEBERG" CC37 A. Stulz; W. Arnold; Patrick Roger Aepli, Switzerland THE BIRD'S BEAK: NOT ALWAYS ACHALASIA Rita Barosa, Portugal; M. Patita; G. Nunes; L. Roque Ramos; L. Novais; P. Pinto-Marques CC38 FATAL ADULT-ONSET HENOCH-SCHONLEIN PURPURA COMPLICATED WITH MASSIVE GASTROINTESTINAL HEMORRHAGE FROM DIFFUSE ULCERS: A CASE RE- PORT WITH AUTOPSY Melissa Llanto, Philippines; G. M. Silla Tuesday, October 18, 2016

We give your ideas green light! UEG provides a great collection of awards, fellowships and prizes to encourage research.

Find out more, visit www.ueg.eu/awards-grants

200 Poster in the Spotlight Poster of Excellence Clinical Case Session 201

16_08_Inserat_UEGWEEK_FP_awards_grants_136x62mm_RZ.indd 1 13.09.16 15:06 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

Poster Sessions by Day Wednesday, October 19, 2016

Posters in the Spotlight P1640 ª 09:00 – 10:00 E-Poster Lounge 1 PERFORMANCE OF THREE PROGNOSTIC RISK SCORES IN Risk factors for non-alcoholic fatty liver disease PREDICTING OUTCOMES IN ELDERLY NON-MALIGNANT Chairs: Helena Cortez-Pinto, Portugal PATIENTS AFTER PERCUTANEOUS GASTROSTOMY Elizabetta Bugianesi, Italy Ç. Kalkan; A. Ç. Kartal; Fatih Karakaya, Turkey; A. Tüzün; I. Soykan P1641 P1102 KNOWLEDGE, ATTITUDES AND EXPERIENCES OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE INTERNAL MEDICINE TRAINEES TOWARDS ENTERAL (LEAN-NAFLD): CHARACTERISTICS AND RISK FACTORS FEEDING TUBE: RESULTS FROM MULTICENTER SURVEY FROM A COMMUNITY COHORT FOLLOW UP STUDY OF CURRENT PRACTICE Madunil Anuk Niriella, Sri Lanka; S. T. De Silva; A. Taehyung Kwon, South Korea; Y. J. Lee; S.-E. Kim; J. Y. Kasturiratne; K. R. Perera; C. E. Subasinghe; S. K. Choi; D. K. Chang; E. R. Kim; J.-O. Kim; S. R. Jeon; E. Kodisinghe; C. Piyarathna; K. Vithiya; A. S. Dassanayake; Y. Kim; J.-S. Koo; S. J. Park; S.-J. Koh; Y. K. Cho; S.-K. A. P. De Silva; A. Pathmeswaran; R. Wickramasinghe; Park; J. Y. Yoon; C. H. Choi; H. S. Moon N. Kato; H. J. De Silva P1642 P1103 THIRTY-DAY MORTALITY AFTER PERCUTANEOUS GAS- NON-ALCOHOLIC FATTY LIVER DISEASE WITH AND TROSTOMY BY ENDOSCOPIC VERSUS RADIOLOGIC PLACE- WITHOUT METABOLIC SYNDROME: DIFFERENT PHENO- MENT: A SYSTEMATIC REVIEW AND META-ANALYSIS TYPES WITH DIFFERENT LONG-TERM OUTCOMES Joo Hyun Lim, South Korea; S. H. Choi; C. Lee; J. I. Aki Käräjämäki, Finland; R. Bloigu; H. Kauma; Y. A. Yang; J. S. Kim Kesäniemi; O.-P. Koivurova; J. Perkiömäki; H. Huikuri; O. Ukkola Posters in the Spotlight P1105 10:30 – 12:00 E-Poster Lounge 1 LOW SERUM MAGNESIUM CONCENTRATION IS INDE- Management of clostridium difficile infection PENDENTLY ASSOCIATED WITH NON ALCOHOLIC FATTY Chairs Mirjana Rajilic-Stojanovic, Serbia LIVER DISEASE AND NON ALCOHOLIC STEATOHEPATITIS Antonio Gasbarrini, Italy Ahad Eshraghian, Iran; S. Nikeghbalian; B. Geramizadeh; S. A. Malek-Hosseini P1106 P1450 GENES AND ENVIRONMENTAL FACTORS INVOLVEMENT PREDICTING TREATMENT FAILURE IN C.DIFFICILE INFEC- TION: A PROSPECTIVE OBSERVATIONAL COHORT STUDY IN DEVELOPMENT OF NAFLD Daniela Neagoe, Romania; G. Ianosi; A. Amzolini; M. Neerav Mukesh Joshi, United Kingdom; J. Goodhand; Popescu; A. Turculeanu; M. Ioana W. Alazawi; S. Das; M. Wilks; D. S. Rampton P1452 Posters in the Spotlight A HOSPITAL-BASED STUDY ON RISK FACTORS OF 09:00 – 10:00 E-Poster Lounge 2 RECURRENT CLOSTRIDIUM DIFFICILE ASSOCIATED Enteral feeding: Pros and cons DISEASE IN HONG KONG CHairs: Sibylle Koletzko, Germany Kai-Fung Tsang, Hong Kong, K. M. Ng; W. F. Luk; Y. W. Chan; C. P. Ho P1453 P1639 PLACEBO RESPONDERS IN A RANDOMISED CON- CT-GUIDED PERCUTANEOUS GASTROSTOMY/JEJUNOS- TROLLED TRIAL OF RBX2660 FOR RECURRENT C. TOMY FOR FEEDING AND DECOMPRESSION DIFFICILE INFECTION: PREDICTIVE VALUE OF 16S RRNA Heinz Albrecht, Germany; P. Schlechtweg; A. F. Hagel; MICROBIOME ANALYSIS T. Foertsch; M. F. Neurath; J. Mudter Courtney Jones, USA; B. Shannon Wednesday, October 19, 2016 19, October Wednesday,

Poster in the Spotlight Poster of Excellence Clinical Case Session 201

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1456 P1514 FECAL MICROBIOTA TRANSPLANTATION - AN OLD FIRST EXPERIENCE IN THE DEPLOYMENT OF HEMOSPRAY TOOL OPENING A NEW ERA IN THE TREATMENT OF AS SALVAGE THERAPY IN GASTROINTESTINAL BLEEDINGS CLOSTRIDIUM DIFFICILE INFECTION Martin Raithel, Germany; H. Albrecht; A. Nägel; F. Ana Ponte, Portugal; R. Pinho; M. Mota; J. Silva; J. P. Vitali; M. Vetter; C. Singer; M. F. Neurath; A. F. Hagel Rodrigues; M. Sousa; J. Carvalho P1515 P1457 APPRAISING AND IMPROVING JUNIOR DOCTORS MAN- FECAL MICROBIOTA TRANSPLANTATION FOR RECUR- AGEMENT OF ACUTE VARICEAL UPPER GI BLEEDS: A RENT CLOSTRIDIUM DIFFICILE INFECTION: TRANSPLANT QUALITY IMPROVEMENT PROJECT PROTOCOL BY ENEMA AND PRELIMINARY RESULTS Amera Elzubeir, United Kingdom C. Cicerone; G. Bruno; L. Lamonaca; Enrico Stefano Corazziari, Italy Poster Champ Session P1458 12:30 – 13:30 Hall X5: Terminal 1 FECAL MICROBIOTA TRANSPLANTATION VIA ENEMA Liver, biliary and pancreatic diseases FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION Chairs: Peter L. M. Jansen, The Netherlands MODULATES THE INFLAMMATORY HOST RESPONSE AND Marcis Leja, Latvia RESTORE INTESTINAL DYSBIOSIS C. Cicerone; G. Bruno; D. Alessandra; A. Oliva; G. Antonella; T. Valentina; V. Iebba; F. Pantanella; M. A. P1101 Zingaropoli; L. Lamonaca; V. Vullo; M. Trancassini; S. DONOR TM6SF2 RS58542926 GENOTYPE IS AN Schippa; Enrico Stefano Corazziari, Italy INDEPENDENT RISK FACTOR FOR DEVELOPMENT OF STEATOSIS AFTER LIVER TRANSPLANTATION Irena Hejlova, Czech Republic; M. Neroldova; J. Posters in the Spotlight Hubacek; D. Dlouha; L. Kolesar; M. Jirsa; E. Honsova; E. 10:30 – 12:00 E-Poster Lounge 2 Sticova; V. Lanska; J. Spicak; P. Trunecka Improving the clinical outcome in patients with upper GI bleeding P1109 Chair: Tomas Hucl, Czech Republic HIP FRACTURE RISK IN PEOPLE WITH ALCOHOLIC CIR- Marc Barthet, France RHOSIS COMPARED WITH THE GENERAL POPULATION: A POPULATION-BASED COHORT STUDY Harmony E. Otete, United Kingdom; T. Deleuran; K. P1510 Fleming; ; T. Card; G. P. Aithal; P. Jepsen; J. West EFFICACY AND SAFETY OF FERRIC CARBOXYMALTOSE IN THE MANAGEMENT OF IRON-DEFICIENCY ANEMIA IN P1110 PATIENTS WITH GASTROINTESTINAL AND LIVER DISEASE WITHDRAWN Marco Mendolaro, Italy; M. Cappello; A. Viola; M. G. P1144 Cilluffo; P. L. Almasio THE INFLUENCE OF FOOD INTAKE ON LIVER STIFFNESS P1511 MEASUREMENTS OBTAINED BY TWO 2D-SWE METHODS PEPTIC ULCER BLEEDING - DOES ETIOLOGY INFLUENCE Alina Popescu, Romania; R. Lupusoru; F. Bende; R. G. CLINICAL OUTCOME? Mare; R. L. D. Sirli; M. Danila; T. Moga; C. Pienar; I. Sporea Artur Gião G. Antunes, Portugal; A. Vaz; P. Queirós; T. P1185 Gago; J. Roseira; B. M. Santos Peixe; H. Guerreiro Wednesday, October 19, 2016 INTESTINAL FATTY ACID BINDING PROTEIN AS A MARK- P1512 ER OF NECROSIS AND SEVERITY IN ACUTE PANCREATITIS RISK OF PEPTIC ULCER BLEEDING ASSOCIATED WITH J. Kupcinskas; Rolandas Gedgaudas, Lithuania; H. Hartman; HELICOBACTER PYLORI INFECTION, NONSTEROIDAL T. Sippola; O. Lindström; C. Johnson; S. Regnér ANTI-INFLAMMATORY DRUGS, LOW-DOSE ASPIRIN IN P1191 PEPTIC ULCER DISEASE: A CASE-CONTROL STUDY A HUNGARIAN FAMILY WITH HEREDITARY PANCRE- H.-Y. Kim; Seung In Seo, South Korea; H. S. Kim; W. G. ATITIS AND THE P.L104P MUTATION IN THE HUMAN Shin; M. K. Jang; J. H. Lee CATIONIC TRYPSINOGENE GENE P1513 Balazs Nemeth, Hungary; A. V. Patai; M. Sahin-Toth; P. MEDICAL VERSUS COMBINED THERAPY OF PEPTIC Hegyi ULCERS WITH ADHERENT CLOTS Jaime P. Rodrigues, Portugal; C. Fernandes; T. Freitas; J. Silva; A. Ponte; M. Sousa; J. Carvalho

202 Poster in the Spotlight Poster of Excellence Clinical Case Session 203 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1193 P1215 CORRELATION BETWEEN THE DEGREE OF PANCREATIC TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS FIBROSIS AND PANCREATIC SECRETION OF BICAR- WITH ACUTE NON VARICEAL UPPER GASTRO INTES- BONATE IN PATIENTS WITH EARLY MORPHOLOGICAL TINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE CHANGES OF CHRONIC PANCREATITIS MULTICENTER OBSERVATIONAL STUDY Julio Iglesias-García, Spain; J. Lariño-Noia; L. Nieto; S. Riccardo Marmo, Italy; M. Soncini; R. Bennato; L. Orsini; Lojo; J. E. Domínguez-Muñoz L. Amitrano; F. Parente; S. Bargiggia; A. Paterlini; P. Cesaro; C. Bucci; A. Bizzotto; B. Germana'; L. G. Cavallaro; P1198 R. De Franchis; A. Dell'Era; G. Costamagna; M. E. Riccioni; DESIGNING OF A NOVEL STRATEGY FOR CANCER GENE C. Marmo; A. Tortora; M. Manno; S. Mangiafico; R. L. THERAPY BY SELECTIVE DELIVERY OF ADENOVIRUS- Conigliaro; G. Bresci; S. Metrangolo; A. Merighi; V. BASED TOXIN Boarino; S. Segato; M. Parravicini; L. Purita; A. Chirico; I. Boustanai; S. Shapira; D. Kazanov; Nadir Arber, Israel G. Imperiali; P. Gasparini; F. Esposito; F. R. De Filippo; P1200 G. Baldassarre; M. Franceschi; A. Nucci; F. De Nigris; CUX1 COOPERATES WITH K-RAS IN THE TUMOR PRO- L. Ferraris; A. Zambelli; C. Londoni; A. Repici; A. GRESSION OF PANCREATIC CANCER IN VIVO Anderloni; M. De Matthaeis; O. Triossi; M. A. Bianco; H. Griesmann; S. Mühl; K. Theuerkorn; B. Sipos; P. G. Rotondano; R. Lamanda; A. Lauri; A. De Fanis; P. Di Michl; Stefanie Gühne, Germany; Giorgio; R. Pumpo; L. Furio; A. Russo; A. Andriulli; G. Napolitano; L. M. Montalbano; F. Bazzoli; R. M. Zagari; P1204 E. Buscarini; L. Cipolletta; D. Conte; G. Spinzi; A. Balzano; A GLYCOPROTEIN AS A NOVEL SEROLOGICAL MARKER F. Cipolletta; E. Di Giulio; G. D'Amico FOR PANCREATIC CANCER Keisuke Taniuchi, Japan; T. Okabayashi; Y. Shima; T. P1216 Saibara PERORAL ENDOSCOPIC MYOTOMY FOR TREATING ACHALASIA PERFORMED BY A GASTROENTEROLOGIST: P1205 4 YEARS' EXPERIENCE FROM A SINGLE ENDOSCOPY THE ACTUAL INCIDENCE OF PANCREATIC CYSTIC NEO- CENTER PLASM RELATED SYMPTOMS: WE ARE OVERESTIMAT- X. Tang; Y. Ren; S. Huang; Q. Gao; Wei Gong, China ING A MAJOR INDICATION FOR SURGERY Stefano Andrianello, Italy; G. Marchegiani; C. Miatello; P1217 A. Pulvirenti; G. Perri; A. Borin; C. Dal Borgo; G. Malleo; PERORAL ENDOSCOPIC MYOTOMY IS SAFE AND EF- C. Bassi; R. Salvia FECTIVE FOR ACHALASIA IN PATIENTS OLDER THAN 60 YEARS OF AGE COMPARED WITH YOUNGER PATIENTS Poster Champ Session X. Tang; Y. Ren; S. Huang; Q. Gao; Wei Gong, China 12:30 – 13:30 Hall X5: Terminal 2 P1248 Surgery, endsocopy and imaging DO VISIBLE VESSELS WITHIN THE POST ENDOSCOPIC Chairs: Roger Leicester, United Kingdom MUCOSAL RESECTION (EMR) DEFECT PREDICT POST Siwan Thomas-Gibson, United Kingdom EMR BLEEDING? Lobke Desomer, Australia; D. J. Tate; F. Bahin; B. Holt; M. J. Bourke P1214 ENDOSCOPIC DUODENAL MUCOSAL RESURFACING P1249 TREATMENT FOR TYPE 2 DIABETES: EARLY MULTI- RANDOMIZED COMPARATIVE EVALUATION OF AN ESD CENTRE EXPERIENCE SELF-LEARNING SOFTWARE IN FRANCE AND JAPAN Annieke Van Baar, The Netherlands; J. Deviere; G. Mathieu Pioche, France; J. Rivory; T. Nishizawa; T. Costamagna; M. Passos Galvão Neto; L. Rodríguez; R. J. Uraoka; S. Touzet; M. O'brien; J. C. Saurin; A. Denis; T. Haidry; J. J. Bergman Ponchon; N. Yahagi P1250 COMPUTER-BASED AUTOMATIC DIFFERENTIATION OF NEOPLASTIC AND NON-NEOPLASTIC POLYPS WITH THE APPLICATION OF DEEP STRUCTURED LEARNING ALGORITHMS OF A CONVOLUTIONAL NEURAL NETWORK

- PRELIMINARY RESULTS 2016 19, October Wednesday, Laszlo Madacsy, Hungary; L. Oczella; M. Szalai; Z. Dubravcsik; A. Z. Szepes

Poster in the Spotlight Poster of Excellence Clinical Case Session 203

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1251 P1339 COLD SNARE POLYPECTOMY DOES NOT INCREASE THE CLINICAL CHARACTERISTICS OF INFLAMMATORY POSSIBILITY OF RESIDUAL POLYP: A PROSPECTIVE BOWEL DISEASE DIAGNOSED BEFORE OR AFTER OF SINGLE-ARM OBSERVATIONAL TRIAL PRIMARY SCLEROSING CHOLANGITIS (PSC): EFFECT ON Yoji Takeuchi, Japan; N. Matsuura; N. Uedo; T. Ito; T. PSC OUTCOME Yamashina; K. Aoi; T. Kanesaka; F. Matsui; M. Fujii; N. Alec Hellström, Finland; M. A. Färkkila Hanaoka; T. Akasaka; K. Higashino; R. Ishihara; H. Iishi P1364 P1284 PREGNANCY DOES NOT AFFECT FAECAL CALPROTEC- APPROPRIATENESS OF ANTIBIOTIC PROPHYLAXIS AND TIN CONCENTRATION IN HEALTHY PREGNANT WOMEN NOVEL RISK FACTORS FOR POST ERCP BACTEREMIA - Anita Balint, Hungary; A. Berényi; K. Farkas; É. Pallagi REAL LIFE EXPERIENCE OF A HIGH VOLUME CENTER Kunstár; Á. Altorjay; A. Csonka; M. Krizsán; M. Szucs; Liat Mlynarsky, Israel; S. Matalon; A. Phillips; A. A. Pál; R. Bor; A. Milassin; Á. Szulcsán; M. Rutka; Z. Melhem; M. Leshno; E. Santo Szepes; T. Molnar P1297 P1365 A PERSONALIZED TREATMENT OF GASTROINTESTI- CLINICAL PREDICTORS OF INTESTINAL BOWEL DAM- NAL STROMAL TUMORS IS ENABLED BY ANALYZING AGE AND DAMAGE PPROGRESSION ASSESSED BY THE ENDOSCOPIC ULTRASOUND-GUIDED BIOPSIES: A LÉMANN INDEX IN PATIENTS WITH CROHN'S DISEASE PROSPECTIVE, TEN-YEAR COHORT STUDY M. Pedaci; Gian Eugenio Tontini, Italy; L. Pescatori; S. Per Hedenström, Sweden; B. Nilsson; C. Andersson; A. Vavassori; L. Spina; L. Pastorelli; M. L. Annunziata; F. Demir; F. Enlund; O. Nilsson; R. Sadik Cavallaro; E. Filippi; F. Ambrogi; L. M. Sconfienza; M. Vecchi P1314 A COMPARATIVE STUDY OF FOUR MATERIALS FOR THE P1366 DEVELOPMENT OF NOVEL DUODENAL-JEJUNAL BYPASS A PILOT STUDY ASSESSING AGREEMENT AMONG NURSE LINER AND GASTROENTEROLOGIST IN COMPUTING IBD-CLIN- J. M. Lee; Hoon Jai Chun, South Korea; S. Y. Lee; B. ICAL SCORES K. Choi; I. K. Yoo; S. H. Kim; H. S. Choi; E. S. Kim; B. F. Mocciaro; Roberto Di Mitri, Italy; D. Scimeca; G. M. Keum; H. S. Lee; C. D. Kim Pecoraro; F. Bossa; G. Russo; G. Martino; D. Varvara; V. Costanza; A. Profita; C. Orlando; G. Profeta; F. Tinè P1315 EUS-GUIDED ENTERO-ANASTOMOSIS WITH LUMEN P1368 APPOSING METAL STENT: PRELIMINARY ASSESSMENT USEFULNESS OF CONSECUTIVE FECAL CALPROTECTIN OF INDICATIONS, EFFECTIVENESS AND SAFETY MEASUREMENTS TO PREDICT RELAPSE IN INFLAMMA- R. Sanchez-Ocana; Irene Peñas-Herrero, Spain; P. TORY BOWEL DISEASE PATIENTS UNDER MAINTENANCE Gil-Simon; C. De La Serna Higuera; M. Pérez-Miranda TREATMENT WITH ANTI-TNF DRUGS Rocio Ferreiro Iglesias, Spain; M. Barreiro-De Acosta; Poster Champ Session A. Lorenzo-González; J. E. Domínguez-Muñoz 12:30 – 13:30 Hall X5: Terminal 3 P1393 Lower gastrointestinal diseases CLINICAL EFFICACY OF THE TOLL LIKE RECEPTOR-9 AG- Chairs: Johan Burisch, Denmark ONIST COBITOLIMOD IN ANTI-TNF-ANTIBODY TREATED Giuseppe Chiarioni, Italy AND NAIVE PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS Wednesday, October 19, 2016 Raja Atreya, Germany; W. Reinisch; L. Peyrin-Biroulet; P1337 F. Scaldaferri; C. Admyre; T. Knittel; J. Kowalski; C. J. TWO NEW GENETIC MOUSE MODELS FOR ULCERATIVE Hawkey COLITIS BASED ON LATERAL TIGHT JUNCTION DISRUPTION Wolfgang Stremmel, Germany; S. Staffer; M. J. Schneider; P1394 H. Gan-Schreier; A. Wannhoff; N. C. Stuhrmann; A. COST-UTILITY OF BIOSIMILAR INFLIXIMAB FOR THE Gauss; H. Wolburg; A. Swidsinski; T. Efferth TREATMENT OF FISTULISING CROHN'S DISEASE IN NINE EUROPEAN COUNTRIES P1338 Petra Baji, Hungary; M. Pentek; V. Brodszky; L. Gulacsi; ROLE OF SLC26A3 (DRA) ION TRANSPORTER IN EN- F. Rencz; P. A. Golovics; K. B. Gecse; Z. Vegh; S. HANCING INTESTINAL EPITHELIAL BARRIER IN COLITIS Danese; P. Irving; P. L. Lakatos M. Li; D. Tian; X. Ding; Yu Qin, China

204 Poster in the Spotlight Poster of Excellence Clinical Case Session 205 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1395 P1549 BODY COMPOSITION PROFILE: A PREDICTOR OF THER- HOX GENE EXPRESSION IN BARRETT'S ESOPHAGUS RE- APEUTIC OUTCOME IN PATIENTS WITH MODERATE TO SEMBLES THAT OF THE COLON, CAN BE MODULATED BY SEVERE CROHN'S DISEASE ACID AND BILE EXPOSURE, AND INDUCES BARRETT'S Nik Sheng Ding, United Kingdom; G. Malitezis; P. F. SPECIFIC GENE PRODUCTS C. Lung; W. M. Yip; L. Penez; T. Ganeshanathan; S. M. Vincent T. Janmaat, The Netherlands; A. P. Verhaar; M. Gabe; I. Jenkins; A. L. Hart J. Bruno; M. C. W. Spaander; M. Peppelenbosch P1396 P1552 PLACENTAL MADCAM1 EXPRESSION - POTENTIAL CON- IMMUNOHISTOCHEMICAL BIOMARKERS FOR RISK SEQUENCES FOR THE TREATMENT WITH VEDOLIZUMAB STRATIFICATION OF NEOPLASTIC PROGRESSION IN DURING PREGNANCY BARRETT ESOPHAGUS: A SYSTEMATIC REVIEW AND Zuzana Zelinkova, Slovalia; K. Berakova; D. Podmanicky; META-ANALYSIS B. Kadleckova Vincent T. Janmaat; The Netherlands; S. H. Van Olphen; M. J. Bruno; K. Biermann; L. Looijenga; M. C. W. P1449 Spaander UNDISSOCIATED GELATINE TANNATE AND XYLOGLUCAN PREVENT GUT LEAKINESS AND MUCOSAL INFLAMMA- P1553 TION INDUCED BY LPS: INSIGHTS IN THE MECHANISM RADIOFREQUENCY ABLATION IN BARRETT'S ESOPH- OF ACTION AGUS : ARE THERE ANY FACTORS PREDICTING LONG Helene Eutamene, France TERM REMISSION OF INTESTINAL METAPLASIA? Joke Vliebergh, Belgium; M. Ferrante; P. H. Deprez; Poster Champ Session H. Willekens; D. De Looze; H. Orlent; E. Macken; P. 12:30 – 13:30 Hall X5: Terminal 4 Christiaens; F. Mana; G. De Hertogh; R. Bisschops Upper gastrointestinal diseases P1575 Chairs: Kalle Kurppa, Finland CHRONIC ATROPHIC GASTRITIS IN ITALY: A POPULA- Pradeep Bhandari, United Kingdom TION STUDY ON 10,000 PEOPLE Francesco Di Mario, Italy; S. Grillo; S. Landi; M. Franceschi; F. Baldassarre; R. Cannizzaro; N. Dal Bo'; P1509 A. Gnocchi; V. Corrente; A. Bertele; G. Grande; M. Rugge IMPAIRMENT IN ACTIVITY OF DAILY LIVING IS A RISK FACTOR FOR HIGH MEDICAL CARE COST IN PATIENTS P1595 WITH NON-VARICEAL UPPER GASTROINTESTINAL CLINICAL, HISTOPATHOLOGICAL, IMMUNOLOGICAL AND BLEEDING MICROBIOLOGICAL CHARACTERIZATION IN A COHORT Yusaku Takatori, Japan; M. Kato; Y. Hirai; Y. Sunata; OF PATIENTS OF TREATMENT-RESISTANT HELICO- Y. Kubosawa; K. Abe; T. Hirata; Y. Takada; S. Banno; BACTER PYLORI INFECTION S. Kinoshita; M. Wada; H. Mori; K. Takabayashi; M. Oddmund Andreas A. Nestegard, Norway; B. Moayeri; R. Goll; K. Osther; F.-A. Halvorsen; T. Tønnesen; S. W. Kikuchi; M. Kikuchi; M. Suzuki; T. Uraoka Sørbye; K. Melby; J. Florholmen P1527 EFFECT OF FAECAL MICROBIOTA TRANSPLANTATION ON P1617 THE SYMPTOMS AND DUODENAL ENTEROENDOCRINE HOW MUCH GLUTEN IS THE GENERAL POPULATION CELLS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME CONSUMING AND DOES IT RELATE TO SYMPTOMS? Tarek Mazzawi, Norway; G. A. Lied; M. El-Salhy; O. H. Matthew Kurien, United Kingdom; I. Aziz; N. Trott; D. Gilja; J. G. Hatlebakk; T. Hausken Brien; H. George; L. Marks; J. Richardson; R. Rigby; D. S. Sanders P1528 FUNCTIONAL HEARTBURN: A PILOT RANDOMIZED P1618 TRIAL COMPARING CITALOPRAM VS. AMITRIPTYLINE A SELF-ADMINISTERED BLIND GLUTEN CHALLENGE AS- AND NO TREATMENT SOCIATED TO AN ANDROID/IOS APPLICATION (TEST33®) Georgios Karamanolis, Greece; K. Denaxas; D. TO DIAGNOSE NON-CELIAC GLUTEN SENSITIVITY Kamberoglou; S. D. Ladas; G. Papatheodoridis Luca Elli, Italy; L. Roncoroni; C. Tomba; A. Catania; V. Lombardo; D. Conte; F. Branchi; F. Ferretti; M. T. Bardella Wednesday, October 19, 2016 19, October Wednesday,

Poster in the Spotlight Poster of Excellence Clinical Case Session 205

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

Metabolic/Genetic disorders P1108 CONTRIBUTION OF B-LYMPHOCYTE ACTIVATING Poster Session FACTOR TO INSULIN RESISTANCE IN PATIENTS WITH 09:00 - 14:00 Hall X4 NONALCOHOLIC STEATOHEPATITIS Liver and biliary III Takashi Himoto, Japan; K. Fujita; T. Nomura; J. Tani; A. Morishita; H. Yoneyama; T. Masaki P1101 DONOR TM6SF2 RS58542926 GENOTYPE IS AN Cirrhosis and complications: Clinical aspects INDEPENDENT RISK FACTOR FOR DEVELOPMENT OF STEATOSIS AFTER LIVER TRANSPLANTATION P1109 Irena Hejlova, Czech Republic; M. Neroldova; J. HIP FRACTURE RISK IN PEOPLE WITH ALCOHOLIC CIR- Hubacek; D. Dlouha; L. Kolesar; M. Jirsa; E. Honsova; E. RHOSIS COMPARED WITH THE GENERAL POPULATION: Sticova; V. Lanska; J. Spicak; P. Trunecka A POPULATION-BASED COHORT STUDY Harmony E. Otete, United Kingdom; T. Deleuran; K. P1102 Fleming; ; T. Card; G. P. Aithal; P. Jepsen; J. West LEAN NON-ALCOHOLIC FATTY LIVER DISEASE (LEAN-NAFLD): CHARACTERISTICS AND RISK FACTORS P1110 FROM A COMMUNITY COHORT FOLLOW UP STUDY WITHDRAWN Madunil Anuk Niriella, Sri Lanka; S. T. De Silva; A. P1111 Kasturiratne; K. R. Perera; C. E. Subasinghe; S. K. THE EFFECT OF SYNBIOTIC AND PROKINETIC ON IN- Kodisinghe; C. Piyarathna; K. Vithiya; A. S. Dassanayake; TESTINAL PERMEABILITY, ENDOTOXEMIA AND CHILD- A. P. De Silva; A. Pathmeswaran; R. Wickramasinghe; PUGH SCORE IN PATIENTS WITH LIVER CIRRHOSIS: A N. Kato; H. J. De Silva PROSPECTIVE COHORT STUDY P1103 Neringa Staikuniene, Lithuania; J. Valantinas; A. Pu- NON-ALCOHOLIC FATTY LIVER DISEASE WITH AND kalskas; R. Simoliuniene; D. Karciauskaite WITHOUT METABOLIC SYNDROME: DIFFERENT PHENO- P1112 TYPES WITH DIFFERENT LONG-TERM OUTCOMES CLIF-C AD SCORE WAS NOT CONSISTENTLY BETTER Aki J. Käräjämäki, Finland; R. Bloigu; H. Kauma; Y. A. THAN THE TRADITIONAL MODELS IN PREDICTING 30 Kesäniemi; O.-P. Koivurova; J. Perkiömäki; H. Huikuri; AND 90 DAY MORTALITY IN CIRRHOTIC PATIENTS WITH O. Ukkola ACUTE DECOMPENSATION WITHOUT ACLF P1104 Artur Gião G. Antunes, Portugal; C. Teixeira; A. Vaz; C. A NOVEL MUTATION OF APOB GENE ASSOCIATED WITH Martins; P. Queirós; B. M. Santos Peixe; A. Alves; A. P. NEUROLOGICAL MANIFESTATIONS IN FAMILIAL HYPO- Oliveira; H. Guerreiro BETALIPOPROTEINEMIA P1113 Joanna Musialik, Poland; A. Boguszewska-Chachulska; THE ROLE OF THE MEAN PLATELET VOLUME AS A A. Pojda-Wilczek; A. Gorzkowska; R. Szymanczak; M. PREDICTION MARKER FOR SPONTANEOUS BACTERIAL Kania; M. Hartleb; B. Blonska-Fajfrowska PERITONTIS P1105 Artur Gião G. Antunes, Portugal; C. Teixeira; A. Vaz; C. LOW SERUM MAGNESIUM CONCENTRATION IS INDE- Martins; P. Queirós; A. Alves; B. M. Santos Peixe; A. P. PENDENTLY ASSOCIATED WITH NON ALCOHOLIC FATTY Oliveira; H. Guerreiro LIVER DISEASE AND NON ALCOHOLIC STEATOHEPATITIS P1114 Wednesday, October 19, 2016 Ahad Eshraghian, Iran; S. Nikeghbalian; B. Geramizadeh; ASSESSMENT OF PROGNOSTIC SCORES IN ALCOHOLIC S. A. Malek-Hosseini HEPATITIS P1106 Artur Gião G. Antunes, Portugal; A. Vaz; P. Queirós; T. GENES AND ENVIRONMENTAL FACTORS INVOLVEMENT Gago; J. Roseira; B. M. Santos Peixe; H. Guerreiro IN DEVELOPMENT OF NAFLD P1115 Daniela Neagoe, Romania; G. Ianosi; A. Amzolini; M. PORTAL VEIN THROMBOSIS AND CIRRHOSIS PROGRES- Popescu; A. Turculeanu; M. Ioana SION: WHAT IS THE RELATION? P1107 Rita Barosa, Portugal; M. Patita; G. Nunes; C. Fonseca; ELEVATED AMINOTRANSFERASE LEVEL IS ASSOCIATED J. Freitas WITH LOW BONE MINERAL DENSITY IN KOREA USING DATA FROM NATIONWIDE SURVEY Myuengguen Oh, South Korea; M. A. Han

206 Poster in the Spotlight Poster of Excellence Clinical Case Session 207 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1116 Viral hepatitis: Basic aspects DIAGNOSTIC ACCURACY OF NON-INVASIVE TESTS FOR PREDICTING ESOPHAGEAL VARICES IN PATIENTS WITH P1124 HCV-RELATED CIRRHOSIS CLINICAL PROFILE OF PATIENTS WITH HEPATITIS E J. T. Correia-Sousa; Marta L. Rocha, Portugal; C. Vegiraju V S Vijayanand Kumar, India; V. L; J. Gonçalves; M. Souto-Moura; J. Mendez; J. M. Ferreira; Krishnaveni; N. Mohandas; M. S; K. Murthy; A. T. Moreira; R. Sarmento-Castro; I. Pedroto Kulkarni; S. R. Dharamsi P1117 P1125 SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC KERATIN VARIANTS ASSOTIATED WITH LIVER DISEASE PATIENTS UNDER SECONDARY ANTIBIOTIC PROPHYLAXIS CAUSED BY HBV IN CHINESE PATIENTS Catarina Atalaia Martins, Portugal; P. Marcos; S. Junzhao Ye, China; W. Yanqin; M. Li; X. Gong; B. Zhong Barbeiro; F. Silva; M. Canhoto; L. Eliseu; A. Santos; C. P1126 Gonçalves; I. Cotrim; H. Vasconcelos ASSOCIATION OF INTERLEUKIN 28B SINGLE NUCLEOTIDE P1118 POLYMORPHISMS WITH THE SUSCPTIBILITY OF HEPA- STUDY OF PRURITUS IN CHRONIC LIVER DISEASES TITIS C VIRUS INFECTION IN EGYPTIAN POPULATION. A Kojiro Michitaka, Japan; H. Yamago; M. Kanetoh; H. MULTICENTRE FAMILY BASED ASSOCIATION STUDY Tomida; Y. Miyamoto; A. Hiraoka; R. Iwasaki; T. Ninomiya Mahmoud El-Bendary, Egypt; M. Neamattallah; G. Esmat; H. Elalfy; T. Besheer; E. Kamel; M. Shabaan; P1119 M. Abd El-Hafeez; K. Farid; A. Zedan; A.-H. Eladl; M. EVALUATION OF SERUM ZINC LEVEL IN PATIENTS El-Setouhy WITH LIVER CIRRHOSIS IN DUHOK GOVERNORATE B. A. Qasim; A. Salih; M. Habibe; Laween S. Aldohuky, Viral hepatitis B: Clinical aspects Iraq; R. F. Abduljaqbbar P1127 P1120 SERUM AUTOTAXIN CAN PREDICT LIVER FIBROSIS IN PREDICTING OUTCOME IN ACUTE-ON-CHRONIC LIVER PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION FAILURE USING ERYTHROPOIETIN LEVELS Yuki Ichikawa, Japan; S. Joshita; T. Umemura; A. Mat- Tamara Alempijevic, Serbia; S. Zec; V. Nikolic; A. sumoto; E. Tanaka Veljkovic; V. Matovic; S. Stankovic; V. Dopsaj P1128 P1121 A PROSPECTIVE STUDY ON THERAPEUTIC EFFECTS OF SUBCLINICAL HYPOTHYROIDISM MAY BE AN INDEPEN- SEQUENTIAL THERAPY IN PATIENTS WITH CHRONIC DENT RISK FACTOR FOR LIVER DECOMPENSATION IN HEPATITIS B RESPONDING TO NUCLEOSIDE ANALOGUES CIRRHOTIC PATIENTS Atsunori Kusakabe, Japan; E. Orito; H. Kanie; S. Shimizu; Francesca D'Errico, Italy; G. Losurdo; N. M. Castellaneta; T. Yamada; K. Hayashi; T. Nakazawa A. Mongelli; A. Iannone; M. Barone; M. Principi; E. G. Ierardi; A. Di Leo P1129 MAY "GILBERT'S-LIKE" SYNDROM BE PART OF SPEC- P1122 TRUM OF PERSISTENT UNCONJUGATED HYPERBILIRU- IN SEARCH OF THE BEST PROGNOSTIC MODEL IN BINEMIA IN POST-HEPATITIS PATIENT? DECOMPENSATED CIRRHOSIS: WHAT IS THE VALUE OF Rong Lin, China; J. Ye; O. Banafa C-REACTIVE PROTEIN? Paula Sousa, Portugal; J. Pinho; D. Martins; J. P1130 Fernandes; R. Araújo; E. Cancela; A. Castanheira; P. DIABETES MELLITUS AND NOT HEPATIC STEATOSIS Ministro; A. Silva ALONE INCREASE THE RISK OF ADVERSE EVENTS IN PATIENTS WITH CHRONIC HEPATITIS B P1123 Rajneesh Kumar, Singapore; W. Q. Leow; K. H. Lim; W. ACUTE-ON-CHRONIC LIVER FAILURE - A DYNAMIC K. Wan; W. C. Chow; G. B. B. Goh SYNDROME Mariana F. Cardoso, Portugal; G. Alexandrino; J. Branco; V. Anapaz; R. Carvalho; D. Horta; A. Martins; J. Reis Wednesday, October 19, 2016 19, October Wednesday,

Poster in the Spotlight Poster of Excellence Clinical Case Session 207

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

Viral hepatitis C: Clinical aspects Immunology, autoimmune liver disease P1131 P1139 EARLY DECREASE OF LIVER STIFFNESS AFTER INITI- SHEAR WAVE ELASTOGRAPHY OF THE LIVER AND ATION OF ANTIVIRAL THERAPY IN PATIENTS WITH SPLEEN IN PATIENTS WITH AUTOIMMUNE HEPATITIS CHRONIC HEPATITIS C INDICATES THAT LOWER CUT-OFF AND ITS VARIANTS – A SINGLE CENTRE STUDY VALUES FOR LIVER STIFFNESS ARE APPROPRIATE FOR Maciej K. Janik, Poland; B. Kruk; K. Kostrzewa; M. MONITORING LIVER FIBROSIS AFTER INITIATION OF Krawczyk; J. Raszeja-Wyszomirska; P. Milkiewicz ANTIVIRAL TREATMENT Stephan Moser, Austria; E. Gutic; M. Gschwantler P1140 IS THERE ANY PROGNOSTIC IMPACT OF EXTRA-HE- P1132 PATIC SYSTEMIC CONDITIONS IN PRIMARY BILIARY REAL LIFE EXPERIENCE WITH DIRECT ACTING ANTI-VI- CHOLANGITIS? RALS IN THE MANAGEMENT OF HCV PATIENTS WITH Marta Gravito-Soares, Portugal; V. Silva; E. Gravito-Soares; REDUCED FUNCTIONAL HEPATIC RESERVE S. Lopes; D. Gomes; C. Agostinho; P. Figueiredo; L. Amr S. Hanafy, Egypt Tomé; C. Sofia P1133 P1141 FEASIBILITY OF ELASTOGRAPHIC METHODS IN AS- EFFECT OF FIBRATE-ADD-ON TREATMENT IN PRIMARY SESSING SPLEEN STIFFNESS IN PATIENTS WITH HCV BILIARY CHOLANGITIS PATIENTS WITH AN INSUFFI- COMPENSATED LIVER CIRRHOSIS CIENT RESPONSE TO URSODEOXYCHOLIC ACID (UDCA) Ana-Maria Stepan, Romania; M. Danila; R. L. D. Sirli; Clarissa Weber-Freissmuth, Austria; K. Kozbial; A. F. A. Popescu; R. G. Mare; F. Bende; A. Pascaru; I. Sporea Staettermayer; S. Beinhardt; R. Stern; P. Ferenci; M. Trauner; H. Hofer P1134 DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS P1142 C GENOTYPE 3: A SYSTEMATIC REVIEW AND NETWORK SERONEGATIVE PRIMARY BILIARY CHOLANGITIS: A META-ANALYSIS DISTINCT ENTITY? Floor A. C. Berden, The Netherlands; B. R. Aaldering; Marta Gravito-Soares, Portugal; E. Gravito-Soares; S. H. Groenewoud; J. Inthout; W. Kievit; J. Drenth Lopes; C. Agostinho; P. Figueiredo; D. Gomes; L. Tomé; C. Sofia P1135 EFFECT OF HEPATITIS C TREATMENT WITH DIRECT-ACT- P1143 ING ANTIVIRALS ON VITAMIN D IS DEPENDENT ON CARDIOVASCULAR RISK ASSESSMENT IN PRIMARY SEASONALITY BILIARY CHOLANGITIS: A SYSTEMIC DISEASE? Mário Jorge Silva, Portugal; P. Russo; C. Bernardes; V. Elisa Soares, Portugal; M. Gravito-Soares; S. Lopes; C. Borges; R. Vasconcelos Loureiro; T. Capela; F. Calinas Agostinho; P. Figueiredo; D. Gomes; L. Tomé; C. Sofia P1136 Imaging, radiology (incl. interventional radiology) FERROKINETICS, CALCIUM, VITAMIN D2 AND RED BLOOD CELL INDICES, DO THEY PREDICT CIRRHOSIS P1144 ON LIVER BIOPSY AND NON-RESPONSE TO ANTIVIRAL THE INFLUENCE OF FOOD INTAKE ON LIVER STIFFNESS TREATMENT IN CHRONIC HEPATITIS C? MEASUREMENTS OBTAINED BY TWO 2D-SWE METHODS Ragesh Babu Thandassery, Qatar; H. Wani; M. E. Soofi; Alina Popescu, Romania; R. Lupusoru; F. Bende; R. G. S. R. Al-Kaabi Mare; R. L. D. Sirli; M. Danila; T. Moga; C. Pienar; I. Wednesday, October 19, 2016 Sporea P1137 REAL-LIFE SIDE EFFECTS OF INTERFERON-FREE P1145 THERAPY (OMBITASVIR / PARITAPREVIR / RITONAVIR + CORRELATION OF LIVER STIFFNESS MEASUREMENT ON DASABUVIR +RIBAVIRIN) AND END OF TREATMENT RE- TRANSIENT ELASTOGRAPHY WITH INCIDENCE OF HYPO- SULTS IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS VASCULAR HYPOINTENSE NODULE ON GADOXETIC ACID- R. L. D. Sirli; A. Lazar; A. Deleanu; I. Dan; Alina ENHANCED MRI IN PATIENTS WITH HEPATITIS B VIRUS Popescu, Romania; M. Danila; I. Sporea Jeong Ah Hwang, South Korea; T. W. Kang P1138 P1146 DISTURBANCES OF VITAMIN D-PARATHYROID HOR- THE PERFORMANCE OF 2D-SWE.GE COMPARED TO MONE AXIS IN HEPATITIS C VIRUS INFECTED PATIENTS TRANSIENT ELASTOGRAPHY FOR THE EVALUATION OF Jung-Chun Lin, Taiwan; T.-Y. Hsieh; Y.-C. Tseng; T.-H. LIVER STIFFNESS Chueh; Y.-L. Shih; H.-H. Lin Ioan Sporea, Romania; F. Bende; R. L. D. Sirli; A. Popescu; M. Danila; R. G. Mare; R. Lupusoru; A.-M. Stepan

208 Poster in the Spotlight Poster of Excellence Clinical Case Session 209 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1147 P1155 INFLUENCING FACTORS ASSOCIATED WITH DIAGNOSTIC TARGETING ALDEHYDE DEHYDROGENASE 2 : NEW ACCURACY OF REAL-TIME SHEAR WAVE ELASTOGRAPHY THERAPEUTIC POTENTIAL FOR PREVENTION OF IN CHRONIC HEPATITIS B PATIENTS WITH LIVER FIBROSIS NONALCOHOLIC STEATOHEPATITIS-RELATED LIVER Junzhao Ye, China; W. Wei; Y. Wang; W. Yanqin; L. CARCINOGENESIS? Bing; B. Zhong Bossng Kang, South Korea; C.-Y. Bang; S.-Y. Choung P1148 Liver neoplasia: Clinical TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT - EIGHT YEARS OF EXPERIENCE OF A PORTU- P1156 GUESE CENTER PROGNOSTIC ROLE OF 25-HYDROXYVITAMIN D IN PA- Irina Mocanu, Portugal; J. Branco; M. Correia; T. Cape- TIENTS WITH LIVER METASTASES FROM COLORECTAL la; T. Bilhim; É. Coimbra CANCER TREATED WITH RADIOFREQUENCY ABLATION Antonio Facciorusso, Italy; N. Crucinio; M. Di Maso; N. Liver neoplasia: Basic Muscatiello P1149 P1157 SERPINB3 MAY AFFECT LIVER CANCER PROGRESSION ROLE OF MIR-122 EXPRESSION IN EVALUATION OF PROG- BY DIFFERENTLY REGULATING HYPOXIA INDUCIBLE NOSIS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA FACTORS -1A AND -2A M. Franck; K. Schuette; P. Malfertheiner; Alexander Beatrice Foglia, Italy; S. Cannito; G. Villano; C. Turato; Link, Germany E. Morello; E. Novo; S. M. Quarta; S. Colombatto; F. Lopitz Otsoa; M. L. Martinez-Chantar; T. Cardoso; P. P1158 Pontisso; M. Parola SORAFENIB IN CLINICAL PRACTICE: POOLED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES IN P1150 HEPATOCELLULAR CARCINOMA (HCC) P53 TRANSCRIPTION FACTORS CONTROL APOPTOSIS G.G. Di Costanzo; Rodolfo Cosma Damiano Sacco, Italy; SUSCEPTIBILITY BY REGULATION OF MCL1 S. D'Angelo; T. Zolfino; V. Lorusso; V. Montesarchio; G. Sophie Schlosser, Germany; S. Frister; M. Meinhard; De Stefano; A. F. Attili; A. Benedetti; D. Sansonno; L. A. Pelc; C. Kunst; E. Aschenbrenner; K. Pollinger; M. Giannitrapani; A. Buonadonna; P. Giovanis; G. Cabibbo; Müller F. De Vita; P. Carucci; M. Pirisi; M. Moscovici; S. Pisconti; B. Daniele P1151 BRG1 PROMOTES HEPATOCARCINOGENESIS BY MODU- P1159 LATING CYCLINB1, D1, E1 AND MATRIX METALLOPRO- IMPROVING SURVIVAL OF PATIENTS WITH HEPATO- TEINASE 7 CELLULAR CARCINOMA BETWEEN 2005 AND 2012 IN Benedikt Kaufmann, Germany; M. Lu; N. Hüser; H. THE FINISTERE AREA Friess; G. Von Figura; D. Hartmann M. Calament; M. Cariou; ; A. Billot-Grasset; F. Tanne; Michel Robaszkiewicz, France; J.-B. Nousbaum P1152 PROTEIN KINASE CK2 REGULATES ONCOGENIC PROP- P1160 ERTIES OF CHOLANGIOCARCINOMA CELLS SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA A. Gentilini; G. Di Maira; E. Rovida; D. Ottaviani; M. (HCC) : A CLINICAL AUDIT Ruzzene; Fabio Marra, Italy Asma Abdul-Sattar, United Kingdom; C. Ch'Ng P1153 P1161 ONCOSTATIN M INDUCES INCREASED INVASIVENESS IN VIRTUAL PALPATION MODEL BASED ON SPIRAL CT HEPATIC CANCER CELLS THROUGH HIF1?-RELATED RE- AND ELASTOGRAPHY DATA - PROOF OF CONCEPT LEASE OF VASCULAR ENDOTHELIAL GROWTH FACTOR A Costin Teodor Streba, Romania; I.A. Gheonea; L. Stefania Cannito, Italy; E. Morello; B. Foglia; C. Turato; Sandulescu; A. Saftoiu; D.-I. Gheonea G. Di Maira; E. Novo; S. Colombatto; P. Pontisso; F. Marra; M. Parola P1162 DIAGNOSTIC PERFORMANCE OF PIVKAII AND NEW PO- P1154 TENTIAL SERUM BIOMARKERS GP3, CSTB, SCCA1 AND METFORMIN AND SORAFENIB SYNERGISTICALLY HGF FOR DIAGNOSIS OF HEPATOCELLULAR CARCINO- INDUCE CELL SENESCENCE IN HEPATOCELLULAR CARCI- MA IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS 2016 19, October Wednesday, NOMA CELLS A. Unic; L. Derek; M. Duvnjak; L. Patrlj; M. Rakic; M. Chun-Ying Wu, Taiwan; H.-P. Chen; J.-T. Lin Kujundzic; V. Renjic; P. Dinjar; T. Bokun; Ivica Grgurevic, Croatia

Poster in the Spotlight Poster of Excellence Clinical Case Session 209

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

Cholestasis and gallstones: Clinical P1172 A PROSPECTIVE STUDY OF THE CLINICAL EFFICACY AND P1163 EFFECT OF PHOTODYNAMIC THERAPY FOR THE TREAT- MIRIZZI SYNDROME: HOW TO MANAGE MENT OF UNRESECTABLE EXTRAHEPATIC CHOLANGIO- Ehab El Hanafy, Egypt CARCINOMA P1164 Jianfeng Yang, China; X. Zhang; H. Jin; H. Shen; Q. Lou ENDOSCOPIC ULTRASOUND-GUIDED GALLBLADDER P1173 DRAINAGE VERSUS ENDOSCOPIC TRANSPAPILLARY PREOPERATIVE ENDOSCOPIC BILIARY DRAINAGE PRO- GALLBLADDER DRAINAGE FOR ACUTE CHOLECYSTITIS CEDURES MAY AFFECT INTRAHEPATIC RECURRENCE OF IN HIGH RISK SURGICAL PATIENTS: WHICH IS BETTER? CHOLANGIOCARCINOMA AFTER SURGICAL RESECTION Dong-Wook Oh, South Korea; S. S. Lee; D. H. Cho; T. J. Young Deok Cho, South Korea; H. J. Choi; T. H. Lee; S.- Song; D. H. Park; D.-W. Seo; S. K. Lee; M.-H. Kim H. Park; S.-W. Cha; J. H. Moon P1165 P1174 BILE DUCT STONES RECURRENCE AFTER ESWL IN THE CONTRAST-ENHANCED ULTRASONOGRAPHY OF GALL- ELDERLY: PREDICTIVE FACTORS BLADDER POLYPOID LESIONS Daniele Mandolesi, Italy; R. Muratori; C. Pierantoni; D. Masashi Hattori, Japan; I. Matuzaki; S. Isobe; K. Hirose; Festi; G. Mazzella; F. Bazzoli; F. Azzarol C. Izumi; T. Marukawa; M. Esaki; S. Nakazawa P1166 P1175 PROCHOLESTATIC GENE VARIANTS AND MUTATIONS IN FACTORS ASSOCIATED WITH TECHNICAL SUCCESS OF SECONDARY SCLEROSING CHOLANGITIS IN CRITICALLY BILATERAL ENDOSCOPIC METALLIC STENTING WITH ILL PATIENTS (SC-CIP) PARTIAL STENT-IN-STENT PLACEMENT IN PATIENTS Christoph Jüngst, Germany; M. Reichert; V. Zimmer; F. WITH MALIGNANT HILAR BILIARY OBSTRUCTION Grünhage; F. Lammert; M. Krawczyk Toshihiro Fujita, Japan; S. Hashimoto; T. Sakae; H. P1167 Hamamoto; H. Yano; H. Maeda; M. Hokonohara; K. Predictors For Detection Of Difficult-To-Treat Bacteria Kawabata; S. Arima; Y. Nasu; F. Sasaki; H. Taguchi; S. In Biliary Tract Infection Kanmura; H. Setoyama; A. Ido Naoki Esaka, Japan; B. Endoh; Y. Mizumoto; S. P1176 Katsushima; N. Shime ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAINAGE P1168 FOR BENIGN BILIARY STRICTURE AND PREOPERATIVE A NOVEL NITINOL GALLBLADDER STENT FOR PREVEN- BILIARY DRAINAGE TION OF STONE MIGRATION AND IMPACTION Kurita Yusuke, Japan; T. Sato; A. Iwasaki; K. Kagawa; K. F. Konikoff;Ivo Boskoski, Italy; S. Ben Muvhar; A. Hosono; A. Nakajima; K. Kubota Tringali; J. Tsehori; G. Costamagna P1177 P1169 STENT PATENCY IN ENDOSCOPIC ULTRASOUND GUIDED RELATIONSHIP BETWEEN GALLBLADDER STONE AND TRANSMURAL VERSUS TRANSPAPILLARY BILIARY CARDIOVASCULAR DISEASE RISK DRAINAGE Elif Borekci, Turkey; M. Celikbilek Amol Bapaye, India; R. Gaadhe; N. A. Dubale; H. Gadhikar; M. Mahadik; R. Pujari; J. A. Bapaye P1170 LAPAROENDOSCOPIC RENDEZVOUS FOR TREATING P1178 Wednesday, October 19, 2016 CHOLELITHIASIS WITH CONCOMITANT CHOLEDOCHOLI- CLINICOPATHOLOGIC STUDY OF BILIARY INTRAEPITHE- THIASIS UNSUITABLE FOR LCBDE LIAL NEOPLASIA IN CHOLANGIOCARCINOMA C. Dai; X. Wang; L. Liu; M. Wang; Zhining Fan, China Jae Seon Kim, South Korea; H. J. Kim; M. K. Joo; B. J. Lee; J.-J. Park; Y.-T. Bak; B.-H. Kim Biliary neoplasia: Clinical P1179 P1171 CLINICAL OUTCOME OF STENT-IN-STENT METHOD IN CLINICAL IMPACT OF PER-ORAL DIGITAL CHOLANGIOS- BILATERAL SELF-EXPANDABLE METALLIC STENT DE- COPY (SPYGLASS) - A SINGLE CENTER EXPERIENCE PLOYMENT FOR MALIGNANT HILAR BILIARY OBSTRUC- Rastislav Hustak, Slovakia; J. Usak; F. Zavada; J. Martinek TION: TWO-CENTER RETROSPECTIVE STUDY Hee Seung Lee, South Korea; J. Y. Heo; S. Bang

210 Poster in the Spotlight Poster of Excellence Clinical Case Session 211 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

Pancreatitis, experimental P1187 INFLUENCE OF FATTY LIVER ON THE CLINICAL OUT- Poster Session COME IN ACUTE PANCREATITIS 09:00 - 14:00 Hall X4 Ivana Mikolasevic, Croatia; L. Orlic; D. Stimac; I. Jakopcic; Pancreas III A. Klanac; S. Milic P1180 P1188 EVIDENCE OF HGF DEPENDED BONE MARROW DE- WITHDRAWN RIVED STEM CELLS MOBILIZATION IN ACUTE PANCRE- P1189 ATITIS - A POTENTIAL LINK WITH REGENERATION? FAT GLOBULES WITHIN ORGANIZED PANCREATIC FLU- Krzysztof Dabkowski, Poland; E. Zuba-Surma; A. ID COLLECTIONS ON CT SCAN IMPACT THE OUTCOMES Labedz-Maslowska; M. Budkowska; D. Salata; B. OF NONSURGICAL DRAINAGE Dolegowska; M. Z. Ratajczak; T. Starzynska Ayesha Kamal, USA; A. Zaheer; S. Ngamruengphong; P1181 R. Moran; Y. H. Chavez; M. Bukhari; M. Khashab; V. PROTECTIVE EFFECT OF CHEMERIN IN ACUTE PANCRE- Kumbhari; E. Akhuemonkhan; V. S. Akshintala; A. N. ATITIS. STUDY ON THE RAT Kalloo; V. Singh J. Jaworek; J. Szklarczyk; M. Kot; U. Czech; M. Goralska; P1190 Anna Leja-Szpak, Poland; R. Tomaszewska THE ROLE OF SOLUBLE UROKINASE PLASMINOGEN P1182 ACTIVATOR RECEPTOR AS AN EARLY BIOMARKER OF DEVELOPMENT OF ACUTE PANCREATITIS PORCINE SEVERITY AND ORGAN FAILURE IN PATIENTS WITH MODEL BY USING ENDOSCOPIC RETROGRADE NOXIOUS ACUTE PANCREATITIS AGENT INFUSION Amir Soleimani, Denmark; L. T. Sørensen; M. B. Jin-Seok Park, South Korea; S. Jeong; D. H. Lee Hansen; S. Ladelund; J. Eugen-Olsen; L. N. Jorgensen; S. Novovic P1183 ACENOCOUMAROL ACCELERATES RECOVERY IN ISCH- Pancreatitis, chronic (including hereditary disorders) EMIA/REPERFUSION-INDUCED ACUTE PANCREATITIS Zygmunt Warzecha, Poland; P. Sendur; P. Ceranowicz; P1191 J. Cieszkowski; M. Dembinski; B. Kusnierz-Cabala; J. A HUNGARIAN FAMILY WITH HEREDITARY PANCRE- Bonior; J. Jaworek; R. Tomaszewska; A. Dembinski ATITIS AND THE P.L104P MUTATION IN THE HUMAN CATIONIC TRYPSINOGENE GENE P1184 Balazs Nemeth, Hungary; A. V. Patai; M. Sahin-Toth; PROTECTIVE MECHANISMS OF N-ACETYL-CYSTEINE P. Hegyi AND SIMVASTATIN AGAINST CHRONIC PANCREATITIS: AN EXPERIMENTAL STUDY IN MICE P1192 J. M. Lee; Hongsik Lee, South Korea; J. J. Hyun; S. Y. DIAGNOSIS OF AUTOIMMUNE PANCREATITIS USING Lee; B. K. Choi; I. K. Yoo; S. H. Kim; H. S. Choi; E. S. ENDOSCOPIC ULTRASOUND GUIDED PANCREATIC CORE Kim; B. Keum; Y. T. Jeen; H. J. Chun; C. D. Kim BIOPSY WITH PROCORE® NEEDLE Dong-Wook Oh, South Korea; S. S. Lee; D. H. Cho; T. J. Pancreatitis, acute Song; D. H. Park; D.-W. Seo; S. K. Lee; M.-H. Kim P1185 P1193 INTESTINAL FATTY ACID BINDING PROTEIN AS A CORRELATION BETWEEN THE DEGREE OF PANCREATIC MARKER OF NECROSIS AND SEVERITY IN ACUTE FIBROSIS AND PANCREATIC SECRETION OF BICAR- PANCREATITIS BONATE IN PATIENTS WITH EARLY MORPHOLOGICAL J. Kupcinskas; Rolandas Gedgaudas, Lithuania; H. CHANGES OF CHRONIC PANCREATITIS Hartman; T. Sippola; O. Lindström; C. Johnson; S. Regnér Julio Iglesias-García, Spain; J. Lariño-Noia; L. Nieto; S. Lojo; J. E. Domínguez-Muñoz P1186 COMPARING HAPS AND BISAP SCORES IN PREDICTING P1194 SEVERITY AND OUTCOME IN ACUTE PANCREATITIS ACCURACY OF DIFFERENT NEEDLES TO OBTAIN Amit Yelsangikar, India; P. Kakkadasam Ramaswamy; HISTOLOGICAL SAMPLES FROM HEALTHY PANCREATIC A. Nagar Krishnamurthy; N. Bhat TISSUE. A COMPARATIVE EXPERIMENTAL STUDY ON HEALTHY PIGS 2016 19, October Wednesday, Julio Iglesias-García, Spain; A. García-Cantalapiedra; I. Abdulkader; O. Varela-López; J. E. Domínguez-Muñoz

Poster in the Spotlight Poster of Excellence Clinical Case Session 211

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1195 Pancreatic cancer: Clinical TREATMENT OF PANCREATIC STONES BY ESWL AND EN- DOSCOPY-OUR EXPERIENCE OF 618 CASES IN 26 YEARS P1204 Tadao Tsuji, Japan A GLYCOPROTEIN AS A NOVEL SEROLOGICAL MARKER FOR PANCREATIC CANCER P1196 Keisuke Taniuchi, Japan; T. Okabayashi; Y. Shima; T. PREVALENCE OF SARCOPENIA IN CHRONIC PANCREATITIS Saibara Imanta Ozola Zalite, Latvia; V. Lyadov; J. Ivanova; A. Viksna; A. Udre; A. Pukitis P1205 THE ACTUAL INCIDENCE OF PANCREATIC CYSTIC NEO- P1197 PLASM RELATED SYMPTOMS: WE ARE OVERESTIMAT- COMPARISON BETWEEN ENDOSCOPIC AND SURGICAL ING A MAJOR INDICATION FOR SURGERY DRAINAGE OF THE PANCREATIC DUCT IN CHRONIC Stefano Andrianello, Italy; G. Marchegiani; C. Miatello; PANCREATITIS A. Pulvirenti; G. Perri; A. Borin; C. Dal Borgo; G. Malleo; Yoshiaki Kawaguchi, Japan; T. Mine C. Bassi; R. Salvia P1206 Pancreatic cancer: Basic DIGITAL SINGLE OPERATOR PANCREATOSCOPE (DSOP) IN P1198 PANCREATIC INTRAPAPILLARY MUCINOUS NEOPLASIA DESIGNING OF A NOVEL STRATEGY FOR CANCER GENE (IPMN) THERAPY BY SELECTIVE DELIVERY OF ADENOVIRUS- Isaac Raijman, USA; R. Shah; P. Tarnasky; A. Duvall; M. BASED TOXIN Othman; P. Kedia; M. Kahaleh; U. Mondal; S. Patel; D. I. Boustanai; S. Shapira; D. Kazanov; Nadir Arber, Israel Nguyen; G. Van Buren; W. Fisher P1199 P1207 GSK3B INHIBITOR DOWN-REGULATES PD-L1 IN THE FEASIBILITY OF TISSUE SPECIMEN OBTAINED FROM KRAS-MUTANT PDAC THROUGH INHIBITING NF-KB EUS-FNA FOR PATIENT-DERIVED TUMOR XENOGRAFT Wataru Shibata, Japan; S. Nagayama; T. Sato; Y. Ishii; IN PANCREATIC CANCER M. Sugimori; E. Kameta; S. Sue; S. Maeda Chang-Min Cho, South Korea; A. N. Seo; H. I. Bae; I. K. Lee P1200 P1208 CUX1 COOPERATES WITH K-RAS IN THE TUMOR PRO- EARLY VERSUS DELAY INITIATION IN ADJUVANT GRESSION OF PANCREATIC CANCER IN VIVO TREATMENT FOR PANCREATIC CANCER H. Griesmann; S. Mühl; K. Theuerkorn; B. Sipos; P. Hyoung Woo Kim, South Korea; J.-C. Lee; J. Lee; J. Kim; Michl; Stefanie Gühne, Germany J.-H. Hwang P1201 P1209 THE FEATURES OF HOST IMMUNE RESPONSE IN PA- RESECTABLE PANCREATIC CANCER: ARE WE PER- TIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA FORMING A GOOD PRE-OPERATIVE STAGING? Takuya Komura, Japan; Y. Sakai; K. Harada; S. Kaneko Rosa Coelho, Portugal; P. Moutinho-Ribeiro; R. Gaspar; P. Andrade; R. Liberal; R. Morais; P. Costa-Moreira; A. P1202 L. Santos; F. Vilas-Boas; S. Lopes; P. Pereira; G. Macedo EXHAUSTIVE ANALYSIS OF MICRORNAS IN THE PANCRE- ATIC CANCER TISSUE OBTAINED BY ENDOSCOPIC ULTRA- P1210 SOUND-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA) VALUE OF CA 19-9 LEVELS FOR PANCREATIC CANCER

Wednesday, October 19, 2016 Kiyohito Kato, Japan; H. Kamada; T. Yamashita; K. SCREENING IN NEW-ONSET DIABETIC PATIENTS RE- Kobayashi; T. Fujimori; T. Masaki GARDLESS OF BILIRUBIN ELEVATION Jae Seon Kim, South Korea; J. W. Choe; H. J. Kim; M. K. P1203 Joo; B. J. Lee; J.-J. Park; Y.-T. Bak EFFECTS OF ARGININE-GLYCINE-ASPARTIC ACID PEPTIDE CONJUGATED QUANTUM DOTS INDUCED PHOTODYNAMIC P1211 THERAPY ON PANCREATIC CARCINOMA IN VIVO CONTINUOUS LOW-DOSE-RATE IRRADIATION OF M. Li; J. Cao; Leiming Xu, China IODINE-125 SEEDS INHIBITS PERINEURAL INVASION IN PANCREATIC CANCER Z. Lu; T. Dong; P. Si; W. Shen; Y. Bi; M. Min; Y. Xu; X. Chen; Yan Liu, China P1212 MENSTRUAL AND REPRODUCTIVE FACTORS AND RISK OF PANCREATIC CANCER IN WOMEN Akram Pourshams, Iran; S. Masoudi; R. Malekzadeh

212 Poster in the Spotlight Poster of Excellence Clinical Case Session 213 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1213 P1218 EUS-ELASTOGRAPHY (STRAIN RATIO) IN THE DIAGNO- TRANSORAL OUTLET REDUCTION FOR THERAPY OF SIS OF SOLID PANCREATIC LESIONS: A PROSPECTIVE WEIGHT REGAIN AFTER GASTRIC BYPASS COHORT STUDY Ivo Boskoski, Italy; R. Landi; P. Familiari; A. Tringali; V. Silvia Carrara, Italy; M. Di Leo; A. Anderloni; A. Zerbi; Perri; G. Costamagna A. Repici P1219 A NEW THERAPEUTIC LASER SYSTEM FOR ADVANCED Endoscopy, upper GI ENDOSCOPIC TREATMENTS IN THE UPPER GI - FIRST RESULTS IN AN ESTABLISHED ANIMAL MODEL Poster Session Gian Eugenio Tontini, Italy; H. Neumann; P. Soriani; F. 09:00 - 14:00 Hall X4 Cavallaro; L. Spina; B. Bruni; C. Clemente; F. Fagnani; Endoscopy and imaging III P.-H. Zhou; L. Carmignani; L. Pastorelli; M. Vecchi P1214 P1220 ENDOSCOPIC DUODENAL MUCOSAL RESURFACING THE IMPORTANCE OF GASTROSCOPY BEFOR BARIAT- TREATMENT FOR TYPE 2 DIABETES: EARLY MULTI- RIC SURGERY, ITS IMPACT ON THE SURGICAL PROCE- CENTRE EXPERIENCE DURE AND FOLLOW-UP COMPLICATIONS Annieke Van Baar, The Netherlands; J. Deviere; G. Fabiana Benjaminov, Israel; D. Feldman; A. Stein; F. Costamagna; M. Passos Galvão Neto; L. Rodríguez; R. J. Konikoff; T. Naftali Haidry; J. J. Bergman P1221 P1215 PERORAL ENDOSCOPIC SHORTER VERSUS LONGER TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS MYOTOMY FOR THE TREATMENT OF ACHALASIA: A WITH ACUTE NON VARICEAL UPPER GASTRO INTES- COMPARATIVE STUDY TINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE X. Tang; Y. Ren; S. Huang; Q. Gao; Wei Gong, China MULTICENTER OBSERVATIONAL STUDY Riccardo Marmo, Italy; M. Soncini; R. Bennato; L. Orsini; P1222 L. Amitrano; F. Parente; S. Bargiggia; A. Paterlini; P. NOVEL DEVICE FOR FULL THICKNESS ENDOSCOPIC Cesaro; C. Bucci; A. Bizzotto; B. Germana'; L. G. Cavallaro; SUTURE, USING BACK AND FORTH NEEDLING: EX VIVO R. De Franchis; A. Dell'Era; G. Costamagna; M. E. Riccioni; ANIMAL STUDY C. Marmo; A. Tortora; M. Manno; S. Mangiafico; R. L. S. Y. Lee; Hoon Jai Chun, South Korea; I. K. Yoo; J. M. Conigliaro; G. Bresci; S. Metrangolo; A. Merighi; V. Lee; S. H. Kim; H. S. Choi; E. S. Kim; B. Keum; Y. T. Boarino; S. Segato; M. Parravicini; L. Purita; A. Chirico; Jeen; H. S. Lee; C. D. Kim; S. H. Park; B. G. Kim; Y. J. G. Imperiali; P. Gasparini; F. Esposito; F. R. De Filippo; Kim; Y. N. Song; D. H. Hong; J. M. Lee; B. K. Choi G. Baldassarre; M. Franceschi; A. Nucci; ; F. De Nigris; P1223 L. Ferraris; A. Zambelli; C. Londoni; A. Repici; A. NEWLY DESIGNED HIGHLY FLEXIBLE MAGNETIC DEVICE Anderloni; M. De Matthaeis; O. Triossi; M. A. Bianco; FOR ENDOSCOPY ASSISTED FERROMAGNETIC FOREIGN G. Rotondano; R. Lamanda; A. Lauri; A. De Fanis; P. Di BODY REMOVAL Giorgio; R. Pumpo; L. Furio; A. Russo; A. Andriulli; G. Vijay Sharma, India; R. Sharma Napolitano; L. M. Montalbano; F. Bazzoli; R. M. Zagari; E. Buscarini; L. Cipolletta; D. Conte; G. Spinzi; A. Balzano; P1224 F. Cipolletta; E. Di Giulio; G. D'Amico CLINICAL OUTCOMES IN VERY ELDERLY PATIENTS WITH GASTRIC CANCER TREATED USING ENDOSCOPIC SUB- P1216 MUCOSAL DISSECTION: ANALYSIS WITH EMPHASIS ON PERORAL ENDOSCOPIC MYOTOMY FOR TREATING ACHA- THE RELATIONSHIP BETWEEN PATIENT CHARACTERIS- LASIA PERFORMED BY A GASTROENTEROLOGIST: 4 YEARS' TICS AND PROGNOSIS EXPERIENCE FROM A SINGLE ENDOSCOPY CENTER Masau Sekiguchi, Japan; I. Oda; H. Suzuki; S. Abe; S. X. Tang; Y. Ren; S. Huang; Q. Gao; Wei Gong, China Nonaka; S. Yoshinaga; H. Taniguchi; S. Sekine; Y. Saito P1217 P1225 PERORAL ENDOSCOPIC MYOTOMY IS SAFE AND EF- THE EFFECT OF A FLEXIBLE 3D ENDOSCOPE ON THE FECTIVE FOR ACHALASIA IN PATIENTS OLDER THAN 60 LEARNING CURVE OF ENDOSCOPIC SUBMUCOSAL YEARS OF AGE COMPARED WITH YOUNGER PATIENTS DISSECTION: A BENCH TOP EX-VIVO STUDY

X. Tang; Y. Ren; S. Huang; Q. Gao; Wei Gong, China Baldwin Po Man Yeung, Hong Kong; D. X. Xia; C. C. H. 2016 19, October Wednesday, Lam; P. W. Y. Chiu

Poster in the Spotlight Poster of Excellence Clinical Case Session 213

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1226 P1234 PRACTICAL STRATEGY FOR INVASION DEPTH PREDIC- MORTALITY CAUSES FROM ACUTE UPPER GASTROIN- TION OF EARLY GASTRIC CANCER BY CONVENTIONAL TESTINAL BLEEDING: A PROSPECTIVE MULTICENTRE ENDOSCOPY AND ENDOSCOPIC ULTRASONOGRAPHY OBSERVATIONAL STUDY Jieyao Cheng, China; X. Wu; X. Lu; A. Yang R. Marmo; M. Soncini; R. Bennato; Cristina Bucci, Italy; F. Cipolletta; L. Orsini; M. Guardascione; F. Parente; P1227 S. Bargiggia; A. Paterlini; P. Cesaro; A. Bizzotto; B. EVALUATION OF ENDOSCOPIC TREATMENT FOR SU- Germana'; L. G. Cavallaro; R. De Franchis; A. Dell'Era; PERFICIAL DUODENAL NEOPLASM G. Costamagna; M. E. Riccioni; C. Marmo; A. Tortora; Yasutoshi Ochiai, Japan; Y. Kiguchi; Y. Mitsunaga; T. M. Manno; S. Mangiafico; R. L. Conigliaro; G. Bresci; S. Akimoto; T. Maehata; A. Fujimoto; R. Nakamura; T. Metrangolo; A. Merighi; V. Boarino; S. Segato; M. Nishizawa; O. Goto; T. Uraoka; N. Yahagi Parravicini; L. Purita; A. Chirico; G. Imperiali; P. P1228 Gasparini; F. Esposito; P. Borgheresi; F. R. De Filippo; CREATION OF GASTROINTESTINAL SUBMUCOSAL TUN- G. Baldassarre; M. Franceschi; A. Nucci; F. De Nigris; NEL UPON SUBMUCOSAL INJECTION OF A PLGA-PEG-PL- L. Ferraris; A. Zambelli; C. Londoni; A. Repici; A. GA THERMOGEL IN A PORCINE MODEL: THE NEXT Anderloni; M. De Matthaeis; O. Triossi; M. A. Bianco; GENERATION OF TUNNEL ENDOSCOPY? (WITH VIDEO) G. Rotondano; R. Lamanda; A. Lauri; A. De Fanis; P. Di Min Min, China; Y. Liu; L. Wang; Y. Bi Giorgio; R. Pumpo; L. Furio; A. Russo; A. Andriulli; G. Napolitano; L. M. Montalbano; F. Bazzoli; R. M. Zagari; P1229 E. Buscarini; L. Cipolletta; D. Conte; G. Spinzi; E. Di IS THERE A PLACE FOR BALLOON DILATATION IN THE Giulio; G. D'Amico; A. Balzano ERA OF PERORAL ENDOSCOPIC MYOTOMY IN PATIENTS WITH ACHALASIA? P1235 Marcel Tantau, Romania; A. Tantau; C. Tefas; C. Buzas FEASIBILITY OF FULL-SPECTRUM ENDOSCOPY GAS- TROSCOPY, PREVALENCE OF DUODENAL PERIAMPUL- P1230 LARY DIVERTICULA, AND FUTURE OF DIRECT PER-ORAL A SIMPLE MATHEMATICAL EQUATION FOR RELIABLE CHOLANGIOSCOPY PREDICTION OF THE GASTRO-ESOPHAGEAL JUNCTION Jeong-Yeop Song Md, South Korea; Y. H. Cho; M. A. THROUGH THE SUB MUCOSAL TUNNEL DURING PER Kim; J.-A. Kim ORAL ENDOSCOPIC MYOTOMY - A PROOF OF CONCEPT PILOT STUDY P1236 Amol Bapaye, India; J. A. Bapaye; N. A. Dubale; M. ENDOSCOPIC PUNCTURE-SUTURE DEVICE IN CLOSING Mahadik; V. Vyas; K. Sheth; S. Date; R. Pujari; A. THE DEFECT OF THE GASTRIC WALL AFTER FULL-THICK- Kulkarni; R. Gaadhe; R. Jajoo NESS RESECTION: SURVIVAL PORCINE STUDY Jintao Guo, China; S. Sun P1231 SAFETY AND EFFICACY OF COLD POLYPECTOMY FOR P1237 NONAMPULLARY DUODENAL ADENOMA: A PROSPEC- PRELIMINARY REPORT OF A NEW SCISSOR-LIKE DEVICE TIVE CLINICAL TRIAL FOR ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) Daisuke Maruoka, Japan; M. Arai; S. Kasamatsu; H. FOR SAFE AND EFFECTIVE TREATMENT OF ZENKER'S Ishigami; T. Taida; K. Okimoto; T. Matsumura; T. DIVERTICULUM Nakagawa; T. Katsuno Helmut Neumann, Germany; S. Ishaq; A. Nägel P1232 P1238

Wednesday, October 19, 2016 ENDOSCOPIC DIAGNOSIS FOR ELEVATED EARLY GAS- THE USE OF A NOVEL EXTRACELLULAR SCAFFOLD TRIC CANCER THAT SHOWED ADENOMA BY BIOPSY MATRIX FOR HAEMOSTASIS DURING ENDOSCOPIC BEFORE ESD RESECTION IN PATIENTS AT HIGH RISK OF BLEEDING: A Hiroaki Sawai, Japan; S. Kushida; T. Mimura; Y. LITTLE GOES A LONG WAY Yamamoto; H. Inokuchi Sharmila Subramaniam, United Kingdom; F. J. Q. Chedgy; K. Kandiah; S. Thayalasekaran; G. Longcroft- P1233 Wheaton; P. Bhandari POEM´S POTPOURRI: THE ROUTINE X-RAY AND EN- DOSCOPY ARE NOT NECESSARY AFTER POEM; ASPIRIN DOES NOT INCREASE THE RISK OF BLEEDING Julia Bayer, Czech Republic; H. Svecova; Z. Vackova; J. Krajciova; J. Spicak; J. Martinek

214 Poster in the Spotlight Poster of Excellence Clinical Case Session 215 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1239 P1247 ENDOSCOPIC TREATMENT FOR METACHRONOUS EARLY LONG TERM OUTCOMES AFTER NON-CURATIVE GASTRIC CARCINOMA IN A RECONSTRUCTED GASTRIC ENDOSCOPIC RESECTION OF EARLY GASTRIC CANCER TUBE AFTER RADICAL OPEREATION FOR ESOPAGEAL ACCORDING TO THE ADDITIONAL TREATMENT CARCINOMA Mi Young Jeon, South Korea; J. C. Park; K. Y. Hahn; H. Yusuke Maeda, Japan; H. Takeuchi; H. Kawakubo; R. Chung; S. K. Shin; S. K. Lee; Y. C. Lee Nakamura; Y. Kikuchi; K. Fukuda; K. Suda; N. Wada; T. Omori; Y. Kitagawa Endoscopy, colon P1240 P1248 ENDOSCOPIC RESECTION FOR HYPERPLASTIC GASTRIC DO VISIBLE VESSELS WITHIN THE POST ENDOSCOPIC POLYPS: IS IT JUSTIFIED? MUCOSAL RESECTION (EMR) DEFECT PREDICT POST Bérénice Petit, France; J. Rivory; V. Lepilliez; J. C. Saurin; EMR BLEEDING? T. Ponchon; M. Pioche Lobke Desomer, Australia; D. J. Tate; F. Bahin; B. Holt; M. J. Bourke P1241 ACCREDITATION OF ENDOSCOPY SERVICES IN ITALY: P1249 PRELIMINARY RESULTS RANDOMIZED COMPARATIVE EVALUATION OF AN ESD Giancarlo Spinzi, Italy; M. Capelli; M. Labardi; A. SELF-LEARNING SOFTWARE IN FRANCE AND JAPAN Merighi; A. Milano; L. Riccardi; F. Torresan Mathieu Pioche, France; J. Rivory; T. Nishizawa; T. Uraoka; S. Touzet; M. O'Brien; J. C. Saurin; A. Denis; T. P1242 Ponchon; N. Yahagi HIGHEST POWER MAGNIFICATION WITH NAR- ROW-BAND IMAGING IS VERY USEFUL TO DIAGNOSE P1250 THE MARGINS OF EARLY GASTRIC CANCERS, ESPE- COMPUTER-BASED AUTOMATIC DIFFERENTIATION OF CIALLY AFTER HELICOBACTER PYLORI ERADICATION NEOPLASTIC AND NON-NEOPLASTIC POLYPS WITH THE Koji Kojima, Japan; K. Uchita; R. Daike; S. Sasaki; K. APPLICATION OF DEEP STRUCTURED LEARNING AL- Iwasaki; A. Kawada; M. Nakayama; M. Okazaki; S. GORITHMS OF A CONVOLUTIONAL NEURAL NETWORK Iwamura - PRELIMINARY RESULTS Laszlo Madacsy, Hungary; L. Oczella; M. Szalai; Z. P1243 Dubravcsik; A. Z. Szepes COMPARATIVE STUDY OF ESD AND SURGICAL RESEC- TION FOR GASTRIC SETS ORIGINATED FROM MUSCU- P1251 LARISPROPRIA COLD SNARE POLYPECTOMY DOES NOT INCREASE THE Chang Beom Ryu, South Korea; M. S. Lee POSSIBILITY OF RESIDUAL POLYP: A PROSPECTIVE SINGLE-ARM OBSERVATIONAL TRIAL P1244 Yoji Takeuchi, Japan; N. Matsuura; N. Uedo; T. Ito; T. A COMPARISON OF EFFICACY, OUTCOME AND COMPLICA- Yamashina; K. Aoi; T. Kanesaka; F. Matsui; M. Fujii; N. TIONS OF ENDOSCOPIC SUBMUCOSAL DISSECTION WITH Hanaoka; T. Akasaka; K. Higashino; R. Ishihara; H. Iishi THE OLYMPUS SECOND GENERATION ELECTROSURGICAL KNIFE DUALKNIFEJTM VS OLYMPUS FIRST GENERATION P1252 DUALKNIFETM. A SINGLE CENTRE RETROSPECTIVE STUDY INTERNAL ARE A COMMON CAUSE OF SE- Jonas Woo, Japan; J. Matsuoka; Y. Kowazaki; M. VERE HEMATOCHEZIA BUT PATIENTS HAVE MUCH BETTER Nishimura OUTCOMES THAN THOSE WITH OTHER COLON DIAGNOSES Marie-Anne Guillaumot, USA; D. M. Jensen; K. P1245 Ghassemi; T. O. Kovacs; G. V. Ohning; A. Sedarat; PREDICTORS FOR FOREIGN BODY PRESENCE AT ENDOS- M. Kaneshiro; G. Machicado; G. Dulai COPY IN FOREIGN BODY INGESTION - A PROSPECTIVE STUDY P1253 Diogo Libânio, Portugal; F. Jácome; J. C. Sousa; M. WHAT IS THE CULPRIT LESION FOR INTERVAL CANCER Dinis-Ribeiro; R. Marcos-Pinto; I. Pedroto AFTER COMPLETE COLONOSCOPY? Takahiro Fujii, Japan P1246 AVAILABILITY OF LAPAROSCOPIC AND ENDOSCOPIC COOPERATIVE SURGERY: AN INTERNATIONAL QUES-

TIONNAIRE SURVEY 2016 19, October Wednesday, Osamu Goto, Japan; H. Takeuchi; T. Akimoto; H. Kawakubo; M. Sasaki; Y. Kitagawa; N. Yahagi

Poster in the Spotlight Poster of Excellence Clinical Case Session 215

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1254 P1262 IS IT EFFECTIVE TO ADD A REMINDER PROPOSING VIR- CLASSIFICATION OF CELL NUCLEI MORPHOLOGY OF EC TUAL COLONOSCOPY OR COLON CAPSULE EXAMINATION FINDINGS IN COLORECTAL ENDOCYTOSCOPY TO IMPROVE PARTICIPATION TO COLORECTAL CANCER Toyoki Kudo, Japan; S.-E. Kudo; Y. Mori; K. Wakamura; SCREENING IN PATIENTS WITH POSITIVE FECAL OCCULT M. Misawa; K. Suzuki; K. Takeda; H. Nakamura; N. BLOOD TEST WHO REFUSED COLONOSCOPY? Toyoshima; T. Hayashi; A. Katagiri; H. Miyachi; F. Ishida Mathieu Pioche, France; C. Ganne; R. Gincul; J. Marsot; A. De Leusse; L. Henry; M. Lapalus; C. Chambon-Augoyard; P1263 R. Malezieux; O. Scalone; J. Qiu; E. Del Tedesco; J.-C. UNDERWATER EMR IS A SAFE AND A WELL-TOLERATED Montoy; P.J. Valette; J. Kuntz-Huon; L. Vecchiato; S. PROCEDURE: THE EXPERIENCE OF TWO UK CENTRES Roux; J. Tomczyk-Ferrero; P. Soler Michel; T. Ponchon Abdulkani Yusuf, United Kingdom; N. Suzuki; H. Htet; N. Gautam; S. Thomas-Gibson; S. Ishaq P1255 ENDOSCOPIC TREATMENT OF GASTROINTESTINAL P1264 TRACT PERFORATIONS, ANASTOMOTIC LEAKAGES AND RANDOMIZED TANDEM COLONOSCOPY OF NARROW FISTULAS USING THE OVER-THE-SCOPE-CLIP SYSTEM BAND IMAGING (NBI) AND WHITE LIGHT ENDOSCOPY (OVESCO): TWO-CENTRE EXPERIENCE IN PATIENTS WITH SERRATED LESIONS Inga Kildusiene, Lithuania; G. Radziunas; Fausto Riu Pons, Spain; M. Andreu; D. Naranjo; M. A. Álvarez-González; A. Seoane; J. M. Dedeu; L. Barranco; P1256 X. Bessa COST-EFFECTIVENESS ANALYSIS OF COLONOSCOPY COL- ORECTAL CANCER SCREENING AMONG CYSTIC FIBROSIS P1265 PATIENTS SHOULD ALL SESSILE SERRATED ADENOMA/POLYPS BE Andrea Gini, The Netherlands; S. Hempstead; A. Fink; TREATED? S. Fischer; A. Zauber; I. Lansdorp-Vogelaar Shinya Ishigooka, Japan; S.-I. Ozawa; Y. Matsuo; M. Yamashita; Y. Sato; H. Yamamoto; H. Yasuda; F. Itoh P1257 MODIFIABLE FACTORS ASSOCIATED WITH PATIENT-RE- P1266 PORTED PAIN DURING AND AFTER SCREENING COLO- EFFICACY AND SAFETY OF THE NOVEL 1L PEG AND NOSCOPY ASCORBATE BOWEL PREPARATION NER1006 VERSUS M. Bugajski; Paulina Wieszczy, Poland; M. F. Kaminski; SODIUM PICOSULFATE + MAGNESIUM CITRATE IN DAY G. Hoff; J. Regula BEFORE SPLIT-DOSING ADMINISTRATION: RESULTS FROM THE PHASE 3 STUDY DAYB P1258 Stefan Schreiber, Germany; D. C. Baumgart; J. P. H. Drenth; A REVIEW OF CURRENT PRACTICE IN FLEXIBLE SIG- R. S. Filip; L. B. Clayton; R. Ng Kwet Shing; C. Hassan MOIDOSCOPY - CAN WE DO BETTER? John Jacob, United Kingdom; J. Leeds P1267 HIGH MENTAL WORKLOAD EXPERIENCED DURING P1259 COLONOSCOPY IS ASSOCIATED WITH POOR ENDOSCO- PREDICTED ADENOMA DETECTION RATE (ADR) AND PIST PERFORMANCE COMPARISON TO ACTUAL PHYSICIANS' ADR Imdadur Rahman, United Kingdom; P. Boger; P. Patel Eelco C. Brand, USA; J. E. Crook; C. S. Thomas; P. D. Siersema; D. K. Rex; M. B. Wallace P1268 NARROW BAND IMAGING VERSUS WHITE LIGHT P1260 ENDOSCOPY IN THE CHARACTERIZATION OF RESIDUAL

Wednesday, October 19, 2016 FIRST CLINICAL EXPERIENCES OF A NOVEL ENDOSCOP- NEOPLASIA AFTER ENDOSCOPIC PIECEMEAL MUCOSAL IC OVER-THE-SCOPE CLIP SYSTEM RESECTION, A RANDOMIZED CONTROLLED TRIAL Marco Dinelli, Italy; B. Omazzi; P. Andreozzi; N. Zucchini; Fausto Riu Pons, Spain; M. Andreu; J. Gimeno; M. A. A. E. Redaelli; G. Manes Álvarez-González; A. Seoane; J. M. Dedeu; L. Barranco; X. Bessa P1261 SPLIT VS SAME-DAY REGIMES FOR BOWEL PREPARA- P1269 TION BEFORE COLONOSCOPY: A META-ANALYSIS OF COLD SNARE POLYPECTOMY MAY REDUCE DELAYED PUBLISHED STUDIES POSTPOLYPECTOMY BLEEDING COMPARED WITH Cristina Bucci, Italy; R. Marmo CONVENTIONAL HOT POLYPECTOMY: A PROPENSITY SCORE-MATCHING ANALYSIS Manabu Fukuhara, Japan; T. Yamashina; T. Maruo; G. Tanke; S. Henmi; A. Sakamoto; M. Taki; Y. Ohara; S. Saito; N. Nishijima; Y. Sawai; A. Nasu; H. Komekado; A. Sekikawa; M. Asada; T. Tsumura; T. Kimura; Y. Osaki

216 Poster in the Spotlight Poster of Excellence Clinical Case Session 217 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1270 P1278 COLORECTAL SURVEILLANCE PROGRAM IN PORTU- TRACTION ASSISTED COLORECTAL ENDOSCOPIC SUBMU- GUESE FAMILIES WITH LYNCH SYNDROME: A SIN- COSAL DISSECTION USING CLIP AND LINE: A FEASIBILITY GLE-CENTRE COHORT STUDY STUDY Rita Vale Rodrigues, Portugal; I. Claro; J. Pereira Da Yasushi Yamasaki, Japan; Y. Takeuchi; N. Uedo; T. Silva; P. Lage; S. Ferreira; I. Rosa; I. Francisco; B. Kanesaka; T. Akasaka; N. Hanaoka; K. Higashino; R. Filipe; C. Albuquerque; P. Chaves; A. Dias Pereira Ishihara; H. Iishi P1271 P1279 THE EFFICACY AND SAFETY OF ENDOSCOPIC MUCOSAL SHOULD WE RECOMMEND A LIQUID DIET OR A LOW FI- RESECTION WITH A CAP FOR RECTAL NEUROENDO- BER DIET THE DAY BEFORE A SCREENING COLONOSCO- CRINE TUMOR COMPARE TO ENDOSCOPIC SUBMUCOSAL PY? NON-INFERIORITY RANDOMISED CLINICAL TRIAL DISSECTION Marco Antonio Alvarez González, Spain; M. A. Kyoung Oh Kim, South Korea; S. H. Jeong; J.-W. Chung; Pantaleón; D. Zaffalón; G. Casals; M. Bonilla; I. Ibañez; Y. J. Kim; J. H. Cho; K. A. Kwon; D. K. Park A. Fernández-Clotet; A. Raga; X. Bessa; J. Amorós; F. Riu Pons; J. M. Dedeu; L. Barranco; A. Seoane P1272 LEVELS OF DIFFICULTY OF COLORECTAL ENDOSCOPIC P1280 SUBMUCOSAL DISSECTION (ESD) IN THE WESTERN ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD): ADOP- SETTING: STEPWISE EVALUATION OF PRE- AND INTRA- TION AND OUTCOME OF POCKET CREATION METHOD IN OPERATIVE VARIABLES A TERTIARY CENTRE IN SINGAPORE Federico Iacopini, Italy; Y. Saito; A. Bella; C. Grossi; W. Weida Chew, Singapore; Y. Morita; H. Yamamoto; S. Tsao Elisei; F. Montagnese; T. Gotoda; P. Rigato; G. Costamagna P1281 P1273 LONG FOLLOW UP AFTER ENDOSCOPIC RESECTION OF ENDOSCOPIC MANAGEMENT OF LARGE RECTAL POLYPS COLORECTAL CARCINOMA WITH SUBMUCOSAL INVASION: Hubertus Heinrich Nietsch, Germany RESULTS OF A MONOCENTRIC RETROSPECTIVE STUDY Erwan Bories, France; F. Poizat; J. P. Ratone; C. Pesenti; P1274 F. Caillol; C. De Chaisemartin; B. Lelong; J. R. Delpero; THE DISCREPANCY IN PATHOLOGY RESULTS BETWEEN M. Giovannini ENDOSCOPIC FORCEPS BIOPSY AND RESECTED SPECI- MEN OF COLORECTAL POLYP P1282 Kyeong-Ok Kim, South Korea; D. E. Jeong; M. J. Hwang; WITHDRAWN B. I. Jang; T. N. Kim; C. H. Yang P1283 P1275 DETECTION OF THE DESMOPLASTIC REACTION USING OPTICAL DETECTION OF COLORECTAL RESIDUAL NEO- ENDOCYTOSCOPY: A NOVEL DIAGNOSTIC MARKER OF PLASIA AFTER ENDOSCOPIC MUCOSAL RESECTION WITH SUBMUCOSAL OR DEEPER INVASIONS IN COLORECTAL HIGH-DEFINITION WHITE LIGHT OR NARROW-BAND IM- CARCINOMA AGING COLONOSCOPY WITH OR WITHOUT NEAR-FOCUS: Mayuko Watanabe, Japan; S.-E. Kudo; M. Misawa; A PROSPECTIVE STUDY K. Wakamura; Y. Sugihara; K. Ogura; K. Suzuki; K. Eelco C. Brand, USA; P. Kandel; W. C. Chen; M. J. Matsumoto; T. Fujii; T. Sakurai; Y. Kouyama; Y. Ogawa; Bartel; R. L. Bingham; E. B. P. Bouras; V. Gomez; M. S. Kataoka; K. Igarashi; K. Ichimasa; K. Takeda; S. Raimondo; T. A. Woodward; M. B. Wallace Matsudaira; T. Ishigaki; S. Hayashi; Y. Mori; T. Kudo; N. Ogata; T. Hayashi; H. Miyachi; A. Katagiri; T. Baba; P1276 F. Ishida ACCURACY OF COLORECTAL POLYP SIZE ESTIMATION BY ENDOSCOPY Endoscopy, ERCP Alain Huerta Madrigal, Spain; A. Fernández Atucha; M. S. Argueta; S. Torres Burgos; A. Bernal Martinez; J. L. P1284 Cabriada Nuño APPROPRIATENESS OF ANTIBIOTIC PROPHYLAXIS AND NOVEL RISK FACTORS FOR POST ERCP BACTEREMIA - P1277 REAL LIFE EXPERIENCE OF A HIGH VOLUME CENTER ANALYSIS OF COLONOSCOPY TO CONTINUOUS AMBU- Liat Mlynarsky, Israel; S. Matalon; ; A. Phillips; A. LATORY PERITONEAL DIALYSIS (CAPD) PATIENTS Melhem; M. Leshno; E. Santo Satoshi Kawamura, Japan; N. Toda; S. Kurosaki; K. 2016 19, October Wednesday, Funato; Y. Karasawa; S. Maeshima; K. Kojima; S. Furuse; T. Ohki; K. Saito; M. Seki; N. Mise; K. Tagawa

Poster in the Spotlight Poster of Excellence Clinical Case Session 217

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1285 P1292 MINIMAL ENDOSCOPIC SPHINCTEROTOMY PLUS LARGE ETOMIDATE WITH MEPERIDINE VS MIDAZOLAM WITH BALLOON DILATION FOR EXTRACTION OF LARGE STONES MEPERIDINE FOR SEDATION DURING ENDODSCOPIC IN PATIENTS WITH PERI-AMPULLARY DIVERTICULA RETROGRADE CHOLANGIO-PANCREATOGRAM (ERCP): Claudio Zulli, Italy; S. Tammaro; F. Fiocca; G. Geraci; C. A SINGLE CENTER, RANDOMIZED CONTROLLED, SINGLE Sciume; O. Labianca; G. Manes; P. Antypas; A. Maurano BLINDED STUDY Byung Hyo Cha, United Arab Emirates; Ras Al Khaimah P1286 A MULTI-CENTER RETROSPECTIVE STUDY ON THE P1293 CLINICAL VALUE OF TWO GENERATIONS OF A SIN- RISK FACTORS FOR THE RELAPSE OF POST-LIVING GLE-OPERATOR CHOLANGIOSCOPE: ANALYSIS OF 239 DONOR LIVER TRANSPLANTATION(LDLT) BILIARY CONSECUTIVE APPLICATIONS STRICTURE AFTER ENDOSCOPIC TREATMENT Werner Dolak, Austria; R. Schwarzer; U. Itzlinger-Monshi; Ju-Il Yang, South Korea; J. K. Lee; K. H. Lee; K. T. Lee; P.-G. Peters; M. Gschwantler; J. Holzinger; U. Olynetz; J. K. Park D. Hubner; J. Weber-Eibel; M. Peck-Radosavljevic; B. Stadler; K. Jilek; P. Herbst; B. Hellmich; P. Rein; T. P1294 Pachofszky; A. Maieron; M. Schöniger-Hekele; B. Tribl; THE USEFULNESS OF DIRECT PERORAL CHOLANGIOS- M. Trauner; A. Püspök; R. Schöfl COPY COMBINING WITH INTRADUCTAL ULTRASONOG- RAPHY FOR THE EVALUATION OF INDETERMINATE BILE P1287 DUCT LESIONS ENDOSCOPIC THERAPY FOR BILE LEAKS AFTER LIVER Hyun Jong Choi, South Korea; J. H. Moon; H. J. Goong; TRANSPLANTATION: AN ANALYSIS OF TWO HIGH-VOL- Y. N. Lee; H. K. Kim; M. H. Choi; T. H. Lee; S.-W. Cha; Y. UME TRANSPLANT CENTERS D. Cho; S.-H. Park Alejandro Fernandez-Simon, Spain; O. Sendino; R. Law; B. K. Abu Dayyyeh; M. Leise; A. Mendez-Bocanegra; J. P1295 Colmenero; G. Crespo; J. Llach; M. Navasa; T. H. Baron; RISK FACTORS AND PROPHYLAXIS OF POST ENDO- A. Cardenas SCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS P1288 David Perdigoto, Portugal; D. Gomes; N. Almeida; S. CAN ULTRASLIM UPPER ENDOSCOPE REPLACE FIVER- Mendes; E. Camacho; R. Mesquita; A. R. Alves; L. Elvas; OPTIC CHOLEDOCHOSCOPE FOR PERCUTANEOUS TRAN- S. Barbeiro; S. Giestas; A. Fernandes; A. Oliveira; C. Sofia SHEPATIC CHOLANGIOSCOPY?: A FEASIBILITY STUDY Hyeon Jeong Goong, South Korea; J. H. Moon; Y. N. Lee; P1296 H. J. Choi; M. H. Choi; T. H. Lee; S.-W. Cha; Y.D. Cho; SAFETY OF ENDOSCOPIC RETROGRADE CHOLAN- S.-H. Park GIOPANCREATOGRAPHY FOR PATIENTS TAKING ANTI- THROMBOTIC AGENTS P1289 Chika Nakashita, Japan; C. Nishioka; T. Kuwashiro; F. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOG- Koga; Y. Kawaguchi RAPHY (ERCP) FOR THE ELDERLY AND EXTREMELY ELDERLY: DOES AGE REALLY MATTER? Endosonography Maria Ana Kopke Tulio, Portugal; L. Carvalho; S. Marques; J. Rodrigues; J. Carmo; B. Charrua; P. P1297 Barreiro; T. Bana E Costa; C. Chagas A PERSONALIZED TREATMENT OF GASTROINTESTINAL STROMAL TUMORS IS ENABLED BY ANALYZING ENDO- P1290 SCOPIC ULTRASOUND-GUIDED BIOPSIES: A PROSPEC- Wednesday, October 19, 2016 EFFICACY OF ENDOSCOPIC GALLBLADDER STENTING IN TIVE, TEN-YEAR COHORT STUDY ACUTE CHOLECYSTITIS Per Hedenström, Sweden; B. Nilsson; C. Andersson; A. Yujiro Kawakami, Japan; K. Suzuki; Y. Hayashi; M. Demir; F. Enlund; O. Nilsson; R. Sadik Akahonai; K. Fukuda; T. Yatsu; K. Yonezawa; T. Abe P1298 P1291 EUS-GUIDED CYST-ENTEROSTOMY USING A SELF-EX- THE USEFULNESS OF ARGON PLASMA COAGULATION PANDING METAL STENT IS A MORE COST-EFFECTIVE ABLATION SUBSEQUENT TO ENDOSCOPIC SNARE PAPIL- STRATEGY FOR THE TREATMENT OF PANCREATIC FLUID LECTOMY FOR AMPULLARY ADENOMA COLLECTIONS Kwangwoo Nam, South Korea; T. J. Song; M. K. Cho; D. Sana Kenshil, Canada; S. Sandha; C. Teshima; P. M. Oh; D. H. Park; S. S. Lee; D.-W. Seo; S. K. Lee; M.-H. Kim D'Souza; G. S. Sandha

218 Poster in the Spotlight Poster of Excellence Clinical Case Session 219 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1299 P1306 AN INTERNATIONAL MULTICENTER STUDY COMPARING PROSPECTIVE STUDY FOR COMPARISON OF ENDOSCOP- EUS-GUIDED PANCREATIC DUCT DRAINAGE WITH IC ULTRASOUND-GUIDED TISSUE ACQUISITION USING ENTEROSCOPY-ASSISTED ENDOSCOPIC RETROGRADE 25- AND 22-GAUGE CORE BIOPSY NEEDLES IN SOLID PANCREATOGRAPHY FOLLOWING WHIPPLE SURGERY PANCREATIC MASSES Yen-I Chen, USA; M. Levy; T. Moreels; G. Hajiyeva; U. Will; Se Woo Park, South Korea E. Artifon; K. Hara; M. Kitano; M. Topazian; B. K. Abu Dayyyeh; A. Reichel; T. Vilela; S. Ngamruengphong; Y. Capsule endoscopy Haito-Chavez; M. Bukhari; P. Okolo; V. Kumbhari; A. Ismail; M. Khashab P1307 A RANDOMIZED CONTROLLED TRIAL COMPARING EARLY P1300 DEPLOYMENT OF A VIDEO CAPSULE VERSUS CONVEN- IMPACT OF THE FORMATION OF A REGIONAL EUS TIONAL WORK-UP OF NON- GASTROIN- INTEREST GROUP AMONGST COMMUNITY HOSPITALS TESTINAL BLEEDING: INTERIM ANALYSES ON THE YIELD OF EUS GUIDED TISSUE ACQUISITION IN N. Marya; S. Jawaid; A. Foley; K. Patel; S. Han; A. SUSPECTED PANCREATIC MALIGNANCY Rupawala; D. Kaufman; C. Marshall; K. Bhattacharya; J. Rutger Quispel, The Netherlands; L. Van Driel; P. Tennyson; David Cave, USA Honkoop; M. Hadithi; C. Fitzpatrick; M.-P. Anten; I. Leeuwenburgh; G. Bezemer; B. Veldt; M. J. Bruno P1308 VALIDATION OF SPICE, A METHOD OF DIFFERENTI- P1301 ATING SMALL BOWEL SUBMUCOSAL LESIONS FROM CLINICAL ROLE OF FORWARD VIEWING ECHOENDO- INNOCENT BULGES ON CAPSULE ENDOSCOPY SCOPE FOR EUS-FNA, ESPECIALLY "SUCTION METHOD Jaime Rodrigues, Portugal; R. Pinho; A. Rodrigues; J. WITH CAP" FOR EUS-FNA OF SUBMUCOSAL TUMORS Silva; A. Ponte; M. Sousa; J. Carvalho Mitsuhiro Kida, Japan; T. Kaneko; H. Yamauchi; K. Okuwaki; T. Iwai; M. Watanabe; H. Imaizumi; W. Koizumi P1309 DEVELOPMENT OF A COMPUTED CLEANSING SCORE P1302 TO ASSESS THE QUALITY OF BOWEL PREPARATION IN EFFICIENCY OF STYLET CAPILLARY SUCTION AND COLON CAPSULE ENDOSCOPY STANDARD SUCTION TECHNIQUE OF ENDOSCOPIC A. Becq; A. Histace; M. Camus; I. Nion Larmurier; E. ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION (EUS- Abou Ali; O. Romain; U. Chaput; P. Marteau; C. Florent; FNA) IN SOLID PANCREATIC CANCER Xavier Dray, France Zoltan Gabor Szepes, Hungary; R. Bor; B. Vasas; A. Fábián; A. Balint; K. Farkas; A. Milassin; M. Rutka; M. P1310 Szucs; L. Czakó; S. Hamar; L. Tiszlavicz; T. Molnar THERAPEUTIC IMPACT OF COLON CAPSULE AS A PAN-ENTEROSCOPIC TEST P1303 Cristina Carretero, Spain; C. Prieto De Frias; F. Zozaya; CHOLEDOCHOLITHIASIS AND COMMON BILE DUCT C. Mateo; M. Muñoz Navas ECTASIA: ALWAYS ASSOCIATED?

João Pinto, Portugal; R. Azevedo; H. Ribeiro; C. Leitão; P1311 A. Caldeira; E. Pereira; A. Banhudo DEVELOPMENT AND VALIDATION OF A HIGHLY SENSI- TIVE AND HIGHLY SPECIFIC COMPUTED ASSESSMENT P1304 OF CLEANSING SCORE FOR SMALL BOWEL CAPSULE ENDOSCOPIC ULTRASOUND (EUS) GUIDED CYANOAC- ENDOSCOPY RYLATE INJECTION FOR VARICEAL OBTURATION AS Einas Abou Ali, France; A. Histace; M. Camus; R. SECONDARY PROPHYLAXIS FOR PATIENTS AT HIGH Gerometta; A. Becq; I. Nion Larmurier; U. Chaput; P. RISK FOR RECURRENT GASTROESOPHAGEAL VARICEAL Marteau; O. Romain; C. Florent; X. Dray BLEEDING: A PILOT STUDY Raymond Tang, Hong Kong; J. C. T. Wong; M. Kyaw; A. P1312 Y. B. Teoh; Y.-K. Tse; T. Lam; J. C. Y. Wu; H. L. Y. Chan; CLINICAL UTILITY OF THE PATENCY CAPSULE J. Y. W. Lau Armando Peixoto, Portugal; M. Silva; R. Coelho; R. Gaspar; R. Liberal; R. Castro; A. Albuquerque; M. P1305 Marques; H. Cardoso; G. Macedo ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAINAGE BY HEPATICOGASTROSTOMY FOR MALIGNANT HILAR P1313 Wednesday, October 19, 2016 19, October Wednesday, BILIARY OBSTRUCTION IS A HELPFUL FEASIBLE PALLIA- SMALL BOWEL MALIGNANCY IN PATIENTS UNDER- TIVE TREATMENT IN DAILY PRACTICE GOING CAPSULE ENDOSCOPY IN A TERTIARY CARE Frederick Moryoussef, France; A. Sportes; S. Leblanc; ACADEMIC INSTITUTION J.-B. Bachet; S. Chaussade; F. Prat C. Johnston; Diana Yung, United Kingdom; A. Koulaouzidis; J. N. Plevris

Poster in the Spotlight Poster of Excellence Clinical Case Session 219

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

Enteral dilatation and stenting (oesophagus, stomach, P1323 duodenum, colon) ENDOSCOPIC MANAGEMENT OF COMPLICATIONS OF SELF-EXPANDABLE METAL STENTS FOR TREATMENT OF P1314 MALIGNANT ESOPHAGEAL STENOSIS AND TRACHEO- A COMPARATIVE STUDY OF FOUR MATERIALS FOR THE ESOPHAGEAL FISTULA DEVELOPMENT OF NOVEL DUODENAL-JEJUNAL BYPASS Renáta Bor, Hungary; A. Fábián; A. Balint; K. Farkas; LINER M. Szucs; A. Milassin; L. Czakó; M. Rutka; T. Molnar; Z. J. M. Lee; Hoon Jai Chun, South Korea; S. Y. Lee; B. Szepes K. Choi; I. K. Yoo; S. H. Kim; H. S. Choi; E. S. Kim; B. Keum; H. S. Lee; C. D. Kim P1324 PREDICTORS OF COMPLICATIONS AND MORTALITY IN P1315 SELF-EXPANDING METAL STENTS FOR PALLIATION OF EUS-GUIDED ENTERO-ANASTOMOSIS WITH LUMEN MALIGNANT COLONIC OBSTRUCTION APPOSING METAL STENT: PRELIMINARY ASSESSMENT Mafalda Sousa, Portugal; R. Pinho; L. Proença; J. Silva; OF INDICATIONS, EFFECTIVENESS AND SAFETY A. Ponte; J. P. Rodrigues; J. Carvalho R. Sanchez-Ocana; Irene Peñas-Herrero, Spain; P. Gil-Simon; C. De La Serna Higuera; M. Pérez-Miranda P1325 ENDOSCOPIC GASTRODUODENAL SELF-EXPANDABLE P1316 METAL STENT PLACEMENT: REVIEW OF OUTCOME IN A SURVEILLANCE IN ESOPHAGEAL ATRESIA PATIENTS: EN- LARGE ACUTE UK HOSPITAL DOSCOPY SHOULD BE A ROUTINE IN POST OPERATIVE? T. Riley; Thomas Hollingworth, United Kingdom; R. Paula Peruzzi Elia, Brazil; A. Freire; D. Oliveira; A. Ellis; A. Fowell; P. Goggin Silveira; I. Abreu; P. Boechat P1317 Small bowel / Colorectal and anal RADIOACTIVE STENT FOR ESOPHAGUS CARCINOMA A. Herskovic; M. J. Rivard; P. J. Hoopes; R. Rothstein; K. Poster Session L. Moodie; Z. Hussain; L. Swanson; R. R. Strawbridge; 09:00 - 17:00 Hall X4 J. K. Saunders; K. Corcoran; A. Townsend; J. Hingston; Surgery III Claude Clerc, USA P1326 P1318 WHAT IS THE EXPERIENCE OF UK GENERAL SURGERY ENDOSCOPIC TREATMENT OF POST-LAPAROSCOPIC TRAINEES IN RELATION TO HAEMORRHOIDECTOMY: SLEEVE GASTRECTOMY LEAKS WITH A SPECIFICALLY OPERATIVE NUMBERS, PROCEDURE-BASED ASSESS- DESIGNED METAL STENT MENTS AND THE ASSOCIATION BETWEEN THESE? V. Bove; Andrea Tringali, Italy; R. Landi; V. Perri; I. Elizabeth Elsey, United Kingdom; G. Griffiths; J. West; Boskoski; P. Familiari; F. Barbaro; G. Costamagna D. Humes P1319 P1327 ULTRA-LONG BENIGN ESOPHAGEAL STRICTURES HAVE NOMOGRAM PREDICTS STOMA REVERSAL RATE AFTER POOR OUTCOME LOW ANTERIOR RESECTION WITH COVERING ILEOSTOMY M. Pang; M. J. Bartel; C. R. Simons Linares; E. C. Brand; Shinya Abe, Japan; K. Kawai; S. Ishihara; K. Sasaki; K. M. Raimondo; M. Wallace; Timothy A. Woodward, USA Murono; K. Yasuda; K. Otani; T. Nishikawa; T. Tanaka; P1320 T. Kiyomatsu; K. Hata; H. Nozawa; T. Watanabe

Wednesday, October 19, 2016 OUTCOMES OF SELF-EXPANDABLE METAL STENTS IN P1328 THE PALLIATIVE TREATMENT OF GASTRODUODENAL METASTATIC SMALL BOWEL ADENOCARCINOMA: OBSTRUCTION: A SINGLE-CENTRE EXPERIENCE SERIES OF 34 RESECTIONS Joana Carvalho E. Branco, Portugal; L. C. C. Lourenço; Pierre Rompteaux, France; J. Gagnière; J.-M. Gornet; R. V. Anapaz; A. Oliveira; R. Carvalho; D. Horta; J. Reis Coriat; I. Baumgaertner; T. Lecomte; P. Afchain; J.-B. P1321 Bachet; N. Bonichon-Lamichhane; O. Bouché; J.-L. FEATURES OF ESOPHAGEAL STENTING USING ULTRA- Faucheron; J. Forestier; M. Kanaan; C. Lecaille; J. THIN ENDOSCOPE L. Legoux; S. Manfredi; C. Sarda; E. Terrebonne; D. Denis Gusev, Russia Tougeron; A.-L. Villing; A. Zaanan; R. Benamouzig; T. Aparicio P1322 USE OF TEMPORARY SELF-EXPANDABLE METALLIC STENT PLACEMENT IN POST-GASTRECTOMY COMPLICATION Hyun-Jin Oh, South Korea; C.-H. Lim

220 Poster in the Spotlight Poster of Excellence Clinical Case Session 221 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1329 P1338 SURGICAL TREATMENT OF ENTEROVESICAL FISTULA - ROLE OF SLC26A3 (DRA) ION TRANSPORTER IN EN- DOES SUTURING URINARY BLADDER MATTER? HANCING INTESTINAL EPITHELIAL BARRIER IN COLITIS Marcin Wlodarczyk, Poland; A. Sobolewska-Wlodarczyk; M. Li; D. Tian; X. Ding; Yu Qin, China L. Dziki; A. Dziki P1339 P1330 CLINICAL CHARACTERISTICS OF INFLAMMATORY NEW SURGICAL APPROACH IN PREVENTION OF ANASTO- BOWEL DISEASE DIAGNOSED BEFORE OR AFTER OF MOTIC LEAKS IN PATIENTS WITH COLON OBSTRUCTION PRIMARY SCLEROSING CHOLANGITIS (PSC): EFFECT ON Stepan Grytenko, Ukraine PSC OUTCOME P1331 Alec Hellström, Finland; M. A. Färkkila DISEASE FREE SURVIVAL IN THE YOUNG PATIENTS P1340 WITH COLORECTAL CANCER: A POSSIBLE ROLE FOR ENDOSCOPIC INJECTION OF MESENCHYMAL STROMAL IMMUNESURVEILLANCE? CELLS INTO THE BOWEL WALL ATTENUATES EXPERI- Alain Fiorot, Italy; A. Pozza; C. Ruffolo; M. Scarpa; M. MENTAL COLITIS Massani; E. Caratozzolo; L. Bonariol; F. Calia Di Pinto; Marieke Barnhoorn, The Netherlands; E. S. M. De C. Castoro; N. Bassi Jonge-Muller; M. A. C. Mierement-Ooms; D. Van Der Helm; M. L. Van Gulijk; J. D. Hoogenboom; I. Molendijk; Laparoscopic techniques A. E. Van Der Meulen-De Jong; L. J. A. C. Hawinkels; H. P1332 W. Verspaget FEASIBILITY AND SAFETY OF LAPAROSCOPIC AND P1341 ENDOSCOPIC COOPERATIVE SURGERY FOR GASTRIC A SCFA-RECEPTOR AGONIST SUPPLEMENTATION AS SUBMUCOSAL TUMORS A NEW STRATEGY TO PROTECT AGAINST INTESTINAL Kazhiro Matsumoto, Japan INFLAMMATION IN MICE P1333 Allison Agus, France; J. Denizot; G. Sevrin; J. Thévenot; LAPAROSCOPY ENDOSCOPY COOPERATIVE SURGERY S. Massier; P. Sauvanet; P. Hofman; R. Bonnet; E. (LECS) PROCEDURE TO BREAKTHROUGH THE LIMITA- Billard; N. Barnich TION OF ESD AND EMR FOR COLORECTAL TUMORS P1342 Yoshiro Tamegai, Japan; Y. Fukunaga; H. Osumi; T. BIOLOGIC FUNCTIONS BETWEEN NON-AFFECTED Kishihara; A. Chino; S. Saito; M. Igarashi AND AFFECTED MARGINS OF ILEUM SAMPLES FROM P1334 CROHN'S DISEASE PATIENTS WHO WILL DEVELOP LAPAROSCOPIC NO-TOUCH PANCREATICODUODENECTOMY POST-SURGICAL RECURRENCE Liudmyla Pererva, Ukraine; V. Kopchak; K. Kopchak; I. Arce Garcia-Jaraquemada, Spain; V. Loren; A. Aterido; Khomiak; A. Duvalko; S. Andronik; I. Skrypnychuk F. Kamberovic; A. Julià; Y. Zabana; A. Alonso; M. Mañosa Ciria; S. Marsal; E. Domènech; E. Cabré; J. Manyé P1335 WITHDRAWN P1343 THE GUT MICROBIOTA PROFILE AND HOST ANTI-MI- P1336 CROBIAL RESPONSE AT ONSET OF ULCERATIVE COLITIS WITHDRAWN IS ASSOCIATED WITH DISEASE COURSE M. K. Magnusson; H. Strid; M. Simrén; Lena Öhman, Basic / pathogenesis / pathology Sweden P1344 Poster Session THE ROLE FOR T CELLS IN THE PATHOGENESIS OF 09:00 - 14:00 Hall X5 CROHN'S DISEASE-ASSOCIATED FISTULAE IBD III Ramona Bruckner, Switzerland; M. R. Spalinger; S. P1337 Lang; G. Rogler; M. Scharl TWO NEW GENETIC MOUSE MODELS FOR ULCERATIVE P1345 COLITIS BASED ON LATERAL TIGHT JUNCTION DISRUPTION CAN TISSUE AND PERIPHERAL EOSINOPHILIA BE USED Wolfgang Stremmel, Germany; S. Staffer; M. J. Schneider; AS PREDICTORS FOR DISEASE OUTCOME IN CHILDREN H. Gan-Schreier; A. Wannhoff; N. C. Stuhrmann; A. WITH ULCERATIVE COLITIS? 2016 19, October Wednesday, Gauss; H. Wolburg; A. Swidsinski; T. Efferth S. Morgenstern; E. Brook; F. Rinawi; R. Shamir; Amit Assa, Israel

Poster in the Spotlight Poster of Excellence Clinical Case Session 221

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1346 P1354 IL-33/ST2 AXIS SUSTAINS GUT MUCOSAL WOUND HEAL- IN DEPTH RESEARCH ON AIEC STRAINS RECOVERED ING AND CANCEROGENESIS IN COLITIS-ASSOCIATED FROM CROHN'S DISEASE PATIENTS AND THEIR HEALTHY COLORECTAL CANCER RELATIVES: A RISK FOR INTRAFAMILIAL TRANSMISSION? Loris Riccardo Lopetuso, Italy; C. De Salvo; L. Di Martino; O. Rahmouni; A. Sivignon; C. Vignal; C. Gower Rousseau; W. Goodman; F. Scaldaferri; A. Gasbarrini; T. T. Pizarro C. Flahaut; J.-L. Desseyn; N. Barnich; Jean-Frederic Colombel, USA; B. Pot; P. Desreumaux; C. Neut P1347 CEACAM1 REGULATION OF BCR SIGNALING IN THE P1355 ACTIVATED B CELLS IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE Akinori Hosoya, Japan; T. Nagaishi; A. Tokai; T. Watabe; IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL N. Jose; Y. Kojima; M. Yamazaki; R. S. Blumberg; M. DISEASE AFTER 4 WEEKS OF ADDITIVE TREATMENT Watanabe WITH MENTHACARIN - A RANDOMIZED, PLACEBO-CON- TROLLED TRIAL P1348 Matthias Engel, Germany; B. Stracke METABONOMICS REVEALS DISTINCT SERUM META- BOLIC CHANGES DURING INFLIXIMAB THERAPY OF P1356 INFLAMMATORY BOWEL DISEASE PROPHYLACTIC AND CURATIVE POTENTIAL OF THE Jacob Wium Bjerrum, Denmark; C. Steenholdt; M. HERBAL PREPARATION STW 5 IN AN EXPERIMENTAL Ainsworth; O. H. Nielsen; M. Reed; K. Atkins; U. MODEL OF CROHN'S DISEASE Günther; F. Hao; Y. Wang Mohamed T. Khayyal, Egypt; W. Wadie; D. Abdallah; M. J. Schneider; T. Efferth; O. Kelber; H. Abdel-Aziz P1349 IDENTIFICATION OF A TRANSCRIPTIONAL SIGNATURE Aetiology / epidemiology ASSOCIATED WITH POST-OPERATIVE RECURRENCE IN CROHN'S DISEASE: A STUDY FROM THE REMIND GROUP P1357 Marjolaine Ngollo, France; C. Auzolle; V. Chardiny; WITHDRAWN C. Stefanescu; S. Nancey; N. Barnich; P. Desreumaux; J.-M. Gornet; P. Marteau; P. Hofman; P. Seksik; L. Le P1358 Bourhis; M. Allez ENVIRONMENTAL FACTORS AND TRENDS IN IBD Stefania Chetcuti Zammit, Malta; A. Brincat; G. Laferla; P1350 J. Burisch; P. Ellul ANTI TNFA THERAPY MODULATES THE INTESTINAL MI- CROBIOTA ACROSS CHRONIC INFLAMMATORY DISEASE P1359 Konrad Aden, Germany; A. Rehmann; W.-H. Pang; IBD-RELATED MALIGNANCIES AND MORTALITIES J. Bethge; S. Nikolaus; R. Zeuner; J. O. Schroeder; S. OBSERVED IN 2015-2016. FIRST RESULTS FROM THE Schreiber; P. Rosenstiel PROSPECTIVE NATIONWIDE HUNGARIAN REGISTRY Tamas Molnar, Hungary; M. Rutka; F. Nagy; P. Fitz; L. P1351 Lakatos; P. Miheller; T. Szamosi; A. Vincze; J. Banai; Á. GAMMADELTA T CELL DEFICIENCY IN THE PERIPHERAL Kovács; J. Novák; A. Salamon; A. Z. Szepes; N. Szigeti; BLOOD OF PATIENTS WITH CROHN'S DISEASE: RELA- M. Juhász; K. Müllner; Z. Barta; O. Kadenczki; T. Kristof; TIONSHIP WITH CLINICAL AND ENDOSCOPICAL ACTIVITY A. Balint; R. Bor; A. Milassin; Z. G. Szepes; K. Farkas Ignacio Catalan-Serra, Norway; C. Garcia-Ballesteros; R. Gil-Borrás; V. Amigó-García; C. Benet; F. Ballester; J. P1360 C. Andreu-Ballester CROHN'S DISEASE BEHAVIOR AND LOCATION IS AL- Wednesday, October 19, 2016 TERED WHEN ASSOCIATED WITH PRIMARY SCLEROSING P1352 CHOLANGITIS INTESTINAL TOTAL BACTERIA CONCENTRATION AND O. Iny; H. Yanai; S. Matalon; E. Santo; O. Shibolet; I. TRANSLOCATION OF BACTERIA AT THE INFLAMMATORY Dotan; Nitsan Maharshak, Israel BOWEL DISEASE S. Vrakas; M. Gazouli; K. Mountzouris; G. Michalopoulos; P1361 G. Karamanolis; G. V. Papatheodoridis; Charalampos THE BODY MASS INDEX DOES NOT INFLUENCE SUCCESS Tzathas, Greece OF ANTI-TNFA THERAPY: RETROSPECTIVE SINGLE CENTER ANALYSIS OF 894 IBD PATIENTS P1353 Markus Brückner, Germany; L. Deckers; T. Nowacki; M. ANALYSIS OF MACRONUTRIENTS INTAKES IN INFLAM- Eveslage; P. Tepasse; F. Cordes; F. Gohar; K. Hengst; F. MATORY BOWEL DISEASE: CORRELATION WITH DISEASE Lenze; D. Bettenworth ACTIVITY M. Principi; Giuseppe Losurdo, Italy; V. Deflorio; N. Ranaldo; A. Iannone; M. Barone; E. G. Ierardi; A. Di Leo

222 Poster in the Spotlight Poster of Excellence Clinical Case Session 223 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1362 P1369 EFFECT OF INFLUENZA VACCINATION ON THE ACTIVITY DEVELOPMENT AND VALIDATION OF A DEVICE FOR OF INFLAMMATORY BOWEL DISEASE RAPID MONITORING OF ADALIMUMAB IN SERUM OF Mariann Rutka, Hungary; K. Farkas; F. Nagy; M. Szucs; INFLAMMATORY BOWEL DISEASE PATIENTS R. Bor; A. Fabian; A. Milassin; A. Balint; Z. G. Szepes; Sumin Bian, Belgium; J. Lu; F. Delport; D. Spasic; S. T. Molnar Vermeire; J. Lammertyn; A. Gils P1363 P1370 SATISFACTION WITH LIFE AND COPING IN CROHN'S PHENOTYPE CORRELATION IN INFLAMMATORY BOWEL DISEASE: A GENDER PERSPECTIVE DISEASE (IBD) COMPARED TO SEROLOGIC ANTIBODY O. Sarid; V. Slonim-Nevo; M. Friger; R. Sergienko; A. ACTIVITY AT DIAGNOSIS AND AFTER TREATMENT Pereg; D. Schwartz; D. Greenberg; E. Chernin; H. Vardi; Trond Espen Detlie, Norway; M. S. Cvancarova; P. Ricanek; Shmuel Odes, Israel S. Brackmann; A. Rydning; M. H. Vatn; J. Jahnsen P1371 Diagnosis and monitoring ACQUIRED VON WILLEBRAND SYNDROME IN PATIENTS P1364 WITH INFLAMMATORY BOWEL DISEASE PREGNANCY DOES NOT AFFECT FAECAL CALPROTEC- D. Owczarek; Dorota Cibor, Poland; K. Salapa; T. Rodacki; TIN CONCENTRATION IN HEALTHY PREGNANT WOMEN R. Domagala-Rodacka; T. Mach Anita Balint, Hungary; A. Berényi; K. Farkas; É. Pallagi P1372 Kunstár; Á. Altorjay; A. Csonka; M. Krizsán; M. Szucs; 7-ALPHA-CHOLESTENONE AND FAECAL CALPROTECTIN A. Pál; R. Bor; A. Milassin; Á. Szulcsán; M. Rutka; Z. IN PATIENTS WITH COLLAGENOUS COLITIS Szepes; T. Molnar R. Trimble; Diana Yung, United Kingdom; A. Koulaouzidis P1365 P1373 CLINICAL PREDICTORS OF INTESTINAL BOWEL DAMAGE BIOLOGICAL THERAPY IS ABLE TO HALT CROHN'S AND DAMAGE PPROGRESSION ASSESSED BY THE DISEASE PROGRESSION: A PROSPECTIVE, LONG TERM LÉMANN INDEX IN PATIENTS WITH CROHN'S DISEASE. STUDY USING THE LÉMANN INDEX M. Pedaci; Gian Eugenio Tontini, Italy; L. Pescatori; S. Giorgia Bodini, Italy; G. Pellegatta; E. Giannini; V. Vavassori; L. Spina; L. Pastorelli; M. L. Annunziata; F. Savarino; C. De Maria; I. Baldissarro; E. Savarino Cavallaro; E. Filippi; F. Ambrogi; L. M. Sconfienza; M. Vecchi P1374 DETECTION OF ANTI-INFLIXIMAB ANTIBODIES IS P1366 IMPACTED BY ANTIBODY TITER, INFLIXIMAB LEVEL A PILOT STUDY ASSESSING AGREEMENT AMONG AND IGG4 ANTIBODIES: A SYSTEMATIC COMPARISON OF NURSE AND GASTROENTEROLOGIST IN COMPUTING THREE DIFFERENT ASSAYS IBD-CLINICAL SCORES Joana Afonso, Portugal; S. Lopes; R. Gonçalves; P. F. Mocciaro; Roberto Di Mitri, Italy; D. Scimeca; G. M. Caldeira; P. Lago; H. Tavares; J. Ramos; A. R. Gonçalves; Pecoraro; F. Bossa; G. Russo; G. Martino; D. Varvara; V. P. Ministro; I. Rosa; A. Vieira; F. Ferreira; Y. Chowers; S. Costanza; A. Profita; C. Orlando; G. Profeta; F. Tinè Ben-Horin; F. Magro P1367 P1375 SYSTEMATIC REVIEW WITH META-ANALYSIS: THE EF- UTILITY OF EMERGENCY DEPARTMENT CT SCANS IN FECT OF TOBACCO SMOKING ON THE NATURAL HISTORY PATIENTS WITH ULCERATIVE COLITIS OF ULCERATIVE COLITIS Dion Booras, USA; M. Chiorean; D. La Selva N. To; A. C. Ford; David John Gracie, United Kingdom P1376 P1368 A CHANGE IN ΔMCV PREDICTS MUCOSAL HEALING IN USEFULNESS OF CONSECUTIVE FECAL CALPROTECTIN PATIENTS WITH CROHN'S DISEASE UNDER COMBINA- MEASUREMENTS TO PREDICT RELAPSE IN INFLAMMA- TION THERAPY TORY BOWEL DISEASE PATIENTS UNDER MAINTE- Sonia Bernardo, Portugal; S. R. R. Fernandes; L. A. NANCE TREATMENT WITH ANTI-TNF DRUGS Correia; J. Velosa Rocio Ferreiro Iglesias, Spain; M. Barreiro-De Acosta; A. Lorenzo-González; J. E. Domínguez-Muñoz P1377

SERUM NEUTROPHIL GELATINASE-ASSOCIATED LIPO- 2016 19, October Wednesday, CALIN IN INFLAMMATORY BOWEL DISEASE: A NEW ACTIVITY MARKER M. Rivero; Maria Jose Garcia, Spain; M. T. Garcia-Unzueta; P. Ruiz; S. Alvarez; A. Cimadevilla; B. Castro; J. Crespo

Poster in the Spotlight Poster of Excellence Clinical Case Session 223

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1378 P1387 BOWEL DAMAGE IN CROHN'S DISEASE: DIRECT COM- RED FLAGS INDEX: VALIDATION AND CLINICAL UTILITY PARISON OF ULTRASONOGRAPHY- AND MAGNETIC Joana Silva, Portugal; C. Fernandes; A. Ponte; J. RESONANCE-BASED LEMANN INDEX Rodrigues; M. Sousa; J. Carvalho Nicola Imperatore, Italy; F. Castiglione; A. Testa; P. P. Mainenti; G. D. De Palma; M. Rea; O. M. Nardone; G. P1388 Luglio; P. Gervetti; A. Rispo SOLUBILE TRANSFERRIN RECEPTOR IN DIAGNOSIS OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAM- P1379 MATORY BOWEL DISEASE PATIENT-NEAR INFLIXIMAB TROUGH-LEVEL TESTING Milica Stojkovic Lalosevic, Serbia; S. Stankovic; L. BY A NOVEL QUANTITATIVE RAPID TEST: THE QUANTUM Martinovic; M. Vojnovic; D. Kojic; S. Boskovic; M. BLUE INFLIXIMAB ASSAY Stojkovic I. Lindsjø; G. H. Malmstrøm; Arne Røseth, Norway P1389 P1380 UPPER ENDOSCOPY IN INFLAMMATORY BOWEL DISEAS- HOME MONITORING OF DISEASE ACTIVITY AND FECAL ES (IBD): WHAT CONTRIBUTION? CALPROCTIN IN ADULT PATIENTS WITH INFLAMMATORY Fadoua Er-Rabie, Morocco; W. Khannoussi; S. E. BOWEL DISEASE Elmahjoubi; A. Elmekkaoui; Z. Ismaili; G. Kharrase Dorit Ankersen, Denmark; D. Marker; J. Burisch; P. Munkholm P1390 SCREENING FOR DYSPLASIA AND COLORECTAL CAN- P1381 CER IN ULCERATIVE COLITIS: AN ALGERIAN STUDY ENDOSCOPY WITH LINKED COLOR IMAGING AND Houria Saoula, Algeria; A. Boutaleb; M. Aissaoui; H. NARROW BAND IMAGING EFFICIENCY FOR EVALUATION Mahiou; A. Salah; D. Hamidouche; R. Osmane; A. Mitiche; OF MUCOSAL HEALING IN PATIENTS WITH QUIESCENT L. Malaoui; L. Gamar; K. Belhocine; Y. Zmiri; L. Kecili; ULCERATIVE COLITIS N. Ali Arous; N. Bounab; K. Saidani; A. Bousseloub; A. Maiko Hanada, Japan; C. Watanabe; S. Tomokiyo; R. E. M. Balamane; H. Asselah; F. Asselah; S. Berkane; Y. Otani; T. Namba; S. Saeki; M. Higashiyama; T. Hiramoto; Aissat; T. Boucekkine; Z. Amir; M. Nakmouche Y. Hiraga; M. Sumioka P1391 P1382 NATURAL HISTORY OF NON SEVERE ULCERATIVE COLI- PATENCY CAPSULE RETENTION IN IBD. IS IT ALWAYS TIS AT DIAGNOSIS DUE TO STRICTURES? Wafa Dahmani, Tunisia; W. Ben Mansour; M. H. Martina Muscat, Malta; J. Gauci; P. Ellul Loghmari; A. Guedich; L. Safer P1383 P1392 UTILITY OF C-REACTIVE PROTEIN (CRP) IN PREDICTING EVALUATION OF PATIENTS WITH QUIESCENT CROHN'S COMPLICATED DISEASE COURSE IN CROHN'S DISEASE DISEASE BASED ON CAPSULE ENDOSCOPY CROHN'S Ian Reilly, United Kingdom; Y. Prasad; S. Subramanian DISEASE ACTIVITY INDEX (CECDAI) Teppei Omori, Japan; H. Kanbayashi; M. Shun; H. P1384 Kashiwagi; T. Hara; T. Kuriyama; A. Ito; M. Yonezawa; RISK FACTORS FOR A DIAGNOSTIC DELAY IN IBD B. Iizuka; K. Tokushige A. Degen; C. Buening; B. Siegmund; M. Prager; J. Maul; J. C. Preiss; B. Wiedenmann; A. Sturm; Anja Treatment-medical Schirbel, Germany

Wednesday, October 19, 2016 P1393 P1385 CLINICAL EFFICACY OF THE TOLL LIKE RECEPTOR-9 AG- RELATIONSHIP BETWEEN SERUM INFLIXIMAB TROUGH ONIST COBITOLIMOD IN ANTI-TNF-ANTIBODY TREATED LEVELS AND LABORATORY PARAMETERS IN PATIENTS AND NAIVE PATIENTS WITH MODERATE TO SEVERE WITH INFLAMMATORY BOWEL DISEASES ACTIVE ULCERATIVE COLITIS Anna Fabian, Hungary; K. Farkas; D. Kanaaneh; A. Raja Atreya, Germany; W. Reinisch; L. Peyrin-Biroulet; Balint; R. Bor; M. Rutka; A. Milassin; T. Ferenci; F. F. Scaldaferri; C. Admyre; T. Knittel; J. Kowalski; C. J. Nagy; Z. G. Szepes; T. Molnar Hawkey P1386 ANAEMIA IN CROHN'S DISEASE - SHOULD WE ASSESS MUCOSAL HEALING IN PATIENTS IN CLINICAL REMISSION? Rita Vale Rodrigues, Portugal; J. Pereira Da Silva; I. Rosa; M. Serrano; A. Dias Pereira

224 Poster in the Spotlight Poster of Excellence Clinical Case Session 225 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1394 P1401 COST-UTILITY OF BIOSIMILAR INFLIXIMAB FOR THE EFFICACY, SAFETY AND LONG-TERM OUTCOME OF TREATMENT OF FISTULISING CROHN'S DISEASE IN ENDOSCOPIC DILATION THERAPY FOR STRICTURING NINE EUROPEAN COUNTRIES CROHN'S DISEASE OF THE UPPER GASTROINTESTINAL Petra Baji, Hungary; M. Pentek; V. Brodszky; L. Gulacsi; TRACT - A COMBINED ANALYSIS OF 127 ENDOSCOPIC F. Rencz; P. A. Golovics; K. B. Gecse; Z. Vegh; S. BALLOON DILATION PROCEDURES Danese; P. Irving; P. L. Lakato Dominik Bettenworth, Germany; M. M. Mücke; A. Singh; R. Lopez; F. Rieder P1395 BODY COMPOSITION PROFILE: A PREDICTOR OF THER- P1402 APEUTIC OUTCOME IN PATIENTS WITH MODERATE TO SCREENING FAILURE RATES IN A LARGE CLINICAL TRIAL SEVERE CROHN'S DISEASE CENTRE FOR INFLAMMATORY BOWEL DISEASES: INCI- Nik Sheng Ding, United Kingdom; G. Malitezis; P. F. DENCE, CAUSES AND CONSEQUENCES C. Lung; W. M. Yip; L. Penez; T. Ganeshanathan; S. M. Liese Gijbels, Belgium; S. Coenen; M. Noman; S. Gabe; I. Jenkins; A. L. Hart Vermeire; G. Van Assche; M. Ferrante P1396 P1403 PLACENTAL MADCAM1 EXPRESSION - POTENTIAL CON- TROUGH LEVELS AND ANTIBODIES TO USTEKINUMAB SEQUENCES FOR THE TREATMENT WITH VEDOLIZUMAB ARE NOT CORRELATED TO RESPONSE TO USTEKINUMAB DURING PREGNANCY TREATMENT IN CROHN'S DISEASE PATIENTS Zuzana Zelinkova, Slovakia; K. Berakova; D. Podmanicky; Claire Painchart, France; S. Brabant; N. Duveau; M. B. Kadleckova Nachury; P. Desreumaux; J. Branche; R. Gerard; M. Boualit; M. Labalette; B. Pariente P1397 NOVEL BUDESONIDE SUPPOSITORIES VERSUS GOLD P1404 STANDARD MESALAZINE SUPPOSITORIES FOR ACTIVE HOSPITALISATIONS AND TREATMENT DISCONTINU- . A PROSPECTIVE, DOUBLE BLIND, RAN- ATION AMONG PATIENTS WITH ULCERATIVE COLITIS DOMISED TRIAL AND CROHN'S DISEASE TREATED WITH VEDOLIZUMAB Wolfgang Kruis, Germany; V. Neshta; M. Pesegova; O. COMPARED WITH INFLIXIMAB Alekseeva; P. Andreev; O. Datsenko; O. Levchenko; S. R. M. Raluy-Callado; N. Alam; R. Wang; Javaria Mona Abdulkhakov; Y. Lozynskyy; Y. Mostovoy; K. Soloviev; A. Khalid, United Kingdom Dorofeyev; R. Mohrbacher; R. Greinwald; B. Siegmund P1405 P1398 EXCESS STEROID USE IN IBD: TOO MUCH, HOW MUCH VSL#3 IS NO LONGER VSL#3 IN CONTINENTAL EU- AND WHY? RESULTS FROM A NATIONWIDE AUDIT ROPE: WARNING FOR DOCTORS AND PATIENTS Bu Hayee, United Kingdom; A. Bassi; E. Fogden; J. K. Claudio De Simone, Italy Limdi; H. Ludlow; S. Mclaughlin; G. C. Parkes; P. Patel; M. Smith; T. Raine; C. Selinger P1399 CALPROTECTIN IS LESS ACCURATE THAN MAYO EN- P1406 DOSCOPY SCORE TO MONITOR CONTINUOUS CLINICAL HOSPITALIZATION RISK AND REINTERVENTION AFTER RESPONSE IN PATIENTS WITH MODERATE TO SEVERE ILEOCOLONIC RESECTION WITH ANASTOMOSIS IN ULCERATIVE COLITIS PATIENTS WITH CROHN'S DISEASE. RESULTS FROM THE W. Reinisch; J.-F. Colombel; A. Khalifa; R. Yao; S. Huyck; PRACTICROHN STUDY G. Philip; Freddy Cornillie, Switzerland Valle García, Spain; M. Calvo; M. D. Martín Arranz; M. Rivero; E. Domènech; M. Barreiro-De Acosta; E. García P1400 Planella; A. Gutiérrez; C. Romero; L. Cea-Calvo; B. Juliá THE COMBINED CELL AND ANTICYTOKINE THERAPY De Páramo PROMOTES DEEP REMISSION OF CROHN'S DISEASE O. Knyazev; Nina Fadeeva, Russia; A. Parfenov; S. P1407 Khomeriki; K. Noskova ASSESSMENT OF IMPACT III WELL-BEING DOMAIN SCORES IN ADALIMUMAB-TREATED PAEDIATRIC PA- TIENTS WITH CROHN'S DISEASE Amy Grant, Canada; A. Otley; J. Escher; J. Hyams; J.-F. Maa; G. Alperovich; A. Lazar; A. M. Robinson; A. W. Wang; S. Eichner 2016 19, October Wednesday,

Poster in the Spotlight Poster of Excellence Clinical Case Session 225

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1408 P1416 FRENCH PROSPECTIVE, LONGITUDINAL OBSERVATION- SYSTEMATIC LITERATURE REVIEW ON THE IMMUNO- AL STUDY OF THE THERAPEUTIC MANAGEMENT OF GENICITY OF BIOLOGICS IN INFLAMMATORY BOWEL MILD TO MODERATE ULCERATIVE COLITIS (OPTIMUM): DISEASE FOLLOW-UP AT 3 YEARS Severine Vermeire, Belgium; A. Gils; P. Accossato; S. S. Nahon; G. Bonnaud; Farah Bahbah, France Lula; A. Marren P1409 P1417 A PILOT STUDY TO EVALUATE THE BENEFITS OF A RE- TREATMENT OF BONE MARROW MESENCHYMAL CRUITMENT PLATFORM, CT-SCOUTTM IN INFLAMMATO- STROMAL CELLS REDUCES THE ACTIVITY ANKYLOSING RY BOWEL DISEASES (IBD) CLINICAL TRIALS: LINKING SPONDYLITIS ASSOCIATED WITH CROHN'S DISEASE POTENTIAL PATIENTS TO CLINICAL TRIALS O. Knyazev; Nina Fadeeva, Russia; A. Parfenov; A. Yoram Bouhnik, France; A. Amiot; A. Nuzzo; L. Konoplyannikov; A. Lishchinskaya; N. Orlova Mansouri; D. Soudan; C. Stefanescu P1418 P1410 BIOLOGICAL THERAPY AND PREGNANCY IN INFLAMA- SWITCHING OF PATIENTS WITH INFLAMMATORY BOWEL TORY BOWEL DISEASE: THE LONG-TERM SAFETY OF IN DISEASE FROM ORIGINAL INFLIXIMAB (REMICADE®) UTERO EXPOSURE IN A TERCIARY CENTER TO BIOSIMILAR INFLIXIMAB (REMSIMATM) IS EFFECTIVE Elisa Soares, Portugal; M. Gravito-Soares; S. Mendes; AND SAFE - ONE-YEAR FOLLOW-UP M. Ferreira; F. Portela; C. Sofia Martin Kolar, Czech Republic; D. Duricova; M. Bortlik; V. Hruba; N. Machkova; K. Mitrova; K. Malickova; M. P1419 Lukas; M. Lukas INFLAMMATORY CYTOKINES AND THEIR REGULATION OF 11 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2 P1411 IN IBD PATIENTS THE EVOLUTION OF INDICATIONS AND OUTCOMES Mary Hussey, Ireland; G. Holleran; S. Smith; M. OF SURGERY FOR PATIENTS WITH CROHN'S DISEASE Sherlock; D. Mcnamara DURING THE BIOLOGICAL AGENT ERA Chloe Attree, Australia; D. Ormonde; J. Staton; C. Platell P1420 A CLINICAL TRIAL OF THE EFFECTS OF VAGUS NERVE P1412 STIMULATION IN BIOLOGIC-REFRACTORY CROHN'S DETERMINATION OF LOWER ADALIMUMAB CUT-OFF DISEASE LEVELS IN PATIENTS WITH CROHN'S DISEASE Geert D'Haens, The Netherlands; Z. Cabrijan; M. Arne Carlsen, Norway; J. T. Kvaloy; R. Omdal; L. Aabakken; Eberhardson; S. Danese; Y. Levine; R. Zitnik N. Bolstad; D. Warren; K. E. A. Lundin; T. Grimstad P1421 P1413 PREDICTORS OF THE RESPONSE TO CORTICOSTEROIDS ANTI-TNF THERAPY IN REFRACTORY POUCHITIS AND TREATMENT IN THE ULCERATIVE COLITIS CROHN'S DISEASE-RELATED COMPLICATIONS OF THE Eva Barreiro Alonso, Spain; C. Saro Gismera; M. Sánchez POUCH AFTER ILEAL POUCH-ANAL ANASTOMOSIS FOLLOWING COLECTOMY FOR ULCERATIVE COLITIS: A P1422 SYSTEMATIC REVIEW AND META-ANALYSIS NUDT15 R139C GENOTYPE IS A DETERMINANT OF THIO- M. Huguet; B. Pereira; M. Goutte; F. Goutorbe; G. PURINE-INDUCED LEUKOPENIA IN CHINESE PATIENTS Bommelaer; Anthony Buisson, France WITH INFLAMMATORY BOWEL DISEASE: A MUTI-CEN- TER ANALYSIS

Wednesday, October 19, 2016 P1414 Kang Chao, China; Q. Cao; H. Yang; J. Liang; X. Zhu; L. PSYCHO-SOCIAL PREDICTORS FOR NONCOMPLIANCE Lin; Z. Huang; M. Huang; P. Hu; K. Wu; J. Qian; X. Gao TO CHRONIC DRUG TREATMENT IN CROHN'S DISEASE Batel Lasry, Israel; D. Schwartz; D. Greenberg; M. P1423 Friger; E. Chernin; H. Vardi; O. Sarid; V. Slonim-Nevo; EFFECTS OF HIGH- AND LOW-FAT MEALS ON THE A. Fich; S. Odes PHARMACOKINETICS OF OZANIMOD, A NOVEL SPHIN- GOSINE 1-PHOSPHATE RECEPTOR MODULATOR P1415 Jonathan Tran, USA; J. P. Hartung; C.-A. Tompkins; P. PATTERNS OF ADALIMUMAB USE AND ASSOCIATED A. Frohna COSTS IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN ANALYSIS OF REAL-WORLD HEALTH CLAIMS DATA IN THE NETHERLANDS Steven Bots, The Netherlands; D. R. Hoekman; M. A. Benninga; H. M. Smeets; G. R. A. M. D'Haens; M. Löwenberg

226 Poster in the Spotlight Poster of Excellence Clinical Case Session 227 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1424 P1431 INFLIXIMAB DOSE DOUBLING IS EFFECTIVE FOR OPTI- INFLIXIMAB BIOSIMILAR CT-P13 THERAPY IS EFFEC- MIZING TROUGH CONCENTRATIONS AND REGAINING TIVE IN MAINTAINING CLINICAL AND ENDOSCOPIC CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE REMISSION IN CROHN'S DISEASE AND ULCERATIVE Erwin Dreesen, Belgium; V. Ballet; G. Compernolle; G. COLITIS - EXPERIENCES FROM A SINGLE CENTER Van Assche; M. Ferrante; S. Vermeire; A. Gils Klaudia Farkas, Hungary; M. Rutka; T. Ferenci; F. Nagy; A. Balint; R. Bor; Á. Milassin; A. Fabian; Z. G. Szepes; P1425 T. Molnar ADD-ON THERAPY FOR INDUCTION OF REMISSION IN MILD-TO-MODERATE ULCERATIVE COLITIS: SYSTEMATIC P1432 REVIEW AND META-ANALYSIS CLINICAL EXPERIENCE WITH VEDOLIZUMAB IN AN- Paschalis Paschos, Greece; A. Katsoula; O. Giouleme; TI-TNF REFRACTORY IBD PATIENTS A.-V. Madenidou; E. Athnasiadou; A. Tsapas Brian Christopher, Ireland; O. Aoko; E. Anderson; C. Garry; M. Forry; M. Kennedy; M. O'Sullivan; A. O'Toole; P1426 S. Patchett; C. Smyth; S. Sengupta; R. J. Farrell EFFICACY OF INFLIXIMAB BIOSIMILAR CT-P13 INDUC- TION THERAPY ON MUCOSAL HEALING IN ULCERATIVE P1433 COLITIS PERCEPTION FROM PATIENTS WITH ULCERATIVE Tamas Molnar, Hungary; R. Bor; M. Rutka; P. A. COLITIS OR CROHN'S DISEASE TOWARDS THE PERFOR- Golovics; Z. Vegh; B. D. Lovasz; T. Nyári; K. B. Gecse; MANCE OF BIOSIMILARS VERSUS BIO-ORIGINATORS M. Kolar; M. Bortlik; D. Duricova; N. Machkova; V. X. Hu; E. Sullivan; J. Piercy; J. Waller; Christopher Hruba; M. Lukas; K. Mitrova; K. Malickova; A. Balint; Black, USA; S. Kachroo F. Nagy; R. Bor; A. Milassin; Z. Szepes; K. Palatka; P. L. Lakatos; M. Lukas; K. Farkas P1434 WEIGHT DISTRIBUTION IN EUROPEAN PATIENTS WITH P1427 CROHN'S DISEASE IN ADELPHI 2015 DSP SUBTHERAPEUTIC LEVELS OF INFLIXIMAB AND ADALI- Dominik Naessens, Belgium; B. Hoskin; J. Lucas MUMAB ARE ASSOCIATED WITH INCREASED DISEASE ACTIVITY IN PATIENTS WITH CROHN'S DISEASE P1435 Arne Carlsen, Norway; K. Isaksen; K. Leitao; A. K. MYCOPHENOLATE MOFETIL IS A VALID OPTION IN Hetta; L. Karlsen; R. Omdal; L. Aabakken; N. Bolstad; HARD-TO-TREAT PATIENTS WITH INFLAMMATORY D. Warren; K. E. A. Lundin; T. Grimstad BOWEL DISEASE Fabio Salvatore Macaluso, Italy; M. Maida; S. Renna; P1428 E. Orlando; M. Affronti; C. Sapienza; M. Dimarco; G. TUBERCULOSIS INFECTION IN AN INFLAMMATORY Rizzuto; R. Orlando; M. Cottone; A. Orlando BOWEL DISEASE COHORT OF PATIENTS RECEIVING ANTI-TNF THERAPY IN A MODERATE TO HIGH TUBER- Treatment-surgical CULOSIS INCIDENCE AREA IN EUROPE Rita Barosa, Portugal; M. Patita; L. Roque Ramos; G. P1436

Nunes; P. Figueiredo; A. Carmo Vieira; V. M. F. Pereira RISK FACTORS FOR COLECTOMY IN ULCERATIVE COLITIS Fernandes; J. Freitas PATIENTS WITH SEVERE FLARE-UP Wafa Dahmani, Tunisia; W. Ben Mansour; A. Guedich; P1429 M. H. Loghmari; L. Safer CUMULATIVE EXPOSURE TO ANTI-TNF ALPHA AND RISK OF CANCER P1437 Luís Maia, Portugal; P. Lago; Â. Rodrigues; M. Santos; THE PROGNOSTIC FACTORS AND OUTCOMES OF C. Caetano; M. Salgado; I. Pedroto RE-OPERATION WITHIN 6 MONTHS IN PATIENTS WITH INTESTINAL BEHCET'S DISEASE P1430 Yong Eun Park, South Korea; J. H. Cheon; W. H. Kim; T. ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL I. Kim; S. J. Park; H. J. Lee DISEASE: EFFECT OF ANTI-TNF THERAPY Marta Patita, Portugal; R. Barosa; L. Roque Ramos; G. P1438 Nunes; A. Vieira OUTCOMES OF ABDOMINAL RESECTIVE SURGERY FOR CROHN´S DISEASE: IMPACT OF BEHAVIOUR AND TREATMENT Panagiotis Katerinis, Germany; C. Schaefer; C. Ulmer; 2016 19, October Wednesday, W. Steurer; E. F. Stange

Poster in the Spotlight Poster of Excellence Clinical Case Session 227

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1439 P1446 PILOT STUDY ORAL ADMINISTRATION OF LACTOBACILLUS COMBINING FECAL IMMUNOCHEMICAL TESTING CASEI DG FOR 8 WEEKS AFTER ILEOSTOMY CLOSURE WITH THE GUT MICROBIOME IN COLORECTAL CANCER TEND TO DECREASE THE ACTIVATION LEVELS OF MACRO- SCREENING PHAGES AND DENDRITIC CELLS IN ILEAL POUCH MUCOSA Elisabeth Jacomina Grobbee, The Netherlands; G. Imerio Angriman, Italy; I. Castagliuolo; M. Scarpa; R. Fuhler; B. Blakaj; S. Konstantinov; M. J. Bruno; M. D'Inca; M. Martinato; A. Caruso; A. Michielan; R. Bardini; Peppelenbosch; E. J. Kuipers; M. C. W. Spaander C. Castoro; G. C. Sturniolo; M. Scarpa P1447 THE INCIDENCE AND TREND OF CLOSTRIDIUM DIFFICILE Microbiology INFECTION AT A JAPANESE UNIVERSITY HOSPITAL FROM 2005 TO 2014 Poster Session Ichiro Yoshikawa, Japan; S. Kumei; T. Watanabe; K. 09:00 - 14:00 Hall X5 Kume; M. Harada Other lower GI disorders III P1448 P1440 METAGENOMICS ANALYSIS THE FUNCTION AND MO- WHOLE METAGENOMICS SEQUENCING GIVE NEW LECULAR MECHANISMS OF THE VARIABLE BACTERIA IN INSIGHTS ON RELATIONSHIPS BETWEEN FODMAPS IN- IBS-D AND DEPRESSION TAKE, GUT MICROBIOTA AND SEVERITY OF SYMPTOMS Lu Zhang, China; S. W. Zhu; X. Q. Wang; Z. Wang; Y. X. IN IRRITABLE BOWEL SYNDROME Liu; K. Wang; H. Q. Zhu; L.-P. Duan Julien Tap, France ; M. Derrien; B. Le Nevé; J. Doré; L. Öhman; S. Storsrud; H. Törnblom; M. Simrén Lower GI infections P1441 P1449 ESCHERICHIA COLI NISSLE 1917 REINFORCES INTESTI- UNDISSOCIATED GELATINE TANNATE AND XYLOGLUCAN NAL EPITHELIAL BARRIER AND PREVENTS PERMEABIL- PREVENT GUT LEAKINESS AND MUCOSAL INFLAMMA- ITY ALTERATIONS INDUCED BY CYTOKINES AND PAR-2 TION INDUCED BY LPS: INSIGHTS IN THE MECHANISM ACTIVATION: AN IN VITRO STUDY OF ACTION M. R. Barbaro; Cesare Cremon, Italy; P. Dino; M. Helene Eutamene, France Carapelle; D. Fuschi; L. Bellacosa; E. Capelli; V. Stanghellini; G. Barbara P1450 PREDICTING TREATMENT FAILURE IN C.DIFFICILE INFEC- P1442 TION: A PROSPECTIVE OBSERVATIONAL COHORT STUDY A PERIANAL SWAB-BASED PCR ASSAY FOR DIAGNOS- Neerav Mukesh Joshi, United Kingdom; J. Goodhand; ING COLONIZATION BY PATHOGENIC C.DIFFICILE W. Alazawi; S. Das; M. Wilks; D. S. Rampton Neerav Mukesh Joshi, United Kingdom; E. Taylor; R. Murphy; A. Whiley; M. Wilks; D. S. Rampton P1451 A STABLE AND CLINICAL REPRESENTATIVE MOUSE MOD- P1443 EL OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE METAGENOMIC CHARACTERISATION OF GUT MICROBIO- Y. Chen; Lin Qianyun, China; F. Jiaxi TA IN IBS PATIENTS P. Sciavilla; F. Strati; G. M. Prati; F. Fornari; M. Modesto; D. P1452 Luiselli; D. Cavalieri; C. De Filippo; Paola Mattarelli, Italy A HOSPITAL-BASED STUDY ON RISK FACTORS OF RECURRENT CLOSTRIDIUM DIFFICILE ASSOCIATED Wednesday, October 19, 2016 P1444 DISEASE IN HONG KONG INCREASED ABUNDANCE OF BENEFICIAL BACTERIA Kai-Fung Tsang, Hong Kong; K. M. Ng; W. F. Luk; Y. W. IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN Chan; C. P. Ho PATIENTS RECEIVING RIFAXIMIN TREATMENT F. R. Ponziani; Franco Scaldaferri, Italy; F. P.Sterbini; P1453 V. Petito; S. Pecere; L. R. Lopetuso; A. Palladini; C. PLACEBO RESPONDERS IN A RANDOMISED CON- Graziani; L. Masucci; M. Pompili; G. Cammarota; M. TROLLED TRIAL OF RBX2660 FOR RECURRENT C. Sanguinetti; A. Gasbarrini DIFFICILE INFECTION: PREDICTIVE VALUE OF 16S RRNA MICROBIOME ANALYSIS P1445 Courtney Jones; USA; B. Shannon DIRECT ISOLATION OF ORAL- AND TUMOUR-DERIVED FUSOBACTERIUM SPECIES IN PATIENTS WITH COLOREC- TAL NEOPLASIA Alasdair Scott, United Kingdom; J. Alexander; J. McDonald; A. Speller; J. Kinross; J. Marchesi; Z. Takats

228 Poster in the Spotlight Poster of Excellence Clinical Case Session 229 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1454 Lower GI malignant disease-epidemiology MECHANISM OF ANTIBIOTIC-ASSOCIATED DIARRHEA: INSIGHT INTO COLONIC WATER AND ION TRANSPORT, P1461 MUCUS SECRETION OBESITY, DIABETES MELLITUS, HEAVY ALCOHOL CON- T. Dovbynchuk; T. Chervinska; A. Dranitzina; T. SUMPTION, SMOKING AND RISK FOR COLORECTAL POLYPS Sergeychuk; A. Putnikov; L. Ostapchenko; L. Zakordonetz; AND CANCER IN A FIT-POSITIVE SCREENING POPULATION Ganna Tolstanova, Ukraine Margherita Fabbri, Italy; R.M. Zagari; D. Colussi; F. Bazzoli; L. Ricciardiello P1455 ENDOSCOPIC BAND LIGATION(EBL) METHOD USING P1462 SMALL-CALIBER COLONOSCOPE FOR COLONIC DIVER- PREVALENCE OF SERRATED POLYPOSIS SYNDROME IN TICULAR BLEEDING A FIT-BASED COLORECTAL CANCER SCREENING COHORT Yoshinori Sato, Japan; H. Yasuda; S. Nakatsu; S.-I. IN ITALY Ozawa; M. Yamashita; Y. Matsuo; H. Yamamoto; F. Itoh Dora Colussi, Italy; R. M. Zagari; B. Morini; M. Fabbri; A. Montale; C. Hassan; C. Senore; F. Bazzoli; L. Ricciardiello P1456 FECAL MICROBIOTA TRANSPLANTATION - AN OLD TOOL P1463 OPENING A NEW ERA IN THE TREATMENT OF CLOS- RECURRENT ADVANCED COLONIC NEOPLASIA AFTER TRIDIUM DIFFICILE INFECTION POLYPECTOMY ON SURVEILLANCE COLONOSCOPY AC- Ana Ponte, Portugal; R. Pinho; M. Mota; J. Silva; J. P. CORDING TO RISK GROUPS AND AGE GROUPS: A RET- Rodrigues; M. Sousa; J. Carvalho ROSPECTIVE STUDY OF 1,974 ASYMPTOMATIC KOREANS Su Jung Baik, South Korea; H. Park; J. J. Park; H.-J. Lee; P1457 S. Y. Jo; Y. M. Park; K. Han FECAL MICROBIOTA TRANSPLANTATION FOR RECUR- RENT CLOSTRIDIUM DIFFICILE INFECTION: TRANSPLANT P1464 PROTOCOL BY ENEMA AND PRELIMINARY RESULTS EVALUATION OF A 25-GENE PANEL IN PATIENTS WITH C. Cicerone; G. Bruno; L. Lamonaca; Enrico Stefano SUSPECTED LYNCH SYNDROME: FAMOSA STUDY Corazziari, Italy Ariadna Sánchez García, Spain; F. Balaguer; J. Balmaña; T. Ocaña; I. Esteban; G. Llort; R. Jover Martínez; J. P1458 Cubiella; M. Herraiz; V. Hernandez; S. Martinez; M. J. FECAL MICROBIOTA TRANSPLANTATION VIA ENEMA Oruezabal Moreno; C. Garau Colom; S. Kohrrami; A. FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION Herreros De Tejada; R. Serrano; R. Morales; J. M. Cano; MODULATES THE INFLAMMATORY HOST RESPONSE AND A. B. Sánchez-Heras; C. Guillen; E. Adrover; E. Carrasco; RESTORE INTESTINAL DYSBIOSIS N. Gadea; J. Brunet C. Cicerone; G. Bruno; D. Alessandra; A. Oliva; G. Antonella; T. Valentina; V. Iebba; F. Pantanella; M. A. P1465 Zingaropoli; L. Lamonaca; V. Vullo; M. Trancassini; S. NEGATIVE TEST RESULTS OF FECAL IMMUNOCHEMICAL Schippa; Enrico Stefano Corazziari, Italy TEST IN PRE-TESTED COLORECTAL CANCER PATIENTS Gernot Leeb, Austria; A. Baierl; A. Püspök; A. Gsur; P. P1459 Hofer; G. Böhm; K. Mach REPEAT FECAL MICROBIOTA TRANSPLANTATION BY COLONOSCOPY FOR CLOSTRIDIUM DIFFICILE-ASSOCIAT- P1466 ED PSEUDOMEMBRANOUS COLITIS: RESULTS FROM A TUMOUR SPECTRUM OF LYNCH SYNDROME IN A POR- PROSPECTIVE, SINGLE-CENTRE COHORT TUGUESE POPULATION Gianluca Ianiro, Italy; L. Masucci; D. Nagel; F. D'Aversa; C. Palmela; P. Lage; Joana Moleiro, Portugal; I. Claro; F. Dibitetto; R. Poto; M. Gesualdo; F. Scaldaferri; M. I. Francisco; S. Ferreira; I. Rosa; L. Glória; B. Filipe; P. Sanguinetti; A. Gasbarrini; G. Cammarota Rodrigues; P. Chaves; C. Albuquerque; A. Dias Pereira P1460 P1467 A PROSPECTIVE STUDY ON THE INCIDENCE AND RISK EVALUATING 12 YEARS OF FECAL IMMUNOCHEMICAL FACTORS FOR NOSOCOMIAL CLOSTRIDIUM DIFFICILE TEST-BASED COLORECTAL CANCER SCREENING IN INFECTION BURGENLAND W. R. Karaoui; R. H. Shayto; J. M. Chalhoub; N. Kara; R. Gernot Leeb, Austria; A. Baierl; A. Püspök; A. Gsur; P. El Sabbagh; S. S. Kanj; Ala Sharara, Lebanon Hofer; G. Böhm; K. Mach Wednesday, October 19, 2016 19, October Wednesday,

Poster in the Spotlight Poster of Excellence Clinical Case Session 229

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

Lower GI malignant disease, pathogenesis P1476 FOUR ROUNDS OF TWO-SAMPLE FECAL IMMUNOCHEM- P1468 ICAL OCCULT BLOOD TEST SCREENING FOR COLORECTAL FAMILIAL COLORECTAL CANCER AND GENETIC SUSCEP- CANCER TIBILITY: A SCREENING OF 99 COLORECTAL RISK GENE Elisabeth Schreuders, The Netherlands; E. J. Grobbee; VARIANTS IN FIRST DEGREE RELATIVES OF PATIENTS A. Kapidzic; A. H. C. Van Roon; A. J. Van Vuuren; I. WITH COLORECTAL CANCER Lansdorp-Vogelaar; K. Izelaar; M. J. Bruno; E. J. Kuipers; Carla Jerusalen Gargallo Puyuelo, Spain; A. Lanas; P. M. C. W. Spaander Carrera; A. Ferrandez; E. Quintero Carrion; M. Carrillo Palau; I. Alonso Abreu; M. A. Garcia Gonzalez P1477 ROLE OF FAECAL BIOMARKERS IN DETECTING COLOREC- P1469 TAL CANCER AND ADENOMA IN SYMPTOMATIC PATIENTS WITHDRAWN Monika Maria Widlak, United Kingdom; C. L. Thomas; P1470 C. Tomkins; S. Smith; N. O'Connell; S. Wurie; L. Burns; MUTYH MUTATIONS IN PATIENTS WITH EARLY-ONSET B. Liu; M. Thomas; J. Cooke; B. Singh; C. Nwokolo; R. COLORECTAL CANCER - PRELIMINARY RESULTS Arasaradnam Joana Moleiro, Portugal; B. Filipe; I. Claro; P. Lage; S. P1478 Ferreira; I. A. Da Luz Rosa; I. Francisco; R. Fonseca; P. MORPHOLOGICAL ANALYSIS OF CARCINOMAS IN Rodrigues; C. Albuquerque; A. Dias Pereira JAPANESE PATIENTS WITH FAMILIAL ADENOMATOUS P1471 POLYPOSIS PROGNOSIS AND CHEMOSENSITIVITY OF COLORECTAL Fumio Ishida, Japan; H. Ishida; H. Ueno; H. Kobayashi; CANCER ARE ASSOCIATED WITH CHANGES IN MICROTU- T. Yamaguchi; T. Konishi; Y. Kanemitsu; T. Hinoi; Y. BULES COMPOSITION Inoue; N. Tomita; N. Matsubara; T. Watanabe; K. Anna Portyanko, Belarus; K. Ruksha; M. Malko; A. Sugihara; Y. Mori; Y. Sugihara; S.-E. Kudo Mezheyeuski; A. Nerovnya; T. Bich; G. Tur; J. Gorgun P1479 P1472 FEATURE- EXTRACTION FROM HISTOLOGY USED IN COMPREHENSIVE METHYLATION ANALYSIS OF IM- A COMPUTER-AIDED GRADING SYSTEM FOR COLON PRINTING-ASSOCIATED DIFFERENTIALLY METHYLATED CANCERS REGIONS IN COLORECTAL CANCER Costin Teodor Streba, Romania; S. S. Mogoanta; C. Hidenori Hidaka, Japan; K. Higashimoto; Y. Takara; H. Gruia; L. Streba Takedomi; N. Okamoto; K. Kawachi; H. Kawakubo; K. P1480 Yamamoto; K. Yamanouchi; R. Iwakiri; K. Fujimoto; H. ADENOMA DETECTION WITH ENDOCUFF-ASSISTED Soejima COLONOSCOPY VERSUS CAP- ASSISTED COLONOSCOPY P1473 Yahaya Bensuleiman, Japan; N. Ikezawa; K. Sasaki; S. IS THE ASSOCIATION BETWEEN PHYSICAL ACTIVITY Yoshida; S. Myoujou; T. Nakajima; S. Yoshida AND COLORECTAL ADENOMA MEDIATED BY MUS- P1481 CLE-DERIVED MYOKINES? CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGI- Vikneswaran Namasivayam, Singapore; A. N. Pryseley; CAL FEATURES OF SPORADIC EARLY ONSET COLOREC- W. Y. Wong; W. K. Wan; K. H. Lim; R. Azhar; J. Connolly TAL CANCERS P1474 Leonardo Henry Eusebi, Italy; C. Ceccarelli; L. Montanaro; M. Derenzini; M.L. Artesiani; F. Dall'olio; A. Ardizzoni;

Wednesday, October 19, 2016 COMPARATIVE MIRNA PROFILING IN PARALLEL COL- ORECTAL BIOPSY AND PLASMA SPECIMENS G. Biasco; D. Adua; F. Bazzoli; L. Ricciardiello Zsofia Nagy, Hungary; B. Wichmann; A. Kalmár; B. K. P1482 Bartak; O. Galamb; Z. Tulassay; B. Molnar THE IMPACT OF PATIENT EDUCATION WITH SMART- PHONE APPLICATION ON THE QUALITY OF BOWEL Lower GI malignant disease, diagnosis/histopathology PREPARATION FOR SCREENING COLONOSCOPY P1475 Hong-Sub Lee, South Korea; S. Lee; Y. B. Lee A SEVEN-GENE SIGNATURE PREDICTS OVERALL SUR- P1483 VIVAL OF PATIENTS WITH COLORECTAL CANCER THE PREDICTIVE VALUE OF FERRITIN IN OLDER PA- H. Chen; Yun Qian, China; W. Ge; S. Zheng TIENTS IN THE DIAGNOSIS OF COLON CANCER Fatih Karakaya, Turkey; Ç. Kalkan; D. Turan; M. Karakaya; A. Ç. Kartal; I. Soykan

230 Poster in the Spotlight Poster of Excellence Clinical Case Session 231 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1484 P1491 COLORECTAL CANCER SCREENING FROM THE VIEWPOINT THE OUTCOMES OF COLD POLYPECTOMY ARE NOT OF ITS TARGET POPULATION - RESULTS OF SURVEY INFERIOR EVEN WHEN IT WAS PERFORMED BY LESS R. Kroupa; Monika Ondrackova, Czech Republic; M. EXPERIENCED ENDOSCOPISTS: A PROPENSITY SCORE Dastych; A. Hep MATCHED CASE CONTROL STUDY OF 1,000 POLYPS Yoshiaki Takada, Japan; M. Kato; Y. Kubosawa; Y. P1485 Sunata; Y. Hirai; K. Abe; T. Hirata; Y. Takatori; S. Banno; EARLY ONSET COLORECTAL CANCERS VS SPORADIC M. Wada; S. Kinoshita; H. Mori; K. Takabayashi; M. COLORECTAL CANCERS: A CLINICOPATHOLOGICAL AND Kikuchi; M. Kikuchi; T. Uraoka MOLECULAR EVALUATION Leonardo Henry Eusebi, Italy; C. Ceccarelli; L. Montanaro; P1492 M. Derenzini; M.L. Artesiani; F. Dall'olio; A. Ardizzoni; A NOVEL ANTI-CD24 MONOCLONAL ANTIBODY, HU- G. Biasco; D. Adua; F. Bazzoli; L. Ricciardiello MANIZED AND AFFINITY MATURATED,FORTARGETING GASTROINTESTINAL CANCERS Lower GI malignant disease, management S. Shapira; D. Kazanov; V. Padler Karavani; I. Benhar; Nadir Arber, Israel P1486 SCREENING COLONOSCOPIES IN FIRST-DEGREE P1493 RELATIVES OF PATIENTS WITH COLORECTAL CANCER MONOTERPENES: A NOVEL AND PROMISING THERA- COMPARED TO AVERAGE RISK POPULATION PEUTIC AGENT, FOUND IN ESSENTIAL OILS, FOR HUMAN Ivana Mikoviny Kajzrlikova, Czech Republic; P. Vitek; J. COLORECTAL CANCER Chalupa; J. Kuchar; J. Platos; P. Reha S. Shapira; D. Kazanov; Nadir Arber, Israel P1487 P1494 A PILOT STUDY TO ASSESS THE EFFICACY OF PROPHY- THE VALIDITY OF COLORECTAL ESD FOR LARGE COL- LACTIC ADMINISTRATION OF ANTIBIOTIC FOR ENDO- ORECTAL TUMORS IN A GENERAL HOSPITAL SCOPIC SUBMUCOSAL DISSECTION IN COLORECTUM Keiichi Ashikari, Japan; H. Chiba; J. Tachikawa; M. Tatsuya Sakurai, Japan; S.-E. Kudo; T. Hayashi; Y. Sato; Nishimura; D. Kurihara; T. Suto; N. Kawano; M. Kaai; S. Y. Kouyama; T. Ishigaki; H. Nakamura; N. Toyoshima; M. Seki; T. Ida; T. Morohashi; T. Goto; Misawa; Y. Mori; K. Wakamura; A. Katagiri; H. Miyachi P1495 P1488 SAFETY, EFFICACY AND PROBLEMS OF COLD SNARE THE OUTCOMES OF SELF-EXPANDING METAL STENTS POLYPECTOMY FOR SMALL COLORECTAL NEOPLASMS AS A BRIDGE TO CURATIVE RESECTION IN PATIENTS Nobuaki Ikezawa, Japan; M. Hanafusa; Y. Bensulei- WITH COLORECTAL CANCER PRESENTING WITH BOWEL man; K. Sasaki; S. Yoshida; T. Nakajima; S. Myojyo; S. OBSTRUCTION Yoshida James Rees, United Kingdom; J.-R. Tanner; P. Patel; N. Trudgill IBS / Lower GI motility: Brain-gut and gut-brain axes, neuro-hormonal, neural-immune and visceral P1489 sensitivity IDENTIFICATION OF THE IRINOTECAN TOXICITY RELATED VARIANTS BY WHOLE EXOME SEQUENCING ANALYSIS P1496 Ryouichi Tsunedomi, Japan; S. Hazama; N. Okayama; DO FUNCTIONAL GASTROINTESTINAL DISORDERS Y. Inoue; N. Suzuki; K. Sakamoto; M. Iida; S. Takeda; T. ORIGINATE IN THE GUT RATHER THAN THE BRAIN? Ueno; S. Yamamoto; S. Yoshino; H. Nagano EVIDENCE FROM A 12 YEAR PROSPECTIVE POPULA- TION-BASED STUDY OF A PREDOMINANT GUT-BRAIN P1490 PATHWAY IN OVER 50% GOOD BOWEL PREPARATION INCREASED THE NUMBER N. A. A Koloski; M. P. Jones; Marjorie Walker, Australia; OF ENDOSCOPICALLY DETECTED POLYPS WHICH WAS G. J. Holtmann; M. Weltman; J. Kalantar; N. J. Talley WELL CORRELATED WITH DETECTION OF ADVANCED NEOPLASIA P1497 Takahiro Amano, Japan; T. Nishida; H. Shimakoshi; ALTERED FUNCTIONAL CONNECTIVITY ASSOCIATED A. Shimoda; A. Sugimoto; K. Takahashi; K. Mukai; T. WITH DISTURBED INTEROCEPTIVE AWARENESS IN Matsubara; M. Yamamoto; S. Hayashi; S. Nakajima; K. PATIENTS WITH IRRITABLE BOWEL SYNDROME Fukui; M. Inada M. Longarzo; Marco Romano, Italy; M. Quarantelli; A. Wednesday, October 19, 2016 19, October Wednesday, Del Prete; C. Cimminiello; S. Cocozza; G. Olivo; C. Logu- ercio; L. Trojano; D. Grossi

Poster in the Spotlight Poster of Excellence Clinical Case Session 231

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1498 IBS / Lower GI motility: Transmitters / signals / VISCERAL HYPERSENSITIVITY REMAINS STABLE OVER receptors / enteric nervous system TIME IN PATIENTS WITH IBS, BUT WITH INDIVIDUAL FLUCTUATIONS P1506 Axel Josefsson, Sweden; A. Rosendahl; P. Jerlstad; G. INTERACTIONS BETWEEN THE ENDOGENOUS OPIOID Näslin; H. Törnblom; M. Simrén AND CANNABINOID SYSTEMS IN THE GASTROINTES- TINAL TRACT ARE CRUCIAL IN THE DEVELOPMENT OF P1499 TOLERANCE TO OPIOIDS IRRITABLE BOWEL SYNDROME WITH POSTPRANDIAL Agata Jarmuz, Poland; M. Zielinska; A. Keasling; J. SYMPTOM OCCURRENCE IS ASSOCIATED WITH A POST- Zjawiony; J. Fichna PRANDIAL WORSENING OF VISCERAL HYPERSENSITIVITY M. Di Stefano; Manuela Bergonzi, Italy; B. Valvo; I. P1507 Benedetti; M. Bresciani; E. Pagani; E. Miceli; G. R. ESTROGEN RECEPTOR BETA AGONIST, LY3201, AMELIO- Corazza RATES HIGH FAT DIET INDUCED COLONIC NEUROPATHY AND MYOPATHY P1500 Francesca D'Errico, Italy; Y. Dai; M. Warner; L. Maneix; FEMALE IBS PATIENTS WITH VISCERAL HYPERSENSI- Y. Miao; W. Wanfu; B. Huang; A. Di Leo; J. A. Gustafsson TIVITY DEMONSTRATE ALTERED AMYGDALA CONNEC- TIVITY WITHIN THE DEFAULT MODE NETWORK Infections (not H. Pylori) Adriane Icenhour, Sweden; M. Lowen; O. Bednarska; S. T. Witt; S. Elsenbruch; K. Tillisch; E. A. Mayer; S. Walter Poster Session P1501 09:00 - 14:00 Hall X5 CHOICE OF RECTAL BAROSTAT PROTOCOL AFFECTS Oesophageal, gastric and duodenal disorders III CLASSIFICATION OF SENSORY FUNCTION AND PREDIC- P1508 TION OF SYMPTOM SEVERITY IN IBS CLINICAL FEATURES OF ESOPHAGEAL ULCERS IN Axel Josefsson, Sweden; P. Jerlstad; G. Näslin; H. HIV-POSITIVE PATIENTS Törnblom; M. Simrén Kentaro Nakagawa, Japan; T. Yamada; S. Kao; A. Shoji; P1502 R. Kiyota; K. Shinkai; T. Tashiro; T. Iwasaki; A. Ishihara; ADULT COLONIC HYPERSENSITIVITY CORRELATES WITH K. Nishio; H. Hasegawa; Y. Sakakibara; S. Nakazuru; H. JUVENIL INTESTINAL DYSBIOSIS IN NEONATAL MOTHER Ishida; E. Mita SEPARATED MICE Amandine Lashermes, France; L. Boudieu; M. Meleine; Upper GI and small intestinal bleeding A. Gelot; R. Bonnet; D. Ardid; F. A. Carvalho P1509 P1503 IMPAIRMENT IN ACTIVITY OF DAILY LIVING IS A RISK ALTERED RESTING STATE FUNCTIONAL CONNECTIVITY FACTOR FOR HIGH MEDICAL CARE COST IN PATIENTS IN ROSTRAL ANTERIOR CINGULATE CORTEX IN IBS WITH NON-VARICEAL UPPER GASTROINTESTINAL WITH COMORBID ANXIETY BLEEDING Suzanne Witt, Sweden; A. Icenhour; O. Bednarska; S. Yusaku Takatori, Japan; M. Kato; Y. Hirai; Y. Sunata; Elsenbruch; S. Walter Y. Kubosawa; K. Abe; T. Hirata; Y. Takada; S. Banno; S. Kinoshita; M. Wada; H. Mori; K. Takabayashi; M. P1504 Kikuchi; M. Kikuchi; M. Suzuki; T. Uraoka ACHALASIA SYMPTOM RESPONSE AFTER POEM SEGRE-

Wednesday, October 19, 2016 GATED BY HIGH-RESOLUTION MANOMETRY SUBTYPES P1510 Meng Li, China; B. Lv; L. Zhang; B. H. Bao EFFICACY AND SAFETY OF FERRIC CARBOXYMALTOSE IN THE MANAGEMENT OF IRON-DEFICIENCY ANEMIA P1505 IN PATIENTS WITH GASTROINTESTINAL AND LIVER PROTEIN DISULFIDE ISOMERASE A3 MEDIATED DISEASE IMMUNE DYSFUNCTION OF DENDRITIC CELLS IN THE Marco Mendolaro, Italy; M. Cappello; A. Viola; M.G. COLON OF RATS WITH VISCERAL HYPERSENSITIVITY Cilluffo; P. L. Almasio Meng Li, China; B. Lv; T. X. Wang; Y. Hu P1511 PEPTIC ULCER BLEEDING - DOES ETIOLOGY INFLUENCE CLINICAL OUTCOME? Artur Gião Antunes, Portugal; A. Vaz; P. Queirós; T. Gago; J. Roseira; B. M. Santos Peixe; H. Guerreiro

232 Poster in the Spotlight Poster of Excellence Clinical Case Session 233 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1512 P1520 RISK OF PEPTIC ULCER BLEEDING ASSOCIATED WITH HLA-DQB1-INSERTION IN IDIOPATHIC ACHALASIA AND HELICOBACTER PYLORI INFECTION, NONSTEROIDAL FIRST GENOTYPE-PHENOTYPE (GXP) STUDY USING ANTI-INFLAMMATORY DRUGS, LOW-DOSE ASPIRIN IN HIGH-RESOLUTION MANOMETRY DATA PEPTIC ULCER DISEASE: A CASE-CONTROL STUDY Zuzana Vackova, Czech Republic; S. Niebisch; J. Becker; H.-Y. Kim; Seung In Seo, South Korea; H. S. Kim; W. G. N. Kosiol; N. Kreuser; V. Schüller; S. Heinrichs; T. Hess; Shin; M. K. Jang; J. H. Lee M. M. Nöthen; I. Gockel; J. Spicak; J. Schumacher; J. Martinek P1513 MEDICAL VERSUS COMBINED THERAPY OF PEPTIC P1521 ULCERS WITH ADHERENT CLOTS IMPACT OF PER ORAL ENDOSCOPIC MYOTOMY ON Jaime Rodrigues, Portugal; C. Fernandes; T. Freitas; J. ESOPHAGEAL HIGH RESOLUTION MANOMETRY PARAM- Silva; A. Ponte; M. Sousa; J. Carvalho ETERS IN PATIENTS WITH ACHALASIA Sabine Roman, France; M. Pioche; E. Chabrun; J. P1514 Rivory; A. Garros; T. Ponchon; F. Zerbib; F. Mion FIRST EXPERIENCE IN THE DEPLOYMENT OF HEMOSPRAY AS SALVAGE THERAPY IN GASTROINTESTINAL BLEEDINGS P1522 Martin Raithel, Germany; H. Albrecht; A. Nägel; F. THE GASTRIC ACCOMODATION REFLEX STUDIED BY Vitali; M. Vetter; C. Singer; M. F. Neurath; A.F. Hagel ULTRASOUND, MANOMETRY AND IMPEDANCEMETRY IN A PILOT STUDY P1515 Eline Lundekvam Storlid, Norway; T. Hausken; G. A. APPRAISING AND IMPROVING JUNIOR DOCTORS MAN- Lied; O. H. Gilja; J. G. Hatlebakk AGEMENT OF ACUTE VARICEAL UPPER GI BLEEDS: A QUALITY IMPROVEMENT PROJECT P1523 Amera Elzubeir, United Kingdom STUDY OF DISTAL CONTRACTILE INTEGRAL IN INEF- FECTIVE ESOPHAGEAL MOTILITY DIAGNOSIS AND ITS P1516 RELATION TO GASTROESOPHAGEAL REFLUX DISEASE REBLEEDING RATE AND THE NEED FOR BLOOD TRANS- Irene Aresté, Spain; A. Zúñiga Ripa; F. Estremera FUSION IN PATIENTS WITH UPPER GASTROINTESTINAL Arévalo; R. Iglesias Picazo TUMOR BLEEDING ARE HIGHER THAN IN PATIENTS WITH PEPTIC ULCER BLEEDING P1524 Dominik Kralj, Croatia; I. Budimir; N. Barsic; M. Nikolic; DYSPHAGIA PATIENTS WITH NORMAL ESOPHAGEAL P. Jurcic; I. Budimir Yr HIGH RESOLUTION MANOMETRY: ASSESSING THE DIAG- NOSTIC VALUE OF BREAD SWALLOWS P1517 Ismail Miah, United Kingdom; T. Orton; G. Sui; T. HISTOACRYL ® THERAPY OF BLEEDING GASTRIC Wong; J. Jafari FUNDAL VARICES; THE EXPERIENCE OF TERTIARY CARE HOSPITALS NAZISH BUTT 1, 2, SEHRISH REEMA 1, P1525 SEHRISH BUTT 2,MOHAMMAD MASOOD 1, ALI AKBAR PER ORAL ENDOSCOPIC MYOTOMY: A PROSPECTIVE 1 .JINNAH POSTGRADUATE MEDICAL CENTRE, 2AGA EVALUATION OF 136 CONSECUTIVE PATIENTS WITH KHAN UNIVERSITY ESOPHAGEAL ACHALASIA Sehrish Reema, Pakistan Hana Svecová, Czech Republic; Z. Vackova; O. Ngo; J. Spicak; P. Stirand; E. Kieslichova; A. Pazdro; J. Martinek P1518 COMPARISON OF GLASGOW-BLATCHFORD SCORE, ROCK- P1526 ALL SCORE, AND AIMS 65 SCORE FOR PREDICTING UPPER WHATS'S THE IMPACT OF CONTINUNG MEDICAL EDUCA- GASTROINTESTINAL BLEEDING OUTCOME IN KOREA TION ON THE INCIDENCE OF ACHALASIA? Jung Wan Choe, South Korea; S. Y. Kim; J. J. Hyun; S. W. Amar Tebaibia, Algeria; M. A. A. Boudjella; N. Oumnia; Jung; J. S. Koo; H. J. Yim; S. W. Lee D. Boutarene; M. Boucelma

Upper GI motility disorders: Clinical Functional upper GI disorders: Clinical P1519 P1527 OESOPHAGEAL HIGH RESOLUTION MANOMETRY IN EFFECT OF FAECAL MICROBIOTA TRANSPLANTATION ON CHRONIC INTESTINAL IDIOPATHIC PSEUDO-OBSTRUCTION THE SYMPTOMS AND DUODENAL ENTEROENDOCRINE Wednesday, October 19, 2016 19, October Wednesday, Aurelio Mauro, Italy; G. Basilisco; M. Franchina; A. CELLS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME Elvevi; D. Pugliese; D. Conte; R. Penagini Tarek Mazzawi, Norway; G. A. Lied; M. El-Salhy; O. H. Gilja; J. G. Hatlebakk; T. Hausken

Poster in the Spotlight Poster of Excellence Clinical Case Session 233

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1528 P1537 FUNCTIONAL HEARTBURN: A PILOT RANDOMIZED TRI- THE OUTCOMES AND QUALITY OF LIFE OF CHINESE PA- AL COMPARING CITALOPRAM VS. AMITRIPTYLINE AND TIENTS WITH ACHALASIA AFTER PERORAL ENDOSCOPIC NO TREATMENT MYOTOMY: A MULTI-CENTER CLINICAL STUDY Georgios Karamanolis, Greece; K. Denaxas; D. Nan Gao, China; R. Li; D. Shi; D. Zhang; W. Chen Kamberoglou; S. D. Ladas; G. Papatheodoridis P1538 P1529 FUNCTIONAL DYSPEPSIA AND BINGE EATING DISOR- BELCHING AND TRANSIT OF GASTRIC GAS IN HEALTHY DERS IN ITALIAN MORBIDLY OBESE PATIENTS HUMANS A. Santonicola; F. Zingone; L. Pellegrini; C. Ciacci; Paola Elba Noemi Caballero De Garcia, Spain; I. Marin Iovino, Italy Fernandez; J. Serra P1539 P1530 METAANALYSIS OF CLINICAL TRIALS ON STW 5 ROLE OF ACID REFLUX AND IMPACT OF HRM PARAME- J. Müller; B. R. Vinson; S. Rabini; H. Abdel-Aziz; O. TERS IN PATIENTS WITH NON-OBSTRUCTIVE DYSPHAGIA Kelber; M. A. Storr; Karen Nieber, Germany; K. Kraft Mentore Ribolsi, Italy; D. Biasutto; P. Balestrieri; M. P1540 Cicala IMPACT OF CONCOMITANT DYSPEPSIA AND IRRITABLE P1531 BOWEL SYNDROME ON SYMPTOM BURDEN AND SUPRAGASTRIC BELCHING (SGB) AND GASTRO-OE- PSYCHOSOCIAL CHARACTERISTICS IN PATIENTS WITH SOPHAGEAL REFLUX: CAUSE AND EFFECT? GASTROESOPHAGEAL REFLUX DISEASE Joseph Roscamp, United Kingdom; J. Patel; T. Wong; I. Wei-Yi Lei, Taiwan; S.-H. Wen; C.-H. Yi; J.-S. Hung; T.-T. Miah; J. Jafari Liu; C.-L. Chen P1532 P1541 PROKINETICS FOR THE TREATMENT OF FUNCTIONAL A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DYSPEPSIA: A BAYESIAN NETWORK META-ANALYSIS STUDY OF THE ADDITIVE EFFECT OF FAMOTIDINE ON Chang Seok Bang, South Korea; G. H. Baik; K. T. Suk; T. ACOTIAMIDE TREATMENT FOR FUNCTIONAL DYSPEPSIA Y. Park; D. J. Kim Mariko Hojo, Japan; A. Nagahara; D. Asaoka; T. Takeda; K. Izumi; K. Matsumoto; H. Ueyama; Y. Shimada; K. P1533 Matsumoto; S. Watanabe PREDICTION OF COMPLICATIONS AFTER PERORAL ENDOSCOPIC MYOTOMY P1542 Kanefumi Yamashita, Japan; H. Shiwaku; T. Matsuoka; INCIDENCE OF REFLUX SYMPTOMS AND EROSIVE T. Ohmiya; H. Okada; S. Nimura; H. Inoue; S. Hasegawa ESOPHIGITIS AFTER PERORAL ENDOSCOPIC MIOMOT- OMY (POEM) FOR ACHALASIA: A SYSTEMATIC REVIEW P1534 WITH META-ANALYSIS RETROSPECTIVE CASE SERIES OF GERD AFTER POEM : A Alessandro Repici, Italy; R. Maselli; F. Mazza; E. COMPARISON OF ANTERIOR AND POSTERIOR MYOTOMY Carlani; U. Fumagalli; S. Carrara; A. Anderloni; M. Di Hironari Shiwaku, Japan; K. Yamashita; T. Matsuoka; Leo; E. C. Ferrara; L. Correale; P. A. Galtieri; L. Amato; T. Ohmiya; H. Okada; S. Nimura; H. Inoue; S. Hasegawa S. Sferrazza; S. Al Awadhi; M. Khashab; T. Roesch; C. Hassan P1535 PROTON PUMP INHIBITOR THERAPY IMPROVES NASAL Reflux disease, diagnosis Wednesday, October 19, 2016 SYMPTOMS AND INFLAMMATION IN PATIENTS WITH NONALLERGIC RHINITIS WITH NEUTROPHILS AND GAS- P1543 TROESOPHAGEAL REFLUX DISEASE ESOPHAGEAL BASELINE IMPEDANCE AS A MARKER Francesco Torresan, Italy; A. Ioannou; P. Schiavon; M. OF PATHOLOGICAL GASTROESOPHAGEAL REFLUX IN Mancini; M. C. Cimatti; D. Mandolesi; E. Liverani; A. CHILDREN Pirodda; F. Bazzoli Lukasz Cichy, Poland; K. Fyderek P1536 P1544 LONG TERM CAPSAICIN INGESTION REDUCES SYMP- SPLITTING ESOPHAGO-GASTRIC JUNCTION MORPHOL- TOMS IN PATIENTS WITH CHEMOSENSITIVE FUNCTION- OGY TYPE I: A BETTER PREDICTION OF GERD PATIENTS AL DYSPEPSIA WITH A POSITIVE IMPEDANCE-PH MONITORING V. Hammer; K. Hammer; M. Führer; Johann Hammer, Salvatore Tolone, Italy; E. Savarino; N. De Bortoli; M. Austria Furnari; M. Frazzoni; S. Parisi; V. Savarino; L. Docimo

234 Poster in the Spotlight Poster of Excellence Clinical Case Session 235 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1545 Barrett's oesophagus: Clinical EXTENDED BRAVO STUDIES (>48 HRS) OFFER AN ADDI- TIONAL DIAGNOSTIC YIELD OF GASTRO-OESOPHAGEAL P1552 REFLUX DISEASE (GORD) IN PATIENTS WITH NORMAL IMMUNOHISTOCHEMICAL BIOMARKERS FOR RISK MULTICHANNEL INTRALUMINAL IMPEDANCE-PH (MII- STRATIFICATION OF NEOPLASTIC PROGRESSION IN PH) STUDIES BARRETT ESOPHAGUS: A SYSTEMATIC REVIEW AND Christopher Chia, Singapore; I. Miah; J. Jafari; I. Nasr; I. META-ANALYSIS Koumoutsos; T. Wong Vincent Janmaat, The Netherlands; S. H. Van Olphen; M. J. Bruno; K. Biermann; L. Looijenga; M. C. W. P1546 Spaander PROLONGED MEASUREMENTS IMPROVE THE ASSESS- MENT OF GASTRO-ESOPHAGEAL JUNCTION BARRIER P1553 FUNCTION BY HIGH-RESOLUTION MANOMETRY IN RADIOFREQUENCY ABLATION IN BARRETT'S ESOPH- GASTRO-ESOPHAGEAL REFLUX DISEASE AGUS : ARE THERE ANY FACTORS PREDICTING LONG Dorothea Jasper, Germany; N. Freitas-Queiroz; M. TERM REMISSION OF INTESTINAL METAPLASIA? Hollenstein; B. Misselwitz; P. Layer; M. Fox; J. Keller Joke Vliebergh, Belgium; M. Ferrante; P. H. Deprez; H. Willekens; D. De Looze; H. Orlent; E. Macken; P. P1547 Christiaens; F. Mana; G. De Hertogh; R. Bisschops THE DIAGNOSTIC VALUE OF 24-HOUR AMBULATORY INTRAESOPHAGEAL PH-IMPEDANCE IN PAT?ENTS WITH P1554 SYMPTOMS COMPARED DURABILITY OF RADIOFREQUENCY ABLATION IN BAR- TO THOSE WITH TYPICAL SYMPTOMS RETT'S OESOPHAGUS WITH DYSPLASIA: A SEVEN-YEAR Y. Serdar Sakin; R. Vardar; B. Sezgin; Z. E. Cetin; Y. AUSTRALIAN EXPERIENCE Alev; E. Yildirim; T. Kirazli; Serhat Bor, Turkey Edward Tsoi, Australia; G. Cameron; P. Mahindra; R. Williams; P. Desmond; A. Taylor P1548 SHOULD MEALS BE BLOCKED DURING AMBULATORY P1555 PH MONITORING? MULTIFOCAL NITROUS OXIDE CRYOBALLOON ABLATION E. Athanasakos; S. Harrington; L. Neilan; A. Raeburn; WITH OR WITHOUT ENDOSCOPIC MUCOSAL RESECTION N. Zarate-Lopez; Anton Emmanuel, United Kingdom; (EMR) FOR TREATMENT OF NEOPLASTIC BARRETT'S R. Sweis ESOPHAGUS: PRELIMINARY RESULTS OF A PROSPEC- TIVE CLINICAL TRIAL IN TREATMENT-NAÏVE AND PREVIOUSLY ABLATED PATIENTS Barrett's oesophagus: Basic Marcia Irene Canto, USA; J. A. Abrams; J. A. Almario; L. P1549 Voltaggio; E. Montgomery; C. Lightdale HOX GENE EXPRESSION IN BARRETT'S ESOPHAGUS RE- P1556 SEMBLES THAT OF THE COLON, CAN BE MODULATED BY THE CASE FOR ENDOSCOPIC SUBMUCOSAL DISSECTION ACID AND BILE EXPOSURE, AND INDUCES BARRETT'S IN BARRETT'S CANCER: OUTCOMES FROM A 100 PA- SPECIFIC GENE PRODUCTS TIENT SERIES Vincent Janmaat, The Netherlands; A. P. Verhaar; M. J. Sharmila Subramaniam, United Kingdom; F. J. Q. Bruno; M. C. W. Spaander; M. Peppelenbosch Chedgy; K. Kandiah; S. P. Terzoudis; S. Thayalasekaran; P1550 G. Longcroft-Wheaton; P. Bhandari EPITHELIUM TYPE AND DISTANCE FROM THE LOWER OE- P1557 SOPHAGEAL SPHINCTER SHOW INFLUENCE ON MUCOSAL SAFETY OF RADIOFREQUENCY ABLATION FOLLOWING BASELINE IMPEDANCE IN BARRETT'S OESOPHAGUS ENDOSCOPIC RESECTION IN BARRETT'S NEOPLASIA: Christian Lottrup, Denmark; A. L. Krarup; M. Ostapiuk; DOES RESECTION METHOD MATTER? P. Ejstrud; A. M. Drewes Sharmila Subramaniam, United Kingdom; F. J. Q. P1551 Chedgy; K. Kandiah; S. Thayalasekaran; P. Bhandari WITHDRAWN P1558 WHAT IS THE CLINICAL IMPORTANCE OF AN INCIDENTAL IRREGULAR Z LINE? A LONG-TERM FOLLOW- UP STUDY David Itskoviz, Israel; A. Vilkin; I. Zvidi; Y. Niv; R. Dickman Wednesday, October 19, 2016 19, October Wednesday,

Poster in the Spotlight Poster of Excellence Clinical Case Session 235

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1559 P1567 COST-EFFECTIVENESS OF ENDOSCOPIC TREATMENT PROGNOSIS AND TREATMENT AFTER RECURRENT WITH RADIOFREQUENCY ABLATION FOR PATIENTS ESOPHAGEAL CANCER FOLLOWING R0 ESOPHAGECTOMY WITH BARRETT'S ESOPHAGUS AND LOW GRADE DYS- Toshiaki Tanaka, Japan; S. Matono; N. Mori; H. Hino; K. PLASIA IN SPAIN Kadoya; R. Nishida; K. Saisho; Y. Akagi José Esteban López-Jamar, Spain; P. González Carro; J. B. Gornals Soler; C. Collados; M. Álvarez Orozco; S. P1568 Serip OUTCOMES OF SM INVASIVE BARRETT'S CANCERS FOLLOWING ENDOSCOPIC RESECTION: RADICAL INTER- P1560 VENTION IS NOT ALWAYS REQUIRED? GOOD AND POOR RESPONDERS TO RADIOFREQUENCY Fergus J. Q. Chedgy, United Kingdom; S. Subramaniam; ABLATION FOR BARRETT'S OESOPHAGUS RELATED K. Kandiah; S. Thayalasekaran; P. Bhandari DYSPLASIA: CAN WE PREDICT WHO THEY ARE? Edward Tsoi, Austalia; G. Cameron; P. Mahindra; R. P1569 Williams; P. Desmond; A. Taylor TOPICAL MITOMYCIN C TREATMENT FOR RELIEVING ESOPHAGEAL RADIATION-INDUCED STENOSIS P1561 L. Zhao; X. Wang; L. Liu; M. Wang; Zhining Fan, China LYMPH NODE METASTASIS RISK IN BARRETT'S ADENO- CARCINOMA DEPENDING ON THE DEPTH OF TUMOUR P1570 INVASION: SHOULD WE ENLARGE THE CURATIVE CRITE- RADIOFREQUENCY ABLATION (RFA) IN PATIENTS RIA FOR ENDOSCOPIC RESECTIONS? WITH BARRETT'S ESOPHAGUS RELATED NEOPLASIA - Marc O'Brien, France; M. Barret; V. Lepilliez; J. Jacques; LONG-TERM OUTCOMES OF THE CZECH NATIONAL RFA J. Rivory; R. Legros; L. Servais; F. Prat; S. Chaussade; D. DATABASE Sautereau; V. Hervieu; T. Ponchon; M. Pioche Jana Krajciova, Czech Republic; O. Ngo; P. Falt; J. Gregar; S. Suchanek; O. Urban; V. Procházka; M. Zavoral; O. P1562 Majek; J. Spicak; J. Martinek REDUCING PATIENT'S BURDEN. A MINIMALISTIC AP- PROACH TO RADIOFREQUENCY ABLATION IN BARRETT'S P1571 EPITHELIUM ACHIEVING COMPLETE ERADICATION EPIDEMIOLOGY OF ESOPHAGEAL ADENOCARCINOMA IN Anniek W. Gotink, The Netherlands; P. Didden; M. J. THE CZECH REPUBLIC. ARE WE AT THE BREAKPOINT OF Bruno; A. D. Koch INCIDENCE? Radek Kroupa, Czech Republic; T. Pavlik; M. Dastych; S. P1563 Konecny; J. Dolina TEMPORAL TRENDS OF CLINICAL CHARACTERISTICS OF BARRETT'S ESOPHAGUS IN RECENT TEN YEARS IN P1572 SOUTH CHINA ENDOSCOPIC PASSAGE IN PATIENTS WITH ESOPHAGEAL X. Yang; Zefeng Zhang, China; W. Sha; Q. Wang SQUAMOUS CELL CARCINOMA TREATED WITH SURGERY OR CONCURRENT CHEMORADIOTHERAPY: IS IT AN P1564 IMPORTANT PROGNOSTIC FACTOR? DEDICATED BARRETT'S OESOPHAGUS SURVEILLANCE Hae Jin Shin, South Korea; H. S. Moon; J. S. Joo; S. H. LISTS IMPROVES DIAGNOSIS AND DOCUMENTATION OF Kang; J. K. Sung; H. Y. Jeong; B. S. Lee; S. H. Kim; K. D. FINDINGS Kim; J. S. Kim Simon Phillpotts, United Kingdom; T. El Menabawey; R. Preedy; K. Besherdas Acid peptic disease (includes NSAIDS, but not H. pylori), epidemiology Wednesday, October 19, 2016 Oesophageal neoplasia: Clinical P1573 P1565 PREVALENCE OF GASTRIC ATROPHY AND INTESTINAL CLINICAL FEASIBILITY OF ENDOSCOPIC SUBMUCOSAL METAPLASIA AMONG PATIENTS WITH GASTRIC AND DISSECTION WITH MINIMUM LATERAL MARGIN OF SU- DUODENAL ULCERS IN SAXONY-ANHALT, A REGION AT PERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA INCREASED RISK FOR GASTRIC CANCER Hiroki Kuwabara, Japan; S. Abe; I. Oda; S. Nonaka; H. Marino Venerito, Germany; C. Schneider; P. Malfertheiner Suzuki; S. Yoshinaga; Y. Saito P1566 KI-67 AND P53 IMMUNOHISTOCHEMISTRY AS AN OBJECTIVE DIAGNOSTIC TOOL FOR MANAGEMENT OF INTRAMUCOSAL TUMOR IN BARRETT'S ESOPHAGUS Tomoki Shimizu, Japan; J. Fujisaki; H. Kawachi; M. Omae; N. Yamamoto

236 Poster in the Spotlight Poster of Excellence Clinical Case Session 237 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

Acid peptic disease (includes NSAIDS, but not P1582 H. pylori), pathogenesis WHAT ARE THE FACTORS ASSOCIATED WITH DIFFICULT GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION? P1574 R. Daegon; D. Kang; H. Kim; C. Choi; S. Park; S. Kim; H. PANTOPRAZOLE DOES NOT INFLUENCE THE ANTI- Nam; Jinhyuck Cho, South Korea; J. Park PLATELET EFFECT OF CLOPIDOGREL: A RANDOMIZED CONTROLLED TRIAL P1583 Nayoung Kim, South Korea; Y. J. Choi; H. Yoon; C. M. CLINICAL IMPACT OF OBESITY FOR THE PATIENTS WHO Shin; D. H. Lee UNDERGO ENDOSCOPIC SUBMUCOSAL DISSECTION Donghoon Kang, South Korea; J. M. Park; M.-G. Choi Gastroduodenal neoplasia: Clinical P1584 P1575 ENDOSCOPIC PAPILLECTOMY FOR AMPULLARY ADENO- CHRONIC ATROPHIC GASTRITIS IN ITALY: A POPULATION MAS: AN ITALIAN SINGLE CENTRE EXPERIENCE STUDY ON 10,000 PEOPLE Francesca Parmeggiani, Italy; M. Cavina; P. Cecinato; F. Francesco Di Mario, Italy; S. Grillo; S. Landi; M. Franceschi; Azzolini; V. Iori; G. Sereni; C. Tioli; F. Decembrino; R. F. Baldassarre; R. Cannizzaro; N. Dal Bo'; A. Gnocchi; V. Zecchini; R. Sassatelli Corrente; A. Bertele; G. Grande; M. Rugge P1585 P1576 THE EFFECTIVENESS AND LONG-TERM OUTCOMES OF RECOVERY OF GASTRIC FUNCTION IN CHRONIC ATRO- CARCINOMATOSIS AND ASCITES STATUS OF PALLIATIVE PHIC GASTRITIS: A 3 YEARS STUDY TREATMENT IN THE PATIENTS OF ADVANCED GASTRIC Francesco Di Mario, Italy; S. Landi; S. Grillo; G. Grande; CANCER WITH BOWEL OBSTRUCTION : STENT PLACE- M. Franceschi; R. Cannizzaro; N. Dal Bo'; A. Gnocchi; V. MENT VERSUS PALLIATIVE SURGERY Corrente; A. Bertele; F. Baldassarre; M. Rugge Yong Eun Park, South Korea; J. C. Park; Y. C. Lee; S. K. Lee; S. K. Shin; H. Chung P1577 LONG-TERM OUTCOMES OF ENDOSCOPIC RESECTION P1586 FOR PAPILLARY ADENOCARCINOMA IN EGC A NOVEL METHOD OF LAPAROSCOPIC-ENDOSCOPIC Jae Jin Hwang, South Korea; J. P. Han; Y. S. Cho; J.-H. COOPERATIVE SURGERY FOR GASTROINTESTINAL Cho; H. K. Kim; B. M. Ko; S. J. Hong; I. K. Jung; J. S. Lee STROMAL TUMORS OF THE STOMACH Eriko Yasutomi, Japan; R. Takenaka; Y. Sato; K. Takei; P1578 S. Okanoue; A. Matsumi; S. Oka; D. Kawai; J. Kataoka; PROPOSAL FOR A NEW AGGRESSIVE VARIANT OF K. Takemoto; H. Tsugeno; S. Fujiki; T. Matsumura; M. GASTRIC ADENOCARCINOMA OF FUNDIC GLAND TYPE Nishizaki (A MULTICENTER STUDY OF 50 CASES) Hiroya Ueyama, Japan; T. Yao; A. Nagahara; Y. Akazawa; P1587 H. Komori; T. Takeda; K. Matsumoto; K. Matsumoto; M. GASTROINTESTINAL STROMAL TUMORS IN THE STOMACH Hojo; S. Watanabe - LONG-TERM PROGNOSIS AFTER CURATIVE RESECTION Chul Hong Park, South Korea; C. J. Park; S. Pyeon; B. E. P1579 Lee; G. H. Kim; G. A. Song THE ELEMENTS THAT MAY CAUSE THE DIFFICULTY TO DIAGNOSE EARLY GASTRIC CANCER AFTER HELICO- P1588 BACTER PYLORI ERADICATION IS RADICAL SURGERY NECESSARY IN ALL PATIENTS Toshiyuki Wakatsuk, Japan; S. Furutachi; H. Yamashita WHO ARE DIAGNOSED WITH EARLY GASTRIC CANCER WITH DEEP SUBMUCOSAL INVASION? RETROSPECTIVE P1580 STUDY IN A SINGLE CENTER THE YIELD OF PEPSINOGEN TESTING IN A GENERAL Shin Kono, Japan; M. Fukuzawa; T. Itoi POPULATION SAMPLE OF CAUCASIAN ORIGIN Olga Sjomina, Latvia; J. Pavlova; P. Janovics; I. Kikuste; P1589 A. Vanags; I. Tolmanis; D. Rudzite; I. Polaka; I. Kojalo; ANALYSIS OF MICROVASCULAR DENSITY IN GASTRIC I. Liepniece-Karele; S. Isajevs; D. Santare; V. Pirags; J. TUMOR USING MAGNIFYING ENDOSCOPY COMBINED Pahomova; V. Dzerve; M. Leja WITH A NARROW-BAND IMAGING SYSTEM Masashi Kawamura, Japan; H. Naganuma; R. Shibuya; P1581 T. Kikuchi; Y. Sakai; F. Nagasaki; E. Nomura; N. Suzuki;

FACTORS THAT ARE ASSOCIATED WITH UPGRADE DIAG- E. Saito 2016 19, October Wednesday, NOSIS TO SUBMUCOSA OR LYMPHOVASCULAR INVASIVE EARLY GASTRIC CANCER FROM HIGH GRADE DYSPLASIA R. Daegon; D. Kang; H. Kim; C. Choi; S. Park; S. Kim; H. Nam; J. Jeon; Jinhyuck Cho, South Korea; J. Park; S. Lee

Poster in the Spotlight Poster of Excellence Clinical Case Session 237

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1590 P1597 POORLY COHESIVE CARCINOMA OF EARLY GASTRIC CURCUMIN UPREGULATES INDOLEAMINE 2,3-DIOXY- CANCER, IS ENDOSCOPIC TREATMENT REALLY RISKY? GENASE (IDO) AND DOWNREGULATES INTERLEUKIN Sun Hyung Kang, South Korea; J. S. Kim; H. S. Moon; E. (IL)-17 PRODUCTION IN HELICOBACTER PYLORI-INFECT- S. Lee; S. H. Kim; J. K. Sung; B. S. Lee; H. Y. Jeong ED HUMAN GASTRIC MUCOSA Tiziana La Russa, Italy; E. Suraci; S. Gervasi; R. Placida; Upper GI / intestinal health services research R. Marasco; M. Imeneo; F. Luzza P1591 P1598 LYMPHOCYTIC GASTRITIS IS PRESENT IN CELIAC DIS- DECREASED GHRELIN RELEASE: POTENTIAL LINK EASE AND IMPROVES AFTER GLUTEN FREE DIET BETWEEN HELICOBACTER PYLORI INFECTION AND Dolores Gabrieli, Italy; G. Valerii; F. Ciccone; M. Di CARDIOVASCULAR DISEASE? Ruscio; D. Serva; A. Capannolo; A. Viscido; D. Melideo; Antonia Gaus, Germany; P. Layer; V. Andresen; J. J. F. Giuseppe; S. Necozione; G. Latella Holst; J. Keller P1592 ª P1599 THE INCIDENCE OF SELF- OF UPPER-GAS- THE PREDICTORS OF THE GASTRODUODENAL ZONE TROINTESTINAL SYMPTOMS IN ALBANIAN COMMUNITY EROSIVE-ULCERATIVE LESIONS DEVELOPMENT IN PHARMACIES PATIENTS WITH LEUKEMIA Alba Themeli, Albania; E. Pistja Igor Skrypnyk, Ukraine; G. Maslova; R. Skrypnyk

P1593 Treatment SHOULD GENERAL PHYSICIANS/INTERNISTS OR GI SPECIALISTS MANAGE PEPTIC ULCER DISEASE? P1600 Benedict Porter, United Kingdom; L. Lim; R. Logan COMPARISON BETWEEN A POTASSIUM-COMPETITIVE ACID BLOCKER AND A PROTON PUMP INHIBITOR FOR P1594 THE EFFICACY OF HELICOBACTER PYLORI ERADICATION IMPROVEMENT OF APPROPRIATENESS OF UPPER GI IN JAPANESE PATIENTS ENDOSCOPY FOR OUT-PATIENTS THROUGH SELECTION Yoshiharu Yamaguchi, Japan; H. Noda; S. Noguchi; T. AND INTRODUCTION OF GASTROPANEL: A SINGLE- Yoshimine; S. Goji; K. Adachi; Y. Tamura; S. Izawa; M. CENTRE PROSPECTIVE STUDY Ebi; S. Yamamoto; N. Ogasawara; Y. Funaki; M. Sasaki; G. Baldassarre; O. Messina; F. Tomba; Antonio Ferronato, K. Kasugai Italy; D. Sella; A. Antico; M. P. Panozzo; F. Di Mario; M. Franceschi P1601 EFFICACY AND TOLERABILITY OF A TRIPLE THERAPY Pathogenesis: Host factors / immunology / inflammation CONTAINING A POTASSIUM-COMPETITIVE ACID BLOCK- ER AS FIRST-LINE TREATMENT FOR HELICOBACTER Poster Session PYLORI INFECTION 09:00 - 14:00 Hall X5 Sho Suzuki, Japan; T. Gotoda; C. Kusano; K. Iwatsuka; H. pylori III M. Moriyama P1595 P1602 CLINICAL, HISTOPATHOLOGICAL, IMMUNOLOGICAL AND A COMPARATIVE STUDY OF POTASSIUM-COMPETITIVE MICROBIOLOGICAL CHARACTERIZATION IN A COHORT ACID BLOCKER (VONOPRAZAN) AND PROTON POMP INHIBITORS IN HELICOBACTER PYLORI ERADICATION Wednesday, October 19, 2016 OF PATIENTS OF TREATMENT-RESISTANT HELICO- BACTER PYLORI INFECTION THERAPY Oddmund Andreas A. Nestegard, Norway; B. Moayeri; Hiroko Suda, Japan; K. Sakurai; Y. Ido; T. Takeichi; A. R. Goll; K. Osther; F.-A. Halvorsen; T. Tønnesen; S. W. Okuda; K. Hasuda; M. Masahiro Hattori Sørbye; K. Melby; J. Florholmen P1603 P1596 EFFECT OF VONOPRAZAN IN TRIPLE THERAPY FOR H. PYLORI-SPECIFIC INDUCTION OF TH17 IMMUNE ERADICATION OF HELICOBACTER PYLORI: INTERIM RESPONSE ANALYSIS OF A SINGLE-CENTRE RANDOMISED CON- Arne Kandulski, Germany; W. Schirrmeister; A. Link; C. TROLLED TRIAL Langner; T. Kalinski; P. Malfertheiner Hayato Sasaki, Japan; K. Fujimasa; M. Yamasaki; T. Fujioka; H. Makita; T. Yamasaki; N. Tokuhiro; T. Satoh

238 Poster in the Spotlight Poster of Excellence Clinical Case Session 239 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

P1604 P1611 A COMPARISON BETWEEN HYBRID AND CONCOMITANT BONE MINERAL DENSITY PREDICTS DUODENAL REGIMENS FOR HELICOBACTER PYLORI ERADICATION: MUCOSAL HEALING IN ADULT PATIENTS WITH CELIAC A RANDOMIZED CLINICAL TRIAL DISEASE ON GLUTEN-FREE DIET Zohreh Bari, Iran; S. Alhooei; H. Fakheri; V. Hosseini; I. Tiziana La Russa, Italy; E. Suraci; R. Marasco; Maleki; S. M. Valizadeh; T. Taghvaei; A. Kazemi M. Imeneo; F. Luzza P1605 P1612 COMPARISON OF LEVOFLOXACIN -AND CLARTHRO- COELIAC DISEASE IN INDIVIDUALS WITH FERTILITY MYCIN- CONTAINING SEQUENTIAL THERAPIES FOR PROBLEMS - A REGIONAL EXPERIENCE HELICOBACTER PYLORI ERADICATION IN IRAN;A Kirsty Macfarlane, United Kingdom; H. N. Haboubi; J. RANDOMIZED CLINICAL TRIAL Bailey; E. Thomas; A. Abdul-Sattar; K. Younas; A. Gebril; Marjan Mokhtare, Iran; S. Agah; M. Nikkhah; M. Masoodi Z. Shehadeh; H. Thompson-Jones; A. Bunkheila; C. Ch'Ng P1606 P1613 EFFICACY OF FIRST-LINE BISMUTH-CONTAINING QUA- OVERWEIGHT STATUS AT DIAGNOSIS OF CELIAC DRUPLE THERAPIES WITH LEVOFLOXACIN OR CLARI- DISEASE IN ADULTS INCREASES RISK FOR METABOLIC THROMYCIN FOR THE ERADICATION OF HELICOBACTER SYNDROME AFTER GLUTEN EXCLUSION PYLORI INFECTION: A ONE-WEEK, OPEN-LABEL, Konstantinos Efthymakis, Italy; M. Serio; F. Del Cotto; A. RANDOMIZED TRIAL Milano; F. Laterza; A. Bonitatibus; M. Neri Xiaoying Zhou, China; G. Zhang P1614 P1607 PREVALENCE OF CELIAC DISEASE AMONG SYMPTOM- ESOMEPRAZOLE BASED TRIPLE THERAPY REGIMENS ATIC PATIENTS IN KUWAIT; A POPULATION BASED (EAC/EAM) ON H.PYLORI ERADICATION THERAPY RETROSPECTIVE COHORT STUDY SHOWED HIGH SUCCESS RATE EVEN IF ON EM OF A. Alfadhli; Mohamed Alboraie, Egypt; Y. Al-Shamali; I. CYP2C19 POLYMORPHISM OR CAM RESISTANCE Al-Jumah; S. George; M. O. Nour Takuji Yamasaki, Japan; M. Chibai; T. Nakayoshi; S. Watanabe P1615 NATIONWIDE POPULATION-BASED COHORT STUDY OF CELIAC DISEASE AND RISK OF EHLER–DANLOS SYN- Coeliac disease (adult) DROME AND JOINT HYPERMOBILITY SYNDROME Monika Laszkowska, USA; A. Roy; B. Lebwohl; P. H. Poster Session Green; H. Sundelin; J. Ludvigsson 09:00 - 14:00 Hall X5 Small intestinal III P1616 USEFULNESS OF CAPSULE ENDOSCOPY IN CELIAC P1608 DISEASE: A EUROPEAN MULTICENTER STUDY THE CLINICAL AND PHENOTYPIC ASSESSMENT OF Enrique Perez-Cuadrado Robles, Spain; M. Lujan; J. SERONEGATIVE VILLOUS ATROPHY; A PROSPECTIVE UK García Lledó; J. F. Juanmartiñena Fernández; L. Elli; V. CENTRE EXPERIENCE EVALUATING 200 CASES OVER A A. Jimenez Garcia; J. Egea Valenzuela; J. Valle Muñoz; 15 YEAR PERIOD (2000-2015) C. Carretero; N. Alonso Lázaro; M. Sanjuan Acosta; F. Imran Aziz, United Kingdom; M.F. Peerally; J.-H. Sánchez Ceballos; B. Rosa; B. González-Suárez Barnes; V. Kandasamy; J. C. Whiteley; D. Partridge; P. Vergani; S. S. Cross; P. H. Green; D. S. Sanders Malabsorption syndromes and food enteropathies (adult) P1609 P1617 PREVALENCE OF DYSBIOSIS AND EFFECT OF LOW FOD- HOW MUCH GLUTEN IS THE GENERAL POPULATION MAP DIET IN CELIAC DISEASE PATIENTS WITH IBS-LIKE CONSUMING AND DOES IT RELATE TO SYMPTOMS? SYMPTOMS Matthew Kurien, United Kingdom; I. Aziz; N. Trott; D. Ida Strindmo, Norway; K. Nuland; G. Kahrs; J. G. Brien; H. George; L. Marks; J. Richardson; R. Rigby; D. Hatlebakk S. Sanders P1610 P1618 HAPTOGLOBIN-2 GENE EXPRESSION IN CELIAC DIS- A SELF-ADMINISTERED BLIND GLUTEN CHALLENGE AS- EASE, NON CELIAC GLUTEN SENSITIVITY AND TYPE 1 SOCIATED TO AN ANDROID/IOS APPLICATION (TEST33®) 2016 19, October Wednesday, DIABETIC PATIENTS TO DIAGNOSE NON-CELIAC GLUTEN SENSITIVITY R. Freire; Anna Sapone, USA; C. Sturgeon; S. Camhi; S. Luca Elli, Italy; L. Roncoroni; C. Tomba; A. Catania; Patel; M. M. Leonard; A. Fasano V. Lombardo; D. Conte; F. Branchi; F. Ferretti; M. T. Bardella

Poster in the Spotlight Poster of Excellence Clinical Case Session 239

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

P1619 P1626 PREDICTORS OF RESPONSE TO TEDUGLUTIDE AMONG ENDOSCOPIC CHARACTERIZATION OF GASTROINTESTI- PATIENTS WITH PARENTERAL NUTRITION-DEPENDENT NAL STROMAL TUMORS OF THE SMALL BOWEL USING DOUBLE-BALLOON ENTEROSCOPY Francisca Joly, France; S. M. Gabe; D. L. Seidner; F. Mu; Álvaro Martínez-Alcalá, USA; J. P. Gutierrez; P. T. J. Xie; S. S. Kelkar; K. Chen; C. Olivier Kroener; K. Mönkemüller P1620 Obesity LACTOSE MALABSORPTION IN SUBJECTS WITH SELF-PERCEIVED MILK INTOLERANCE ASSESSED WITH THE ROMA III QUESTIONNAIRE FOR IBS Poster Session Flavio Valiante, Italy; A. Buda; M. De Bona; A. Bellumat; 09:00 - 14:00 Hall X5 M. Tollardo; M. De Boni Nutrition III P1621 P1627 POST HOC ANALYSIS OF POLYPS IN 9 SHORT BOWEL THE FIRST PROCEDURELESS GASTRIC BALLOON FOR SYNDROME PATIENTS TREATED WITH TEDUGLUTIDE WEIGHT LOSS: FINAL RESULTS FROM A MULTI-CENTER, Palle Bekker Jeppesen, Denmark; S. Rudzki; PROSPECTIVE STUDY EVALUATING SAFETY, EFFICACY, D. Armstrong; A. Forbes; H.-M. Lee PARTICIPANT PREFERENCE, AND LONG TERM FOLLOW-UP R. Chuttani, USA; I. Raftopoulos; A. Giannakou; K. Small intestinal neoplasia Ioannis; M. Bojkova; T. Kupka; M. Buzga; K. Stecco; S. Levy; S. Gaur; E. Machytka P1622 THE UTILITY OF SMALL INTESTINE CAPSULE ENDOS- P1628 COPY AND BALLOON-ASSISTED ENTEROSCOPY IN THE CHILD WEIGHT STATUS INFLUENCES THE IMPROVEMENT DIAGNOSIS OF SMALL INTESTINAL TUMORS IN INSULIN SENSITIVITY FOLLOWING A SHORT-TERM Ryosuke Miyazaki, Japan; Y. Nagata; R. Sawada; M. ENERGY RESTRICTION IN SEVERELY OBESE PATIENTS Ogawa; T. Nishimura; S. Kanba; D. Ide; T. Iwasaki; Y. E. Baldry; Guruprasad Aithal, United Kingdom; P. C. Nakao; J. Mitobe; M. Mitsunaga; S. Arihiro; M. Matsuoka; Leeder; I. R. Idris; A. Bennett; I. A. Macdonald T. Kato; M. Saruta P1629 P1623 ARGON PLASMA COAGULATION FOR FAILED ROUX-AND-Y DOUBLE BALLOON ENTEROSCOPY IN SMALL BOWEL GASTRIC BYPASS (RYGB): AN ENDOSCOPIC ALTERNATIVE TUMORS: 11 YEARS' EXPERIENCE AT A TERTIARY-CARE IN BARIATRIC PATIENTS WITH WEIGHT REGAIN HOSPITAL Bruno Q. Sander, Brazil; G. A. P. Baretta; J. I. B. Marta Gravito-Soares, Portugal; E. Gravito-Soares; S. Scarparo; R. Fittipaldi-Fernandez; J. Schemberk Jr; M. Lopes; N. Almeida; P. Figueiredo; C. Sofia P. Sander; M. Galvao Neto P1624 P1630 RISK FACTORS FOR ADVANCED SMALL BOWEL DISEASE ASSESSMENT OF THE EFFECTIVENESS OF DIET REDUC- IN FAMILIAL ADENOMATOUS POLYPOSIS: A PROSPEC- ING WEIGHT GAIN IN POSTMENOPAUSAL OVERWEIGHT TIVE, SINGLE-CENTER STUDY WOMEN Marianny Sulbaran, Brazil; F. G. Campos; U. Ribeiro Jr; K. Lokiec; Ewa Maria Walecka-Kapica, Poland; C. H. S. Kishi; E. G. H. De Moura; P. Sakai; L. Bustamante- Rudnicki; K. Stec-Michalska López; M. Tomitao; S. C. Nahas; A. V. Safatle-Ribeiro Wednesday, October 19, 2016 P1631 P1625 USING AN INTRAGASTRIC BALLOON FOR A SECOND ONCOFETAL PROTEIN IMP3 EXPRESSION IN LYMPH TIME: IS IT A GOOD ATTEMPT? NODE METASTASES OF SMALL-INTESTINE NEUROEN- Ricardo Jose Fittipaldi-Fernandez, Brazil; C. F. Diestel; DOCRINE NEOPLASMS: A NEW PREDICTOR OF RECUR- M. Passos Galvão Neto RENCE INDEPENDENT OF THE KI-67 INDEX P1632 S. Massironi; A. Del Gobbo; F. Cavalcoli; S. Fiori; D. CD24 POLYMORPHISMS ARE ASSOCIATED WITH OBESITY Conte; A. Pellegrinelli; Alessandra Zilli, Italy; M. Milione; RISK S. Ferrero I. Boustanai; D. Sion; N. Shemesh; S. Shapira; D. Kazanov; S. Zigdon; L. Galazan; A. Leshno; S. Abu-Abeid; S. Kraus; Nadir Arber, Israel

240 Poster in the Spotlight Poster of Excellence Clinical Case Session 241 Wednesday, October 19, 2016 Poster Sessions : UEG Week Final Programme

Nutrients and gut function P1641 P1633 KNOWLEDGE, ATTITUDES AND EXPERIENCES OF INTER- LYSOZYME FRACTION FROM DONKEY MILK (DM) NAL MEDICINE TRAINEES TOWARDS ENTERAL FEEDING SUPPORTS VISCERAL ANTINOCICEPTIVE PROPERTIES TUBE: RESULTS FROM MULTICENTER SURVEY OF CUR- OF DM, REDUCES PROTEASE ACTIVITY AND RESTORES RENT PRACTICE ANTIMICROBIAL LEVELS IN PANETH CELLS IN A MODEL Taehyung Kwon, South Korea; Y. J. Lee; S.-E. Kim; J. Y. OF CHRONIC STRESS IN MICE Choi; D. K. Chang; E. R. Kim; J.-O. Kim; S. R. Jeon; E. Sophie Yvon, France; V. Bézirard; V. Tondereau; C. Y. Kim; J.-S. Koo; S. J. Park; S.-J. Koh; Y. K. Cho; S.-K. Harkat; G. Jard; H. Tormo; D. Ali Haimoud-Lekhal; M. Park; J. Y. Yoon; C. H. Choi; H. S. Moon Peter; H. Eutamene P1642 P1634 THIRTY-DAY MORTALITY AFTER PERCUTANEOUS GAS- WITHDRAWN TROSTOMY BY ENDOSCOPIC VERSUS RADIOLOGIC PLACE- MENT: A SYSTEMATIC REVIEW AND META-ANALYSIS P1635 Joo Hyun Lim, South Korea; S. H. Choi; C. Lee; J. I. DEVELOPMENT AND VALIDATION OF A GLIADIN 33-MER- Yang; J. S. Kim BASED IMMO-ASSAY FOR THE MONITORING OF A GLUTEN-FREE DIET P1643 Dmitri Rehan, Germany; F.-P. Armbruster; J. Stein SERUM TRACE ELEMENTS AND PROTEINS BEFORE ENDOSCOPIC GASTROSTOMY AND DURING LONG TERM P1636 ENTERAL FEEDING ANALYSIS OF TREATMENT RESULTS WITH TEDUGLU- Jorge Fonseca, Portugal; C. A. Santos TIDE ON INTESTINAL ABSORPTION AND NUTRITIONAL STATUS IN PATIENTS WITH SHORT BOWEL SYNDROME P1644 Sophie Pevny, Germany; S. Maasberg; M. Karber; B. TREATMENT OF SHORT BOWEL SYNDROME WITH Knappe-Drzikova; D. Thurmann; U. A. Gerlach; V. A. GLP-2-ANALOGUE TEDUGLUTIDE - FIRST CLINICAL DATA Müller; A. Pascher; U.-F. Pape FROM TUEBINGEN UNIVERSITY HOSPITAL, GERMANY Marc Schoeler, Germany; S. Bernhard; T. Klag; H. P1637 Mühlberg; N. Malek; M. Götz; J. Wehkamp FOLATE SUPPLEMENTATION PROMOTES STEMNESS ON HT-29 COLORECTAL CANCER CELL LINE VIA P1645 NOTCH1 SIGNALING PATHWAY ADJUSTING THE TIMING OF REFEEDING AFTER PER- J. M. Rodriguez; R. Troncoso; C. Fuentes; D. Bunout; M. CUTANEOUS ENDOSCOPIC GASTROSTOMY PLACEMENT P. De La Maza; Sandra Hirsch, Chile - WHEN EARLY IN NOT TOO EARLY! Tiago Cúrdia Gonçalves, Portugal; S. Monteiro; M. P1638 Barbosa; S. Xavier; P. Boal Carvalho; C. Marinho; J. Cotter ORAL INTAKE OF PURIFIED AQUEOUS SOLUTION OF OAT BETA-GLUCANS HAS LIMITED EFFECT ON OXIDATIVE P1646 ANAESTHETIST ASSISTED PERCUTANEOUS ENDOSCOP- STRESS IN PATIENTS WITH CHRONIC GASTRITIS: A PILOT PHASE II CLINICAL TRIAL IC GASTROSTOMY WITH GASTROPEXY; A SAFE AND Rafal Filip, Poland; S. Gudej; J. Wilczak; M. Juszczak; EFFICIENT PROCEDURE E. Lange; J. Harasym; D. Suchecka; K. Blaszczyk; J. Ioannis Stasinos, United Kingdom; M. Lim; H. Dent; C. Gromadzka-Ostrowska Nunes P1647 Enteral and parenteral nutrition EFFECT OF ENTERAL NUTRITION ON METABOLIC SYM- P1639 DROME WITH NONALCOHOLIC FATTY LIVER DISEASE IN CT-GUIDED PERCUTANEOUS GASTROSTOMY/JEJUNOS- ELDERLY PATIENTS TOMY FOR FEEDING AND DECOMPRESSION Wei Wang, China Heinz Albrecht, Germany; P. Schlechtweg; A. F. Hagel; T. Foertsch; M. F. Neurath; J. Mudter Poster Session 09:00 - 14:00 Hall X5

P1640 ª Clinical cases: Liver and pancreas PERFORMANCE OF THREE PROGNOSTIC RISK SCORES IN

PREDICTING OUTCOMES IN ELDERLY NON-MALIGNANT 2016 19, October Wednesday, PATIENTS AFTER PERCUTANEOUS GASTROSTOMY Cc41 Ç. Kalkan; A. Ç. Kartal; Fatih Karakaya, Turkey; A. Tüzün; SPONTANEOUS BACTERIAL PERITONITIS BY LISTERIA I. Soykan MONOCYTOGENES: A RARE DISEASE Rui Gaspar, Portugal; S. Rodrigues; G. Macedo

Poster in the Spotlight Poster of Excellence Clinical Case Session 241

UEG Week Final Programme : Poster Sessions Wednesday, October 19, 2016

Cc42 Cc51 DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED AS A ACUTE PORTAL VEIN THROMBOSIS AND HEPATITIS E REFRACTORY ASCITES - A SINGULAR CASE IN A CIRRHOTIC PATIENT - ADDING INSULT TO INJURY Diana Martins, Portugal; P. Sousa; J. Pinho; R. Araújo; Diogo Branquinho, Portugal; E. Gravito-Soares; S. E. Cancela; A. Castanheira; P. Ministro; A. Silva Campos; R. Cardoso; L. Tomé; C. Sofia Cc43 Cc52 HEPATITIS B VIRUS REACTIVATION DURING THERAPY LAMIVUDINE IN FULMINANT LIVER FAILURE DUE TO WITH SOFOSBUVIR AND SIMEPREVIR IN PATIENT WITH ACUTE HBV INFECTION IN INFANT HEPATITIS B VIRUS/HEPATITIS C VIRUS CO-INFECTION Tudor Lucian Pop, Romania; A. Grama; A. Popa Tarek Besheer, Egypt; M. Abd El-Maksoud; A. M. Elnakib Cc53 ENDOSCOPIC TREATMENT OF BRONCHOBILIARY FISTULA Cc44 AFTER LIVER METASTASIS RESECTION: CASE REPORT HEPATIC NODULES IN PATIENT RECEIVING THERAPY T. F. De Souza; Victor Andrade, Brazil; V. G. Garcia; M. FOR CHRONIC HEPATITIS B - JUST A COINCIDENCE? Frazão; L. Marques; E. Grecco Marta Patita, Portugal; R. Barosa; G. Nunes; D. Gonçalves; M. J. Brito; C. Fonseca Cc54 PYLORIC GLAND ADENOMA OF THE COMMON BILE Cc45 DUCT: A CASE REPORT AND REVIEW OF LITERATURE MULTIPLE LIVER ABSCESSES IN A PATIENT WITH CHRONIC Gian Carlo A. Carpio, Philippines; G. T. Ang; A. E. Ismael GRANULOMATOUS DISEASE - TREATMENT DIFFICULTIES Mihaela Bataneant, Romania; O. Belei; M. Pop; S. Cc55 Arghirescu; P. Urtila; A. Popoiu; S. Cerbu; C. Popoiu THERAPEUTIC CHALLENGES IN PANCREATIC ASCITES: MASSIVE THROMBOEMBOLISM AND THE ROLE OF Cc46 ENDOSCOPY SURVIVAL OF A CASE OF ACUTE FATTY LIVER OF Paula Sousa, Portugal; D. Martins; J. Pinho; R. Araújo; PREGNANCY (AFLP) WITH ACUTE PANCREATITIS (AP) E. Cancela; A. Castanheira; P. Ministro; A. Silva O. M. Alhaddad; M. M. Alsabaawy; Omar A. Elshaarawy, Egypt; E. A. Rewisha; T. A. Salman; H. Cc56 Badran; I. A. Waked FRANTZ'S TUMOR: A RARE PANCREATIC NEOPLASM INCIDENTALLY DIAGNOSED Cc47 Claudio Martins, Portugal; C. Teixeira; É. Gamito; A. P. SUBACUTE OPHTHALMOPLEGIA IN A CIRRHOTIC PATIENT Oliveira Pedro Marques Da Costa, Portugal; S. Bernardo; C. M. Moura; N. Fatela; R. T. Marinho; F. Ramalho; J. Velosa Cc57 A RARE CASE OF PANCREATIC EWINGS SARCOMA PRE- Cc48 SENTING WITH OBSTRUCTIVE JAUNDICE AND GASTRIC THE PROBLEMATIC OF LIVER NODULE... NOT ALWAYS OUTLET OBSTRUCTION HISTOLOGY IS DEFINITIVE Vijay Sharma, India; A. Agarwal; R. Sharma Elisa Soares, Portugal; M. Gravito-Soares; D. Gomes; J. Fraga; M. Cipriano; S. Carlos Cc58 BILIARY LEAK AFTER TRANSCATHETER ARTERIAL CHE- Cc49 MO-EMBOLIZATION SUCCESSFULLY TREATED BY ERCP: SUCCESSFUL STENTING OF A STENOSIS IN THE HEPATIC A RARE CASE REPORT Wei Shen, China; X. Liu

Wednesday, October 19, 2016 VENOUS OUTFLOW TRACT IN A PATIENT WITH SEC- ONDARY BUDD-CHIARI-SYNDROME AND REFRACTORY ASCITES Cc59 Patrick Roger Aepli, Switzerland; D. Venetz; M. Hoff- INTESTINAL MIGRATION OF ENDOVASCULAR COIL - A mann RARE CAUSE FOR LOWER INTESTINAL BLEEDING Diana Martins, Portugal; P. Sousa; J. Fernandes; R. Cc50 Araújo; A. Castanheira; A. Silva BUDD CHIARI SYNDROME SECONDARY TO ESSENTIAL THROMBOCYTHEMIA SHOWING CLINICAL AND MOLEC- Cc60 ULAR REMISSION ON PEGYLATED INTERFERON ALFA METASTATIC NEUROENDOCRINE TUMOR - A CHAL- TREATMENT: CASE REPORT LENGING DIAGNOSTIC MARCH F. S. Mohamed; Sameh A. Lashen, Egypt; A. A. Abdelmoety Marta Patita, Portugal; R. Barosa; G. Nunes; J. Nogueira; M. J. Brito; C. Fonseca

242 Poster in the Spotlight Poster of Excellence Clinical Case Session 243 Visit the Scientific Centre in Halls X4 and X5, hosting all possibilities to present your abstract

P n os io ter Exhibit

P t ost igh er in the Spotl

C li s nical Case

A b ire stracts on F P e o c s n te le r of Excel

View the programme schedule directly in the UEG Week App (www.ueg.eu/app) and on www.ueg.eu/week

243

16_08_Inserat_UEGWEEK_FP_ScientificCentre_160x220mm_RZ.indd 1 13.09.16 15:02 Get ready for practice on Level 1

Sat – Tue 9:00 – 18:00 Wed 9:00 – 14:00

ESGE Learning Area Ultrasound ESGE Hands-on Training Learning Area in cooperation with ESGENA Take the opportunity to hone → Meet with ultrasonography experts your endoscopy skills → Take part in a 2-day basic – check the programme and advanced course of for session details ultrasonography with real-time video clips

ESGE Lecture Theatre Meet and learn from Surgical leading experts Learning Area ESGE eLibrary Surgical Hands-on Training Learning Centre and educational modeling in View latest ESGE releases GI Surgery in sync with associated disciplines

www.ueg.eu/week

16_09_Inserat_UEGWEEK_FP_handson_learningareas_160x220mm_RZ.indd 1 15.09.16 11:22 ESGE Learning Area

The European Society of Gastrointestinal Endoscopy welcomes all delegates of UEG Week to the ESGE Learn- ing Area where many accomplished doctors and nurses volunteer their expertise for you: to promote good en- doscopy, to show the basics as well as the latest devel- opments, to support training and to offer small-group teaching activities to everyone with a real interest in the how and why of current endoscopy. The ESGE Learn- ing Area provides a unique and ideal platform for live encounter and interaction among aspiring endoscopists and renowned experts in the field.

Please come and be a part of it!

The programme is as of September 16, 2016.

UEG Week Final Programme : ESGE Learning Area

ESGE Learning Area

Hands-on Training Centre Saturday, October 15, 2016 Test your skills and experience the latest technology. The • EMR 90-minute training sessions in the Hands-on Theatre offer • Hemostasis (injection, clipping, varices ligation) unique access to state of the art endoscopic equipment • Polypectomy/colonoscopy and accessories. Participants will have the opportunity to • ERCP look, learn, ask questions and perform techniques them- selves under personal doctor and nurse tutoring. In coop- Session 1 14:00 – 15:30 eration with ESGENA, the aim of this activity is to increase Session 2 16:00 – 17:30 the awareness of diagnostic and therapeutic techniques and to offer delegates the possibility of checking their skills. Basic and advanced training is offered. Advanced Sunday, October 16, 2016 endoscopists are welcome to join the Monday sessions. • EMR Here we focus on EUS and FNA procedures where experi- • Hemostasis (injection, clipping, varices ligation) ence with a scope is necessary. The pediatric stations are • Polypectomy/colonoscopy limited to doctors working in child medicine. • ERCP

Registration Session 1 11:00 – 12:30 There is limited availability of tickets for the training Session 2 14:00 – 15:30 sessions from Saturday to Monday. Please go the ESGE Session 3 16:00 – 17:30 desk in the Learning Area and secure your ticket (starts on Saturday at 9:00). Participation will be on a first- come-first-served basis. To maintain a high standard of Monday, October 17, 2016 teaching each workstation is limited to a maximum of • FNA – fine needle aspiration eight participants. • EUS – endoscopic ultrasound • Pediatric endoscopy – (Dilation, PEG, Bleeding) Endoscopic training on GI Simulators is available on a walk-in basis throughout UEG Week as are the Hands- Session 1 10:30 – 12:00 on sessions on Tuesday and Wednesday. Session 2 12:30 – 14:00 Session 3 14:30 – 16:00 ESGE Learning Area 2015

246 ESGE Learning Area : UEG Week Final Programme

Tuesday, October 18, 2016 ESGE E-learning Stations No registration required The ESGE E-learning Stations offer UEG Week delegates 9:30 – 11:00 the opportunity to view the latest training material on • Colonoscopy – the basics video screens with headphone sound transmission. • Modern clip (OTSC) treatment for bleeding, fistulae and perforations The ESGE teaching units presented at the Learning Area • RFA Balloon Catheter for treatment of Barrett’s are otherwise only available to ESGE members via the Esophagus ESGE website. If you are not already a member of ESGE, • Image enhancement systems: Zoom and BLI endoscopy this is your chance to catch a glimpse of one of the many benefits ESGE provides when you join. 11:30 – 13:00 • Hands-on experience of the instinct clip and hemo- The ESGE teaching units are complemented by selected spray video submissions from ASGE and JGES. Any time you • Colonoscopy: From better navigation to better lesion are in the Learning Area take a seat, grab a headphone detection and tune in to the topic of your interest. • EUS FNA/FNB – disease states and procedural advances On Tuesday the live demonstration sessions broadcast 14:00 – 15:30 to the large auditorium at the Austria Center from the • EUS anatomy and diagnostics Hôpital Erasme, Brussels will additionally be projected • Modern clip (OTSC) treatment for bleeding, fistulae to a large screen in the Learning Area. We want to make and perforations sure you do not miss the important things – wherever • Image enhancement systems: Zoom and BLI endoscopy you are.

16:00 – 17:30 • Hands-on experience of the instinct clip and hemo- ESGE Lecture Theatre spray • Colonoscopy: From better navigation to better lesion In the ESGE Lecture Theatre highly qualified and well- detection known endoscopists have been invited to present their • RFA Balloon Catheter for treatment of Barrett’s views and experience with current endoscopic proce- Esophagus dures and techniques. Their counterparts in discussion • Hemostasis – injection therapy and band ligation are equally well known, in several cases more senior specialists whose role it is to moderate the talk and perhaps critically question the case at hand. The num- Wednesday, October 19, 2016 ber of participants is limited to 70 in order to ensure a No registration required small-forum atmosphere where active participation is possible. 9:30 – 11:00 • Hands-on experience of the instinct clip and hemo- In addition, there will be presentations of guidelines, spray various networking meetings and informative sessions • Colonoscopy: From better navigation to better lesion on topics evolving around manuscript publication. detection • RFA Balloon Catheter for treatment of Barrett’s The ESGE General Assembly will take place on Monday, Esophagus October 17 at 12:30 in the ESGE Lecture Theatre. • EUS FNA/FNB – disease states and procedural advances

11:30 – 13:00 • Modern clip (OTSC) treatment for bleeding, fistulae and perforations • FNA – fine need aspiration • Image enhancement systems: Zoom and BLI endoscopy

247 UEG Week Final Programme : ESGE Learning Area

Sunday, October 16, 2016 Tuesday, October 18, 2016

10:30 – 11:00 Cholangiocarcinoma: Do we need 10:00 – 10:30 Anti reflux endoscopy: Anything new intraductal diagnosis and therapy? that works? T. Hucl, Czech Republic D. Golger, Germany M. Löhr, Germany H. Messmann, Germany 11:30 – 12:00 Submucosal full thickness resec- 11:00 – 11:30 Colorectal cancer screening: Stool or tion: What to use and when endoscopy? A. Schmidt, Germany M. Häfner, Austria K. Caca, Germany S. Suchanek, Czech Republic 12:30 – 13:00 G-POEM: Is it going to work? 14:00 – 14:30 Pancreatic cancer precursors: How do M. Ramchandani, India we find them? M. Barthet, France I. Hritz, Hungary 14:00 – 14:30 Bariatric endoscopy: What is there E. Santo, Israel and does it work? 15:00 – 15:30 ERCP: Success versus failure D. Stimac, Croatia T. Gyökeres, Hungary P. Fockens, The Netherlands J. Spicak, Czech Republic 16:30 – 17:00 Upper GI endoscopy in children: 16:00 – 18:00 Recent ESGE Guidelines – meet the Differences and similarities authors and have them explain L. Dall'Oglio, Switzerland Self-expandable metal stents for ob- A. Tringali, Italy structing colonic and extracolonic cancer Diagnosis and management of nonvariceal upper gastrointestinal Monday, October 17, 2016 hemorrhage Endoscopic submucosal dissection 10:30 – 11:00 Cold snare resection: When, why, C. Hassan, Italy how? G. Manes, Italy P. Bhandari, UK I. Gralnek, Israel S. Meisner, Denmark J.M. Dumonceau, Brazil 12:30 – 14:00 ESGE GENERAL ASSEMBLY 15:45 – 16:15 Managing antithrombotic agents during endoscopy Wednesday, October 19, 2016 N.N. I. Gralnek, Israel 10:30 – 11:00 EUS guided interventions: From drain- 16:30 – 18:00 Grasping endoscopic research age to tumor treatment Getting the handle on manuscripts. T. Wong, UK From reader to reviewer P. Vilmann, Denmark Getting the most from guidelines? 12:00 – 12:30 Pre/early gastric neoplasia: When and Interpreting practice regulations how to look, follow and treat What about videos? Moving from R. Kuvaev, Russia impact factor and other metrics M. Dinis-Ribeiro, Portugal L. Aabakken, Norway M. Dinis-Ribeiro, Portugal P. Siersema, The Netherlands M. Polkowski, Poland C. Hassan, Italy I. Papanikolao, Greece

248 ULA

Ultrasound Learning Area

The Ultrasound Learning Area promotes the role of a major diagnostic and interventional tool in gastroen- terology: Clinical ultrasonography in the hands of the gastroenterologist. The Ultrasound Learning Area offers individual Hands-on Training, a basic and an advanced course on ultrasonography for the gastroenterologist, which are designed for both the beginner and the ex- perienced and lectures in abdominal ultrasonography in the topics liver, GIT and pancreas presented by expert gastroenterologists.

Course directors Dieter Nuernberg, Neuruppin, Germany Odd Helge Gilja, Bergen, Norway Ioan Sporea, Timisoara, Romania

Faculty members Gabriele Hanenberg, Düren, Germany

Roald Flesland Havre, Bergen, Norway, Christian Jenssen, Strausberg-Wriezen, Germany Horst Kinkel, Düren, Germany, Thomas Mueller, Reutlingen, Germany Alina Popescu,Timisoara, Romania, Adrian Saftoiu, Craiova, Romania Stefan Uebel, Hitachi Co. Jonas Valentinas, Vilnius, Lithuania

The programme is as of September 16, 2016. UEG Week Final Programme : Ultrasound Learning Area

Ultrasound Learning Area Room L6

Programme Overview Ultrasonography for the Gastroenterologist

Saturday Sunday Monday Tuesday Wednesday October 15, 2016 October 16, 2016 October 17, 2016 October 18, 2016 October 19, 2016 09:00 PART I PART II Hands-on Training C Hands-on Training E PART V 09:00 – 16:00 09:00 – 16:00 09:00 – 11:30 09:00 – 11:30 09:00 – 11:00 Basic Course Advanced Course Morning Session 10:00

11:00 Hands-on Training G PART III PART IV 11:00 – 14:00 12:00 11:30 – 14:00 11:30 – 14:00 Noon Lectures Noon Lectures

13:00

14:00

Hands-on Training D Hands-on Training F 15:00 14:30 – 18:00 14:30 – 18:00

16:00 Hands-on Training A Hands-on Training B 16:00 – 18:00 16:00 – 18:00 17:00

Saturday, October 15, 2016 Moderation: A. Popescu, H. Kinkel

Basic Course 11:00 – 11:15 Examination of liver I. Sporea Part I 09:00 – 16:00 11:15 – 11:30 Examination of gall bladder and bile Basics and introduction in abdominal ultrasound duct examinations H. Kinkel Moderation: I. Sporea, T. Mueller 11:30 – 12:30 Hands-on Training: Focus liver and biliary system 09:00 – 09:10 Introduction and aims of the course Faculty I. Sporea 12:30 – 12:45 Physics and technique – setting up 09:10 – 09:25 The view in the body – examination the machine and small introduction to technique and Sonoanatomy technical details A. Popescu S. Uebel 09:25 – 09:40 Abdominal vessels – landmarks 12:45 – 13:00 Examination of pancreas T. Mueller R. Havre 09:40 – 10:30 Hands-on Training: Focus abdominal 13:00 – 14:00 Lunch Break vessels Faculty Moderation: R. Havre, A. Popescu 10.30 – 11:00 Coffee Break

250 Ultrasound Learning Area : UEG Week Final Programme

14:00 – 14:15 Examination of (abdominal) lymph 11:40 – 12:25 Hands-on Training: Liver segments, nodes abdominal vessels R. Havre Faculty 14:15 – 15:00 Hands-on Training: Focus pancreas 12:25 – 12:45 Pathology of and retroperitoneum O.H. Gilja Faculty 12:45 – 13:00 Better examination (tips and tricks) – 15:00 – 15:15 Where to check for free fluid and gas? live demonstration – how to find the A. Popescu ? 15:15 – 15:30 First look at stomach and bowel – T. Mueller typical positions 13:00 – 14:00 Lunch Break T. Mueller 15:30 – 15:55 Live demonstration and QUIZZ Moderation: O.H. Gilja, D. Nuernberg H. Kinkel, G. Hanenberg, A. Popescu 15:55 – 16:00 Closing remarks for the first day 14:00 – 14:15 Pancreas pathology – focal lesions A. Popescu, I. Sporea C. Jenssen 14:15 – 14:30 Pancreas pathology – inflammatory Hands-on Training A changes R. Havre 16:00 – 18:00 14:30 – 15:15 Hands-on Training: Focus pancreas Ultrasonography for the Gastroenterologist and bowel Faculty 15:15 – 15:30 Other abdominal and retroperitoneal Sunday, October 16, 2016 pathology interesting for gastroenter- ologists Advanced Course D. Nuernberg Part II 09:00 – 16:00 15:30 – 15:55 Interesting cases – (video demonstration) Pathology and special topics in abdominal ultrasound Faculty examinations 15:55 – 16:00 Closing remarks, certificates Moderation: D. Nuernberg, I. Sporea O.H. Gilja, D. Nuernberg

09:00 – 09:05 Introduction and aims of the course Hands-on Training B D. Nuernberg 16:00 – 18:00 09:05 – 09:20 Gall bladder pathology: Stones and Ultrasonography for the gastroenterologist tumours A. Popescu 09:20 – 09:35 Bile duct pathology: Causes of ob- Monday, October 17, 2016 struction H. Kinkel 09:35 – 09:50 Liver pathology: Diffuse changes Hands-on Training C I. Sporea 09:00 – 11:30 09:50 – 10:30 Hands-on Training: Bile duct, liver Ultrasonography for the gastroenterologist and portal system Faculty PART III 11:30 – 14:00 10:30 – 11:00 Coffee Break Ultrasound Learning Area – Noon Lectures: Ultrasound in liver diseases Moderation: C. Jenssen, T. Mueller Moderation: I. Sporea, C.F. Dietrich

11:00 – 11:10 Better examination (tips and tricks) – 11:30 Ultrasound and CEUS (Contrast Enhanced US) live demonstration in differentiation of solid liver tumours D. Nuernberg C.F. Dietrich 11:10 – 11:25 Focal liver lesions 12:00 Ultrasound in diagnostic and therapy of HCC H. Kinkel H. Kinkel 11:25 – 11:40 Pathology of abdominal vessels T. Mueller

251 UEG Week Final Programme : Ultrasound Learning Area

12:30 Ultrasound and elastography in the diagnostic 13:00 EUS in diagnostic and staging of GI tumours and staging of cirrhosis, chronic hepatitis and A. Saftoiu NASH 13:30 US in ischemic problems of the bowel A. Popescu C. Jenssen 13:00 Indications and problems in US-guided liver biopsy Hands-on Training F I. Sporea 13:30 Ultrasound in diagnostic and follow up of 14:30 – 18:00 portal hypertension Ultrasonography for the gastroenterologist D. Nuernberg Wednesday, October 19, 2016 Hands-on Training D 14:30 – 18:00 PART V 09:00 – 11:00 Ultrasonography for the gastroenterologist Ultrasound Learning Area – Morning Session: Ultrasound in pancreatic diseases Moderation: C. Jenssen, T. Mueller Tuesday, October 18, 2016 09:00 Acute Pancreatitis – role of ultrasound Hands-on Training E T. Mueller 09:00 – 11:30 09:30 Abdominal vascular complications in pancre- Ultrasonography for the gastroenterologist atic diseases C. Jenssen 10:00 Pancreatic tumours – differential diagnosis PART IV 11:30 – 14:00 with US and EUS Ultrasound Learning Area – Noon Lectures: R. Havre Ultrasound in diseases of GIT 10:30 US in chronic pancreatitis and management Moderation: O.H. Gilja, A. Saftoiu of liquid formations J. Valentinas 11:30 US in diagnostic of appendicitis T. Mueller 12:00 US in diagnostic of diverticulitis Hands-on Training G D. Nuernberg 11:00 – 14:00 12:30 US in IBD (primary diagnostic, complications, Ultrasonography for the gastroenterologist follow up) O.H. Gilja

Organised and supported by EFSUMB and ISCUS Supported by Hitachi Co., GE Co. and Bracco

252 Surgical Learning Area

The Surgical Learning Area welcomes UEG Week dele- Faculty members gates to have firsthand experience at the various Hands- M. Adham, France on Training and educational modeling in GI Surgery A. Arezzo, Italy in sync with associated disciplines. The four surgical L. Boni, Italy member Societies, EAES, EDS, EFISDS and ESCP, look N. Francis, UK forward to reach out to the GI community with live J. Izbicki, Germany Hands-on Training and demonstrations involving both J. Jakimowicz, The Netherlands simulation and anatomical models. I. Jenkins, UK M. Morino, Italy The purpose of the area is to offer opportunities for sur- E. Schoon, The Netherlands geons to upskill and/or benchmark their skill sets and M. van Berge Henegouwen, The Netherlands attract attendees to gain a broader insight in surgical Y. Vashist, Switzerland education and Hands-on training procedures. N. Yassin, UK

Activities include meet the expert sessions, multidis- The programme is as of September 16, 2016. ciplinary case discussions, videos edited and unedited plus 2 fully fledged Hands-on Training courses repeat- ing twice in trans-anal Endoscopic surgery and laparo- scopic colorectal surgery with associated certification.

UEG Week Final Programme : Surgical Learning Area

Surgical Learning Area Saturday, October 15, 2016 Sunday, October 16, 2016

Information desk | Simulation demonstrations | Simulation demonstrations | Running videos Running videos 09:00 – 12:30 General Area 09:00 – 12:00 General Area Multi-disciplinary Discussion corner

Course One: Laparoscopic Surgical Skills Grade 2 Complications management Colorectal Surgery Hands-on Course • Insufficiency management 09:00 – 18:00 Room B • Role of endo-sponge • Stent Programme • Conservative management Baseline evaluation, suturing and left side colectomy Re-operations 09:00 Welcome, introduction & Course outline 09:30 Base line evaluation Group 1: VR simulations in colorectal surgery Course One: Laparoscopic Surgical Skills Grade 2 10:30 Group 2: Laparoscopic suturing Colorectal Surgery Hands-on Course 11:00 Export session: Interactive clinical based 09:00 – 15:30 Room B discussion 11:30 Safe use of tissue of energizers Programme 12:00 Safe use of tissue, approximation and stapling Baseline evaluation, suturing and left side colectomy 13:30 Expert session: set-up for left hemicolectomy 09:00 Outline day 2 critical steps in left hemicolectomy 09:30 Introduction to right hemicolectomy 14:00 Practical: Step by step of left hemicolectomy Anatomy of right hemicolectomy set-up and Stapling and bowel anastomosis steps of RH 16:30 Expert session: Case scenario about left 11:00 Expert session: Interactive clinical based hemicolectomy discussion on right hemicolectomy 18:00 Closure of day 11:30 Laparoscopic bowel suturing 13:30 Testing session: Case scenarios (decision making) Simulation demonstrations | Running videos | Discus- VR Simulation sions | Decision making Bowel suturing 14:00 – 18:00 General Area 15:30 Closure of the day

4 talks each 20-30 minutes followed by a 15 minutes discussion. Simulation demonstrations | Running videos Topics 14:00 – 18:00 General Area • Who is responsible • Circumstances Multi-disciplinary Discussion corner • Role of MM conference • Complication • Can we educate a surgeon in 6 years? • Fistula • The impact of EU working hour regulations • Role of drains • Conservative management Re-operations General Information 10:30 – 11:00 Coffee Break General Information 13:00 – 14:00 Lunch Break 10:30 – 11:00 Coffee Break 15:30 – 16:00 Coffee Break 13:00 – 14:00 Lunch Break 15:30 – 16:00 Coffee Break

254 Surgical Learning Area : UEG Week Final Programme

Monday, October 17, 2016

Simulation demonstrations | Running videos | Case Course One: Transanal Endoscopic Operation (TEO) discussions | Esophagus Bariatrics Hands-on Course 09:00 – 12:30 General Area 14:00 – 18:00 Room A

Selection of 6-8 cases Programme 14:00 Anatomical hints for transrectal excision S. Arolfo Course Two: Laparoscopic Surgical Skills Grade 2 14:10 Indications and Results for local excision of Colorectal Surgery Hands-on Course rectal lesions 09:00 – 18:00 Room B M. Morino 14:30 The instrumentation: evolution, present Programme standard, future development Baseline evaluation, suturing and left side colectomy M. Allaix 09:00 Welcome, introduction & Course outline 14:40 The technique: tips and tricks 09:30 Base line evaluation A. Arezzo Group 1: VR simulations in colorectal surgery 14:50 General or spinal anaesthesia? 10:30 Group 2: Laparoscopic suturing M. Morino 11:00 Export session: Interactive clinical based 15:00 Hands-on discussion 18:00 End of the course 11:30 Safe use of tissue of energizers 12:00 Safe use of tissue, approximation and sta- General Information pling 10:00 – 10:30 Coffee Break 13:30 Expert session: Set-up for left hemicolectomy 12:00 – 14:00 Lunch Break critical steps in left hemicolectomy 15:30 – 15:45 Coffee Break 14:00 Practical: Step by step of left hemicolectomy Stapling and bowel anastomosis 16:30 Expert session: Case scenario about left hemicolectomy 18:00 Closure of day

Simulation demonstrations | Running videos 14:00 – 18:00 General Area

Panel discussion ISDS-ISS-ESSAT – UEG live link

255 UEG Week Final Programme : Surgical Learning Area

Surgical Learning Area Tuesday, October 18, 2016

Simulation demonstrations | Running videos Course Two: Transanal Endoscopic Operation (TEO) 09:00 – 12:30 General Area Hands-on Course 14:00 – 18:00 Room A

Course Two: Laparoscopic Surgical Skills Grade 2 Programme Colorectal Surgery Hands-on Course 14:00 Anatomical hints for transrectal excision 09:00 – 15:30 Room B S. Arolfo 14:10 Indications and Results for local excision of Programme rectal lesions Baseline evaluation, suturing and left side colectomy M. Morino 09:00 Outline day 2 14:30 The instrumentation: Evolution, present stan- 09:30 Introduction to right hemicolectomy dard, future development Anatomy of right hemicolectomy set-up and M. Allaix steps of RH 14:40 The technique: Tips and tricks 11:00 Expert session: Interactive clinical based A. Arezzo discussion on right hemicolectomy 14:50 General or spinal anaesthesia? 11:30 Laparoscopic bowel suturing M. Morino 13:30 Testing session: Case scenarios (decision 15:00 Hands-on making) 18:00 End of the course VR Simulation Bowel suturing General information 15:30 Closure of the day 10:00 – 10:30 Coffee Break 12:00 – 14:00 Lunch Break 15:30 – 15:45 Coffee Break Prep for TEO Course 09:00 – 12:30 Room A

Wednesday, October 19, 2016 Simulation demonstrations | Running videos 14:00 – 18:00 General Area Simulation demonstrations | Running videos Panel discussion ISDS-ISS-ESSAT- UEG live link to US. 09:00 – 14:00 General Area

General Information 10:00 – 10:30 Coffee Break 12:00 – 14:00 Lunch Break

The Surgical Learning Area is run courtesy of: And kindly supported by:

256 UEG, Ordinary Members and National Society Members – United for Digestive Health EDS European Digestive Surgery EDS is an Associate Member of the United European Gastroenterology (UEG)

Join European Digestive Surgery now to get: - yearly Postgraduate Courses - travel grants for education and training - free subscription to “Digestive Surgery”

for more information: www.edsurgery.org

Digestiv an e e Su p r ro g EDS Secretary u e r Prof. Helmut Friess E y Department of General Surgery Klinikum rechts der Isar Technische Universität München Ismaninger Strasse 22 81675 Munich (Germany) Tel. +49 89 4140 2121 www.ehmsg.org Fax +49 89 4140 4870 E-Mail [email protected]

The aim of EDS is to foster the practice of digestive surgery through clinical and basic scientific research and postgraduate training. Communication and collaboration are the keys to bringing visceral surgery education and research to the attention of the scientific community, not only in Europe, but worldwide. ESCP European Society of Coloproctology

National Society Members

Find us on Level 0 www.ueg.eu

16_08_Inserat_UEGWEEK_FP_UEGMembersGraphic_160x220mm_RZ.indd 1 13.09.16 15:00 The universal source of knowledge in gastroenterology

Search over 23,000 items

Learn whenever and Standards wherever you are and Guidelines Online Courses

Recordings Library Postgraduate Teaching Programme

Keep on track with your training at UEG Week Choose your way of

Evidence Based Summer learning! Medicine School Course

Journal Mistakes in … watch

Classroom Latest News courses Stay up to date in the field Get hands-on training, discuss and learn face-to- face with your colleagues Blogs Solve cases discussing with the hot topics community online Basic Young Science Investigators Course Meeting Find out more, visit www.ueg.eu/education

16_08_Inserat_UEGWEEK_FP_Education_Infographic_160x220mm_RZ.indd 1 13.09.16 15:05 Evidence Based Medicine Course

UEG Week Final Programme : Evidence Based Medicine Course

Evidence Based Medicine Course Saturday and Sunday, October 15–16, 2016

Please note that this meeting takes place outside of the Programme Overview core scientific programme and attendance is by invita- tion only. Module A Clinical Questions – From clinical practice to answer- This course, designed for junior and senior physicians able questions alike, aims to teach Evidence Based Medicine (EBM) Exercises based on patient histories principles and how they can be applied in daily clinical work. Module B Search Literature Databases – From the question to po- The course combines interdisciplinary clinical cases tentially relevant evidence with questions of diagnosis and therapy, and identifies Interactive lecture, hands-on exercise on the computer opportunities to integrate EBM into clinical practice. Delegates will be guided by tutors and stimulated with Module C short input lectures, they will work in break-out groups Critical Appraisal – From the papers to critically ap- and discuss the results achieved. praised new knowledge Small group work, interactive lectures Faculty • Pascal O. Berberat (Munich, Germany) Module D • Alexander Ford (Leeds, UK) EBM Transfer – From critically appraised new knowl- • Leonardo Eusebi (Bologna, Italy) edge to changed practice & from learning to teaching • Lise Hobolth (Hvidovre, Denmark) EBM skills • John Kane (Leeds, UK) Small group work, theory input and video analysis • Björn Lindkvist (Gothenburg, Sweden) • Sanjiv Mahadeva (Kuala Lumpur, Malaysia) • Christina Reimer (Hvidovre, Denmark) Apply for the upcoming Evidence Based Medicine Course, taking place at UEG Week Barcelona 2017!

Application deadline: July 21, 2017

The 'UEG Evidence Based Medicine Course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. The 'UEG Evidence Based Medicine Course' is designated for a maximum of 12 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

260 20th ESGENA Conference

Hosted by the Austrian Society of Endoscopy Nurses and Associates (IVEPA)

In Conjunction with the 24th United European Gastro- enterology Week

Further information: www.esgena.org

The programme is as of September 16, 2016.

UEG Week Final Programme : 20th ESGENA Conference

20th ESGENA Conference Word of Welcome

Jayne Tillett Anita Beyer President of ESGENA President of IVEPA Dear colleague,

On behalf of ESGENA and the Austrian Society of En- The ESGENA conference is also an excellent opportu- doscopy and Gastroenterology Nurses and Associates nity to meet colleagues from different countries. The (IVEPA), it is our great pleasure to welcome you to the exchange with nurses from all over the world combined 20th ESGENA Conference which is being held during the with the opportunity to attend the medical programme 24th United European Gastroenterology Week, October of the UEG Week ensures the ESGENA conference is an 15-17, 2016 in Vienna, Austria. exceptional educational event.

ESGENA is celebrating its 20th Anniversary in Vienna. The three day ESGENA conference includes state-of- Since its foundation in Berlin in 1996, ESGENA has es- the-art lectures, free papers & posters, lunch sessions, tablished close co-operation with more than 40 coun- several workshops with Hands-on Training and live tries within Europe and overseas. ESGENA provides an transmissions covering current topics in gastroenterol- excellent platform for strong networking and the ex- ogy and endoscopy. change of information. Educational structures include the development of curricula, standards and guidelines We welcome you to the 20th ESGENA Conference in Vienna, as well as the establishment of clinical grants for indi- Austria. vidual nurses.

The Conference in Vienna is a good chance to reflect on the recent developments of the society and to discuss cutting-edge ideas. The jubilee also invites you to dis- cuss new projects and the advancement of the profes- Jayne Tillett Anita Beyer sion with experts. President of ESGENA President of IVEPA

262 20th ESGENA Conference : UEG Week Final Programme

Programme Overview

Saturday, October 15, 2016

Lecture Halls Room M Room L7 Room L8 ESGE Learning Area 09:00 – 10:30

10:30 – 11:00 Coffee Break 11:00 – 13:00 UEG Week Postgraduate 13:00 – 14:00 Lunch Break Teaching Workshop 1 Workshop 2 Workshop 3 Workshop 4 Programm It’s in your hands – Endoscope reprocess- The nurse’s role in Hands–on Training on 09:00 – 16:00 The nurse in ERCP ing: Trends, current reducing the risk in biosimulators: standards, process delayed bleeds • Upper GI bleeding innovations • ERCP Organised by Olympus Organised by BHT & Organised by Boston • Colonoscopy 14:00 – 15:30 Europa Chemische Werke Scientific Dr. Weigert 15:30 – 16:00 Coffee Break Workshop 5 Workshop 6 Workshop 7 Workshop 8 Infections in Endos- Electro surgery How to build a good Hands–on Training on copy – Relevance of – Prevention of team? biosimulators Clostridium difficile complication • Upper GI bleeding in endoscope • ERCP reprocessing • Colonoscopy 16:00 – 17:30 16:00 Organised by Olympus Organised by Erbe Organised by ESGENA Europa Elektromedizin

ESGENA Annual General Assembly 17:30 – 19:00 17:30

263 UEG Week Final Programme : 20th ESGENA Conference

Sunday, October 16, 2016

Room G Room K Poster Area ESGE Learning Area Session 1 Session 2 Free Paper I Inflammatory Bowel Dis- ease (IBD) 09:00 – 10:30

10:30 – 11:00 Coffee Break 10:30 – 11:00 Poster Round I Session 3 Session 4 Workshop 9 Free Paper II Education & Management Hands-on Training on bio simulators • Upper GI Bleeding

11:00 – 13:00 • ERCP 13:00 – 14:00 Lunch Break Lunch Session 1 Lunch Session 2 13:30 – 15:00 Workshop 10 New Techniques & Devel- New Techniques & Develop- Poster Round II Hands-on Training on bio opments I ments II simulators: • ERCP

13:30 – 15:00 13:30 • Colonoscopy Session 5 Session 6 Around the Oesophagus Quality Assurance 15:00 – 16:30 15:00

16:30 – 17:00 Coffee Break Session 7 Session 8 Hygiene Updates Complication & Adverse Events 17:00 – 18:00 17:00

Monday, October 17, 2016

Room F1 Best Free Paper and Best Poster Award 08:30 – 10:00 ESGENA 20th Anniversary Achievements & Future Invitation to next conferences 10:30 – 11:00 Coffee Break Visit of Exhibition 11:00 – 12:30 ESGE Learning Area UEG Week Sessions 12:30 – 14:00 Lunch Break Visit of Exhibition 14:00 – 15:30 ESGE Learning Area UEG Week Sessions 15:30 – 16:00 Coffee Break Visit of Exhibition 16:00 – 18:00 ESGE Learning Area UEG Week Sessions

264 20th ESGENA Conference : UEG Week Final Programme

Scientific Programme Saturday, October 15, 2016

Workshop 1 • How good is the cleaning performance of different 14:00 – 15:30 Room M chemicals and how is it tested? • What impact different process chemistry to the treat- It’s in your hands – The nurse in ERCP ment processes? This workshop is organised by OLYMPUS EUROPA SE & CO. KG Workshop language: English Presentations: Chairs: Sebastian Ullrich, Germany Different active substances in the cleaning and disinfec- Frank Rudolph, Germany tion of flexible endoscopes Markus Kamer, Germany Aims & Content The role of the nurse in successful ERCP is essential and Part 2: Process improvements in endoscope reprocess- handling of the devices is one part of it. Practise ERCP ing:simple – safe – fast – cost-effective procedures step by step at different Hands-on stations. Automated reprocessing with WD (washer disinfec- Exchange experience and ask questions to renowned tor) has become the standard. This part of the work- experts to improve your skills set and confidence. shop works out what to look for even more hygienic their treatment processes – simple – to make faster and The participants will be able to train the following tech- cheaper. There are numerous innovations and process niques under the supervision of experienced tutors: optimisation. • Simple: There are numerous starting points, as the Station 1: Balloon dilation process for the preparation staff is simple, for exam- Station 2: Lithotripsy: Standard and emergency cases ple, the documentation. Station 3: Cannulation, device exchange with long and • Safe: Technical solutions for enhanced safety in au- short guidewire techniques, stent placement tomated endoscope reprocessing. Marketplace: Display of ERCP devices with demonstration • Fast: Often wait doctor's directly to the endoscopes. Find out how you can speed up the process incl. the drying. Workshop 2 • Low cost: The cost of treatment is high – especially 14:00 – 15:30 Room L7 in the chemical consumption, consequential costs, damage endoscope and endoscope purchases. The Endoscope reprocessing: Trends, current standards, workshop is worked out what the possibilities are process innovations for cost savings. This workshop is organised by Chemische Werke Dr. Weigert and BHT Workshop language: English Presentations: Chairs: Thomas Brümmer, Germany Process improvements in endoscope reprocessing: Stefan Stülpnagel, Germany Simple – safe – fast – cost-effective Patrick Mertens & Stefan Stülpnagel, Germany Aims & Content Part 1: Process chemistry: Overview – trends – agents – cleaning & disinfection processes Workshop 3 The individual steps for a safe reprocessing of endo- 14:00 – 15:30 Room L8 scopes defined by national- and international recom- mendations. In the process chemistry for manual and The nurse’s role in reducing the risk in delayed bleeds automated reprocessing of endoscopes are different ac- This workshop is organised by Boston Scientific tive ingredients and procedures established. This part Workshop language: English of the workshop will answer the following questions: Chairs: N.N. • What are the different agents for the manual- and N.N. WD (washer disinfector) reprocessing?

265 UEG Week Final Programme : 20th ESGENA Conference

Aims & Content Aims & Content The workshop will offer a unique opportunity to review Is Clostridium difficile of relevance in endoscopy? This the GI clinical overview, disease states and we will workshop is intended to give an update about survival learn how to manage the challenges as a nurse in our strategies of Clostridium difficile and the impact of their daily practices during the haemostasis procedures. The bacterial spores for humans and in the area of endosco- view of our experienced guest nurse will show us how py. It is also intended to provide helpful information on the risk can be reduced and will share tip and tricks questions about preferred disinfectants against Clostrid- learned among the years. After the nurse lecture and ium difficile and about reprocessing strategies for safe the round of questions from the audience, we will move reuse of medical flexible endoscopes. to the Hands-on session where we will be able to see and play with current and new hemostasis devices to This workshop will: warrantee the best performance from them. • Inform about relevance of bacterial spores, especial- ly from Clostridium difficile, in endoscopy 14:00 Presentation begins • Explain the efficacy of Glutaraldehyde and Peracetic 14:45 Hands-on Acid against Clostridium difficile and their bacterial 15:30 Session end spores • Give support on staff and patient protection and suitable equipment for endoscope reprocessing Workshop 4 • Practically show the phases of effective endoscope 14:00 – 15:30 ESGE Learning Area pre-cleaning

Hands-on Training on bio simulators This workshop is organised by ESGENA Workshop 6 Workshop language: English 16:00 – 17:30 Room L7 Chair: Eric Pflimlin, Switzerland Electrosurgery – Prevention of complication Aims & Content This workshop is organised by ERBE Elektromedizin GmbH Hands-on training on bio simulators (pig models) un- Workshop language: English der the supervision of highly experienced tutors: Partic- Chairs: Thomas Beck, Germany ipants will have the opportunity to perform endoscopic Björn Fehrke, Switzerland techniques on the following topics: • OGD with Injection techniques, ligation, clipping, Aims & Content APC Electrosurgery offers the possibility of pressure-free and • Colonoscopy with polypectomy, EMR and APC precise cutting and at the same time control of bleed- • ERCP with stone extraction and stenting ing during endoscopic resection techniques. With argon As participation will be limited, registration will be plasma coagulation tissue can be devitalised. The wa- treated on a first-come-first-served basis: Tickets will ter-jet surgery provides additional options for resection: be available onsite only – at the entrance of the ESGE Learning Area. The aim of the workshop is: • To update on principles of electrosurgery and rele- vant safety measures Workshop 5 • To demonstrate different settings for different applica- 16:00 – 17:30 Room M tions like Polypectomy, EMR, ESD, Papilloectomy, etc. in order to achieve max safety and to prevent adverse Infections in Endoscopy – Relevance of Clostridium events and complications difficile in endoscope reprocessing This workshop is organised by OLYMPUS EUROPA SE & CO. KG Workshop language: English Chairs: Holger Biering, Germany Reinhard Blum, Germany Jürgen Gebel, Germany

266 20th ESGENA Conference : UEG Week Final Programme

Workshop 7 Scientific Programme 16:00 – 17:30 Room L8 Sunday, October 16, 2016 How to build a good team? This workshop is organised by ESGENA Workshop language: English Chairs: Marjon de Pater, The Netherlands Session 1 Ulrike Beilenhoff, Germany 09:00 – 10:30 Room G

Aims and Content Free Paper I Endoscopy teams are multidisciplinary teams which Chairs: Anita Jorgensen, Norway function under time pressure and high work load. Wendy Waagenes, Denmark Stress, staff shortages and hierarchies can be ideal Gunilla Strand, Sweden breeding grounds for conflicts. Therese Schober, Austria

The ideal team has 09:00 – 09:10 • Clear objectives, effective processes and good com- Welcome munication Jayne Tillett, United Kingdom • A good balance of skills, abilities and aspirations • Appropriate leadership 09:10 – 09:30 • Support, trust and openness Developing a Hands-on interventional endoscopy nurse • A structure for individual development training course in Ireland Sheila King, Clare Cunningham, Stephen Patchett, Ireland The aim of the workshop is • To look at different ways of team building 09:30 – 09:50 • To identify keep issues for the integration of new Checklists in endoscopy as a tool for patient safety staff members in existing teams. Nils Andersen, Germany • To develop different approaches for conflict man- agement in team 09:50 – 10:10 The implementation of Team Time Out in Germany – An evaluation in endoscopy nurse courses Workshop 8 Ulrike Beilenhoff, Germany 16:00 – 17:30 ESGE Learning Area 10:10 – 10:30 Hands-on Training on bio simulators Colorectal cancer screening by nurse endoscopists This workshop is organised by ESGENA show specialist level in colonoscopy according to the Workshop language: English first Danish national report. Chair: Eric Pflimlin, Switzerland Helle Roy Tillgaard, Denmark

Aims & Content Hands-on Training on bio simulators (pig models) un- Session 2 der the supervision of highly experienced tutors: 09:00 – 10:30 Room K Participants will have the opportunity to perform endo- scopic techniques on the following topics: Inflammatory Bowel Disease (IBD) • OGD with Injection techniques, ligation, clipping, Chairs: Irene Dunkley, United Kingdom APC Gerlinde Weilguny, Austria • Colonoscopy with polypectomy, EMR and APC • ERCP with stone extraction and stenting 09:00 – 09:10 Welcome As participation will be limited, registration will be Jadranka Brljak, Croatia treated on a first-come-first-served basis: Tickets will be available onsite only – at the entrance of 09:10 – 09:30 the ESGE Learning Area. Living with IBD – “And suddenly I was a patient” Helen Griffith, United Kingdom

267 UEG Week Final Programme : 20th ESGENA Conference

09:30 – 09:50 11:00 – 11:20 Vaccination and IBD Parental presence during endoscopic procedures in a Tom Moreels, Belgium Spanish endoscopy room: Perceptions, satisfaction and attitudes in parents and staff members. 09:50 – 10:10 Abraham Gaitano, Ana Belén Aguilera, Natalia Serrano, Diagnosis and therapy of IBD Luz Cuevas, Emilia Tebar; Ángel Arias, Alfredo J Lucen- Sieglinde Reinisch, Austria do, Spain

10:10 – 10:30 11:20 – 11:40 Psychosocial health and health related quality life Health-related quality of life in patients with chronic among children and young adults with inflammatory hepatitis C receiving Sofosbuvir-Based Treatment, with bowel disease and without Interferon: A prospective study in Egypt. Randi Opheim, Norway Naglaa Youssef, Mohamed El Kassas, Amany Moham- med, Ashley Shepherd, Egypt

Posterround I 11:40 – 12:00 10:30 – 11:00 Poster area in front of Room G Which risk factors are related to colonoscopy severe complications in an organised population-based col- Chairs: Deirdre Clune, Ireland orectal cancer screening programme? Jayne Tillett, United Kingdom Isabel Idigoras, Eunate Arana-Arri, Isabel Bilbao, Jo- Enriqueta Hernandez-Soto, Spain sebe Fernández, Iragartxe Fernández, Martínez-Indart Fanny Durand, France Lorea, Iñaki Gutiérrez-Ibarluzea, Euskolon Work Group, Isabel Portillo, Spain P-1 Haemovigilance nurse role in haemosiderosis sec- ondary to blood transfusion 12:00 – 12:20 Dania-Rocio Diaz-Rodriguez, Maria-Pilar Soldevil- Comparison of tolerability and patients’ perceived bur- la-de-la-Esperanza, Monica Granados-Martin, Pilar den of bowel preparation with Picosulphate/ Magne- Villanueva-Jiménez, Spain sium Citrate and Ascorbic Acid enrichted Polyethylene Glycol solution in a non-colon-cancer screening outpa- P-2 Analysis of patient preparation for small bowel tient population video capsule endoscopy J.S. Stadwijk, I.J. Wignand-van der Storm, K. van der Katarina Karlovic, Croatia Vliet, E.M.H. Mathus-Vliegen, The Netherlands

P-3 Effectiveness of gentle strokes to patients’ backs 12:20 – 12:40 during esophagogastroduodenoscopy Quality control in GI endoscopic reprocessing Sayaka Furukawa, Sachiyo Kanekuni, Ikumi Yamaguchi, Siriporn Ratanalert, Sopa Boonviriya, Varaporn Senapi- Itoko Yamazaki, Tomoko Kobayashi, Shizuka Numasa- takkul, Nittaya Promdet, Thailand wa, Shiho Tsubouchi, Shuhichi Okada, Yoko Meguro, Keiko Maruta, Tamao Kaneko, Naoki Ishii, Japan 12:40 – 13:00 The nurses’ role in the making of a new and better re- P-4 The role of the nurse in inserting a percutaneous processing room gastrostome by way of endoscopic techniques Maria da Luz Barros e Cunha, Portugal Ghica Tania, Brodetchi Ionela, Romania

Session 4 Session 3 11:00 – 13:00 Room K 11:00 – 13:00 Room G Education & Management Free Paper II Chairs: Ulrike Beilenhoff, Germany Chairs: Anita Jorgensen, Norway Marjon de Pater, The Netherlands Wendy Waagenes, Denmark Gunilla Strand, Sweden 11:00 – 11:20 Therese Schober, Austria Establishing an endoscopy unit in Nepal – A report Urte Stahlberg, Germany

268 20th ESGENA Conference : UEG Week Final Programme

11:20 – 11:40 Hygiene Lean management in endoscopy Susanne Haenlein, Austria P-5 Environmental and hygienic circumstances in en- doscopic units in slovenia 11:40 – 12:00 Marija Petrinec Primožič, Stanka Popovič, Slovenia Nurses perception of research work – application in daily practice P-6 Duodenoscopes reprocessing procedure in China: Maja Čebohin, Croatia a survey of 142 hospitals in 2015 Ma Jiuhong, China 12:00 – 12:20 Teaching new staff – The role of the mentor P-7 Rinsibility of Orthophthalaldehyde within different Ulrike Beilenhoff, Germany final rinsing methods MaJiuhong, China 12:20 – 12:40 European Accreditation Network: Improving the qual- P-8 Immediate re-use of endoscopes after reprocess- ity of educational activities for health professionals in ing: is there any safe time frame? Preliminary microbi- Europe ological data Jean Baptiste Rouffet, France Cinzia Rivara, Davide Cordioli, E Festa, Italy Room 12:40 – 12:55 P-9 Evidences on endoscopes manual cleaning auto- Educare and Endosuite: Digital Learning Platform (Bos- mation artecipants ton Scientific) Cinzia Rivara, G Zamboni, A. Dallevacche, Manuela Eugenie Pieck-Burchard, France Menin Ostani, Italy

12:55 – 13:00 P-10 Hand hygiene in gastroenterological endoscopy Discussion units Katarina Karlovic, Croatia

Workshop 11 Service & Quality Assurance 11:00 – 12:30 ESGE Learning Area P-11 Anxiety and pain reduction in gastrointestinal en- Hands-on Training on Bio Simulators doscopy: Counseling and sedation This workshop is organised by ESGENA Roberta Mattiola, Maurizio Coppolino, Luca Chiarioni, Chair: Eric Pflimlin, Switzerland Luigi Lamanna, Stefania Locoro, Davide Puddu, Ivana Violino, Giulia Marika Futura Beorchia, Italy Hands-on training on bio simulators (pig models) un- der the supervision of highly experienced tutors. P-12 Patient-reported quality of life, anxiety and de- Participants will have the opportunity to perform endo- pression in patients with walled-off pancreatic necrosis scopic techniques on the following topics: Sisse Rysgaard, Astrid Naver, Camilla Nøjgaard, Palle • Upper GI Bleeding Nordblad Schmidt, Lise Lotte Gluud, Srdan Novovic, • ERCP Denmark As participation will be limited, registration will be treated on a first-come-first-served basis. P-13 Day Surgery/Endoscopy Nurses Handbook: Poli- Ticket will be available onsite only – at the entrance of cies, Practices and Care Pathways the ESGE Learning Area. Marie-Claire Pellegrini, Malta

P-14 Assessment of the quality of outpatient endoscopic Posterround II procedures by using a patient satisfaction questionnaire 13:30 – 15:00 Poster area in front of Room G Daniela Burtea, Mihaela Caliţa, Tatiana Cârțână, Adrian Săftoiu, Romania Chairs: Deirdre Clune, Ireland Jayne Tillett, United Kingdom Enriqueta Hernandez-Soto, Spain Fanny Durand, France

269 UEG Week Final Programme : 20th ESGENA Conference

P-15 Patterns of complementary and alternative med- 13:30 – 13:40 icine (CAM) use and attitudes to CAM among patients Haemostasis in Gastroenterology (Micro-Tech Europe with inflammatory bowel disease in Korea: An 8-year GmbH) follow-up survey Andreas Jung, Germany Yun Kyung Cho, Kiju Chang, Ki Seok Seo, Sang Hyoung Park, Hyungil Seo, Gwang-Un Kim, Eun Mi Song, My- 13:40 – 13:50 eongsook Seo, Ho-Su Lee, Sung Wook Hwang1, Youn Endoscopic balloon dilatation with Olympus latest Hwa Cha, Eun Ah Kwak, Se Min Choi, Dong-Hoon Yang, EZDilate balloons – Tips & tricks for easy handling Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk- (Olympus Europa) Kyun Yang, Republic of Korea Heike Hartmann, Germany

Colon 13:50 – 14:00 New aspects of reprocessing with the latest generation P-16 What can we do to optimise preparation for colo- of KARL STORZ duodenoscope (Karl Storz) noscopy Branko Gulic, Germany Eisa Hag, Yehuda Chowers and Elizabeth Half, Israel 14:00 – 14:10 P-17 Improvement activities for reducing the number of It's time for a reliable retrieval: Rescuenet™ (Endo- poor bowel preparation Choice GmbH) Su-A Yang, South Korea Helen Griffiths, United Kingdom

P-18 Outpatients bowel preparation verses inpatient 14:10 – 14:20 bowel preparation. Decreasing interval colon cancer by increasing visuali- Margaret Raggett, Niamh Dalton, Ireland sation (Cantel Medical) Cheri Ackert-Burr, The Netherlands P-19 Interventions of the GI nurse to improve quality indicators of colonoscopy in an outpatient setting 14:20 – 15:00 Mihaela Caliţa, Daniela Burtea, Tatiana Cârţână, Romania Hands-on Training with the companies

IBD Lunch Session 2 P-20 The importance of self administration of biological 13:30 – 15:00 Room K therapy with TNF in IBD Lucia Helena Lourenço, Carlos A R Martinez; Claudio S R New Techniques & Developments II Coy; Maria L S Ayrizono and Raquel F Leal, Brazil This lunch session is organised by ESGENA Chairs: Björn Fehrke, Switzerland P-21 Endoscopy services’ nurses and therapeutic patient Silvia Lahey, The Netherlands education in inflammatory bowel disease population. Giulia Marika Futura Beorchia, Italy 13:30 – 13:40 Emerging multidrug resistant organisms and endosco- py: What we should really fear, how we should react in Lunch Session 1 practice (CBC Group) 13:30 – 15:00 Room G Monica Cimbro, Italy

New Techniques & Developments I 13:40 – 13:50 This lunch session is organised by ESGENA Steelco Octopus Single Hand Connection – one size fits Chairs: Stanka Popovic, Slovenia all ARES reprocessing devices (Steelco) Christine Petersen, The Netherlands Monica Menin Ostani, Italy

13:50 – 14:00 High-level disinfection or sterilization of heat-labile flexible endoscopes? (Soluscope SAS) Cécile Paya, France

270 20th ESGENA Conference : UEG Week Final Programme

14:00 – 14:10 15:55 – 16:15 Endoscope decontamination...or not quite?" (PULL THRU™) Self Dilatation – a special class for patients Rodolphe Hervé, United Kingdom Jacques Bergmann, The Netherlands

14:10 – 14:20 16:15 – 16:30 UltraZonic Endo- Endoscopy future as it should be (Ul- Discussions traZonic Endo) Nancy Steenbakkers, Belgium Sessions 6 14:20 – 15:00 15:00 – 16:30 Room K Hands-on Training with the companies Quality Assurance Chairs: Patricia Burga, Italy Workshop 12 Herdis Astradsdottir, Iceland 14:00 – 15:30 ESGE Learning Area 15:00 – 15:20 Hands-on Training on Bio Simulators The importance of ergonomics for advanced procedures Chair: Eric Pflimlin, Switzerland (Cook Medical ) Simon Brouwers, Ireland Hands-on training on bio simulators (pig models) un- der the supervision of highly experienced tutors. 15:20 – 15:40 Participants will have the opportunity to perform endo- New ESGE statement: Requirements and standards fa- cilitating quality improvement for reporting systems in scopic techniques on the following topics: gastrointestinal endoscopy • Colonoscopy Michael Bretthauer, Norway • ERCP As participation will be limited, registration will be 15:40 – 16:00 treated on a first-come-first-served basis. Electronic assessment and documentation of sign-in, Ticket will be available onsite only – at the entrance of team-time-out and sign-out the ESGE Learning Area. Marjon de Pater, The Netherlands

16:00 – 16:20 Session 5 20 years’ experience with nurse endoscopists – advan- 15:00 – 16:30 Room G tages, challenges & limitation Irene Dunkley, United Kingdom Around the Oesophagus Chairs: Christine Petersen, The Netherlands 16:20 – 16:30 Clara Kratzik, Austria Discussion

15:00 – 15:15 EVIS EXERA III: What are the proven benefits for the Session 7 nursing staff? (OLYMPUS EUROPA) 17:00 – 18:00 Room G Romy Klausnitzer, Germany Hygiene Updates 15:15 – 15:35 Chairs: Jadranka Brljak, Croatia Endoscopic treatment in Barretts Marjon de Pater, The Netherlands Kirsh Ragunath, United Kingdom 17:00 – 17:15 15:35 – 15:55 Hygiene in endoscope reprocessing (Pentax Medical) Eosinofiele oesophagitis Aaron Overlöper, Germany Marijn Warners, The Netherlands 17:15 – 17:30 How safe are our duodenoscopes? Magda Diab-Elschahawi, Austria

271 UEG Week Final Programme : 20th ESGENA Conference

17:30 – 17:45 Scientific Programme Storage of endoscopes – How do time frame and con- Monday, October 17, 2016 ditions matter Jadranka Brljak, Croatia

17:45 – 18:00 New guidelines on endoscope reprocessing Session 9 Ulrike Beilenhoff, Germany 08:00 – 10:00 Room F1

ESGENA 20th Anniversary Session 8 Chairs: Jayne Tillett, United Kingdom 17:00 – 18:00 Room K Gerlinde Weilguny, Austria

Complication & Adverse Events 08:30 – 08:50 Chairs: Björn Fehrke, Switzerland Best Free Paper and Best Poster Awards Wendy Waagenes, Denmark PENTAX Medical supports the ESGENA Free Paper and Poster Award The winner of the best free papers – oral presentation 17:00 – 17:20 and the best poster presentations – will be announced. Did this really happen? – Rare, interesting and obscure Presenting authors are requested to attend this session. cases in endoscopy • Jayne Tillett, United Kingdom Alexander Dechêne, Germany • Gerlinde Weilguny, Austria

17:20 – 17:40 08:30 – 08:50 Managing a GI bleeding service – The nurse manager´s What does microbiological surveillance really detect? perspective New data about sampling techniques and culturing Victoria Jackson, United Kingdom Lionel Pineau, France

17:40 – 18:00 09:10 – 09:30 Emergency endoscopy – When, where, by whom? Endoscopy over the last 20 years – The multidisciplinary Hrvoje Ivecovic, Croatia approach Jean Francois Rey, France

09:30 – 09:50 The role of the endoscopy nurses – Achievements and future steps Ulrike Beilenhoff, Germany

09:50 – 10:00 Invitation to the next ESGENA Conference 2017 in Barcelona Enriqueta Hernandez-Soto, Spain

272 Scientific Programme Monday, October 17, 2016

Common Interest Group Meetings

UEG Week Final Programme : Common Interest Group Meetings

Common Interest Group Meetings

Saturday, October 15, 2016 Tuesday, October 18, 2016

08:30 – 17:15 Room 1.61/1.62 07:00 – 08:30 Room 2.17 Evidence Based Medicine Course GENIEUR-reloaded – Up-Date Upon invitation only (UEG) (ESNM)

Please see further information on page 260. Up-Date GENIEUR actitvities

LINK Award project 'HELP EU in IBS' Sunday, October 16, 2016 Lobbying for IBS research 08:30 – 17:00 Room 1.61/1.62 Evidence Based Medicine Course AOB Upon invitation only (UEG) 17:30 – 19:00 Room M Please see further information on page 260. Microbiota Interventions for Chronic Gastrointestinal and Liver Diseases 16:00 – 18:00 Room L7 (GM&H Section, ESNM, ECCO, ESPGHAN, EASL) PRO-MC collaboration – building a European registry for microscopic colitis Dysbiosis of the gut microbiota is associated with a (EMCG) range of gastrointestinal and liver disorders. Currently, several treatments to revert dysbiosis are being inves- Our knowledge on microscopic colitis (MC) is still tigated. Chaired by Fernando Azpiroz, Joël Doré (“Mi- limited. Therefore, the European Microscopic Colitis crobiota modulation by Diet”), Harry Sokol (“Faecal Group (EMCG) is starting the PRO-MC Collaboration, Microbiota Transplantation (FMT): protocols and poten- a European registry for MC to systematically and pro- tial applications”) and German Soriano ("Probiotics in spectively collect data on the disease course, etc. and Liver Diseases”) will discuss several options. to improve awareness on MC across Europe. All centres with interest in MC can participate.

17:00 – 19:00 Room L8 GERD consensus meeting: Presentation of preliminary conclusions (ESNM)

The meeting is dedicated to the presentation of rec- ommendations for GERD testing. These recommenda- tions have been developed following discussion and consensus by the International Working Group over previous meetings.

Agenda 1. Welcome 2. Optimal tests and metrics for evaluation of GERD 3. Clinical value of HRM/HRIM in GERD 4. Discussion

274 Classroom Courses

Education from every angle Our classroom courses offer hands-on training in a range of medical specialities, with activities including practical skills sessions, small-group discussions, workshops and lectures as well as networking events. Young Investigators Meeting February 10-12, 2017 Vienna, Austria

Basic Summer School Science Course June 8-11, 2017 June 22-24, 2017 Prague, Czech Republic Rome, Italy

Evidence Based Medicine Course October 28-29, 2017 Barcelona, Spain

Find out more, visit www.ueg.eu/education

16_08_Inserat_UEGWEEK_FP_ClassroomCourses_160x220mm_RZ.indd 1 13.09.16 15:05 Improving Clinical Standards and Services Reducing health inequalities across Europe

• Repository of clinical practice guidelines and standards developed by leading European gastroenterological societies and centrally available on the UEG website • Survey of Digestive Health Across Europe – the “White Book” • Development and promotion of specific European standards of care and service provision together with UEG Member Societies • Visiting Fellowship Programmes for young clinicians and researchers

Find guidance for your daily practice through the central repository of evidence-based clinical practice guidelines including recommendations, position papers and standard protocols in the field of digestive health.

Digestive Oncology Neurogastroenterology & Motility Small Intestine & Nutrition Endoscopy Oesophagus Stomach & H. Pylori Gut Microbiota Paediatrics Surgery Hepatobiliary Pancreas and many more Histopathology Primary Care IBD Radiology & Imaging

Search and browse the Standards & Guidelines repository at www.ueg.eu/standards-guidelines

Find out more, visit www.ueg.eu

16_08_Inserat_UEGWEEK_FP_StandardsGuidelines_160x220mm_RZ.indd 1 13.09.16 15:01 Improving Clinical Standards and Services Reducing health inequalities across Europe

• Repository of clinical practice guidelines and standards developed Business Meetings by leading European gastroenterological societies and centrally available on the UEG website • Survey of Digestive Health Across Europe – the “White Book” • Development and promotion of specific European standards of care and service provision together with UEG Member Societies • Visiting Fellowship Programmes for young clinicians and researchers

Find guidance for your daily practice through the central repository of evidence-based clinical practice guidelines including recommendations, position papers and standard protocols in the field of digestive health.

Digestive Oncology Neurogastroenterology & Motility Small Intestine & Nutrition Endoscopy Oesophagus Stomach & H. Pylori Gut Microbiota Paediatrics Surgery Hepatobiliary Pancreas and many more Histopathology Primary Care IBD Radiology & Imaging

Search and browse the Standards & Guidelines repository at www.ueg.eu/standards-guidelines

Find out more, visit www.ueg.eu

16_08_Inserat_UEGWEEK_FP_StandardsGuidelines_160x220mm_RZ.indd 1 13.09.16 15:01 UEG Week Final Programme : Business Meetings

Business Meetings (as of September 7, 2016)

Several business meetings – association, board and committee meetings for elected (UEG) leadership – will take place during UEG Week 2016. Please note that attendance is by invitation only.

UEG Friday, October 14, 2016 15:00 – 20:00 Council Meeting House of European Gastroenterology

Saturday, October 15, 2016 09:00 – 13:00 Journal Management Board Meeting UEG Meeting Room 2 13:00 – 15:00 National Societies Committee – Meeting with LINK Programme Awardees UEG Meeting Room 1 15:30 – 16:30 Standards & Guidelines Task Force – Update Meeting UEG Meeting Room 1 16:30 – 17:00 Meeting of Best of UEG Week Team for DDW UEG Meeting Room 2

Sunday, October 16, 2016 08:00 – 11:00 Public Affairs Committee – Update Meeting UEG Meeting Room 2 11:30 – 12:30 National Societies Committee – Update Meeting Room F1 12:30 – 14:30 UEG Journal Editorial Board Meeting UEG Meeting Room 3 13:00 – 15:00 National Societies Forum Room F1 14:30 – 17:30 E–learning Web Editor Meeting UEG Meeting Room 1 16:00 – 19:00 Meeting of Members Room F1 17:30 – 19:00 Scientific Committee – PGT Programme Committee UEG Meeting Room 2

Monday, October 17, 2016 16:00 – 18:00 Scientific Committee – Group Coordinators' Meeting UEG Meeting Room 2

Tuesday, October 18, 2016 12:00 – 13:30 Equality & Diversity Task Force Meeting UEG Meeting Room 1

Wednesday, October 19, 2016 08:00 – 10:00 Young Talent Group Meeting UEG Meeting Room 2 08:30 – 09:45 Industry Debrief Meeting Room –2.31

UEG Press Briefing Monday, October 17, 2016 12:15 – 13:30 UEG Meeting Room 3 Tuesday, October 18, 2016 12:15 – 13:30 UEG Meeting Room 3

278 Business Meetings : UEG Week Final Programme

ESDO Sunday, October 16, 2016 14:30 – 16:00 Governing Board & Advisory Council Meeting Room 2.31 Tuesday, October 18, 2016 12:30 – 14:00 ESDO General Assembly Room 2.31

ESGENA Monday, October 17, 2016 11:00 – 14:00 ESGENA Education Working Group Meeting Room 1.85

ESPGHAN Sunday, October 16, 2016 08:00 – 12:30 IBD Porto Group – Position Paper on Nutrition in IBD Room 2.15

EUREOS Monday, October 17, 2016 11:00 – 13:00 EUREOS Update 2016 Room 2.31 fEMGA Sunday, October 16, 2016 14:00 – 15:30 fEMGA/Medical Block Association Meeting Room 2.97

OMCCV Saturday, October 15, 2016 09:00 – 12:00 OMCCV Members Meeting Room 1.86

Can’t make it to a specific session in time? Join in via livestream wherever you are. Watch livestreams now on www.live.ueg.eu/week

16_08_Inserat_UEGWEEK_FP_livestream_136x62mm_RZ.indd 1 13.09.16 15:04279

Industry Sponsored Symposia

The programme of industry sponsored symposia is not affiliated with UEG and as of September 16, 2016.

UEG Week Final Programme : Industry Sponsored Symposia

Industry Sponsored Symposia Sunday, October 16, 2016

Industry Sponsored Symposium Industry Sponsored Symposium 16:15 – 17:45 Room B 18:00 – 19:30 Room E1 New Insights and Technologies to Improve Manage- New perspectives in IBD: a practical guide for busy ment and Outcomes in UC Patients clinicians (MSD) (Hospira, a Pfizer company) Chair: Gert Van Assche, Belgium Chair: Brian Feagan, Canada Welcome and Introduction Welcome and introduction Gert Van Assche, Belgium Brian Feagan, Canada The Role of Patient-Reported Outcomes in UC Management Treatment strategies in 2016: what, when and why? Q&A Edouard Louis, Belgium Gionata Fiorino, Italy Predicting treatment response in 2016: TDM and beyond Achieving a Continuous Clinical Response for Patients Axel Dignass, Germany with UC Q&A Infliximab biosimilars: how should we be using them Walter Reinisch, Austria in 2016? Charlie Lees, United Kingdom Integrating eTools to Improve Patient Care and Out- comes in UC Meeting summary Q&A Brian Feagan, Canada Gert Van Assche, Belgium Meeting close Panel Disussion Gert Van Assche, Belgium Industry Sponsored Symposium 18:00 – 19:30 Room D Industry Sponsored Symposium Clinical Trial Evidence to Real World Experience with 16:15 – 17:45 Room E1 Vedolizumab: Addressing Patients’ Needs in CD Weighing the Therapeutic Potential of Current and (Takeda Pharmaceuticals International AG) Emerging UC Therapies Chair: Séverine Vermeire, Belgium (Pfizer) Welcome, agenda and objectives Chair: Jean-Frédéric Colombel, USA Introduction Welcome and Introductions Séverine Vermeire, Belgium Jean-Frédéric Colombel, USA Beyond response and remission: What matters to indi- Perspectives on Immunomodulators for the Treatment vidual patients of UC Séverine Vermeire, Belgium Iris Dotan, Israel Visualizing treatment success in CD Clinical Applications of Therapeutic Drug Monitoring Markus Neurath, Germany Remo Panaccione, Canada Using vedolizumab to optimise outcomes for our patients Targeting Inflammatory Pathways in UC Peter Gibson, Australia Jean-Frédéric Colombel, USA Audience questions Audience Q&A All Faculty All The story continues in UC Early Use to Long Term Management with Vedolizumab: A Spotlight in UC. Tuesday 18th October 7:00 am – 8:00 am Séverine Vermeire, Belgium Summary and close Séverine Vermeire, Belgium

282 Industry Sponsored Symposia : UEG Week Final Programme

Industry Sponsored Symposia Monday, October 17, 2016

Industry Sponsored Symposium Industry Sponsored Symposium 07:00 – 08:00 Room F2 17:45 – 19:15 Room F1 Expert Perspectives on the Management of PBC: A Discover the truth about IBS: Rethinking current Case-Based Approach opinions in gastroenterology (Chronic Liver Disease Foundation) (Allergan Pharmaceuticals Ireland) Chairs: Cynthia Levy, USA Chairs: Fermín Mearin, Spain Gideon M. Hirschfield, United Kingdom Jan Tack, Belgium Welcome & Introduction Welcome and Introduction Gideon M. Hirschfield, United Kingdom Fermín Mearin, Spain Jan Tack, Belgium Diagnosis and Risk Stratification in PBC Cynthia Levy, USA Why we need to think again about IBS Fermín Mearin, Spain Management of PBC: New and Future Treatments Gideon M. Hirschfield, United Kingdom Mind the gap! Is there an easy way to diagnose IBS? Viola Andresen, Germany Case #1: The High Risk Patient Gideon M. Hirschfield, United Kingdom Panel debate: IBS as a disease with a positive diagnosis? Case #2: The Symptomatic Patient State-of-the-art in IBS: From single to multi-symptom Cynthia Levy, USA therapy Lin Chang, USA Panel Discussion/Q&A Cynthia Levy, USA Panel discussion, Q&A from the floor and close Gideon M. Hirschfield, United Kingdom Industry Sponsored Symposium Industry Sponsored Symposium 17:45 – 19:15 Room E1 17:45 – 19:15 Room B Evidence Based Switching Preventing Collateral Damage in the IBD Patient – (Celltrion Healthcare Co., Ltd.) Using disease assessment and prognostic factors Chair: Silvio Danese, Italy to optimise clinical outcomes (AbbVie) Welcome and Introduction: Chair: Laurent Peyrin-Biroulet, France Perceptual Evolution on Biosimilar Silvio Danese, Italy Changing the IBD patient's life by altering the course of disease Clinical and Medical Evidence of Biosimilar Laurent Peyrin-Biroulet, France 1. NOR-SWITCH Prevention and prognostication of IBD in clinical practice Jørgen Jahnsen, Norway Jean-Frédéric Colombel, USA 2. PROSIT-BIO Maintaining quality of life for IBD patients by Gionata Fiorino, Italy re-defining disease severity 3. PLANET Study and Clinical Data Updates Laurent Peyrin-Biroulet, France Stefan Schreiber, Germany Interactive case discussion: Panel Discussion Predictive factors All Treatment targets / measuring severity and progress/ measures of success Questions and Answers Subrata Ghosh, United Kingdom All Q&A All Close

283 UEG Week Final Programme : Industry Sponsored Symposia

Industry Sponsored Symposium Industry Sponsored Symposia 17:45 – 19:15 Room F2 Tuesday, October 18, 2016 Image-enhanced endoscopy with BLI and LCI – Increased accuracy in sight? Industry Sponsored Symposium (FUJIFILM Europe GmbH) Chairs: Alexander G. Meining, Germany 07:00 – 08:00 Room F2 Hironori Yamamoto, Japan Biosimilars: Experts Discuss Real-World Considerations (Amgen Inc.) How to help the human eye in the endoscopic detection of early Barrett's neoplasia Roundtable Discussion Jacques Bergman, The Netherlands Adressing Questions in the Evolving Biosimilar Landscape Silvio Danese, Italy Enhanced imaging by BLI and LCI in colonic polyps Laurent Peyrin-Biroulet, France Emmanuel Coron, France Simon Travis, United Kingdom Diagnosis and therapy of IBD with BLI Helmut Neumann, Germany Industry Sponsored Symposium 07:00 – 08:00 Room F1 BLI-assisted advanced tissue resection for colonic lesions NOR-SWITCH: Another piece of the puzzle Alessandro Repici, Italy Illuminating the future for clinicians and payers? Panel discussion and closing remarks (Pfizer) Alexander G. Meining, Germany Chair: Stefan Schreiber, Germany Hironori Yamamoto, Japan Welcome and introduction Stefan Schreiber, Germany Industry Sponsored Symposium 17:45 – 19:15 Room G Dissecting the data Challenges in the management of GERD and Helico- Tore Kvien, Norway bacter pylori Cost-effectiveness: the bigger picture (Takeda Pharmaceuticals International AG) Michael Sobanja, United Kingdom Chair: Peter Katelaris, Australia Clinical implications for gastroenterology Welcome Stefan Schreiber, Germany Peter Katelaris, Australia Summary Tailoring antisecretory therapy: the old and the new Stefan Schreiber, Germany Richard Hunt, United Kingdom Meeting Close PPIs: spotlight on recent safety data Peter Katelaris, Australia H. pylori: current treatment, future trends Peter Malfertheiner, Germany Audience Q&A Faculty Meeting summary and close Peter Katelaris, Australia

284 Industry Sponsored Symposia : UEG Week Final Programme

Industry Sponsored Symposium Industry Sponsored Symposium 07:00 – 08:00 Room E1 17:45 – 19:15 Room K Early Use to Long Term Management with Vedolizum- Introducing new biosimilars into current IBD treat- ab: A Spotlight on UC ment algorithms: interactive panel discussion (Takeda Pharmaceuticals International AG) (Biogen Intl. GmbH) Chair: Peter Irving, United Kingdom Chair: Simon Travis, United Kingdom Welcome, agenda and objectives Opening and introduction Introduction Simon Travis, United Kingdom Peter Irving, United Kingdom Interactive panel discussion Stepping up in UC - choices and challenges Discussion topics: Edouard Louis, Belgium • Establishing comparability • Proving pharmacokinetic equivalence Early use of vedolizumab in UC • Confirming similarity with reference product Pierre Michetti, Switzerland • Translating the totality of evidence into clinical practice Treatment success and long-term safety with vedolizum- • Integrating biosimilars into IBD treatment algorithms ab in UC Geert d’Haens, The Netherlands Peter Irving, United Kingdom Julián Panés, Spain Stefan Schreiber, Germany Audience questions All Faculty Conclusions Panel Summary and close Peter Irving, United Kingdom Industry Sponsored Symposium 17:45 – 19:15 Room E1 Industry Sponsored Symposium Crohn’s disease: supporting patients in their pursuit 17:45 – 19:15 Room G of disease control Sustainable IBD Healthcare with the Patient in Focus (Janssen) – Idealistic or realistic? Chair: Séverine Vermeire, Belgium (AbbVie) Chair: Remo Panaccione, Canada Welcome and overview of learning objectives Séverine Vermeire, Belgium Introduction Remo Panaccione, Canada Unmet medical needs: is Crohn’s disease (CD) sufficiently controlled? Sustainable healthcare in IBD, looking into the future Séverine Vermeire, Belgium Remo Panaccione, Canada Current therapeutic options in CD treatment: Where do Tailored approach for optimal outcome we stand? Edouard Louis, Belgium Alessandro Armuzzi, Italy Patient, doctor and healthcare preferences New developments in the treatment of inflammatory Gerhard Rogler, Switzerland bowel disease Q&A Laurent Peyrin-Biroulet, France Moderated by Remo Panaccione, Canada Interactive Q&A and discussion All speakers

285 UEG Week Final Programme : Industry Sponsored Symposia

Industry Sponsored Symposium Industry Sponsored Symposia 17:45 – 19:15 Room F2 Wednesday, October 19, 2016 Challenges in the medical management of reflux symptoms: what’s new? Industry Sponsored Symposium (RB) Chair: Peter Kahrilas, USA 07:00 – 08:00 Room F2 Get Ready for the Global Epidemic of NASH: Evolving Pathophysiology of breakthrough symptoms Diagnosis and Treatment Strategies Daniel Sifrim, United Kingdom (Chronic Liver Disease Foundation) Postprandial breakthrough symptoms Chairs: Zobair M. Younossi, USA Guy Boeckxstaens, Belgium Vlad Ratziu, France Managing breakthrough symptoms – what is new? Welcome & Introduction to Epidemiology of NAFLD Cathal Coyle, United Kingdom Zobair M. Younossi, USA

Industry Sponsored Symposium Recent Advances in the Diagnosis, Management and Treatment of Patients with NASH 17:45 – 19:15 Room F1 Vlad Ratziu, France Broadening the horizon of intravenous iron treatment to improve patient outcomes in gastroenterology Case #1: Progression of Liver Disease (Vifor Pharma) Vlad Ratziu, France Chair: Axel Dignass, Germany Case #2: Fatty Liver & HCC Welcome and introductions Zobair M. Younossi, USA Axel Dignass, Germany Panel Discussion/Q&A Exploring iron deficiency in gastroenterology: current Zobair M. Younossi, USA clinical evidence Vlad Ratziu, France Axel Dignass, Germany Realising the benefits of intravenous iron through real- world data Satish Keshav, United Kingdom The patient perspective in IBD: why is it important? Silvio Danese, Italy Luisa Avedano, Belgium Summary and close Axel Dignass, Germany

286

1.0 AMA PRA Category 1 Credit ™

MONDAY OCTOBER 17, 2016 ROOM F2 Austria Center Vienna (ACV) Cynthia Levy, MD University of Miami Medical School Registration/Breakfast: 6:45 AM Miami, Florida, USA Symposium: 7:00 – 8:00 AM There is no fee to attend and breakfast will be provided. Space is limited; please arrive promptly. Gideon M. Hirschfield, MB BChir FRCP PhD This symposium is not affiliated with UEG. University of Birmingham Supported by an educational grant from Intercept Pharmaceuticals, Inc. Birmingham, United Kingdom Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

THE CHRONIC LIVER DISEASE FOUNDATION PRESENTS 1.0 AMA PRA Category 1 Credit ™

WEDNESDAY OCTOBER 19, 2016 ROOM F2 AUSTRIA CENTER VIENNA (ACV) ZOBAIR M. VLAD YOUNOSSI, MD, MPH RATZIU, MD, PhD Registration/Breakfast: 6:45 AM Inova Health System Hôpital Pitié Salpêtrière Falls Church, Virginia, USA Paris, France Symposium: 7:00 – 8:00 AM There is no fee to attend and breakfast will be provided. Space is limited; please arrive promptly. This symposium is not affiliated with UEG. Supported by an educational grant from Intercept Pharmaceuticals, Inc. Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UEGW_ProgrammeAds_LEFT_final.indd 1 8/30/16 4:24 PM 1.0 AMA PRA Category 1 Credit ™

MONDAY OCTOBER 17, 2016 ROOM F2 Austria Center Vienna (ACV) Congress Information Cynthia Levy, MD University of Miami Medical School Registration/Breakfast: 6:45 AM Miami, Florida, USA Symposium: 7:00 – 8:00 AM Congress Venue There is no fee to attend and breakfast will be provided. Austria Center Vienna Space is limited; please arrive promptly. Gideon M. Hirschfield, Bruno-Kreisky-Platz 1 1220 Vienna, Austria MB BChir FRCP PhD This symposium is not affiliated with UEG. University of Birmingham Supported by an educational grant from Intercept Pharmaceuticals, Inc. Birmingham, United Kingdom Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and the Congress Registration Counter Chronic Liver Disease Foundation. All congress material and documentation is available at The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council the congress counters located in the Entrance Foyer for Continuing Medical Education to provide continuing medical education for physicians. Opening Hours Friday October 14 14:00 – 18:00 THE CHRONIC LIVER DISEASE FOUNDATION PRESENTS Saturday October 15 07:30 – 18:00 1.0 Sunday October 16 07:30 – 18:00 AMA PRA Monday October 17 07:00 – 18:00 Category 1 Tuesday October 18 07:00 – 18:00 Credit ™ Wednesday October 19 07:00 – 16:00

During these opening hours the congress registration desk can be reached at: T +43 676 845 880 703

WEDNESDAY OCTOBER 19, 2016 ROOM F2 AUSTRIA CENTER VIENNA (ACV) ZOBAIR M. VLAD YOUNOSSI, MD, MPH RATZIU, MD, PhD Registration/Breakfast: 6:45 AM Inova Health System Hôpital Pitié Salpêtrière Falls Church, Virginia, USA Paris, France Symposium: 7:00 – 8:00 AM There is no fee to attend and breakfast will be provided. Space is limited; please arrive promptly. This symposium is not affiliated with UEG. Supported by an educational grant from Intercept Pharmaceuticals, Inc. Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UEGW_ProgrammeAds_LEFT_final.indd 1 8/30/16 4:24 PM UEG Week Final Programme : Congress Information

Congress Information

On-site Registration portation ticket free of charge from Saturday through to On-site Registration does not necessarily entitle the Monday, October 15–17. Vienna’s public transportation participants to receive all congress material. On-site system includes bus, Strassenbahn (tram), U-Bahn (un- Registration will be handled upon a first-come, first- derground) and S-Bahn (express city train). However, served basis, priority will be given to pre-registered transportation to/from the airport using the CAT train, delegates. or S-Bahn (express city train) once the city boundaries are left, requires the purchase of a separate ticket.

Congress Language Please see page 295 for a metro map of Vienna. The official language of UEG Week is English. No simultaneous translation will be provided. Kindly note that the congress badge only serves as a public transportation ticket if shown in conjunction with a valid ID (passport) in case of ticket checks. Name Badges Participants are requested to wear their name badge at How to get from the city centre to the venue all times during the congress. The colours of the name The fastest way to get from the city centre to the ACV is the badges have the following significance: underground line U1 (red) with direction "Leopoldau". Delegate of UEG Week Get off the U1 at "Kaisermühlen – VIC" and take exit Faculty, Officers, Organisers of UEG Week "Schüttaustrasse" (Austria Center Vienna is also indicated). Delegate of Postgraduate Teaching Programme Delegate of UEG Week and Postgraduate How to get to the airport Teaching Programme Vienna International Airport – VIE is easily accessible Delegate of ESGENA from the ACV by public transportation and by taxi. The Exhibitor trip by taxi takes approx. 25 minutes, by public transpor- Press tation approx. 50 minutes. Please take the underground Congress Staff line U1 (red) from the station “Kaisermühlen – VIC” with Guest/Common Interest Group/Business Meeting direction "Reumannplatz". Change at “Schwedenplatz” YGN Young GI Network and take the underground line U4 (green) with direc- tion "Hütteldorf". Get off the train at “Landstrasse” and Please note that according to the EU Directive 2001/83/ take the City Airport Train. The City Airport Train oper- EC promotional material related to prescription-only ates every 30 minutes. medicines must be distributed or provided exclusively to Healthcare Professionals who are authorised to pre- Taxi scribe or dispense them. A taxi stand is located close to the ACV next to the under- ground station "Kaisermühlen – VIC". Taxis can be called day and night at the telephone numbers: How to get around +43 1 401 00, +43 1 601 60 or +43 1 313 00. We ask all of our visitors to think of the environment and use public transport wherever possible: Abstracts Public Transportation Ticket The abstracts of UEG Week Vienna 2016 will be available The congress badge serves as a public transportation online in the UEG Education Library and on a USB stick. ticket if it includes the logo of the public transportation Registered participants receive a voucher at the congress company Wiener Linien alongside the validity date. All material counters in the Entrance Foyer and can pick up registered UEG Week and Fellow in Training delegates their USB stick at the poster service desk in Hall X4 “Sci- are entitled to use the public transportation system free entific Centre”, from Monday through to Wednesday, Oc- of charge from Monday through to Wednesday, October tober 17–19, during the exhibition opening times. 17 – 19. ESGENA delegates may use the public trans-

290 Congress Information : UEG Week Final Programme

Congress News and Website Opening Hours The UEG website, UEG Week App and our social me- Saturday October 15 09:00 – 17:00 dia channels will provide an overview of sessions and Sunday October 16 09:00 – 17:00 data presented each day and “what not to miss” the Monday October 17 09:00 – 17:30 following day along with hot topics and snapshots of Tuesday October 18 09:00 – 17:30 the congress. For more information, visit the UEG Week Wednesday October 19 09:00 – 14:00 website (www.ueg.eu/week)

UEG Members Village Livestreaming of Sessions Meet representatives of UEG’s Member Societies in the Become part of UEG Week and view 50% of all sessions Entrance Foyer. of Europe’s largest GI meeting from wherever you want!

UEG will connect everyone to its annual meet- UEG Young GI Lounge ing via livestream on the UEG Week Live web- Join the Young GI Network on Level 0. For more info site. Lean back and get updated on relevant please see page 23. GI and liver topics free of charge, and connect with the community via the UEG Week Social Wall. Simply sign in to myUEG. For more information, please visit live.ueg.eu Speakers Centre The Speakers Centre is located on Level 0. Speakers are asked to hand in their CD-ROM or USB stick, containing UEG Week 2016 App the Power-Point Presentation (IBM format or compati- Get the UEG Week 2016 App for your smartphone now ble, no multisession) or video preferably one day before and experience the congress at your fingertips! Send their presentation but at the latest 3 hours prior to the questions as text messages during a session or quick- presentation. The presentation will be transferred to the ly find your way through the most up-to-date congress central congress server and will be available afterwards schedule. Cast your vote in interactive sessions via the on a special congress notebook in the hall of the pre- app. Have a look at the latest floor plans and browse sentation. Due to time and technical reasons we kindly through the exhibition and company profiles. Stop car- ask the speakers not to use their own notebook. In the rying around piles of paper. Just take the congress with speakers centre there are several PCs where speakers you, wherever and whenever you want! can also work on their slides in a quiet area. Technical The app is completely free of charge and provides staff will be happy to assist. iPhone/iPad, and Android smartphone users at UEG Week Vienna 2016 with on-the-go access to the con- Opening Hours gress’ most exciting interactive features. Friday October 14 14:00 – 18:00 The Q&A tool is available in the following session Saturday October 15 07:30 – 18:00 rooms: Room A, B, C, D, E1, E2, F1, and F2. Sunday October 16 07:30 – 18:00 Monday October 17 07:00 – 18:00 The UEG Week 2016 App is available at: Tuesday October 18 07:00 – 18:00 Wednesday October 19 07:00 – 14:00

Internet Centre and WiFi The Internet Centre with several terminals is located on Programme Changes Level -2 in Foyer D. UEG cannot assume liability for any changes in the conference programme due to external or unforeseen Opening Hours circumstances. Monday October 17 09:00 – 17:30 Tuesday October 18 08:30 – 17:30 Wednesday October 19 08:30 – 14:00 Meet UEG Find out more about the work we do at the UEG Booth WiFi is available throughout the venue. in the Entrance Foyer. Please select the WiFi network: UEG Week No password is needed.

291 UEG Week Final Programme : Congress Information

Poster Exhibition Please note that according to the EU Directive 2001/83/ Posters are displayed from Monday, October 17 until EC promotional material related to prescription-only Wednesday, October 19 in the poster exhibition on Level medicines must be distributed or provided exclusively 0 in Halls X4 and X5. The posters are changed daily and to healthcare professionals who are authorised to pre- are at display during the following times: scribe or dispense them.

Monday October 17 10:30 – 17:00 Opening Hours Tuesday October 18 09:00 – 17:00 Monday October 17 09:00 – 17:30 Wednesday October 19 09:00 – 14:00 Tuesday October 18 08:30 – 17:30 Wednesday October 19 08:30 – 14:00 The poster presenters are asked to put up and remove their poster on the day of presentation according to the schedule below: Press Centre The Press Centre is located on Level 0. It is open from Hanging: On the day of display 10:00 – 10:30 (Mon) and 08:00 – 18:00 (Sun – Tue, October 16 – 18) and 08:00 – 08:00 – 09:00 (Tue – Wed). 16:00 (Wed, October 19). Removal: On the day of display 17:00 – 17:30 (Mon – Tue) All press/media representatives are invited to attend and 14:00 – 14:30 (Wed). the press briefings in UEG Meeting Room 3:

Posters that have not been removed by the respective Press Briefings time will be disposed of. Poster material to put up the Monday October 17 12:15 – 13:30 poster is available at the poster service desk in the post- Tuesday October 18 12:15 – 13:30 er exhibition area. Local and international speakers will be available to answer questions. If you have submitted a poster for printing for UEG Week 2016 through the CTI Poster Printing Service, please pick The Press Centre is managed by the press agency Spink. up your poster on Monday, October 17 from 10:00 until The agency’s staff is pleased to provide more detailed 17:30, on Tuesday, October 18 from 08:00 until 14:30 and information related to press activities during UEG Week on Wednesday, October 19 from 08:00 until 14:00 at the Vienna 2016. poster service desk in the poster area.

Silent Room E-Posters There is a room set apart for prayer. It is a quiet place, E-Posters will be available on Level 0 in Halls X4 and where delegates may withdraw to seek divine strength X5 in the poster area. All poster presenters have been and guidance. The silent room is located in Room 0.81 invited to upload their poster prior to UEG Week. All on Level 0. uploaded E-Posters can be searched for and viewed electronically on the 6 terminals in the poster area throughout Monday, October 17 to Wednesday, October Coffee Breaks and Lunch 19 during the above mentioned times. PGT Programme and ESGENA Conference (Sat – Sun) Coffee and light lunches are provided in the catering areas in Foyer A and C on Level 2 for Technical Exhibition PGT Programme and ESGENA Conference delegates UEG Week is accompanied by a major technical exhibi- on Saturday, October 15. On Sunday, October 16, tion taking place in Halls X1, X2, X3, Foyer X4, Hall X5 Catering for PGT Programme delegates will be provided and Foyer D on Levels -2 and 0. This provides an excel- again in Foyer A and C and for ESGENA Conference lent opportunity for physicians, pharmacists, pharmacy delegates In Foyer G on Level -2. assistants, nurse practitioners, physician assistants to interact with the industry and familiarise themselves PGT Catering Times with the latest advances in technology and pharma- Saturday, October 15 and Sunday, October 16 cology. For further information and floor plans please Coffee Break 10:30 – 11:00 see the list of exhibitors on page 299 and following, in Lunch 13:00 – 14:00 the UEG Week 2016 App as well as on the UEG website www.ueg.eu/week.

292 Congress Information : UEG Week Final Programme

ESGENA Catering Times Car Park Saturday, October 15 The Austria Center Vienna provides covered, secure Coffee Break 10:30 – 11:00 // 15:30 – 16:00 parking for delegates. The parking fee of € 3 per hour Lunch 13:00 – 14:00 or € 10 per day is not included in the registration fee. Sunday, October 16 Coffee Break 10:30 – 11:00 // 16:30 – 17:00 Lunch 13:00 – 14:00 Smoking The Austria Center Vienna is a non-smoking venue. UEG Week Programme (Mon – Wed) Smoking is prohibited within the congress venue. Coffee and tea as well as a light lunch are served free of charge to all registered UEG Week participants in the designated catering stations located within the exhibi- Photos, Filming and Recording of Scientific Sessions tion area in Hall X1, X2, X3 and X5. It is strictly forbidden to film, take photos or record any oral or poster presentation of UEG UEG Week Catering Times Week without the consent of the organiser (in- Monday, October 17 and Tuesday, October 18 cluding smart phones, mobile devices, etc). Coffee Break 10:00 – 10:30 // 15:30 – 15:45 Please note that numerous sessions will be recorded Lunch 12:00 – 14:00 and published at www.ueg.eu/education/library im- Wednesday, October 19 mediately after the congress and will be available for Coffee Break 10:00 – 10:30 all congress delegates. This archive will also include all Lunch 12:00 – 14:00 abstracts, E-Posters and the Syllabus of the Postgradu- ate Teaching Programme. Throughout the venue there will be water dispensers and catering kiosks to buy refreshments and snacks. Insurance / Liability UEG does not accept any liability for damages and/or Networking Areas losses of any kind which may be incurred by the con- The perfect meeting point to network with colleagues gress participants, during either the official activities are our designated networking areas in the exhibition or official UEG networking events. Delegates attend the area where we provide charging stations for your mo- congress at their own risk. Participants are advised to bile devices. Or join us at the UEG Booth in the Entrance take out insurance against loss, accidents or damage Foyer to network and catch up with peers. The Live that could be incurred during the congress. Endoscopy will also be transmitted to the networking areas on Tuesday. Safety Congress delegates below 40 are also invited to meet As in all major cities and congress venues, people other young fellows in the Young GI Lounge at Level 0, should always keep an eye on their personal belong- where they can form new collaborations, surf the net, ings. Please be aware of pickpocketing and bag-snatch- charge their devices and join our social media activities! ing and make sure to take off your name badge and congress bag when you go sightseeing in downtown Vienna. Wearing the name and bag identifies you as a Cloakroom tourist which might attract pickpockets. The cloakrooms are located on Level 0 (entrance area) and can be used free of charge from Saturday, October 15 through to Wednesday, October 19. Participants can also store their luggage there.

Emergency and First Aid In case of emergency please contact the staff at the registration counter in the Entrance Foyer. The attentive staff will be pleased to help.

293

Public Transportation : UEG Week Final Programme

295 UEG Week Final Programme : Acknowledgements

Acknowledgements (as of September 7, 2016)

UEG gratefully acknowledges the support of the following companies:

Premium Partners

AbbVie Pfizer

FUJIFILM Europe GmbH Takeda Pharmaceuticals International AG

Olympus Europa SE & Co. KG

Major Partners

Allergan Pharmaceuticals MEDTRONIC Ireland

Biogen Intl. GmbH MSD

Celltrion Healthcare Co., Ltd. PENTAX Europe GmbH

Janssen Shire

General Sponsors and Exhibitors

3D MATRIX BÜHLMANN Laboratories AG Alfa Wassermann S.p.A. C2 Therapeutics Alton (Shanghai) Medical Instruments Co.,Ltd CALPRO AS American Molecular Laboratories Inc. Cantel Medical amg International GmbH CapsoVision Ankon Medical Technologies Co., LTD Casen Recordati S.L Anrei Medical(HZ) Co.,Ltd CBC Group Apollo Endosurgery CDx Diagnostics Astellas Pharma Europe Ltd Celgene Corporation Bedfont Scientific Limited Chronic Liver Disease Foundation Beijing Richen-force Science & Technology Co., LTD CMI BHT Hygienetechnik GmbH CONMED BIOCODEX Cook Medical Biohit Oyj Creo Medical Boehringer Ingelheim Pharma GmbH & Co KG CROSPON Boston Scientific International Dr. Falk Pharma GmbH

296 Acknowledgements : UEG Week Final Programme

General Sponsors and Exhibitors

ELLA-CS Medix Biochemica EMcision International Inc. medwork GmbH EMED SP. Z O. O. SP. K. Mendes SA ENDALIS SARL Micro-Tech-Europe GmbH/ Micro-Tech (Nanjing) Co. Ltd. Endoaccess Gmbh MTW-Endoskopie EndoAid Ltd. Nature Reviews Disease Primers EndoClot Plus, Inc. NIKKISO Europe GmbH Endoscopic Ultrasound Journal Niso Biomed Endoscopy / ESGE - Thieme Norgine Limited Endosoft NOVENTURE, S.L. EndoStim BV Otsuka Pharmaceutical Europe Ltd Endotics Ovesco Endoscopy AG epigenomics Oxford University Press ERBE Elektromedizin GmbH Peter Pflugbeil GmbH, Medizinische Instrumente Eurospital ProStrakan Finemedix RB GE Healthcare R-Biopharm AG Genetic Analysis Robarts Clinical Trials B.V. Gilead Sciences S&G BIOTECH INC. Hangzhou AGS MedTech Co.,Ltd. Sandhill Scientific Inc. Hospira, a Pfizer Company Shangxian Minimal Invasive Inc. Huger Medical Instrument Co., Ltd SHENZHEN ZHONGHE HEADWAY BIO-SCI & TECH CO., LTD IMAGE 2017 - 8th International Live Endoscopy Course Shionogi Immundiagnostik AG SMART MEDICAL SYSTEMS LTD. INFAI GMBH SOFAR SPA INSTITUT ALLERGOSAN pharmazeutische Produkte Soluscope SAS Forschungs- und Vertriebs GmbH SonoScape Medical Corp. Intercept Pharmaceuticals STEELCO SPA IntroMedic Co., Ltd SUMITOMO BAKELITE CO.,LTD. invendo medical GmbH Surgical Science Ipsen Pharma Taewoong Medical Co., Ltd Jiangsu ATE Medical Technology Co., Ltd TEAC Europe GmbH Jinshan Science & Technology The Lancet KARL STORZ GMBH & CO. KG The Standard Co., Ltd LA LETTRE DE L´HEPATO-GASTROENTEROLOGUE Tillotts Pharma AG LABORIE (MMS) UltraZonic BVBA Leo Medical Co., Ltd US Endoscopy Life Partners Europe Vifor Pharma M.I. Tech Co., Ltd Vital Therapies, Inc. MAYOLY SPINDLER Walz Elektronik Mederi Therapeutics Inc. WILEY Medify BV Wilson Instruments(SHA)Co.,Ltd. Medi-Globe GmbH/ Endo-Flex GmbH Wisepress Ltd MEDIGUS Ltd. ZheJiang ChuangXiang Medical technology Co.,Ltd MEDITALIA S.A.S. Zhuji Pengtian Medical Instrument Co.,ltd UEG thanks its long-term partners for their continuous support!

297

List of Exhibitors and Exhibition Floor Plans

Technical Exhibition UEG Week is accompanied by a major technical exhibi- tion taking place in Halls X1, X2, X3, Foyer X4, Hall X5 and Foyer D on Levels -2 and 0.

Opening Hours Monday October 17 09:00 – 17:30 Tuesday October 18 08:30 – 17:30 Wednesday October 19 08:30 – 14:00

UEG Week Final Programme : List of Exhibitors and Exhibition Floor Plan

List of Exhibitors (as of September 7, 2016)

Premium Partners Booth No. Major Partners Booth No. AbbVie X3/14 Allergan Pharmaceuticals Ireland X3/12 AbbVie X3/5 Biogen Intl. GmbH X3/11 FUJIFILM Europe GmbH X5/18 Celltrion Healthcare Co., Ltd. X3/6 OLYMPUS Europa SE & Co. KG X5/19 Janssen X3/10 Pfizer X3/13 MEDTRONIC X3/1 TAKEDA Pharmaceuticals International AG X2/16 MEDTRONIC X3/2 TAKEDA Pharmaceuticals International AG X2/15 MSD X3/7 PENTAX Europe GmbH X5/7 Shire X5/6

General Exhibitors Booth No. General Exhibitors Booth No.

3D MATRIX D/4 EMcision International Inc. X1/21 Alfa Wassermann S.p.A. X2/18 EMED SP. Z O. O. SP. K. X2/2 Alton (Shanghai) Medical Instruments Co.,Ltd X3/21 ENDALIS SARL X1/20 American Molecular Laboratories Inc. X1/22 Endoaccess Gmbh X4/3 amg International GmbH X3/20 EndoAid Ltd. X5/23 Ankon Medical X5/2 EndoChoice GmbH X2/42 Anrei Medical(HZ) Co.,Ltd X3/24 EndoClot Plus, Inc. X5/10 Apollo Endosurgery X1/24 Endoscopic Ultrasound Journal D/3 Bedfont Scientific Limited X1/5 Endoscopy / ESGE - Thieme D/6 Beijing Richen-force Science & Technology Co., LTD X2/40 Endosoft X1/25 BHT Hygienetechnik GmbH X5/8 EndoStim BV X3/16 BIOCODEX X3/8 Endotics X2/35 Biohit Oyj X3/23 epigenomics X2/1 Boehringer Ingelheim Pharma GmbH & Co KG X2/33 ERBE Elektromedizin GmbH X2/22 Boston Scientific International X2/20 Eurospital X2/9 BÜHLMANN Laboratories AG X2/31 Finemedix X3/26 C2 Therapeutics X5/3 GE Healthcare X3/4 CALPRO AS X5/25 Genetic Analysis X3/19 CapsoVision X5/21 Gilead Sciences X1/11 Casen Recordati S.L X2/12 Hangzhou AGS MedTech Co.,Ltd. X1/3 CBC Group X2/7 Hospira, a Pfizer Company X3/15 CDx Diagnostics X3/22 Huger Medical Instrument Co., Ltd X2/11 Celgene Corporation X2/21 IMAGE 2017 - 8th International Live Endoscopy Course X5/24 CMI X5/14 Immundiagnostik AG X4/8 CONMED X2/39 INFAI GMBH X4/7 Cook Medical X2/24 INSTITUT ALLERGOSAN pharmazeutische Creo Medical X5/12 Produkte Forschungs- und Vertriebs GmbH D/9 CROSPON X1/13 Intercept Pharmaceuticals X1/9 Dr. Falk Pharma GmbH X2/28 IntroMedic Co., Ltd X1/12 ELLA-CS D/10 invendo medical GmbH X1/23

300 List of Exhibitors and Exhibition Floor Plan : UEG Week Final Programme

General Exhibitors Booth No. General Exhibitors Booth No.

Jiangsu ATE Medical Technology Co., Ltd X5/16 The Lancet D/2 Jinshan Science & Technology X3/9 The Standard Co., Ltd D/5 KARL STORZ GMBH & CO. KG X3/3 UltraZonic BVBA X1/16 LA LETTRE DE L´HEPATO-GASTROENTEROLOGUE X2/41 US Endoscopy X2/37 LABORIE (MMS) X2/30 Vifor Pharma X5/20 Leo Medical Co., Ltd X5/11 Vital Therapies, Inc. X1/15 Life Partners Europe X2/4 Walz Elektronik X2/10 M.I. Tech Co., Ltd X2/5 WILEY D/2A MAYOLY SPINDLER X2/14 Wilson Instruments(SHA)Co.,Ltd. X2/8 Mederi Therapeutics Inc. X1/19,X1/18 Wisepress Ltd D/8 Medify BV X5/24A ZheJiang ChuangXiang Medical technology Co.,Ltd X5/15 Medi-Globe GmbH/ Endo-Flex GmbH X2/34 Zhuji Pengtian Medical Instrument Co.,ltd X5/9 MEDIGUS Ltd. X2/32 MEDITALIA S.A.S. X1/14 Members Village - Level 0 Booth No. Medivators X5/1 medwork GmbH X2/23 EAES MV0/7 Mendes SA X4/2 EAGEN MV0/13 Micro-Tech-Europe GmbH EASL MV0/1 Micro-Tech (Nanjing) Co. Ltd. X2/26 ECCO MV0/14 MTW-Endoskopie X2/19 EDS MV0/3 NIKKISO Europe GmbH X4/1 EFISDS MV0/6 Niso Biomed X5/22 EHMSG MV0/10 Norgine Limited X2/17 EPC MV0/2 NOVENTURE, S.L. X2/38 ESCP MV0/8 Otsuka Pharmaceutical Europe Ltd X1/1 ESDO MV0/4 Ovesco Endoscopy AG X4/4 ESGAR MV0/12 Oxford University Press D/1 ESGE MV0/15 Peter Pflugbeil GmbH, Medizinische Instrumente X2/3 ESNM MV0/5 ProStrakan Limited X2/29 ESPCG MV0/9 RB D/7 ESPGHAN MV0/11 R-Biopharm AG X2/6 SAGE MV0/16 Robarts Clinical Trials B.V. X1/2 S&G BIOTECH INC. X3/25 Association & Future Events Area – Level 1 Booth No. Sandhill Scientific X5/5 Shangxian Minimal Invasive Inc. X3/27 EFCCA AFA1/13 SHENZHEN ZHONGHE HEADWAY Egypt GastroHep Congress AFA1/12 BIO-SCI & TECH CO., LTD X3/17 European Section & Board of Shionogi X3/18 Gastroenterology and Hepatology (ESBGH) AFA1/14 SMART MEDICAL SYSTEMS LTD. X2/27 GEEW AFA1/5 SOFAR SPA X2/36 Gut Microbiota for Health (ESNM) AFA1/2 Soluscope SAS X5/13 ISDE AFA1/6 SonoScape Medical Corp. X5/4 OESO 2017 AFA1/4 STEELCO SPA X5/17 Rome Foundation AFA1/3 SUMITOMO BAKELITE CO.,LTD. X2/13 Sociedade Portuguesa de Gastenterologia AFA1/1 Surgical Science X1/10 WEO AFA1/15 Taewoong Medical Co., Ltd X2/25 World Gastroenterology Organisation AFA1/16 TEAC Europe GmbH X4/6

301 UEG Week Final Programme : List of Exhibitors and Exhibition Floor Plan Level -2 Level

302 List of Exhibitors and Exhibition Floor Plan : UEG Week Final Programme Level 0 Level

303 advancing science, linking people

Barcelona, Spain October 28 – November 1, 2017 Venue: Fira Gran Via

Share your research with renowned experts and peers from across the globe

• Present your clinical and basic science gastroenterology research • Your abstract is eligible for UEG Week Awards • Ground-breaking research is chosen to be featured at the Abstract on Fire Sessions in the UEG Week Hotspot • E-Poster terminals, Posters in the Spotlight and Poster Champ Sessions boost exposure and interactivity • Daily poster sessions on clinical cases provide a forum Abstract for the discussion of challenging clinical problems Submission Make your scientific achievements visible on an international Deadline: stage and prepare your abstract for UEG Week. April 27, 2017

Find out more, visit www.ueg.eu/week

16_08_Inserat_UEGWEEK_FP_weekad_160x220mm_RZ.indd 1 13.09.16 14:58 List of Reviewers

UEG Week Final Programme : Letter of Thanks

Letter of Thanks

Dear Colleagues,

On behalf of the UEG Scientific Committee, I would like that UEG Week is the most important forum at which to to take this opportunity to thank you most sincerely for present your best research. your contribution as an abstract reviewer for the original programme of UEG Week Vienna 2016. The abstract re- We have received 52 video cases which were formally viewing process has been again very important this year evaluated by the Scientific Committee for presentation with a number of innovations introduced to improve es- in Vienna. As in previous years, late breaking abstracts pecially the poster abstract presentations. have been scored by the Scientific Committee for pre- sentation in Vienna. The quality of reviewing this year I know just how much time and effort reviewing ab- was excellent, but if you have any further (positive or stracts takes, but without your expertise we would not negative) comments, please do let us know! Finally, but have the quality that I believe we have achieved in the most importantly, thanks to all investigators both within free paper and poster sessions, and UEG Week would and outside Europe who have submitted their research not be the top international digestive diseases meet- to the meeting, and who are clearly contributing to mak- ing that it has become today. Thank you! We received a ing UEG Week Vienna 2016 such a great success! number of 3,242 abstracts in total for UEG Week Vienna 2016. In total, 2,050 abstracts were accepted, giving an acceptance rate of 68,97%. 403 abstracts will be deliv- ered as oral presentations and 1,647 as posters.

I am even more pleased to tell you that standards have again reached a very high level and we can expect to be exposed to most interesting research and great pre- Magnus Simrén sentations. This high volume and high standard confirm Chair, UEG Scientific

306 List of Reviewers : UEG Week Final Programme

List of Reviewers

A Bornschein, Jan Depoortere, Inge Goetz, Martin Aabakken, Lars Bouhnik, Yoram Deprez, Pierre Henri Gordon, Harriet Abraldes, Juan Bourreille, Arnaud Deviere, Jacques Gottrand, Frederic Acalovschi, Monica Bredenoord, Albert Jan D'Haese, Jan Goesta Graf, Rolf Adamina, Michel Brigidi, Patrizia di Pietro, Massimiliano Graziadei, Ivo Adham, Mustapha Bures, Jan Dignass, Axel Gress, Thomas M. Adolph, Timon Erik Burisch, Johan Dinis-Ribeiro, Mario Grgurevic, Ivica Agreus, Lars Burra, Patrizia Djuranovic, Srdjan Grundy, David Albano, Emanuele Busch, Olivier R. C. Dorta, Gian Allez, Matthieu Bytzer, Peter Dotan, Iris H Almasio, Piero Luigi Drenth, Joost P. H. Haddad, Fouad Almeida, Raquel C Drewes, Asbjørn Hahnloser, Dieter Andresen, Viola Caca, Karel Ducrotté, Philippe Halfvarson, Jonas Annibale, Bruno Caprioli, Flavio Dziki, Adam Hammad, Essam Arlt, Alexander Capurso, Gabriele Hammer, Heinz Florian Armengol-miro, Jose Cardenas, Andres E Handra-Luca, Adriana Ramon Carneiro, Fatima Eliakim, Rami Harbord, Marcus Arvanitakis, Marianna Carter, Ross El-Omar, Emad Hassan, Cesare Atherton, John Caseiro Alves, Filipe Emmanuel, Anton Hatakeyama, Masanori Aziz, Qasim Castiella Eguzkiza, Agustin Enck, Paul Havre, Roald Flesland Azpiroz, Fernando Castro, Rui Eduardo Ensari, Arzu Heieck, Frank Cellier, Christophe Eutamene, Helene Hellström, Per Martin B Chermesh, Irit Helmberger, Thomas Bahr, Matthias J. Chmiela, Magdalena F Henderson, Neil Balaguer, Francesc Cholongitas, Evangelos Färkkila, Martti A. Herszényi, László Barbara, Giovanni Colombel, Jean-Frederic Ferenci, Peter Hofer, Harald Barbu, Sorin Traian Copăescu, Catalin Ferreira, Rui M. Hoffman, Arthur Barthet, Marc Corsetti, Maura Fichna, Jakub Hojsak, Iva Basoli, Antonio Cortez-Pinto, Helena Fitzgerald, Rebecca Clare Hong, Sung Pil Bazzoli, Franco Cosnes, Jacques Fockens, Paul Hovde, Øistein Beaugerie, Laurent Costamagna, Guido Ford, Alexander Charles Huberty, Vincent Beglinger, Christoph Cravo, Marilia Fox, Mark Huibregtse, Inge L. Beldi, Guido Cremers, Isabelle Francoz, Claire Hull, Mark A. Bemelman, Willem Friess, Helmut Hultcrantz, Rolf Benamouzig, Robert D Froehlich, Florian Hytiroglou, Prodromos Bendtsen, Flemming de Boer, Nanne Fujishiro, Mitsuhiro Bernink, Jochem Huib Jan de Franchis, Roberto I Bhala, Neeraj De Giorgio, Roberto G Iacopini, Giampaolo Biancone, Livia de Knegt, Robert J. Gangl, Alfred Ilan, Yaron Biesiekierski, Jessica De Palma, Giovanni Gasbarrini, Antonio Izbicki, Jakob R. Binder, Henry J. De Simone, Claudio Gemilyan, Manik Binek, Janek De Wit, Niek J. Ghaneh, Paula J Bisschops, Raf Dejaco, Clemens Ghia, Jean-Eric Jackson, Simon Bléro, Daniel Dekker, Evelien Giangregorio, Francesco Jansen, Peter L. M. Böcker, Ulrich Del Chiaro, Marco Gionchetti, Paolo Jaroszewicz, Jerzy Boermeester, Marja A. Delhaye, Myriam Giovannini, Marc Jenkins, Ian Bor, Serhat Delladetsima, Johanna Gisbert, Javier Jesenofsky, Ralf Bories, Erwan de-Madaria, Enrique Gisbertz, Suzanne S. Jonkers, Daisy Mae

307 UEG Week Final Programme : List of Reviewers

K Maillard, Michel Nieveen van Dijkum, Ricciardiello, Luigi Karagiannis, John Makristathis, Athanasios E. J. M. Riis, Lene Buhl Karlsen, Tom Hendrik Malagelada, Juan Ramon Nowakowska-Dulawa, Risio, Mauro Kaser, Arthur Malagelada, Carolina Ewa Rodrigues, Cecília Maria Kaukinen, Katri Malfertheiner, Peter Pereira Kelly, Paul Manns, Michael O Roeb, Elke Keshav, Satish Manolakopoulos, Spilios Ohlsson, Bodil Rogler, Gerhard Keszthelyi, Daniel Mantzaris, Gerassimos Öhman, Lena Rokkas, Theodore Kida, Mitsuhiro Marchesini, Giulio Okolicsanyi, Lajos Roman, Sabine Kleger, Alexander Marinho, Rui Tato Oliveira, Carla Romano, Marco Kobara, Hideki Marquardt, Jens Uwe Oliveira, Claudia Ronkainen, Jukka Koletzko, Berthold Marti-Bonmati, Luis O'Morain, Colm Rösch, Thomas Koletzko, Sibylle Martinek, Jan Öresland, Tom Rosendahl, Jonas Koning, Frits Masclee, Ad Russo, Francesco Paolo Kori, Michal Matysiak Budnik, Tamara P Ruszniewski, Philippe Korponay-Szabo, Ilma Rita Mayerle, Julia Panés, Julian Krishnadath, Kausilia K. Mcalindon, Mark Papadopoulou, Alexandra S Kuipers, Ernst J. McColl, Kenneth Papatheodoridis, George Salkic, Nermin Kupcinskas, Limas McLaughlin, John Pár, Alajos Salupere, Riina Kurppa, Kalle Mearín Manrique, Paradis, Valerie Sanders, David Surendran Fermin Parola, Maurizio Santos, Javier L Megraud, Francis Pech, Oliver Sarnelli, Giovanni Lackner, Karoline Meier, Peter Pedersen, Natalia Savarino, Vincenzo Laghi, Andrea Meining, Alexander Peeters, Harald Savarino, Edoardo Laharie, David Meisner, Soren Penagini, Roberto Scharl, Michael Lakatos, Peter László Menu, Yves Pereira, Stephen Schemann, Michael Lamarque, Dominique Michetti, Pierre Pérez-Miranda, Manuel Schölmerich, Jürgen Lambregts, Doenja M. Michl, Patrick Péron, Jean-Marie Schoon, Erik Jan Langner, Cord Milashka, Mariana Petrosillo, Nicola Schreiber, Stefan Laukkarinen, Johanna Milosavljevic, Tomica Peyrin-Biroulet, Laurent Schrumpf, Erik Le Moine, Olivier Mion, Francois Plentz, Ruben Seewald, Stefan Leicester, Roger Moeller, Soeren Pokrotnieks, Juris Seifert, Bohumil Leja, Marcis Mönkemüller, Klaus Prifti, Skerdi Sekiguchi, Masau Lemmers, Arnaud Moreels, Tom Püspök, Andreas Serra, Jordi Lennon, Anne Marie Morino, Mario Seufferlein, Thomas Leroi, Anne Marie Moschen, Alexander R. Q Shamir, Raanan Lévy, Philippe Müller-Lissner, Stefan Quante, Michael Sheridan, James P. Lindberg, Greger Muñoz Navas, Miguel Shimosegawa, Tooru Lindsay, James Murray, Charles R SHIRIN, Haim Lopes, Ana Isabel Musala, Carmen Racz, Istvan Siegmund, Britta Louis, Hubert Musso, Alessandro Ragunath, Krish Sifrim, Daniel Louis, Edouard Myrelid, Pär Rajilic-Stojanovic, Simrén, Magnus Lügering, Andreas Mirjana Singh, Baljit Lugli, Alessandro N Rakonczay, Zoltan Smout, André Lundell, Lars Nakajima, Takeshi Ramadori, Giuliano Sokol, Harry Lundin, Knut E. A. Nardone, Gerardo Rautelin, Hilpi Sookoian, Silvia Luzza, Francesco Naylor, Gregory Rautou, Pierre-Emmanuel Spada, Cristiano Neesse, Albrecht Rebours, Vinciane Spiller, Robin M Ness-Jensen, Eivind Reenaers, Catherine Spinelli, Antonino Maaroos, Heidi-Ingrid Neuberger, James Reeves, Helen Sporea, Ioan Maaser, Christian Neuhaus, Horst Regula, Jaroslaw Staiano, Annamaria Machado, Jose Carlos L. Ng, Siew Chien Reif, Shimon Stanghellini, Vincenzo Machado, Mariana Luisa Nielsen, Ole Haagen Rey, Jean-Francois Stauber, Rudolf Moutinho Verdelho Niesler, Beate Ricart Gomez, Elena Stengel, Andreas

308 List of Reviewers : UEG Week Final Programme

Stieger, Bruno Trukhmanov, Alexander Van Laethem, Jean-Luc Y Stoker, Jaap Tsochatzis, Emmanuel van Leerdam, Monique Yamaoka, Yoshio Stoyanova, Daniela Tulassay, Zsolt Van Oudenhove, Lukas Yao, Kenshi Syn, Wing-Kin Turner, Dan Vande Casteele, Niels Tutuian, Radu Veereman, Gigi Z T Veres, Gabor Laszlo Zachariah, Khaled Serag Tacke, Frank U Vermeire, Severine Zachou, Kalliopi Tamori, Akihiro Uranues, Selman Vilmann, Peter Zaninotto, Giovanni Targarona, Eduardo Uraoka, Toshio Vinter-Jensen, Lars Zeissig, Sebastian Taylor, Stuart Urbonas, Vaidotas Vlachogiannakos, John Zelinkova, Zuzana Thabut, Dominique Vogel, Wolfgang Zerbib, Frank Theodorou, Vassilia V Vogel, Arndt Zins, Marc Thorlacius, Henrik Valantinas, Jonas von Hahn, Thomas Tilg, Herbert Válek, Vlastimil Vucelic, Boris Tiniakos, Dina van Berge Henegouwen, Tomazic, Ales Mark Ivo W Tomlinson, Ian Van Cutsem, Eric Walker, Marjorie Törnblom, Hans van den Brink, Gijs R. Wedemeyer, Heiner Torres, Joana van der Woude, Janneke Weersma, Rinse K. Tözün, Nurdan Ayse van Eijck, Casper H. J. Welsch, Christoph Trauner, Michael van Herwaarden, Yasmijn Wilder-Smith, Clive Trifan, Anca-Victorita Van Hootegem, Philippe Wittenburg, Henning Trovato, Cristina Maria Van Kemseke, Catherine Won, Kim

Don’t wander alone – join our new Guided Poster Tours

A dedicated guide will show you around his themed selection. The best opportunity to interact with the presenters! Meet us at the poster service desk on Mon–Wed at 12:30

309 Where Basic Science meets Gastroenterology – our targeted activities are anything but Basic! Visiting Fellowship Programme for researchers

UEG Committee membership UEG Journal publication

Submit your original research abstract to UEG Week Basic in order to be eligible for the following Science Course abstract related Scientific Awards: Young Investigators Travel grants Meeting Poster Awards Translational / Basic Top Abstract Prizes Science symposia UEG Research Prize Today’s Science; Tomorrow’s Medicine Rising Star Awards symposia

Find out more, visit www.ueg.eu

16_08_Inserat_UEGWEEK_FP_BasicScience_160x220mm_RZ.indd 1 13.09.16 15:06 Index of Authors and Co-Authors

UEG Week Final Programme : Index of Authors and Co-Authors

Index of Authors and Co-Authors

A Abrams, J. A...... 235 Ahluwalia, A...... 70, 144, 189 Albrecht, H...... 133, 202, 233, Aabakken, L...... 38, 55, 68, 89, Abrantes, A...... 159, 167 Ahmad, Y...... 120 201, 241 101, 180, 188, Abreu, I...... 220 Ahmadullina, O...... 91 Albrecht, P...... 153 226, 227, 248 Abreu, L...... 128, 172 Ahmad Al-Saffar, H...... 151 Albuquerque, A...... 93, 119, 155, Aalbers, A...... 87, 132 Abu Dayyyeh, B. K...... 218, 219 Ahmed, A. K...... 117, 147 187, 199, 219 Aaldering, B. R...... 208 Abu Hilal, M...... 168 Ahmed, A...... 126 Albuquerque, C...... 149, 185, 217, Aarnio, M...... 106 Abu-Abeid, S...... 240 Ahmed Rewisha, E...... 165 229, 230 Abassi, Z...... 94 Accarino, A...... 85, 187 Ahn, S.-B...... 162 Alcedo, J...... 97, 103, 194 Abayev, E...... 172 Accarino, G...... 138, 151 Aho, V...... 81 Aldeguer, X...... 112, 133 Abazia, C...... 66 Accossato, P...... 226 Ai, J...... 60 Aldohuky, L. S...... 207 Abbas, A...... 71 Aceituno, M...... 179 Aiba, T...... 156, 164 Aleem, U...... 175 Abbas, S...... 119 Aceves, S...... 190 Aichelburg, M...... 78 Alekseeva, O...... 225 Abbatini, F...... 64 Achécar Justo, L...... 129 Aigner, E...... 185 Aleksandrova, K...... 50 Abbes, L...... 128 Adachi, K...... 238 Aikou, S...... 102 Aleman, S...... 56, 83 Abbott, C...... 178 Adachi, S...... 139 Ainora, M. E...... 88 Alempijevic, T...... 163 Abd El Moety, A. A...... 165 Adachi, T...... 128 Aisenberg, J...... 70 Alessandra, D...... 202, 229 Abd El-Hafeez, M...... 207 Adamczyk, L...... 129 Aissaoui, M...... 224 Alessio, L...... 164 Abd El-Kader, M...... 120 Adams, A. T...... 72, 93 Aissat, Y...... 224 Alev, Y...... 235 Abd El-Maksoud, M...... 88, 242 Adamski, J...... 189 Aithal, G. P...... 202, 206, 240 Alexander, J...... 72, 190, 228 Abd-Elsalam, S...... 104, 120 Adar, T...... 77, 116, 141 Ajana, F. Z...... 152 Alexandrakis, G...... 55 Abdallah, D...... 222 Adedeji, O...... 101 Akagi, M...... 139, 183 Alexandrino, G...... 207 Abdel-Aziz, H...... 147, 151, 222, 234 Adel, E...... 119 Akagi, Y...... 148, 176, 236 Alexandrino, P...... 114, 120 Abdel-Mageed, W...... 88 Aden, K...... 93, 94, 222 Akane, S...... 170 Alfadhli, A...... 239 Abdelaal, E...... 119 Adesanya, M...... 148 Akasaka, T...... 84, 126, 204, Alfaro, E...... 70 Abdelmoety, A. A...... 242 Adham, M...... 81, 253 215, 217 Alfaro Perez, I...... 56 Abdelmoez, A. T...... 119 Admyre, C...... 62, 204, 224 Akazawa, Y...... 136, 150, 170, Alfieri, R...... 132, 133, 191 Abdi, T...... 126 Adolph, T. E...... 100, 105 . 190, 237 Alfthan, H...... 51 Abdul-Sattar, A...... 209, 239 Adrover, E...... 229 Akbar, A...... 181 Algül, H...... 60 Abduljaqbbar, R. F...... 207 Adua, D...... 230, 231 Akhuemonkhan, E...... 211 Alhaddad, O. M...... 242 Abdulkader, I...... 131, 174, 211 Aepli, P. R...... 159, 171, 200, 242 Akimoto, T...... 114, 125, 129, Alhakam, A...... 94 Abdulkhakov, S. R...... 117, 123, 150, Afchain, P...... 220 148, 214, 215 Alhooei, S...... 239 191, 225 Affronti, M...... 139, 227 Akinola, O...... 128, 157, 171 Ali, A...... 168 Abdulkhakova, A...... 123 Afif, W...... 135 Akiyama, D...... 122 Ali Arous, N...... 224 Abdulla, M...... 142, 170 Afifi, R...... 152 Akpinar, Z...... 93, 146 Ali Haimoud-Lekhal, D...... 241 Abdurashitov, A...... 194 Afonso, C...... 198 Akshintala, V. S...... 211 Aliberti, C...... 142 Abe, K...... 205, 231, 232 Afonso, J...... 126, 136, 184, 223 Aktar, R...... 53 Aljebreen, A...... 63 Abe, S...... 132, 170, 173, 192, Afonso, L...... 59 Aktas, A...... 119 Alkandari, A. A...... 142, 170 213, 220, 236 Afonso, M. B...... 99, 118 Akutsu, D...... 99 Allam, N...... 165 Abe, T...... 218 Agah, S...... 239 Al Hajjar, N...... 121, 156, 165 Allen, P. B...... 144 Abe, Y...... 186 Agarwal, A...... 242 Al-Jumah, I...... 239 Allez, M...... 46, 72, 73, 81, Abel, J. L...... 58, 113, 143, 144 Agarwal, B...... 133 Al-Kaabi, S. R...... 165, 208 88, 89, 95, 222 Abellà-Ametller, C...... 74 Agarwal, K...... 83, 108 Al-Saffar, A...... 180 Alliet, P...... 47, 183 Abergel, A...... 105 Aggarwal, N...... 141, 185 Al-Shamali, Y...... 239 Allimant, C...... 116, 135 Abid, F...... 72 Aggio, R...... 185 Aladl, A.-H...... 88 Alloni, R...... 105 Abitbol, V...... 73, 137 Agha, A...... 184 Alakkari, A...... 152 Almario, J. A...... 97, 235 Abo Ali, L...... 104 Aghdassi, A. A...... 132 Alam, N...... 225 Almasio, P. L...... 202, 232 Abo el Kheir, H. F...... 146 Aghemo, A...... 41, 61 Alawad, A...... 51, 174 Almeida, N...... 174, 218, 240 Abols, A...... 142 Agostinho, C...... 119, 208 Alazawi, W...... 201, 228 Almeida, P...... 198 Abou Ali, E...... 175, 219 Agranovich, I...... 194 Albano, E...... 117 Almer, S...... 77 Abou Rached, A...... 121 Agrawal, A...... 128, 144 Albazaz, R...... 82, 89 Almuhamamdi, A...... 184 Abou Saif, S...... 120 Agréus, L...... 147 Albéniz Arbizu, E...... 147 Aloi, M...... 72, 85, 175, 183 Abougergi, M. S...... 74 Aguila, G...... 161, 190 Alberti, A...... 191 Alonso, A...... 221 Abramowich, D...... 104 Agus, A...... 74, 134, 221 Alboraie, M...... 239 Alonso, M...... 194

312 313 Index of Authors and Co-Authors : UEG Week Final Programme

Alonso Abreu, I...... 87, 230 Anderloni, A...... 130, 142, 168, Aoi, K...... 194, 204, 215 Arnold, D...... 76, 86, 91, 96 Alonso Lázaro, N...... 173, 239 172, 175, 176, 203, Aoki, H...... 103, 107 Arnold, W...... 200 Alper, E...... 93 213, 214, 234 Aoki, I...... 119 Arnoletti, P...... 129 Alperovich, G...... 225 Andersen, V...... 77 Aoko, O...... 227 Aro, P...... 147 Alrubaiy, L...... 146, 187 Anderson, E...... 227 Aparicio, T...... 50, 76, 83, 103, 220 Arola, J...... 51, 81, 130 Alsabaawy, M. M...... 242 Anderson, J...... 129 Apine, I...... 179 Aronsson, M...... 73 Alsebaey, A...... 165 Anderson, S. H...... 138 Apostolopoulos, P...... 55 Arora, A...... 158, 163 Alsenbesy, M...... 130 Andersson, C...... 204, 218 Appenrodt, B...... 199 Arrigo, S...... 184 Alsina, D...... 172 Ando, M...... 142 Arai, J...... 65 Arrigoni, G...... 105 Alswaifi, A...... 72 Andorka, C...... 166 Arai, M...... 214 Arrizabalaga, B...... 119 Altomare, A...... 57, 105, 144 Andorsdóttir, G...... 116, 134 Arai, S...... 121 Arroyo, J...... 189 Altorjay, Á...... 204, 223 Andrade, P...... 135, 162, 175, Arai, Y...... 131 Arroyo-Villarino, M. T...... 56 Altorjay, I...... 136 180, 196, 198, 212 Araki, H...... 115, 125 Arruebo, M. P...... 178 Altwegg, R...... 73 Andrade, R...... 96 Arana-Arri, E...... 129, 157, 171, 268 Arsenic, R...... 168 Alustiza, J. M...... 119 Andrade, V...... 242 Aranda, R...... 62, 97 Artesiani, M. L...... 230, 231 Alvarado, H...... 63, 80, 115, Andrae, D. A...... 86 Arasaradnam, R...... 230 Artifon, E...... 219 130, 159, 169 Andrealli, A...... 104 Arau, B...... 196 Arts, W...... 47, 183 Alvarez, S...... 223 Andreev, P...... 225 Araujo, I...... 151 Arvanitakis, M...... 37, 38, 68, 75, Álvarez De Sotomayor, D...... 173 Andreeva, L. A...... 145 Araújo, R...... 119, 126, 154, 155, 82, 90, 102, Alvarez González, M. A.....129, 216 Andreone, P...... 121, 166 198, 199, 207, 242 107, 159, 167 Álvarez Orozco, M...... 236 Andreozzi, P...... 157, 171, 216 Arber, N...... 50, 115, 131, 197, Asada, M...... 88 ,216 Álvarez-González, M. A...... 217 Andresen, V...... 75, 82, 98, 151, 203, 212, 231, 240 Asada-Hirayama, I...... 172 Alves, A...... 104, 114, 119, 190, 238, 283 Arcidiacono, D...... 191 Asai, S...... 124 164, 206 Andreu, M...... 216 Arcidiacono, P. G...... 168 Asai, Y...... 159, 175 Alves, A. R...... 218 Andreu-Ballester, J. C...... 222 Arciuolo, D...... 151 Asakuma, Y...... 128 Alves, S...... 80 Andreuzzi, E...... 52 Ardengh, J. C...... 50, 124, 168 Asakura, A...... 150 Alvisi, C...... 196 Andrews, J. M...... 143, 188 Ardid, D...... 232 Asaoka, D...... 150, 170, 190, 234 Alvisi, P...... 56 Andrianello, S...... 177, 203, 212 Ardizzone, S...... 41, 56, 84, 100 Asati, P. K...... 162 Amano, T...... 231 Andriulli, A...... 203, 213, 214 Ardizzoni, A...... 230, 231 Asbun, H. J...... 168 Amano, Y...... 150 Andronik, S...... 221 Arebi, N...... 77, 144, 178 Aschenbrenner, E...... 162, 209 Amara, J...... 134 Anese, M...... 166 Areia, M...... 80 Ascione, A...... 164 Amaral, J. D...... 99 Ang, D...... 58 Arena, I...... 157, 171 Ascon, N...... 157, 171 Amaral, P...... 198 Ang, G. T...... 242 Arena, M...... 153 Ashikari, K...... 129, 142, 231 Amarasinghe, G...... 190 Ang, T.-L...... 63, 130, 173 Arena, R...... 144 Aslan, F...... 93, 146 Amaro, P...... 128 Angele, M...... 184 Arena, V...... 134 Aslanian, H...... 126 Amato, A...... 72, 104, 175 Angelino, G...... 184 Aresté, I...... 113, 147, 148, 233 Aso, A...... 64, 124 Amato, L...... 142, 234 Angelucci, E...... 56 Aresté Anduaga, I...... 113, 147, 148 Aspinall, R...... 105 Amaz, C...... 105 Angermayr, B...... 119, 163 Arghirescu, S...... 242 Assa, A...... 153, 183, 221 Ambrogi, F...... 127, 204, 223 Angriman, I...... 73, 151, 176, Argüello, L...... 173 Assadi, G...... 87 Ambrosch, S...... 164 194, 228 Argueta, M. S...... 217 Assadsangabi, A...... 134 Ambrosius Christensen, L...... 182 Angsuwatcharakon, P...... 187 Arias Arias, Á...... 97, 136 Asselah, F...... 224 Amieva, M. R...... 52 Aniwan, S...... 187 Arihiro, S...... 131, 240 Asselah, H...... 224 Amigó-García, V...... 222 Ankersen, D...... 224 Arima, S...... 210 Assouline-Dayan, Y...... 97 Amin, K...... 130 Annamalai, T...... 116, 137, 177 Arisaka, Y...... 98 Atalaia Martins, C...... 207 Amininejad, L...... 85 Annibale, B...... 116, 145 Arismendi-Morillo, G...... 150 Atanassova, A...... 135 Amiot, A...... 73, 137, 226 Annunziata, M. L...... 204, 223 Arita, K...... 115, 125 Atay, K...... 161, 178 Amir, Z...... 224 Ansorge, C...... 114, 115, 124, Ariza-Fernandez, J. L...... 99, 189 Aterido, A...... 221 Amitai, M. M...... 180 129, 160, 176 Arjona Ferreira, J. C...... 98 Athanasakos, E...... 146, 235 Amitrano, L...... 203, 213 Antal-Szalmas, P...... 51, 163 Arlt, A...... 52 Atherton, J...... 47, 69, 91 Amo Alonso, R...... 176 Anten, M.-P...... 219 Armbruster, F.-P...... 241 Athnasiadou, E...... 227 Amodio, A...... 173 Antico, A...... 116, 145, 238 Armelao, F...... 128 Atkins, K...... 222 Amorós, J...... 217 Antoljak, N...... 141 Armignacco, O...... 164 Atkinson, N...... 106 Amoruso, A...... 196 Anton, Á. D...... 137 Armstrong, D...... 240 Atmani, K...... 178 Amri, M...... 139 Antonella, G...... 202, 229 Armuzzi, A...... 47, 56, 138, 139, Atreya, I...... 57, 72, 93, 105 Amurrio, C...... 199 Antonini, A...... 96 179, 182, 285 Atreya, R...... 62, 105, 181, 204, 224 Amzolini, A...... 201, 206 Antunes, A. G. G...... 103, 104 Arnaout, A. H...... 195 Atrott, K...... 50, 92, 100, 178 Anagnostou, O...... 165 Antunes, A. G...... 114, 119, 232 Arnau, A...... 157, 171 Attalla, M...... 119 Anania, C...... 153 Antunes, T...... 123, 157, 167, 198 Arnelo, U...... 115, 129 Atteka, S...... 179 Anapaz, V...... 119, 207, 220 Antypas, P...... 218 Arnhold, J...... 183 Attili, A. F...... 209

313 UEG Week Final Programme : Index of Authors and Co-Authors

Attili, F...... 50, 130, 209 Bahbah, F...... 226 Bang, C. S...... 130, 234 Barreiro Alonso, E...... 226 Attree, C...... 226 Baier, L...... 163 Bang, C.-Y...... 193, 209 Barreiro-De Attwood, S...... 100, 109 Baierl, A...... 185, 229 Bang, J.-Y...... 50 Acosta, M...... 134, 136, 138, 139, Aubert, A...... 98 Baik, G. H...... 130, 234 Bang, Ji Y...... 129 178, 181, 204, 223, 225 Auge, J. M...... 77 Baik, S. J...... 150 Bang, S...... 125, 130, 210 Barresi, L...... 130, 131 Augustijns, P...... 52 Baik, Su J...... 229 Banhudo, A...... 155, 198, 219 Barret, M...... 62, 236 Augusto, F...... 164 Bailey, J...... 239 Banic, M...... 141, 156, 165 Barrichello, S...... 197 Aumais, G...... 186 Bailey, Y...... 77 Banks, M...... 146 Barrio, J...... 52 Ausloos, F...... 159, 167 Baines, J...... 52 Banno, S...... 205, 231, 232 Barrio Andrés, J...... 56 Auttret, A...... 130 Bajador Andreu, E...... 125 Bansal, R...... 57, 60, 118 Barrison, I...... 53 Auvinen, P...... 81 Bajer, L...... 134, 164 Bao, B. H...... 232 Barroca, H...... 93, 187 Auzbikiene, R...... 194 Bajeux, E...... 135, 178 Bapaye, A.....115, 125, 167, 210, 214 Barsic, N...... 146, 188, 233 Auzolle, C...... 72, 81, 222 Baji, P...... 70, 204, 225 Bapaye, J. A...... 115, 125, 167, Barta, Z...... 222 Avallone, E. V...... 182 Bajor, J...... 123 210, 214 Bartak, B. K...... 141, 230 Avancini, I...... 128 Bak, Y. T...... 106 Bapiro, T. E...... 86 Bartel, M. J...... 217, 220 Averbach, M...... 188 Bak, Y.-T...... 210, 212 Bar, S...... 135 Barth, T...... 86 Avidan, B...... 180 Bakaeva, Z. V...... 145 Bar Gil Shitrit, A...... 182 Barthet, M...... 48, 50, 54, 61, Ávila, F...... 142, 149, 157, 171 Baker, R...... 142 Bar-Yoseph, H...... 181 71, 144, 172, 202, 248 Avni, I...... 135, 137 Bakers, F...... 132 Barabino, A...... 184 Bartolo, O...... 147, 190, 194 Avni-Biron, I...... 182 Bakhos, J.-J...... 134 Barakat, S...... 120, 153 Bartsch, K...... 94 Awad, H...... 94 Bakke, I...... 52 Baranovsky, A...... 61 Basha, H. F...... 162 Awadelkarim, B...... 191 Bakker, O...... 114, 123 Barauskas, G...... 177 Basha, J...... 51 Awadie, H...... 115, 127 Bakula, A...... 162 Barba, E...... 85 Basic, M...... 52 Azevedo, R...... 155, 191, 198, 219 Balaban, D. V...... 195 Barbakadze, G...... 199 Basilisco, G...... 233 Azhar, R...... 230 Balaguer, F...... 229 Barbara, G...... 48, 53, 75, 84, 228 Bassi, A...... 225 Azhar, S...... 175 Balamane, A. E. M...... 224 Barbarini, G...... 164 Bassi, C...... 175, 177, 203, 212 Azimzadeh, P...... 118 Balassone, V...... 71, 101, 130 Barbaro, F...... 130, 220 Bassi, M...... 153 Aziz, I...... 80, 205, 239 Balbi, T...... 112, 133 Barbaro, M. R...... 228 Bassi, N...... 221 Aziz, Q...... 69, 78, 92, 191 Baldaia, C...... 194, 198 Barbeiro, S...... 207, 218 Bassioukas, S...... 101 Azpiroz, F...... 54, 78, 85, Baldan, A...... 130 Barbosa, M...... 63, 166, 175, 180 Bastens, B...... 159, 167 95, 187, 274 Baldassarre, F...... 192, 205, 237 Barcellos, M...... 188 Bastiaansen, B. A. J...... 190 Azukisawa, S...... 59 Baldassarre, G...... 116, 203, Bardella, M. T...... 205, 239 Bästlein, E. C...... 143 Azuma, M...... 96 213, 214, 238 Bardelli, A...... 46 Baston-Rey, I...... 134, 178 Azuma, T...... 139 Baldissarro, I...... 223 Bardini, R...... 73, 148, 151, Basurto-Acevedo, N. E...... 177 Azzam, A...... 172 Baldry, E...... 240 176, 194, 228 Bataneant, M...... 242 Azzolini, F...... 174, 237 Baldwin, B...... 173 Bareggi, E...... 65 Batista, S...... 51 Balestrieri, P...... 234 Barendse, R. M...... 102, 158, 185 Batista, W. A...... 188 Balihar, K...... 140 Barera, S...... 105 Battaglin, F...... 142 B Balint, A...... 70, 99, 137, 139, 204, Baretta, G. A. P...... 240 Batteux, F...... 62 Baamonde, I...... 159, 176 219, 220, 222, 224, 227 Bargiggia, S...... 203, 213, 214 Batu, D...... 105 Baba, T...... 55, 79, 129, 141, Ballantyne, S...... 52 Bari, Z...... 239 Bauder, M...... 125 158, 185, 186, 217 Ballerini, A...... 65 Baribaud, F...... 72, 93 Bauer, D...... 66, 158, 162 Babayan, A...... 181 Ballester, F...... 222 Barjas, E...... 173 Bauerfeind, P...... 42, 90 Babenko, L. P...... 197 Ballet, V...... 47, 56, 70, 227 Barkun, J...... 168 Baum, P...... 61 Bachet, J.-B...... 219 Balmaña, J...... 229 Barlattani, A...... 164 Baumann, U...... 56, 83 Bachlitzanaki, M...... 178 Baltar, J...... 159, 176 Barnes, J.-H...... 239 Baumgaertner, I...... 220 Backes, Y...... 114, 126 Balzano, A...... 203, 213, 214 Barnhoorn, M...... 221 Baumgart, D. C...... 181, 216 Badaloni, A...... 53 Bamias, G...... 179 Barnich, N...... 57, 72, 74, 81, 93, Baumstark, M. W...... 66 Baddour, N...... 153, 165 Bammer, T...... 152 112, 133, 134, 160, Bautzova, T...... 87 Badea, M. A...... 162 Bampton, P...... 178 177, 221, 222 Bayer, J...... 214 Badran, H...... 242 Bamshad, M...... 87 Barnoy, S...... 135 Bazzoli, F...... 48, 89 ,112, 130, Bae, H. I...... 174, 212 Ban, T...... 52, 124 Baron, T. H...... 50, 51, 60, 69, 76, 133, 203, 210, 213, Bae, J.-M...... 197 Banach, M...... 160, 177 114, 123, 174, 218 214, 229, 231, 234 Baek, D. H...... 193 Banafa, O...... 207 Barone, M...... 196, 207, 222 Beaini, C...... 134 Baenkler, H...... 155 Banai, J...... 70, 99, 137, 222 Barosa, R...... 162, 198, 199, 200, Beard, K. W...... 71 Baert, F...... 47, 182, 183 Banasiuk, M...... 153 206, 227, 242 Beath, A...... 190 Bagherzadeh, M...... 195 Banaszkiewicz, A...... 153 Barranco, L...... 216, 217 Beaugerie, L...... 57, 68, 76, 77 Bagnasco, F...... 153 Banda, I...... 195 Barreau, F...... 177 Bechthold, C...... 200 Bagolini, F...... 127 Bang, B...... 86 Barreiro, P...... 127, 164 Becker, H...... 165

314 315 Index of Authors and Co-Authors : UEG Week Final Programme

Becker, J...... 233 Benes, M...... 140 Bertani, L...... 190 Billot-Grasset, A...... 209 Becker, T...... 52 Benesic, A...... 158, 162 Bertele, A...... 205, 237 Bilski, J...... 116, 133 Beckers, R...... 88, 131 Benesova, L...... 141 Bertrais, S...... 128 Bilsland, A...... 168 Becq, A...... 219 Benet, C...... 222 Besheer, T...... 88, 207, 242 Bilzer, M...... 120 Bednarska, O...... 92, 232 Benezech, A...... 71 Besherdas, K...... 152, 195, 236 Bin Dorel, S...... 81 Bedny, F...... 50, 197 Bengs, S...... 50 Bessa, X...... 216, 217 Bing, L...... 209 Beeckmans, D...... 52 Benhar, I...... 231 Bessède, E...... 194 Bingham, R. L...... 217 Beets, G. L...... 87, 88, 131, 132 Benítez Cantero, J. M...... 56, 179 Besselink, M. G. H...... 68, 90,98, Birnbaum, D...... 144 Beets-Tan, Benjaminov, F...... 213 114, 123, 158, Biro, E...... 137 R. G. H...... 87, 88, 131, 132 Benmediouni, F...... 154 160, 168, 176 Bischof, M...... 163 Beg, S...... 129 Bennato, R...... 203, 213, 214 Bessho, R...... 140 Bischoff, S...... 86, 108 Beger, H...... 114, 123 Bennet, S. M. P...... 46, 81 Bessissow, T...... 135 Bispo, M...... 164, 199 Begini, P...... 164 Bennett, A...... 240 Betés Ibáñez, M...... 142 Bisschops, R...... 42, 48, 68, 75, Begka, C...... 94 Benninga, M. A...... 54, 61, 116, Bethge, J...... 222 80, 82, 129, 205, 235 Beglinger, C...... 59 137, 226 Bettencourt, M. J...... 187 Bitton, A...... 135, 198 Behary, J...... 174 Benosman, H...... 128 Bettenworth, D...... 222, 225 Bizzochi, A...... 184 Behl, A. B...... 196 Benson, A...... 104 Betti, E...... 196 Bizzotto, A...... 203, 213, 214 Behl, N. S...... 196 Bensuleiman, Y...... 230, 231 Beuers, U. H. W...... 40, 62 Bjarnason, I...... 179 Behm, A...... 168 Benton, S...... 188 Beuvon, F...... 62 Bjerke, T...... 74 Beiderwellen, K...... 135 Ber, Y...... 81 Beyer, A...... 85, 262 Bjerrum, J. W...... 222 Beinhardt, S...... 78, 208 Beer, A...... 50 Beyer, G...... 132, 168 Björnsson, B...... 114, 124, 160, 176 Bekkali, N...... 122, 123 Berakova, K...... 205, 225 Beyer, L...... 144 Black, C...... 227 Bekkers, I...... 132 Berardi, M. G...... 153 Beyna, T...... 39, 65, 69, 80, 90 Blackshaw, A...... 53 Belaïd, A...... 154 Bercik, P...... 81 Bezemer, G...... 219 Blakaj, B...... 228 Belei, O...... 153, 166, 242 Berdah, S...... 144 Bézirard, V...... 241 Blancas Valencia, J. M...... 50 Belgers, E...... 106 Berden, F. A. C...... 165, 208 Bezobchuk, S...... 79 Blanco Velasco, G...... 50 Belghazi, K...... 80 Beregova, T...... 152 Bhala, N...... 117, 145 Blanpied, C...... 177 Belhocine, K...... 224 Berenguer, M...... 42, 83 Bhandari, A...... 116, 137, 177 Blanquet-Diot, S...... 74 Belkin, E...... 79 Berényi, A...... 204, 223 Bhandari, P...... 42, 49, 79, 90, Blaszczyk, K...... 145, 241 Bell, S...... 134, 168, 182 Bereswill, M...... 183 101, 104, 127, 140, 142, 148, Blatt, A...... 181 Bella, A...... 217 Bereza, B...... 139 170,205, 214, 235, 236, 248 Blazquez, E...... 128, 172 Bellacosa, L...... 228 Bereznitsky, Y. S...... 93 Bharucha, A...... 187 Blazquez Gomez, I...... 129 Bellanova, M...... 112, 133 Berg, S...... 160, 181 Bhat, N...... 157, 167, 211 Bleich, A...... 52 Bellini, M...... 187, 190 Bergamo, F...... 142 Bhatia, V...... 142 Blein, C...... 105 Bellissimo, M. C...... 132 Bergemalm, D...... 72 Bhatnagar, G...... 179 Bléro, D...... 68, 75, 82 Belluco, C...... 142 Berger, A...... 86, 128 Bhattacharya, K...... 79, 200, 219 Bligh, S...... 189 Bellumat, A...... 172, 240 Bergman, J. J...... 38, 39, 79, 80, Bhattacharyya, R...... 49, 104, 127 Bloigu, R...... 201, 206 Belluzzi, A...... 112, 133 84, 90, 108, 203, 213 Bi, Y...... 118, 169, 212, 214 Blomberg, J...... 115, 129, 160, 176 Belostotsky, N...... 91 Bergmann, L...... 96 Biagi, E...... 112, 133 Blonska-Fajfrowska, B...... 206 Belousova, E...... 77 Bergonzi, M...... 59, 232 Biagi, F...... 196 Blumberg, R. S...... 52, 93, 222 Belsanova, B...... 141 Bergstrom, M...... 189 Bian, S...... 70, 223 Boal Carvalho, P...... 63, 79, 166, Beltrame, V...... 176 Berkane, S...... 224 Bianchi, L...... 169, 170 175, 199, 241 Beltran Niclos, A. B...... 138 Berlakovich, G. A...... 164 Bianco, F...... 87 Boardman, H...... 188 Bemelman, W. A.....41, 44, 46, 73, Bermejo, F...... 138 Bianco, M. A...... 203, 213, 214 Boarino, V...... 130, 203, 213, 214 100, 102, 106 Bermudez, L...... 172 Biancone, L...... 56, 116, 135, 183 Bocca, C...... 117 Ben Mansour, W...... 224, 227 Bernal Martinez, A...... 217 Biasco, G...... 230, 231 Bochar, O...... 118 Ben Mustapha, N...... 135, 139 Bernardes, C...... 154, 164, 183 Biasutto, D...... 234 Bochar, V...... 118 Ben Muvhar, S...... 210 187, 193, 208 Bibbò, S...... 151 Bodelier, A. G. L...... 85 Ben-Bassat, O...... 135, 182 Bernardo, D...... 105, 178, 182 Bich, T...... 230 Bodini, G...... 115, 132, 147, Ben-Horin, S...... 47, 180, 182, 223 Bernardo, S...... 189, 198, 223. 242 Bidewell-Sullivan, J...... 138 184, 190, 223 Benamouzig, R...... 105, 220 Bernardoni, L...... 173 Biedermann, L...... 184 Bodnar, P...... 152 Bende, F...... 88, 117, 120, 163, Bernasconi, S...... 145 Biermann, K...... 174, 205, 235 Bodor, A...... 141 202, 208 Bernhard, S...... 241 Biesiekierski, J...... 53, 54, 59, 64, Boechat, P...... 220 Bendezu, A...... 187 Bernklev, T...... 56, 78 90, 102, 161, 197 Boecher, W...... 61 Bene, L...... 70, 137 Bernstein, C...... 100 Bilbao, I...... 129, 157, 171, 268 Boeckxstaens, G. E...... 55, 68, Benedetti, A...... 209 Berretti, D...... 157, 167 Bilder, C...... 53 78, 102 Benedetti, I...... 59, 232 Berstad, P...... 78 Bilhim, T...... 209 Boeriu, A...... 127 Bénéjat, L...... 194 Bertalot, T...... 151 Billard, E...... 221 Boermeester, M.A...... 41, 69, 84, Benelbarhdadi, I...... 152 Bertani, H...... 130 Billiet, T...... 56 106, 109

315 UEG Week Final Programme : Index of Authors and Co-Authors

Bogdanova, I...... 145 Bornschein, J...... 105, 192 Brackmann, S...... 223 Brown, V...... 168 Boger, P...... 216 Borody, T. J...... 57 Braegger, C...... 184 Brown-Clarke, C...... 138 Boggi, U...... 168 Borovicka, J...... 121, 159, 171 Bramli, S...... 197 Bruce, H...... 188 Bogie, R. M. M...... 73, 79, 104, Borowski, K...... 93 Branche, J...... 181, 225 Bruck, R...... 172 128, 157, 171 Borralho, P. M...... 52, 99, 141 Branchi, F...... 152, 205, 239 Bruckner, R...... 221 Boguszewska-Chachulska, A...206 Borrelli De Andreis, F...... 71 Branco, J...... 162, 207, 209 Brückner, M...... 222 Boguszewska-Czubara, A...... 124 Bortlik, M...... 70, 182, 183, Branco, J. C. E...... 220 Bruijnen, R...... 98 Boher, J.-M...... 50 226, 227 Brand, E. C...... 216, 217, 220 Bruining, D. H...... 136 Böhm, G...... 185, 229 Bortolato, C...... 151 Brandão, C...... 55, 184 Bruland, T...... 52 Böhn, L...... 46 Bortoli, A...... 183 Brandimarte, G...... 144 Bruley, S...... 60 Bohndiek, S...... 46, 50 Bortoluzzi, F...... 183 Branigan, P...... 93 Bruley des Varannes, S...... 60 Bohndiek, S. E...... 80 Bos, A...... 78 Branquinho, D...... 118, 174, 242 Brun, P...... 64 Bojkova, M...... 240 Bosch, J...... 200 Brasil, M. F...... 168 Brun, R...... 115, 131 Boka, V...... 145 Boschetti, E...... 87 Braun, S...... 137 Bruneau, M. M...... 154 Bokemeyer, B...... 47, 139, 182 Boskoski, I..... 71, 94, 210, 213, 220 Braverman, M...... 104 Brunet, J...... 229 Bokun, T...... 57, 65, 156, Boskovic, S...... 224 Brazeilles, R...... 143 Bruni, B...... 213 165, 187, 209 Bossa, F...... 204, 223 Brazowski, E...... 50 Brunner, T...... 109 Bolado, F...... 124 Bossuyt, P...... 47, 182 Bredenoord, A. J...... 190 Bruno, G...... 202, 229 Boland, C. R...... 51 Bossuyt, P. M...... 46, 73, 78, 140 Brennan, D...... 194 Bruno, M. J...... 69, 76, 77, 93, 106, Boldyreva, O...... 181 Bots, S...... 226 Brenner, H...... 128 108, 114, 123, 132, 157, Bollen, T...... 98, 114, 123 Bottai, M...... 105 Bresci, G...... 203, 213, 214 161, 171, 174, 197, 205, Bolstad, N...... 226, 227 Bou Jaoude, J...... 121 Bresciani, M...... 232 219, 228, 230,235, 236 Bolt, F...... 72 Boualit, M...... 181, 225 Bretagne, J.-F...... 135, 137, 171, 178 Bruno, M. S...... 151 Boltin, D...... 193 Boubaker, J...... 135, 139 Bretin, A...... 112, 133 Bruns, T...... 181, 187 Bomme, M...... 194 Boucekkine, T...... 224 Bretthauer, M...... 46, 84, 106, Bruns, C...... 48, 83 Bommelaer, G...... 116, 135, 160, 177 Boucelma, M...... 233 127, 271 Brusilovskaya, K...... 66 Bonariol, L...... 221 Bouché, O...... 220 Brezina, J...... 134 Brusnic, O...... 127 Bonaz, B...... 60, 181 Boudieu, L...... 232 Bridonneau, C...... 57 Brusselaers, N...... 65 Bonazza, D...... 118, 161 Boudjella, M. A. A...... 233 Brien, D...... 205, 239 Bruzzì, S...... 117 Bond, A...... 185 Bouguen, G...... 135, 137, 171, 178 Brierley, S. M...... 92, 98 Brzozowska, I...... 70, 189 Bonello, J...... 180 Bouhnik, Y...... 226 Brigatti, C...... 116, 145 Brzozowski, B...... 116, 133 Bonichon-Lamichhane, N...... 220 Boulant, J...... 197 Brigidi, P...... 86, 109, 112, 133 Brzozowski, T...... 70, 116, 189 Bonifacio, P. C...... 50 Bouma, G...... 43 Brincat, A...... 222 Bubnov, R...... 197 Bonilla, M...... 217 Bounab, N...... 224 Brindle, K...... 80 Buc, E...... 81 Bonior, J...... 94, 134, 211 Bouras, E. B. P...... 217 Brink, L...... 128 Bucci, C...... 152, 203, 213, 214, 216 Bonitatibus, A...... 152, 239 Boureille, A...... 137 Brink, M. A...... 46 Buchholtz, M.-L...... 158, 162 Bonnart, C...... 177 Bourke, M. J...... 49, 63, 77, 90, Briones-Fraga, S. L...... 177 Büchler, M...... 86 Bonnaud, G...... 226 101, 115, 127, Brito, D...... 80 Bucsics, T...... 78, 119, 156, 163, 164 Bonnet, R...... 112, 133, 221, 232 203, 215 Brito, H. M. D. S...... 51 Buda, A...... 172, 175, 176, 240 Bonora, E...... 87 Bourke, S...... 178 Brito, M. J...... 242 Buder, T...... 126 Bonsing, B. A...... 98 Bourlière, M...... 41, 61, 88 Britto-Arias, M...... 104 Budhiraja, S...... 133, 162 Bontems, P...... 47, 183 Bourrier, A...... 77 Brix, M...... 127 Budimir, I...... 146, 188, 233 Booras, D...... 223 Bousseloub, A...... 224 Brkljacic, B...... 156, 165 Budimir Yr, I...... 146, 188, 233 Bor, R...... 70, 99, 139, 146, Boustanai, I...... 203, 212, 240 Brodmerkel, C...... 72 Budkowska, M...... 211 147, 204, 219, 220, Boutaleb, A...... 224 Brodszky, V...... 70, 204, 225 Budovska, L...... 144 222, 224, 227 Boutarene, D...... 233 Broeders, I. A. M. J...... 106 Budzynska, A...... 183 Bor, S...... 113, 147, 235 Bouvier, D...... 160, 177 Broers, C...... 59, 113, 147 Buening, C...... 224 Borbély, Y...... 53 Bouviet, A...... 186 Broide, E...... 153 Bugajski, M...... 216 Borchert, K...... 137 Bouvy, N...... 53, 97 Brokstad, K. A...... 85 Buggisch, P...... 120 Bordaçahar, B...... 62, 159, 167 Bouzid, L...... 192 Broly, F...... 92 Bugianesi, E.... 83, 91, 108, 117, 201 Bordin, D...... 191 Bove, V...... 71, 94, 220 Brønstad, I...... 195 Buisson, A...... 72, 73, 81, 116, 135, Bordin, D. S...... 52, 89, 161, 193 Bovens, S. M...... 182 Bronzwaer, M...... 158 160, 177, 226 Borekci, E...... 210 Bower, L...... 105 Bronzwaer, M. E. S...... 185 Bujanda, L...... 56, 89 Borges, A. C. S...... 101 Bowlus, C...... 121 Brook, E...... 221 Bujanda Fernández Borges, V.... 154, 164, 187, 193, 208 Boyd, S...... 130 Brooklyn, T...... 129, 172 de Piérola, L...... 129 Borgheresi, P...... 214 Bozzani, A...... 53 Brot, L...... 81 Bukhari, M...... 51, 71, 87, 101, Bories, E...... 50, 51, 127, 130, 217 Brabant, S...... 225 Brouwers, E...... 47 161, 170, 174, Borin, A...... 203, 212 Brachman, Y...... 104 Brown, G...... 49 190, 211, 219 Born, T...... 181 Bracke, K. R...... 65 Brown, S...... 144 Bulajic, M...... 130, 157, 167

316 317 Index of Authors and Co-Authors : UEG Week Final Programme

Bunby, L...... 113, 143 Cadoni, S...... 72 Capannolo, A...... 116, 137, 238 Carroll, N. R...... 123 Bunkheila, A...... 239 Caetano, C...... 227 Capela, T...... 154, 164, 187, Carson, R. T...... 58, 113, 143, 144 Bunout, D...... 241 Cagol, M...... 132, 133, 191 193, 208, 209 Carter, C. R...... 168 Buntseva, O...... 192 Cahen, D. L...... 174 Capelli, E...... 215, 228 Carter, D...... 148, 187, 188 Buonadonna, A...... 142, 209 Cai, M...... 126 Capelli, M...... 215 Carter, R...... 114, 123, 168 Bureau, C...... 105 Cai, Z...... 103 Capelli, P...... 177 Carucci, P...... 209 Bures, J...... 189 Caiazzo, B...... 60 Capitán, D...... 151 Caruso, A...... 142, 151, 228 Burganova, G. R...... 118 Caillol, F...... 50, 98, 127, 130, 217 Capobianco, D...... 144 Carvalhana, S..... 103, 163, 189, 198 Burger, D...... 135 Cainap, C...... 156, 165 Capoluongo, E...... 151 Carvalho, B...... 79 Burgess, N...... 49, 115 Cainap, S...... 166 Capone, P...... 151, 196 Carvalho, C. C...... 99 Burgos, A...... 157, 171 Cakerri, L...... 191 Caporaso, N...... 77, 90, 151, 196 Carvalho, D...... 183 Burisch, J...... 77, 85, 100, 112, Calabrese, E...... 56, 116, 135, 136 Cappello, M...... 183, 202, 232 Carvalho, F. A...... 232 116, 134, 178, 180, Calafat Sard, M...... 180 Capuani, G...... 144 Carvalho, J...... 119, 131, 144, 157, 187, 204, 222, 224 Calament, M...... 209 Capurso, G...... 95 167, 175,179, 198, Burke, A...... 72 Calavas, L...... 126 Carabotti, M...... 64, 116, 145 202, 219, 220,224, Burkitt, M. D...... 184 Caldeira, A...... 155, 198, 219 Carapelle, M...... 228 229, 233, 320 Burkov, S...... 89 Caldeira, P...... 136 Carapina, M...... 118 Carvalho, J. R...... 123, 165 Burns, A. J...... 46 Calì, A...... 71 Caratozzolo, E...... 221 Carvalho, L...... 127, 164, 199, 218 Burns, L...... 230 Calia Di Pinto, F...... 221 Carboneli, J...... 72 Carvalho, R...... 119, 123, 165, Burr, N...... 72 Calinas, F...... 164, 208 Carbonnel, F...... 41, 47, 56, 68, 75 207, 220 Burra,P...... 49, 67 Calleja, J. L...... 128, 172 Card, T...... 73, 202, 206 Carvalho, S...... 184 Burrell, L. M...... 105 Calligaris, R...... 66 Cardenas, A...... 104, 107,173, 218 Carvalho, T...... 198 Busby-Whitehead, J...... 98 Calligaris, S...... 166 Cardoso, H...... 119, 120, 163, 165, Casale, R...... 120 Buscail, L...... 98 Calpe, J...... 161, 196 175, 196, 199, 219 Casals, G...... 217 Buscarini, E...... 203, 213, 214 Calpe, S...... 80 Cardoso, M...... 199 Casanova, J.-P...... 127 Busch, A...... 174 Calvi, A...... 153 Cardoso, M. F...... 207 Casanova Ortiz, L...... 141 Busch, O. R. C...... 98, 168 Calviño-Suárez, C...... 174 Cardoso, R...... 126, 199, 242 Casciani, E...... 175, 183 Buskens, C. J...... 46, 73 Calvo, M...... 225 Cardoso, T...... 209 Casellas Jorda, F...... 196 Buskermolen, M...... 74 Camacho, E...... 174, 218 Cariani, G...... 130 Casén, C...... 81, 143 Busquets Casals, D...... 138 Cameron, G...... 235, 236 Caridade, M...... 99 Caserta, L...... 183 Bussmann, C...... 190, 191 Cameron, J. L...... 176 Cariou, M...... 209 Casimiro, C...... 154 Bustamante, M...... 157, 171 Cameron, S...... 72 Carlo Pescatori, L...... 120 Casneuf, V...... 74 Bustamante-Balén, M...... 173 Camhi, S...... 239 Carlos, S...... 242 Carotti Cassaro, M...... 191 Bustamante-López, L...... 240 Camilleri, M...... 58 Carlsen, A...... 180, 226, 227 Cassieri, C...... 182 Busto, V...... 176 Cammarota, G...... 64, 81, 88, 109, Carlsen, K...... 134 Castagliuolo, I...... 64, 191, 228 But, D. Y...... 63 134, 151, 179, Carlsson, P...... 73 Castanheira, A...... 119, 154, 155, Butler, A. J...... 87 228, 229 Carmignani, L...... 213 198, 199, 207, 242 Butler, P...... 188 Camo, P...... 70 Carmo, J...... 127, 164, 199, 218 Castela, J...... 142, 157, 171, 172 Butov, M. A...... 191 Campbell, B...... 184 Carmo Vieira, A...... 227 Casteleyn, C...... 65 Buzas, C...... 214 Campo Fernandez, R...... 157, 171 Carmona, R...... 133 Castellaneta, N. M...... 207 Buzga, M...... 240 Campos, F. G...... 240 Carneiro, F...... 54, 63, 79 Castells, A...... 77, 179 Buzinec, P...... 144 Campos, S...... 183, 242 Caroli-Bosc, F.-X...... 128 Castera, L...... 61, 108, 156 Byeon, J.-S...... 140, 186, 270 Camprubí, C...... 74, 178 Carotti, S...... 144 Castiella Eguzkiza, A...... 119 Byrne, M. F...... 107 Camus, M...... 62, 174, 219 Carpio, G. C. A...... 242 Castiglione, F...... 56, 77, 90, Canbakan, B...... 161, 178 Carr, R...... 129 138, 224 Cancela, E...... 119, 126, 154, 155, Carrara, S...... 142, 168, 175, Castoro, C...... 132, 133, 142, 191, C 198, 199, 207, 242 176, 213, 234 221, 228 Caamano, J...... 184 Candela, M...... 112, 133 Carrasco, A...... 161, 196 Castro, B...... 223 Caballero de Garcia, E. N...... 234 Candrlic, B...... 184 Carrasco, E...... 229 Castro, J...... 98 Caballero-Mateos, A...... 99, 189 Canhoto, M...... 207 Carrat, F...... 56 Castro, L...... 181 Caberlotto, C...... 133 Cannito, S...... 117, 209 Carrera, P...... 70, 87, 185, 230 Castro, M...... 52, 178, 181 Cabibbo, G...... 209 Cannizzaro, R...... 52, 142, 192, Carrera Alonso, E...... 134 Castro, R...... 187, 219 Cabral, 205, 237 Carretero, C...... 142, 219, 239 Castro, R. E...... 51, 52, 99, 118, 141 J. G. G. G. D. A. L...... 124, 168 Cano, J. M...... 229 Carrier, P...... 169, 170 Castro, V...... 53, 187 Cabré, E...... 139, 180, 221 Canto, M. I...... 55, 62, 69, 97, 235 Carrière, J...... 93 Catalano, G...... 113, 130, 148 Cabriada Nuño, J. L...... 56, 217 Cantù, P...... 130 Carrillo, M...... 87 Catania, A...... 205, 239 Cabrijan, Z...... 226 Canzonieri, V...... 142 Carrillo Palau, M...... 230 Cattan, S...... 181 Caca, K...... 61, 82, 96, 125, 248 Cao, J...... 212 Carrington, E...... 187 Cauchin, E...... 186 Cadime, A. T...... 80 Cao, Q...... 226 Carrington, E. V...... 98 Causada Calo, N...... 81

317 UEG Week Final Programme : Index of Authors and Co-Authors

Cava, M...... 168 Chang, J. S...... 188 Chernov, V...... 117, 150 Choi, H. S...... 142, 151, 159, 169, Cavalcoli, F...... 145, 152, 240 Chang, L...... 48, 60, 74, Chervinska, T...... 229 175, 204, 211, 213, 220 Cavalieri, D...... 228 94, 98, 283 Chesters, M...... 188 Choi, J...... 47, 127, 159, 173, Cavallaro, F...... 203, 204, 213, Chang, L.-C...... 157, 171 Chetcuti, S...... 180, 222 193, 210, 218, 237 214, 223 Chao, C.-Y...... 112, 133, 135, 198 Chetcuti Zammit, S...... 222 Choi, J. H...... 135 Cavallaro, L. G...... 172 Chao, K...... 226 Cheung, D. Y...... 93, 186 Choi, J. W...... 123 Cavallin, F...... 132, 133, 142, 191 Chapados, N...... 107 Chew, W...... 144, 217 Choi, J. Y...... 172, 201, 241 Cavazza, A...... 148 Chaparro, M...... 56, 138, 178, 182 Chey, W. D...... 86 Choi, M. H...... 123, 159, 173, 218 Cave, D...... 79, 219 Chaput, U...... 219 Chia, C...... 192, 235 Choi, M. S...... 121 Cavina, M...... 174, 237 Chardiny, V...... 222 Chia, C. T. W...... 168 Choi, M.-G...... 93, 123, 139, 186, Cea Soriano, L...... 184 Charles, M...... 195 Chiaramonte, C...... 136 188, 197, 237 Cea-Calvo, L...... 139, 181, 225 Charnley, R...... 114, 123 Chiarioni, G...... 39, 98,186, Choi, S. C...... 188 Ceccarelli, C...... 230, 231 Charpentier, C...... 89 187, 204 Choi, S. H...... 201, 241 Cecinato, P...... 174, 237 Charpentier, J...... 200 Chiba, H...... 129, 142, 231 Choi, S. W...... 149 Cejna, M...... 119, 163 Charro, M...... 56 Chiba, M...... 150 Choi, W...... 59, 106, 123, Cela, A...... 161, 196 Charrua, B...... 218 Chibai, M...... 239 142, 149, 170 Celikbilek, M...... 119, 210 Chassaing, B...... 81, 185 Chieco, P...... 112, 133 Choi, Y...... 121, 122, 188, 201, 241 Cellier, C...... 128 Chatterjee, P...... 70 Chiesara, F...... 164 Choi, Y. J...... 47, 189, 193, 237 Cen, C...... 88 Chauhan, A...... 178 Chikugo, T...... 174 Cholet, F...... 137, 197 Cenac, N...... 87 Chaussade, S...... 62, 137, 174, Chin, Y. K...... 131 Choong, L. M...... 136, 179 Cennamo, V...... 198 219, 236 China, L...... 187 Choudhary, S...... 191 Cenzi, C...... 151 Chaves, P...... 185, 198, 217, 229 Chino, A...... 128, 221 Choung, S.-Y...... 193, 209 Ceranowicz, D...... 134 Chaves Marques, S...... 199 Chiorean, M...... 223 Chow, W. C...... 133, 207 Ceranowicz, P...... 94, 134, 211 Chavez, Y. H...... 71, 87, 101 Chiriac, G...... 119 Chowdhury, S...... 168 Ceranto, E...... 104 Chavez-Rivera, K..170, 173, 174, 211 Chirico, A...... 203, 213, 214 Chowers, Y...... 47, 94, 107, 180, Cerbu, S...... 242 Chayama, K...... 158, 185, 193 Chiu, C.-T...... 150, 153 182, 223, 270 Cerofolini, A...... 130 Chazouilleres, O...... 40 Chiu, H. M...... 157, 171 Christ, C...... 160, 179 Cesaro, P...... 214 Chedgy, F. J. Q...... 101, 104, 127, Chiu, P. W. Y...... 213 Christein, J...... 129 Cesbron Metivier, E...... 128 . 140, 142, 148, 170, Chmielowiec- Christiaens, P...... 205, 235 Cesmeli, E...... 159, 167 214, 235, 236 Korzeniowska, A...... 112, 133 Christodoulou, D. K...... 134 Cetin, Z. E...... 235 Chedgy, F. J. Q. J...... 49, 79 Chmura, A...... 189 Christopher, B...... 227 Ceulemans, A...... 99 Chehade, M...... 190 Cho, C.-M...... 123, 130, 174, 176, 212 Chromy, D...... 78 Ceyhan, G. O...... 158 Chen, C. Y...... 149 Cho, D. H...... 175, 210, 211 Chu, M. S...... 197 Ch‘ng, C...... 209, 239 Chen, C.-L...... 147, 234 Cho, G. S...... 192 Chu, Y...... 62, 126, 199 Cha, B.H...... 218 Chen, H...... 49, 138, 165, 230 Cho, J...... 106, 122, 142, Chueh, T.-H...... 208 Cha, S.-W...... 159, 173, 210, 218 Chen, H.-P...... 209 149, 170, 237 Chuman, K...... 169 Chaber-Ciopinska, A...... 127 Chen, H.-Z...... 169 Cho, J. H...... 217 Chun, H. J...... 59, 106, 142, 151, Chabrun, E...... 233 Chen, J.-M...... 159, 167 Cho, J. Y...... 148, 192 159, 175, 211 Chackelevicius, C. M...... 161 Chen, K...... 240 Cho, J.-H...... 237 Chun, H. Jai ...... 204, 213, 220 Chackelevicius, C...... 118 Chen, N...... 183 Cho, J.-W...... 188 Chung, C...... 116, 141, 150 Chaddock, G...... 186 Chen, P.-Y...... 195 Cho, K. B...... 123, 130, 148 Chung, D. C...... 116, 141 Chae, H. B...... 122, 188 Chen, T...... 59, 65, 126 Cho, M. K...... 218 Chung, H...... 149, 193, 215, 237 Chae, H.-S...... 184 Chen, T.-H...... 153 Cho, S. K...... 121 Chung, I. H...... 193 Chagas, C...... 104,127, 154, 164, Chen, W...... 99, 126, 179, 234 Cho, T...... 141 Chung, I.-K...... 49, 195, 198 199, 218 Chen, W. C...... 217 Cho, Y. D...... 159, 173, 210, 218 Chung, J.-W...... 150, 217 Chalhoub, J. M...... 229 Chen, X...... 212 Cho, Y. H...... 214 Chung, Y. F. A...... 133 Chalupa, J...... 74, 231 Chen, Y...... 118, 134, 149, Cho, Y. K...... 162, 201, 241 Chung-Faye, G...... 104, 136, 138, Chambon-Augoyard, C...... 173, 216 178, 181, 228 Cho, Y. S...... 49, 195, 198, 237 179, 181 Chan, A. T...... 50, 97 Chen, Y.-I...... 51, 71, 87, 219 Cho, Y.-S...... 93, 139, 186 Chuttani, R...... 240 Chan, D...... 61 Chen, Y.-J...... 168 Chodick, G...... 135, 139 Ciacci, C...... 90, 102, 152, 234 Chan, H. L. Y...... 219 Chen, Z...... 99 Choe, J. W...... 174, 212, 233 Ciafardini, C...... 145 Chan, H. S...... 188 Cheng, C.-Y...... 197 Choi, B. K...... 142, 151, 159, 169, Cibor, D...... 223 Chan, Y...... 219 Cheng, H. R...... 73, 128 175, 204, 211, 213, 220 Cicala, M...... 57, 105, 144, 234 Chandelier, F...... 107 Cheng, J...... 214 Choi, C...... 106, 122, 142, 149, Ciccocioppo, R...... 196 Chang, C.-H...... 146 Cheng, L.-S...... 72 170, 188, 237 Ciccone, F...... 238 Chang, C.-Y...... 78 Cheng, S...... 50 Choi, C. H...... 201, 241 Cicenia, A...... 64 Chang, D...... 168 Cheon, J. H...... 135, 136, 227 Choi, E. K...... 188 Cicerone, C...... 202, 229 Chang, D. K...... 201, 241 Cheow, P. C...... 133 Choi, H. H...... 93, 184, 186 Cichy, L...... 234 Chang, H.-T...... 169 Chernin, E...... 223, 226 Choi, H. J...... 159, 173, 210, 218 Cid, L...... 157, 171

318 319 Index of Authors and Co-Authors : UEG Week Final Programme

Cidoni, F...... 186 Colussi, D...... 229 Costa, T. B. E...... 164 Cunningham, D...... 72 Ciemniejewska, E...... 81, 143 Compernolle, G...... 47, 227 Costa Santos, M. P...... 173, 199 Cuomo, G...... 135 Cieszkowski, J...... 211 Conigliaro, R. L...... 130, 203, 214 Costa-Moreira, P...... 212 Cuomo, R...... 64 Cijevschi Prelipcean, C...... 162 Conjaerts, S. H. P...... 85 Costamagna, G...... 55, 71, 75, 89, Curcio, G...... 131 Cilluffo, M. G...... 202 Conlon, K...... 168 94, 101, 130, 159, Cúrdia Gonçalves, T...... 166, 175, Cimadevilla, A...... 223 Connolly, J...... 230 171, 203, 210, 213, 180, 241 Cimatti, M. C...... 234 Connor, S...... 57 214, 217, 220 Curic, J...... 156, 165 Cimminiello, C...... 231 Conroy, G...... 187 Costanza, V...... 204, 223 Curtis, R...... 182 Ciotola, F...... 53 Consonni, D...... 146 Costigan, C...... 186 Curvers, W. L...... 79, 80 Cipelli, R...... 105 Constanço, C...... 198 Cotrim, I...... 207 Cvancarova, M. S...... 85, 223 Cipolletta, F...... 203, 213, 214 Constantin, A...... 146 Cotteau-Leroy, A...... 181 Cvetko, D...... 156, 165 Cipolletta, L...... 130, 203, 213, 214 Constantinescu, G...... 146 Cotter, J...... 63, 131, 164, 166, 175, Cybulski, M...... 114, 123 Cipriano, M...... 242 Consten, E...... 46 180, 199, 241 Cyrany, J...... 140, 141 Ciria Avila, J. A...... 101 Consten, E. C. J...... 102, 106 Cottone, M...... 139, 227 Czakó, L...... 123, 219, 220 Cisarò, F...... 113, 148 Conte, D...... 130, 145, 146, 152, Coughlin, O...... 186 Czech, U...... 211 Ciuca, I...... 166 203, 205, 213, 214, Coupé, V. M. H...... 78, 159, 171 Czechowska, G...... 124 Civitelli, F...... 72, 85, 175, 183 233, 239, 240 Couquet, C.-Y...... 169, 170 Czelecz, J...... 166 Clark, M...... 181 Conti Bellocchi, M. C...... 173 Courillon-Mallet, A...... 89 Czimmer, J...... 123 Clark, S. K...... 181 Cook, H...... 81 Couvelard, A...... 159, 167 Clarke, P...... 188 Cooke, J...... 230 Covington, P. S...... 86 Claro, I...... 157, 171, 172, 185, Cooney, R...... 73, 181 Cowppli-Bony, A...... 192 D 217, 229, 230 Cooper, J...... 46 Cox, C...... 98 D‘Abrosca, V...... 135 Clayton, L. B...... 104, 129, 216 Copaci, I...... 119 Cox, E...... 186 D‘Albuquerque, L. A. C...... 56 Clemente, C...... 213 Corazza, G. R...... 59, 232 Craig, P. I...... 174 D‘Amato, M...... 72, 87, 93 Clemente, J...... 57 Corazziari, E. S...... 182, 202, 229 Cramer, H...... 138 D‘Ambrosio, C...... 164 Clementi, M...... 140 Corbett, G...... 129 Cravets, M...... 62 D‘Amico, G...... 203, 213, 214 Clemons, N...... 80 Corcoran, K...... 220 Cravo, M...... 173, 199 D‘Angelo, R...... 87 Clerc, C...... 220 Cordes, F...... 222 Cremer, A...... 44, 85, 104 D‘Angelo, S...... 209 Clevers, E...... 58 Cordes, M...... 79 Cremers, I...... 25, 53, 164 D‘Arcangelo, G...... 183 Cleynen, I...... 56 Cordonnier, C...... 74 Cremon, C...... 228 D‘Assuncao, M. A...... 121 Clos, A...... 139 Corfe, B. M...... 134, 185 Crespo, G...... 173, 218 D‘Aversa, F...... 81, 229 Close, H...... 186 Coriat, R...... 62, 174, 220 Crespo, J...... 223 D‘Errico, F...... 207, 232 Cocca, S...... 57, 105, 144 Cornean, R...... 166 Crespo, P...... 154 D‘Haens, G...... 44, 46, 88, 89, Coche, J.-C...... 47, 183 Cornillie, F...... 225 Criblez, D...... 159, 171 107, 226, ,285 Cocozza, S...... 231 Coron, E...... 172, 284 Crinó, S. F...... 173 D‘Haens, G. R...... 61 Coelho, A...... 144 Correia, A...... 80, 132, 179, 182, Crispino, P...... 182 D‘Haens, G. R. A. M...... 46, 62, 73, Coelho, D...... 114, 123 194, 198, 223 Crocè, L. S...... 66 137, 182, 226 Coelho, R...... 93, 120, 126, 165, Correia, L. A...... 132, 179, 182, 194, Croft, N. M...... 90 D‘Inca, R...... 56, 73, 151, 228 187, 212, 219 198, 223 Croitoru, K...... 177, 195 D‘Souza, P. M...... 218 Coenen, S...... 225 Correia, M...... 209 Crook, J. E...... 216 da Costa, G...... 57 Coffin, B...... 60 Correia-Sousa, J. T...... 207 Crooks, B...... 183 da Luz Rosa, I. A...... 230 Cogan, Y...... 172 Corrente, V...... 192, 205, 237 Crooks, C. J...... 73 Da Roit, A...... 148 Cohen, S...... 175 Corsetti, M...... 40, 82, 95 Cross, S. S...... 239 da Silva, A...... 138 Cohen-Kedar, S...... 94 Corte, C...... 72 Crowther, S...... 152 da Silva, J. P...... 128, 142, 149 Coimbra, É...... 209 Corte-Real Nunes, A...... 126 Crucinio, N...... 209 Dabizzi, E...... 168 Cojocaru, M. L...... 182 Cortelezzi, C...... 183 Crudeli, A...... 172 Dabkowski, K...... 211 Colecchia, A...... 121, 153 Cortés Gil, X...... 113, 143 Csabai, I...... 141 Daegon, R...... 106, 122, 142, Collados, C...... 236 Cortez-Pinto, H...... 39, 66, 91, 99, Csefko, K...... 123 149, 170, 237 Colle, I...... 56, 65 103, 107, 163, Cseko, K...... 94 Daejin, K...... 130 Collin, L...... 46 194, 198, 201 Csonka, A...... 204, 223 Dahan, A...... 181 Collin, P...... 151 Cortez-Pinto, J...... 157, 171 Csontos, A. A...... 137, 180 Dahan, L...... 51 Collins, M...... 81, 97 Corwin, C...... 196 Csupor, D...... 94 Daher, S...... 182 Collins, S. M...... 81 Cosin-Roger, J..... 92, 100, 105, 134 Cubas, V...... 101 Dahl, B...... 114, 123, 159, 167 Colmenero, J...... 173, 218 Coslovsky, M...... 190 Cubiella, J...... 229 Dahlerup, J. F...... 77 Colombatti, A...... 52 Cosnes, J...... 73, 77 Cucchiara, S...... 72, 85, 153, Dahmani, W...... 224, 227 Colombatto, S...... 209 Cossignani, M...... 116, 135 175, 183 Dai, C...... 210 Colombel, J.-F...... 47, 57, 68, 70, Costa, F...... 183, 187 Cui, S.-J...... 185 Dai, N...... 144 82, 89, 182, 222, 225 Costa, I...... 86, 94 Cukovic Cavka, S...... 77 Dai, Y...... 232 Colombo, M...... 130 Costa, P...... 104, 164, 198 Cundall, J...... 186 Daike, R...... 215

319 UEG Week Final Programme : Index of Authors and Co-Authors

Dakó, S...... 180 de Filippo, C...... 228 de Silva, A. P...... 201, 206 Delli Pizzi, A...... 87, 132 Dal Ben, M...... 166 de Filippo, F. R...... 203, 213, 214 de Silva, H. J...... 201, 206 Dellon, E...... 97, 190 Dal Bo‘, N...... 205, 237 de Franchis, R...... 203, 213, 214 de Silva, S. T...... 201, 206 Deloose, E...... 59, 160, 189 Dal Borgo, C...... 203, 212 de Francisco Garcia, R...... 138 de Simone, C...... 225 Delpero, J. R...... 217 Dal Monego, S...... 66 de Gara, L...... 105 de Sordi, L...... 57 Delport, F...... 223 Dal Pont, E...... 172 de Gasperi, S...... 148 de Souza, T. F...... 50, 242 Demanzini, N...... 118, 161 Dalekos, G...... 120 de Geus, S. W. L...... 60 de Stefano, G...... 209 Demarco, D...... 79 Dall‘Oglio, L...... 62, 148, 248 de Giorgio, R.... 78, 87, 91, 102, 184 de Teresa, J...... 99, 189 DeMartino, S...... 168, 192 Dall‘Olio, F...... 230, 231 de Gottardi, A...... 99 de Vallée, A...... 57 Dembinski, A...... 134, 211 Dall‘Olmo, L...... 191 de Graaf, E. J. R...... 102, 158, 185 de Valliere, C...... 134 Dembinski, M...... 211 Dalla Piccola, B...... 57 de Greef, E...... 47, 183 de Vallière, C...... 92, 100 Demchenko, O. M...... 197 Dalla Valle, L...... 151 de Groof, A. J...... 46, 73 de Villiers, W...... 116, 137 Demcsák, A...... 166 Dalmasso, G...... 112, 133 de Hertogh, G...... 80, 205, 235 de Vita, F...... 209 Demedts, I...... 128 Dalton, H. R...... 103 de Hingh, I. C...... 102 de Vos, M...... 46, 47, 82, 182, 183 DeMicco, M...... 104 Dam, R. V...... 98 de Jong, K...... 98 de Vries, A. C...... 161, 197 Demir, A...... 204, 218 Dam-Larsen, S...... 96 de Jong, M. J...... 85 de Vries, J. J. J...... 98 Demir, M...... 173 Dan, I...... 208 de Jonge-Muller, E. S. M...... 221 de Vries, S. D. J...... 79 Demuth, D...... 139, 182 Danese, S...... 57, 61, 70, 82, 160, de Juan, M. D...... 119 de Weerdt, V...... 138 Denadai-Souza, A...... 177 180, 183, 204, 225, de Koning, H...... 74 de Wit, N. J...... 85 Denaxas, K...... 205, 234 226, 283, 284, 286 de la Coba, C...... 89 de Wit, S...... 182 Deng, J...... 134 Dang, Y...... 151, 194 de la Iglesia-García, D...... 94, 131, de With, P...... 80 Denis, A...... 203, 215 Daniel, C...... 198 174 De-Leon-Rendon, J...... 177 Denizot, J...... 74, 221 Daniele, B...... 209 de la Llama, N...... 103 de-Madaria, E...... 68, 124 Denley, S...... 168 Danila, M...... 88, 114, 117, 120, 156, de la Maza, M. P...... 241 Deacon, J...... 148 Dent, H...... 241 163, 165, 202, 208 de la Mora, G...... 49 Dear, B...... 64 Depoortere, I...... 59, 64, 160, 189 Dankner, R...... 197 de la Morena, F...... 178 Debarbieux, L...... 57 Deprez, P. H...... 58, 62, 69, 79, 80, Dantas, E...... 164 de la Poza, G...... 157, 171 Debette-Gratien, M...... 169 95, 99, 167, 205, 235 Daperno, M...... 56 De La Revilla Negro, J...... 157, 171 Decarli, N. L...... 174 Deraison, C...... 177 Dapoigny, M...... 60 de La Serna Higuera, C.....131, 176, Decembrino, F...... 174, 237 Derakhshan, M...... 52, 168 Darzi, A...... 72 204, 220 Decimoni, T...... 139 Derek, L...... 209 Das, S...... 201, 228 de Lange, T...... 78, 188 Deckers, L...... 222 Derenzini, M...... 230, 231 Dassanayake, A. S...... 201, 206 de Leusse, A...... 197 Decsi, T...... 166 Derikx, L...... 77 Dastych, M...... 231, 236 de Looze, D...... 80, 205, 235 Dede, K...... 52 Derova, J...... 138 Date, S...... 214 de Man, M...... 74 Dedeu, J. M...... 216, 217 Derovs, A...... 57, 134 Datsenko, O...... 225 de Manzoni, G...... 54, 160 Dedja, A...... 191 Derrien, M...... 81, 143, 228 Datz, C...... 185 de Maria, C...... 223 Deflorio, V...... 222 Desai, A...... 130 Daugule, I...... 151 de Mascarel, A...... 192 Degasperi, S...... 194 Desai, P...... 71, 169 Dauth, W...... 127 de Matthaeis, M...... 203, 213, 214 Degen, A...... 224 Desai, P. N...... 122 Dauvarte, H...... 57, 134 de Mestier, L...... 44 Dehghani, S. M...... 164 Desfourneaux, V...... 137 Davidson, H. W...... 116, 145 de Moura, D. T. H...... 101 Deibert, P...... 66 Desilets, D...... 71 de Alessandri, A...... 153 de Moura, E. G. H...... 50, 101, 240 Dejong, C. H. C...... 131 Desjeux, A...... 144 de Amici, M...... 59 de Moura, E. T. H...... 101 Dekker, E...... 50, 54, 55, 73, 77, Desmond, P...... 235, 236 de Angelis, P...... 184 de Nigris, F...... 203, 213, 214 78, 84, 102, 140, 141, Desomer, L...... 49, 115, 127, de Bastiani, R...... 53 de Nitto, D...... 182 158, 159, 171, 185 203, 215 de Biase, D...... 198 de Novellis, V...... 64 Del Chiaro, M...... 114, 124, 160, 176 Desormeaux, C...... 87 de Boer, Y...... 43 de Nucci, G...... 157, 171 Del Chierico, F...... 57, 138 Desreumaux, P...... 57, 222, 225 de Bona, M...... 172, 240 de Padova, A...... 134 Del Cotto, F...... 239 Desseyn, J.-L...... 222 De Boni, M...... 172, 240 de Palma, G...... 81 del Genio, G...... 115, 132 Deterding, K...... 61 de Bortoli, N...... 58, 97, 115, de Palma, G. D...... 90, 224 Del Gobbo, A...... 240 Detjen, K. M...... 60, 168 132, 147, 187, de Paoli, A...... 142 Del Pozo-García, A...... 124 Detlie, T. E...... 223 190, 194, 234 de Páramo, B. J...... 139, 181, 225 Del Prete, A...... 231 Deutsch, M...... 165 de Bruyn, J...... 73 de Pastena, M...... 175 Del Río Izquierdo, M...... 129 Devani, M...... 157, 171 de Caestecker, J...... 79 de Pretis, G...... 128 Del Tedesco, E...... 70, 216 Devereaux, B...... 63 de Cassan, C...... 127 de Re, V...... 142 Delchier, J.-C...... 52, 89 Deviere, J..... 49, 54, 61, 68, 75, 82, de Castro, L...... 157, 171 de Reuver, P. R...... 65, 166 Deleanu, A...... 208 85, 90, 146, 203, 213 de Chaisemartin, C...... 130, 217 de Ridder, R...... 73, 104 DeLeuran, T...... 202, 206 Devisscher, L...... 65 de Cobelli, F...... 168 de Rooij, T...... 98, 168 Delhaye, M...... 41, 68, 159, 167 Devitt, P...... 139 de Falco, L...... 151 de Salvo, C...... 222 Dell’Era, A...... 203, 213, 214 Devroey, B...... 154 de Fanis, A...... 203, 213, 214 de Schepper, H...... 187 Della Coletta, M...... 53, 147, 190 DeWit, O...... 47, 183

320 321 Index of Authors and Co-Authors : UEG Week Final Programme

DeWitt, J...... 50 Dijkgraaf, M. G...... 98, 102, 114, Doré, J...... 228 Durivage, G...... 186 Dexheimer, C...... 163 123, 166, 168 Dorofeyev, A...... 138, 225 Durkovicova, Z...... 170 Dhakhwa, R...... 139 Dilillo, A...... 72, 85 Dorwat, S...... 71, 169 Duthie, F...... 168 Dhaliwal, A...... 154 Dimarco, M...... 139, 227 Dos Santos, J. S...... 124 Duvalko, A...... 221 Dhar, A...... 148, 191 Dimidi, E...... 98 Dos Santos, M. E. L...... 50 Duvall, A...... 212 Dharamsi, S. R...... 207 Dimitroulopoulos, D...... 101 Doseth, B...... 52 Duveau, N...... 181, 225 Dhooghe, B...... 182 Dinelli, M...... 216 Doshi, J. A...... 144 Duvnjak, M...... 209 Di Biase, A. R...... 153 Ding, N. S....116, 135, 181, 205, 225 Dotan, I...... 41, 44, 88, 94, 107, Dvir, R...... 140 Di Camillo, S...... 172 Ding, X...... 204, 221 139, 180, 182, 222 Dwarkasing, R. S...... 98 Di Carlo, E...... 52 Ding, Z...... 168 Douane, F...... 186 Dyer, N...... 184 Di Costanzo, G. G...... 209 Dinis-Ribeiro, M...... 39, 48, 55, Douda, T...... 189 Dzerve, V...... 237 Di Giorgio, P...... 203, 213, 214 59, 68, 85, 96, 126, Dousset, B...... 81 Dziewas, R...... 42 Di Giulio, E...... 203, 213, 214 184, 188, 215, 248 Dovbynchuk, T...... 229 Dziki, A...... 133, 221 Di Leo, A...... 196, 207, 222, 232 Dinjar, P...... 209 Dove, L. S...... 86 Dziki, L...... 133, 221 Di Leo, G...... 120 Dino, P...... 228 Doyama, H...... 80, 115, 125 Di Leo, M...... 142, 168, 175, Dinya, T...... 163 Draaisma, W. A...... 106 176, 213, 234 DiTaranto, A...... 53 Draganov, P. V...... 71, 79 E Di Liddo, R...... 151 Dixit, V. K...... 162 Dragoi, D...... 158, 162 East, J. E...... 55, 77, 102, 106 Di Maira, G...... 209 Djenidi, F...... 72 Dranga, M...... 162 Eberhardson, M...... 226 Di Mambro, A...... 143 Dlouha, D...... 202, 206 Dranitzina, A...... 229 Eberlin, M...... 196 Di Mario, F...... 192, 205, 237, 238 Dmitrieva, N...... 98 Drastich, P...... 134, 164 Ebi, M...... 58, 129, 238 Di Martino, L...... 222 Dobashi, A...... 126 Dray, X...... 175, 219 Ebling, Z...... 141 Di Maso, M...... 120, 124, 209 Dobbels, P...... 74 Dray-Spira, R...... 47, 56 Echarri Piudo, A...... 138 Di Matteo, F. M...... 174 Dobos, G...... 138 Dreesen, E...... 47, 138, 227 Eckel, R...... 184 Di Maurizio, L...... 130 Dobrin, R...... 72 Dreher, B...... 120 Eder, S...... 185 Di Mitri, R...... 56, 130, 204, 223 Dobru, E. D...... 54, 99, 127 Drenth, J...... 208 Edir, A...... 177 Di Nicolantonio, F...... 79, 86, 103 Dobrucali, A. M...... 161 Drenth, J. P. H...... 42, 56, 65, Efferth, T...... 204, 221, 222 Di Pietro, M...... 38, 50, 63, 80 Docimo, L...... 115, 132, 234 67, 83, 90, 103 Efthymakis, K...... 152, 239 Di Ruscio, M...... 116, 137, 238 Doctor, N...... 114, 123 118, 165, 166, 197, 216 Egan, R...... 68, 88, 175 Di Sario, A...... 130 Dogan, I...... 146 Drewe, J...... 59 Egawa, S...... 195 Di Stasio, E...... 88, 166 Doglioni, C...... 174 Drewes, A. M...41, 48, 85, 167, 235 Egberts, J.-H...... 52 Di Stefano, M...... 59, 232 Dohi, O...... 59, 65, 125, 170 Drobne, D...... 69, 107, 160 Egea Valenzuela, J...... 239 Di Tommaso, L...... 168 Doi, A...... 140 Drossman, D....25, 48, 60, 94, 108 Eggert, T...... 49 Diakopoulos, K. N...... 60 Doi, S...... 115, 124 Duan, L...... 146 Egorov, V. I...... 124, 167 Dias, C. C...... 59 Dokladanska, A...... 128 Duan, L.-P...... 81, 191, 228 Eguchi, T...... 52, 167 Dias De Castro, F...... 63 Dolak, W...... 25, 58, 163, 218 Duarte, A...... 99 Eichhorn, I...... 168 Dias Pereira, A...... 128, 133, 142, Dolegowska, B...... 211 Duarte, P...... 154 Eichner, S...... 182, 225 149, 157, 171, 173, 185, Dolina, J...... 191, 236 Dubale, N. A...... 115, 125, 167, Einarson, T...... 139 198, 217, 224, 229, 230 Domagala-Rodacka, R...... 223 169, 210, 214 Einwächter, H...... 60 Diaz, H...... 180 Domagk, D...... 55, 74, 96 Dubois, A...... 160, 177 Eisa, M...... 130 Diaz, M...... 77 Domènech, E...... 56, 139, 180, 181, Dubois, P...... 136, 138, 179, 181 Eisendrath, P..... 41, 68, 75, 82, 128 Díaz, F. C...... 173 221, 225 Dubravcsik, Z...... 203 Eissa, N...... 100 Diaz-Guerra, A...... 178 Dominguez, F...... 157, 171 Ducons García, J...... 157, 171 Ejima, F. H...... 188 Díaz-Hernández, L...... 131 Dominguez-Jimenez, J. L...... 194 Ducournau, A...... 194 Ejima, G. W...... 188 Dib, N...... 128 Domínguez-Muñoz, J. E...... 54, 94 Ducrotté, P...... 60 Ejstrud, P...... 235 Dibitetto, F...... 81, 229 131, 134, 136, 159, Duffy, S...... 188 Ekberg, O...... 42 Dickman, R...... 148, 187, 235 174, 176, 178, 203, Dufour, J.-F...... 44, 49, 64, 83 Ekbom, A...... 73, 105 Diculescu, M...... 182 204, 211, 223 Dughera, L...... 113, 148 Ekinci, N...... 93 Didden, P...... 171, 236 Donald, N...... 141, 185 Dulai, G...... 58, 115, 125, 215 El Aidy, R. A...... 162 Didkowska, J...... 106 Donato, M. F...... 130 Dumonceau, J.-M...... 60, 63, 69 El Bechwaty, M...... 81 Dieli-Crimi, R...... 196 Donday, M. G...... 52, 89, 138 Dumortier, J...... 173 El Gharib, M...... 120 Diermayr, M...... 119, 163 Dondurmaci, M...... 147 Dumoulin, A...... 60 El Haija, M. A...... 166 Diestel, C. F...... 152, 240 Dong, T...... 212 Duncan, J...... 138 El Hanafy, E...... 166, 210 Dietrich, C...... 62 Dong, Y...... 106, 141 Duncan, S. H...... 112, 133 El Mahjoubi, S...... 136, 180 Dietrich, G...... 177 Donisi, L...... 180 Dunckley, P...... 115, 127, 129 El Mekkaoui, A...... 136, 180 Diez-Redondo, P...... 157, 171, 176 Doody, A...... 59 Dupas, J.-L...... 92 El Menabawey, T...... 152, 236 Digby-Bell, J...... 138 Doornebosch, P. G...... 102 Duran, A...... 198 El Sabbagh, R...... 229 Dignass, A...... 44, 83, 85, 138, 160, Dopsaj, V...... 207 Durant, L...... 105 El Zahry, M. A...... 119 179, 181, 183, 282, 286 Dor, R...... 200 Duricova, D... 77, 182, 183, 226, 227 El-Amien, H. A...... 130

321 UEG Week Final Programme : Index of Authors and Co-Authors

El-Bendary, M...... 88, 207 Ergun, P...... 113, 147 Faitini, K...... 128 Férec, C...... 159, 167 El-Gendy, W...... 120 Eri, T...... 149 Faiz, O...... 178 Ferenci, P...... 56, 78, 83, 103, 208 El-Salhy, M...... 195, 205, 233 Erickson, R...... 160, 180 Fakheri, H...... 239 Ferenci, T...... 224, 227 El-Setouhy, M...... 207 Erriu, M...... 72 Falalyeyeva, T. M...... 152 Ferhat Çelik, A...... 136 Elad, H...... 94 Esaka, N...... 210 Falconi, M...... 168 Ferlitsch, A...... 78, 119, 163 Eladl, A.-H...... 207 Esaki, M...... 59, 65, 210 Faleschini, G...... 157, 167 Ferlitsch, M...... 104, 128 Elalfy, H...... 88, 207 Esatoglu, S. N...... 136 Fallingborg, J...... 182 Fernandes, A...... 87, 218 Eldridge, M...... 105 Escher, J...... 225 Falt, P...... 72, 236 Fernandes, C..... 144, 202, 224, 233 Elewaut, A...... 182 Eshraghian, A...... 118, 163, 164, Familiari, P...... 71, 94, 213, 220 Fernandes, I...... 198 Elfert, A...... 104 201, 206 Fan, J. K...... 185 Fernandes, J...... 119, 126, 155, Elgoweini, M...... 168 Eshuis, E...... 46 Fan, Z...... 66, 146, 193, 210, 236 207, 242 Eliakim, R...... 47, 83, 90, 180, 182 Eskander, M. F...... 160, 176 Fanczal, J...... 94, 123 Fernandes, S. R...... 132, 182 Elisei, W...... 144, 159, 171 Eskeland, S. L...... 188 Fanetti, I...... 152 Fernandes, S. R. R...... 114, 120, Eliseu, L...... 207 Esmat, G...... 88, 207 Fang, J...... 144 123, 223 Eljaky, M. A...... 119 Espina, S...... 125 Fang, K. C...... 146 Fernandez, I...... 157, 171 Ellenrieder, V...... 86 Espinosa, P...... 133 Fantin, A...... 130 Fernandez, J...... 67, 157, 171 Elli, L...... 205, 239 Esposito, F...... 203, 213, 214 Faraci, S...... 184 Fernández Atucha, A...... 217 Ellis, R...... 104, 220 Essaid, A...... 152 Farès, N...... 134 Fernández Bonilla, E. M...... 138 Ellul, P...... 180, 222, 224 Essink-Bot, M.-L...... 140 Faresjö, Å...... 113, 143 Fernandez de Pinedo, V...... 147 Elmahjoubi, S. E...... 224 Essoi, B...... 144 Farid, K...... 207 Fernández Rial, J...... 128, 172 Elmekkaoui, A...... 224 Esteban, I...... 229 Farioli, A...... 97 Fernández Salazar, L...... 89 Elnakib, A. M...... 242 Esteban López-Jamar, J. M...... 236 Farkas, G...... 114, 123 Fernandez Y Viesca, M...... 159, 167 Eloranta, J. J...... 134 Esteve, M...... 161, 197, 196 Farkas, K...... 70, 99, 137, 139, Fernández-Bañares, F...... 161, 179 Elosua, A...... 141 Esteves, J...... 193 182, 204, 219, 220, 196 Elsenbruch, S...... 92, 138, 232 Estevez, P...... 157, 171 222, 224, 227 Fernández-Clotet, A...... 217 Elsey, E...... 220 Estremera Arévalo, F...... 113, 141, Färkkila, M. A...... 51, 80, 81, Fernandez-Del Castillo, C...... 114, Elshaarawy, O. A...... 165, 242 147, 148, 233 130, 174, 204, 221 123, 177 Elvas, L...... 80, 218 Etherson, K. J...... 186 Farmer, A. D...... 144 Fernández-Esparrach, G...... 151 Elverfeldt, D...... 66 Etienne-Mesmin, L...... 74 Farnbacher, M...... 133 Fernandez-Simon, A...... 173, 218 Elvevi, A...... 146, 147, 233 Ettorre, G...... 164 Farré Marti, R. L...... 52, 113, 147 Ferrandez, A...... 157, 185, 230 ElZein, M...... 101, 170, 174 Eugen-Olsen, J...... 211 Farrell, R. J...... 227 Ferrante, A...... 178 Elzubeir, A...... 202, 233 Eugenicos, M...... 144 Farrugia, M...... 180 Ferrante, E...... 135 Emerenziani, S...... 57 Eusebi, L. H...... 230, 231 Fasano, A...... 151, 239 Ferrante, M...... 47, 56, 70, 138, Emmanuel, A...... 38, 40, 82, 144, Eutamene, H...... 205, 228, 241 Fasching, E...... 104 182, 205, 225, 227, 235 146, 235 Evans, C...... 134 Fasoli, A...... 130 Ferrara, E. C...... 142, 234 Emparanza, J. I...... 119 Evans, L...... 97 Fassan, M...... 64, 191 Ferraris, L...... 203, 213, 214 Emura, F...... 49 Everlo, L...... 161, 197 Fassler, I...... 197 Ferraro, P. M...... 139 Ende, K...... 181 Eveslage, M...... 222 Fateen, W...... 160, 172, 179 Ferreira, A...... 173 Enderle, M...... 168 Evgenidi, E...... 161, 195 Fatela, N...... 165, 194, 242 Ferreira, A. M...... 183 Endo, M...... 115, 125 Evison, F...... 73, 117, 145, 181 Fattahi, M. R...... 163 Ferreira, A. O...... 63 Endoh, B...... 210 Ezoe, Y...... 125, 149 Faucheron, J.-L...... 220 Ferreira, C...... 189 Engel, J...... 135, 184 Ezziddin, S...... 199 Fazio, C...... 112, 133 Ferreira, F...... 136, 223 Engel, M...... 222 Feagan, B. G...... 61, 62, 116, 137 Ferreira, J. M...... 120, 207 Engel, P. J...... 135 Fechner, K...... 51, 136 Ferreira, M...... 120, 183, 207, 226 Engler, H...... 138 F Federico, A...... 135 Ferreira, P...... 198 English, N...... 105 Fabbri, C...... 50, 130, 198 Federico, D...... 168 Ferreira, R...... 173, 199 Engstrand, K...... 187 Fabbri, M...... 229 Fedorov, E. D...... 175, 192 Ferreira, S...... 133, 157, 171, 173, Enko, D...... 196 Fabian, A...... 99, 223, 224, 227 Fehér, B...... 166 198, 217, 229, 230 Enlund, F...... 204, 218 Fábián, A...... 219, 220 Fehlert, V...... 152 Ferreiro Iglesias, R...... 134, 136, Enochsson, L...... 115, 129 Fabisiak, A...... 112, 133 Feichtinger, J...... 118 178, 204, 223 Enomoto, M...... 78, 164 Facchinello, N...... 151 Fekih, M...... 135, 139 Ferrer, C...... 161, 196 Enrich-Capó, N...... 112, 133 Facciorusso, A.....88, 120, 124, 209 Feldager, E...... 158, 167 Ferrer-Guixeras, M...... 74 Ensari, A...... 63, 77 Fadeenko, G...... 89 Felder, T...... 185 Ferrero, S...... 240 Eom, B. W...... 197 Fadeeva, N...... 181, 225, 226 Feldman, D...... 213 Ferretti, A...... 153 Epshtein, J...... 104 Fagenholz, P...... 114, 123 Feldner-Busztin, M...... 119 Ferretti, F...... 205, 239 Epstein, M. S...... 104 Fagnani, F...... 213 Felice, C...... 139 Ferronato, A...... 183, 238 Er-Rabie, F...... 224 Fahy, E...... 194 Fellegara, G...... 174 Ferrone, C. R...... 177 Erdogdu, C...... 118 Faigel, D. O...... 173 Felux, J...... 174 Festi, D...... 121, 210 Erendgenova, K...... 192 Faith, J...... 57 Feng, Y...... 63 Fich, A...... 226

322 323 Index of Authors and Co-Authors : UEG Week Final Programme

Fichna, J...... 87, 92, 95, 100, Foldi, I...... 163 Fraser, C. H...... 174 Fujishiro, M...... 102, 132, 172 112, 133, 141, 160, 177, 232 Foley, A...... 219 Frazão, M...... 242 Fujita, H...... 176 Fidalgo, C...... 173 Foliaki, A...... 169, 188 Frazzoni, L...... 50, 58, 97 Fujita, K...... 157, 167, 206 Fiedler, T...... 143 Fomin, P...... 114, 118 Frazzoni, M...... 58, 97, 115, Fujita, M...... 124, 159, 175, 189 Fifere, A...... 131 Fon, J...... 178 132, 190, 234 Fujita, T...... 65, 210 Figueiredo, N...... 76, 91 Fondacaro, L...... 164 Freeman, M. L...... 48, 114 Fujita, Y...... 52 Figueiredo, P...... 119, 163, 208, Fong, S...... 138 Frei, R...... 121, 159, 171 Fujiwara, A...... 155 227, 240 Fonseca, C...... 162, 198, 206, 242 Freire, A...... 220 Fujiwara, J...... 125 Fikree, A...... 191 Fonseca, J...... 241 Freire, R...... 151, 239 Fujiwara, S...... 169 Filali, A...... 135, 139 Fonseca, R...... 230 Freissmuth, C...... 78 Fujiyoshi, T...... 142 Filip, R...... 145, 241 Fontaine, F...... 47, 183 Freitas, J...... 206, 227 Fukahori, O...... 168 Filip, R. S...... 216 Fontaine, S...... 60 Freitas, L...... 189 Fukami, Y...... 177 Filipe, B...... 185, 217, 229, 230 Fontana, P...... 65 Freitas, T...... 144, 202, 233 Fukase, K...... 65 Filippi, E...... 204, 223 Fontana, R...... 54, 96, 104 Freitas-Queiroz, N...... 235 Fukayama, M...... 132 Filipponi, F...... 130 Forbes, A...... 240 Frenkel-Nir, Y...... 153 Fukuda, H...... 125 Filser, J...... 71 Forcelledo, J. L. F...... 138 Frey-Wagner, I...... 92, 100, Fukuda, K...... 215, 218 Fine, J. S...... 61 Forcén, R...... 100, 178 105, 178 Fukuda, M...... 72 Fink, A...... 216 Forcén García, R...... 100 Fried, M...... 105, 134 Fukuda, S...... 192 Finney-Hayward, T...... 160, 183 Ford, A. C...... 38, 160, 179, 223 Frieri, G...... 116, 137 Fukuhara, M...... 88, 216 Finzel, S...... 155 Forestier, J...... 220 Fries, P...... 199 Fukui, K...... 231 Fiocca, F...... 218 Forman, D...... 47 Fries, W...... 56 Fukuma, Y...... 72 Fiori, S...... 240 Fornari, F...... 228 Friess, H...... 118, 158, 184, 209 Fukunaga, K...... 70 Fiorot, A...... 221 Fornasarig, M...... 142 Friger, M...... 223, 226 Fukunaga, Y...... 221 Fischbach, W...... 128 Fornelli, A...... 198 Friginal-Ruiz, A. B...... 136 Fukushima, M...... 175 Fischer, A...... 105 Fornells Sala, M...... 157, 171 Frilling, A...... 95 Fukuzawa, M...... 237 Fischer, C...... 60, 168 Forrest, D...... 169 Frister, S...... 209 Fumagalli, C...... 139 Fischer, S...... 72, 216 Forry, M...... 227 Fritsch, C...... 138 Fumery, M...... 73, 81, 89, 92 Fisher, W...... 212 Forsberg, A...... 73 Fritscher-Ravens, A..... 84, 96, 102 Fumio, S...... 158, 185 Fishman, D...... 130 Forssell, H...... 152 Froehlich, F...... 136 Funaki, Y...... 129, 238 Fishman, E. K...... 97 Forsyth, K...... 138 Frohna, P...... 62, 97 Funato, K...... 74, 127 Fishman, S...... 99, 126 Fortea, M...... 97 Frozanpor, F...... 115, 129 Furgala, A...... 196 Fiskerstrand, T...... 195 Forti, E...... 130 Frulloni, L...... 173 Furiano, A...... 64 Fittipaldi-Fernandez, R...... 240 Fossmark, R...... 52 Fry, L...... 73, 84 Furio, L...... 203, 213, 214 Fittipaldi-Fernandez, R. J.. 152, 240 Fotedar, K...... 133 Frykos, K...... 155 Furnari, M...... 58, 97, 115, 132, Fitz, P...... 222 Foubert, F...... 128 Fuccio, L...... 50, 58, 97 153, 190, 234 Fitzgerald, R. C...... 79, 80, 86, Fowell, A...... 220 Fuchs, E.-M...... 118, 163 Furukawa, K...... 156, 164 102, 105, 107 Fox, M...... 37, 44, 58, 75, 92, 108 Fudim, E...... 47 Furukawa, S...... 197 Fitzpatrick, C...... 219 Foy, C...... 129 Fuentes, C...... 241 Furuse, S...... 217 Flahaut, C...... 222 Fraga, J...... 242 Fuertjes, T...... 162 Furuta, G...... 190 Fléjou, J.-F...... 77 Fragkaki, M...... 178 Fuh, F...... 160, 180 Furutachi, S...... 237 Fleming, K...... 202, 206 Frago, S...... 103 Fuhler, G...... 228 Fuschi, D...... 228 Fliss Isakov, N...... 184 Fraile González, M...... 147 Führer, M...... 234 Fushimi, S...... 149, 193 Floreani, A...... 121 Franceschi, F...... 130, 134 Fujii, H...... 164 Fyderek, K...... 234 Florent, C...... 175, 219 Franceschi, M.... 116, 145, 192, 203, Fujii, M...... 155, 204, 215 Fyodorov, D...... 154 Flores, N. M...... 58, 113, 143 213, 214, 237, 238 Fujii, S...... 192 Florholmen, J...... 205, 238 Franceschini, G...... 128 Fujii, T...... 215, 217 Florie, J...... 132 Franch, R...... 128 Fujii, Y...... 115, 125 G Fluxa, D...... 87 Franchimont, D..... 47, 85, 182, 183 Fujikawa, K...... 131 Gaadhe, R...... 115, 125, 167, Fockens, P...... 38, 46, 54, Franchina, M...... 146, 233 Fujiki, S...... 166, 237 210, 214 91, 102, 108 Francies, H...... 64 Fujimasa, K...... 238 Gabbrielli, A...... 173, 175 Foerster, D...... 137 Francisco, I...... 149, 185, 217, 229, Fujimori, S...... 70 Gabe, S. M...... 205, 225, 240 Foertsch, T...... 201, 241 230, 114, 123, 158, 185, 190, 248 Fujimori, T...... 176, 212 Gabieta-Sonmez, S...... 190 Fogden, E...... 225 Franck, M...... 209 Fujimoto, A...... 114, 125, 129, Gabovitz, V...... 137 Fogg, C...... 104 Francois, E...... 199 148, 169, 214 Gabrieli, D...... 238 Foglia, B...... 117, 209 Francoz, C...... 43, 67, 104 Fujimoto, K...... 117, 145, 230 Gadea, N...... 229 Fogliati, V. J...... 64 Franczyk, R...... 106, 127 Fujimura, Y...... 161 Gadeke, L...... 104 Foisy, H...... 146 Frankish, P...... 188 Fujioka, T...... 238 Gadhikar, H...... 167, 210 Fojtik, P...... 72 Franklin, J...... 173 Fujisaki, J...... 114, 125, 127, Gadhok, R...... 155, 200 Fokra, A...... 50 Franzini, T...... 50 149, 150, 236 Gaetani, E...... 179

323 UEG Week Final Programme : Index of Authors and Co-Authors

Gagnière, J...... 220 Garcia-Puig, R...... 97 Gegova, A...... 93 Gijbels, L...... 225 Gago, T...... 103, 119, 202, 206, 232 Garcia-Romero, R...... 97 Geldhof, A...... 181 Gil-Borrás, R...... 222 Gainant, A...... 81 Garcia-Unzueta, M. T...... 223 Gelot, A...... 232 Gil-Simon, P...... 131, 176, Gal, E...... 137 Garcovich, M...... 88, 166 Gemmell, L...... 81 204, 220 Galamb, O...... 52, 141, 230 Gardenbroek, T...... 46 Gen, Y...... 125, 170 Gildea, L...... 72 Galanopoulos, M...... 196 Gardezi, S. A. A...... 169, 188 Genov, J...... 114, 123, 124 Gilja, O. H...... 59, 62, 195, Galazan, L...... 240 Gardner, T...... 114, 123 Genre, D...... 50 205, 233 249 Galazka, K...... 134 Gárdos, L...... 166 Gentilini, A...... 209 Gillespie, G...... 181 Galeano, C...... 137 Garg, M...... 105 George, H...... 205, 239 Gils, A...... 47, 56, 70 Galeazzi, F...... 147, 190 Gargallo Puyuelo, C. J...... 87, 230 George, S...... 239 138, 223, 226, 227 Galkova, Z...... 192 Garin, E...... 171 Georgi, S...... 143 Gimeno, J...... 216 Gallagher, C...... 175 Garkalne, L...... 161, 193 Geraci, G...... 218 Gimeno Garcia, A. Z...... 157, 171 Galliani, E...... 172 Garre, A...... 138, 182 Geramizadeh, B...... 164, 201, 206 Gimier, E...... 74 Gallittu, P...... 72 Garros, A...... 71, 233 Gerard, R...... 181, 225 Ginard, D...... 138 Galtier, M...... 57 Garry, C...... 227 Gerbes, A. L...... 158, 162 Gincul, R...... 216 Galtieri, P. A...... 142, 234 Garvey, T...... 185 Gerbino, N...... 151, 196 Gines, A...... 151 Galvao Neto, M...... 240 Gasbarrini, A. 52, 73, 81, 91, 109, Gerdes, L. U...... 77 Gingold Belfer, R...... 193 Galvão Neto, M...... 197 130, 134, 138, 151, Gerfaud, A...... 135, 178 Gini, A...... 216 Galyavieva, A...... 123 166, 179, 180, 198, 201, Gerhards, M. F...... 98 Ginsberg, G. G...... 63, 109, 115 Galyuk, V...... 177 222, 228, 229 Gerlach, U. A...... 241 Gionchetti, P...... 183 Gamar, L...... 224 Gasenko, E...... 161, 193 Germanà, B...... 172 Giorgetti, G...... 144 Gambaccini, D...... 187 Gasink, C...... 47, 61, 116, 137 Germano, G...... 103 Giorgio, F...... 196 Gambaro, S. E...... 118, 161, 166 Gaspar, R...... 119, 120, 162, 163, Gerometta, R...... 175, 219 Giorgio, V...... 184 Gambitta, P...... 65 165, 180, 198, Geron, A...... 176 Giorgio Arcidiacono, P...... 174 Gamito, É...... 155, 189, 242 212, 219, 241 Gerova, V...... 93 Giouleme, O...... 158, 185, 227 Gan-Schreier, H...... 204, 221 Gasparini, C...... 176 Gervain, J...... 123 Giovanelli, S...... 198 Ganduglia, P...... 153 Gasparini, P...... 203, 213, 214 Gervasi, S...... 238 Giovanis, P...... 209 Ganeshanathan, T...... 205, 225 Gasslander, T...... 114, 124 Gervetti, P...... 138, 224 Giovannini, M...... 50, 51, 54, 68, Gannavarapu, V. R...... 180 Gast, P...... 159, 167 Gessl, I...... 104 75, 82, 98, 127, Ganne, C...... 216 Gasztonyi, B...... 70, 137 Gesualdo, M...... 81, 229 130, 217 Ganss, A...... 194 Gatta, A...... 104 Gevers, T. J. G...... 65, 118 Giráldez-Montero, J. M...... 136 Gantz, M...... 187 Gauci, J...... 224 Gewecke, K...... 151 Girard, P...... 187 Gao, J...... 87 Gaudart, J...... 51 Gewirtz, A...... 81, 185 Giraudi, P. J...... 118, 161 Gao, L. L...... 47 Gault, N...... 73 Geyer, P...... 120 Girleanu, I...... 104 Gao, N...... 99, 179, 234 Gaur, S...... 240 Geyl, S...... 169, 170 Gisbert, J. P...... 47, 52, 56, 89 Gao, Q...... 113, 125, 203, 213 Gaus, A...... 190, 238 Ghadir, M...... 85 138, 139, 178, 182, 194 Gao, X...... 138, 180, 226 Gausman, V...... 98 Ghassemi, K...... 58, 115, 125 Gisbertz, S. S...... 133 Garanina, E...... 118 Gauss, A...... 204, 221 Gheonea, D.-I...... 209 Gislason, E...... 116, 134 Garau Colom, C...... 229 Gautam, N...... 216 Gheonea, I. A...... 209 Giuricin, M...... 118, 161 Garcia, D...... 124 Gavini, S...... 132 Gheorghe, C...... 182 Giuseppe, F...... 238 Garcia, M. J...... 223 Gavrilescu, O...... 162 Gheorghe, L. S...... 182 Gjika, S...... 191 Garcia, S...... 56, 138, 139 Gawron-Kiszka, M...... 183 Ghia, J.-E...... 100 Gkeros, F...... 196 Garcia, V. G...... 242 Gawronska, A...... 153 Ghilain, J. M...... 154 Gkolfakis, P...... 55 García, V...... 138, 139, 179, 181, 225 Gaxiola-Werge, R...... 177 Ghinolfi, D...... 130 Glasinovic, E...... 190 Garcia Aguilera, X...... 129 Gaya, D. R...... 160, 181, 183 Ghosh, S...... 47, 61, 62, 116, 128, Glória, L...... 173, 229 Garcia Alonso, J...... 157 Gazouli, M...... 222 136, 137, 157, 171 283 Gluck, N...... 104, 115, 126, Garcia Cano, J...... 121 Gazzin, S...... 166 Giacometti, C...... 191 131, 158, 166 Garcia Gonzalez, M. A...... 87, 230 Ge, P...... 98 Giacomin, A...... 172 Glund, S...... 70 García Lledó, J...... 157, 171, 239 Ge, W...... 230 Giacomin, D...... 128 Gnocchi, A...... 205, 237 García Planella, E...... 225 Ge, Y...... 146 Giangaspero, A...... 196 Go, Y. Y...... 87 García Rodríguez, L. A...... 184 Gearhart, N...... 181 Giannakopoulos, A...... 161, 195 Gockel, I...... 233 García Sánchez, V...... 179 Geboes, K...... 182 Giannakou, A...... 240 Goda, K...... 126 García Tercero, I...... 138 Gebril, A...... 239 Giannini, E...... 184, 223 Goda, Y...... 130 Garcia-Ballesteros, C...... 222 Gecov, P...... 114, 123, 124 Giannitrapani, L...... 209 Godat, S...... 127, 191 García-Cantalapiedra, A...... 211 Gecse, K. B...... 42, 68, 70, 89 Giannotti, S...... 190 Godfrey, E. M...... 123 Garcia-Caraballo, S...... 92, 98 137, 182, 204, 225, 227 Gibiino, G...... 130, 198 Gódi, S...... 123 García-Figueiras, R...... 131 Gedgaudas, R...... 202, 211 Gibson, P. R...... 105, 143, 188 Godny, L...... 139 Garcia-Gil, J...... 74, 112, 133, 134 Geelkerken, R. H...... 161 Giestas, S...... 218 Goenka, M. K...... 63 Garcia-Jaraquemada, A...... 221 Geerts, A...... 65 Gigante, G...... 71 Goeser, T...... 173

324 325 Index of Authors and Co-Authors : UEG Week Final Programme

Goetz, M...... 104, 174 Gooszen, H...... 123 Gravito-Soares, M...... 119, 151, 189, Guardascione, M...... 214 Goggin, P...... 104, 220 Goralska, M...... 211 ...... 208, 226, 242 Guardiola, J...... 56, 139 Goggins, M...... 76, 97 Gordan, M...... 118 Gray, M...... 112, 133 Guarino, M. P. L...... 57, 105, 144 Goh, G. B. B...... 207 Gordillo, J...... 139 Graziani, C...... 134, 138, 228 Guarner-Argente, C...... 97, 194 Goh, K. P. B...... 133 Gorgun, J...... 230 Graziano, C...... 87 Gudej, S...... 145, 241 Gohar, F...... 222 Gornals Soler, J. B...... 236 Grecco, E...... 197, 242 Guedich, A...... 224, 227 Göhrig, A...... 60, 168 Gornbein, J...... 58, 115, 125 Green, P. H...... 196, 239 Guenthert, S...... 115, 132 Goida, E...... 57, 134 Gornet, J.-M...... 73, 220, 222 Green, S...... 186 Guerbau, L...... 181 Going, J...... 52 Gorzkowska, A...... 206 Greenberg, D...... 223, 226 Guerci, B...... 60 Gois, W. A. F...... 188 Göschl, N...... 119, 163 Grega, T...... 140 Guerra Lacunza, A...... 141 Goishi, H...... 139, 183 Gotink, A. W...... 236 Gregar, J...... 236 Guerreiro, H...... 103, 104, 114, Goji, S...... 238 Goto, A...... 124 Greget, M...... 174 119, 202, 206, 232 Gök Sargin, Z...... 138 Goto, D...... 101 Gregório, C...... 118 Guglielmi, F. W...... 183 Gold, M. J...... 58, 160, 179 Goto, H...... 65 Greinwald, R...... 138, 225 Gühne, S...... 203, 212 Goldberg, R...... 138 Goto, O...... 114, 125, 129, Gress, F. G...... 98 Gui, X...... 128, 157, 171 Goldin, R...... 39, 72 148, 214, 215, 169, Gress, T. M...... 60, 76, 82, 86, 95 Guida, F...... 64 Goldis, A...... 61, 77, 134 Goto, T...... 129, 142, 231 Greten, T...... 49, 114 Guidi, L...... 56, 139 Golemanov, B...... 114, 123, 124 Gotoda, T...... 59, 65, 159, Greuter, T...... 184 Guillaud, O...... 173 Goll, R...... 205, 238 171, 217, 238 Greuter, E. J. M...... 78 Guillaumot, M.-A...... 215 Golovics, P. A...... 137, 182, Gotor, J...... 194 Grgurevic, I...... 156, 165 Guillen, C...... 229 204, 225, 227 Gottier, C...... 50, 100 Grieco, A...... 88 Guillon-Dellac, N...... 89 Gomaa, A...... 88, 165 Gottlieb, K...... 186 Griesmann, H...... 203, 212 Guiramand, J...... 130 Gomaa, A. I...... 165 Gottrand, F...... 62, 69, 96 Griffiths, G...... 220 Gujrathi, S...... 97 Gomes, D...... 52, 119, 123, 174, Gottschall, H...... 185 Griffiths, K...... 51 Gulacsi, L...... 70, 204, 225 208, 218, 242 Götz, M...... 241 Grigoryeva, T...... 117, 150 Gulati, S...... 138, 179, 181 Gomes, S. E...... 141 Gouda, K...... 189 Grillo, S...... 192, 205, 237 Gumerova, A. A...... 118, 123 Gomez, B...... 135 Goukos, D...... 179 Grimaud, J. C...... 60, 144 Gundogdu, S...... 149 Gomez, V...... 217 Gould, S...... 98, 187 Grimm, A. A...... 87 Günther, U...... 222 Gómez, G...... 151 Goulis, J...... 120 Grimm, I. S...... 51 Gual, A...... 39 Gomollon, F...... 72, 81, 93, 157, 171 Gourcerol, G...... 60, 178 Grimm, M...... 97 Guo, C.-Y...... 181 Gonçalves, A. R...... 136, 198, 223 Goutorbe, F...... 116, 135, 226 Grimstad, T...... 180, 226, 227 Guo, J...... 214 Gonçalves, B...... 198 Goutte, M...... 116, 135, Grobbee, E. J...... 140, 171, 228, 230 Guo, X...... 144 Gonçalves, C...... 207 160, 177, 226 Groenen, M. J...... 178 Gupta, R...... 51 Gonçalves, D...... 242 Gouveia, C...... 173 Groenewoud, H...... 208 Gupta, S...... 97, 169, 190 Gonçalves, R...... 120, 136, 163, Gower Rousseau, C...... 89, 92, Gromadzka-Ostrowska, J. .145, 241 Gupta, V...... 49 165, 198, 223 181, 222 Grönroos, J...... 106 Gurzu, S...... 193 Gonczi, L...... 182 Gowland, P...... 186 Groot Koerkamp, B...... 98 Gusev, D...... 220 Gonda, T. A...... 98 Grabmeier-Pfistershammer, K. ... 78 Grooteman, K...... 103 Gusmini, S...... 168 Gong, W...... 113, 125, 203, 213 Grabsch, H...... 132 Gross, S. A...... 104 Gustafsson, J. A...... 232 Gong, X...... 207 Grabsch, H. I...... 73 Grossi, C...... 159, 171, 217 Guthy, I...... 166 Gonsalves, N...... 190 Gracie, D. J...... 58, 160, 179, 223 Grossi, D...... 231 Gutic, E...... 164, 208 Gonzalez, J.-M...... 71, 144, 172 Gradiser, M...... 188 Groth, S...... 42 Gutierrez, J. P...... 122, 129, 240 González Alayón, C...... 179 Graepler, F...... 174 Grötzinger, C...... 168 Gutiérrez, A...... 138, 139, 181, 225 González Carro, P...... 236 Graf, R...... 60, 86 Groza, I...... 121 Gutierrez-Ibarluzea, I...... 157 González Lois, C...... 128 Grahovac, B...... 118 Gruenberger, T...... 83, 109 Gutman, C. R...... 86 González Pino, A...... 129 Gralnek, I. M...... 79, 84, 95, 103 Gruenenfelder, F...... 70 Guttman, D...... 195 González-Castro, A. M...... 97 Grama, A...... 166, 242 Gruia, C...... 230 Guy, R...... 140 González-Cervera, J...... 97 Granata, A...... 131 Grundy, D...... 184 Guyonnet, D...... 143 Gonzalez-Cordero, P. L...... 97 Grande, G...... 205, 237 Grundy, L...... 92 Guz, M...... 114, 123 González-Lama, Y...... 138 Grandval, P...... 51 Grünhage, F...... 210 Guz Mark, A...... 183 González-Lois, C...... 172 Grant, A...... 225 Gruppo, M...... 176 Gwak, G.-Y...... 121 González-López, J...... 136 Grant-Casey, J...... 140 Grys, T. E...... 173 Gwee, K. -A...... 48, 58, 91 González-Suárez, B...... 151, 239 Grasa, L...... 100, 178 Grytenko, S...... 221 Gyimesi, G...... 99 Gonzalo, V...... 161, 196 Grassi, F...... 53 Gschwantler, M...... 104, 164, Gyökeres, T...... 69, 82, 99, 248 Goodhand, J...... 201, 228 Grasso, G...... 192 208, 218 Goodman, W...... 222 Grattagliano, I...... 53 Gschwind, D...... 162 H Goolsby Hunter, A...... 144 Grau, J...... 77 Gsur, A...... 185, 229 Ha, D. W...... 149 Goong, H. J...... 79, 218 Gravito-Soares, E...... 123, 184, Gu, J.-F...... 185 Haas, J...... 137 Goos, K.-H...... 183 208, 240, 242 Guang, Y...... 176 Habendorf, W...... 194

325 UEG Week Final Programme : Index of Authors and Co-Authors

Habibe, M...... 207 Hammoud, D...... 183 Hartleb, M...... 183, 206 Hayes, P. C...... 164, 194 Habibinejad, H...... 85 Hampe, J...... 52, 181 Hartman, H...... 202 Haysom-Newport, B...... 104 Haboubi, H. N...... 239 Hamvas, J...... 123 Hartmann, D...... 93, 118, 120, 209 Hazama, S...... 231 Hachiya, H...... 122 Han, H.-S...... 168 Hartmann, F...... 85, 160, 179, 181 Hazewinkel, Y...... 159, 171 Hackert, T...... 86 Han, J...... 49, 123, 130 Hartung, J. P...... 226 He, H...... 117 Haddiya, I...... 180 Han, J. H...... 122 Haruma, K...... 101 He, J...... 176 Haderer, M...... 162 Han, J.-H...... 188 Harustiak, T...... 117, 148 He, K...... 146 Hadi, S...... 171 Han, J. P...... 192, 237 Hasab El-Naby, A...... 153 He, X...... 165 Hadithi, M...... 219 Han, K...... 229 Hasan, F...... 160, 179 He, Y...... 181 Hadjadj, S...... 60 Han, H.-S...... 168 Hasan, M...... 50, 63, 129 He, Z...... 191 Hadley, S...... 177 Han, M. A...... 149, 206 Hasegawa, G...... 191 Healey, P...... 61 Hafi, M...... 135, 139 Han, S...... 121, 219 Hasegawa, H...... 232 Healy, J...... 139 Häfner, M...... 38, 79, 96, 106 Han, Seong-Hee...... 140, 182 Hasegawa, S...... 170, 234 Hebuterne, X...... 61 Hagege, H...... 105 Han, S. J...... 49, 195, 198 Hashad, D...... 165 Hecht, E...... 98 Hagel, A. F.. 127, 133, 200, 202, 241 Hanabata, N...... 88, 115, 125, 192 Hashiba, M...... 195 Hedenström, P...... 204, 218 Hagenmüller, F...... 131 Hanada, M...... 224 Hashimoto, S...... 210 Hedjoudje, A...... 176 Hagihara, A...... 78, 164 Hanada, R...... 70 Hassan, C...... 55, 80, 107, 172, Hefny, S...... 120 Hahn, K. Y...... 149, 215 Hanafusa, M...... 231 175, 216, 229, 234, 248 Hefny, Z. M...... 119 Hahnloser, D...... 39, 47, 73, 91 Hanafy, A...... 121 Hasuda, K...... 238 Hegyi, P...... 94, 123, 166, 202, 211 Haick, H...... 161, 193 Hanafy, A. S...... 53, 78, 208 Hasui, K...... 88 Heidari, A...... 85 Haidich, A.-B...... 158, 185 Hanaoka, N...... 125, 127, 204, Hata, K...... 135, 142, 220 Heikenwälder, M...... 49, 60 Haidry, R. J...... 146, 203, 213 215, 217 Hatamori, H...... 175 Heinrich, H...... 146 Hai, H...... 78 Hanaoka, N...... 84 Hata, Y...... 71 Heinrichs, S...... 233 Hainzl, O...... 138 Hanauer, S. B...... 136 Hatemi, A. I...... 136, 161 Heitland, W...... 184 Haito-Chavez, Y...... 51, 71, 161, Hanauer, St...... 61, 62 Hatemi, G...... 136 Hejlova, I...... 202, 206 190, 219 Handa, O...... 125, 170 Hatemi, I...... 136, 161, 178 Hellmich, B...... 218 Hajale, J...... 134 Hanevik, K...... 195 Hatlebakk, J. G....91, 205, 233, 239 Hellström, A...... 204, 221 Hajal, J...... 121 Hankey, C...... 188 Hatta, W...... 59, 65 Hellström, P. M...... 180 Haji, A...... 71 Hannemann, A...... 132 Hattori, M...... 210 Helwig, U...... 143 Hajiyeva, G..51, 71, 87, 161, 190, 219 Hannink, G...... 92, 98, 114, 123 Hatzievangelinou, C...... 196 Helyes, Z...... 94 Haj-Natour, O...... 47 Hanno, A. E. F...... 146 Haupt, M...... 153 Hempen, P...... 127 Halász, A...... 123 Hansen, B...... 77, 121, 174, 211 Haupt, R...... 153 Hempstead, S...... 216 Hale, M. E...... 98 Hansen, J. M...... 194 Haupt, W...... 133 Hendel, J...... 104 Halfvarson, J...... 72, 77, 81, 93 Hansen, M. B...... 211 Hauser, B...... 47, 183 Hendrickx, K...... 74 Halilbasic, E...... 117, 152 Hansen, P. D...... 168 Hauser, G...... 184 Hendy, P...... 105, 116 Halkova, T...... 141 Hao, F...... 222 Hausken, T...... 85, 195, 205, 233 Heneghan, M...... 181 Hall, G...... 180 Hara, K...... 142, 219 Hausmann, M...... 105 Hengst, K...... 222 Hallas, J...... 194 Hara, T...... 139, 149, 224 Haustermans, K...... 91, 102 Henke, R. P...... 113, 125 Haller, D...... 64, 91, 100, 178 Harada, E...... 107 Havertz, B...... 144, 147 Henmi, S...... 88, 216 Haltmayer, H...... 164 Harada, H...... 159, 169 Havnhoj Frandsen, T...... 194 Henriksen, O...... 116, 137 Halvorsen, F.-A...... 196, 205, 238 Harada, K...... 73, 179, 212 Hawes, R...... 50, 63, 129 Henrique, R...... 59 Hamada, K...... 59, 126, 127, Harada, M...... 121, 228 Hawinkels, L. J. A. C...... 221 Henry, L...... 216 149, 170 Haraldsson, S...... 158, 167 Hawkey, C. J...... 38, 62, 88, Heo, J...... 123, 176 Hamada, Y...... 168 Harasym, J...... 145, 241 97, 204, 224 Heo, J. Y...... 210 Hamaguchi, K...... 131 Harb, Y...... 194 Hayasaka, K...... 159, 169 Hep, A...... 231 Hamaguchi, Y...... 177 Hardt, T...... 137 Hayashida, M...... 70 Herba, K...... 174, 186 Hamamoto, H...... 115, 125, 210 Hardwick, J. C. H...... 102 Hayashi, K...... 52, 124, 207 Herbst, P...... 218 Hamanaka, M...... 149 Harfoush, R...... 153 Hayashi, N...... 106, 158, 185 Hercogova, J...... 183 Hamano, M...... 150 Harinck, F...... 76 Hayashi, R...... 192 Herculano, R...... 164 Hamar, S...... 219 Harkat, C...... 241 Hayashi, S...... 122, 128, 217, 231 Herman-Edelstein, M...... 193 Hambruch, E...... 158, 162 Harmon, J. W...... 117, 147 Hayashi, T...... 55, 79, 84, 131,141, Hermann, P. C...... 86 Hamdy, S...... 42, 64 Harm, S...... 117, 152 158, 185, 186, 216, 217, 231 Hernández Conde, M...... 128, Hamidouche, D...... 224 Harrington, A. M...... 98 Hayashi, Y...... 59, 65, 84, 218 157, 171, 172 Hamilton, W...... 172 Harrington, S...... 235 Hayato, I...... 144 Hernández-Gallego, A...... 180 Hamlin, P. J...... 181 Harrison, M. E...... 173 Haycock, A...... 115, 127, 172 Hernandez, I...... 150 Hammer, H. F...... 43, 53 Harrison, Pille...... 61 Hayden, H...... 66, 158, 162 Hernandez Mondragon, Hammer, J...... 153, 154, 234 Hart, A...... 41, 116 Hayden, L...... 113, 143 O. V. V...... 50 Hammer, K...... 153, 154, 234 Hart, A. L...... 47 , 105 , 116, Hayee, B...... 71, 104, 136, Hernandez, V...... 50, 134, 157, Hammer, V...... 153, 154, 234 135, 181, 205, 225 138, 179, 181, 225 171, 229

326 327 Index of Authors and Co-Authors : UEG Week Final Programme

Hernandez, V...... 77 Hjartåker, A...... 78 Hori, K...... 169, 192 Hughes, D...... 52 Herraiz, M...... 142, 229 Hjortswang, H...... 135 Horikawa, Y...... 149, 193 Hughes, F...... 117, 146 Herrero, R...... 151, 161, 193 Hlavaty, T...... 136, 160, 179 Horimatsu, T...... 106 Hugot, J.-P...... 160, 177 Herreros de Tejada, A...... 128, Hochberger, J...... 174 Hori, S...... 115, 125, 192 Huguet, A...... 137 172, 229 Hoebertz, A...... 66 Hori, Y...... 124 Huguet, M...... 226 Hershcovici, T...... 104 Hoefnagel, S...... 80 Horjus Talabur Horje, C. S...... 178 Huh, K...... 121 Hershkovitz, M...... 137 Hoekman, D. R...... 137, 226 Hörmannsperger, G...... 178 Huhtala, H...... 151, 152 Herskovic, A...... 220 Hoentjen, F...... 77 Horta, D...... 207, 220 Huikuri, H...... 201, 206 Hervieu, V...... 236 Hofer, H...... 78, 208 Horta-Vale, A. M...... 165 Hujioka, S...... 142 Hessmann, E...... 86 Hofer, P...... 185, 229 Horvath, K...... 114, 123 Hultcrantz, R...... 73, 105 Hess, T...... 233 Hoff, C...... 102 Hoshi, N...... 139 Humes, D...... 220 Hetta, A. K...... 227 Hoff, G...... 78, 216 Hoskin, B...... 227 Hunato, K...... 65 Heusch, P...... 135 Hoffman, A...... 104 Hosokawa, A...... 115, 125 Hünger, M...... 128 Heymen, S...... 98, 186, 187 Hoffman, I...... 47, 183 Hosono, H...... 99, 177 Hung, I...... 140 Heyries, L...... 197 Hoffmann, M...... 242 Hosono, K...... 210 Hungin, P...... 53, 75, 107 Hiasa, Y...... 197 Hoffmeister, M...... 128 Hosoya, A...... 222 Hung, I...... 63 Hibi, T...... 61 Hofmann, H.-P...... 138 Hosseini, N...... 200 Hung, J.-S...... 147, 234 Hibiya, S...... 94 Hofman, P...... 221, 222 Hosseini, V...... 239 Huo, J...... 190 Hidaka, E...... 129 Hogan, M. C...... 118 Hoteya, S...... 59, 65, 192 Huorka, M...... 160, 179 Hidaka, H...... 230 Hohenester, S...... 121 Hotta, K...... 51, 106, 117, 140, Hupkens, B...... 88 Hieda, N...... 142 Hohwieler, M...... 86 149, 150, 158, 186 Huppertz-Hauss, G...... 56 Higashimori, A...... 141 Hoibian, S...... 127 Hough, R...... 185 Hurme, S...... 106 Higashimoto, K...... 230 Höijer, J...... 105 Houghton, L...... 53, 75, 92, 95 Hüser, N...... 118, 209 Higashino, K...... 84, 126, 127, Hojo, M...... 150, 170, 190, 234, 237 Hourigan, L...... 49 Hussaini, S. I...... 169 204, 215, 217 Hokonohara, M...... 210 Hoyeau, N...... 77 Hussain, Y...... 170 Higashiyama, M...... 224 Hollemans, R...... 114, 123 Hritz, I...... 123, 248 Hussain, Z...... 220 Higgins, B...... 104 Holleran, G...... 73, 103, 139, Hruban, R. H...... 97 Hussey, M...... 139, 194, 196, 226 Hijos, G...... 185 194, 196, 226 Hruba, V...... 70, 182, 226, 227 Hustak, R...... 210 Hikichi, T...... 115, 125 Hollington, P...... 142 Hsieh, T.-Y...... 208 Huyck, S...... 225 Hillebrand, P...... 117, 152 Hollingworth, T...... 220 Hsu, Y.-C...... 78 Huyhn, J...... 184 Himoto, T...... 206 Hollosi, P...... 141 Htet, H...... 216 Huysentruyt, C. J...... 128 Hinata, N...... 170 Holm, A...... 178 Hu, H.-Y...... 146 Hvas, C. L...... 182 Hindryckx, P...... 182 Holme, Ø...... 106 Hu, J...... 114, 126 Hwang, J. J...... 161, 192, 237 Hingh, I. D...... 98 Holmes, B...... 144 Hu, J.-W...... 59 Hwang, J. A...... 208 Hingston, J...... 220 Holmes, E...... 116, 135 Hu, M...... 81 Hwang, J.-H...... 130, 212 Hino, H...... 148, 176, 236 Holst, J. J...... 190, 238 Hu, P...... 138, 179, 180, 226 Hwang, K. B...... 192 Hinoi, T...... 230 Holt, B...... 203, 215 Hu, X...... 227 Hwang, M. J...... 217 Hipolito, R...... 133 Holtmann, G...... 112, 133 Hu, X.-M...... 185 Hwang, S. W...... 140 Hiraga, Y...... 224 Holtmann, G. J...... 113, 135, 143, 231 Hu, Y...... 232 Hwang, Y. J...... 47 Hirai, Y...... 205, 231, 232 Holvoet, T...... 182 Huang, B...... 160, 181, 232 Hyams, J...... 225 Hiramoto, T...... 224 Holzinger, J...... 218 Huang, H...... 100 Hybner, L. S...... 124, 168 Hirano, D...... 158, 185 Holzmann, B...... 118 Huang, L...... 122 Hyodo, I...... 99, 185 Hirano, I...... 97 Hombu, T...... 173 Huang, M...... 226 Hyun, J. J...... 94, 124, 174, 211, 233 Hirano, M...... 59, 65 Hompes, R...... 63, 92 Huang, S...... 113, 125, 203, 213 Hiraoka, A...... 207 Honarvar, B...... 165 Huang, T...... 106 Hiraoka, S...... 73, 179 Honein, K...... 121 Huang, Y...... 126 I Hirasawa, K...... 115, 125 Hong, D. H...... 213 Huang, Z...... 122, 226 Iacopini, F...... 159, 171, 217 Hirata, I...... 106 Hong, J...... 79, 86, 192, 237 Huan, H...... 163 Iacucci, M...... 128, 136, 157, 171 Hirata, N...... 74 Hong, S. J...... 79, 192, 237 Hubel, E...... 99 Iafrate, A. J...... 116, 141 Hirata, T...... 205, 231, 232 Hong, S. P...... 136 Huber-Schönauer, U...... 185 Ialongo, P...... 164 Hirayama, M...... 115, 125 Honjo, M...... 124, 159, 175 Huberty, V...... 62, 69, 84, 146 Iancu, C...... 121 Hirayama, Y...... 142 Honkoop, P...... 219 Hubner, D...... 218 Iancu, M...... 118 Hirose, A...... 161 Honma, T...... 191 Hubner, R...... 168 Ianiro, G...... 57, 81, 134, 151, Hirose, H...... 140 Honsova, E...... 117, 148, 202, 206 Hucl, T...... 124, 248 187, 228 Hirose, K...... 97, 210 Hoogenboom, J. D...... 221 Hucl, T...... 75, 95, 107, 202 Iannone, A...... 196, 207, 222 Hirschfield, G...... 40 Hoopes, P. J...... 220 Hudson, M...... 105 Iannotta, M...... 64 Hirsch, S...... 241 Hoppo, K...... 115, 125 Hudson, N...... 154 Iannuzzi, F...... 65 Hisayuki, T..... 79, 141, 158, 185, 186 Hordonneau, C...... 116, 135 Huerta Madrigal, A...... 217 Ianosi, G...... 201, 206 Histace, A...... 175, 219 Horie, M...... 149, 195 Huggett, M...... 123 Ibañez, I...... 217

327 UEG Week Final Programme : Index of Authors and Co-Authors

Ibarra, M...... 161, 196 Imagawa, H...... 49, 103, 114, Ishida, Y...... 168 Iwai, N...... 125, 170 Ibis, M...... 138 122,186 Ishigaki, K...... 122 Iwai, T...... 219 Iborra, M...... 139 Imai, H...... 98, 123 Ishigaki, T...... 217, 231 Iwakiri, K...... 70 Ibrahim, M. I...... 25, 49, 68, 75, Imai, K...... 51, 117, 140, Ishigami, H...... 214 Iwakiri, R...... 117, 145, 230 82 ,146 149, 150, 158, 186 Ishigooka, S...... 216 Iwamoto, H...... 60 Ibrahimi, S...... 199 Imaizumi, H...... 219 Ishihara, A...... 232 Iwamura, S...... 215 Icenhour, A...... 92, 232 Imajoh, M...... 173 Ishihara, M...... 142 Iwamuro, M...... 58 Ichikawa, T...... 119 Imamura, K...... 169 Ishihara, R...... 84, 126, 127, 149, Iwano, H...... 121 Ichikawa, Y...... 207 Imanieh, M. H...... 164 194, 204, 215, 217 Iwao, Y...... 117, 140, 152 Ichimasa, K...... 79, 141, 158, Imaoka, H...... 115, 124, 142 Ishihara, S...... 53, 115, 116, Iwasa, T...... 64 185, 186, 217 Imeneo, M...... 238, 239 125, 142, 220 Iwasaki, A...... 210 Ida, T...... 129, 142, 231 Imperatore, B...... 164 Ishii, H...... 192 Iwasaki, K...... 215 Ide, D...... 131, 240 Imperatore, N...... 77, 90, 138, Ishii, M...... 189 Iwasaki, R...... 125, 207 Idigoras Rubio, I...... 129, 157, 171 151, 196, 224 Ishii, S...... 146 Iwasaki, S...... 161 Ido, A...... 210 Imperiali, G...... 104, 203, 213, 214 Ishii, T...... 130 Iwasaki, T...... 131, 232, 240 Ido, Y...... 238 Inada, M...... 231 Ishii, Y...... 212 Iwatate, M...... 106 Idris, I. R...... 240 Inagaki, N...... 177 Ishikawa, H...... 80, 106, 115, Iwatsuka, K...... 238 Iebba, V...... 202, 229 Indart, I...... 129 124, 125, 149 Iyer, K...... 87 Ierardi, E. G...... 196, 207, 222 Inoki, K...... 192 Ishikawa, T...... 125, 170 Izawa, S...... 129, 238 Igarashi, A...... 106 Inokuchi, H...... 214 Ishimi, A...... 150 Izbéki, F...... 123 Igarashi, K...... 79, 156, 164, 217 Inokuchi, T...... 73, 179 Ishiwatari, H...... 51, 117, 140, Izelaar, K...... 230 Igarashi, M...... 128, 221 Inokuma, T...... 175 149, 158, 186 Izumi, C...... 210 Igarashi, S...... 88 Inoue, A...... 146 Ishiyama, A...... 114, 127 Izumi, K...... 190, 234 Igarashi, Y...... 157, 167 Inoue, E...... 135 Ishiyama, S...... 155 Izuta, M...... 168 Iglesias Flores, E...... 179 Inoue, H...... 55, 71, 84, Ismael, A. E...... 242 Izzi, A...... 164 Iglesias Picazo, R...... 113, 147, 101, 129, 170, 234 Ismail, A...... 51, 71, 87, 101, 148, 233 Inoue, J...... 139 161, 170, 174, 190, 219 Iglesias-García, J...... 94, 131, Inoue, N...... 140 Ismaili, Z...... 136, 180, 224 J 159, 174, 176, Inoue, T...... 146 Isobe, S...... 210 Jackson, S...... 95 203, 211 Inoue, Y...... 231 Isomoto, H...... 136 Jacob, H...... 104 Iglesias Picazo, R...... 113, 147, Inthout, J...... 208 Israeli, E...... 104, 182 Jacob, J. P...... 216 148, 233 Inui, K...... 157, 167 Ito, A...... 139, 224 Jacob, P...... 197 Ignatavicius, P...... 177 Invernizzi, F...... 130 Ito, H...... 59, 65 Jacobstein, D...... 47, 61, 116, 137 Ignazzi, A...... 64 Invernizzi, P...... 121 Ito, M...... 155 Jácome, F...... 215 Iguchi, T...... 87 Iny, O...... 222 Ito, S...... 51, 122, 140, Jacques, J...... 84, 169, 170, 236 Ihara, E...... 64, 124 Ioana, M...... 201, 206 146, 149, 150, 158, 186 Jaenisch, S...... 178 Iiboshi, T...... 139, 183 Ioanitescu, S...... 119 Ito, T...... 124, 128, 150, Jafari, J...... 148, 233, 235 Iida, M...... 231 Ioannis, K...... 240 199, 204, 215 Jagodzinski, R...... 199 Iida-Ueno, A...... 164 Ioannou, A...... 147, 234 Itoh, F...... 216, 229 Jahnsen, J...... 72, 81, 93, Iio, S...... 49, 103, 114, 122, 186 Iolascon, A...... 151 Itoh, T...... 59, 170 223, 283 Iishi, H...... 84, 126, 127, Ionas, E...... 165 Itoh, Y...... 125, 170 Jain, A. K...... 162 149, 204, 215, 217 Iori, V...... 174, 237 Itoi, T...... 51, 63, 115, Jairath, V...... 140 Iizuka, B...... 139, 224 Iovino, P...... 147, 152, 234 124, 159, 174, 175, 237 Jajoo, R...... 214 Iizuka, T...... 65, 125, 192 Iqbal, N...... 107 Itskoviz, D...... 235 Jakopcic, I...... 164, 211 Ijspeert, J...... 106, 141 Iqbal, T...... 117, 145, 178 Itzhak, A...... 158, 166 Jaksch, P...... 117, 152 Ikari, N...... 170 Irani, F. G...... 133 Itzlinger-Monshi, U...... 218 Jalan,R...... 46, 76 Ikeda, H...... 101 Iravani, S...... 118 Iughetti, L...... 153 Jamet, P...... 192 Ikeda, Y...... 115, 125 Irie, K...... 130 Iuzzolino, P...... 172 Jamieson, N. B...... 168 Ikematsu, H...... 106, 169, 173, 192 Irisawa, A...... 115, 124 Ivanova, A...... 154 Janczyk, W...... 162 Ikemura, M...... 132 Irving, P...... 70, 107, 138, Ivanova, J...... 212 Jang, B. I...... 146, 217 Ikezawa, N...... 230 181, 204, 225, 285 Ivascu-Siegfried, C...... 114, 120, Jang, D. K...... 122, 124 Ila, V...... 166 Isajevs, S...... 145, 151, 237 156, 165 Jang, G. H...... 150 Ilan, N...... 94 Isaksen, K...... 180, 227 Ivashkin, V...... 117, 120, 147, Jang, H...... 122, 150 Ilie, M...... 70, 93, 146 Isava, A...... 157, 171 154, 166, 186 Jang, M. K...... 202, 233 Ilkiv, I...... 70 Isayama, H...... 74, 122 Ivashuk, S...... 121 Jang, S...... 121 Illés, A...... 123 Ishaq, S...... 104, 214, 216 Ivekovic, H...... 99, 141 Janik, M. K...... 208 Illiasch, C...... 118 Ishida, F...... 55, 79, 84, 129, 141, Iven, J...... 64, 160, 189 Janikowska, K...... 127 Illing, A...... 86, 94 158, 185, 186, 216, 217, 230 Iwabuchi, M...... 141, 142, 199 Janmaat, V...... 235 Im, J. P...... 127 Ishida, H...... 230, 232 Iwahashi, K...... 149, 195 Janmaat, V. T...... 106, 205

328 329 Index of Authors and Co-Authors : UEG Week Final Programme

Janousek, R...... 164 Jimenez Garcia, V. A...... 239 Jung, K...... 123, 130, 150, Kamal, A...... 87, 161, 190, 211 Janovics, P...... 237 Jimenez-Rosales, R...... 99, 189 74, 176, 184, 237 Kamata, K...... 98, 123 Jansen, J. M...... 102 Jin, H...... 65, 210 Jung, M. K...... 123, 130, 174, 176 Kamberoglou, D...... 205, 234 Jansen, M. E...... 141 Jinga, M...... 195 Jung, S. W...... 233 Kamberovic, F...... 221 Jansen, P. L. M...... 96, 102 Jirsa, M...... 202, 206 Jung, S.-W...... 174 Kamel, E...... 88, 207 Januszewicz, W...... 103, 126 Jo, S...... 121 Jung, Y...... 49, 195, 198 Kamel, I. R...... 97 Jard, G...... 241 Jo, S. Y...... 229 Jung, Y.-K...... 174 Kameta, E...... 212 Jarmuz, A...... 232 Jobin, G...... 186 Jüngst, C...... 210 Kaminski, M. F...... 54, 55, 77, 106 Januszewicz, W...... 103, 126 Jodrell, D. I...... 86 Junji, S...... 155 Kamm, M. A...... 57 Jartti, A...... 106 Joh, T...... 124 Jurcic, P...... 233 Kammann, P...... 187 Jasper, D...... 235 Johanns, J...... 47, 61, 137 Juszczak, M...... 145, 241 Kämpe, O...... 198 Jauch, K.-W...... 184 Johansson, S.-E...... 147 Jutabha, R...... 58, 115, 125 Kamysz, E...... 112, 133 Javed, M. A...... 168 John, C...... 188 Juzlova, K...... 183 Kamysz, W...... 112, 133 Jawaid, S...... 219 John, S...... 126, 129, 172 Kanaan, M...... 224 Jawhari, A...... 160, 179 Johnson, C...... 202, 211 Kanaaneh, D...... 220 Jaworek, J...... 94, 134, 211 Johnson, G. J...... 123 K Kanai, M...... 149 Jayanna, M...... 115, 127 Johnson, S...... 116, 137 Kaai, M...... 129, 142, 231 Kanai, N...... 170 Jayasekeran, V...... 94 Johnsson, Å...... 148 Kaakoush, N...... 57 Kanai, T...... 169 Jayne, D...... 188 Johnsson, E...... 148 Kabacaoglu, D...... 60 Kanamori, A.....52, 53, 113, 147, 167 Jean, M...... 115, 127 Johnston, C...... 219 Kabakchiev, B...... 93 Kanazawa, A...... 74 Jeen, Y. T...... 142, 151, 159, Johnston, E...... 138 Kabrawala, M. V...... 122 Kanazawa, K...... 88 169, 175, 211, 213 Johnston, J. M...... 144 Kachroo, S...... 227 Kanba, S...... 131, 240 Jeleniewicz, W...... 114, 123 Jokelainen, K...... 51, 81 Kacso, G...... 156, 165 Kanbayashi, H...... 224 Jelovskis, I...... 145 Joly, F...... 44, 240 Kadenczki, O...... 222 Kandasamy, V...... 239 Jenkins, I...... 38, 39, 44, 102, Jonaitis, L. V...... 138, 145, 194 Kadleckova, B...... 205, 225 Kandeel, L...... 88 159, 205, 225, 253 Jonefjäll, B...... 58 Kadota, T...... 125, 173, 192 Kandel, P...... 217 Jensen, D. M...... 58, 115, 125, Jones, C...... 73, 201, 228 Kadoya, K...... 148, 176, 236 Kandiah, K...... 49, 79, 101, 104, 140, 215 Jones, D...... 40, 62, 126, 129, 172 Kadusevicius, E...... 194 127, 140, 142, 148, Jensen, M. D...... 152 Jones, G...... 42, 56 Kaffes, A. J...... 63 170, 214, 235, 236 Jenssen, C...... 62, 249 Jones, M. K...... 70 Kagawa, K...... 210 Kandulski, A...... 238 Jente, R...... 183 Jones, M. P...... 64, 190 Kagramanova, A...... 18 Kane, C...... 185 Jentzsch, M...... 93 Jonkers, D. M...... 78, 85, 86, 109 Kahaleh, M...... 130, 212 Kane, J...... 260 Jeon, H. K...... 193 Jonsson, K...... 191 Kahrs, G...... 91, 239 Kane, J. S...... 160, 179 Jeon, J...... 124, 237 Jönsson, C...... 160, 176 Kaido, T...... 177 Kane, S...... 160, 179 Jeon, J. W...... 106 Joo, J. S...... 236 Kaimakliotis, I...... 77, 134 Kaneko, K...... 106, 132, 169, Jeon, M. Y...... 215 Joo, M. K...... 59, 106, 210,212 Kaise, M...... 65, 192 173, 192 Jeon, S. R...... 201, 241 Jorgensen, L. N...... 211 Kajihara, T...... 139, 183 Kaneko, M...... 87, 185 Jeon, S. W...... 149-150 Jose, N...... 222 Kakkadasam Kaneko, S...... 212 Jeon, T. J...... 124 Josefsson, A...... 191, 232 Ramaswamy, P...... 157, 167, 211 Kaneko, T...... 99, 130,219 Jeon, T. Y...... 193 Joshi, N. M...... 201, 228 Kakugawa, Y...... 106 Kanemitsu, Y...... 230 Jeong, D. E...... 217 Joshita, S...... 207 Kakushima, N...... 51, 117, 140, Kaneoka, Y...... 177 Jeong, H. Y...... 140, 169, 193, Jovanovic, I...... 121, 122 149, 150, 158, 186 Kanesaka, T...... 80, 126, 127, 236, 238 Jover Martínez, R...... 128, 229 Kakuta, A...... 88 169, 204, 215, 217 Jeong, S...... 211 Jovine, E...... 198 Kalager, M...... 106 Kaneshiro, M...... 215 Jeong, S. H...... 217 Juan Juan, A...... 56 Kalantar, J...... 231 Kaneto, M...... 155 Jeppesen, P. B...... 240 Juanmartiñena Kalauz, M...... 141 Kanetoh, M...... 207 Jepsen, P...... 202, 206 Fernández, J. F...... 239 Kalinski, T...... 238 Kang, B...... 193, 209 Jerie, M...... 190 Jucha, B...... 138 Kalish, S...... 117, 147 Kang, C...... 94 Jerlstad, P...... 144, 187, 191, 232 Juday, T...... 116, 137 Kalkan, C...... 189, 190 Kang, D...... 106, 122, 142, Jervez-Puente, P...... 99, 189 Julià, A...... 221 Kalla, R...... 72, 81, 93 149, 170, 188, 237 Jeschek, P...... 104 Julsgaard, M...... 182 Kallon, F...... 138 Kang, Da...... 106 Jevans, B. S...... 46 Jun, D. W...... 162 Kalloo, A. N...... 211 Kang, Do...... 237 Jezerskyte, E...... 133 Jung, D. H...... 150 Kalmár, A...... 52, 141, 230 Kang, H. W...... 186 Jiang, W...... 66, 72, 165 Jung, E. S...... 135 Kalnina, Z...... 142, 145 Kang, M...... 121 Jiang, X...... 180 Jung, H. C...... 127, 189 Kalpala, R...... 51 Kang, S. H...... 140, 169, 236, 238 Jiaxi, F...... 22 Jung, H.-Y...... 188 Kaltenbach, T...... 157, 171 Kang, S.-G...... 176 Jilek, K...... 218 Jung, I...... 193 Kama, C...... 125 Kang, T. W...... 208 Jimenez, M...... 179 Jung, I. K...... 237 Kamada, H...... 176, 212 Kang, W...... 103, 106,121, Jimenez, N...... 56 Jung, J. G...... 186 Kamada, K....124, 125, 159, 170, 175 141, 186, 208

329 UEG Week Final Programme : Index of Authors and Co-Authors

Kang, Y...... 121 Katayama, H...... 125 Kazemier, G...... 98 Kieslichova, E...... 233 Kania, M...... 206 Katelaris, P...... 72, 284 Kazmierak, W...... 124 Kiesslich, R...... 157, 171 Kanie, H...... 207 Katerinis, P...... 227 Kazuki, B...... 158, 185 Kievit, W...... 103, 118, 165, 208 Kanj, S. S...... 229 Katicic, M...... 141 Ke, Y...... 191 Kiguchi, Y...... 148, 214 Kanmura, S...... 210 Kato, A...... 52, 124 Keasling, A...... 232 Kijima, H...... 192 Kanou, S...... 117 Kato, K...... 176, 212 Keating, D...... 139 Kikuchi, D...... 65, 192 Kanzaki, H...... 58 Kato, M...... 126, 127, 205, 231, 232 Kecili, L...... 224 Kikuchi, M...... 205, 231, 232 Kao, J. Y...... 81 Kato, N...... 201, 206 Kedia, P...... 130, 212 Kikuchi, T...... 237 Kao, S...... 232 Kato, T...... 92, 131, 196, 240 Keir, M...... 160, 180 Kikuchi, Y...... 215 Kapidzic, A...... 230 Kato, Y...... 149, 193 Keita, Å...... 92 Kikuste, I...... 151, 237 Kapoor, S...... 81 Katopodi, K...... 179 Kelber, O...... 147, 222, 234 Kiladze, M...... 199 Kappelle, W. F. W...... 114, 126 Katsanos, K. H...... 77 Kelkar, S. S...... 240 Kilander, C...... 65 Kara, N...... 229 Katsoula, A...... 227 Keller, J...... 151, 190, 235, 238 Kildusiene, I...... 216 Karacaoglu, S...... 113, 147 Katsumata, R...... 189 Kellici, I...... 191 Killinger, Z...... 136 Karagiannis, J...... 161, 195 Katsuno, T...... 214 Kellmann, P...... 99 Kim, B. G...... 213 Käräjämäki, A. J...... 201, 206 Katsushima, S...... 210 Kelly, O...... 177 Kim, B. S...... 197 Karakan, T...... 118, 138 Katsuyama, Y...... 159, 169 Kelly, R...... 93 Kim, B.-H...... 210 Karakaya, F...... 201, 230, 241 Katz, L...... 153, 188 Kemp, R...... 107 Kim, C. D...... 142, 151, 159, Karakaya, M...... 230 Katz, S. F...... 72 Ken, Y...... 124 169, 174, 175, Karamanolis, D. G...... 179 Kaufman, D...... 219 Kendrick, M. L...... 168 204, 211, 213, 220 Karamanolis, G...... 179, 222 Kaufmann, B...... 209 Kenjiro, S...... 158, 185 Kim, D...... 122, 140, 142, Karaoui, W. R...... 229 Kaukinen, K.....80, 90, 108, 151-152 Kennedy, J...... 143, 172 151, 159, 169, Karasawa, Y...... 65, 74, 127, 217 Kauma, H...... 201, 206 Kennedy, M...... 227 174, 175, 204, Karasulu, E...... 113, 147 Kaur, P...... 181 Kenshil, S...... 218 211, 213, 220, 236 Karatzas, P...... 179 Kautiainen, H...... 51 Ken, Y...... 158, 185 Kim, D. G...... 122, 142 Karavolos, M. H...... 164 Kautznerova, D...... 190 Kepil, N...... 161 Kim, D. H...... 193 Karber, M...... 241 Kawabata, K...... 210 Kepuladze, O...... 199 Kim, D. J...... 130, 234 Karciauskaite, D...... 206 Kawachi, H...... 236 Kermeen, M...... 72 Kim, D.-H...... 122 Kariv, R...... 184 Kawachi, K...... 230 Kersten, E...... 132 Kim, E. B...... 188 Karlsen, L...... 180, 277 Kawada, A...... 215 Kesäniemi, Y. A...... 201, 206 Kim, E. R...... 201, 241 Karlsen , T. H...... 40 Kawada, N...... 164 Keshav, S...... 188, 286. Kim, E. S...... 142, 151, 159, Karmiris, K...... 178 Kawaguchi, Y...... 170, 212, 218 Kessels, A...... 131 169, 175, 211, 213, 220 Karnel, F...... 119, 163 Kawahara, Y...... 58, 169 Kessler-Icekson, G...... 193 Kim, E. Y...... 201, 241 Karner, J...... 119, 163 Kawai, D...... 166,237 Keum, B...... 142, 151, 159, Kim, E.-K...... 122 Karstensen, J. G...... 104 Kawai, K...... 116, 142, 220 169, 175, 204, Kim, G. H...... 149, 193, 237 Kartal, A. Ç...... 201, 230, 241 Kawai, T...... 150 211, 213, 220 Kim, G. U...... 140 Karunanithi, V...... 148 Kawakami, Y...... 218 Kevalaite, G...... 194 Kim, H...... 106, 122, 136, 140, 142, Kasamatsu, S...... 214 Kawakubo, H...... 117, 145, 192, Kevans, D...... 93, 195 149, 150, 154, 159, 162, 168, Kaser, A...... 52, 66, 68, 88, 93, 95 215, 230 Khalid, Javaria M...... 47, 135, 139, 170, 175, 176, 184, 193, 204, Kashida, H...... 106, 115, 125, 128 Kawamoto, H...... 101 181, 225 211, 213, 220, 227, 236, 238 Kashin, S...... 173, 193 Kawamura, E...... 78, 164 Khalid, J. M...... 138-139, 182 Kim, H. G...... 123, 130 Kashiwagi, H...... 139, 224 Kawamura, M...... 237 Khalifa, A...... 225 Kim, H. J...... 210, 212 Kashiwagi, K...... 140 Kawamura, S...... 65, 74, 127, 217 Khamaysi, I...... 94 Kim, H. K...... 123, 173, 184, Kashyap, P. C...... 152 Kawamura, T...... 157, 167 Khan, I...... 130 192, 218, 237 Kasim, A...... 186 Kawanaka, M...... 101 Khanna, M...... 165 Kim, H. S...... 188, 202, 233 Kasper, S. H...... 50, 100 Kawano, H...... 106 Khannoussi, W...... 136, 180, 224 Kim, H. W...... 130, 212 Kasprowicz, F...... 132 Kawano, N...... 129, 142, 231 Kharchenko, O...... 145 Kim, H.-K...... 86 Kasturiratne, A...... 201, 206 Kawano, S...... 58 Kharrase, G...... 224 Kim, H.-S...... 123, 130 Kasugai, K...... 129, 238 Kawasaki, K...... 115, 125 Kharrasse, G...... 136, 180 Kim, H.-Y...... 202, 233 Katada, C...... 125. Kawasaki, Y...... 150 Khashab, M...... 51, 71, 87, 101, Kim, I. H...... 122, 142 Katagiri, A...... 55, 79, 84, Kawata, N...... 117, 140, 149, 161, 170, 174, 190, Kim, J...... 122, 123, 130, 50, 129, 141, 158, 185, 150, 158, 186 211, 219, 234 174, 176, 192, 199, 210, 186, 216, 217, 231 Kawata, Y...... 51, 59, 65 Khater, S...... 128 212, 213, 217, 234 Katano, T...... 58 Kawaura, K...... 191 Khayyal, M. T. T...... 222 Kim, J. C...... 186 Kataoka, H...... 58 Kayal, M...... 98 Khomeriki, S...... 225 Kim, J. H...... 131, 150, 168, 184 Kataoka, J...... 166, 237 Kazanov, D...... 50, 197, 203, Khomiak, I...... 221 Kim, J. J...... 192 Kataoka, S...... 129, 150, 217 212, 231, 240 Khusnutdinova, D...... 117, 150 Kim, J. S...... 127, 139, 169, Kataoka, Sh...... 150 Kazemi, A...... 239 Kiassov, A...... 123 186, 201, 210, Kataoka, Y...... 185 Kazemi-Shirazi, L...... 117, 152 Kida, M...... 96, 219 212, 236, 238, 241

330 331 Index of Authors and Co-Authors : UEG Week Final Programme

Kim, J. Y...... 142 Kirnake, V...... 158, 163 Kocot, B...... 106 Kono, Y...... 58 Kim, J.-A...... 214 Kirsners, A...... 151 Kodama, Y...... 157, 167 Konopka, L...... 143 Kim, J.-O...... 79, 201, 241 Kirthi, S...... 138 Kodashima, S...... 115, 125, 172 Konoplyannikov, A...... 181, 226 Kim, K...... 123, 148, 173, Kishi, H. S...... 240 Kodetova, D...... 117, 148 Konstantinov, S...... 228 184, 188, 192, 218, 237 Kishida, Y...... 140 Kodisinghe, S. K...... 201, 206 Kontos, G...... 165 Kim, K. B...... 188 Kishihara, T...... 128, 221 Koecke, J...... 138 Kontula, K...... 51 Kim, K. D...... 140, 236 Kita, R...... 88 Koekoek, B...... 141 Koo, H...... 121 Kim, K. J...... 123, 174, 176 Kitagawa, T...... 195 Koens, L...... 158, 185 Koo, J. S...... 233 Kim, K. O...... 150, 217 Kitagawa, Y...... 114, 125, 149, Kofod Vinding, K...... 77 Koo, J.-S...... 174, 201, 241 Kim, K.-H...... 123, 130 169, 192, 215 Koga, F...... 218 Koo, S...... 233 Kim, K.-J...... 123, 140 Kitakata, H...... 59 Kogure, H...... 122 Kooby, D. A...... 168 Kim, K.-O...... 214 Kitano, M...... 63, 98, 123, 174, 219 Koh, D. H...... 122 Kopacova, M...... 189 Kim, M. A...... 214 Kitano, Y...... 60, 88 Koh, K. C...... 121 Kopchak, K...... 221 Kim, M. H...... 176 Kiudelis, G...... 134, 158, 162 Koh, S.-J...... 201, 241 Kopchak, V...... 221 Kim, M.-H...... 175, 210, 211, 218 Kiyasov, A. P...... 118 Kohlmann, T...... 132 Kopke Tulio, M. A...... 164, 165, 218 Kim, N...... 47, 123, 130, Kiyomatsu, T...... 116, 142, 220 Kohn, A...... 56, 183 Kopperud, G. S...... 116, 137 161,172, 189, Kiyota, R...... 232 Kohno, H...... 49, 103, 186 Kopylov, U...... 181 192, 193, 217, 237 Kizer, J. S...... 98 Kohrrami, S...... 229 Kordek, R...... 141, 160, 177 Kim, S...... 93, 106, 122, 127, Kjeldsen, J...... 182 Koike, K...... 102, 122, 132, 172 Koroglu, E...... 161, 178 139, 142, 149, 151, 169, Klag, T...... 241 Koike, T...... 115, 125 Korolczuk, A...... 124 170,184, 186, 188,197, Klanac, A...... 167, 211 Koivurova, O.-P...... 201, 206 Kosaka, T...... 59 201, 202,204, 211, 213, Klang, E...... 180 Koizumi, A...... 52, 167, 170 Kosiol, N...... 233 220, 233, 236, 238, 241 Kleger, A...... 60, 86, 94, 97 Koizumi, K...... 74 Koslovsky, B...... 182 Kim, S. B...... 122, 142 Klein, A...... 49 Koizumi, W...... 96, 219 Kostovcik, M...... 134 Kim, S. E...... 150, 184 Kleine, E...... 70 Kojalo, I...... 186, 237 Kostrzewa, K...... 208 Kim, S. G...... 127 Kleinschmidt, K...... 121 Kojalo, U...... 186 Kostuk, O...... 145 Kim, S. H...... 122, 140, 142, 154, Klemm, W...... 183 Kojic, D...... 224 Kot, M...... 94, 211 159, 162, 169, 175, 204, Klenter, S...... 172 Kojima, K...... 65, 74, 217 Kotake, S...... 170 211, 213, 220, 236, 238 Klepetko, W...... 117, 152 Kojima, Ko...... 115, 125, 215 Kotsafti, A...... 191 Kim, S. K...... 148, 188 Klimesova, K...... 134 Kojima, M...... 169 Koukias, N...... 53 Kim, S. S...... 184 Kliminski, V...... 193 Kojima, T...... 169 Koukofiki, A...... 120 Kim, S. W...... 122, 142, 184 Klompmaker, S...... 160, 176 Kojima, Y...... 222 Koukouratos, T...... 179 Kim, S. Y...... 150, 174, 233 Klonis, A...... 184 Kok, N...... 87, 132 Koulaouzidis, A...... 174, 223 Kim, S.-E...... 201, 241 Klopocka, M...... 61 Kolar, M...... 70, 182-183, 226, 227 Koumoutsos, I...... 138, 168, Kim, S.-H...... 197 Kmiotek, J...... 162 Kolesar, L...... 202, 206 192, 235 Kim, S.-J...... 49, 195, 198 Knappe-Drzikova, B...... 241 Koletzko, B...... 90 Koundouros, N...... 72 Kim, T...... 59, 106 Knight, R...... 181 Koletzko, S...... 75, 108, 201 Kouno, H...... 49, 103, 114, Kim, T. I...... 136, 227 Knight, S. C...... 105 Kolkman, J. J...... 141, 161, 179 122, 186 Kim, T. N...... 123, 130, 217 Knittel, T...... 62, 204, 224 Kollar, M...... 117, 148 Kourikou, A...... 120, 165 Kim, T. W...... 193 Knowles, C. H...... 75, 87, 186 Koller, T...... 136, 160, 179 Kouyama, Y...... 79, 141, 158, Kim, W. H...... 136, 227 Knudsen, M. D...... 78 Kollerova, J...... 136 185, 186, 217, 231 Kim, Y. J...... 122, 150, 199, 213, 217 Knyazev, O...... 181, 225, 226 Koloski, N...... 135 Kovacheva-Slavova, M...... 114, 123, Kim, Y. W...... 159, 176 Ko, B. M...... 79, 192, 237 Koloski, N. A. A...... 143, 231 124 Kim, Y.-T...... 122 Ko, W. J...... 148, 192 Komeda, Y...... 128 Kovacs, G...... 136 Kim, Y.-W...... 197 Kobatake, T...... 121 Komekado, H...... 88, 216 Kovacs, T. O...... 115, 125, 215 Kimura, A...... 156, 164 Kobayashi, A...... 177 Komori, H...... 150, 170, 190, 237 Kovacs, V...... 99 Kimura, E...... 149, 195 Kobayashi, H...... 115, 125, 23 Komura, T...... 212 Kovács, Á...... 222 Kimura, H...... 135 Kobayashi, K...... 115, 125, Kondo, H...... 52, 124 Kovács, I...... 137 Kimura, M...... 180 176, 212 Kondo, M...... 65 Kovarsky, B...... 117, 150 Kimura, T...... 88, 216 Kobayashi, N...... 106, 170 Kondo, S...... 65 Kovatchki, D...... 93 Kimura, Y...... 158, 185-186 Kobayashi, R...... 59 Kondo, Y...... 73 Kowalski, J...... 62, 204, 224 Kinami, S...... 59 Kobayashi-Uchida, S...... 78 Kondou, Y...... 129 Kowazaki, Y...... 115, 125, 127, 215 Kinoshita, S...... 205, 231, 232 Kobiela, J...... 106, 127 Kondrackiene, J...... 158, 162 Kozbial, K...... 78, 208 Kinross, J...... 72, 228 Koblova, K...... 183 Konecny, S...... 191, 236 Kozicka, J...... 114, 123 Kipcak, S...... 113, 147 Kobyliak, N...... 152 Konikoff, F...... 210, 213 Kozlov, I. G...... 145 Kira, M...... 195 Koch, A. D...... 38, 236 Konishi, H...... 125, 170 Kozuka, R...... 78, 164 Kirazli, T...... 235 Koch, S...... 176 Konishi, T...... 230 Kozumi, K...... 149, 195 Kirchgesner, J...... 47, 56, 77 Kochhar, R...... 63 Kono, M...... 128 Kraft, K...... 234 Kirilenko, N. P...... 191 Kocollari, A...... 191 Kono, S...... 237 Kraja, B...... 191

331 UEG Week Final Programme : Index of Authors and Co-Authors

Krajciova, J...... 117, 148, 190, Kudo, T...... 55, 79, 84, Kuvaev, R...... 173, 248 Lakatos, L...... 51, 70, 77, 83, 90, 214, 236 129, 141, 158, Kuwabara, H...... 236 134, 136, 137, 182, Krajcovicova, A...... 136, 160,179 185, 186, 216, 217 Kuwai, T...... 49, 74, 103, 204, 222, 227 Krajewska, U...... 141 Kudo, Y...... 132 114, 122, 186 Lakatos, P. L...... 51, 70, 77, 83, Krak, N. C...... 98 Kuehbacher, T...... 61 Kuwashiro, T...... 218 90, 107, 134, 136, Kralj, D...... 146, 188, 233 Kuehni, C...... 190 Kuzma, M...... 136 137, 182, 204, 227 Kranidioti, H...... 165 Kuetting, F...... 173 Kvaloy, J. T...... 180, 226 Lakhtakia, S...... 51 Krarup, A. L...... 191, 235 Kuhlmann, L...... 167 Kverka, M...... 134 Lakner, L...... 70 Krastev, R...... 147 Kühn, J. P...... 132 Kvetina, J...... 189 Lalor, P. F...... 178 Kraszewska, E...... 127 Kuhns, S...... 181 Kwak, M. S...... 186 Lam, C...... 186 Kraus, M...... 120 Kui, B...... 123 Kwak, M.-O...... 186 Lam, C. C. H...... 213 Kraus, S...... 50, 240 Kuiper, J...... 93 Kwek, A. B. E...... 173 Lam, F. Y...... 140 Krauth, C...... 165 Kuipers, E. J...... 8, 46, 59, 73, 77, Kwiecien, S...... 189 Lam, T...... 219 Krawczyk, M...... 208, 210 82, 89, 106, 140, 161, Kwon, D.-H...... 140 Lamanda, R...... 203, 213-214 Kraynova, E...... 173 171, 197, 228, 230 Kwon, J. G...... 148 Lamas, B...... 57 Kreis, G...... 46 Kujundzic, M...... 141, 156, 165, 209 Kwon, K...... 86, 197 Lamas-Díaz, M. J...... 136 Kreisel, W...... 66 Kulkarni, A...... 167, 214 Kwon, K. A...... 150, 217 Lambeth, L...... 113, 143 Kremoser, C...... 158, 162 Kullak-Ublick, G. A...... 134 Kwon, O. K...... 197 Lambregts, D. M...... 63, 87, 88, Krenacs, T...... 52 Kullavanijaya, P...... 187 Kwon, T...... 201, 241 91, 131, 132 Krenz, D...... 184 Küllmer, A...... 125 Kwon, Y. H...... 150 Lammert, F...... 158, 162, 199, 210 Kressel, J...... 155 Kumar, A...... 158,163 Kyaw, M...... 219 Lammertyn, J...... 223 Kreuser, N...... 233 Kumar, R...... 207 Kypraios, D...... 101 Lamonaca, L...... 202, 229 Kriegshäuser, G...... 196 Kumar, S...... 81 Kyriakopoulou, M...... 154 Lampasona, V...... 116, 145 Kriel, H...... 172 Kumar, U...... 122 Lanas, A...... 185,230 Krike, P...... 145, 151 Kumbhari, V...... 51, 71, 87, Lancaster, P...... 61 Krishnadath, K. K...... 80 101, 161, 170, L Landi, R...... 71,94, 213, 220 Krishnaveni, J...... 207 174, 190, 211, 219 L, V...... 207 Landi, S...... 192, 205, 237 Kristo, N...... 167 Kume, K...... 228 La Cognata, C...... 151 Landman, C...... 77 Kristof, T...... 70, 137, 222 Kumei, S...... 228 La Russa, T...... 238, 239 Landon, M...... 127 Krizsán, M...... 204, 223 Kundratova, E...... 140 La Selva, D...... 223 Lang, S...... 178, 221 Krmac, H...... 66 Kuninty, P...... 60 Labalette, M...... 225 Lang, Y...... 61, 116, 137 Kroener, P. T...... 122, 129, 173 Kunst, C...... 162, 209 Labardi, M...... 215 Langbein, C...... 181 Kroner, P...... 74 Kuntz-Huon, J...... 216 Labedz-Maslowska, A...... 211 Lange, E...... 145, 241 Kroupa, R...... 191, 231, 236 Kuo, C.-J...... 150 Labenz, G...... 53 Langella, P...... 57 Krug, S...... 168 Kupcinskas, J...... 145, 151, 158, Labenz, J...... 38, 53, 79, 97 Langholz, E...... 134 Kruis, W...... 43, 109, 143, 225 162, 194, 202, 211 Laberenne, J.-E...... 89 Langhorst, J...... 135, 138 Kruk, B...... 208 Kupcinskas, L...... 145, 151, Labianca, O...... 218 Langlois, L...... 178 Krumina, A...... 57, 134 158, 162, 194 Labrador, E...... 124 Langner, C...... 63, 75, 90, Krumina, G...... 179 Kupka, T...... 240 Lachance, J.-R...... 186 96, 151, 194, 238 Kryukova, T...... 173, 193 Kuppen, P. J. K...... 60 Lacima, G...... 113, 143 Lankarani, K. B...... 165 Krzeczewski, B...... 127 Kuraoka, K...... 168 Lacognata, C...... 142 Lannes, A...... 128 Kubicka,S...... 87, 103 Kurien, M...... 152, 205, 239 Ladas, S. D...... 179, 205, 234 Lansdorp-Vogelaar, I...... 73, 74, Ku, J...... 85 Kurihara, D...... 129, 142, 231 Ladefoged, K...... 77 77, 140, 216, 230 Kubis, E...... 177 Kurihara, M...... 193 Ladelund, S...... 211 Lanska, V...... 202, 206 Kubo, A...... 168 Kuriyama, T...... 224 Laferla, G...... 222 Lantinga, M. A...... 65 Kubo, H...... 124, 170 Kurokawa, K...... 65 Lage, J...... 126, 184 Lantto, E...... 130, 174 Kubo, M...... 70 Kuroki, K...... 193 Lage, P...... 157, 171, 172, 185, Lapalus, M...... 216 Kubosawa, Y...... 205, 231-232 Kurosaki, S...... 65, 127, 217 198, 217, 229, 230 Larabi, A...... 93 Kubota, K...... 210 Kurotaki, H...... 88 Lagergren, J...... 65 Laredo, V...... 70 Kuca, K...... 189 Kurppa, K...... 151-152 Lagergren, P...... 161, 191 Larghi, A...... 50, 130, 174 Kuchar, J...... 231 Kurti, Z...... 70, 137, 182 Laghi, A...... 47 Lariño-Noia, J...... 131, 159, 174, Kucharzik, T...... 136 Kurtz, C. B...... 92, 98 Lago, P...... 136, 223, 227 203, 211 Kucinskiene, R...... 194 Kurzepa, J...... 114, 123-124 Laharie, D...... 73 Lasch, K...... 181 Kucuk, M...... 93, 146 Kusaka, T...... 105 Lahat, A...... 180 Lashen, S. A...... 242 Kudo, M...... 98, 123, 128 Kusakabe, A...... 199, 207 Lahaye, M...... 87, 132 Lashermes, A...... 232 Kudo, S...... 79, 129, 141 Kusano, C...... 238 Lahmek, P...... 137 Laslop, A...... 82 Kudo, S.-E...... 55, 84, 106, 141, Kushida, S...... 214 Lahner, E...... 116, 145 Lasry, B...... 226 157, 158, 171, 185, 186, Kusnierz-Cabala, B...... 134, 211 Lai, T.-L...... 197 Laszkowska, M...... 196, 239 216, 217, 230, 231 Küttner Magalhães, R...... 188 Lai, Y.-H...... 146 Lasztity, N...... 166

332 333 Index of Authors and Co-Authors : UEG Week Final Programme

Latchford, A...... 106 Lee, H...... 47, 49, 81, 121, 122, 124, Lee, Y. J...... 130, 193, 201, 241 Levhar, N...... 180 Latella, G...... 116, 137, 238 142, 159, 161, 172, 176, 188, Lee, Y. N...... 159, 173, 218 Levi, Z...... 153 Laterza, F...... 152, 239 189, 192, 193, 195, 198, 202, Lee, Y. S...... 123, 130 Levine, Y...... 226 Latorre, E...... 178 210, 211, 218, 233, 237 Leeb, G...... 185, 229 Levy, M...... 219 Latorre, P...... 199 Lee, H. J...... 136, 193, 227 Leeder, P. C...... 240 Levy, S...... 240 Latorre, R...... 184 Lee, H. S...... 125, 210 Leedham, S...... 97 Lévy, P...... 82, 159, 167 Lau, J. Y. W...... 63, 219 Lee, H.-H...... 139 Leeds, J...... 81, 216 Lewandowska, M...... 177 Lauche, R...... 138 Lee, H.-J...... 197, 229 Leemreis, D...... 132, 161, 197 Lewandowska, U...... 141 Lauenstein, T...... 135 Lee, H.-M...... 87, 240 Leeuwenburgh, I...... 219 Lewis, S...... 185 Laugier, R...... 51 Lee, H.-S..... 151, 159, 169, 204, 213, Lees, C...... 42, 68, 116, 282 Ley, D...... 92 Lauri, A...... 203, 213, 214 220, 230, 270 Lefere, S...... 65 Leyland, H...... 81 Laurikka, P...... 152 Lee, I. K...... 212 Leggett, C. L...... 79 Li, D...... 100 Laurila, K...... 151, 195 Lee, I.-S...... 123, 139 Legoux, J. L...... 220 Li, J...... 66, 100, 114, 122, 130, 173 Laursen, S. B...... 103 Lee, J...... 59, 63, 106, 123, 130, Legros, R...... 84, 169-170, 236 Li, M.....119, 204, 207, 212, 221, 232 Lauwers, G. Y...... 116, 141 136, 150, 193, 201, Lehours, P...... 194 Li, Q...... 114, 126, 170, 181 Lavie-Richard, M...... 57 210, 212, 227, 241 Lei, W.-Y...... 147, 234 Li, Q.-L...... 59, 71, 170 Lavrinovica, E...... 57, 134 Lee, J. A...... 59, 106 Leibovici-Weissman, Y...... 153 Li, R...... 99, 119, 179, 234 Law, G. R...... 58, 160, 179 Lee, J. H...... 121, 192, 202, 233 Leicester, R...... 37, 41, 44, 50, Li, W. J...... 173 Law, R...... 58, 160, 179, 218 Lee, J. K...... 94, 122, 124, 176, 218 102, 158, 203 Li, X...... 103, 121 Law, W. L...... 140 Lee, J. M...... 142, 151, 159, 169, 175, Leiro, J. M...... 134, 178 Li, Y...... 118, 135 Layer, P...... 151, 190, 235, 238 204, 211, 213, 220 Leise, M...... 218 Liang, J...... 226 Layunta, E...... 100, 178 Lee, J. S...... 237 Leitao, K...... 180, 227 Liang, Q...... 49 Lazar, A...... 183, 208, 225 Lee, J. W...... 122 Leitão, C...... 155, 198, 219 Liang, X...... 58, 158, 162 Lázár, G...... 139 Lee, J. Y...... 130, 148 Leja, M...... 47, 92, 142, 145, 151, 161, Libânio, D...... 59, 215 Lazare Iglesias, H...... 131, 174 Lee, J.-C...... 130, 212 179, 186, 193, 202, 237 Liberal, R...... 199, 212, 219 Lazarenko, L. M...... 197 Lee, J.-H...... 197 Leja-Szpak, A...... 211 Libes, M...... 172 Lazaris, V...... 154 Lee, J.-Y...... 169 Lejnieks, A...... 57, 134 Libier, L...... 181 Lazaro, A...... 66 Lee, K. H...... 124, 176, 218 Lelli, F...... 139 Licastro, D...... 66 Lazaro, M...... 103 Lee, K. J...... 123 Lelong, B...... 130, 217 Lichtenstein, L...... 137, 182 Le, N...... 168 Lee, K. T...... 168, 176, 218 Lemaistre, A. I...... 98 Lictenstein, L...... 135 Le Bourhis, L...... 72, 222 Lee, K.-B...... 122 Lemaitre, M...... 47, 56 Lidén, A...... 187 le Clercq, C. M. C...... 79 Lee, M...... 58, 79, 142, 151, 159, 169, Lemieux, C...... 135 Liebert, R...... 58, 113, 143 Le Moine, O...... 41, 68, 75, 82, 146 175, 204, 211, 213, 220 Lemmers, A...... 68, 75, 82, 146 Lied, G. A...... 85, 205, 233 Le Nevé, B...... 81, 143, 144, Lee, M. S...... 215 Lennon, A. M...... 97 Liefferinckx, C...... 85 152, 228 Lee, O.-Y...... 188 Lenoci, N...... 104 Liepniece-Karele, I...... 151, 237 Le-Sidaner, A...... 169 Lee, S...... 79, 106, 123, 128, 140, Lenoir, L...... 171 Lièvre, A...... 171 Leblanc, S...... 219 149, 151, 159, 169, 170, Lenze, F...... 222 Liew, I. Y...... 136 Lebre, L...... 164 175, 204, 210, 211, 213, Leodolter, A...... 97 Liggi, M...... 72 Lebwohl, B...... 196, 239 215, 218, 220, 230, 236, 238 Leon, H...... 147 Lightdale, C...... 235 Lecaille, C...... 220 Lee, S. H...... 122, 124 Leonard, M. M...... 239 Ligresti, D...... 131 Lecca, G. P...... 182 Lee, S. K...... 149, 175, 210, 211, Leong, R. W...... 57, 72 Liliana, C...... 154 Lechat, E...... 137 215, 218, 237 Leopoldo, M...... 172 Liljebo, T...... 46 Lechel, A...... 72, 86, 94 Lee, S. O...... 122, 142 Leow, W. Q...... 207 Lillemoe, K. D...... 177 Lechter, J...... 131 Lee, S. S...... 175, 210, 211, 218 Lepilliez, V...... 215, 236 Liluashvili, K...... 144 Lecleire, S...... 175 Lee, S. T...... 122, 142, 188 Lerch, M. M...... 41, 48, 68, 132 Lim, A...... 186 Lecomte, T...... 220 Lee, S. W...... 59, 106, 174, 233 Lérias, C...... 119, 151, 189 Lim, C...... 170 Leducq, V...... 57 Lee, S. Y...... 142, 151, 159, 169, 175, Leroith, D...... 191 Lim, C.-H...... 220 Lee, B. E...... 149, 193, 237 204, 211, 213, 220 Leshno, A...... 240 Lim, D. N. F. N. F...... 79 Lee, B. J...... 59, 106, 210, 212 Lee, S.-H...... 188 Leshno, M...... 158, 166, 204, 217 Lim, J. H...... 127, 201, 241 Lee, B. S...... 123, 140, 236, 238 Lee, S.-J...... 188 Lesina, M...... 60 Lim, K. H...... 207, 230 Lee, B.-I...... 93, 139, 186 Lee, T...... 121, 122, 142, Leskova, Z...... 136, 160, 179 Lim, L...... 150, 238 Lee, C...... 53, 149, 188, 201, 176, 188, 218 Lestelle, V...... 71, 127 Lim, M...... 241 215, 237, 241 Lee, T. H...... 49, 159, 173, 195, Lesyk, R...... 70 Lim, S...... 144 Lee, C. H...... 81 198, 210, 218 Letamendi, G...... 119 Lim, T. Y...... 181 Lee, D. H...... 47, 161, 172, 188, Lee, T. Y...... 94 Leung, F. W...... 72 Limdi, J. K...... 183, 225 189, 192, 193, 211, 237 Lee, T.-C...... 169 Leung, J...... 190 Limsrivilai, J...... 187 Lee, D. W...... 123, 130, 174 Lee, X. Y...... 139 Leung, W. K...... 140 Lin, C. Y...... 150 Lee, E...... 138, 149, 193, 237 Lee, Y. B...... 230 Leurs, I...... 105 Lin, E...... 57 Lee, E. S...... 140, 238 Lee, Y. C...... 149, 188, 215, 237 Levchenko, O...... 225 Lin, H.-C...... 146

333 UEG Week Final Programme : Index of Authors and Co-Authors

Lin, H.-H...... 208 Llovet, L...... 77 Losurdo, G...... 196, 207, 222 Luzius, A...... 93 Lin, J.-C...... 208 Lo, H. G. R...... 133 Lottrup, C...... 235 Luzza, F...... 238, 239 Lin, J.-T...... 78, 195, 197, 209 Lo Secco, G...... 113, 148 Lou, Q...... 210 Lv, B...... 232 Lin, L...... 226 Lobaton, T...... 138 Louis, E. J...... 47, 160, 181, Lv, L...... 190 Lin, Q...... 86, 94 Lobatón, T...... 139, 180 182, 282, 285 Lyadov, V...... 212 Lin, R...... 168, 207 Loberg, M...... 106 Louis, H...... 71, 113 Lyamina, S...... 117, 147 Lin, S.-K...... 146 Lobo, A. J...... 134 Loureiro, R...... 173 Lycousi, S...... 161, 195 Lin, S.-Y...... 146 Locato, V...... 105 Lourenço, L. C. C...... 220 Lynch, V...... 168 Lin, Z...... 165 Löfberg, R...... 160, 181 Loustaud-Ratti, V...... 169, 170 Linares Perez, M...... 107, 178, 182 Logan, R...... 80, 150, 238 Lovasz, B. D...... 70, 137, 182, 227 Lind, K...... 130, 174 Loghmari, M. H...... 227 Lovat, L. B...... 146 M Lindahl, T...... 143 Loguercio, C...... 231 Lowenberg, M...... 89 Ma, S...... 126 Lindberg, G...... 87 Löhr, H...... 120 Lowen, M...... 232 Ma, X...... 128 Lindblad, M...... 161, 191 Löhr, J. M...... 86 Lowry, A...... 187 Ma, Y. T...... 168 Lindfors, K...... 152 Löhr, M...... 48, 68, 86, Loza, A...... 131 Maa, J.-F...... 160, 181, 182, 225 Lindfors, P...... 46 114, 124, 248 Loza, M. J...... 93 Maas, M...... 88, 131 Lindsay, J...... 47, 75, 89, Lohse, M...... 162 Lozynskyy, Y...... 225 Maasberg, S...... 241 138, 139, 182 Loitto, V...... 178 Lu, B...... 127, 149 Maaser, C...... 136 Lindsay, J. O...... 160, 183 Lojo, S...... 203, 211 Lu, J...... 81, 223 Mabrut, J.-Y...... 81 Lindsjø, I...... 224 Lokiec, K...... 240 Lu, M...... 118, 209 Macaluso, F. S...... 139, 227 Lindstrom, J...... 72 Lolli, E...... 116, 135, 136 Lu, X...... 214 Maccioni, F...... 72, 175 Lindström, O...... 202, 211 Lomash, A...... 81 Lu, Z...... 212 Macconell, L...... 121, 163, 166 Line, A...... 142, 145 Lombardi, G...... 130 Lubel, J...... 105 Macdonald, I. A...... 240 Linedale, E. C...... 143, 188 Lombardo, V...... 205, 239 Lucas, C...... 93 Macedo, G...... 93, 119, 120, 126, Ling, Q...... 88 Lombay, B...... 51 Lucas, J...... 227 135, 154, 155, 162, 165, Link, A...... 105, 151, 161, Lonardi, S...... 142 Lucci, L...... 138, 151 175, 180, 187, 191, 193, 193-194, 209, 238 Londoni, C...... 203, 213, 214 Lucendo, A. J...... 138 196, 198, 199, 212, 219, 241 Linzenbold, W...... 168 Longarzo, M...... 231 Lucendo Villarin, A. J...... 136 Macenlle, R...... 157, 171 Liou, J.-M...... 195 Longcroft-Wheaton, G...... 79, 104, Luchini, C...... 177 Macfarlane, K...... 239 Lisboa, C...... 155 140, 142, Ludlow, H...... 225 Mach, K...... 185, 229 Lishchinskaya, A...... 181, 226 148, 170, 235 Ludvigsson, J...... 90, 102, 196, 239 Mach, T...... 196, 223 Lisotti, A...... 144 Looijenga, L...... 205, 235 Ludvigsson, J. F...... 105 Machado, M. V.....99, 103, 163, 198 Litta, F...... 180 Looney, C...... 160, 180 Luet, D...... 128, 186 Machicado, G...... 58, 115, 125, 215 Liu, B...... 126, 128, 176, 230 Lopes, J...... 103, 135, 163 Luglio, G...... 90, 224 Machida, H...... 106 Liu, D...... 80, 116, 137, 154, Lopes, S...... 119, 123, 135, 136, 162, Luhn, J...... 164 Machida, N...... 119 177, 190, 199 165, 180, 184, 193, 199, Lui, H. F...... 133 Machkova, N...... 182, 226, 227 Liu, K...... 63 208, 212, 223, 240 Luigiano, C...... 130 Machytka, E...... 152, 240 Liu, L...... 66, 146, 193, 210, 236 Lopetuso, L. R...... 134, 138, 179, Luiselli, D...... 228 Macinga, P...... 124, 164 Liu, M...... 99, 100 222, 228 Lujan, M...... 239 Maciuca, R...... 160, 180 Liu, T.-T...... 147, 234 Lopez, R...... 225 Luk, L...... 98 Mackay, D...... 168 Liu, W...... 193 Lopez De Hierro, M...... 99, 189 Luk, W. F...... 201, 228 Macken, E...... 80, 182, 205, 235 Liu, X..... 58, 117, 158, 162, 228, 242 Lopez Gomez, M...... 128, 172 Lukas, M...... 70, 182, 183, 226, 227 Maconi, G...... 136 Liu, Y...... 81, 118, 162, 169, 212, 214 López Ibáñez, M...... 157, 171 Luketic, V...... 121, 166 Macrae, S...... 105 Liu, Y. X...... 228 López López, S...... 141 Lukic, A...... 156, 165 Macrì, E...... 172 Liu, Z...... 66, 81, 191 López Vicente, J...... 157, 171 Lukyanenko, O...... 166 Madacsy, L...... 203, 215 Liu, Z.-H...... 185 López Vivancos, J...... 196 Lula, S...... 226 Madacsy, T...... 94, 123 Liusiana, E...... 120 Lopez-Ceron, M...... 77, 157, 171 Lundberg, P...... 92 Madanchi, M...... 134 Liverani, E...... 234 López-Díaz, J...... 174 Lundell, L...... 115, 129, 148, 161, 191 Madani, A...... 141 Livrelli, V...... 74 López-López, A...... 94 Lundin, K. E. A...... 226, 227 Maddern, J...... 92 Livzan, M...... 197 Lopez-Posadas, R...... 105 Lung, P. F. C...... 205, 225 Maddison, R...... 87 Lizarzabal, M...... 150 Lopez-Siles, M...... 74, 112, 133 Luo, M...... 181 Made, S...... 130 Ljaljukova, E...... 197 Lopitz Otsoa, F...... 209 Luongo, L...... 64 Maden, A...... 190 Ljubicic, N...... 146, 188 Lördal, M...... 180 Lupescu, I...... 119 Madenidou, A.-V...... 227 Ljung, T...... 180 Loren, V...... 221 Lupusoru, R...... 88, 117, 120, Madisch, A...... 191 Llach, J...... 151, 173, 218 Lorente Poyatos, R...... 56 163, 202, 208 Madl, C...... 118, 163 Llanto, M...... 200 Lorenzo, D...... 144 Luthra, P...... 72 Madrigal-Rubiales, B...... 131 Llao, J...... 139, 157, 171 Lorenzo-González, A...... 204, 223 Lutz, L...... 66 Madro, A...... 114, 123-124 Llordés, M...... 161, 196 Lorinczy, K...... 99 Luypaerts, A...... 59 Madsen, K...... 195 Llort, G...... 229 Lorusso, V...... 209 Luz, G. O...... 50 Madzak, A...... 167

334 335 Index of Authors and Co-Authors : UEG Week Final Programme

Maeda, A...... 177 Malek, N...... 241 Marabotto, E...... 58, 147, 190, 194 Martelius, T...... 80 Maeda, H...... 210 Malek, N. P...... 49, 66 Marasco, G...... 121, 153 Martella, B...... 176 Maeda, K...... 150 Malek-Hosseini, S. A...... 163, 164, Marasco, R...... 238, 239 Marti Romero, L...... 138 Maeda, S...... 212 201, 206 Marcén, B...... 70 Martin, C...... 98, 144 Maeda, Y...... 55, 129, 215 Maleki, I...... 239 Marchart, K...... 164 Martin, D...... 53 Maehata, T....114, 125, 129, 148, 214 Malekzadeh, R...... 212 Marchegiani, G.....175, 177, 203, 212 Martin, J...... 134 Maes, T...... 65 Maléth, J...... 94, 123 Marchesi, J...... 72, 228 Martin, N...... 135 Maeshima, S...... 74, 127, 217 Malezieux, R...... 216 Marchesini, J. C. D...... 197 Martin, R. C...... 98 Maeshiro, K...... 168 Malfertheiner, P...... 38, 80, 82, Marchi, S...... 58, 97, 147, 187, 190 Martin, S...... 73 Maetani, I...... 74 89, 105, 151, 161, 192, Marciani, L...... 186 Martín Arranz, M. D....139, 181, 225 Maev, I...... 117, 147, 193 194, 209, 236, 238, 284 Marcos, P...... 162, 207 Martin-Arranz, M...... 56, 138 Magalhães, J...... 63, 131, 164, 199 Maliar, A...... 104 Marcos-Pinto, R...... 188, 215 Martin-Lorente, J. L...... 97 Maggino, L...... 177 Malickova, K...... 70, 182, 226, 227 Marcovici, T...... 153 Martín-Rodríguez, D...... 138 Magierowska, K...... 116, 133, 189 Malik, H...... 200 Mare, R. G...... 88, 117, 120, 156, Martinato, M...... 228 Magierowski, M...... 116, 133, 189 Malik, S...... 141, 185 163, 165, 208 Martinek, J...... 117, 148, 190, Magina, S...... 180 Malini, A...... 123 Marginean, C...... 153 210, 214, 233, 236 Magnusson, M. K...... 221 Malinverno, F...... 130 Marginean, C. O...... 153 Martinez, F. A...... 101 Magris, R...... 142 Malitezis, G...... 205, 225 Marginean, M. O...... 153 Martinez, S...... 229 Magro, F...... 77, 134, 136, 180, 223 Malko, M...... 230 Marginean, O...... 153 Martinez Alcala, A...... 101 Magzenik, S...... 172 Mallant-Hent, R. C...... 73 Margos, W...... 99 Martínez Fernández, P...... 97 Mahadeva, S...... 91, 260 Malleo, G...... 173, 175, 177, 203, 212 Mariette, C...... 81 Martínez López, M...... 134 Mahadik, M...... 167, 169, 210, 214 Malmstrøm, G. H...... 224 Marignani, M...... 164 Martinez Medina, M...... 134 Mahadik, M. R...... 115, 125 Maluskova, J...... 117, 148 Marin, A. C...... 178, 182 Martinez Moneo, E...... 125 Maharshak, N...... 139, 182, 197, 222 Malyshev, I...... 117, 147 Marin, I...... 138, 234 Martinez Montiel, M. P...... 56 Maheshwari, P...... 175 Mana, F...... 80, 182, 205, 235 Marin, V...... 161-162, 166 Martínez Turnes, A...... 157, 171 Mahindra, P...... 235, 236 Mancebo Gimenez, A...... 178 Marín, E...... 124 Martinez-Alcala, A. G...... 126 Mahiou, H...... 224 Mancini, M...... 234 Marín Pedrosa, S...... 179 Martínez-Alcalá, Á...... 121, 129, Mahmood, T...... 145, 166, 169 Mandelli, G...... 104 Marinaki, A...... 138 173, 240 Maia, L...... 188, 227 Mandolesi, D...... 210, 234 Marinho, C...... 164, 241 Martinez-Alcala García, F...... 101 Maida, M...... 139, 187, 227 Mandorfer, M...... 78, 119, 163 Marinho, R. T..... 114, 120, 165, 242 Martinez-Ares, D...... 157, 171 Maier, H...... 72 Maneix, L...... 232 Mariniello, A...... 174 Martinez-Bauer, E...... 157 Maier, R...... 186 Manes, G...... 157, 171, 216, 218, 248 Marino, M...... 157, 167 Martinez-Cara, J. G...... 99, 189 Maiero, S...... 142 Manfredi, R...... 173 Marinopoulos, G...... 179, 190 Martinez-Chantar, M. L...... 209 Maieron, A...... 218 Manfredi, S...... 220 Mario, B...... 144 Martinez-Indart, L...... 157, 171 Maillard, M. H...... 94, 136 Manfrini, R...... 128 Marker, D...... 224 Martínez-Indart, L...... 129 Mainenti, P. P...... 77, 90, 224 Mangia, A...... 42, 78 Marks, L...... 205, 239 Martínez-Martínez, L...... 134, 178 Maione, F...... 90 Mangiafico, S...... 203, 213, 214 Markus, T...... 85 Martinez-Medina, M...... 74, 112, Maione, S...... 64 Mangiola, F...... 138 Marlicz, W. M...... 177 133-134, 178 Maire, F...... 98 Manguso, F...... 183 Marmo, C...... 203, 213, 214 Martínez-Moneo, E...... 124-125 Mairiang, P...... 187 Manini, M...... 130 Marmo, R...... 203, 213-214, 216 Martínez-Pallí, G...... 151 Maisonneuve, P...... 168 Mannami, T...... 115, 125 Marmon, T...... 121, 163, 166 Martini, A...... 104 Majcher, B...... 128 Manning, J...... 129 Maroto Arce, N...... 138 Martino, G...... 204, 223 Majek, O...... 140, 236 Manno, M...... 203, 213, 214 Marotte, H...... 70 Martino, M...... 174 Majima, A...... 125, 170 Manns, M...... 5, 38, 43, 46, 49, Marques, I...... 142, 157, 171, 172 Martinovic, L...... 224 Majumdar, D...... 134 54, 66, 83, 165 Marques, L...... 242 Martins, A...... 119, 207 Makanyanga, J...... 179 Manolakopoulos, S...... 120, 165 Marques, M...... 175, 196, 219 Martins, C.....114, 119, 155, 157, 164, Maki, M...... 151, 195 Mañosa Ciria, M...... 56, 180 Marques, S....127, 154, 162, 164, 218 171, 172, 189, 206, 242 Makin, A...... 123 Mansfield, S...... 142 Marques da Martins, D...... 119, 126, 154, 155, Makino, I...... 117, 147 Mansour, A...... 120 Costa, P...... 103, 163, 165, 198, 199, 207, 242 Makino, K...... 140 Mansour, D...... 81 179, 194, 198, 242 Martinucci, I...... 58, 97, 115, 132, Makino, Y...... 60 Mansouri, L...... 226 Márquez Mosquera, L...... 56 147, 187, 190 Makins, R...... 143 Mantei, A...... 153 Marra, F...... 209 Marukawa, T...... 210 Makita, H...... 238 Mantoan, S...... 132-133 Marra-Lopez, C...... 124 Maruo, T...... 88, 192, 216 Malachias, A...... 101 Mantzaris, G...... 56, 88, 179, 196 Marren, A...... 61, 160, 180, 226 Maruoka, D...... 214 Malagelada, C...... 187 Manyé, J...... 221 Marsal, S...... 221 Marusawa, H...... 164 Malagelada, J. R...... 187 Manzano, R...... 103 Marseglia, G...... 59 Maruyama, N...... 106 Malamut, G...... 128 Manzhalii, E. G...... 162-163 Marshall, C...... 219 Marya, N...... 219 Malaoui, L...... 224 Mão De Ferro, S...... 157, 171, 172 Marsot, J...... 216 Marzio, L...... 97 Malats, N...... 76 Mão Ferro, S...... 133 Marteau, P...... 175, 219, 222 Masahiro Hattori, M...... 238

335 UEG Week Final Programme : Index of Authors and Co-Authors

Masaki, T...... 176, 206, 212 Matsui, S...... 128 McCoy, K...... 99 Mercer-Jones, M...... 186 Masamune, A...... 157, 167 Matsui, T...... 51 McDonald, C...... 72 Merfort, I...... 66 Masaru Shinozaki, M...... 135 Matsukawa, M...... 115, 125 McDonald, J...... 228 Merga, Y...... 184 Mascarenhas, L...... 193 Matsumato, H...... 189 McFall, H...... 186 Merighi, A...... 130, 203, 213, 215 Maschke, S...... 156, 164 Matsumi, A...... 237 McFarlane, A...... 105 Merino Rodríguez, E...... 134 Masclee, A. A...... 73, 85, 128 Matsumoto, A...... 207 McKay, C...... 168 Merlin, D...... 185 Masclee, A. A. M...... 79 Matsumoto, K...... 52, 150, 170, 189, McKay, C. J...... 114, 123 Merolla, R...... 183 Masding, A...... 195 190, 217, 221, 234, 237 McKenzie, J...... 72 Mesenas, S. J...... 133 Maselli, M. A...... 64 Matsumoto, S...... 149 McLain-Smith, S...... 144 Mesonero, F...... 138 Maselli, R...... 71, 142, 175, 234 Matsumura, T...... 214, 237 McLaughlin, J...... 80, 144 Mesonero, J. E...... 100, 178 Masetti, R...... 121 Matsumura, Y...... 195 McLaughlin, S...... 225 Mesquita, R...... 218 Mashari, S...... 138 Matsunaka, T...... 168 McLeod, D...... 115, 127 Messina, C...... 120 Mashimo, Y...... 121 Matsunami, Y...... 124, 159, 175 McMahon, B. P...... 189 Messina, O...... 238 Masiques-Mas, M. L...... 97 Matsuo, Y...... 216, 229 McNamara, D...... 138, 139, 152, 175, Messina, V...... 164 Maslova, G...... 238 Matsuoka, J...... 115, 125, 127, 215 179, 194, 196, 226 Messmann, H...... 39, 84, 99 Mason, J...... 186 Matsuoka, K...... 180 McNaughton, D...... 190 Metairie, S...... 186 Masoodi, M...... 239 Matsuoka, M...... 131, 240 McNicholl, A. G...... 52, 89, 194 Metrangolo, S...... 203, 213, 214 Masoudi, S...... 212 Matsuoka, T...... 170, 234 McNulty, D...... 117, 145 Metz-Boutigue, M.-H...... 100 Massani, M...... 221 Matsushima, K...... 136 McPhail, M...... 43 Meucci, G...... 56 Massey, D. C. O...... 87 Matsushita, H.-O...... 107 Meadows, J...... 72 Meyenberger, C...... 121 Massier, S...... 134, 221 Matsushita, M...... 150 Mearín Manrique, F...... 61, 74, 82 Meyer, T...... 52, 194 Massignani, M...... 177 Matsuura, B...... 197 Mecklin, J.-P...... 106 Meyer-Gerspach, A. C...... 59, 160, Massinha, P...... 183 Matsuura, N...... 126, 127, 149, Medcalf, L...... 136, 138, 179 189 Massironi, S...... 145, 152, 240 204, 215 Medhat, E...... 88 Mezheyeuski, A...... 230 Masson, E...... 159, 167 Matsuura, S...... 117, 145 Meenan, J...... 168, 192 Mezzina, N...... 66 Mastromarino, P...... 144 Matsuyama, M...... 122 Meggio, A...... 128 Miaglia, C...... 173 Masucci, L...... 81, 134, 228, 229 Matsuzaki, J...... 117, 152 Megraud, F...... 52, 89, 194 Miah, I...... 148, 233, 235 Masuda, A...... 98 Matsuzawa, T...... 74 Meier, B...... 125 Miao, L...... 121 Masutti, F...... 66 Mattarelli, P...... 228 Meijer, C. H...... 180 Miao, Y...... 232 Masuy, I...... 161, 197 Mattheakis, L...... 116, 137, 177 Meijer, G. A...... 78, 79 Miatello, C...... 203, 212 Matallanos, P...... 128, 172 Mattia, A...... 116, 141 Meijer, J. W. R...... 178 Miccheli, A...... 144 Matalon, S...... 104, 204, 217, 222 Matuguma, S. E...... 50 Meijer, S. L...... 79, 80 Miceli, E...... 232 Matcovschi, S...... 163 Matuzaki, I...... 210 Meinhard, M...... 209 Michalopoulos, G...... 222 Mateo, C...... 219 Matysiak Budnik, T...... 38, 57, Meinhardt, C...... 113, 125, 159, 167 Michel, M.-L...... 57 Materacki, L. B...... 143, 172 186, 192 Meining, A...... 38, 39, 48, Michetti, P...... 69, 100, 136, 285 Materna, A...... 85 Matzel, K...... 109 54, 63, 86 Michida, T...... 128, 199 Mathieu, N...... 60 Maul, J...... 181, 224 Meireles, L. C...... 194 Michielan, A...... 228 Mathijssen, R. H. J...... 106 Maunoury, V...... 181 Meisner, S...... 74, 248 Michitaka, K...... 125, 170, 207 Mathot, R...... 89 Maura, D...... 57 Meistere, I...... 145 Michl, P...... 203, 212 Mathou, N...... 161, 195 Maurano, A...... 130, 218 Mel, R...... 172 Michopoulos, S...... 103 Mathurin, P...... 39 Mauro, A...... 146, 147, 194, 233 Melby, K...... 205, 238 Michou, E...... 42 Matono, S...... 148, 176, 236 Mavlikeev, M. O...... 118 Meleine, M...... 178, 232 Micu, L...... 119 Matouk, K...... 186 Mawdsley, J...... 136 Melhem, A...... 204, 217 Middendorf, J...... 162 Matovic, V...... 163, 207 May, A...... 48, 90, 102, 107, 113 Melhem, H...... 92, 134, 178 Middleton, S. J...... 87 Matsubara, N...... 230 Mayat, E...... 192 Melideo, D...... 238 Miehlke, S...... 135, 191 Matsubara, S...... 122 Maydeo, A...... 63 Melit, L...... 153 Mierement-Ooms, M. A. C...... 221 Matsubara, T...... 231 Mayer, E. A...... 232 Meluzinova, E...... 190, 193 Miglioresi, L...... 164 Matsubayashi, H...... 51, 117, 140, Mayerle, J...... 41, 48, 60, 86, Mendarte, U...... 119 Mihai, C...... 162 149, 150, 158, 186 97, 108, 132 Mendes, M...... 154 Miheller, P...... 70, 137, 180, 222 Matsuda, A...... 115, 125 Mazan, A...... 153 Mendes, S...... 174, 183, 218, 226 Mikami, S...... 154 Matsuda, M...... 59, 65 Mazur-Bialy, A...... 116, 133 Mendez, J...... 207 Mikami, T...... 192 Matsuda, S...... 169 Mazza, F...... 142, 234 Mendez-Bocanegra, A...... 173, 218 Mikhaleva, L...... 192 Matsuda, T...... 106, 157, 171 Mazzaferro, V...... 130 Mendlovic, S...... 153 Miki, K...... 150 Matsudaira, S...... 79, 141, 158, Mazzawi, T...... 195, 205, 233 Mendolaro, M...... 202, 232 Mikocka-Walus, A...... 143, 188 185, 186, 217 Mazzella, G...... 121, 210 Mendoza, J...... 157, 171 Mikolasevic, I...... 158, 161, Matsueda, K...... 140 McBride, H...... 181 Meng, W...... 121 167, 211 Matsui, D...... 117, 147 McCann, C. J...... 46 Mengual, E...... 150 Mikoviny Kajzrlikova, I...... 74, 231 Matsui, F...... 204, 215 McCartney, S...... 160, 183 Mensink, P. B...... 161 Milani, V...... 127 Matsui, H...... 99 McColl, K...... 52 Menys, A...... 179 Milano, A...... 152, 215, 239

336 337 Index of Authors and Co-Authors : UEG Week Final Programme

Milassin, A...... 70, 99, 139, 204, Mitsui, K...... 70 Mokrozub, V. V...... 197 Moreira, T...... 120, 207 219, 220, 222, 224, 227 Mitsui, T...... 102 Moleda, L...... 163 Morello, E...... 117, 209 Milchem, A...... 115, 131 Mitsunaga, M...... 131, 240 Moleiro, J...... 133, 157, 171, 173, Moreno-Osset, E...... 199 Miletic, D...... 184 Mitsunaga, Y...... 114, 125, 148, 214 185, 229, 230 Moretti, A...... 164 Milic, S...... 118, 158, 161, 167, 211 Miu, N...... 166 Molenaar, I. Q...... 98 Morgan, R. D...... 168 Milione, M...... 240 Miura, K...... 58 Molendijk, I...... 221 Morgenstern, S...... 193, 221 Milkiewicz, P...... 208 Miura, T...... 139, 183 Molero, X...... 187 Morgner, A...... 191 Millastre, J...... 124 Miutescu, B...... 163 Molina Infante, J...... 52, 97, 194 Mori, A...... 122 Millastre Bocos, J...... 125 Miwa, H...... 130 Molnar, B...... 52, 141, 230 Mori, H...... 115, 125, 205, 231, 232 Miller, B. H...... 183 Miyabe, K...... 124 Molnar, T...... 70, 99, 137, 139, Mori, K...... 55, 84, 96 Miller, L. J...... 173 Miyachi, H...... 55, 79, 84, 129, 182, 204, 219, 220, Mori, M...... 150 Mimori, K...... 87 141, 158, 185, 186, 222, 224, 227 Mori, N...... 148, 176, 236 Mimori, N...... 149, 193 216, 217, 231 Molnár, A...... 137, 180 Mori, Y...... 55, 58, 79, 84, 129, Mimura, T...... 214 Miyahara, K...... 117, 145 Monahan, K...... 141, 185 141, 149, 158, 185, 186, Min, B.-H...... 192 Miyake, T...... 197 Monast, C...... 72, 93 216, 217, 230, 231 Min, I. S...... 122, 142 Miyamoto, S...... 177 Mondal, U...... 130, 212 Morikawa, H...... 164 Min, K.-W...... 122 Miyamoto, Y...... 149, 170, 207 Mongelli, A...... 207 Morimoto, H...... 173 Min, M...... 118, 169, 212, 214 Miyaoka, Y...... 115, 125 Mongiat, M...... 52 Morini, B...... 229 Min, Y. W...... 192 Miyasako, Y....49, 103, 114, 122, 186 Mönkemüller, K..... 73, 84, 101, 121, Morini, S...... 144 Minaga, K...... 98, 123 Miyashita, T...... 117, 147 122, 126, 129, 172, 173, 240 Morino, M...... 39, 63, 96, 113, 148, Minami, H...... 136 Miyata, T...... 98, 123 Monnereau, A...... 192 159, 253, 255, 256 Minamino, H...... 115, 125 Miyazaki, M...... 149, 195 Montagnese, F...... 159, 171, 217 Moris, M...... 98 Minarik, M...... 141 Miyazaki, R...... 240 Montagnini, A. L...... 168 Morishita, A...... 206 Minarikova, P...... 141 Miyoshi, H...... 157, 167 Montalbano, L. M...... 203, 213, 214 Morita, Y...... 125, 217 Minashi, K...... 125 Miyoshi, Y...... 81 Montale, A...... 229 Moriyama, M...... 238 Minatsuki, C...... 172 Mizgulin, V...... 192 Montanaro, L...... 230, 231 Morlion, C...... 59 Minda, K...... 139 Mizokami, Y...... 99 Monteiro, S...... 131, 175, 180, Morohashi, T...... 129, 142, 231 Mine, H...... 128 Mizrahi, M...... 104 199, 241 Moroi, I...... 146 Mine, T...... 212 Mizumoto, T...... 193 Monteleone, G...... 136 Morris, D. L...... 148 Minet-Quinard, R...... 160, 177 Mizumoto, Y...... 210 Montenegro, A...... 187 Mortensen, N...... 140 Minguez, M...... 56, 138, 181 Mizuno, M...... 140 Montenegro, L...... 196 Morton, J...... 60 Minguzzi, M...... 112, 133 Mizuno, N...... 142 Montesarchio, V...... 209 Moryoussef, F...... 219 Minicucci, L...... 153 Mizuno, S...... 122 Montgomery, E...... 235 Moschen, A. R...... 64, 86, 91, 107 Ministro, P...... 119, 126, 136, Mizusawa, J...... 125 Monti, L...... 166 Moschetta, A...... 71, 91 154, 155, 198, 199, Mizushima, T...... 99 Montoro, M...... 56 Moscovici, M...... 209 207, 223, 242 Mizuta, H...... 195 Montoy, J.-C...... 216 Moser, A. J...... 160, 176 Mino-Kenudson, M...... 177 Mizutamari, H...... 149, 193 Montrucchio, G...... 113, 148 Moser, S...... 164, 208 Minoda, Y...... 124 Mizutani, H...... 132 Montserrat, G...... 161, 196 Moshkowitz, M...... 104, 115, 131 Mion, F...... 60, 71, 146, 233 Mlynarsky, L...... 158, 166, 204, 217 Montuori, M...... 153 Mosinska, P...... 100 Miori, G...... 128 Moayeri, B...... 205, 238 Moodie, K. L...... 220 Mostovoy, Y...... 225 Mira, J...... 113, 143 Moayyedi, P..... 40, 57, 88, 102, 109 Mookerjee, R...... 43 Mosztbacher, D...... 166 Miranda, A...... 135 Mocan, T...... 156, 165 Moon, H. S...... 140, 169, 201, Mota, M...... 202, 229 Mircea, P. A...... 118 Mocanu, I...... 198, 209 236, 238, 241 Mota-Huertas, T...... 97 Miremadi, A...... 105. Mocciaro, F...... 56, 130, 204, 223 Moon, J. H...... 63, 124, 159, Motohashi, O...... 115, 125 Mirosevic, G...... 146 Modesto, M...... 228 173, 210, 218 Motoyama, H...... 78, 164 Misawa, M...... 55, 79, 84, 129, 141, Modolell, I...... 89, 97, 194 Moon, J. S...... 188 Moulon, I...... 82 158, 185, 186, 216, 217 Moelker, A...... 132, 161, 197 Moon, W...... 150, 184 Moum, B...... 56, 77 Mise, N...... 217 Moeni-Jazani, M...... 190 Moons, L. M. G...... 114, 126 Mountford, C...... 81 Misra, R...... 116, 135, 178 Moerch, U...... 116, 137 Moore, A...... 79, 136 Mountzouris, K...... 222 Missbichler, A...... 200 Moga, T...... 156, 163, 165, 202, 208 Mora-Gutierrez, I...... 178 Moura, C. M...... 157, 167, 179, 242 Misselwitz, B...... 134, 235 Moghadamrad, S...... 99 Morais, R..... 126, 165, 191, 199, 212 Moura, M...... 157, 167, 179, 242 Mita, E...... 125, 232 Mogoanta, S. S...... 230 Morales, R...... 229 Moura, R. N...... 50 Mitchell, D...... 52 Mohamed, F. S...... 242 Moran, G. W...... 160, 179 Moureau, L...... 130 Mitchell, H...... 57 Mohammadi, A...... 93 Moran, R...... 211 Mouri, H...... 140 Mitiche, A...... 224 Mohammed, H. I...... 162 Moreea, S...... 170 Mousa, N...... 88 Mitobe, J...... 131, 240 Mohammed, N...... 72 Moreels, T...... 44, 47, 92, Moutinho-Ribeiro, P...... 212 Mitova, R...... 114, 123, 124 Mohandas, N...... 207 183, 219, 268 Mross, M...... 143 Mitrova, K...... 182, 226, 227 Mohrbacher, R...... 225 Moreira, M. J...... 131, 175, 180, 199 Mroue, A...... 199 Mitrowski, M...... 153 Mokhtare, M...... 239 Moreira, P. C...... 193 Mroz, A...... 72, 126, 199

337 UEG Week Final Programme : Index of Authors and Co-Authors

Mu, F...... 240 Muscatiello, N...... 120, 124, 209 Nahon, S...... 137, 226 Nasadyuk, C...... 145 Mu, H...... 100 Musialik, J...... 206 Naidoo, A...... 128 Näslin, G...... 187, 232 Mucignat-Caretta, C...... 64 Musilek, K...... 189 Naik, S...... 169 Nasr, A. Y...... 191 Mücke, M. M...... 225 Mussetto, A...... 144 Naitoh, I...... 52, 124 Nasr, I...... 168, 192, 235 Mudter, J...... 201, 241 Mustapic, S...... 156, 165 Naito, Y...... 125, 168, 170 Nasu, A...... 88, 216 Mueck, T...... 196 Musters, G. D...... 102, 158, 185 Nakagawa, K...... 232 Nasu, J...... 155 Muellem, S...... 123 Musto, D...... 77 Nakagawa, M...... 59, 65, 115, 125 Nasu, Y...... 210 Muff, S...... 52 Mustonen, H...... 51, 130, 174 Nakagawa, T...... 190 Natarajan, D...... 46 Mühl, S...... 203, 212 Muta, K...... 64 Nakahara, R...... 159, 169 Natsume, M...... 52, 124 Mühlberg, H...... 241 Mutignani, M...... 130 Nakai, Y...... 122 Naumann, U...... 120 Mukai, K...... 231 Muto, M...... 125, 149 Nakajima, A...... 92, 196, 210 Nava, C. D...... 124, 168 Mukai, S...... 124, 159, 175 Myasoedov, N. F...... 145 Nakajima, N...... 191 Navaneethan, U...... 63, 129 Mukasa, M...... 115, 125 Myojyo, S...... 231 Nakajima, S...... 231 Navarro, M...... 185 Mulder, M. J. A...... 141 Myoujou, S...... 230 Nakajima, T...... 106, 230, 231 Navasa, M...... 173, 218 Müller, J...... 234 Myrelid, P...... 39, 75 Nakamatsu, D...... 149, 195 Nawrocka, A...... 141 Müller, M...... 86, 163, 209 Mytton, J...... 73, 181 Nakamura, H...... 55, 106, 129, Nayar, M...... 123 Müller, V. A...... 241 Myung, S. J...... 140 173, 216, 231 Nayer, N...... 146 Müller-Schilling, M...... 77, 99 Nakamura, J...... 71, 101 Neagoe, D...... 201, 206 Müllner, K...... 222 Nakamura, K...... 55, 64, 124, 125 Neamattallah, M...... 88, 207 Muls, V...... 47, 183 N Nakamura, M...... 124 Nechaeva, G...... 197 Mumolo, M. G...... 187 Na, G...... 63, 139, 140, Nakamura, R...... 65, 192, 214, 215 Nechypurenko, O. O...... 197 Munakata, M...... 88 172, 203, 213, 214 Nakamura, T...... 65, 94 Necozione, S...... 238 Munarini, A...... 112, 133 Nabi, Z...... 51 Nakanishi, H...... 115, 125 Neesse, A...... 86, 168 Münch, A...... 109, 135, 178 Nacak, T...... 138 Nakano, T...... 125 Negm, O...... 120 Munck, L. K...... 135 Nachury, M...... 72, 73, 81, 181, 225 Nakao, K...... 136 Nehra, V...... 152 Munekage, K...... 161 Nacu, N...... 163 Nakao, Y...... 240 Neijenhuis, M. K...... 118 Munkholm, P...... 64, 77, 107, 109, Nadal, E...... 130 Nakarai, A...... 73 Neilan, L...... 235 134, 178, 224 Nadano, S...... 192 Nakase, H...... 103 Nemeth, B...... 166, 202, 211 Muñoz, MªC...... 56 Nadesalingham, V...... 172 Nakashima, H...... 150 Neoptolemos, J...... 60, 76, 82, Muñoz Gonzalez, G...... 125 Naessens, D...... 137, 227 Nakatsu, S...... 229 114, 123 Muñoz Navas, M...... 219 Nafee, A. M. N. M...... 162 Nakayama, H...... 87 Nerad, E...... 132 Muñoz Villafranca, C...... 138 Naftali, T...... 213 Nakayama, M...... 215 Neri, B...... 116, 135 Munsaka, M...... 47 Nagahama, T...... 80, 169 Nakayama, Y...... 168 Neri, M...... 152, 239 Munteanu, M. A...... 118 Nagahara, A...... 150, 170, Nakaya, N...... 59, 65 Neroldova, M...... 202, 206 Muragaki, Y...... 170 190, 234, 237 Nakayoshi, T...... 239 Nerovnya, A...... 230 Murakami, B...... 96 Nagahori, M...... 180 Nakazawa, S...... 210 Neshta, V...... 225 Murakami, D...... 159, 169 Nagaishi, T...... 222 Nakazawa, T...... 144, 207 Netten, G. P. C. A...... 165 Murakami, K...... 115, 125 Nagai, T...... 128, 222 Nakazuru, S...... 232 Neuberger, J...... 39, 56 Murakami, M...... 96 Nagano, H...... 231 Nakov, R...... 93 Neufert, C...... 105 Murakami, S...... 96 Naganuma, H...... 237 Nakov, V...... 93 Neuhaus, H...... 41, 61, 82, Murakami, Y...... 78, 106, 115, Nagaoka, I...... 186 Nakstad, B...... 85 89, 90, 101, 108 124, 164 Nagar Krishnamurthy, A...... 157, Nakura, M...... 117 Neuhuber, W...... 126 Murao, T...... 189 167, 211 Namasivayam, V...... 230 Neumann, F...... 140 Murata, M...... 149, 195 Nagasaka, M...... 174 Namba, T...... 224 Neumann, H...... 73, 84, 104, 121, Muratori, R...... 210 Nagasaki, F...... 237 Nam, B.-H...... 197 122, 126, 129, 172, Murawska, N...... 112, 133 Nagashima, Y...... 170 Nam, H...... 47, 106, 122, 142, 149, 173, 213, 214, 284 Muricy, G...... 139 Nagata, Y...... 240 189, 197, 237, 290, 293 Neuman, S...... 180 Murillo, R...... 151, 161, 193 Nagayama, S...... 212 Nam, J. H...... 47 Neurath, M. F...... 127, 133, 155, Murono, K...... 116, 142, 220 Nagel, A...... 200 Nam, K...... 218 181, 201, 202, 233, 241 Murphy, M...... 140 Nägel, A...... 126, 202, 214, 233 Nam, R. H...... 189 Neut, C...... 222 Murphy, R...... 228 Nagel, D...... 81, 229 Nam, S...... 47, 149, 150 Nevens, F...... 121, 166 Murray, D...... 142 Nagórniewicz, B...... 57 Nancey, S...... 72, 73, 81, 222 Neves, A. A...... 80 Murray, I. A...... 103 Nagtegaal, I. D...... 50, 63, 65, Nannen-Ottens, S...... 151 Neville, S...... 98 Murray, J. A...... 152 77, 87, 106, 141 Naoki, A...... 158, 185, 331 Ng, S. C...... 87 Murthy, K...... 207 Nagy, F.....70, 99, 137, 222, 224, 227 Napoléon, B...... 50, 98 Ng, S. S...... 141 Murzi Pulgar, M. C...... 97, 194 Nagy, G. A...... 118 Napolitano, G...... 203, 213, 214 Ng, W...... 57 Musala, C...... 159, 167 Nagy, Z...... 230 Naranjo, D...... 216 Ngamruengphong, S...... 51, 71, 87, Musaus, J...... 82 Nagy, Z. B...... 141 Nardi, M. T...... 191 161, 170, 174, 190, 211, 219 Muscat, M...... 224 Nahas, S. C...... 240 Nardone, O. M...... 77, 90, 224 Ng Kwet Shing, R...... 104, 129, 216

338 339 Index of Authors and Co-Authors : UEG Week Final Programme

Ngo, O...... 140, 233, 236 Nishina, T...... 192 Nowakowska-Dulawa, E...... 183 Ogawa, Y...... 217 Ngollo, M...... 72, 222 Nishino, K...... 96, 101 Nozaki, R...... 77 Ogliari, C...... 147 Ngu, J. H. J...... 103, 133 Nishio, K...... 232 Nozawa, H...... 116, 142, 220 Ogura, K...... 217 Ngu, M...... 72 Nishioka, C...... 218 Nucci, A...... 203, 213, 214 Oh, D...... 175, 218 Nguyen, C. C...... 173 Nishisaki, H...... 115, 125 Nuernberg, D...... 249 Oh, D.-W...... 210, 211 Nguyen, D...... 130, 212 Nishiumi, S...... 139 Nuland, K...... 91, 239 Oh, H.-J...... 220 Nguyen, G. C...... 47, 138, 139, 182 Nishi, Y...... 94, 124 Numao, H...... 88 Oh, K...... 52, 88, 99, 102, Nguyen, H. T. T...... 93, 112, 133 Nishiyama, H...... 115, 125 Numata, K...... 130 136, 142, 149, 174, 180 Nguyen, N. Q...... 63 Nishi, Y...... 52 Numata, M...... 115, 125 Oh, M...... 206 Niaz, S...... 63 Nishizaki, M...... 237 Nunes, A. C...... 180 Oh, M. G...... 149 Nicholson, J...... 72 Nishizawa, T...... 114, 125, 129, Nunes, C...... 180, 241 Oh, K...... 142, 149 Nickerson, D...... 87 148, 203, 214, 215 Nunes, G...... 198, 200, 206, Oh, S. D...... 132 Nie, Y...... 117, 181 Nissen, L...... 77 227, 242 Oh, S. J...... 132 Nieber, K...... 183, 234 Nissinen, R...... 181 Nunes, J...... 173, 199 Oh, Y...... 132, 188, 189, 216 Niebisch, S...... 233 Nitsche, U...... 158, 184 Nuñez, C...... 196 Oh, T.-Y...... 188 Niedermaier, T...... 128 Niubo-Carulla, L...... 74 Nuñez, H...... 157, 171 Ohara, H...... 52, 124, 157, 167 Niedermeier, S...... 187 Niv, G...... 135 Nüssler, N...... 184 Ohara, Y...... 88, 216 Niederseer, D...... 185 Niv, Y...... 89, 135, 137, 193, 235 Nuzzo, A...... 226 Ohki, T...... 74, 127, 217 Nielsen, K. R...... 116, 134 Niwa, Y...... 115, 125, 142 Nwokolo, C...... 230 Ohlin, B...... 148 Nielsen, O. H...... 222 Nobili, V...... 166 Nyári, T...... 227 Öhman, L...... 46, 58, 81, Nieponice, A...... 53, 97 Noble, A...... 105 Nydegger, A...... 184 143, 221, 228 Nierhoff, D...... 173 Nóbrega, S...... 57 Nylund, K...... 195 Ohmiya, N...... 174 Nieto, A...... 187 Nobusawa, S...... 144 Nyssen, O. P...... 52, 89 Ohmiya, T...... 170, 234 Nieto, J...... 51, 174 Noda, H...... 129, 238 Ohning, G. V...... 58, 115, 125, Nieto, L...... 94, 159, 176, 203, 211 Noda, T...... 117, 145, 148, 168 140, 215 Nietsch, H. H...... 217 Nogales Rincon, O...... 97, 157, 171 O Ohnishi, R...... 177 Niezychowski, W...... 61, 137 Noguchi, S...... 238 O’Brien, M...... 203, 215, 236 Ohnishi, S...... 99, 177 Niimi, K...... 102, 172 Noguchi, T...... 170 O’Byrne, S...... 182 Ohnita, K...... 59, 65, 136 Nikaki, K...... 190 Nogueira, J...... 242 O’Connell, N...... 116, 137 Ohno, Y...... 132 Nikeghbalian, S...... 163, 164, Nohara, K...... 197 O’Connell, T...... 230 Ohta, T...... 117, 147 201, 206 Noh, Myung H...... 94 O’Connor, S. A...... 129 Ohtsuka, K...... 72, 180 Nikkhah, M...... 239 Noh, S. H...... 193, 197 O’Donovan, M...... 80, 105 Ohtsuka, T...... 124 Nikolaus, S...... 222 Nøjgaard, C...... 158, 167, 269 O’Dwyer, O...... 196 Ohtsuru, S...... 164 Nikolic, M...... 146, 188, 233 Noman, M...... 47, 70, 225 O’Keefe, S. J...... 87 Ohya, T...... 102 Nikolic, V...... 163, 207 Nomura, E...... 237 O’Morain, C...... 52, 82, 85, 89 Oien, K. A...... 168 Nilsson, B...... 204, 218 Nomura, S...... 58 O’Sullivan, M...... 227 Oishi, H...... 132 Nilsson, M...... 148, 161, 191 Nomura, T...... 206 O’Toole, A...... 227 Oittinen, M...... 152 Nilsson, O...... 204, 218 Nonaka, S...... 170, 192, 213, 236 Oakland, K...... 140 Ojanguren, I...... 139, 180 Nimmo, E. R...... 93 Noreen, E...... 152 Obst, W...... 80 Ojetti, V...... 130, 179 Nimura, S...... 170, 234 Norheim, K. B...... 180 Ocaña, T...... 229 Ojima, H...... 66 Ninomiya, T...... 125, 170, 207 Norihiro, O...... 88, 117, 145, 346 Ochiai, T...... 186 Okabayashi, T...... 203, 212 Nio, C. Y...... 98 Norlin, A.-K...... 113, 143 Ochiai, Y...... 114, 125, 129, Okabe, Y...... 98, 168 Nion Larmurier, I...... 77, 219 Norman, G. L...... 51, 136, 145 148, 169, 214 Okada, A...... 52, 53, 167, 170, 189 Nip, K...... 137, 183 Noro, H...... 199 Ochi, T...... 117, 152, 161 Okada, H...... 58, 73, 115, 125, Niriella, M. A...... 201, 206 Noseda, A...... 94 Ochiya, T...... 117, 152 170, 179, 234, 268 Nishida, R...... 148, 176, 236 Nosegbe, U...... 183 Oczella, L...... 203, 215 Okagawa, Y...... 131 Nishida, T...... 128, 231 Noskova, K...... 225 Oda, I...... 125, 132, 170, Oka, M...... 115, 125, 215 Nishidate, T...... 103 Nos Mateu, P...... 56 192, 213, 236 Okamoto, N...... 173, 195, 230 Nishide, N...... 192 Nöthen, M. M...... 233 Oda, M...... 55, 84 Okamoto, R...... 94 Nishijima, N...... 88, 216 Nour, M. O...... 239 Odes, S...... 77, 223, 226 Okanoue, S...... 237 Nishikawa, T...... 116, 142, 220 Nousbaum, J.-B...... 209 Odstrcil, E...... 79 Oka, S...... 106, 158, 185, 193, 237 Nishimura, K...... 49, 103, 140, 186 Novais, L...... 200 Oehmann, L...... 143, 152 Oka, T...... 101, 125, 170, 203, 212 Nishimura, M...... 115, 125, 127, Novák, J...... 123, 222 Oertel, C...... 107 Okayama, N...... 231 129, 142, 215, 231 Novak, K. L...... 136 Ofengeim, D...... 99 Okayama, T...... 125, 170 Nishimura, N...... 140 Novo, E...... 117, 209 Ogasawara, N...... 129, 238 Okazaki, M...... 215 Nishimura, R...... 94 Novotny, A...... 176 Ogata, H...... 140 Okimoto, K...... 214 Nishimura, T...... 49, 103, 114, Novovic, S...... 158, 167, 211, 269 Ogata, N...... 217 Oki, T...... 65 115, 122, 125, Nowacki, T...... 222 Ogawa, C...... 168 Okolo, P...... 219 131, 186, 240 Nowak, A...... 133 Ogawa, M...... 131, 156, 164, 240 Oksanen, Pia M...... 77

339 UEG Week Final Programme : Index of Authors and Co-Authors

Okubo, S...... 149, 193 Orlandi, P...... 128 Ozawa, S.-I...... 216 Panic, M...... 163 Okuda, A...... 238 Orlando, A...... 56, 139, 183, 227 Ozdemir, Z. T...... 119 Panic, N...... 52, 157, 167 Okujava, M...... 144 Orlando, C...... 204, 223 Ozguler, Y...... 136 Panis, Y...... 39, 73, 75, 109 Okumura, S...... 177 Orlando, E...... 139, 227 Ozola, I...... 212 Pannala, R...... 173 Okuno, N...... 142 Orlando, R...... 139, 227 Ozola Zalite, I...... 212 Pannu, D...... 71 Okuno, Y...... 149 Orlemann, A. L...... 165 Öztürk, B...... 118 Panozzo, M. P...... 116, 145, 238 Olafsson, S...... 196 Orlent, H...... 80, 205, 235 Pansart, Y...... 187 Oláh, A...... 114, 123 Orlic, L...... 158, 161, 167, 211 Pantaleón, M. A...... 217 Olariu, L...... 153 Orlova, N...... 181, 226 P Pantanella, F...... 202, 229 Olbjørn, C...... 85 Orlowska, J...... 193 Paajanen, H...... 106 Paoluzi, P...... 182 Olesen, S. S...... 85, 167 Ormonde, D...... 226 Pace Palitti, V...... 164 Papa, A...... 139 Olesen, S. S. S...... 167 Orosz, P...... 51 Pachlewski, J...... 199 Papanikolaou, I. S...... 55 Oliva, A...... 202, 229 Orsini, L...... 203, 213, 214 Pachofszky, T...... 163, 218 Papastergiou, V...... 161, 165, 195 Oliva, S...... 72, 85, 175, 183 Ortega, I...... 129 Padhan, R...... 231 Papatheodoridi, M...... 120 Oliveira, A...... 118, 218, 220 Ortiz, C...... 53 Padler Karavani, V...... 124 Papatheodoridis, G. .120, 205, 234 Oliveira, A. P...... 104, 114, 119, Ortiz, I...... 199 Paduani, G. F...... 168 Papatheodoridis, G. V...... 222 155, 164, 189, 206, 242 Orton, T...... 233 Padula, S...... 61 Pape, U.-F...... 87, 241 Oliveira, C...... 91, 96 Ortuño, J...... 52, 89 Pagani, E...... 59, 232 Papi, C...... 56, 183 Oliveira, D...... 220 Oruezabal Moreno, M. J...... 229 Pagenault, M...... 171, 178 Papp, M...... 51, 70, 136, 163 Oliveira, M...... 154 Osadchuk, M. A...... 145 Paggi, S...... 72, 104 Pappalardo, B. L...... 160, 181, 183 Olivier, A...... 128 Osadchuk, M. M...... 145 Pahomova, J...... 237 Paquot, I...... 47, 183 Olivier, C...... 87, 240 Osaki, A...... 156, 164 Paiella, S...... 175, 177 Par, A...... 7, 10, 20, 25, 51, Olivo, G...... 231 Osaki, Y...... 88, 216 Paik, S. W...... 121 57, 59, 81, 94, 106, 117, Ollero, L...... 103 Osera, S...... 173 Paik, W. H...... 124 123, 127, 147, 166, 180, Olsen, J...... 116, 134 Oshima, S...... 94 Painchart, C...... 94, 225 181, 186, 225, 226, 266, Olson, A...... 62 Oshita, M...... 149, 195 Pajares Villarroya, R...... 138 267, 269, 271, 274, 293 Olsson, G...... 115, 129 Osmane, R...... 224 Pal, P...... 51, 123 Par, G...... 51, 107, 158, 141, 188 Olynetz, U...... 218 Osoegawa, T...... 124 Pál, A...... 204, 223 Paramsothy, R...... 57 Omae, M...... 236 Ospina, J...... 63, 80, 115, Palanivelu, C...... 168 Paramsothy, S...... 57 Omazzi, B...... 157, 171, 216 130, 159, 169 Palatka, K...... 70, 136, 137, 227 Paraskeva, K. D...... 195 Omdal, R...... 180, 226, 227 Ostapchenko, L...... 229 Palazzo, L...... 50, 98 Paraskevova, A...... 117, 147 Omorgbe, J...... 194 Ostapchenko, L. I...... 152 Palazzo, M...... 98 Pardo, J...... 100, 178 Omori, T...... 192, 215, 224 Ostapiuk, M...... 235 Palcevski, G...... 184 Pardon, N...... 113, 147 Ondrackova, M...... 231 Osther, K...... 205, 238 Pálfi, E...... 137 Parello, A...... 180 Ong, S. H...... 137 Osumi, H...... 114, 127, 128, 150, 221 Palladini, A...... 228 Parente, F...... 203, 213, 214 Onimaru, M...... 71 Otani, K...... 116, 142, 220 Pallagi, P...... 123 Parfenov, A...... 181, 225, 226 Onishi, Y...... 150 Otani, R...... 224 Pallagi Kunstár, É...... 204, 223 Paridaens, A...... 65 Onisor, D...... 127 Ota, Y...... 60 Pallio, S...... 130 Pariente, B...... 89, 181, 225 Ono, A...... 128, 157, 171 Otazua, P...... 119 Pallone, F...... 56, 136 Parihar, V...... 123, 152 Onodera, H...... 132 Otete, H. E...... 202, 206 Pallotta, L...... 64 Parisi, P...... 153 Onoe, S...... 177 Otha, H...... 131 Pallotta, S...... 65 Parisi, S...... 234 Ono, H...... 51, 117, 125, 132, Othman, F...... 73 Palma, R...... 103, 163, 194, 198 Park, B. J...... 47 140, 149, 150, 158, 186 Othman, M...... 212 Palmela, C...... 173, 185, 199, 229 Park, C. H...... 94, 149, 193, 237 Ono, M...... 161, 195 Otley, A...... 225 Palmer, D...... 168 Park, C. J...... 149, 237 Ono, S...... 132, 172, 177 Otsuka, T...... 139 Palmisano, S...... 118, 161 Park, C. W...... 124 Ooi, J...... 117, 146, 190 Ottaviani, D...... 209 Palsson, O...... 58, 92, 98, 186, 187 Park, C.-H...... 94, 149 Ooi, M...... 72, 139 Ott, E...... 116, 137 Palsson, O. S...... 187, 189 Park, D. H...... 175, 210, 211, 218 Oomoto, S...... 98, 123 Ouchchane, L...... 160, 177 Palsson, O. S. S...... 58, 187 Park, D. K...... 150, 217 Oonishi, S...... 142 Ou, D...... 154 Palumbo, I...... 64 Park, E. T...... 94 Oono, Y...... 169, 173, 192 Ouhlous, M...... 161, 197 Palviainen, M...... 142 Park, H...... 93, 140, 149, 150, 159, Oostendorp, M...... 166 Oumnia, N...... 233 Panaccione, R...... 136, 157, 173, 175, 193, 195, 198, Oppong, K...... 123 Overbeek, L...... 141 171, 282, 285 210, 211, 213, 218, 229, 293 Oquiñena Legaz, S...... 141, 147 Owari, M...... 150 Panczak, R...... 190 Park, H. J...... 135, 149 Orange, C...... 52, 168 Owczarek, D...... 223 Pandolfi, M...... 174 Park, H. Y...... 149, 150 Orazio, S...... 192 Owczarek, K...... 141 Pandolfino, J. E...... 190 Park, H...... 150 Oreja Arrayago, M...... 113, 148 Owens-Grillo, J...... 166 Panés, J...... 46, 61, 95, 160, 180 Park, J...... 47, 122, 135, 136, Orera Peña, M. L...... 124 Owyang, C...... 81 Panescu, P...... 195 149, 150, 184, 201, 210, Orito, E...... 207 Oyama, T...... 59, 65, 101, 148 192 Pang, M...... 220 212, 227, 229, 237, 241 Orlandi, D...... 120 Oyon Lara, D...... 141 Pang, W.-H...... 222 Park, J. C...... 149, 215, 237

340 341 Index of Authors and Co-Authors : UEG Week Final Programme

Park, J. -S...... 211 Patchett, S...... 227, 267 Pelc, A...... 209 Perona Vincenti, M. C...... 194 Park, J. J...... 59, 106, 150, Patel, H...... 138, 139, 182 Peleman, C...... 187 Perret, C...... 186 229, 210, 212 Patel, J...... 129, 234 Pelitari, S...... 170, 179, 190 Perretta, S...... 71 Park, J. K...... 176, 218 Patel, K...... 219 Pellegatta, G...... 223 Perri, G...... 203, 212 Park, J. M...... 139, 237 Patel, L...... 71 Pellegrinelli, A...... 240 Perri, V...... 71, 94, 130, 213, 220 Park, J. -J...... 59, 106 Patel, P...... 73, 181, 216, 225, 231 Pellegrini, L...... 234 Persing, D...... 173 Park, J...... 106, 142, 149, 170 Patel, S...... 130, 138, 212, 239 Pelletier, A. L...... 73 Persson, J...... 148 Park, J. W...... 136 Paterlini, A...... 203, 213, 214 Pellicani, R...... 52 Pertile, R...... 128 Park, J. Y...... 151 Paterson, A...... 195 Pellicelli, A...... 164 Peruzzi Elia, P...... 220 Park, K. S...... 130 Pathmeswaran, A...... 201, 206 Pellise, M...... 77, 115, 127, 157, 171 Pesanti, C...... 197 Park, M. I...... 150, 184 Patiño, A...... 142 Pellizzaro, A...... 64 Pescatori, L...... 120, 204, 223, 322 Park, P.-O...... 189 Patita, M...... 198, 199 200, Pena, B...... 198 Peschel, G...... 163 Park, S...... 47, 122, 130, 142, 149, 206, 227, 227, 242 Peña-Galo, E...... 103, 194 Pesegova, M...... 225 154, 161, 162, 170, 172, Patrlj, L...... 209 Penagini, R. .130, 146, 147, 194, 233 Pesenti, C...... 50, 127, 130, 217 192, 193, 197, 237 Patsch, W...... 185 Peñas, B...... 157, 171 Pession, A...... 121 Park, S. B...... 193 Patti, R...... 66 Peñas-Herrero, I. .131, 176, 204, 220 Peter, M...... 241 Park, S. -H...... 49, 159, 173, 195, Patzak, M...... 86 Pencek, R...... 166 Peter, S...... 42, 47, 51, 69, 70, 198, 210, 218 Paul, J...... 47, 183 Pendsé, D...... 179 90, 129, 202, 308, 314, Park, S. H...... 93, 140, 186, 213 Paul, S...... 54, 57, 62, 70, 88, Penez, L...... 116, 135, 205, 225 333, 339, 346 Park, S. W...... 219 307, 323, 325, 332 Peng, J.-S...... 185 Péterfia, B...... 141 Park, S. J...... 136, 150, 184, Paúles, M. J...... 139 Penman, I...... 123 Peterli, R...... 59 201, 227, 241 Paulitti, A...... 52 Pentek, M...... 70, 204, 225 Peters, P.-G...... 218 Park, S.-K...... 201, 241 Pauwels, A...... 59, 113, 147 Peppelenbosch, M...... 93, 106, Petersson, J...... 182 Park, S. M...... 122, 188 Pavlenko, V...... 138 205, 235 Petit, B...... 215 Park, S...... 106 Pavlidis, P...... 136, 138, 179, 181 Perbtani, Y...... 71 Petitcolin, V...... 116, 135 Park, S. W...... 131 Pavlidis, S...... 93 Percival Andersen, L...... 194 Petito, V...... 134, 138, 228 Park, T. Y...... 130, 234 Pavlik, T...... 191, 236 Perdigoto, D...... 163, 218 Petrenkiene, V...... 162 Park, W. S...... 197 Pavlov, C...... 120 Perdones-Monteiro, A...... 72 Petrone, M. C...... 168 Park, Y. E...... 227, 237 Pavlova, J...... 237 Pereg, A...... 223 Petrov, R...... 124, 167 Park, Y. K...... 193, 197 Pawloff, M...... 156, 164 Peregrin, J...... 190 Petrova, T...... 94 Park, Y. M...... 150, 229 Payer, B. A...... 158, 162 Pereira, B...... 226 Petruzziello, C...... 56, 130 Park, Y. S...... 47, 154, 161, 162, Payer, J...... 136 Pereira, D...... 141 Petruzziello, L...... 128 172, 192, 193 Pazdro, A...... 117, 148, 233 Pereira, D. M...... 52 Petryka, R...... 61 Park, Y. W...... 184 Pea, A...... 176 Pereira, E...... 155, 198, 219 Petukhova, M...... 124 Parkes, G. C...... 225 Peach, R...... 97 Pereira, J...... 157, 171, 172, Peuker, K...... 52 Parks, R...... 114, 123 Pecere, S...... 138, 151, 228 198, 217, 224 Pevnev, G...... 118, 123 Parmeggiani, F...... 174, 237 Pech, O...... 42, 43, 55, 69, 79 Pereira, N...... 128, 141 Pevny, S...... 241 Parniczky, A...... 123, 166 Peck-Radosavljevic, M...... 66, 78 Pereira, P...... 81, 120, 123, Peyrin-Biroulet, L...... 47, 62, 70, Parodi, M. C...... 130 119, 163, 218 163, 165, 212 82, 89, 100, 139, Parola, M...... 117, 209 Pecoraro, G. M...... 130, 204, 223 Pereira, S. P...... 120, 123, 165, 212 182, 204, 224, 283, 285 Parravicini, M...... 203, 213 Pedaci, M...... 204, 223 Pereira da Silva, J...... 157, 171, 172, Pfeffer-Gik, T...... 139 Parshutin, S...... 151 Pedersen, J...... 97 198, 217, 224 Pfisterer, N...... 118, 163 Parthasarathy, S...... 132 Pedersen, N...... 77 Pereira Fernandes, V. M. F...... 227 Phelip, J. M...... 70 Partridge, D...... 239 Pedersen, S...... 142 Perera, K. R...... 201, 206 Philip, G...... 225, 326 Parzanese, I...... 130 Pedrajas Crespo, C...... 179 Pererva, L...... 221 Phillips, A...... 68, 90, 204, 217 Pascarenco, O...... 127 Pedrazzani, C...... 187 Perez, J...... 172 Phillips, J...... 181 Pascaru, A...... 208 Pedroto, I. .. 120, 188, 207, 215, 227 Perez, J. M. P...... 101 Phillips, W...... 80 Pascher, A...... 168, 241 Peerally, M. F...... 239 Perez, P...... 101, 142 Phillpotts, S...... 152, 236 Paschos, P...... 158, 185, 227 Peeters, E...... 47, 138 Perez Aisa, A...... 89 Phoa, S. S...... 98 Pascual, A...... 199 Peeters, H...... 47, 183 Pérez Lasala, J...... 129 Piazuelo, E...... 87 Pascual, J. M...... 157, 171 Peeters, M...... 47 Pérez Rodríguez, E...... 124 Piazzi, G...... 112, 133 Pascut, D...... 66 Peev, M...... 114, 123 Perez-Cuadrado Robles, E...... 239 Pica, R...... 182 Pasetti, A...... 116, 137 Peiris, M...... 53 Pérez-Miranda, M...... 131, 176, Picard, O...... 47 Paspatis, G...... 178 Peixe, P...... 164 204, 220 Picchio, M...... 144 Passos Galvão Neto, M. ... 101, 152, Peixoto, A...... 93, 119, 120, 126, Perinel, J...... 81 Picone, C...... 196 203, 213, 240 154, 163, 165, 187, Perisc, M...... 184 Piekuse, L...... 57 Pastorelli, L...... 127, 204, 213, 223 193, 199, 219 Perkiömäki, J...... 201, 206 Piemonti, L...... 116, 145 Patai, A...... 70, 137 Pekarska, K...... 57, 134 Perminow, G...... 85 Pienar, C...... 156, 163, 165, Patai, A. V...... 52, 202, 211 Pekki, H...... 151 Perner, J...... 105 166 202, 208

340 341 UEG Week Final Programme : Index of Authors and Co-Authors

Pierantoni, C...... 210 Plusa, S...... 186 Pouillon, L...... 70 Pulvirenti, A...... 176, 203, 212 Piercy, J...... 227 Pocard, M...... 81, 104 Poulogiannis, G...... 72 Pumpo, R...... 203, 213, 214 Pierik, M. J...... 72, 81, 85, 135 Pochapin, M...... 104 Poulsen, J. L...... 167 Punnoose, S...... 148 Pierre Vullierme, M...... 159, 167 Pockros, P...... 121 Pourshams, A...... 212 Purchiaroni, F...... 106 Pierzchalski, P...... 94 Podesser, B...... 66 Pouw, R. E...... 80 Purita, L...... 203, 213, 214 Piessevaux, H...... 99 Podmanicky, D...... 205, 225 Powell, N...... 138 Püspök, A...... 185, 218, 229 Pietruszka, S...... 172 Poewe, W...... 96 Poznanski, P...... 141 Putignani, L...... 57, 138 Pietrzak, A. M...... 199 Pohl, D...... 143, 152 Pozo, A...... 77 Putnikov, A...... 229 Piggott, C...... 188 Pohl, J...... 42, 131 Pozza, A...... 221 Putzeys, V...... 159, 167 Pigneur, B...... 57 Poizat, F...... 217 Pradeep, R...... 51 Puylaert, C...... 179 Pigrau, M...... 81 Pojda-Wilczek, A...... 206 Prager, M...... 224 Pyeon, S...... 149, 237 Pimentel, M...... 186 Pokrotnieks, J...... 179 Prakash, J...... 57, 60, 118 Pylypchuk, V. I...... 177 Pikkarainen, S...... 80 Polaka, I...... 145, 151, 161, 193, 237 Parsad, V...... 95 Pimentel-Nunes, P...... 59 Polanco, A. D...... 199 Prasad, Y...... 224 Pineda, J. R...... 138 Polipalli, S. K...... 81 Prat, F...... 62, 174, 176, 219, 236 Q Pinero, C...... 93, 187 Polkowski, M...... 127, 248 Prati, G. M...... 228 Qasim, B. A...... 207 Pinho, J...... 119, 126, 154, Pollack, C. V...... 70 Pravadelli, C...... 128 Qian, J...... 226 198, 199, 207, 242 Pollack, P...... 61 Pree, I...... 139, 182 Qian, Y...... 165, 230 Pinho, R...... 131, 175, 202, Pollinger, K...... 162, 209 Preedy, R...... 152, 236 Qianyun, L...... 228 219, 220, 229 Polster, A...... 143 Preiss, J. C...... 181, 224 Qin, W...... 126 Pinto, E...... 132, 133, 191 Poluektova, E...... 154 Prema, R...... 133 Qin, Y...... 204, 221 Pinto, J...... 155, 198, 219 Polymeros, D...... 55 Premathilaka, C...... 148 Qiu, J...... 216 Pinto-Marques, P...... 199, 200 Pompili, M...... 166, 228 Pressman, S...... 181 Quaranta, G...... 134 Pioche, M...... 71, 84, 126, 146, 173, Ponce, M...... 88, 173 Preston, S. L...... 117, 146 Quarantelli, M...... 231 203, 215, 216, 233, 236 Ponchon, T...... 38, 55, 71, 82, Prete, A...... 121 Quarta, S. M...... 209 Piqueras Cano, M...... 56, 138 84, 92, 109, 126, Prieto De Frias, C...... 219 Queirós, P...... 103, 114, 119, Pirags, V...... 237 146, 173, 203, 215, Prieto-Garcia, A...... 97, 194 202, 206, 232 Pirani, T...... 181 216, 233, 236 Prieux-Klotz, C...... 137 Quertinmont, E...... 85 Pires, S...... 126, 184 Ponds, F. A...... 190 Prifti, S...... 191 Quintas, P...... 157, 171 Piri, Z. M...... 180 Poneros, J. M...... 98 Principe, F...... 198 Quintero Carrion, E...... 87, 230 Pirici, D...... 131 Pongprasobchai, S...... 187 Principi, M...... 196, 207, 222 Quispel, R...... 121, 219 Pirisi, M...... 209 Ponsioen, C. Y...... 40, 46, 48, 137 Prins, H. A...... 106 Qvigstad, G...... 52 Pirodda, A...... 234 Pontas, C...... 196 Pritchard, D. M...... 184 Pirvan, A...... 166 Ponte, A. .... 131, 144, 175, 198, 202, Pritchard, S...... 186 Pisani, A...... 130 219, 220, 224, 229, 233 Probert, C...... 181, 184, 185 R Piscaglia, F...... 83 Pontisso, P...... 104, 117, 209 Procházka, V...... 236 Rabbi, F...... 100 Piscitelli, D...... 196 Ponziani, F. R...... 228 Procopet, B. D...... 54 Rabbitt, P...... 142 Pisconti, S...... 209 Pop, M...... 166, 201, 206, 242 Proctor, D. D...... 25 Rabe, B...... 94 Pisera, M...... 127 Pop, T. L...... 166, 242 Proença, L...... 198, 220 Rabilloud, M.-L...... 135, 178 Pisespongsa, P...... 187 Popa, A...... 242 Profeta, G...... 204, 223 Rabini, S...... 234 Pismennaja, A...... 145 Popescu, A...... 88, 114, 117, 120, Profita, A...... 204, 223 Racine, A...... 47, 56 Pistja, E...... 238 156, 163, 165, 166, 202, Prossomariti, A...... 112, 133 Racz, I...... 99 Pistone, M. T...... 179 208, 249, 250, 252 Provençal, M...... 186 Radaelli, F...... 72, 104 Pitanga Lukashok, H...... 63, 80, Popescu, M...... 201, 206 Pryseley, A. N...... 230 Radhakrishna, K...... 132 115, 130, 159, 169 Popoiu, A...... 242 Przybylska-Felus, M...... 196 Radic, M...... 184 Pittet, V...... 136 Popoiu, C...... 242 Przytulski, K...... 89 Radochova, V...... 189 Piyarathna, C...... 201, 206 Popova, O. N...... 93 Puchkov, K...... 144 Radu, P...... 121, 156, 165 Pizarro, T. T...... 222 Popp, A...... 90, 195 Pueyo Royo, A...... 141 Radwan, A...... 105 Pizzoferrato, M...... 138, 180 Poropat, G...... 167 Puga, M...... 63, 80, 115, Rady, A. M...... 165 Placida, R...... 238 Porta, F...... 157, 171 130, 159, 169 Radziunas, G...... 216 Plakhov, R...... 192 Portela, F...... 183, 226 Pugliese, D...... 139, 146, 233 Raeburn, A...... 146, 235 Platell, C...... 226 Porter, B...... 150, 238 Puig, I...... 157, 171 Raessens, J...... 65 Platos, J...... 74, 231 Portillo Villares, M. I. ..129, 157, 171 Pujals, M...... 161, 196 Raevens, S...... 65 Plaza, M. A...... 178 Portyanko, A...... 230 Pujari, R...... 210, 214 Raftery, T...... 10, 46 Plehutsa, O...... 121, 182 Porzionato, A...... 64 Pujol, B...... 98 Raftopoulos, I...... 240 Pleininger, F...... 118 Poscia, A...... 134, 179 Pukalskas, A...... 206 Raga, A...... 217 Plevris, J. N...... 164, 174, 194, 219 Pot, B...... 222 Pukite, I...... 179 Ragunath, K...... 38, 70, 84, 129 Plumb, A...... 179, 185 Poto, R...... 81, 229 Pukitis, A...... 212 Ragusa, S...... 94 Plumé, G...... 173 Pouderoux, P...... 60 Pulit-Prociak, J...... 160, 177 Rahal, D...... 168

342 343 Index of Authors and Co-Authors : UEG Week Final Programme

Rahden, B. H. A...... 71 Ravelli, P...... 130 Renna, S...... 56, 139, 227 Rincon, M. L...... 119 Rahier, J.-F...... 47, 183 Rea, F...... 184 Rennie, R...... 195 Rindi, G...... 174 Rahman, I...... 170, 190, 216 Rea, M...... 138, 224 Repetto, O...... 142 Ringel, J...... 143 Rahmi, G...... 128, 175, 197 Read, M...... 77, 80, 90 Repici, A...... 55, 71, 91, 95, Ringström, G...... 144, 187 Rahmouni, O...... 57, 222 Read, T...... 117, 145 130, 142, 168, 172, Rioux, L.-C...... 186 Raijman, I...... 130, 212 Realdon, S...... 191 175, 176, 203, 213, Rispo, A...... 77, 90, 138, Raimondo, M...... 217, 220 Reasner, D. S...... 144 214, 234, 284 151, 196, 224 Raine, T...... 225 Reavis, K...... 71 Rerknimitr, R...... 63, 187 Ritz, A...... 85 Raithel, M...... 127, 133, 155, Rebolledo Olmedo, S...... 131, 134 Resendez, A...... 195 Riu Pons, F...... 157, 171, 216, 217 200, 202, 233 Rebours, V...... 41, 62, 86, Reutens, D...... 112, 133 Rivera-Cadena, H. J...... 177 Rajendran, A...... 106, 115, 127 108, 159, 167 Reuterwall-Hansson, M. ...115, 129 Rivero, M...... 56, 223, 225 Rajilic-Stojanovic, M...... 81, 86, Redaelli, A. E...... 216 Reuther, M...... 159, 167 Rivero Sanchez, L...... 157, 171 109, 201 Reddi, D...... 105 Rewisha, E. A...... 242 Rivero Sánchez, L...... 77 Rakic, M...... 209 Reddy, D. N...... 51, 62, 89, 108 Rex, D. K...... 107, 216 Rivory, J...... 71, 84, 126, 146, Rakonczay, Z...... 94, 123 Reddy, J...... 98 Rey, J. W...... 104 173, 203, 215, 236 Raluy-Callado, M...... 181, 225 Reddy, P. M...... 51 Rezaie, A...... 186 Rizvanov, A...... 118 Ramagopalan, S...... 47 Reding-Bernal, A...... 177 Rhee, P.-L...... 188 Rizzatti, G...... 179 Ramalho, F...... 165, 242 Redondo Cerezo, E...... 99, 189 Riauka, R...... 177 Rizzuto, G...... 139, 227 Ramas, M...... 182 Reece-Bolton, O...... 148 Ribeiro, A...... 199 Robaszkiewicz, M...... 135, 159, Ramboz, J...... 74 Reed, K...... 188 Ribeiro, G...... 184 167, 178, 209 Ramchandani, M. K...... 51 Reed, M...... 222 Ribeiro, H...... 120, 126, 155, Roberts, M...... 58, 158, 162 Rameshshanker, R...... 93, 106, Reema, S...... 233 163, 198, 219 Robinson, A. M...... 160, 181, 183, 129 172 Reenaers, C...... 105, 107, 182 Ribeiro, I...... 198 225 Ramirez, M...... 53 Rees, J...... 73, 181, 231 Ribeiro, L. C...... 132, 189 Robinson, R. J...... 79 Ramirez Montagut, T...... 160, 180 Reeze, N...... 176 Ribeiro Jr, U...... 240 Robles-Medranda, C. .. 63, 80, 115, Ramos, J...... 136, 183, 223 Regnér, S...... 202, 211 Ribli, D...... 141 130, 159, 169 Rampado, S...... 148, 194 Regula, J...... 55, 77, 84, 106 Riboli, E...... 108 Roblin, X...... 61, 70 Rampton, D. S...... 201, 228 121, 126, 127, 199, 216 Ribolsi, M...... 234 Rocco, A...... 103 Rana, S. A. Q...... 106 Reha, P...... 74, 231 Ribot-Mariotte, E...... 105 Rocha, M. L...... 120, 207 Ranaldo, N...... 222 Rehan, D...... 241 Ricanek, P...... 72, 81, 93, 223 Rochberger, S...... 104 Rance, M...... 144 Rehfeld, J. F...... 59 Ricca, O. A...... 184 Röcken, C...... 52 Ransohoff, D...... 106 Rehmann, A...... 222 Riccardi, L...... 88, 215 Rodacki, T...... 223 Rantanen, T...... 106 Reiberger, T...... 54, 66, 76, 78, Ricchiuti, A...... 187 Rodella, L...... 130 Rao, G. V...... 51 103, 118, 119, 156, Ricci, R...... 151 Rodgers, L. H...... 116, 141 Rao, N...... 177 158, 162, 164 Ricciardiello, L...... 25, 50, 67, 72 Rodrigues, A...... 131, 175, 219 Rao, S. S. C...... 187 Reichardt, W...... 66 112, 133, 229, 231 Rodrigues, Â...... 227 Rao, S.-X...... 131 Reichel, A...... 219 Riccioni, M. E. .... 96, 203, 213, 214 Rodrigues, C. M. P...... 51, 52, 99 Raoul, J. L...... 130 Reichenberger, J...... 63 Richard-Molard, B...... 89 118, 141 Rapaccini, G. L...... 88, 139 Reichert, M...... 210 Richardson, J...... 205, 239 Rodrigues, J...... 127 154, 164, Raposo, J...... 198 Reid, F...... 80 Richter, E...... 187 198, 218, 219, 233 Raraty, M...... 114, 123 Reilly, I...... 224 Richter, V...... 153 Rodrigues, J. P...... 131, 175, 198, Rasekhi, A...... 164 Reilly, P...... 70 Rickard, S...... 188 202, 220, 229, Raselli, T...... 50 Reim, D...... 159, 176 Ridolfi, F...... 128 144, 202 Raseni, A...... 166 Rein, P...... 218 Ridtitid, W...... 187 Rodrigues, P...... 51, 52, 59, 99, Rasmussen, H. H...... 167 Reinhard, C...... 85 Rieder, F...... 225 118, 131, 141, 144, Rasmussen, M...... 74, 171 Reinisch, W...... 44, 62, 95, 137, Riedl, F...... 66 175, 185, 198, 202, Rasoul-Rockenschaub, S. .156, 164 160, 181, 182, 204, Riedl, R. G...... 79 220, 229, 230 Raszeja-Wyszomirska, J...... 208 224, 225, 282 Riegler, G...... 56 Rodrigues, P. M...... 99 Ratanachu-Ek, T...... 187 Reis Alvares-da-Silva, M. ....41, 78 Rieker, R...... 155, 200 Rodrigues, P. P...... 118 Rath, T...... 126 Reis, J...... 119, 207, 220 Riemann, J. F...... 128 Rodrigues, R. V...... 154 Rathjen, F. G...... 60 Rejchrt, S...... 189 Riethorst, D...... 52 Rodrigues, S...... 127, 162, Ratone, J. P...... 50, 127, 130, 217 Rembacken, B...... 39, 43, 54, 157 Rigato, P...... 217 165, 191, 199, 241 Ratto, C...... 180 Ren, J...... 98 Rigault, E...... 171 Rodrigues, T...... 165 Ratziu, V...... 163, 286 Ren, Y...... 99, 113, 125, 203, 213 Rigby, R...... 205, 239 Rodriguez, E...... 56 Rau, B...... 114, 123 Rencz, F...... 70, 204, 225 Rijnders, M. K...... 178 Rodriguez, J. M...... 241 Rau, H.-G...... 184 Rengo, M...... 64, 101 Riley, T...... 220 Rodríguez, L...... 53, 203, 213 Rautio, T...... 106 Reni, M...... 168 Rimbas, M...... 50, 130 Rodriguez de Miguel, C. ...151, 173 Rauzina, S...... 192 Renier, S...... 74 Rinaldi, R...... 87 Rodriguez Gutierrez, C...... 56 Ravaioli, F...... 121, 153 Renjic, V...... 209 Rinawi, F...... 183, 221 Rodriguez Perez, A...... 56

343 UEG Week Final Programme : Index of Authors and Co-Authors

Rodriguez-Alcalde, D...... 157, 171 Røseth, A...... 224 Russo, S...... 115, 132, 187, 190 Saitoh, Y...... 185 Rodriguez-Justo, M...... 157, 171 Rosinach, M...... 161, 196 Ruszniewski, P...... 44, 159, 167 Sakae, H...... 58 Rodríguez-Martínez, P...... 139 Rosini, F...... 72 Rutgeerts, P...... 61, 182 Sakae, T...... 210 Roepstorff, S...... 171 Roskams, T...... 99 Rüther, C...... 131 Sakaguchi, Y...... 172 Roesli, C...... 180 Rosok, B. I...... 168 Rutka, M...... 70, 99, 137, 139, 182, Sakai, C. M...... 101 Roessner, A...... 194 Rossi, A...... 56 204, 219, 220, 222, 224, 227 Sakai, P...... 50, 101, 240 Roeyen, G...... 159, 167 Rossi, G...... 130 Rutter, C. S...... 87 Sakai, Y...... 212, 237 Rogai, F...... 56 Rosso, N...... 118, 161, 162, 166 Rutter, M...... 54, 157, 171 Sakaki, N...... 150 Roggenbuck, D...... 51 Rothstein, R...... 220 Ruzzene, M...... 209 Sakakibara, M...... 65 Rogler, G...... 50, 92, 100, 105, Rotimi, O...... 72 Ryan, B...... 123, 139 Sakakibara, Y...... 232 285, 134, 178, 184, 221 Rotondano, G...... 203, 213, 214 Rychkov, G...... 92 Sakamoto, A...... 87, 88, 216 Roh, J. H...... 150 Rotondo, A...... 59 Rydning, A...... 223 Sakamoto, C...... 70 Rohr-Udilova, N...... 66, 158, 162 Roug, S...... 158, 167 Ryozawa, S...... 121 Sakamoto, K...... 231 Rohwer, N...... 185 Rougeron, A...... 74 Ryu, C. B...... 215 Sakamoto, N...... 99, 106, 177 Roland, C...... 177 Rougier, P...... 76, 83, 96, 186 Ryu, H. Y...... 154, 162 Sakamoto, T...... 106 Roldo, C...... 172 Rouvelas, I...... 161, 191 Ryu, J. K...... 122 Sakata, Y...... 117, 145 Rolland, C...... 87 Roux, S...... 216 Ryu, K...... 121, 122 Sakin, Y. S...... 235 Romain, O...... 175, 219 Rovers, M...... 114, 123 Ryu, K. W...... 193, 197 Sakiyama, N...... 121 Roman, S...... 50, 126, 130, 146 Rovida, E...... 209 Ryu, S. Y...... 149, 197 Sakuma, S...... 178 55, 71, 75, 96, 109, 233 Rowe, A...... 93 Rzeszotek, S...... 177 Sakurada, A...... 131 Romanelli, J...... 71 Roy, A...... 196, 239 Sakurai, K...... 238 Romanisio, G...... 153 Royce, S...... 105 Sakurai, T...... 70, 128, 217, 231 Romano, M...... 153, 231 Royg, D...... 173 S Salaga, M...... 100, 141 Romatowski, J...... 138 Rozengurt, E...... 184 Saadeh, L. M...... 132, 133, 142 Salah, A...... 224 Romberg Camps, M...... 85 Rozhkova, M...... 197 Sabat-Mir, M...... 112 Salamon, A...... 70, 137, 222 Rombouts, S. J...... 98 Rubin, G...... 85, 107, 116, 172 Sabate, J.-M...... 60 Salapa, K...... 196, 223 Romeo, E...... 184 Rubio, S...... 138 Sabbagh, L. C...... 49 Salas, A...... 61, 179 Romeo, S...... 116, 135 Rudler, M...... 43, 66 Sabelnikova, E...... 91 Salata, D...... 211 Romero, C...... 151, 139, 181, 225 Ruchkina, I...... 181 Sacco, R. C. D...... 164, 209 Saldaña Dueñas, C...... 141 Romero, G...... 139, 150, Rudnichi, A...... 56 Sacharczuk, M...... 141 Salgado, M...... 227 151, 181, 225 Rudnicki, C...... 240 Sachlova, M...... 140 Salgueiro, P. S...... 103, 188 Romero, P...... 56 Rudule, A...... 151 Sacleux, S.-C...... 89 Saliba, Y...... 134 Romero, Y...... 190 Rudzite, D. .... 57, 134, 145, 151, 237 Sadik, R...... 204, 218 Salih, A...... 207 Rommel, N...... 42, 59, 147 Rudzki, S...... 240 Sadr-Azodi, O...... 65, 86, 108 Salizzoni, M...... 113, 130, 148 Rompteaux, P...... 220 Ruemmele, F...... 57 Saeki, S...... 224 Sallinger, D...... 104, 128 Ron, Y...... 94, 115, 131, Ruess, D...... 60 Safatle-Ribeiro, A. V...... 240 Salman, T. A...... 242 139, 182 Ruffa, A...... 56, 116, 135 Safer, L...... 224, 227 Salmaso, B...... 142 Roncales, P...... 87, 185 Ruffolo, C...... 221 Safina, D...... 117, 150 Salminen, P...... 106 Roncoroni, L...... 205, 239 Rugge, M...... 48, 85, 102, Safroneeva, E...... 184, 190, 191 Salupere, R...... 77 Rondonotti, E...... 72, 104 191, 192, 205, 237 Saftoiu, A...... 131, 209, 249, 252 Salvador, E...... 119 Ronkainen, J...... 147 Ruiz, L...... 70, 179 Sagawa, T...... 131 Salvador, J...... 51 Roope, R...... 188 Ruiz, P...... 161, 196, 223 Sahami, S...... 73 Salvia, R...... 175, 176, 177, 203, 212 Ropert, A...... 60 Ruiz Del Castillo, B...... 134, 178 Saibara, T...... 161, 195, 203, 212 Samaan, M...... 138, 181 Roque Ramos, L...... 199, 200, 227 Ruiz-Castro, P. A...... 92, 134 Saibeni, S...... 157, 171 Samaha, E...... 128 Rosa, B...... 63, 131, 166, 175, 239 Ruiz-Cerulla, A...... 139 Said, M...... 130 Samija, M...... 141 Rosa, I...... 94, 128, 136, Ruksha, K...... 230 Saida, Y...... 74 Sampaio, E...... 188 142, 157, 171, 172, Rullan Iriarte, M...... 141 Saidani, K...... 224 Sampietro, G...... 73, 89 217, 223, 224, 229, 342 Rund, K...... 185 Saifullina, K. N...... 123 Sampziotis, F...... 97 Rosa, R...... 130 Rupawala, A...... 219 Saiki, H...... 128, 150, 199 Samuel, D...... 57 Roscamp, J...... 234 Rupinska, M...... 106, 127 Saiote, J...... 183 Sánchez, M...... 134, 226 Rösch, T...... 42, 69, 84 Rupinski, M...... 106, 126, 127 Saisho, K...... 148, 176, 236 Sánchez Ceballos, F...... 239 114, 115, 123, 131, 190 Ruppert, R...... 184 Saito, E...... 237 Sánchez Da Silva, M...... 134 Rose John, S...... 94 Ruskoné-Fourmestraux, A...... 192 Saito, K...... 217 Sánchez García, A...... 229 Roseira, J...... 103, 119, 202, Russell, N. K...... 87 Saito, S...... 74, 88, 106, 128, Sanchez Yague, A...... 157, 171 206, 232 Russell, R. K...... 160, 183 155, 216, 221 Sánchez-Heras, A. B...... 229 Rosendahl, A...... 86, 232 Russo, A...... 138, 203, 213, 214 Saito, T...... 169 Sanchez-Ocana, R...... 131, 176, Rosendahl, J...... 86 Russo, G...... 204, 223 Saito, Y...... 39, 49, 55, 106, 115, 204, 220 Rosenkranz, I...... 130 Russo, P...... 154, 164, 183, 124, 132, 159, 170, 171, Sánchez-Tembleque Rosenstiel, P...... 93, 94, 184, 222 187, 193, 208 173, 192, 213, 217, 236 Zarandona, Mª.D...... 134

344 345 Index of Authors and Co-Authors : UEG Week Final Programme

Sancho Serra, M. D. C...... 80 Sarlós, P...... 123 Scarpa, A...... 177 Scholz, D...... 159, 167 Sand, J...... 106, 114, 124 Sarmento, J. A...... 93, 154, 187 Scarpa, M...... 73, 132, 133, 142, Schöniger-Hekele, M...... 218 Sandborn, W...... 47, 61 Sarmento-Castro, R...... 207 151, 191, 221, 228 Schoon, E. J...... 80, 102 Sandborn, W. J...... 61, 62, 137, 180 Saro Gismera, C...... 226 Scarparo, J...... 197 Schoorlemmer, A...... 98 Sander, B...... 197 Sarter, H...... 89, 92 Scarparo, J. I. B...... 240 Schramm, C...... 173 Sander, B. Q...... 240 Saruta, M...... 131, 240 Scarpignato, C...... 54, 68 Schreiber, S...... 52, 61, 91, 93, 95, Sander, M. P...... 240 Sasahira, N...... 122 Schaefer, C...... 227 216, 222, 283, 284, 285 Sanders, D. S...... 48, 75, 84, 95, Sasaki, F...... 210 Schaefer, M...... 138 Schrenk, S...... 151 152, 205, 239 Sasaki, H...... 119, 238 Schaffalitzky Schreuders, E...... 230 Sanderson, J...... 138 Sasaki, K. ... 116, 142, 220, 230, 231 de Muckadell, O. B...... 194 Schreuders, E. H...... 77 Sandha, G. S...... 218 Sasaki, M.....114, 125, 129, 215, 238 Schaffner, D...... 66 Schroeder, J. O...... 222 Sandha, S...... 218 Sasaki, S...... 87, 215 Schafmayer, C...... 52 Schrope, B. A...... 98 Sandru, V...... 146 Sasaki, T...... 74, 122 Scharl, M...... 50, 100, 105, Schrumpf, E...... 51, 96, 108 Sands, B. E...... 47, 61, 116, 137 Sasaki, Y...... 192 184, 221 Schrutka-Kölbl, C...... 163 Sanduleanu, S...... 73, 79, 104, Sassatelli, R...... 174, 237 Schaubeck, M...... 178 Schubert-Fritschle, G...... 184 128, 157, 171 Sastrillo, M...... 138 Schebb, N...... 185 Schuette, K...... 209 Sandulescu, L...... 120 Sathasivam, R...... 148 Scheers, I...... 159, 167 Schulick, R...... 97 Sandvik, A. K...... 52 Sato, A...... 169 Scheiner, B...... 78 Schüller, V...... 233 Sanelli, R...... 152 Sato, H...... 115, 125, 191 Scheller, I...... 173 Schultze Kool, L. J...... 65 Sanga, K...... 130 Sato, M...... 156, 164 Schellerer, V...... 133 Schulz, H...... 53, 97 Sangchan, A...... 187 Sato, T.....64, 115, 125, 163, 210, 212 Schemberk Jr, J...... 197, 240 Schulze, H...... 181 Sanguinetti, M.... 81, 134, 228, 229 Sato, Y...... 131, 141, 150, 191, Schembri, J...... 129 Schulze, S...... 118 Sanjeevi, S...... 114, 124 199, 216, 231, 237, 229 Scheppach, W...... 133 Schumacher, J...... 233 Sanjuan Acosta, M...... 239 Satoh, H...... 115, 125 Scherer, M...... 163 Schuppan, D...... 46, 48, 64, 102 Sano, F...... 149, 195 Satoh, T...... 238 Schiavon, P...... 234 Schütte, A...... 113, 125 Sano, T...... 124 Satorres, C...... 173 Schiavoni, E...... 138, 179 Schütz, A...... 164 Sano, Y...... 106 Satoshi, E...... 149 Schiefke, I...... 188 Schwabl, P...... 66, 78, 119, Sanomura, Y...... 193 Satsangi, J...... 72, 81, 93 Schiepatti, A...... 196 158, 162, 163 Sansone, S...... 129 Sauar, J...... 196 Schiestl, M...... 160, 180 Schwartz, D...... 115, 131, 134, Sansonno, D...... 209 Saunders, B. P...... 93, 106, 129, 172 Schippa, S...... 202, 229 160, 181, 223, 226 Santander, C...... 97 Saunders, J. K...... 220 Schirbel, A...... 224 Schwartz, M. P...... 102 Santare, D...... 142, 151, 186, 237 Saur, D...... 79, 103 Schirrmeister, W...... 194, 238 Schwarzer, R...... 78, 218 Santi, G...... 136 Saurin, J. C...... 197, 203, 215 Schlaermann, P...... 194 Schwerdel, D...... 86 Santiago, J...... 128, 172 Sautereau, D...... 84, 103, 169, Schlechtweg, P...... 201, 241 Sciavilla, P...... 228 Santo, E...... 126, 158, 166, 172, 170, 236 Schlosser, S...... 162, 209 Scifo, G...... 164 204, 217, 222, 248 Sauvanet, A...... 81, 159, 167 Schlüter, D...... 194 Scimeca, D...... 204, 223 Santonicola, A...... 234 Sauvanet, P...... 221 Schmelz, R...... 181 Scirocco, A...... 64 Santos, A...... 173, 207, 241 Savarino, E...... 53, 55, 58, 75, 97, Schmid, R...... 61 Sciume, C...... 218 Santos, A. A...... 173 115, 132, 147, 148, 184, Schmidt, A...... 125, 152, 248 Sconfienza, L. M...... 120, 204, 223 Santos, A. L...... 193, 212 190, 194, 223, 234 Schmidt, B. A...... 152 Scott, A...... 72, 228 Santos, C. A...... 241 Savarino, V...... 58, 97, 115, 132, 147, Schmidt, C...... 181 Scott, J...... 183 Santos, I...... 128 153, 184, 190, 223, 234 Schmidt, H...... 60 Scott, S. M...... 98 Santos, L...... 119, 193, 212 Savchuk, O...... 145 Schmidt, P. N...... 158, 167 Scribano, M. L...... 56, 183 Santos, M...... 103, 104, 114, 119, Savoye, G...... 89, 92 Schmiegel, W...... 109 Sebastian, S...... 77, 160, 181, 183 202, 206, 227, 232 Sawada, M...... 122 Schmöcker, C...... 185 Secrier, M...... 105 Santos, P...... 123, 157, 167, 179, 198 Sawada, R...... 131, 240 Schnabel, R...... 138 Sedarat, A...... 58, 115, 125, 215 Santos, S...... 104, 154 Sawai, H...... 214 Schneider, C...... 236 Seewald, S...... 38, 68, 75, 82 Santos Peixe, B. M..... 103, 104 114, Sawai, Y...... 88, 216 Schneider, M...... 90 Segal, J. P...... 181 119, 202, 206, 232 Saxena, P...... 71, 101 Schneider, M. J...... 204, 221, 222 Segato, S...... 203, 213, 214 Sanyal, A. J...... 163 Sayegh, R...... 121, 134 Schneider, T...... 133 Segersvärd, R...... 114, 124 Saoula, H...... 224 Scaglione, G...... 103 Schnerr, R...... 131 Segol, O...... 172 Sapienza, C...... 139, 227 Scaglione, G. L...... 151 Schnúr, A...... 94 Seicean, A...... 156, 165 Sapone, A...... 239 Scaioli, E...... 112, 133 Schober, M...... 168 Seidl, A...... 138 Sarafian, M...... 116, 135 Scaldaferri, F...... 62, 81, 134, 138, Schoder, M...... 119, 163 Seidler, U...... 100 Saraiva, S...... 80 179, 180, 184, 204, Schoeler, M...... 241 Seidner, D. L...... 240 Sarda, C...... 220 222, 224, 228, 229 Schoels, M...... 138 Seifert, B...... 91, 140, 160 Sardanelli, F...... 120 Scalese, G...... 116, 145 Schoepfer, A...... 97, 184, 190, 191 Seifert, H...... 113, 114, 123, Sarid, O...... 223, 226 Scalone, O...... 216 Schofield, C...... 160, 180 125, 159, 167 Sarimpegioglou, N...... 101 Scannone, D...... 134 Schöfl, R...... 218 Seitz, J. F...... 51

345 UEG Week Final Programme : Index of Authors and Co-Authors

Sejben, A...... 139 Seto, Y...... 102 Sherlock, M...... 226 Shmunis, Y...... 172 Sekelja, M...... 81 Setoyama, H...... 210 Sherwood, R...... 136, 179 Shnell, M...... 104, 126 Seki, M...... 65, 74, 127, 217 Seufferlein, T...... 60, 72, 79, 83, Shestopaloff, K...... 195 Shoichiro, M...... 136 Seki, S...... 129, 142, 231 86, 94, 101, 108 Sheth, K...... 214 Shoji, A...... 232 Seki, Y...... 179 Seuwen, K...... 100, 134 Shi, D...... 99, 234 Shonova, O...... 140 Sekiguchi, M...... 106, 192, 213 Sevdalis, N...... 115, 127 Shi, X...... 161, 193 Shonová, O...... 77 Sekikawa, A...... 88, 216 Severi, C...... 64 Shibata, C...... 65 Shpak, B...... 104, 115, 131 Sekine, S...... 213 Sevrin, G...... 134, 221 Shibata, J...... 116, 142 Shrikhande, S. V...... 168 Seksik, P...... 72, 73, 77, 81, 222 Seward, E...... 185 Shibata, T...... 174 Shringarpure, R...... 163 Seleem, W. M...... 53 Seyyedmajidi, M...... 195 Shibata, W...... 212 Shukla, S. K...... 162 Selenius, J...... 80 Sezgin, B...... 235 Shibatoge, M...... 168 Shums, Z...... 51, 136, 145 Seleznev, D. E...... 175 Sferrazza, S...... 130, 142, 234 Shibolet, O...... 99, 222 Shun, M...... 224 Selgrad, M...... 105, 163, 192 Sgambato, A...... 134 Shibutani, K...... 88 Shvets, O...... 89 Selinger, C...... 225 Sgambato, D...... 135 Shibuya, R...... 237 Shwana, S...... 143, 146 Sella, D...... 238 Sha, W...... 146, 185, 236 Shieh, J.-J...... 197 Si, J...... 165 Sellier, F...... 51, 127 Shabaan, M...... 207 Shiffman, M...... 121 Si, P...... 212 Selvendran, S...... 141, 185 Shachar, E...... 104 Shifrin, O...... 154 Siau, K...... 184 Semadeni, G.-M...... 121 Shafigullina, A...... 118 Shih, Y.-L...... 208 Sibertin-Blanc, C...... 51 Sempoux, C...... 191 Shah, A...... 135 Shim, C. S...... 94 Sicília Aladrén, B...... 56, 138 Semyachkina- Shah, R...... 130, 212 Shim, K.-N...... 188 Siciliano, M...... 88, 164 Glushkovskaya, O...... 194 Shah, S...... 154 Shima, Y...... 203, 212 Siczek, K...... 160, 177 Sendino, O...... 151, 173, 218 Shalev, V...... 135, 139 Shimada, M...... 74 Sidani, S...... 81 Sendur, P...... 211 Shallue, C...... 105 Shimada, Y...... 190, 234 Sidhu, M...... 49, 101 Senellart, H...... 186 Shames, R...... 116, 137 Shimakoshi, H...... 231 Sie, D...... 79 Sengupta, S...... 227 Shamir, R...... 153, 183, 221 Shimaya, K...... 88 Sieghart, W...... 49, 78, 119, 163 Senore, C...... 229 Shams, A...... 194 Shimayoshi, A...... 149, 195 Siegmund, B...... 57, 76, 181, Senturk, H...... 161 Shannon, B...... 201, 228 Shime, N...... 210 224, 225 Seo, A. N...... 174, 212 Shannon, K. M...... 116, 141 Shimizu, S...... 207 Sielezneff, I...... 81 Seo, D.-W...... 63, 175, 210, 211, 218 Shapira, M...... 154 Shimizu, T...... 114, 127, 146, Sier, C. F...... 60 Seo, M. S...... 140 Shapira, S...... 50, 197, 203, 159, 169, 236 Sierra-Ausin, M...... 138 Seo, S. I...... 202, 233 212, 231, 240 Shimizu, Y...... 126 Siersema, P. D...... 55, 69, 104, 216 Seo, S. Y...... 122, 142 Shapiro, D...... 121, 163 Shimizu-Hirota, R...... 117, 140, 152 Sifré, E...... 194 Seoane, A...... 216, 217 Sharaf-Eldin, M...... 120 Shimoda, A...... 231 Sifrim, D...... 53, 117, 146, Seol, S.-Y...... 188 Sharaiha, R. Z...... 130 Shimoda, R...... 59, 115, 125 190, 191, 286 Seppänen, M...... 80 Sharara, A...... 229 Shimodate, Y...... 140 Sigal, M...... 52 Serban, D...... 166 Sharipova, E. I...... 118 Shimosegawa, T...... 59, 65, 91 Sigounas, D. E...... 194 Serejo, F...... 165 Sharkey, L. M...... 87 Shimura, T...... 58 Sihuay, D...... 187 Serek, R...... 126 Sharma, N..... 117, 145, 170, 179, 190 Shin, C. M...... 47, 161, 172, 189, Sike, R...... 61 Sereni, G...... 174, 237 Sharma, P...... 158, 163 192, 193, 237 Silecchia, G...... 64 Sergeychuk, T...... 229 Sharma, R...... 151, 213, 242 Shin, E. J...... 97 Siljander, P...... 142 Serghini, M...... 135, 139 Sharma, V...... 151, 213, 242 Shin, H. J...... 236 Silla, G. M...... 200 Sergienko, R...... 223 Shaw, I...... 160, 183 Shin, S. K...... 149, 215, 237 Silos-Santiago, A...... 92, 98 Seri, M...... 87 Shaya, G...... 105 Shin, S. P...... 130 Silva, A...... 119, 126, 154, 155, Serin, H. I...... 119 Shayakhmetova, G...... 145 Shin, S. W...... 121 198, 199, 207, 242 Serio, M...... 152, 239 Shayto, R. H...... 229 Shin, W. G...... 202, 233 Silva, F...... 207 Serip, S...... 236 Shaza, L...... 99 Shin, Y...... 86, 188 Silva, G. L. R...... 50, 101 Serizawa, A...... 170 Shcherbakova, A...... 147 Shinkai, K...... 232 Silva, J...... 131, 144, 154, 175, 187, Serra, J...... 234 Shehab El-Din, I...... 104 Shinoki, K...... 158, 186 193, 198, 199, 202, 219, Serradesanferm, A...... 77 Shehadeh, Z...... 239 Shinozaki, T...... 192 220, 229, 233, 224 Serrano, M.... 133, 157, 171, 173, 224 Shehata, E...... 120 Shiomi, H...... 98 Silva, M...... 93, 119, 120, 126, Serrano, R...... 229 Sheibani-Tezerji, R...... 93 Shiotani, A...... 189 154, 155, 163, 165, Serrano-Montalbán, B...... 136 Shemesh, N...... 240 Shioyama, T...... 170 187, 193, 199, 219 Serrano-Morillas, N...... 134 Shen, H...... 65, 210 Shiozawa, E...... 141 Silva, M. J.... 154, 164, 187, 193, 208 Serrão, R...... 93, 187 Shen, J...... 49 Shirai, H...... 177 Silva, M. M. C...... 51 Serva, D...... 238 Shen, W...... 212, 242 Shirasaki, T...... 94 Silva, N...... 184 Servais, L...... 236 Shen, X...... 144, 162, 168 Shirin, H...... 104, 153 Silva, V...... 208 Servajean, C...... 127 Shephard, E...... 172 Shirokova, E...... 166 Silva, W. C...... 188 Serwin, K...... 177 Shepherd, N...... 129 Shiwaku, H...... 170, 234. Silveira, A...... 220 Sethi, A...... 98 Sheptulina, A...... 166 Shiwaku, Y...... 170 Silveira, M...... 133

346 347 Index of Authors and Co-Authors : UEG Week Final Programme

Silverberg, M. S...... 177, 195 Slater, J...... 181 Son, B.-K...... 122, 124, 162 Spergel, J...... 190 Sim, Y. R...... 59, 106 Slavin, J...... 168 Son, C...... 199 Spicak, J...... 117, 134, 148, 164, Sima, A...... 156, 165 Slim Karam, R...... 121 Son, J. H...... 122 190, 202, 206, 214, Simantov, R...... 104 Sliman, J...... 186 Soncini, M...... 203, 213, 214 233, 236, 248 Simão, A...... 99 Sliwowski, Z...... 116, 133, 189 Song, B...... 114, 122 Spielmann, P...... 92 Simão, A. L...... 118 Sloan, J. A...... 118 Song, E. M...... 140, 270 Spiller, R...... 40, 43, 75, Simedrea, I...... 153, 166 Slonim-Nevo, V...... 223, 226 Song, G. A...... 149, 188, 193, 237 108, 160, 186 Siminkovitch, S...... 114, 123, 124 Sloth, S...... 104 Song, G. W...... 148, 192 Spina, L...... 56, 127, 204, 213, 223 Simionescu, B...... 166 Sluka, P...... 105 Song, H...... 161, 191 Spinelli, Antonino...... 41, 63 Simmen, S...... 92 Smajstrla, V...... 72 Song, J.-T...... 126, 176 Spinzi, G...... 104, 215, 203, Simmura, T...... 129 Smayra, V...... 134 Song, K...... 121 213, 214 Simões, A. E. S...... 52, 141 Smedh, U...... 148 Song, M...... 140, 173, 270 Spisák, S...... 52 Simoliuniene, R...... 206 Smeets, H. M...... 226 Song, T. J...... 175, 210, 211, 218 Spivak, M. Y...... 197 Simon, H.-U...... 191 Smets, F...... 47, 183 Song, Y. N...... 213 Sporea, I...... 88, 114, 117, 120, 156, Simon, M. A...... 157, 171 Smids, C...... 178 Song Md, J.-Y...... 214 163, 165, 166, 202, Simons Linares, C. R...... 220 Smiech, M...... 160, 177 Sonsuz, A...... 161 208, 249, 250, 252 Simrén, M...... 15, 46, 58, 81, 92, Smith, H...... 62, 97 Sood, R...... 58, 72, 160, 179 Sportes, A...... 174, 176, 219 98, 143, 144, 152, 186, Smith, J. D...... 87 Soofi, M. E...... 165, 208 Srinivasan, S...... 81 187, 189, 191, 221, Smith, M...... 225 Sopena, F...... 185 Stack, R...... 152 228, 232, 306 Smith, M. I...... 93, 195 Soppelsa, F...... 172 Stadler, B...... 218 Sinatti, D...... 130 Smith, S...... 154, 194, 196, Sørbye, S. W...... 205, 238 Stadlmayr, A...... 185 Sinayoko, L...... 137 226, 230 Sørdal, Ø...... 52 Staffer, S...... 204, 221 Singaram, B...... 195 Smout, A...... 53, 96, 107, 109, 190 Sørensen, L. T...... 211 Stahmeyer, J. T...... 165 Singer, C...... 202, 233 Smyth, C...... 227 Soria, M...... 63, 80, 115, Staikuniene, N...... 206 Singh, A...... 225 Smyth, M...... 47, 138 130, 159, 169 Staller, K...... 67 Singh, B...... 230 Soares, C...... 128 Soriani, P...... 127, 213 Stallmach, A...... 181 Singh, J. R...... 51 Soares, E...... 119, 151, 189, Soriano-Gabarró, M...... 184 Stam, M...... 106 Singh, P...... 94 208, 226, 242 Sostres, C...... 70, 157, 171 Stamenic, V...... 141 Singh, R...... 49, 51 Sobajima, Y...... 65 Soto, S...... 157, 171 Stanel, I...... 182 Singh, V...... 87, 161, 190, 211 Sobh, M. A...... 130 Sottisuporn, J...... 187 Stange, E. F...... 227 Singhal, D...... 133 Sobolewska, J...... 133 Sottisuporn, O.-A...... 187 Stanghellini, V...... 54, 61, 68, 87 Sinha, R...... 164 Sobolewska-Wlodarczyk, A...... 221 Soudan, D...... 226 Stankovic, S...... 207, 224 Sinn, D. H...... 121 Socha, P...... 162 Soudan, F...... 107 Stanley, A...... 103 Sinnett-Smith, J...... 184 Sodatonou, H...... 105 Souma, D...... 197 Stanley, S...... 129, 172, 188 Sion, D...... 240 Söderholm, J. D...... 81, 93 Sousa, J. C...... 120, 215 Stanton, A...... 138 Sipeki, N...... 51, 136 Soejima, H...... 230 Sousa, M...... 52, 131, 144, 175, Stanzani, A...... 87 Sipos, B...... 203, 212 Soetikno, R...... 157, 171 198, 202, 219, 220, Stanzel, C...... 105 Sippola, S...... 106 Sofia, C...... 118, 119, 123, 151, 163, 224, 229, 233 Stapley, S...... 172 Sippola, T...... 202, 211 174, 183, 184, 189, 208, Sousa, M. M...... 52 Starostina, N...... 167 Siproudhis, L...... 135, 137, 171, 178 218, 226, 240, 242 Sousa, P...... 119, 126, 154, 155, Starshinov, Y. P...... 145 Siriwardena, A. K...... 123 Sofuni, A...... 124, 159, 175 198, 199, 207, 242 Starzynska, T...... 211 Sirli, R. L. D...... 88, 114, 117, 120, Soggiu, F...... 130 Sousa, R...... 198 Stasinos, I...... 241 156, 163, 165 Sogomonyan, E...... 145 Souto-Moura, M...... 207 Stassen, E. J...... 161, 197 , 202, 208 Sohn, T. S...... 193, 197 Soykan, I...... 189, 190, 201, Staton, J...... 226 Sivignon, A...... 57, 222 Sokol, H...... 57, 72, 77, 81, 274 230, 241 Stättermayer, A. F...... 78, 208 Sivins, A...... 145 Sokolviak, O. Y...... 197 Spaander, Staufer, K...... 117, 152 Sjödahl, J...... 113, 143 Sola Tapias, N...... 177 M. C. W...... 73, 74, 77, Stavrinidis, S...... 101 Sjomina, O...... 237 Solaman, A...... 182 78, 93, 106, 140, 171, Stec-Michalska, K...... 240 Skieceviciene, J...... 151, 158, 162 Solbiati, L...... 62 205, 228, 230, 235 Stecco, K...... 240 Sklyarov, E...... 118 Soleimani, A...... 211 Spada, C...... 55, 90, 128 Stecher, L...... 158 Sklyarov, O...... 70, 145 Soler Michel, P...... 216 Spalinger, M. R...... 50, 100, 221 Steed, H...... 184 Skobo, T...... 151 Soliman, S...... 104 Spano, G...... 64 Steenholdt, C...... 222 Skoko Poljak, D...... 141 Soliman, T...... 156, 164 Sparchez, Z. A...... 121, 156, 165 Stefanescu, A...... 166 Skrypnychuk, I...... 221 Solodenkova, K. S...... 145 Sparrow, M. P...... 182 Stefanescu, C...... 72, 81, 222, 226 Skrypnyk, I...... 238 Soloviev, K...... 225 Spasic, D...... 223 Steffen, H.-M...... 173 Skrypnyk, R...... 238 Solovyeva, A. V...... 191 Spatoliatore, A...... 183 Steffens, H...... 120 Skuja, V...... 57, 134 Soltys, K...... 160, 179 Spechler, S. J...... 54, 69 Stein, A...... 213 Skup, M...... 116, 137, 183 Somarathna, T...... 129 Speller, A...... 228 Stein, J...... 85, 115, 132, 134, 137, Slaman, A. E...... 133 Someya, T...... 132 Sperber, A. D...... 58, 187, 189 160, 179, 183, 188, 241

347 UEG Week Final Programme : Index of Authors and Co-Authors

Steinbrueck, I...... 131 Strobel, D...... 136 Sun, B...... 100 Szentesi, A...... 123, 166 Steiner, S...... 78 Strobel, O...... 86 Sun, H...... 99 Szentirmay, Z...... 193 Stengel, Andreas...... 48, 64, 108 Ström, M...... 92 Sun, J...... 144 Szepes, A. Z...... 99, 123, 203, Stepan, A.-M...... 117, 163, 208 Stronati, L...... 85 Sun, L...... 165 215, 222 Stephan, D...... 53 Stroobants, A. K...... 73 Sun, S...... 214 Szepes, Z...... 70, 99, 123, 137, 203, Stephansson, O...... 105 Stroppa, I...... 130 Sunata, Y...... 205, 231, 232 204, 215, 220, 222, 223, 227 Steponaitiene, R...... 151, 162 Stuchlik, S...... 160, 179 Sund, M...... 168 Szepes, Z. G...... 99, 139, 219, Stepulak, A...... 114, 123 Stuhrmann, N. C...... 204, 221 Sundbom, M...... 148 222, 224, 227 Sterbini, F. P...... 228 Stulz, A...... 200 Sunde, B...... 161, 191 Szewczyk, M...... 133 Stern, R...... 78, 208 Sturdik, I...... 136, 160, 179 Sundelin, H...... 239 Szigeti, N...... 222 Sternbach, J. M...... 190 Sturgeon, C...... 151, 239 Sundin, J...... 81 Szklarczyk, J...... 211 Sternini, C...... 184 Sturm, A...... 224 Sundström, J...... 196 Szlak, J...... 126 Steurer, W...... 227 Sturm, E...... 174 Sung, J...... 193 Szucs, M...... 204, 219, 220, 223 Steyerberg, E. W...... 106 Sturniolo, G. C...... 73, 151, 228 Sung, J. J. Y...... 49, 71, 87, 91, Szulcsán, Á...... 204, 223 Sticova, E...... 164, 202, 206 Su, C...... 61, 137, 160, 180 95, 103, 107 Szymanczak, R...... 206 Stier, C...... 115, 132 Su, M...... 180 Sung, J. K...... 140, 169, 236, 238 Stigaard, T...... 104 Su, M.-Y...... 150 Supper, P...... 66, 158, 162 Stimac, D...... 118, 141, 158, 161, Subasinghe, C. E...... 201, 206 Surace, L...... 147, 190 T 167, 184, 211, 248 Subramaniam, S...... 101, 127, 140, Suraci, E...... 238, 239 Taavela, J...... 195 Stirand, P...... 233 142, 170, 214, Sureddi, B. V. N K...... 51 Tabacelia, D...... 146 Stoilov, G...... 93 235, 236 Surin, A. M...... 145 Taberna-Arana, L...... 121 Stojkovic, M...... 224 Subramaniam, Y...... 160, 172, 179 Suto, T...... 129, 142, 231 Tabouret, T...... 169 Stojkovic Lalosevic, M...... 224 Subramanian, S...... 224 Sutti, S...... 117 Tacheci, I...... 189 Stojmirovic, A...... 72 Subramanian, V...... 72 Suzuki, A...... 121 Tachikawa, J...... 129, 142, 231 Stoker, J...... 179 Suchanek, S...... 140, 141, 236, 248 Suzuki, H...... 99, 103, 107, 170, Tack, J...... 10, 40, 46, 52, 58, Stokkeland, K...... 105 Suchecka, D...... 145, 241 185, 192, 213, 236 59, 64, 68, 92, 108, Stokkers, P...... 46 Sud, R...... 63 Suzuki, K...... 216, 218 113, 143, 147, 152, 160, Stordeur, P...... 85 Suda, H...... 238 Suzuki, M...... 205, 232 161, 189, 190, 197, 283 Stork, T...... 156, 164 Suda, K...... 215 Suzuki, N...... 216, 231, 237 Tacke, F...... 61, 91 Storlid, E. L...... 233 Sue, S...... 212 Suzuki, S...... 238 Tada, M...... 122 Storm, G...... 57, 118 Suehiro, M...... 101 Suzuki, T...... 81, 149 Tadokoro, H...... 117, 152 Storonova, O...... 117, 147, 186 Suehiro, S...... 159, 169 Suzuki, Y...... 60, 157, 167 Tadokoro, K...... 141, 142, 199 Storr, M. A...... 234 Sueiro, A...... 134, 159, 176, 178 Svecova, H...... 214 Tagao, F...... 128 Storsrud, S...... 144, 228 Sueiro, R. A...... 134, 178 Svecová, H...... 190, 233 Tagawa, K...... 65, 74, 127, 217 Störsrud, S...... 46, 144 Sugahara, A...... 157, 167 Svenningsen, L...... 182 Taghavi, S. A. R...... 163 Stöß, C...... 158, 184 Sugai, T...... 103, 107 Svinarenko, M...... 72 Taghvaei, T...... 239 Stoyanova, K...... 61 Sugihara, K...... 116, 142 Svinarov, D...... 124 Tagliente, G...... 151 Straathof, J. W. A...... 73, 128 Sugihara, Y...... 73, 179, 217, 230 Svistunov, A. A...... 145 Taguchi, H...... 210 Stracke, B...... 222 Sugimori, K...... 130 Svrcek, M...... 77 Taha, A...... 44 Strassburg, C...... 69, 96, 108 Sugimori, M...... 212 Swager, A...... 79, 80 Tahara, T...... 174 Strasser, S...... 121 Sugimoto, A...... 231 Swanson, L...... 220 Taida, T...... 214 Strati, F...... 228 Sugimura, H...... 193 Sweis, R...... 146, 235 Taisei, M...... 70 Straub, D...... 80 Sugimura, M...... 141, 142, 199 Swidsinski, A...... 204, 221 Tajika, M...... 125, 142 Straumann, A...... 97, 100, 109, Sugino, Y...... 140 Sydorchuk, A...... 114, 118, 121, 182 Tajima, H...... 117, 147 190, 191 Sugiyama, M...... 157, 167 Sydorchuk, I...... 114, 118, 121, 182 Tajiri, H...... 55, 65 Straume, Z...... 57, 134 Suh, B. J...... 132 Sydorchuk, L...... 114, 118, 121, 182 Takabayashi, K...... 169, 205, Strawbridge, R. R...... 220 Sui, G...... 233 Sydorchuk, R...... 114, 118, 121, 182 231, 232 Streba, C. T...... 209, 230 Suk, K. T...... 130, 234 Symonds, E. L...... 142 Takács, R...... 123 Streba, L...... 230 Sulaberidze, G...... 144 Syzenko, G...... 144 Takács, T...... 123 Stremmel, W...... 204, 221 Sulbaran, M...... 240 Szabo, E...... 99 Takada, J...... 59 Streuper, C...... 116, 137 Sullivan, E...... 227 Szabó, I...... 123 Takada, S...... 117 Strid, H...... 58, 221 Sulyma, V. P...... 93 Szaflarska-Poplawska, A...... 153 Takada, Y...... 205, 231, 232 Stridsberg, M...... 81 Sulz, M. C...... 121 Szalai, M...... 203, 215 Takagi, K...... 122 Strigli, A...... 89 Sümegi, J...... 123 Szalay, B...... 70, 182 Takagi, R...... 107 Strik, A. S...... 89 Sumida, Y...... 49, 103, 114, 122, 186 Szalay, F...... 51 Takagi, T...... 170 Strindmo, I...... 91, 239 Sumimoto, K...... 106, 158, 185 Szamosi, T...... 70, 137, 222 Takahara, M...... 73, 179 Strittmatter, N...... 72 Sumioka, M...... 224 Szantova, M...... 170 Takahara, N...... 122 Strnad, P...... 56 Summers, J...... 80 Szapary, P...... 47, 61, 116, 137 Takahashi, A...... 59, 65, 101, Strobel, B...... 66 Sumskiene, J...... 158, 162 Szczepanik, A...... 172 148, 192

348 349 Index of Authors and Co-Authors : UEG Week Final Programme

Takahashi, H...... 169 Tan, H. K...... 133 Taylor, A...... 144, 235, 236 Theocharis, G...... 154, 179 Takahashi, K...... 60, 231 Tan, M...... 160, 179 Taylor, D. C. A...... 144 Theodoropoulos, L...... 101 Takahashi, M...... 126 Tan, T...... 58 Taylor, E...... 228 Theodoropoulou, A...... 178 Takahashi, Y...... 131 Tan, Y...... 154, 190 Taylor, S...... 69, 107, 179 Theuerkorn, K...... 203, 212 Takamaru, H...... 106 Tanabe, M...... 66 Tazuma, S...... 157, 167 Thévenot, J...... 74, 221 Takano, M...... 77 Tanabe, S...... 96, 115, 125 Tcaciuc, A...... 163 Thiel, A...... 199 Takara, Y...... 230 Tanaka, E...... 207 Tcaciuc, E...... 163 Thiis-Evensen, E...... 85 Takasago, T...... 49, 103, 114, Tanaka, K...... 59, 65, 121, 130 Tcymbarevich, I...... 100 Thomas, C. L...... 230 122, 186 Tanaka, M. 51, 117, 140, 149, Teare, J...... 72 Thomas, C. S...... 216 Takashima, K...... 173 150, 158, 186 Tearney, G. J...... 79 Thomas, E...... 239 Takashima, S...... 73, 179 Tanaka, R...... 124, 128, 159, 175 Tebaibia, A...... 154, 233 Thomas, M...... 105, 230 Takatalo-Laine, M...... 142 Tanaka, S...... 106, 157, 158, Tefas, C...... 214 Thomas, T...... 130 Takatori, Y...... 205, 231, 203 171, 185, 193 Teich, N...... 181 Thomas-Gibson, S...... 41, 115, 127, Takats, Z...... 72, 228 Tanaka, T...... 116, 139, 142, 148 Teisseyre, M...... 162 203, 216 Takayama, M...... 140 176, 183, 220, 236 Teixeira, C...... 104, 114, 119, Thomopoulos, K...... 154 Takayama, Y...... 177 Tanaka, Y...... 107, 132, 192 155, 162, 164, Thompson, C. C...... 48, 61 Takeda, H...... 164, 177 Taneishi, K...... 149 189, 206, 242 Thompson, N...... 81 Takeda, K...... 55, 84, 129, 216, 217 Tang, C...... 114, 122, 163 Tekkis, P...... 106, 129 Thompson-Jones, H...... 239 Takeda, S...... 231 Tang, J...... 179 Tellan, G...... 64 Thoufeeq, M. H...... 129 Takeda, T...... 150, 170, 190, Tang, M...... 160, 180 Tellechea, J. I...... 172 Thurairajah, P. H...... 173 234, 237 Tang, R...... 219 Tenca, A...... 130, 146, 174 Thurmann, D...... 241 Takedomi, H...... 230 Tang, X...... 113, 125, 203, 213 Tennyson, J...... 219 Thursby-Pelham, F...... 104, 140 Takehara, T...... 84 Tani, J...... 206 Tenover, F...... 173 Thursz, M...... 39, 61, 107 Takei, D...... 73, 179 Tanigawa, T...... 101 Teodorescu, C...... 131 Thygesen, H...... 172 Takei, K...... 237 Taniguchi, H...... 213 Teoh, A. Y. B...... 219 Tian, D...... 100, 204, 221 Takeichi, T...... 238 Taniguchi, K...... 170 Tepasse, P...... 222 Tibbatts, C...... 169, 188 Takemoto, K...... 166, 237 Tanis, P...... 73, 158, 185 Tepe, B...... 52, 89 Tieppo, C...... 128 Takenaka, K...... 180 Tanisaka, Y...... 121 Teppei, O...... 139 Tighe, D...... 194 Takenaka, M...... 98, 123 Taniuchi, K...... 203, 212 Terai, S...... 191 Tikellis, C...... 105 Takenaka, R...... 166, 237 Tanke, G...... 88, 216 Terai, T...... 106 Tikhomirova, E. V...... 175 Takeshima, F...... 136 Tankova, L...... 93 Teranishi, Y...... 78 Tilburg, S. V...... 77 Takeuchi, H...... 114, 125, 192, Tannapfel, A...... 72 Terasaki, K...... 125, 170 Tilg, H...... 37, 43, 64, 71, 83, 109 195, 215 Tanne, F...... 209 Terasaki, M...... 99 Tillisch, K...... 232 Takeuchi, Y...... 49, 84, 106, Tanner, J.-R...... 231 Terhalle, A...... 105 Timar, R...... 156, 165 126, 127, 149, Tantau, A...... 214 Terheggen, G...... 143 Tinè, F...... 130, 204, 223 204, 215, 217 Tantau, M...... 214 Terrebonne, E...... 220 Tingstedt, B...... 160, 176 Takeyama, Y...... 157, 167 Tao, L.-Y...... 126 Terreni, N. M. L...... 104 Tiniakos, D...... 83, 96, 101 Taki, M...... 88, 216 Tap, J...... 81, 143, 228 Terris, B...... 62 Tioli, C...... 174, 237 Takimoto, M...... 141 Tapper, S...... 92 Terrosu, G...... 172 Tiribelli, C...... 66, 118, 161, Takizawa, K...... 51, 117, 125, 140, Tarabar, D...... 137 Tertychnyy, A...... 154 162, 166 149, 150, 158, 186 Tarantino, I...... 50, 130, 131 Terzoudis, S. P...... 142, 235 Tisell, A...... 92 Talaat, R...... 88 Targan, S...... 47 Teshima, C...... 218 Tiszlavicz, L...... 139, 219 Talbot, M...... 53 Tarnasky, P...... 130, 212 Testa, A...... 77, 90, 138, 224 Titov, N...... 64 Tallet, A...... 130 Tarnawski, A. S...... 70, 144, 189 Testa, G...... 59 Titova, A...... 118 Talley, N. J...... 64, 112, 113, 133, Tarnok, A...... 166 Testoni, P. A...... 104, 152 Titova, M. A...... 118 135, 143, 147, 190, 231 Tarquini, P...... 164 Testoni, S. G. G...... 168 Tittoni, R...... 116, 137 Talukdar, R...... 51 Tarticchio, G...... 52 Teuber, G...... 120 To, K. F...... 106 Tamai, N...... 106 Tashiro, T...... 232 Teubner, D...... 104 To, N...... 58, 160, 179, 223 Tamai, Y...... 177 Tasini, E...... 128 Tew, W...... 160, 180 Tobin, A.-M...... 138 Tamaki, H...... 168 Tasset, C...... 61 Tez, M...... 149 Tobin, R...... 133 Tamara, F...... 131 Tate, D...... 115, 127 Thabut, D...... 37, 43, 54, 76, 103 Toda, N...... 65, 74, 127, 217 Tamegai, Y...... 128, 221 Tate, D. J...... 49, 101, 115, Thakkar, R. B...... 183 Toes-Zoutendijk, E...... 74 Taminiau, J...... 75, 82 127, 203, 215 Thandassery, R. B...... 165, 208 Toex, U...... 173 Tammaro, S...... 218 Tate, H...... 181 Thapar, N...... 46 Tokai, A...... 222 Tammer, I...... 194 Tatsumi, N...... 128, 150, 199 Tharwa, E. S...... 119 Tokai, Y...... 150 Tamori, A...... 78, 164 Tavares, H...... 136, 223 Thayalasekaran, S...... 49, 101, 127, Tokodi, I...... 166 Tamura, F...... 115, 125 Tavares De Sousa, H...... 136 140, 142, 214, Tokuda, T...... 150 Tamura, Y...... 238 Tawefeek, S...... 120 235, 236 Tokuda, Y...... 150, 199 Tan, C. K...... 133 Taxonera Samso, C...... 181 Themeli, A...... 238 Tokuhiro, N...... 238

349 UEG Week Final Programme : Index of Authors and Co-Authors

Tokushige, K...... 139, 224 Tóth, A...... 166 Tsoi, E...... 235, 236 Uchita, K...... 80, 115, 125, 215 Toleikiene, R...... 142 Tóth, E...... 94, 123 Tsoi, H...... 87 Uchiyama, K...... 125, 170 Tollardo, M...... 172, 240 Tóth, G...... 166 Tsoi, K. K...... 71 Udre, A...... 212 Tolmanis, I...... 237 Tóth, K...... 94 Tsolias, C...... 154, 179 Ueda, M...... 87 Tolone, S...... 58, 97, 115, 132, Touchefeu, Y...... 186 Tsoukali, E...... 196 Ueda, T...... 125, 170 147, 190, 194, 234 Tougeron, D...... 220 Tsoulas, C...... 120 Ueda, Y...... 164 Tolstanova, G...... 229 Touzet, S...... 203, 215 Tsuchida, O...... 64 Uedo, N...... 49, 80, 84, 194 Tomà, P...... 166 Townsend, A...... 220 Tsuchida, T...... 125 Ueki, T...... 169 Tomaszewska, R...... 211 Toyonaga, T...... 193 Tsuchiya, I...... 92, 177, 196 Uemoto, S...... 164, 177 Tomba, C...... 205, 239 Toyoshima, N...... 231 Tsuchiya, K...... 94 Ueno, H...... 230 Tomba, F...... 238 Tözün, N. A...... 83 Tsuchiya, T...... 115, 124, 159, 175 Ueno, T...... 231 Tomczyk-Ferrero, J...... 216 Tozzi, L...... 116, 137 Tsuda, M...... 99 Ueo, T...... 80 Tomé, A...... 193 Trabulo, D...... 164, 187 Tsugeno, H...... 166, 237 Ueyama, H...... 150, 170, Tomé, L...... 119, 208, 242 Traina, M...... 130, 131 Tsujimae, M...... 52, 167 190, 234, 237 Tomida, H...... 125, 170 Traini, S...... 130 Tsuji, S...... 124, 159, 175 Ujiki, M...... 71 Tominaga, K...... 74 Trancassini, M...... 202, 229 Tsuji, T...... 59, 65, 212 Ukai, K...... 141, 142, 199 Tomioka, T...... 192 Tran, F...... 93, 94 Tsuji, Y...... 172 Ukkola, O...... 201, 206 Tomita, N...... 230 Tran, J...... 226 Tsumano, E...... 195 Ul-Haq, Z...... 168 Tomita, Y...... 149 Trauner, M...... 40, 46, 66, 71, 78, Tsumura, T...... 88, 216 Ulmer, C...... 227 Tomitao, M...... 240 104, 108, 117, 119, Tsunedomi, R...... 231 Ulrich-Merzenich, G...... 147 Tomkins, C...... 230 121, 128, 152, 156, Tsuruta, O...... 106, 168 Ulrich-Rueckert, S...... 134 Tomohiro, T...... 114, 127 158, 162, 164, 208, 218 Tsutsui, K...... 131 Ulyanin, A...... 154 Tomokiyo, S...... 224 Travis, S...... 76, 183, 284, 285 Tsuzuki, Y...... 65 Umefune, G...... 122 Tompkins, C.-A...... 97, 226 Treacy, C...... 194 Tsvang, E...... 104 Umemura, S...... 52, 124 Tonai, Y...... 126, 127, 149 Trebicka, J...... 54, 76 Tucker, C...... 58, 113, 143 Umemura, T...... 207 Tondereau, V...... 241 Treskes, P...... 164 Tuk, M...... 190 Umutlu, L...... 135 Tong, H...... 114, 122, 163 Treton, X...... 72, 73, 81 Tulassay, Z...... 52, 141, 230 Ungar, B...... 47, 181, 182 Tong, J. H. M...... 106 Triantafyllou, K...... 55 Túlio, M...... 127 Unger, L...... 156 Tønnesen, T...... 205, 238 Triantos, C...... 120, 179 Túlio, M. A...... 154 Unger, L. W...... 164 Tonozuka, R...... 124, 159, 175 Tribl, B...... 218 Tumova, J...... 179 Ungureanu, B...... 131 Tontini, G. E...... 73, 84, 120, 127, Trimble, K. C...... 174 Tuncer, M...... 161 Unic, A...... 209 172, 204, 213, 223 Trimble, R...... 223 Turan, D...... 230 Unsal, B...... 93, 146 Toorenvliet, B...... 106 Trindade, A...... 99 Turato, C...... 209 Uraoka, T...... 129, 148, 203, 205, Topazian, M...... 219 Tringali, A...... 41, 71, 82, 94, Turcan, S...... 77, 134 214, 215, 231, 232 Torimura, T...... 168 130, 213, 220, 248 Turck, D...... 92 Uraoka, T...... 106, 169 Torizumi, C...... 149, 195 Triossi, O...... 144, 203, 213, 214 Turco, F...... 64 Urasinska, E...... 177 Tormo, H...... 241 Tripathi, M. K...... 162 Turculeanu, A...... 201, 206 Urata, N...... 101 Tornai, D...... 51, 163 Tristan Barros, J...... 198 Tur, G...... 230 Urban, O...... 72, 236 Tornai, I...... 51, 163 Trojano, L...... 231 Turnbull, L...... 195 Urbonas, V...... 194 Tornai, T...... 51, 163 Troncoso, R...... 241 Turpin, W...... 177, 195 Uribarri González, L...... 131, 134, Törnblom, H. ....46, 58, 81, 84, 92, Tron, I...... 135, 178 Turro, R...... 152 159, 176, 178 102, 113, 143, 144, Tronstad, R. R...... 195 Tursi, A...... 144 Urke, A...... 145 152, 187, 191, 228, 232 Troschel, P...... 113, 125, 159, 167 Turuoka, N...... 117, 145 Urreta, I...... 119 Torralba González Trott, N...... 152, 205, 239 Tutein Nolthenius, C. E...... 179 Urtila, P...... 242 De Suso, M...... 134 Trovato, C. M...... 153 Tüzün, A...... 201, 241 Urushibara, F...... 141 Torre, C...... 59 Trudgill, N...... 73, 181, 231 Tyberg, A...... 130 Usak, J...... 210 Torres Burgos, S...... 217 Trukhmanov, A...... 117, 147, 186 Tyler, A...... 177 Ushijima, T...... 168 Torres-Rodríguez, P...... 180 Trunecka, P...... 164, 202, 206 Tymczyna, L...... 160, 177 Ushiku, T...... 132 Torresan, F...... 147, 215, 234 Tsang, K.-F...... 201, 228 Tzathas, C...... 222 Uzzan, M...... 73 Torroni, F...... 184 Tsao, S...... 217 Tziortziotis, I...... 196 Torshin, V. I...... 145 Tsapas, A...... 158, 185, 227 Tzouvara, E...... 154 Tortora, A...... 130, 203, 213, 214 Tschurtschenthaler, M...... 93 V Tortora, R...... 151, 196 Tsehori, J...... 210 Vackova, Z...... 117, 148, 190, Tortosa, F...... 198 Tseng, J. F...... 160, 176 U 214, 233 Toshiaki, T...... 64 Tseng, Y.-C...... 208 Ubeda-Muñoz, M...... 99, 189 Vadalà Di Prampero, S. F...157, 167 Toshiaki Ochiai, T...... 64 Tse, Y.-K...... 219 Uberoi, R...... 140 Vadan, R...... 182 Toshimitsu, F...... 180 Tsiamoulos, Z. P...... 93, 106 Überschlag, M.-E...... 85 Vafaeimanesh, J...... 195 Toth, E...... 128, 194 Tsiaousis, G...... 154 Uchida-Kobayashi, S...... 164 Vahrmeijer, A...... 60 Toth, G. T...... 70, 137 Tsigaridas, A...... 196 Uchino, R...... 122 Vaira, D...... 89

350 Index of Authors and Co-Authors : UEG Week Final Programme

Vaishnav, V...... 151 van Hooft, J. E...... 39, 69, 89, Vegh, Z...... 70, 134, 137, Vilas-Boas, F...... 212 Vaizey, C...... 40, 75, 89 98, 101 182, 204, 225, 227 Vilela, T...... 219 Valantiene, I...... 158, 162 Van Houtte, B...... 59, 147 Velayos, B...... 56 Vilkin, A...... 104, 235 Valantinas, J...... 206 Vankovich, A...... 167 Veldt, B...... 121, 219 Villagrasa, J...... 182 Valcz, G...... 52 Van Laethem, J.-L...... 44, 60, 95 Velea, P.-I...... 166 Villalba, C...... 131 Vale Rodrigues, R...... 128, 149, van Leerdam, M...... 39, 74, 79, Velikova, V...... 135 Villa, M. P...... 153 157, 198, 171, 109, 158 Velin, D...... 94 Villani, R...... 164 172, 217, 224 van Milligen de Wit, Veljkovic, A...... 163 Villano, G...... 117, 209 Valean, S. D...... 118 A. W. M...... 102 Velkoska, E...... 105 Villing, A.-L...... 220 Valente, A...... 103, 163, 198 Vannini, C...... 105 Velosa, J...... 103, 114, 120, 123, Villoria, A...... 56 Valentina, T...... 202, 229 Van Oudenhove, L...... 58, 59, 64, 132, 157, 163, 167, Vilmann, P...... 50, 62, 104, Valerii, G...... 94, 238 67, 92, 143 179, 182, 189, 194, 108, 248 Valerio, L...... 81, 151 Van Riet, P...... 174 198, 223, 242 Vincent, C...... 121 Valero, M...... 63, 80, 115, van Roon, A. H. C...... 230 Venerito, M...... 52, 89, 105, Vinci, A...... 168 130, 159, 169 van Ryn, J...... 70 194, 236 Vincze, A...... 70, 123, 137, 222 Valeur, J...... 85 van Santvoort, H...... 114, 123 Venetz, D...... 242 Vinisko, R...... 61 Valiante, F...... 240 van Stappen, T...... 138 Venglovecz, V...... 94, 123 Vinson, B. R...... 234 Valitutti, F...... 153 Van Steenbergen, S...... 70 Venkatachalapathy, S. V...... 72, 123 Viola, A...... 202, 232 Valizadeh, S. M...... 239 van Steenbergen, W...... 159, 167 Veraldi, S...... 166 Viola, F...... 72, 85, 175, 183 Valle, J...... 168, 239 van Steenkiste, C...... 187 Verbeke, K...... 59 Virchenko, O. V...... 162, 163 Vallejo-Senra, N...... 94 Vanuytsel, T...... 59, 113, 147 Verde, M...... 135 Viriyautsahakul, V...... 187 Valle Muñoz, J...... 239 van Zoggel, D...... 160, 176 Veres, G...... 51, 136, 166 Virtanen, J...... 106 Valori, R...... 55, 72, 104, 129 Varadarajulu, S...... 129 Vergani, P...... 239 Viscido, A...... 116, 137, 238 Valpiani, D...... 77 Varadarajulu, S...... 50, 63 Vergnolle, N...... 87, 177 Vissiennon, C...... 183 Valverde-Lopez, F...... 99 Vardar, R...... 235 Verhaar, A. P...... 93, 205, 235 Viswanath, Y...... 148 Valvo, B...... 59, 232 Vardas, E...... 178 Verhaegh, B. P. M...... 135 Vitali, F...... 133, 155, 202, 233 Vanags, A...... 237 Vardi, H...... 223, 226 Verhagen, H. J. M...... 161, 197 Vitalis, Z...... 51, 163 Van Assche, G...... 44, 47, 56, Varela-López, O...... 211 Verheij, J...... 53 Vitek, P...... 74, 231 70, 100, 282 Varga, M...... 123 Verhelst, X...... 65 Vithiya, K...... 201, 206 van Baar, A...... 203, 213 Vargas, V...... 121 Verhoef, C...... 131 Vitor, S...... 114, 120 Vanbiervliet, G...... 172 Varkalaite, G...... 158, 162 Verhulst, S...... 99 Vitton, V...... 71 van Brunschot, S...... 46 Varol, C...... 50 Verleye, M...... 187 Vladimirov, B...... 114, 123, 124 van Buren, G...... 212 Varvara, D...... 204, 223 Verlinden, W...... 187 Vlasov, L...... 163 Van Cutsem, E...... 76, 87, 91 Varytimiadis, L...... 196 Vermeire, S...... 41, 47, 56, 61, Vleggaar, F. P...... 114, 126 van den Bosch, H...... 132 Vasas, B...... 219 62, 70, 82, 89, 137, Vleugels, J...... 159, 171 van den Brink, G. R...... 42, 44, 52, Vascocelos, M...... 165 138, 160, 180, 182, Vliebergh, J...... 80, 205, 235 57, 73, 89, 92, 107 Vasconcelos, H...... 207 183, 223, 226, 227 Vlodavsky, I...... 94 van den Brink, G. R...... 137 Vasconcelos Loureiro, R.....154, 164, Vernia, P...... 182 Voermans, R...... 187 van der Meulen-de Jong, A. E.....221 187, 193, 208 Verspaget, H. W...... 221 Vogel, J. A...... 98 van der Valk, H...... 174 Vashistha, N...... 133 Verstockt, B...... 74 Vogel, J. A. A...... 98 van der Vlugt, M...... 73, 78, 140 Vasseur, F...... 92 Vertemati, M...... 65 Vogelsang, H...... 85 Vandervoort, J...... 74 Vass, I...... 166 Veselkov, K...... 72 Voicu Moga, T...... 114, 120 van der Woude, J...... 69 Vatn, M. H...... 72, 81, 85, 93, 223 Vetter, M...... 202, 233 Vojnovic, M...... 224 van Dijk, A. H...... 65 Vatn, S...... 81 Veysey, M...... 113, 143 Vojtechova, G...... 140 van Dijk, L...... 132, 197 Vavassori, S...... 127, 204, 223 Viale, E...... 104 Vollmer, C. M...... 168 van Driel, W...... 132 Vavricka, S. R...... 92, 134, 184 Viazis, N...... 179, 196 Vollmer, S...... 183 van Eden, W. H...... 87, 132 Vaz, A...... 103, 114, 119, Vicario, M...... 97 Volpe, M...... 179 Vanelli, L...... 196 202, 206, 232 Vida, F...... 157, 171 Voltaggio, L...... 235 van Etten, T...... 85 Vazeille, E...... 160, 177 Vidal-Puig, A...... 71 Völzke, H...... 132 Vange, P...... 52 Vaziri, A...... 148 Vieceli, F...... 172 von Arnim, U...... 100, 181 van Goor, H...... 114, 123 Vecchiato, L...... 216 Vieira, A...... 136, 223, 227 von Castell, C...... 151 Van Gossum, A...... 44, 85, 90, Vecchi, M...... 56, 127, 147, Viel, J.-F...... 135, 178 von Figura, G...... 209 96, 102 204, 213, 223 Viennois, E...... 185 von Volkmann, H...... 195 Vangravs, R...... 142 Veereman, G...... 47, 76, 82, 183 Vieth, M...... 73, 84, 172, 192 von Volkmann, H. L...... 195 van Gulik, T...... 89, 101 Vega, A...... 133 Vignal, C...... 222 Vosco, S...... 153 Vanheel, H...... 52, 113, 147 Vega, P...... 157, 171 Vignally, P...... 164 Vos, F...... 179 van Herwaarden, Y...... 72, 106 Vega, R...... 185 Vikmanis, U...... 145 Vrakas, S...... 222 van Hilst, J...... 98, 168 Vegas, A. M...... 194 Viksna, A...... 212 V S Vijayanand Kumar, V...... 207 van Hoeij, F...... 190 Vegezzi, G...... 184 Vikström, E...... 178 Vuitton, L...... 60, 176 UEG Week Final Programme : Index of Authors and Co-Authors

Vullo, V...... 202, 229 Wang, Z...... 139, 228 Wensaas, K.-A...... 58 Wohlmuth, P...... 191 Vutukuru, V...... 132 Wani, H...... 165, 208 Wen, S.-H...... 234 Wojciechowska, Z...... 172 Vyas, V...... 115, 125, 167, 169, 214 Wannerberger, K...... 57 Wenzlau, J. M...... 116, 145 Wojcik, D...... 116, 133, 189 Wannhoff, A...... 204, 221 Werner, J...... 184 Wolburg, H...... 204, 221 Wan, W. K...... 207, 230 Werner, Y...... 190 Wolf, D...... 61, 62 W Wardan, H...... 105 Wernisch, L...... 105 Wolfgang, C...... 97, 176 Wacher, V...... 186 Warlop, L...... 190 Westert, G. P...... 166 Wolfram, L...... 105 Wada, M...... 72, 205, 231, 232 Warner, B...... 138 West, J...... 202, 206, 220 Wölnerhanssen, B...... 59 Wada, N...... 192, 215 Warner, M...... 232 Weusten, B. L. A. M...... 38, 69, Wong, C. C...... 103, 165 Wada, Y...... 72, 106 Warren, D...... 226, 227 80, 102 Wong, H...... 168 Wadie, W...... 222 Warusavitarne, J...... 93 Wex, T...... 194 Wong, J. C. T...... 219 Wagner, A. D...... 54 Warzecha, Z...... 94, 134, 211 Weylandt, K...... 185 Wong, T...... 148, 219, 233, 235, 248 Wagner, C. A...... 100, 134 Wasilewski, A...... 141 Wheeler, C...... 181 Wong, V...... 71 Wagner, M...... 86 Watabe, T...... 222 Whelan, K...... 53, 95, 98, 108 Wong, W. Y...... 230 Waguri, N...... 156, 164 Watanabe, C...... 224 Whiley, A...... 228 Wong, Y. J...... 133 Wahab, P. J...... 178 Watanabe, D...... 139 Whitehead, W...... 38, 40 Woo, A...... 97 Waizbard, A...... 104 Watanabe, K...... 179 Whitehead, W. E...... 58, 75, 92, Woo, J...... 115, 125, 127, 215 Wakabayashi, G...... 168 Watanabe, M...... 94, 136, 180, 98, 103, 186, Woodland, P...... 53, 117, 146, 190 Wakabayashi, M...... 125 219, 217, 222 187, 189 Woodward, J. M...... 87 Wakamura, K...... 55, 79, 84 Watanabe, S...... 94, 150, 170, 190, Whiteley, J. C...... 239 Woodward, T. A...... 217, 220 129, 141, 158, 185, 234, 237, 239 Whiteman, D...... 84, 96 Woodworth, D...... 61, 137, 160, 180 186, 216, 217, 231 Watanabe, T...... 116, 142, 220, Wichmann, B...... 52, 141, 230 Wörmann, S. M...... 60 Waked, I. A...... 165, 242 228, 230 Wickramasinghe, R...... 201, 206 Worms, K...... 191 Waldmann, E...... 104, 128 Waterhouse, D. J...... 80 Widlak, M. M...... 230 Wouters, M. M...... 67, 78, 108 Waldum, H. L...... 52 Waterman, M...... 47 Wiedenmann, B...... 60, 168, 224 Wright, K...... 143 Walecka-Kapica, E. M...... 240 Waterman, S...... 143 Wieszczy, P...... 106, 126, 127, 216 Wu, C.-Y...... 78, 209 Walker, M...... 113, 143, 231 Watkins, A. A...... 160, 176 Wieten, E...... 171 Wu, C.-J...... 197 Walker-Samuel, S...... 50, 92 Watson, A...... 105 Wijnands, T. F. M...... 65 Wu, C.-Y...... 145, 197 Wallace, M...... 220 Wauters, L. I...... 183 Wilcox, C. M...... 129 Wu, H...... 163 Wallace, M. B...... 98, 216, 217 Webb, D.-L...... 180, 195 Wilczak, J...... 145, 241 Wu, J. C. Y...... 219 Waller, J...... 227 Weber, B...... 120 Wilder-Smith, C. H...... 85 Wu, K...... 226 Wall Vd, B...... 106 Weber-Eibel, J...... 218 Wild, G...... 135 Wu, M.-S...... 195 Walma, M. S...... 98 Weber-Freissmuth, C...... 208 Wild, J...... 98 Wu, S...... 162 Walsh, A...... 57 Weber, J...... 85 Wildt, S...... 182 Wu, S.-R...... 197 Walsh, R...... 175 Weber-Mangal, S...... 183 Wilhelm, D...... 158, 184 Wu, X...... 214 Walter, F. M...... 84 Webster, G. J. M...... 122 Wilks, M...... 201, 228 Wulandari, A. A...... 85 Walter, S...... 92, 113, 143, 232 Wedemeyer, H...... 41 , 165 Willeke, F...... 53 Wurie, S...... 230 Wanfu, W...... 232 Wehkamp, J...... 188, 241 Willekens, H...... 80, 205, 235 Wurm, P...... 79 Wang, A. W...... 160, 181, 225 Wei, B...... 163 Williams, J. M...... 184 Wu, W.-C...... 146 Wang, D...... 98 Weigand, K...... 163 Williams, R...... 235, 236 Wymenga, L...... 161, 197 Wang, H...... 58, 87, 121, 158, 162 Weigl, K. J...... 128 Williams, S. J...... 49 Wyrwicz, L...... 126 Wang, H.-P...... 169 Weigmann, H...... 187, 196 Williet, N...... 70 Wyszynska, P...... 172 Wang, J...... 52, 162 Weigt, J...... 80, 194 Will, U...... 219 Wang, K...... 81, 146, 191, 228 Wei, H...... 81 Wilmink, J. W...... 98 Wang, L...... 161, 162, 169, 193, 214 Weil, C...... 135, 139 Wilson, A...... 106, 129 X Wang, M...... 146, 193, 210, 236 Weiner, R...... 115, 132 Wilson, S. R...... 136 Xavier, S...... 131, 164, 241 Wang, N...... 161, 191 Weise, R...... 97 Winkens, B...... 73, 157, 171 Xi, H...... 126 Wang, Q...... 146, 185, 228, 236 Weiss, B...... 180 Winstanley, A...... 122 Xia, D. X...... 213 Wang, R...... 225 Weiss, M...... 97, 176 Winter, D. C...... 43, 63, 73, 83, 102 Xia, Z...... 146 Wang, S...... 183 Weiss, W...... 104 Wintgens, K. F...... 85 Xiang, G...... 179 Wang, S.-Q...... 72 Wei, W...... 209 Wirz, A...... 52 Xiao, F...... 100 Wang, T. C...... 54, 103 Weltens, N...... 160, 189 Wisniewska Jarosinska, M...... 61 Xiaopeng, B...... 64 Wang, T. X...... 232 Weltman, M...... 231 Wisniewski, A...... 77 Xie, J...... 240 Wang, W...... 241 Welzel, M...... 60 , 168 Wisse, P. H. A...... 93 Xie, Y...... 114, 122 Wang, X...... 121, 127, 146, 149, Wendon, J...... 43 Witthöft, T...... 120 Xinopoulos, D...... 101 154, 190, 193, 210, 232, 236 Wendt, R...... 188 Witt, S...... 232 Xu, C...... 118 Wang, X. W...... 49 Wenger, R. H...... 92 Witt, S. T...... 92, 232 Xu, J...... 103 Wang, X. Q...... 228 Wennerblom, J...... 160, 176 Wlodarczyk, J...... 133 Xu, L...... 212 Wang, Y...... 209, 222 Wennmacker, S. Z...... 65, 166 Wlodarczyk, M...... 133, 221 Xu, M...... 126

352 353 Index of Authors and Co-Authors : UEG Week Final Programme

Xu, M.-D...... 59, 62, 65, Yamasaki, Y...... 126, 127, 217 Yavzori, M...... 47 Yoshinaga, S...... 115, 124, 170, 114, 126, 170 Yamashina, T...... 49, 88 Yazaki, E...... 117, 146, 190 192, 213, 236 Xu, W...... 195 204, 215, 216 Yazbeck, R...... 178 Yoshino, S...... 231 Xu, Y...... 212 Yamashita, H...... 52, 53, 102, Yazici, H...... 136 Yoshioka, M...... 155 Xu, Z...... 146, 181 113, 148, 167, Yazumi, S...... 157, 167 Yoshio, T...... 114, 125, 127, 149 Xu, Z. Z...... 181 170, 189, 237 Ye, J...... 119, 207, 209 Younas, K...... 239 Yamashita, K...... 170, 234 Yegin, A...... 96 Young, G...... 142 Yamashita, M...... 216, 229 Yelsangikar, A...... 157, 167, 211 Young, S...... 184 Y Yamashita, S...... 197 Yeo, C...... 97 Younossi, Z...... 163 Yaari, S...... 104 Yamashita, T...... 176, 212 Yeo, S. J...... 176 Youn, S. J...... 188 Yablecovitch, D...... 180 Yamashita, Y...... 154 Yerushalmi, B...... 153 Youn, Y. H...... 149 Yaghi, C...... 121 Yamasita, H...... 115, 125 Yeung, B. P. M...... 213 Yousef, M...... 120 Yagi, S...... 177 Yamauchi, H...... 219 Yeung, R. C. P...... 99 Yousuf, H...... 175 Yagüe-Compadre, J. L...... 97 Yamazaki, M...... 222 Yi, C.-H...... 147, 234 Ystad, S. O...... 85 Yahagi, N...... 48, 108 114, Yamazato, T...... 115, 125 Yi, S. Y...... 94 Yu, C...... 118 125, 129, 148, 169, 192, Yamochi, T...... 141 Yiannakou, Y...... 144, 186 Yu, C. S...... 186 203, 214, 215 Yanai, H...... 139, 180, 182, 222 Yildirim, E...... 147, 235 Yu, D...... 61, 137 Yair, M...... 104 Yang, A...... 63, 214 Yildirim Sozmen, E...... 147 Yu, J...... 49, 87, 88, Yalinay, M...... 118 Yang, B.-L...... 146 Yildirim, T...... 119 103, 141, 184 Yamabe, A...... 115, 124 Yang, C...... 162 Yildiz, B...... 149 Yu, K...... 121 Yamada, A...... 122 Yang, C. H...... 217 Yildiz Turkyilmaz, G...... 113, 147 Yu, L...... 170 Yamada, K...... 77, 197 Yang, D...... 71 Yim, H. J...... 174, 233 Yu, S...... 88, 186, 193, 197 Yamada, M...... 106, 128, 144 Yang, D.-H...... 140, 186, 270 Yip, W. M...... 205, 225 Yu, W. S...... 193, 197 Yamada, S...... 59, 65 Yang, D. H...... 193 Yiqun, Z...... 126 Yuan, F...... 114, 122 Yamada, T...... 58, 74, 98, Yang, H...... 193, 217, 226 Ylstra, B...... 79 Yuan, J...... 99 170, 207, 232 Yang, H.-K...... 197 Yokoo, H...... 144 Yuki, N...... 158, 185 Yamago, H...... 207 Yang, J...... 65, 130, 210 Yokoyama, Y...... 146 Yumura, T...... 122 Yamaguchi, A...... 49, 103, 114, Yang, J.-I...... 176, 218 Yoneyama, H...... 206 Yuna, K...... 139 122, 186 Yang, J. I...... 201, 241 Yoneyama, O...... 156, 164 Yun, C...... 52 Yamaguchi, D...... 149 Yang, Ju-Il...... 218 Yonezawa, K...... 218 Yung, D...... 219, 223 Yamaguchi, H...... 169 Yang, Q...... 138 Yonezawa, M...... 224 Yung, D. E...... 174 Yamaguchi, N...... 136 Yang, S.-K...... 140, 270 Yoo, I. K...... 142, 151, 159, 169, Yun, H. Y...... 193 Yamaguchi, T...... 49, 103, 114, Yang, W...... 114, 122 175, 204, 211, 213, 220 Yun, H. J...... 197 122, 149, 186, 230 Yang, X...... 236 Yook, J. H...... 193, 197 Yun, Q...... 103 Yamaguchi, Y...... 106, 158, 186, 238 Yang, Y...... 128, 144, 181 Yoon, H...... 47, 130, 150, 161, Yun, S.-H...... 182 Yamairi, H...... 139 Yang, Y. J...... 130 172, 178, 192, 193, 237 Yurtlu, D. A...... 93 Yamakita, K...... 60 Yan, J...... 121, 144, 149, 193 Yoon, H. M...... 197 Yusuf, A...... 216 Yamamichi, N...... 102, 132, 172 Yano, H...... 210 Yoon, J. H...... 122, 130 Yusuke, K...... 210 Yamamori, S...... 170 Yano, M...... 84 Yoon, J. Y...... 201, 241 Yuta Nakagawa, Y...... 190 Yamamoto, E...... 103, 107 Yano, T...... 125, 169, 173, 192 Yoon, S. B...... 123 Yuzuru, T...... 158, 185 Yamamoto, H...... 140, 216, 217, Yanova, O. B...... 191 Yoon, S. M...... 188 Yvon, S...... 241 229, 284 Yano, Y...... 195 Yoon, S.-W...... 140, 182 Yamamoto, K...... 117, 124, 128, Yanqin, W...... 119, 207, 209 Yoon, Y. H...... 150 145, 150, 159, Yao, K...... 55, 80, 84, Yoon, Y. S...... 186 Z 175, 199, 230 91, 115, 125, 169 Yorimitsu, N...... 101, 192 Zaanan, A...... 220 Yamamoto, M...... 170, 231 Yao, L...... 126 Yorozu, A...... 103 Zabana, Y...... 56, 221 Yamamoto, N...... 122, 236 Yao, R...... 225 Yoshida, E...... 149, 195 Zachou, K...... 120 Yamamoto, S...... 115, 125, 126, Yao, T...... 150, 237 Yoshida, K...... 192 Zaffalón, D...... 217 149, 157, 167, 197, 231, 238 Yarden, A...... 135, 139 Yoshida, M...... 52, 59, 65, Zagari, R. M...... 203, 213, Yamamoto, Y...... 117, 173, 192 Yashchenko, A...... 145 124, 139, 150 214, 229 Yamano, H.....103, 115, 125, 157, 171 Yashima, K...... 115, 125 Yoshida, N...... 106, 125, 170 Zagonel, V...... 142 Yamano, H.-O...... 106, 107 Yasuda, H...... 216, 229 Yoshida, S...... 74, 106, 230, 231 Zaheer, A...... 211 Yamanouchi, K...... 65, 117, Yasuda, I...... 50, 63, 115, 124 Yoshida, T...... 140, 142 Zakaria, S...... 104 145, 230 Yasuda, K...... 116, 142, 220 Yoshifuku, Y...... 59, 65 Zakordonetz, L...... 229 Yamao, K...... 115, 123, 124, 142 Yasukawa, S...... 174 Yoshihuku, Y...... 193 Zala, A. V...... 113, 143 Yamaoka, R...... 169 Yasumoto, M...... 168 Yoshikawa, I...... 228 Zambelli, A...... 203, 213, 214 Yamao, K...... 98 Yasutomi, E...... 139, 237 Yoshikawa, K...... 107 Zamfirescu, N...... 182 Yamasaki, M...... 238 Yatsu, T...... 218 Yoshimine, T...... 129, 238 Zampetas, D...... 165 Yamasaki, T...... 150, 238, 239 Yau, Y...... 72 Yoshimizu, S...... 114, 127 Zanconati, F...... 118, 161

353 UEG Week Final Programme : Index of Authors and Co-Authors

Zaninotto, G...... 55, 69, 102 Zhang, G...... 58, 151, 161, 191, Zielinska, M...... 100, 141, 232 Zandberga, E...... 142 193, 194, 239 Zigdon, S...... 240 Zapata, E...... 119 Zhang, H...... 61, 137, 160, 180 Zilli, A...... 145, 152, 240 Zarate-Lopez, N...... 146, 155, 235 Zhang, J...... 87 Zilli, M...... 130, 157, 167 Zarchin, M...... 180 Zhang, L...... 81, 121, 163, Zimmer, V...... 210 Zari, M...... 187 191, 228, 232 Zingales, F...... 176 Zatorski, H...... 141, 160, 177 Zhang, M...... 58, 100, 149, 180 Zingaropoli, M. A...... 202, 229 Zauber, A...... 216 Zhang, Q...... 168 Zinger, S...... 80 Zavada, F...... 210 Zhang, R...... 58 Zingone, F...... 234 Zavgorodnya, N...... 166 Zhang, S...... 127, 149 Zingone, F...... 152 Zavoral, M...... 140, 141, 236 Zhang, T...... 178 Zinicola, T...... 180 Zavyalov, D...... 173 Zhang, X...... 65, 210 Zini, O...... 73 Zaytsev, O...... 89 Zhang, X.-C...... 71 Zippi, M...... 182 Zdarova Karasova, J...... 189 Zhang, Y...... 87, 141 Zisimopoulos, K...... 120 Zec, S...... 163, 207 Zhang, Z...... 146, 185, 236 Zitnik, R...... 226 Zecchini, R...... 174, 237 Zhao, D...... 64, 160, 189, 190 Zjawiony, J...... 232 Zedan, A...... 207 Zhao, L...... 177, 236 Zmiri, Y...... 224 Zeh, H...... 168 Zheng, S...... 88, 230 Zocco, M. A...... 88, 166 Zehnter, E...... 120 Zhi, M...... 138, 179, 180 Zolfino, T...... 209 Zeid, A...... 165 Zhong, B...... 119, 207, 209 Zorzi, F...... 136 Zeissig, S...... 52 Zhou, H...... 181 Zou, X...... 161, 193 Zeitz, J...... 92, 134 Zhou, J...... 99, 180 Zozaya, F...... 219 Zejly, H...... 152 Zhou, L...... 88 Zuba-Surma, E...... 211 Zelber-Sagi, S...... 184 Zhou, P...... 126 Zubiaurre, L...... 119 Zelinkova, Z...... 205, 225 Zhou, P.-H...... 59, 61, 71, Zubieta, C...... 53 Zemede, G...... 177 84, 170, 213 Zucchini, N...... 216 Zemmour, C...... 50 Zhou, W...... 121 Zucman-Rossi, J...... 79, 86, 99 Zender, L...... 49 Zhou, X...... 58, 161, 191, Zulli, C...... 130, 218 Zeng, P...... 144 193, 239 Zundler, S...... 105 Zenke, M...... 86 Zhou, Y...... 106, 181 Zuniga, R...... 195 Zentilin, P...... 147 Zhu, H...... 199 Zúñiga Ripa, A...... 113, 147, Zerabruck, E...... 174 Zhu, H. Q...... 228 148, 233 Zerbi, A...... 168, 213 Zhu, K...... 121 Zureik, M...... 47, 56 Zerbib, F...... 60, 61, 75, 233 Zhurenkova, T...... 124 Zvibel, I...... 99, 197 Zeuner, R...... 222 Zhurina, J...... 124 Zvidi, I...... 235 Zhang, B...... 161, 193 Zhu, S...... 81 Zwahlen, M...... 190 Zhang, C...... 62, 114, 126, 170 Zhu, S. W...... 228 Zwolinska-Wcislo, M...... 196 Zhang, D...... 99, 234 Zhu, X...... 121, 226

354 Floor Plans Austria Center Vienna

UEG Week Final Programme : Floor Plans Austria Center Vienna

Level -2

356 Floor Plans Austria Center Vienna : UEG Week Final Programme

Level 0

357 UEG Week Final Programme : Floor Plans Austria Center Vienna

Level 1

Level 2

358

UEG gratefully acknowledges the support of this year's Premium Partners:

Final Programme available for download www.ueg.eu/week